PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Diener, HC				Diener, Hans-Christoph			Preventing major gastrointestinal bleeding in elderly patients	LANCET			English	Editorial Material							ATRIAL-FIBRILLATION		[Diener, Hans-Christoph] Univ Duisburg Essen, Dept Neurol, D-45147 Essen, Germany	University of Duisburg Essen	Diener, HC (corresponding author), Univ Duisburg Essen, Dept Neurol, D-45147 Essen, Germany.	h.diener@uni-essen.de	Diener, Hans-Christoph/AAF-7275-2019		AstraZeneca; Boehringer Ingelheim; GSK; Janssen-Cilag; Lundbeck; Novartis; Sanofi Aventis; Syngis; Talecris; German Research Council (DFG); German Ministry of Education and Research (BMBF); European Union; National Institute of Health USA; Bertelsmann Foundation; Heinz Nixdorf Foundation	AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GSK(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lundbeck(Lundbeck Corporation); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Syngis; Talecris; German Research Council (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); National Institute of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bertelsmann Foundation; Heinz Nixdorf Foundation	I have received honoraria for participation in clinical trials, contribution to advisory boards, or oral presentations from AstraZeneca, Bayer Vital, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Sanofi Aventis, and Servier, related to antiplatelet therapy or proton-pump inhibitors, and from Abbott, Allergan, CoAxia, Corimmun, Covidien, D-Pharm, Fresenius, GlaxoSmithKline (GSK), Janssen-Cilag, Johnson & Johnson, Knoll, Lilly, Medtronic, Merck, Sharp, & Dohme, MindFrame, Neurobiological Technologies, Novartis, Novo Nordisk, Paion, Parke-Davis, Pfizer, Schering-Plough, Solvay, St Jude, Syngis, Talecris, Thrombogenics, WebMD Global, Wyeth, and Yamanouchi. I have received financial support for research projects from AstraZeneca, Boehringer Ingelheim, GSK, Janssen-Cilag, Lundbeck, Novartis, Sanofi Aventis, Syngis, and Talecris. The Department of Neurology at the University Duisburg-Essen (Duisburg and Essen, Germany) received research grants from the German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, National Institute of Health USA, Bertelsmann Foundation, and Heinz Nixdorf Foundation. I have no ownership interest and do not own stocks of any pharmaceutical company. Within the past year, I have served as editor of Aktuelle Neurologie, Arzneimitteltherapie, Kopfschmerz News, Stroke News, and as coeditor of Cephalalgia, and on the editorial board of Lancet Neurology, European Neurology, and Cerebrovascular Disorders. I chair the Treatment Guidelines Committee of the German Society of Neurology and have contributed to the European Heart Rhythm Association and European Society of Cardiology guidelines for the treatment of atrial fibrillation.	Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342; de Jong HJI, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003044; Gomm W, 2016, JAMA NEUROL, V73, P410, DOI 10.1001/jamaneurol.2015.4791; Hacke W, 2016, EUR HEART J; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Li L, 2017, LANCET; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Tan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135372; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306	9	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					435	437		10.1016/S0140-6736(17)31507-6	http://dx.doi.org/10.1016/S0140-6736(17)31507-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28622952	hybrid			2022-12-28	WOS:000406463400007
J	Childers, CP; Maggard-Gibbons, M; Shekelle, PG				Childers, Christopher P.; Maggard-Gibbons, Melinda; Shekelle, Paul G.			Antiplatelet Therapy in Patients With Coronary Stents Undergoing Elective Noncardiac Surgery Continue, Stop, or Something in Between?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Childers, Christopher P.; Maggard-Gibbons, Melinda] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, 10833 Le Conte Ave,72-235 CHS, Los Angeles, CA 90095 USA; [Maggard-Gibbons, Melinda; Shekelle, Paul G.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Childers, CP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Ronald Reagan UCLA Med Ctr, 10833 Le Conte Ave,72-235 CHS, Los Angeles, CA 90095 USA.	cchilders@mednet.ucla.edu	Childers, Christopher P/L-6935-2017; Childers, Christopher P/HHM-4860-2022	Childers, Christopher P/0000-0002-6489-8222; Childers, Christopher P/0000-0002-6489-8222	AHRQ HHS [F32 HS025079] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS025079] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Gibbons M Maggard, MANAGEMENT ANTIPLATE; Hawn MT, 2013, JAMA-J AM MED ASSOC, V310, P1462, DOI 10.1001/jama.2013.278787; Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0; Levine GN, 2016, J THORAC CARDIOV SUR, V152, P1243, DOI 10.1016/j.jtcvs.2016.07.044; Palmerini T, 2015, J AM COLL CARDIOL, V65, P1092, DOI 10.1016/j.jacc.2014.12.046; van Kuijk JP, 2009, AM J CARDIOL, V104, P1229, DOI 10.1016/j.amjcard.2009.06.038; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055	7	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					120	121		10.1001/jama.2017.7845	http://dx.doi.org/10.1001/jama.2017.7845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28628711				2022-12-28	WOS:000405190800009
J	Mai, LQ; Yan, MY; Zhao, YL				Mai, Liqiang; Yan, Mengyu; Zhao, Yunlong			Track batteries degrading in real time	NATURE			English	Editorial Material							ELECTROCHEMICAL LITHIATION; PERFORMANCE; DEVICES		[Mai, Liqiang] Wuhan Univ Technol, Int Sch Mat Sci & Engn, State Key Lab Adv Technol Mat Synth & Proc, Wuhan, Hubei, Peoples R China; [Mai, Liqiang] Wuhan Univ Technol, Int Sch Mat Sci & Engn, Int Affairs, Wuhan, Hubei, Peoples R China; [Yan, Mengyu] Univ Washington, Seattle, WA 98195 USA; [Zhao, Yunlong] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Wuhan University of Technology; Wuhan University of Technology; University of Washington; University of Washington Seattle; Harvard University	Mai, LQ (corresponding author), Wuhan Univ Technol, Int Sch Mat Sci & Engn, State Key Lab Adv Technol Mat Synth & Proc, Wuhan, Hubei, Peoples R China.; Mai, LQ (corresponding author), Wuhan Univ Technol, Int Sch Mat Sci & Engn, Int Affairs, Wuhan, Hubei, Peoples R China.	mlq518@whut.edu.cn	Mai, Liqiang/B-8299-2014; Yan, Mengyu/M-1298-2015; Zhao, Yunlong/AAF-8235-2019	Mai, Liqiang/0000-0003-4259-7725; Yan, Mengyu/0000-0003-1028-0627; Zhao, Yunlong/0000-0002-7574-7315				Chu S, 2017, NAT MATER, V16, P16, DOI 10.1038/nmat4834; Grey CP, 2017, NAT MATER, V16, P45, DOI [10.1038/NMAT4777, 10.1038/nmat4777]; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Liu H, 2014, SCIENCE, V344, DOI 10.1126/science.1252817; Liu XH, 2012, NAT NANOTECHNOL, V7, P749, DOI [10.1038/nnano.2012.170, 10.1038/NNANO.2012.170]; Mai LQ, 2007, ADV MATER, V19, P3712, DOI 10.1002/adma.200700883; Mai LQ, 2014, CHEM REV, V114, P11828, DOI 10.1021/cr500177a; Mai LQ, 2010, NANO LETT, V10, P4273, DOI 10.1021/nl102845r; Nykvist B, 2015, NAT CLIM CHANGE, V5, P329, DOI 10.1038/nclimate2564; Yan MY, 2013, J AM CHEM SOC, V135, P18176, DOI 10.1021/ja409027s	10	84	84	15	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					469	470		10.1038/546469a	http://dx.doi.org/10.1038/546469a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28640281	Bronze			2022-12-28	WOS:000403814100016
J	Phelan, S; Hagobian, T; Brannen, A; Hatley, KE; Schaffner, A; Munoz-Christian, K; Tate, DF				Phelan, Suzanne; Hagobian, Todd; Brannen, Anna; Hatley, Karen E.; Schaffner, Andrew; Munoz-Christian, Karen; Tate, Deborah F.			Effect of an Internet-Based Program on Weight Loss for Low-Income Postpartum Women A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLY LABELED WATER; YOUNG-ADULTS; RISK-FACTORS; INTERVENTIONS; MANAGEMENT; MOTHERS; CARE; CHILDBEARING; OVERWEIGHT; OBESITY	IMPORTANCE Postpartum weight retention increases lifetime risk of obesity and related morbidity. Few effective interventions exist for multicultural, low-income women. OBJECTIVE To test whether an internet-basedweight loss programin addition to the Special Supplemental Nutrition ProgramforWomen, Infants, and Children (WIC program) for low-income postpartumwomencouldproducegreaterweight lossthantheWICprogramaloneover 12months. DESIGN, SETTING, AND PARTICIPANTS A 12-month, cluster randomized, assessor-blind, clinical trial enrolling 371 adult postpartum women at 12 clinics in WIC programs from the California central coast between July 2011 and May 2015 with data collection completed in May 2016. INTERVENTIONS Clinics were randomized to the WIC program (standard care group) or the WIC program plus a 12-month primarily internet-based weight loss program (intervention group), including a website with weekly lessons, web diary, instructional videos, computerized feedback, text messages, and monthly face-to-face groups at the WIC clinics. MAIN OUTCOMES AND MEASURES The primary outcomewasweight change over 12 months, based on measurements at baseline, 6 months, and 12 months. Secondary outcomes included proportion returning to preconceptionweight and changes in physical activity and diet. RESULTS Participants included 371women (mean age, 28.1 years; Hispanic, 81.6%; meanweight above prepregnancyweight, 7.8 kg; mean months post partum, 5.2 months) randomized to the intervention group or standard care group; 89.2% of participants completed the study. The intervention group produced greater mean 12-monthweight loss compared with the standard care group. More participants in the intervention group than the standard care group returned to preconceptionweight by 12 months. [GRAPHICS] . The intervention group and standard care group did not significantly differ in 12-month changes in physical activity, calorie intake, or incidences of injury or lowbreastmilk supply from baseline to month 6 (21 of 61 participants in the intervention group vs 23 of 72 participants in the standard care group) and from month 6 to 12 (13 of 32 participants in the intervention group vs 14 of 37 participants in the standard care group). CONCLUSIONS AND RELEVANCE Among low-income postpartumwomen, an internet-based weight loss program in addition to the Special Supplemental Nutrition Program forWomen, Infants, and Children (WIC program) compared with the WIC program alone resulted in a statistically significant greater weight loss over 12 months. Further research is needed to determine program and cost-effectiveness as part of the WIC program.	[Phelan, Suzanne; Hagobian, Todd; Brannen, Anna; Schaffner, Andrew; Munoz-Christian, Karen] Calif Polytech State Univ San Luis Obispo, Dept Kinesiol, 1 Grand Ave, San Luis Obispo, CA 93407 USA; [Hatley, Karen E.; Tate, Deborah F.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Hatley, Karen E.; Tate, Deborah F.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA	California State University System; California Polytechnic State University San Luis Obispo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Phelan, S (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Kinesiol, 1 Grand Ave, San Luis Obispo, CA 93407 USA.	sphelan@calpoly.edu		Schaffner, Andrew/0000-0002-7413-0153; Phelan, Suzanne/0000-0003-2260-0499	National Institutes of Health (NIH) [DK087889]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK087889] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grant DK087889 from the National Institutes of Health (NIH).	Bennett GG, 2014, OBES REV, V15, P146, DOI 10.1111/obr.12218; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Bureau of Labor Statistics, 2016, OCC EMPL WAG; Bureau of Labor Statistics, 2017, OCC EMPL WAG; Chang MW, 2010, J NUTR EDUC BEHAV, V42, pS11, DOI 10.1016/j.jneb.2010.01.010; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Evenson KR, 2009, J WOMENS HEALTH, V18, P1925, DOI 10.1089/jwh.2008.1309; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Griffiths F, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e10; Gunderson EP, 2004, INT J OBESITY, V28, P525, DOI 10.1038/sj.ijo.0802551; Herring SJ, 2014, J NUTR EDUC BEHAV, V46, P610, DOI 10.1016/j.jneb.2014.06.002; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Jakicic JM, 2012, JAMA-J AM MED ASSOC, V307, P2617, DOI 10.1001/jama.2012.6866; Kirkpatrick SI, 2014, AM J CLIN NUTR, V100, P233, DOI 10.3945/ajcn.114.083238; Krummel D, 2010, J NUTR EDUC BEHAV, V42, pS52, DOI 10.1016/j.jneb.2010.02.012; Manzoni Gian Mauro, 2011, Clin Pract Epidemiol Ment Health, V7, P19, DOI 10.2174/1745017901107010019; National Cancer Institute, AUT SELF ADM 24 HOUR; National Institute for Health and Care Excellence, 2010, NICE PUBL HLTH GUID; Olson CM, 2008, J RURAL HEALTH, V24, P60, DOI 10.1111/j.1748-0361.2008.00138.x; Ostbye T, 2009, AM J PREV MED, V37, P173, DOI 10.1016/j.amepre.2009.05.016; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pew Research Center, AM INTERNET ACCESS 2; Phelan S, 2010, CALIF J HLTH PROM, V8, P1; Phelan S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0573-9; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Rooney BL, 2005, OBSTET GYNECOL, V106, P1349, DOI 10.1097/01.AOG.0000185480.09068.4a; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Smeeth L, 2002, CONTROL CLIN TRIALS, V23, P409, DOI 10.1016/S0197-2456(02)00208-8; STEVENSSIMON C, 1986, J ADOLESCENT HEALTH, V7, P250, DOI 10.1016/S0197-0070(86)80017-1; Tate DF, 2006, ARCH INTERN MED, V166, P1620, DOI 10.1001/archinte.166.15.1620; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Trabulsi J, 2001, AM J PHYSIOL-ENDOC M, V281, pE891, DOI 10.1152/ajpendo.2001.281.5.E891; Truesdale KP, 2006, INT J OBESITY, V30, P1397, DOI 10.1038/sj.ijo.0803307; United States Department of Agriculture, 2008, WIC SPEC SUPPL NUTR; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Walker LO, 2004, WOMEN HEALTH, V40, P19, DOI 10.1300/J013v40n02_02; Walker LO, 2012, WESTERN J NURS RES, V34, P654, DOI 10.1177/0193945911403775; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415	41	68	68	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2381	2391		10.1001/jama.2017.7119	http://dx.doi.org/10.1001/jama.2017.7119			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY0NJ	28632867	Green Published			2022-12-28	WOS:000403654600012
J	Cassels, L; Barde, YA				Cassels, Laura; Barde, Yves-Alain			Scaling pain threshold with microRNAs	SCIENCE			English	Editorial Material							NEUROPATHIC PAIN		[Cassels, Laura; Barde, Yves-Alain] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Barde, YA (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	bardey@cardiff.ac.uk		Barde, Yves/0000-0002-7627-461X; Cassels, Laura/0000-0002-1214-7179				Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Elramah S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00031; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Li X, 2013, J BONE MINER RES, V28, P2512, DOI 10.1002/jbmr.2002; Lin CR, 2014, EUR J NEUROSCI, V39, P1682, DOI 10.1111/ejn.12522; Peng CG, 2017, SCIENCE, V356, P1168, DOI 10.1126/science.aam7671; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008	8	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1124	1125		10.1126/science.aan6784	http://dx.doi.org/10.1126/science.aan6784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619901	Green Accepted			2022-12-28	WOS:000403327400016
J	Normile, D				Normile, Dennis			ASTRONOMY Designers squabble over giant Chinese scope	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1107	1108						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619890				2022-12-28	WOS:000403327400005
J	Wang, CY; Froberg, JE; Blum, R; Jeon, Y; Lee, JT				Wang, Chen-Yu; Froberg, John E.; Blum, Roy; Jeon, Yesu; Lee, Jeannie T.			Comment on "Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing"	SCIENCE			English	Editorial Material							RNA		[Wang, Chen-Yu; Froberg, John E.; Blum, Roy; Jeon, Yesu; Lee, Jeannie T.] Harvard Med Sch, Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol,Dept Genet, 185 Cambridge St, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol,Dept Genet, 185 Cambridge St, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu		Froberg, John/0000-0003-3391-7619; Blum, Roy/0000-0002-3987-7198; Lee, Jeannie/0000-0001-7786-8850; Wang, Chen-Yu/0000-0002-3912-5113	NIH [R01-GM090278]; NSF predoctoral award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF predoctoral award(National Science Foundation (NSF))	This work was funded by an NIH grant to J.T.L. (R01-GM090278) and an NSF predoctoral award to J.E.F. J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Chen CK, 2016, SCIENCE, V354, P468, DOI 10.1126/science.aae0047; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Rego A, 2008, J CELL SCI, V121, P1119, DOI 10.1242/jcs.026104; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	8	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343							eaal4976	10.1126/science.aal4976	http://dx.doi.org/10.1126/science.aal4976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619887				2022-12-28	WOS:000403327400001
J	Reardon, S				Reardon, Sara			US mental-health agencys push for basic research has slashed support for clinical trials	NATURE			English	News Item																			0	7	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					338	+		10.1038/546338a	http://dx.doi.org/10.1038/546338a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28617481	Bronze			2022-12-28	WOS:000403250900009
J	Moffat, B				Moffat, Bill			David Burns Moffat OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MOFFAT DB, PUBLICATION LIST	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2017	357								j2895	10.1136/bmj.j2895	http://dx.doi.org/10.1136/bmj.j2895			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UT	28615180				2022-12-28	WOS:000403753400012
J	Tang, SKY; Marshall, WF				Tang, Sindy K. Y.; Marshall, Wallace F.			Self-repairing cells: How single cells heal membrane ruptures and restore lost structures	SCIENCE			English	Review							FLAGELLAR ELONGATION; CHLAMYDOMONAS; CALCIUM; REGENERATION; MECHANISMS; DYNAMICS; PROTEIN; FUSION; DEATH; MODEL	Many organisms and tissues display the ability to heal and regenerate as needed for normal physiology and as a result of pathogenesis. However, these repair activities can also be observed at the single-cell level. The physical and molecular mechanisms by which a cell can heal membrane ruptures and rebuild damaged or missing cellular structures remain poorly understood. This Review presents current understanding in wound healing and regeneration as two distinct aspects of cellular self-repair by examining a few model organisms that have displayed robust repair capacity, including Xenopus oocytes, Chlamydomonas, and Stentor coeruleus. Although many open questions remain, elucidating how cells repair themselves is important for our mechanistic understanding of cell biology. It also holds the potential for new applications and therapeutic approaches for treating human disease.	[Tang, Sindy K. Y.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Tang, SKY (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.; Marshall, WF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	sindy@stanford.edu; wallace.marshall@ucsf.edu		Tang, Sindy/0000-0003-1465-2432	NSF [1517089, 1548297]; NIH [GM113602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113602] Funding Source: NIH RePORTER; Direct For Biological Sciences [1515494] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank members of their respective labs for many interesting conversations. Work in the authors' labs on wound healing and regeneration is supported by NSF award no. 1517089 (S.K.Y.T. and W.F.M.) and NIH grant GM113602 (W.F.M.), respectively. Both authors acknowledge support from NSF award no. 1548297.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Bement WM, 1999, CURR BIOL, V9, P579, DOI 10.1016/S0960-9822(99)80261-9; Bertini I., 1994, BIOINORGANIC CHEM; BURCHILL BR, 1968, J EXP ZOOL, V167, P427, DOI 10.1002/jez.1401670405; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chambers R, 1918, BIOL BULL-US, V34, P121, DOI 10.2307/1536349; CHAMBERS R, 1952, EXP CELL RES, V3, P564, DOI 10.1016/0014-4827(52)90080-3; Chan YHM, 2016, CURR BIOL, V26, P1221, DOI 10.1016/j.cub.2016.03.020; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5; COYNE B, 1970, J CELL BIOL, V47, P777, DOI 10.1083/jcb.47.3.777; Davenport NR, 2016, MOL BIOL CELL, V27, P2272, DOI 10.1091/mbc.E16-04-0223; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; DUNCAN JL, 1975, J CELL BIOL, V67, P160, DOI 10.1083/jcb.67.1.160; Fishman HM, 2003, NEWS PHYSIOL SCI, V18, P115, DOI 10.1152/nips.01429.2002; Godin LM, 2011, AM J PHYSIOL-LUNG C, V300, pL615, DOI 10.1152/ajplung.00265.2010; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Heilbrunn LV, 1927, ARCH EXP ZELLFORSCH, V4, P246; HYVERT N, 1972, Revue Suisse de Zoologie, V79, P1060; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; LEMASTERS JJ, 1987, NATURE, V325, P78, DOI 10.1038/325078a0; Ludington WB, 2012, CURR BIOL, V22, P2173, DOI 10.1016/j.cub.2012.09.040; Lund EJ, 1917, J EXP ZOOL, V24, P1, DOI 10.1002/jez.1400240102; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Milo R., 2015, CELL BIOL NUMBERS; Moe AM, 2015, SEMIN CELL DEV BIOL, V45, P10, DOI 10.1016/j.semcdb.2015.09.026; Morgan T. H., 1901, Biol Bull, Vii, P311; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; ROSCOE R, 1949, PHILOS MAG, V40, P338; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Slabodnick M, 2013, JOVE-J VIS EXP, DOI 10.3791/50848; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Spaeth CS, 2010, J NEUROSCI, V30, P15790, DOI 10.1523/JNEUROSCI.4155-10.2010; Steinhardt RA, 2005, ANN NY ACAD SCI, V1066, P152, DOI 10.1196/annals.1363.017; Stephens DJ, 2001, P NATL ACAD SCI USA, V98, P4295, DOI 10.1073/pnas.081065198; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; TARTAR V, 1958, J EXP ZOOL, V139, P479, DOI 10.1002/jez.1401390307; TARTAR V, 1954, J EXP ZOOL, V127, P511, DOI 10.1002/jez.1401270306; Tartar V., 1956, CELLULAR MECH DIFFER, P73; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 1999, J CELL SCI, V112, P719; VanDersarl JJ, 2012, NANO LETT, V12, P3881, DOI 10.1021/nl204051v; Venugopalan V, 1996, BIOPHYS J, V70, P2981, DOI 10.1016/S0006-3495(96)79868-5; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822	48	65	65	9	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1022	1025		10.1126/science.aam6496	http://dx.doi.org/10.1126/science.aam6496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596334	Green Accepted			2022-12-28	WOS:000402871700040
J	Limb, M				Limb, Matt			Dennis Newton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												limb@btinternet.com						Newton D, 2011, J BONE JOINT SURG BR, V93B, P1646, DOI 10.1302/0301-620X.93B12.27048; NEWTON D, PUBLICATION LIST	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2017	357								j2737	10.1136/bmj.j2737	http://dx.doi.org/10.1136/bmj.j2737			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4QY	28588037				2022-12-28	WOS:000403221000006
J	Bergenstal, RM; Gal, RL; Connor, CG; Gubitosi-Klug, R; Kruger, D; Olson, BA; Willi, SM; Aleppo, G; Weinstock, RS; Wood, J; Rickels, M; DiMeglio, LA; Bethin, KE; Marcovina, S; Tassopoulos, A; Lee, S; Massaro, E; Bzdick, S; Ichihara, B; Markmann, E; McGuigan, P; Woerner, S; Ecker, M; Beck, RW				Bergenstal, Richard M.; Gal, Robin L.; Connor, Crystal G.; Gubitosi-Klug, Rose; Kruger, Davida; Olson, Beth A.; Willi, Steven M.; Aleppo, Grazia; Weinstock, Ruth S.; Wood, Jamie; Rickels, Michael; DiMeglio, Linda A.; Bethin, Kathleen E.; Marcovina, Santica; Tassopoulos, Andreana; Lee, Sooji; Massaro, Elaine; Bzdick, Suzan; Ichihara, Brian; Markmann, Eileen; McGuigan, Paul; Woerner, Stephanie; Ecker, Michelle; Beck, Roy W.		T1D Exchange Racial Differences St	Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A(1c) Levels	ANNALS OF INTERNAL MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; MEAN PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; BLOOD-GLUCOSE; ETHNIC DISPARITIES; GLYCEMIC CONTROL; HBA(1C) LEVELS; A1C; CHILDREN	Background: Debate exists as to whether the higher hemoglobin A(1c) (HbA(1c)) levels observed in black persons than in white persons are due to worse glycemic control or racial differences in the glycation of hemoglobin. Objective: To determine whether a racial difference exists in the relationship of mean glucose and HbA(1c). Design: Prospective, 12-week observational study. Setting: 10 diabetes centers in the United States. Participants: 104 black persons and 104 white persons aged 8 years or older who had had type 1 diabetes for at least 2 years and had an HbA(1c) level of 6.0% to 12.0%. Measurements: Mean glucose concentration, measured by using continuous glucose monitoring and compared by race with HbA(1c), glycated albumin, and fructosamine values. Results: The mean HbA(1c) level was 9.1% in black persons and 8.3% in white persons. For a given HbA(1c) level, the mean glucose concentration was significantly lower in black persons than in white persons (P = 0.013), which was reflected in mean HbA(1c) values in black persons being 0.4 percentage points (95% CI, 0.2 to 0.6 percentage points) higher than those in white persons for a given mean glucose concentration. In contrast, no significant racial differences were found in the relationship of glycated albumin and fructosamine levels with the mean glucose concentration (P > 0.20 for both comparisons). Limitation: There were too few participants with HbA(1c) levels less than 6.5% to generalize the results to such individuals. Conclusion: On average, HbA(1c) levels overestimate the mean glucose concentration in black persons compared with white persons, possibly owing to racial differences in the glycation of hemoglobin. However, because race only partially explains the observed HbA(1c) differences between black persons and white persons, future research should focus on identifying and modifying barriers impeding improved glycemic control in black persons with diabetes.	Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA; Jaeb Ctr Hlth Res, Tampa, FL USA; [Gubitosi-Klug, Rose; McGuigan, Paul] Univ Hosp Cleveland, 11100 Euclid Ave,Suite 737, Cleveland, OH 44106 USA; [Kruger, Davida; Tassopoulos, Andreana] Henry Ford Hlth Syst, 3031 West Grand Blvd,Suite 800, Detroit, MI 48202 USA; Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Willi, Steven M.; Lee, Sooji] Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd,Suite 11NW30, Philadelphia, PA 19104 USA; Univ Penn, Rodebaugh Diabet Ctr, Philadelphia, PA 19104 USA; [Aleppo, Grazia; Massaro, Elaine] Northwestern Univ, 675 North St Claire St,Suite 14-100, Chicago, IL 60611 USA; [Weinstock, Ruth S.; Bzdick, Suzan] SUNY Upstate Med Univ, 750 East Adams St,CWB 353, Syracuse, NY 13210 USA; [Wood, Jamie; Ichihara, Brian] Childrens Hosp Los Angeles, 4650 Sunset Blvd,Mail Stop 61, Los Angeles, CA 90027 USA; [DiMeglio, Linda A.; Woerner, Stephanie] Indiana Univ Sch Med, 702 Barnhill Dr,Room 5960, Indianapolis, IN 46202 USA; SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Marcovina, Santica] Northwest Lipid Metab & Diabet Res Labs, 401 Queen Ann Ave North, Seattle, WA 98109 USA; [Connor, Crystal G.; Beck, Roy W.] Jaeb Ctr Hlth Res, 15310 Amberly Dr,Suite 350, Tampa, FL 33647 USA; [Bergenstal, Richard M.; Olson, Beth A.] Int Diabetes Ctr, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA; [Rickels, Michael; Markmann, Eileen] Univ Penn, Perelman Sch Med, Rodebaugh Diabet Ctr, 3400 Civ Ctr Blvd,Bldg 421,12th Floor, Philadelphia, PA 19104 USA; [Bethin, Kathleen E.; Ecker, Michelle] Univ Buffalo, Jacobs Sch Med & Biomed Sci, 219 Bryant St, Buffalo, NY 14222 USA	International Diabetes Center; JAEB Center For Health Research; University Hospitals of Cleveland; Henry Ford Health System; Henry Ford Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Northwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Children's Hospital Los Angeles; Indiana University System; Indiana University Bloomington; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; JAEB Center For Health Research; International Diabetes Center; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gal, RL (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Suite 350, Tampa, FL 33647 USA.	rgal@jaeb.org	Rickels, Michael/D-1380-2009; Bethin, Kathleen/L-8904-2019; DiMeglio, Linda A./F-9277-2019	Rickels, Michael/0000-0002-9253-838X; Bethin, Kathleen/0000-0002-6100-4983; DiMeglio, Linda A./0000-0002-8033-6078; Willi, Steven/0000-0002-4910-2425	Helmsley Charitable Trust	Helmsley Charitable Trust	Helmsley Charitable Trust.	Bailey T, 2015, DIABETES TECHNOL THE, V17, P787, DOI 10.1089/dia.2014.0378; Beck RW, 2012, DIABETES TECHNOL THE, V14, P877, DOI 10.1089/dia.2012.0079; Boltri JM, 2005, ETHNIC DIS, V15, P562; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Cohen RM, 2006, DIABETES CARE, V29, P1739, DOI 10.2337/dc06-0286; Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834; Hempe JM, 2013, ANAL BIOCHEM, V442, P205, DOI 10.1016/j.ab.2013.07.016; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2016, DIABETES CARE, V39, P1458, DOI 10.2337/dc15-2686; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kilpatrick ES, 2007, DIABETOLOGIA, V50, P2553, DOI 10.1007/s00125-007-0820-z; Kilpatrick ES, 2007, CLIN CHEM, V53, P897, DOI 10.1373/clinchem.2006.079756; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Malka R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9304; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nayak AU, 2011, DIABETES CARE, V34, P1712, DOI 10.2337/dc10-1767; Petitti DB, 2009, J PEDIAT, V155, DOI [10.1016/j.jpeds.2009.05.025, DOI 10.1016/J.JPEDS.2009.05.025]; Rodbard D, 2016, DIABETES TECHNOL THE, V18, P3, DOI 10.1089/dia.2015.0417; Rodriguez-Segade S, 2012, DIABETES CARE, V35, P2447, DOI 10.2337/dc11-2450; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Selvin E, 2016, DIABETES CARE, V39, P1462, DOI 10.2337/dc16-0042; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; Snieder H, 2001, DIABETES, V50, P2858, DOI 10.2337/diabetes.50.12.2858; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Velasquez-Mieyer PA, 2003, INT J OBESITY, V27, P1359, DOI 10.1038/sj.ijo.0802415; Welsh KJ, 2016, DIABETES CARE, V39, P1299, DOI 10.2337/dc15-2727; Willi SM, 2015, PEDIATRICS, V135, P424, DOI 10.1542/peds.2014-1774; Wilson DM, 2008, DIABETES CARE, V31, P381, DOI 10.2337/dc07-1835; Wilson DM, 2011, DIABETES CARE, V34, P1315, DOI 10.2337/dc10-1661; Wilson DM, 2011, DIABETES CARE, V34, P540, DOI 10.2337/dc10-1054; Xing DY, 2011, DIABETES TECHNOL THE, V13, P351, DOI 10.1089/dia.2010.0156; YUDKIN JS, 1990, DIABETOLOGIA, V33, P208, DOI 10.1007/BF00404798; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	39	154	158	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					95	102		10.7326/M16-2596	http://dx.doi.org/10.7326/M16-2596			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28605777				2022-12-28	WOS:000405573400015
J	Richarme, G; Liu, CL; Mihoub, M; Abdallah, J; Leger, T; Joly, N; Liebart, JC; Jurkunas, UV; Nadal, M; Bouloc, P; Dairou, J; Lamouri, A				Richarme, Gilbert; Liu, Cailing; Mihoub, Mouadh; Abdallah, Jad; Leger, Thibaut; Joly, Nicolas; Liebart, Jean-Claude; Jurkunas, Ula V.; Nadal, Marc; Bouloc, Philippe; Dairou, Julien; Lamouri, Aazdine			Guanine glycation repair by DJ-1/Park7 and its bacterial homologs	SCIENCE			English	Article							PROTEIN DJ-1/PARK7; MUTANT DEFICIENT; DNA; METHYLGLYOXAL; NUCLEOTIDE; STRESS; DAMAGE; DJ-1; YAJL; GLYOXAL	DNA damage induced by reactive carbonyls (mainly methylglyoxal and glyoxal), called DNA glycation, is quantitatively as important as oxidative damage. DNA glycation is associated with increased mutation frequency, DNA strand breaks, and cytotoxicity. However, in contrast to guanine oxidation repair, how glycated DNA is repaired remains undetermined. Here, we found that the parkinsonism-associated protein DJ-1 and its bacterial homologs Hsp31, YhbO, and YajL could repair methylglyoxal-and glyoxal-glycated nucleotides and nucleic acids. DJ-1-depleted cells displayed increased levels of glycated DNA, DNA strand breaks, and phosphorylated p53. Deglycase-deficient bacterial mutants displayed increased levels of glycated DNA and RNA and exhibited strong mutator phenotypes. Thus, DJ-1 and its prokaryotic homologs constitute a major nucleotide repair system that we name guanine glycation repair.	[Richarme, Gilbert; Mihoub, Mouadh; Abdallah, Jad; Liebart, Jean-Claude] Univ Paris Diderot, UMR7592, Inst Jacques Monod, Stress Mol, 15 Rue Helene Brion, F-75013 Paris, France; [Richarme, Gilbert; Dairou, Julien] Univ Paris 05, Sorbonne Paris Cite, UMR 8601, Chim & Biochim Pharmacol & Toxicol, F-75270 Paris, France; [Liu, Cailing; Jurkunas, Ula V.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02114 USA; [Abdallah, Jad] Lebanese Amer Univ, Sch Pharm, Byblos 20381401, Lebanon; [Leger, Thibaut] Univ Paris Diderot, UMR7592, Inst Jacques Monod, Prote Facil, F-75013 Paris, France; [Joly, Nicolas] Univ Paris Diderot, UMR7592, Inst Jacques Monod, Cellular Cycle & Dev, F-75013 Paris, France; [Nadal, Marc] Univ Paris Diderot, CNRS, UMR7592, Inst Jacques Monod, F-75013 Paris, France; [Bouloc, Philippe] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,Commissariat Energie Atom & Energies Alterna, F-91198 Gif Sur Yvette, France; [Lamouri, Aazdine] Univ Paris Diderot, UMR 7086, Interfaces Traitements Org & Dynam Syst ITODYS, 15 Rue J-A de Baif, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Lebanese American University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Richarme, G (corresponding author), Univ Paris Diderot, UMR7592, Inst Jacques Monod, Stress Mol, 15 Rue Helene Brion, F-75013 Paris, France.; Richarme, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, UMR 8601, Chim & Biochim Pharmacol & Toxicol, F-75270 Paris, France.	richarme@paris7.jussieu.fr	Léger, Thibaut/GPP-5828-2022; Joly, Nicolas/H-6851-2018; Bouloc, Philippe/ABA-5732-2021; Abdallah, Jad/AAD-3595-2020	Joly, Nicolas/0000-0003-2731-3827; Bouloc, Philippe/0000-0003-4601-3387; Abdallah, Jad/0000-0001-5267-4953; Jurkunas, Ula/0000-0002-5059-608X; NADAL, Marc/0000-0001-9637-7694; Leger, Thibaut/0000-0002-6304-3433	NATIONAL EYE INSTITUTE [R01EY020581] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY020581] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Abdallah J, 2016, BIOCHEM BIOPH RES CO, V470, P282, DOI 10.1016/j.bbrc.2016.01.068; Advedissian T, 2016, BIOCHEM BIOPH RES CO, V473, P87, DOI 10.1016/j.bbrc.2016.03.056; Bidmon C, 2007, J CHROMATOGR B, V855, P51, DOI 10.1016/j.jchromb.2006.11.033; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; Kim Dong Ryoung, 2011, Proteome Sci, V9, P62, DOI 10.1186/1477-5956-9-62; Kthiri F, 2010, J BACTERIOL, V192, P6302, DOI 10.1128/JB.01077-10; Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Messaoudi N, 2013, J BACTERIOL, V195, P1167, DOI 10.1128/JB.02202-12; Mironova R, 2005, MOL MICROBIOL, V55, P1801, DOI 10.1111/j.1365-2958.2005.04504.x; Pischetsrieder M, 1999, BIOCHEM BIOPH RES CO, V264, P544, DOI 10.1006/bbrc.1999.1528; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rai P, 2010, MUTAT RES-GEN TOX EN, V703, P71, DOI 10.1016/j.mrgentox.2010.07.010; Richarme G, 2017, BIOCHEM BIOPH RES CO, V483, P387, DOI 10.1016/j.bbrc.2016.12.134; Richarme G, 2016, BIOCHEM BIOPH RES CO, V478, P1111, DOI 10.1016/j.bbrc.2016.08.077; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Rodriguez-Rojas A, 2009, J BACTERIOL, V191, P844, DOI 10.1128/JB.01081-08; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2010, NUCLEIC ACIDS RES, V38, P5432, DOI 10.1093/nar/gkq306; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1372, DOI 10.1042/BST0311372; Van Schaftingen E, 2012, AMINO ACIDS, V42, P1143, DOI 10.1007/s00726-010-0780-3; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481	26	107	111	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		208	211		10.1126/science.aag1095	http://dx.doi.org/10.1126/science.aag1095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28596309				2022-12-28	WOS:000405391700048
J	Larson, AG; Elnatan, D; Keenen, MM; Trnka, MJ; Ohnston, JBJ; Burlingame, AL; Agard, DA; Redding, S; Narlikar, GJ				Larson, Adam G.; Elnatan, Daniel; Keenen, Madeline M.; Trnka, Michael J.; Ohnston, Jonathan B. J.; Burlingame, Alma L.; Agard, David A.; Redding, Sy; Narlikar, Geeta J.			Liquid droplet formation by HP1 alpha suggests a role for phase separation in heterochromatin	NATURE			English	Article							ANALYTICAL ULTRACENTRIFUGATION; HISTONE H3; CHROMATIN; PROTEINS; MASS; SPECTRA; DECONVOLUTION; RECOGNITION; ASSOCIATION; SPECIFICITY	Gene silencing by heterochromatin is proposed to occur in part as a result of the ability of heterochromatin protein 1 (HP1) proteins to spread across large regions of the genome, compact the underlying chromatin and recruit diverse ligands(1-3). Here we identify a new property of the human HP1 alpha protein: the ability to form phase-separated droplets. While unmodified HP1 alpha is soluble, either phosphorylation of its N-terminal extension or DNA binding promotes the formation of phase-separated droplets. Phosphorylation-driven phase separation can be promoted or reversed by specific HP1 alpha ligands. Known components of heterochromatin such as nucleosomes and DNA preferentially partition into the HP1 alpha droplets, but molecules such as the transcription factor TFIIB show no preference. Using a single-molecule DNA curtain assay, we find that both unmodified and phosphorylated HP1 alpha induce rapid compaction of DNA strands into puncta, although with different characteristics(4). We show by direct protein delivery into mammalian cells that an HP1 alpha mutant incapable of phase separation in vitro forms smaller and fewer nuclear puncta than phosphorylated HP1 alpha. These findings suggest that heterochromatin-mediated gene silencing may occur in part through sequestration of compacted chromatin in phase-separated HP1 droplets, which are dissolved or formed by specific ligands on the basis of nuclear context.	[Larson, Adam G.; Elnatan, Daniel; Keenen, Madeline M.; Agard, David A.; Redding, Sy; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Larson, Adam G.; Elnatan, Daniel; Keenen, Madeline M.] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Trnka, Michael J.; Ohnston, Jonathan B. J.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Narlikar, GJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	Geeta.narlikar@ucsf.edu		Elnatan, Daniel/0000-0002-8359-0522; Redding, Sy/0000-0003-3463-7985; Trnka, Michael/0000-0002-8808-5146	NSF; UCSF Program for Breakthrough Biomedical Research (PBBR) by Sandler Foundation; NIH [8P41GM103481, 1S10D016229, R01GM108455]; PBBR (New Frontier Research Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, R35GM118099, R01GM108455] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016229] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); UCSF Program for Breakthrough Biomedical Research (PBBR) by Sandler Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PBBR (New Frontier Research Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Cooke for the peltier device, R. Isaac for nucleosome arrays, A. Lyon and P. O'Farrell for discussions, D. Canzio, L. Racki and C. Zhou for helpful comments, P. Schuck for advice on analytical ultracentrifugation, and I. Sterin and R. Almeida for cell culture help. This work was supported by an NSF pre-doctoral fellowship to A.G.L, funding from the UCSF Program for Breakthrough Biomedical Research (PBBR) provided by the Sandler Foundation to S.R., grants from the NIH (8P41GM103481 and 1S10D016229) to A.L.B, and grants from NIH (R01GM108455) and PBBR (New Frontier Research Award) to G.J.N.	Azzaz AM, 2014, J BIOL CHEM, V289, P6850, DOI 10.1074/jbc.M113.512137; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Canzio D, 2013, NATURE, V496, P377, DOI 10.1038/nature12032; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Correll SJ, 2012, EMBO J, V31, P2416, DOI 10.1038/emboj.2012.80; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Gallardo IF, 2015, LANGMUIR, V31, P10310, DOI 10.1021/acs.langmuir.5b02416; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Hansen S, 2000, J APPL CRYSTALLOGR, V33, P1415, DOI 10.1107/S0021889800012930; Hiragami-Hamada K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11310; Hiragami-Hamada K, 2011, MOL CELL BIOL, V31, P1186, DOI 10.1128/MCB.01012-10; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Iborra FJ, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-15; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kilic S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8313; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; LOCKE J, 1988, GENETICS, V120, P181; Lu J, 2015, J AM SOC MASS SPECTR, V26, P2141, DOI 10.1007/s13361-015-1235-6; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Mishima Y, 2013, J MOL BIOL, V425, P54, DOI 10.1016/j.jmb.2012.10.018; Nishibuchi G, 2014, NUCLEIC ACIDS RES, V42, P12498, DOI 10.1093/nar/gku995; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Strom A. R., 2017, NATURE; Sugimoto K., 2005, J BIOCH, V120, P153; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Velez G, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-015-2874-z; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	37	821	830	15	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					236	+		10.1038/nature22822	http://dx.doi.org/10.1038/nature22822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28636604	Green Accepted, Green Submitted			2022-12-28	WOS:000405314500043
J	Malhotra, A; Wu, X; Forman, HP; Nardini, HKG; Matouk, CC; Gandhi, D; Moore, C; Sanelli, P				Malhotra, Ajay; Wu, Xiao; Forman, Howard P.; Nardini, Holly K. Grossetta; Matouk, Charles C.; Gandhi, Dheeraj; Moore, Christopher; Sanelli, Pina			Growth and Rupture Risk of Small Unruptured Intracranial Aneurysms A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							NATURAL-HISTORY; CEREBRAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; ENLARGEMENT; ANGIOGRAPHY; MANAGEMENT; QUALITY; PATIENT; SINGLE; SIZE	Background: Small unruptured intracranial aneurysms (UIAs) are increasingly diagnosed. Management depends on growth and rupture risks, which may vary by aneurysm size. Purpose: To summarize evidence about the growth and rupture risk of UIAs 7 mm and smaller and to explore differences in growth and rupture risks of very small (<= 3 mm) and small (<= 5 mm) aneurysms. Data Sources: MEDLINE, EMBASE, Scopus, and the Cochrane Library from inception to 2017 (with no language restrictions). Study Selection: Published case series and observational studies that reported natural history data on UIAs 7 mm and smaller. Data Extraction: 2 reviewers abstracted study information, evaluated study quality, and graded strength of evidence. Data Synthesis: Of 26 studies, 5, 10, and 8 described the growth rate of aneurysms 3 mm and smaller, 5 mm and smaller, and 7 mm and smaller, respectively, whereas rupture rates were reported in 7, 11, and 13 studies for aneurysms 3 mm and smaller, 5 mm and smaller, and 7 mm and smaller, respectively. The annualized growth rate was less than 3% in all but 1 study for all 3 size categories. The annualized rupture rate was 0%, less than 0.5%, and less than 1% for the 3 size categories, respectively. Strength of evidence was very low quality for growth rates and low quality for rupture rates. Limitation: Heterogeneous definitions of growth; heterogeneous and selective treatment and follow-up methods, particularly in high-risk patients. Conclusion: Poor-quality evidence suggests that small UIAs have low growth and rupture rates and very small UIAs have little or no risk for rupture.	Yale Sch Med, New Haven, CT USA; Yale Univ, New Haven, CT USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Northwell Hlth, Manhasset, NY USA	Yale University; Yale University; University System of Maryland; University of Maryland Baltimore; Northwell Health	Malhotra, A (corresponding author), Yale Sch Med, Dept Radiol & Biomed Imaging, Box 208042,Tompkins East 2,333 Cedar St, New Haven, CT 06520 USA.	ajay.malhotra@yale.edu	Nardini, Holly Grossetta/AAC-3330-2019; Forman, Howard/ABH-8695-2020; Malhotra, Ajay/ABC-2951-2020; Matouk, Charles/AAF-7694-2019; wu, xiao/L-1421-2019	Nardini, Holly Grossetta/0000-0001-5563-6848; Malhotra, Ajay/0000-0001-9223-6640				Backes D, 2016, STROKE, V47, P951, DOI 10.1161/STROKEAHA.115.012162; Backes D, 2015, STROKE, V46, P1221, DOI 10.1161/STROKEAHA.114.008198; Bor ASE, 2015, STROKE, V46, P42, DOI 10.1161/STROKEAHA.114.005963; Brinjikji W, 2016, AM J NEURORADIOL, V37, P615, DOI 10.3174/ajnr.A4575; Broderick JP, 2009, STROKE, V40, P1952, DOI 10.1161/STROKEAHA.108.542571; Byoun HS, 2016, J KOREAN NEUROSURG S, V59, P11, DOI [10.3340/jkns.2015.59.1.11, 10.3340/jkns.2016.59.1.11]; Chien AC, 2013, J NEUROSURG, V119, P190, DOI 10.3171/2013.3.JNS121469; Chmayssani M, 2011, NEUROSURGERY, V68, P1164, DOI 10.1227/NEU.0b013e31820edbd3; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Edward MT, 2016, WORLD NEUROSURG, V90, P20, DOI 10.1016/j.wneu.2016.02.008; Ferns SP, 2011, STROKE, V42, P313, DOI 10.1161/STROKEAHA.110.591594; Gondar R, 2016, J NEUROL NEUROSUR PS, V87, P1277, DOI 10.1136/jnnp-2016-313584; Guresir E, 2013, STROKE, V44, P3027, DOI 10.1161/STROKEAHA.113.001107; INAGAWA T, 1991, SURG NEUROL, V36, P99, DOI 10.1016/0090-3019(91)90225-X; Jeon JS, 2014, J NEUROL NEUROSUR PS, V85, P289, DOI 10.1136/jnnp-2013-305019; Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838; Kashiwazaki D, 2013, STROKE, V44, P2169, DOI 10.1161/STROKEAHA.113.001138; Korja M, 2014, STROKE, V45, P1958, DOI 10.1161/STROKEAHA.114.005318; Matsubara S, 2004, J NEUROSURG, V101, P908, DOI 10.3171/jns.2004.101.6.0908; Matsumoto K, 2013, ACTA NEUROCHIR, V155, P211, DOI 10.1007/s00701-012-1566-z; Mitchell P, 2000, J NEUROL NEUROSUR PS, V69, P760, DOI 10.1136/jnnp.69.6.760; Miyazawa N, 2006, NEUROSURGERY, V58, P1047, DOI 10.1227/01.NEU.0000217366.02567.D2; Mizoi K, 1995, SURG NEUROL, V44, P114, DOI 10.1016/0090-3019(95)00035-6; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Murayama Y, 2016, STROKE, V47, P365, DOI 10.1161/STROKEAHA.115.010698; Nardini HK Grossetta, 2017, YALE MESH ANALYZER; National Heart Lung and Blood Institute, 2014, QUAL ASS TOOL OBS CO; R Development Core Team, 2009, R LANG ENV STAT COMP; Sonobe M, 2010, STROKE, V41, P1969, DOI [10.1161/STROKEAHA.110.585059, DOI 10.1161/STROKEAHA.110]; Stehbens WE, 1972, PATHOLOGY CEREBRAL B; Thien A, 2017, WORLD NEUROSURG, V97, P326, DOI 10.1016/j.wneu.2016.09.118; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; Tsutsumi K, 2000, J NEUROSURG, V93, P550, DOI 10.3171/jns.2000.93.4.0550; Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Wermer MJH, 2006, STROKE, V37, P414, DOI 10.1161/01.STR.0000199077.06390.35; Wermer MJH, 2005, BRAIN, V128, P2421, DOI 10.1093/brain/awh587; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; WIEBERS DO, 1987, J NEUROSURG, V66, P23, DOI 10.3171/jns.1987.66.1.0023; Yamaki VN, 2016, AM J NEURORADIOL, V37, P862, DOI 10.3174/ajnr.A4651; Zylkowski J, 2015, VIDEOSURGERY MINIINV, V10, P178, DOI 10.5114/wiitm.2015.52707	44	17	17	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2017	167	1					26	+		10.7326/M17-0246	http://dx.doi.org/10.7326/M17-0246			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ3DW	28586893				2022-12-28	WOS:000404591600007
J	Brown, GC; St George-Hyslop, PH				Brown, Guy C.; St George-Hyslop, Peter H.			Deciphering microglial diversity in Alzheimer's disease	SCIENCE			English	Editorial Material							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; COMMON VARIANTS; CD2AP; EPHA1; CD33; CLU		[Brown, Guy C.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [St George-Hyslop, Peter H.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Neurosci, Hills Rd, Cambridge CB2 0XY, England; [St George-Hyslop, Peter H.] Univ Toronto, Dept Med Neurol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [St George-Hyslop, Peter H.] Univ Hlth Network, Toronto, ON M5T 2S8, Canada	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Brown, GC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	gcb3@cam.ac.uk; phs22@cam.ac.uk	Brown, Guy C./HHC-1102-2022	St George-Hyslop, Peter/0000-0003-0796-7209; Brown, Guy/0000-0002-3610-1730	Medical Research Council [MR/L010593/1, MC_G1000734] Funding Source: Medline; Wellcome Trust [203249/Z/16/Z] Funding Source: Medline; MRC [MR/L010593/1, MC_G1000734, MR/N012453/1] Funding Source: UKRI; Medical Research Council [MR/N012453/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	14	14	14	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1123	1124		10.1126/science.aan7893	http://dx.doi.org/10.1126/science.aan7893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619900				2022-12-28	WOS:000403327400015
J	Chen, CK; Chow, A; Lai, M; Guttman, M				Chen, Chun-Kan; Chow, Amy; Lai, Mason; Guttman, Mitchell			Response to Comment on "Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing"	SCIENCE			English	Editorial Material							RNA; BINDING; PROTEIN		[Chen, Chun-Kan; Chow, Amy; Lai, Mason; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu		Guttman, Mitchell/0000-0003-4748-9352				Chen CK, 2016, SCIENCE, V354, P468, DOI 10.1126/science.aae0047; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; GAYNOR R, 1989, P NATL ACAD SCI USA, V86, P4858, DOI 10.1073/pnas.86.13.4858; GRAHAM GJ, 1990, P NATL ACAD SCI USA, V87, P5817, DOI 10.1073/pnas.87.15.5817; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Katsamba PS, 2001, J BIOL CHEM, V276, P21476, DOI 10.1074/jbc.M101624200; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; SCHERLY D, 1989, EMBO J, V8, P4163, DOI 10.1002/j.1460-2075.1989.tb08601.x; Senner CE, 2011, DEVELOPMENT, V138, P1541, DOI 10.1242/dev.056812; Wang CY, 2017, SCIENCE, V356, DOI 10.1126/science.aal4976; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	13	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343							aam5439	10.1126/science.aam5439	http://dx.doi.org/10.1126/science.aam5439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619888				2022-12-28	WOS:000403327400002
J	Attinger, A; Wang, B; Keller, GB				Attinger, Alexander; Wang, Bo; Keller, Georg B.			Visuomotor Coupling Shapes the Functional Development of Mouse Visual Cortex	CELL			English	Article							RECEPTIVE-FIELDS; AUDITORY-FEEDBACK; GABAERGIC NEURONS; BEHAVIORAL STATE; CRE-RECOMBINASE; DRIVER LINES; INTERNEURONS; RESPONSES; CONNECTIVITY; POPULATIONS	The emergence of sensory-guided behavior depends on sensorimotor coupling during development. How sensorimotor experience shapes neural processing is unclear. Here, we show that the coupling between motor output and visual feedback is necessary for the functional development of visual processing in layer 2/3 (L2/3) of primary visual cortex (V1) of the mouse. Using a virtual reality system, we reared mice in conditions of normal or random visuomotor coupling. We recorded the activity of identified excitatory and inhibitory L2/3 neurons in response to transient visuomotor mismatches in both groups of mice. Mismatch responses in excitatory neurons were strongly experience dependent and driven by a transient release from inhibition mediated by somatostatin-positive interneurons. These data are consistent with a model in which L2/3 of V1 computes a difference between an inhibitory visual input and an excitatory locomotion-related input, where the balance between these two inputs is finely tuned by visuomotor experience.	[Attinger, Alexander; Wang, Bo; Keller, Georg B.] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Attinger, Alexander; Wang, Bo; Keller, Georg B.] Univ Basel, Fac Nat Sci, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Keller, GB (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.; Keller, GB (corresponding author), Univ Basel, Fac Nat Sci, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	georg.keller@fmi.ch		Keller, Georg/0000-0002-1401-0117	Swiss National Science Foundation; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation	We thank Antonia Drinnenberg, Thomas Mrsic-Flogel, and Rainer Friedrich for comments on earlier versions of the manuscript. We thank Daniela Gerosa-Erni for production of the AAV vectors and the members of the Keller lab for discussion, support, and comments on the manuscript. This work was supported by the Swiss National Science Foundation and the Novartis Research Foundation.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GREGORY RL, 1980, PHILOS T ROY SOC B, V290, P181, DOI 10.1098/rstb.1980.0090; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; HEIN A, 1967, SCIENCE, V158, P390, DOI 10.1126/science.158.3799.390; HELD R, 1963, J COMP PHYSIOL PSYCH, V56, P872, DOI 10.1037/h0040546; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Leinweber M, 2014, JOVE-J VIS EXP, DOI 10.3791/50885; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sinha P, 2014, P NATL ACAD SCI USA, V111, P15220, DOI 10.1073/pnas.1416797111; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Zmarz P, 2016, NEURON, V92, P766, DOI 10.1016/j.neuron.2016.09.057	46	65	66	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1291	+		10.1016/j.cell.2017.05.023	http://dx.doi.org/10.1016/j.cell.2017.05.023			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28602353	Bronze			2022-12-28	WOS:000403332400017
J	McInnes, IB; Schett, G				McInnes, Iain B.; Schett, Georg			Pathogenetic insights from the treatment of rheumatoid arthritis	LANCET			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; ALPHA MONOCLONAL-ANTIBODY; CLINICAL-RESPONSE; DOUBLE-BLIND; B-CELL; INADEQUATE RESPONSE; RITUXIMAB TREATMENT; GENE-EXPRESSION; PARALLEL-GROUP; BONE LOSS	Rheumatoid arthritis is a chronic autoimmune disease that causes progressive articular damage, functional loss, and comorbidity. The development of effective biologics and small-molecule kinase inhibitors in the past two decades has substantially improved clinical outcomes. Just as understanding of pathogenesis has led in large part to the development of drugs, so have mode-of-action studies of these specific immune-targeted agents revealed which immune pathways drive articular inflammation and related comorbidities. Cytokine inhibitors have definitively proven a critical role for tumour necrosis factor a and interleukin 6 in disease pathogenesis and possibly also for granulocyte-macrophage colony-stimulating factor. More recently, clinical trials with Janus kinase (JAK) inhibitors have shown that cytokine receptors that signal through the JAK/STAT signalling pathway are important for disease, informing the pathogenetic function of additional cytokines (such as the interferons). Finally, successful use of costimulatory blockade and B-cell depletion in the clinic has revealed that the adaptive immune response and the downstream events initiated by these cells participate directly in synovial inflammation. Taken together, it becomes apparent that understanding the effects of specific immune interventions can elucidate definitive molecular or cellular nodes that are essential to maintain complex inflammatory networks that subserve diseases like rheumatoid arthritis.	[McInnes, Iain B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Schett, Georg] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany; [Schett, Georg] Univ Klinikum Erlangen, Erlangen, Germany	University of Glasgow; University of Erlangen Nuremberg; University of Erlangen Nuremberg	McInnes, IB (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland.	iain.mcinnes@glasgow.ac.uk	Duarte, Graziela Biude Silva/Q-7728-2016		Abbvie; BMS; Janssen; MSD; Astra Zeneca; Pfizer; Roche; UCB; Celgene; Chugai; Novartis; Medical Research Council [MR/N005813/1] Funding Source: researchfish; MRC [MR/N005813/1] Funding Source: UKRI	Abbvie(AbbVie); BMS(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Astra Zeneca(AstraZeneca); Pfizer(Pfizer); Roche(Roche Holding); UCB(UCB Pharma SA); Celgene(Bristol-Myers SquibbCelgene Corporation); Chugai; Novartis(Novartis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	IBM declares honoraria or research grants from Abbvie, BMS, Janssen, MSD, Astra Zeneca, Pfizer, Roche, UCB. GS declares honoraria or research grants from Abbvie, BMS, Celgene, Chugai, Novartis, Roche, UCB.	Aletaha D, 2017, LANCET, V389, P1206, DOI 10.1016/S0140-6736(17)30401-4; Alvaro-Gracia JM, 2017, ANN RHEUM DIS, V76, P196, DOI 10.1136/annrheumdis-2015-208918; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Bell GM, 2017, ANN RHEUM DIS, V76, P227, DOI 10.1136/annrheumdis-2015-208456; Benham H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9301; Blume J, 2011, BRAIN BEHAV IMMUN, V25, P221, DOI 10.1016/j.bbi.2010.10.008; Bonelli M, 2016, RHEUMATOLOGY, V55, P710, DOI 10.1093/rheumatology/kev403; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Boyle DL, 2015, ANN RHEUM DIS, V74, P1311, DOI 10.1136/annrheumdis-2014-206028; Bozec A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007764; Bresnihan B, 2009, J RHEUMATOL, V36, P1800, DOI 10.3899/jrheum.090348; Brink M, 2013, ARTHRITIS RHEUM; Buch MH, 2008, RHEUMATOLOGY, V47, P1469, DOI 10.1093/rheumatology/ken261; Buch MH, 2009, ANN RHEUM DIS, V68, P1220, DOI 10.1136/ard.2008.091876; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Burmester GR, 2017, ANN RHEUM DIS, V76, P1020, DOI 10.1136/annrheumdis-2016-210624; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Carmona L, 2007, ANN RHEUM DIS, V66, P880, DOI 10.1136/ard.2006.067660; Catrina AI, 2016, IMMUNOL REV, V269, P162, DOI 10.1111/imr.12379; Cavanagh J, 2010, ANN RHEUM DIS, V69, P1251, DOI 10.1136/ard.2009.107912; Charles P, 1999, J IMMUNOL, V163, P1521; Charles-Schoeman C, 2015, ARTHRITIS RHEUMATOL, V67, P616, DOI 10.1002/art.38974; Chatzidionysiou K, 2011, ANN RHEUM DIS, V70, P1575, DOI 10.1136/ard.2010.148759; Clemente-Casares X, 2016, NATURE, V530, P434, DOI 10.1038/nature16962; Cutolo M, 2016, EXPERT REV CLIN IMMU, V12, P417, DOI 10.1586/1744666X.2016.1133295; Das S, 2014, ANN RHEUM DIS, V73, P909, DOI 10.1136/annrheumdis-2013-204417; De Vita S, 2002, ARTHRITIS RHEUM, V46, P2029, DOI 10.1002/art.10467; Di Giuseppe D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4218; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Ducreux J, 2014, ARTHRITIS RHEUMATOL, V66, P15, DOI 10.1002/art.38202; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Figueiredo CP, 2017, ANN RHEUM DIS, V76, P399, DOI 10.1136/annrheumdis-2016-209297; Gabay C, 2016, ANN RHEUM DIS, V75, P1806, DOI 10.1136/annrheumdis-2015-207872; Gerlag DM, 2008, BEST PRACT RES CL RH, V22, P311, DOI 10.1016/j.berh.2008.02.002; Gerlag DM, 2016, RHEUMATOLOGY, V55, P607, DOI 10.1093/rheumatology/kev347; Giles JT, 2016, 2016 AM COLL RHEUM A; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; Gutierrez-Roelens I, 2011, ARTHRITIS RHEUM-US, V63, P1246, DOI 10.1002/art.30292; Hamilton JA, 2017, NAT REV DRUG DISCOV, V16, P53, DOI 10.1038/nrd.2016.231; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Herenius MMJ, 2011, ANN RHEUM DIS, V70, P1160, DOI 10.1136/ard.2010.141549; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Hodge JA, 2016, CLIN EXP RHEUMATOL, V34, P318; Hogan VE, 2012, ANN RHEUM DIS, V71, P1888, DOI 10.1136/annrheumdis-2011-201115; Izquierdo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008131; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Kanbe K, 2013, RHEUMATOL INT, V33, P1883, DOI 10.1007/s00296-011-2326-8; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kavanaugh A, 2008, ANN RHEUM DIS, V67, P402, DOI 10.1136/ard.2007.074229; Klaasen R, 2009, ARTHRITIS RHEUM-US, V60, P3217, DOI 10.1002/art.24913; Klein K, 2016, ANN RHEUM DIS, V75, P422, DOI 10.1136/annrheumdis-2014-205809; Klein K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4074; Kleyer A, 2014, ANN RHEUM DIS, V73, P854, DOI 10.1136/annrheumdis-2012-202958; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Krishnamurthy A, 2016, ANN RHEUM DIS, V75, P721, DOI 10.1136/annrheumdis-2015-208093; Kunwar S, 2016, RHEUMATOL INT, V36, P1065, DOI 10.1007/s00296-016-3480-9; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Lindberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011310; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; McInnes IB, 2016, NAT REV RHEUMATOL, V12, P63, DOI 10.1038/nrrheum.2015.171; McInnes IB, 2015, ANN RHEUM DIS, V74, P694, DOI 10.1136/annrheumdis-2013-204345; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Micha R, 2011, AM J CARDIOL, V108, P1362, DOI 10.1016/j.amjcard.2011.06.054; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patakas A, ABATACEPT INHIBITION; Pfeifle R, 2017, NAT IMMUNOL, V18, P104, DOI 10.1038/ni.3579; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM; Robertson J, 2013, NAT REV RHEUMATOL, V9, P513, DOI 10.1038/nrrheum.2013.91; Rosengren S, 2012, ANN RHEUM DIS, V71, P440, DOI 10.1136/ard.2011.150284; Rosengren S, 2011, RHEUMATOLOGY, V50, P603, DOI 10.1093/rheumatology/keq337; Rosengren S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2497; Ruiz-Heiland G, 2014, ANN RHEUM DIS, V73, P771, DOI 10.1136/annrheumdis-2012-202907; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schett G, 2008, ARTHRITIS RHEUM-US, V58, P2936, DOI 10.1002/art.23951; Schett G, 2017, MOD RHEUMATOL, V27, P193, DOI 10.1080/14397595.2016.1265907; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Sellam J, 2013, ARTHRITIS RHEUM-US, V65, P2253, DOI 10.1002/art.38023; Siebert S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40473; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209831; Smolen JS, 2013, ANN RHEUM DIS, V72, P3, DOI 10.1136/annrheumdis-2012-202361; Solomon DH, 2015, ARTHRITIS RHEUMATOL, V67, P1995, DOI 10.1002/art.39195; Tak PP, 2012, ARTHRITIS RHEUM-US, V64, P360, DOI 10.1002/art.33353; Tak PP, 1996, ARTHRITIS RHEUM, V39, P1077, DOI 10.1002/art.1780390702; Takeuchi T, 2016, ANN RHEUM DIS, V75, P983, DOI 10.1136/annrheumdis-2015-208052; Tan EM, 2016, J EXP MED, V213, P1937, DOI 10.1084/jem.20160792; Teng YKO, 2009, ANN RHEUM DIS, V68, P1011, DOI 10.1136/ard.2008.092791; Thurlings RM, 2010, ANN RHEUM DIS, V69, P409, DOI 10.1136/ard.2009.109041; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; van Vollenhoven RF, 2011, ARTHRITIS RHEUM-US, V63, P1782, DOI 10.1002/art.30372; Vos K, 2007, ARTHRITIS RHEUM, V56, P772, DOI 10.1002/art.22400; Walsh CAE, 2008, CLIN EXP RHEUMATOL, V26, P656; Weinblatt ME, 2014, ARTHRITIS RHEUMATOL, V66, P3255, DOI 10.1002/art.38851; Wenink MH, 2012, ANN RHEUM DIS, V71, P80, DOI 10.1136/annrheumdis-2011-200348; Wright HL, 2015, RHEUMATOLOGY, V54, P743, DOI 10.1093/rheumatology/keu488; Wunderlich C, 2017, SEMIN ARTHRITIS RHEU, V46, P709, DOI 10.1016/j.semarthrit.2016.09.011	102	655	720	16	258	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2328	2337		10.1016/S0140-6736(17)31472-1	http://dx.doi.org/10.1016/S0140-6736(17)31472-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW9XM	28612747	Green Accepted			2022-12-28	WOS:000402872700027
J	van Esbroeck, ACM; Janssen, APA; Cognetta, AB; Ogasawara, D; Shpak, G; van der Kroeg, M; Kantae, V; Baggelaar, MP; de Vrij, FMS; Deng, H; Allara, M; Fezza, F; Lin, Z; van der Wel, T; Soethoudt, M; Mock, ED; den Dulk, H; Baak, IL; Florea, BI; Hendriks, G; de Petrocellis, L; Overkleeft, HS; Hankemeier, T; De Zeeuw, CI; Di Marzo, V; Maccarrone, M; Cravatt, BF; Kushner, SA; van der Stelt, M				van Esbroeck, Annelot C. M.; Janssen, Antonius P. A.; Cognetta, Armand B., III; Ogasawara, Daisuke; Shpak, Guy; van der Kroeg, Mark; Kantae, Vasudev; Baggelaar, Marc P.; de Vrij, Femke M. S.; Deng, Hui; Allara, Marco; Fezza, Filomena; Lin, Zhanmin; van der Wel, Tom; Soethoudt, Marjolein; Mock, Elliot D.; den Dulk, Hans; Baak, Ilse L.; Florea, Bogdan I.; Hendriks, Giel; de Petrocellis, Luciano; Overkleeft, Herman S.; Hankemeier, Thomas; De Zeeuw, Chris I.; Di Marzo, Vincenzo; Maccarrone, Mauro; Cravatt, Benjamin F.; Kushner, Steven A.; van der Stelt, Mario			Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474	SCIENCE			English	Article							ACID AMIDE HYDROLASE-1; MOLECULAR CHARACTERIZATION; CLINICAL-TRIAL; ESTERASE; PF-04457845; ANANDAMIDE; BLOCKADE; RECEPTOR; ENZYME; PAIN	A recent phase 1 trial of the fatty acid amide hydrolase (FAAH) inhibitor BIA 10-2474 led to the death of one volunteer and produced mild-to-severe neurological symptoms in four others. Although the cause of the clinical neurotoxicity is unknown, it has been postulated, given the clinical safety profile of other tested FAAH inhibitors, that off-target activities of BIA 10-2474 may have played a role. Here we use activity-based proteomic methods to determine the protein interaction landscape of BIA 10-2474 in human cells and tissues. This analysis revealed that the drug inhibits several lipases that are not targeted by PF04457845, a highly selective and clinically tested FAAH inhibitor. BIA 10-2474, but not PF04457845, produced substantial alterations in lipid networks in human cortical neurons, suggesting that promiscuous lipase inhibitors have the potential to cause metabolic dysregulation in the nervous system.	[van Esbroeck, Annelot C. M.; Janssen, Antonius P. A.; Baggelaar, Marc P.; Deng, Hui; van der Wel, Tom; Soethoudt, Marjolein; Mock, Elliot D.; den Dulk, Hans; Baak, Ilse L.; van der Stelt, Mario] Leiden Univ, Leiden Inst Chem, Dept Mol Physiol, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Janssen, Antonius P. A.; Cognetta, Armand B., III; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Shpak, Guy; van der Kroeg, Mark; de Vrij, Femke M. S.; Kushner, Steven A.] Erasmus Univ, Med Ctr, Dept Psychiat, NL-3000 CA Rotterdam, Netherlands; [Kantae, Vasudev; Hankemeier, Thomas] Leiden Univ, Leiden Acad Ctr Drug Res, Analyt Biosci, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Allara, Marco; de Petrocellis, Luciano; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Via Campi Flegrei 34, I-80078 Pozzuoli, Italy; [Fezza, Filomena] Tor Vergata Univ Rome, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy; [Lin, Zhanmin; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Florea, Bogdan I.; Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, Department Bioorgan Synth, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Hendriks, Giel] Toxys BV, Robert Boyleweg 4, NL-2333 CG Leiden, Netherlands; [De Zeeuw, Chris I.] Royal Dutch Acad Arts & Sci, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Maccarrone, Mauro] Brain Res Inst Res & Healthcare IRCCS Santa Lucia, Via Fosso Fiorano 65, I-00143 Rome, Italy; [Maccarrone, Mauro] Univ Rome, Dept Med, Via Alvaro Portillo 21, I-00128 Rome, Italy	Leiden University; Leiden University - Excl LUMC; Scripps Research Institute; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University - Excl LUMC; Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Sapienza University Rome	van der Stelt, M (corresponding author), Leiden Univ, Leiden Inst Chem, Dept Mol Physiol, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.; Kushner, SA (corresponding author), Erasmus Univ, Med Ctr, Dept Psychiat, NL-3000 CA Rotterdam, Netherlands.	s.kushner@erasmusmc.nl; m.van.der.stelt@chem.leidenuniv.nl	de Vrij, Femke M.S./O-9706-2019; Di Marzo, Vincenzo/AAD-7742-2019; Maccarrone, Mauro/K-5398-2012; van Esbroeck, Annelot Clementine Mathilda/AAD-5181-2022; Hankemeier, Thomas/V-5407-2019; Ogasawara, Daisuke/V-7041-2019; Florea, Bogdan I./AAM-9975-2020; Mock, Elliot/HGU-3426-2022	de Vrij, Femke M.S./0000-0003-0825-3806; Di Marzo, Vincenzo/0000-0002-1490-3070; Maccarrone, Mauro/0000-0002-3990-2963; van Esbroeck, Annelot Clementine Mathilda/0000-0003-0631-2403; Hankemeier, Thomas/0000-0001-7871-2073; Ogasawara, Daisuke/0000-0002-2178-4698; Cognetta, Armand/0000-0003-0773-0674; Florea, Bogdan Iulius/0000-0001-7114-2266; Kantae, Vasudev/0000-0001-8541-0882; Mock, Elliot/0000-0002-1500-2856; van der Wel, Tom/0000-0002-6449-3233; Baggelaar, Marc Pieter/0000-0002-9784-6250	Dutch Research Council-Chemical Sciences ECHO grant; ECHO-STIP grant; Leiden University, Faculty of Science ("Profiling Programme: Endocannabinoids"); Chinese Scholarship Council; NIH [DA033760]; Dutch Organization for Medical Sciences; Life Sciences; ERC-adv; ERC-POC; Netherlands Organisation for Scientific Research [NWO 024.003.001]; Italian Ministry of Education, University and Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033760] Funding Source: NIH RePORTER	Dutch Research Council-Chemical Sciences ECHO grant; ECHO-STIP grant; Leiden University, Faculty of Science ("Profiling Programme: Endocannabinoids"); Chinese Scholarship Council(China Scholarship Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Organization for Medical Sciences; Life Sciences(European Commission); ERC-adv; ERC-POC; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The human brain samples were obtained from the Netherlands Brain Bank (NBB), Netherlands Institute for Neuroscience, Amsterdam (open access: www.brainbank.nl). All material was collected from donors for whom, or from whom, the NBB had obtained written informed consent for a brain autopsy and the use of the material and clinical information for research purposes. We thank R. M. Suciu for assistance with the computational analysis of ABPP data. This work was supported by a Dutch Research Council-Chemical Sciences ECHO grant (to A.P.A.J. and M.v.d.S.); an ECHO-STIP grant (to M.S. and M.v.d.S.); Leiden University, Faculty of Science ("Profiling Programme: Endocannabinoids"; M.v.d.S., E.D.M., T.H., and V.K.); grants from the Chinese Scholarship Council (to H.D.); the NIH (DA033760 to B.F.C.); the Dutch Organization for Medical Sciences, Life Sciences, and ERC-adv and ERC-POC (C.I.d.Z.); and the Netherlands Organisation for Scientific Research (NWO 024.003.001 to S.A.K.). The work of F.F. and M. M. was partly supported by the Italian Ministry of Education, University and Research (competitive PRIN 2015 grant to M.M.). B.F.C. is a founder and adviser to Abide Therapeutics, a biotechnology company interested in developing serine hydrolase inhibitors as therapeutics. G.H. is founder of Toxys B.V., a company that performs cytotoxicity testing of compounds. The ToxTracker platform used for toxicological profiling is available for research purposes from Toxys B.V. under a material transfer agreement.	Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Baggelaar MP, 2015, J AM CHEM SOC, V137, P8851, DOI 10.1021/jacs.5b04883; Begaud B., 2016, REPORT TEMPORARY SPE, P1; Bertrand D, 2010, ANTIMICROB AGENTS CH, V54, P5399, DOI 10.1128/AAC.00840-10; Butler D, 2016, NATURE, V529, P263, DOI 10.1038/nature.2016.19189; Chang PA, 2010, INT J BIOCHEM CELL B, V42, P573, DOI 10.1016/j.biocel.2009.12.007; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Eddleston M, 2016, BRIT J CLIN PHARMACO, V81, P582, DOI 10.1111/bcp.12920; Hampson AJ, 1998, J NEUROCHEM, V70, P671; Hufnagel RB, 2015, J MED GENET, V52, P85, DOI 10.1136/jmedgenet-2014-102856; Huggins JP, 2012, PAIN, V153, P1837, DOI 10.1016/j.pain.2012.04.020; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kerbrat A, 2016, NEW ENGL J MED, V375, P1717, DOI 10.1056/NEJMoa1604221; Kiss L. E., 2010, WO, Patent No. 2010074588; Lannine BR, 2014, NAT CHEM BIOL, V10, P760, DOI [10.1038/NCHEMBIO.1582, 10.1038/nchembio.1582]; Li GL, 2012, BRIT J CLIN PHARMACO, V73, P706, DOI 10.1111/j.1365-2125.2011.04137.x; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; Patat A., 2016, PRESENTATION SAFETY; Read DJ, 2009, J NEUROSCI, V29, P11594, DOI 10.1523/JNEUROSCI.3007-09.2009; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; Topaloglu AK, 2014, J CLIN ENDOCR METAB, V99, pE2067, DOI 10.1210/jc.2014-1836; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784	28	195	196	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1084	1087		10.1126/science.aaf7497	http://dx.doi.org/10.1126/science.aaf7497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596366	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000402871700056
J	Huang, B; Clark, G; Navarro-Moratalla, E; Klein, DR; Cheng, R; Seyler, KL; Zhong, D; Schmidgall, E; McGuire, MA; Cobden, DH; Yao, W; Xiao, D; Jarillo-Herrero, P; Xu, XD				Huang, Bevin; Clark, Genevieve; Navarro-Moratalla, Efren; Klein, Dahlia R.; Cheng, Ran; Seyler, Kyle L.; Zhong, Ding; Schmidgall, Emma; McGuire, Michael A.; Cobden, David H.; Yao, Wang; Xiao, Di; Jarillo-Herrero, Pablo; Xu, Xiaodong			Layer-dependent ferromagnetism in a van der Waals crystal down to the monolayer limit	NATURE			English	Article							TRANSITION; BEHAVIOR; PHASE; SUPERCONDUCTIVITY; NANOSHEETS; MAGNETISM	Since the discovery of graphene(1), the family of two-dimensional materials has grown, displaying a broad range of electronic properties. Recent additions include semiconductors with spin-valley coupling(2), Ising superconductors(3-5) that can be tuned into a quantum metal(6), possible Mott insulators with tunable charge-density waves(7), and topological semimetals with edge transport(8,9). However, no two-dimensional crystal with intrinsic magnetism has yet been discovered(10-14); such a crystal would be useful in many technologies from sensing to data storage(15). Theoretically, magnetic order is prohibited in the two-dimensional isotropic Heisenberg model at finite temperatures by the Mermin-Wagner theorem(16). Magnetic anisotropy removes this restriction, however, and enables, for instance, the occurrence of two-dimensional Ising ferromagnetism. Here we use magneto-optical Kerr effect microscopy to demonstrate that monolayer chromium triiodide (CrI3) is an Ising ferromagnet with out-of-plane spin orientation. Its Curie temperature of 45 kelvin is only slightly lower than that of the bulk crystal, 61 kelvin, which is consistent with a weak interlayer coupling. Moreover, our studies suggest a layer-dependent magnetic phase, highlighting thickness-dependent physical properties typical of van der Waals crystals(17-19). Remarkably, bilayer CrI3 displays suppressed magnetization with a metamagnetic effect(20), whereas in trilayer CrI3 the interlayer ferromagnetism observed in the bulk crystal is restored. This work creates opportunities for studying magnetism by harnessing the unusual features of atomically thin materials, such as electrical control for realizing magnetoelectronics(12), and van der Waals engineering to produce interface phenomena(15).	[Huang, Bevin; Seyler, Kyle L.; Zhong, Ding; Schmidgall, Emma; Cobden, David H.; Xu, Xiaodong] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Clark, Genevieve; Xu, Xiaodong] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA; [Navarro-Moratalla, Efren; Klein, Dahlia R.; Jarillo-Herrero, Pablo] MIT, Dept Phys, Cambridge, MA 02139 USA; [Cheng, Ran; Xiao, Di] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [McGuire, Michael A.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Yao, Wang] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Yao, Wang] Univ Hong Kong, Ctr Theoret & Computat Phys, Hong Kong, Hong Kong, Peoples R China	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Carnegie Mellon University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Hong Kong; University of Hong Kong	Xu, XD (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.; Xu, XD (corresponding author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.; Jarillo-Herrero, P (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	pjarillo@mit.edu; xuxd@uw.edu	Navarro-Moratalla, Efrén/S-9049-2016; Cheng, Ran/M-9260-2014; Xiao, Di/B-1830-2008; Zhong, Ding/U-7360-2019; McGuire, Michael/B-5453-2009; Yao, Wang/C-1353-2008; Jarillo-Herrero, Pablo/E-3755-2013	Navarro-Moratalla, Efrén/0000-0002-3430-6599; Cheng, Ran/0000-0003-0166-2172; Xiao, Di/0000-0003-0165-6848; Zhong, Ding/0000-0003-3149-2071; McGuire, Michael/0000-0003-1762-9406; Yao, Wang/0000-0003-2883-4528; Huang, Bevin/0000-0002-8301-4058; Jarillo-Herrero, Pablo/0000-0001-8217-8213	Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-SC0008145, SC0012509]; University of Washington Innovation Award; Center for Integrated Quantum Materials under NSF [DMR-1231319]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4541]; Center for Excitonics, an Energy Frontier Research Center - US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DESC0001088]; DOE [BES DE-SC0012509]; Croucher Foundation (Croucher Innovation Award); RGC of Hong Kong [HKU17305914P]; HKU ORA; US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division; Cottrell Scholar Award; Clean Energy Institute; State of Washington; Boeing Distinguished Professorship in Physics;  [DE-SC0002197]	Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); University of Washington Innovation Award; Center for Integrated Quantum Materials under NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation's EPiQS Initiative; Center for Excitonics, an Energy Frontier Research Center - US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Croucher Foundation (Croucher Innovation Award); RGC of Hong Kong(Hong Kong Research Grants Council); HKU ORA; US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Cottrell Scholar Award; Clean Energy Institute; State of Washington; Boeing Distinguished Professorship in Physics; 	Work at the University of Washington was mainly supported by the Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division (DE-SC0008145 and SC0012509), and a University of Washington Innovation Award. Work at the Massachusetts Institute of Technology was supported by the Center for Integrated Quantum Materials under NSF grant DMR-1231319 as well as the Gordon and Betty Moore Foundation's EPiQS Initiative (grant GBMF4541 to P.J.-H.). Device fabrication was supported in part by the Center for Excitonics, an Energy Frontier Research Center funded by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Award Number DESC0001088. D.H.C.'s contribution is supported by DE-SC0002197. Work at Carnegie Mellon University is supported by DOE BES DE-SC0012509. W.Y. is supported by the Croucher Foundation (Croucher Innovation Award), the RGC of Hong Kong (HKU17305914P), and the HKU ORA. Work at Oak Ridge National Laboratory (M.A.M.) was supported by the US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division. X.X. and D.X. acknowledge the support of a Cottrell Scholar Award. X.X. acknowledges the support from the Clean Energy Institute (funded by the State of Washington) and from a Boeing Distinguished Professorship in Physics.	BACK CH, 1995, NATURE, V378, P597, DOI 10.1038/378597a0; BEAL AR, 1975, J PHYS C SOLID STATE, V8, P4236, DOI 10.1088/0022-3719/8/24/015; Blake P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768624; CARTEAUX V, 1995, EUROPHYS LETT, V29, P251, DOI 10.1209/0295-5075/29/3/011; Castellanos-Gomez A, 2013, NANO RES, V6, P191, DOI 10.1007/s12274-013-0295-9; de Jongh LJ, 2001, ADV PHYS, V50, P947, DOI 10.1080/00018730110101412; DILLON JF, 1965, J APPL PHYS, V36, P1259, DOI 10.1063/1.1714194; EBERT H, 1996, Patent No. 591665; Elmers HJ, 1996, PHYS REV B, V54, P15224, DOI 10.1103/PhysRevB.54.15224; Fei Z., 2016, PREPRINT; Grant P. M., 1968, B AM PHYS SOC, V13, P3; Herzinger CM, 1998, J APPL PHYS, V83, P3323, DOI 10.1063/1.367101; HUANG F, 1994, PHYS REV B, V49, P3962, DOI 10.1103/PhysRevB.49.3962; Li XX, 2014, J MATER CHEM C, V2, P7071, DOI 10.1039/c4tc01193g; Lin MW, 2016, J MATER CHEM C, V4, P315, DOI 10.1039/c5tc03463a; Lu JM, 2015, SCIENCE, V350, P1353, DOI 10.1126/science.aab2277; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; McGuire MA, 2015, CHEM MATER, V27, P612, DOI 10.1021/cm504242t; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; Sachs B, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.201402; Saito Y, 2016, NAT PHYS, V12, P144, DOI [10.1038/NPHYS3580, 10.1038/nphys3580]; Sander D, 2004, J PHYS-CONDENS MAT, V16, pR603, DOI 10.1088/0953-8984/16/20/R01; SATO K, 1981, JPN J APPL PHYS, V20, P2403, DOI 10.1143/JJAP.20.2403; Sivadas N, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.235425; Soumyanarayanan A, 2016, NATURE, V539, P509, DOI 10.1038/nature19820; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; STRYJEWSKI E, 1977, ADV PHYS, V26, P487, DOI 10.1080/00018737700101433; Tian Y, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/2/025035; Tsen AW, 2016, NAT PHYS, V12, P208, DOI 10.1038/NPHYS3579; Wang XZ, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/3/031009; Xi XX, 2016, NAT PHYS, V12, P139, DOI [10.1038/NPHYS3538, 10.1038/nphys3538]; Xu XD, 2014, NAT PHYS, V10, P343, DOI [10.1038/NPHYS2942, 10.1038/nphys2942]; Yu YJ, 2015, NAT NANOTECHNOL, V10, P270, DOI [10.1038/NNANO.2014.323, 10.1038/nnano.2014.323]; Zhang WB, 2015, J MATER CHEM C, V3, P12457, DOI 10.1039/c5tc02840j	37	2612	2634	200	2777	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					270	+		10.1038/nature22391	http://dx.doi.org/10.1038/nature22391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593970	Green Submitted			2022-12-28	WOS:000402823400033
J	Williams, DR; Medlock, MM				Williams, David R.; Medlock, Morgan M.			Health Effects of Dramatic Societal Events - Ramifications of the Recent Presidential Election	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RACIAL-DISCRIMINATION; IMMIGRATION LAW; PREJUDICE; LEVEL; RACE		[Williams, David R.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Medlock, Morgan M.] Massachusetts Gen Hosp, McLean Psychiat Residency Program, Boston, MA 02114 USA; [Williams, David R.] Harvard Univ, Dept African & African Amer Studies, Cambridge, MA 02138 USA; [Medlock, Morgan M.] McLean Hosp, Spiritual & Mental Hlth Program, Belmont, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; McLean Hospital	Williams, DR (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.; Williams, DR (corresponding author), Harvard Univ, Dept African & African Amer Studies, Cambridge, MA 02138 USA.							Adam EK, 2015, PSYCHONEUROENDOCRINO, V62, P279, DOI 10.1016/j.psyneuen.2015.08.018; American Psychological Association, 2017, STRESS AM COP CHANG; [Anonymous], 2016, 10 DAYS HARASSMENT I; Beelmann A, 2014, J APPL DEV PSYCHOL, V35, P10, DOI 10.1016/j.appdev.2013.11.002; Brody GH, 2016, PSYCHOL SCI, V27, P530, DOI 10.1177/0956797615626703; Brody GH, 2014, CHILD DEV, V85, P989, DOI 10.1111/cdev.12213; Burnett-Zeigler I., 2016, D TRUMP AFFECTS THER; Chae DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122963; Costello M., 2016, TRUMP EFFECT IMPACT; Hatzenbuehler ML, 2017, SOC SCI MED, V174, P169, DOI 10.1016/j.socscimed.2016.11.040; Hatzenbuehler ML, 2014, SOC SCI MED, V103, P33, DOI 10.1016/j.socscimed.2013.06.005; Jimenez-Silva M., 2014, ASS MEXICAN AM ED, V7, P50; Lauderdale DS, 2006, DEMOGRAPHY, V43, P185, DOI 10.1353/dem.2006.0008; Lee Y, 2015, AM J PUBLIC HEALTH, V105, P2349, DOI 10.2105/AJPH.2015.302776; Leitner JB, 2016, PSYCHOL SCI, V27, P1299, DOI 10.1177/0956797616658450; Lenz R., 2016, NEO NAZI A ANGLIN CH; Lewis TT, 2015, ANNU REV CLIN PSYCHO, V11, P407, DOI 10.1146/annurev-clinpsy-032814-112728; Moody M, 2012, J NEW MEDIA CULT SUM; MUNDINGER MO, 1985, NEW ENGL J MED, V313, P44, DOI 10.1056/NEJM198507043130110; Novak NL, 2017, INT J EPIDEMIOL; Ofri D, 2017, SLATE; Padela AI, 2010, AM J PUBLIC HEALTH, V100, P284, DOI 10.2105/AJPH.2009.164954; Parker CS, 2016, ANNU REV SOCIOL, V42, P217, DOI 10.1146/annurev-soc-081715-074246; Richman LS, 2008, ANN BEHAV MED, V35, P105, DOI 10.1007/s12160-007-9013-8; Toomey RB, 2014, AM J PUBLIC HEALTH, V104, pS28, DOI 10.2105/AJPH.2013.301655; White K, 2014, J HEALTH CARE POOR U, V25, P1844, DOI 10.1353/hpu.2014.0194; Williams DR, 2013, AM BEHAV SCI, V57, P1200, DOI 10.1177/0002764213487341	27	90	90	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2295	2299		10.1056/NEJMms1702111	http://dx.doi.org/10.1056/NEJMms1702111			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW8WG	28591522				2022-12-28	WOS:000402798200018
J	Garon, EB				Garon, Edward B.			Cancer Immunotherapy Trials Not Immune from Imprecise Selection of Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELL LUNG-CANCER; DOCETAXEL; PEMBROLIZUMAB; NIVOLUMAB		[Garon, Edward B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Garon, EB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.							Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Rebelatto MC, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0545-8; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Shaverdian N, 2017, LANCET ONCOL; SPIGEL DR, 2015, J CLIN ONCOL, V33; Sunshine J, 2015, CURR OPIN PHARMACOL, V23, P32, DOI 10.1016/j.coph.2015.05.011	12	24	24	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2483	2485		10.1056/NEJMe1705692	http://dx.doi.org/10.1056/NEJMe1705692			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY2BW	28636845				2022-12-28	WOS:000403774400013
J	Davidoff, F				Davidoff, Frank			Heterogeneity in Treatment Effects RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Davidoff, Frank] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA	Dartmouth College	Davidoff, F (corresponding author), Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA.							Basu S, 2017, ANN INTERN MED, V166, P354, DOI 10.7326/M16-1756; Kent DM, 2016, INT J EPIDEMIOL; Vohra S, 2016, J CLIN EPIDEMIOL, V76, P9, DOI 10.1016/j.jclinepi.2015.05.004	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					914	915		10.7326/L17-0156	http://dx.doi.org/10.7326/L17-0156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630985				2022-12-28	WOS:000403579000027
J	Padwal, R				Padwal, Raj			Review: Compared with systolic BP target of < 160 mm Hg, targeting < 120 is more effective; < 130 balances benefits and harms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Padwal, Raj] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Padwal, R (corresponding author), Univ Alberta, Edmonton, AB, Canada.		Padwal, Raj/G-6903-2016	Padwal, Raj/0000-0003-3541-2817				Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC64	JC64		10.7326/ACPJC-2017-166-12-064	http://dx.doi.org/10.7326/ACPJC-2017-166-12-064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630976				2022-12-28	WOS:000403579000005
J	Boyle, EA; Li, YI; Pritchard, JK				Boyle, Evan A.; Li, Yang I.; Pritchard, Jonathan K.			An Expanded View of Complex Traits: From Polygenic to Omnigenic	CELL			English	Review							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; HUMAN ADAPTATION; HUMAN-DISEASES; HERITABILITY; RARE; SCHIZOPHRENIA; ARCHITECTURE; MUTATIONS; VARIANTS	A central goal of genetics is to understand the links between genetic variation and disease. Intuitively, one might expect disease-causing variants to cluster into key pathways that drive disease etiology. But for complex traits, association signals tend to be spread across most of the genome-including near many genes without an obvious connection to disease. We propose that gene regulatory networks are sufficiently interconnected such that all genes expressed in disease-relevant cells are liable to affect the functions of core disease-related genes and that most heritability can be explained by effects on genes outside core pathways. We refer to this hypothesis as an "omnigenic" model.	[Boyle, Evan A.; Li, Yang I.; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Boyle, EA; Li, YI; Pritchard, JK (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Pritchard, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Pritchard, JK (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	eaboyle@stanford.edu; yangili@stanford.edu; pritch@stanford.edu		Li, Yang/0000-0002-0736-251X	National Science Foundation graduate research fellowship program [RO1 HG008140]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008140, T32HG000044] Funding Source: NIH RePORTER	National Science Foundation graduate research fellowship program(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by RO1 HG008140, the National Science Foundation graduate research fellowship program, and the Howard Hughes Medical Institute. We thank many colleagues for helpful conversations or comments, including D. Golan, W. Greenleaf, A. Harpak, A. Marson, J. Pickrell, M. Przeworski, G. Sella, and three anonymous reviewers.	Alasoo K., 2017, GENETIC EFFECTS CHRO; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; BARTON NH, 1990, GENETICS, V124, P773; Barton NH, 2016, INFINITESIMAL MODEL; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Chakravarti A, 2016, BIOESSAYS, V38, P578, DOI 10.1002/bies.201500203; Chatterjee S, 2016, CELL, V167, P355, DOI 10.1016/j.cell.2016.09.005; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jo B, 2016, DISTANT REGULATORY E; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Preininger M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003362; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Sonawane A. R., 2017, UNDERSTANDING TISSUE; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sullivan P. F., 2017, PSYCHIAT GENOMICS UP; Sun B. B., 2017, CONSEQUENCES NATURAL; The Psychiatric Genetics Consortium, 2016, NAT GENET, V49, P27; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2016, NAT GENET, V48, P707, DOI 10.1038/ng.3604; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiner D. J., 2016, POLYGENIC TRANSMISSI; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	67	1322	1339	12	275	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1177	1186		10.1016/j.cell.2017.05.038	http://dx.doi.org/10.1016/j.cell.2017.05.038			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622505	Green Accepted, Bronze			2022-12-28	WOS:000403332400008
J	Chervonsky, AV				Chervonsky, Alexander V.			Just a Spoonful of Sugar Helps the Tolerance Go Up	CELL			English	Editorial Material							CONFERS TOLERANCE; DISEASE	Survival of deleterious infections depends significantly on how much stress the affected organism can tolerate. In this issue, Weis et al. find that mice can survive sepsis by maintaining normoglycemia through ferritin's capacity to inactivate Fe2+ ions that otherwise induce free radicals impacting gluconeogenesis in the liver.	[Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu						[Anonymous], CELL; Deak M, 1999, NAT BIOTECHNOL, V17, P192, DOI 10.1038/6198; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Gozzelino R, 2012, CELL HOST MICROBE, V12, P693, DOI 10.1016/j.chom.2012.10.011; JENSEN SB, 1963, P SOC EXP BIOL MED, V113, P710, DOI 10.3181/00379727-113-28469; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026	9	3	3	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1170	1172		10.1016/j.cell.2017.05.040	http://dx.doi.org/10.1016/j.cell.2017.05.040			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622502	Bronze			2022-12-28	WOS:000403332400005
J	Kobayashi, T; Zhang, HX; Tang, WWC; Irie, N; Withey, S; Klisch, D; Sybirna, A; Dietmann, S; Contreras, DA; Webb, R; Allegrucci, C; Alberio, R; Surani, MA				Kobayashi, Toshihiro; Zhang, Haixin; Tang, Walfred W. C.; Irie, Naoko; Withey, Sarah; Klisch, Doris; Sybirna, Anastasiya; Dietmann, Sabine; Contreras, David A.; Webb, Robert; Allegrucci, Cinzia; Alberio, Ramiro; Surani, M. Azim			Principles of early human development and germ cell program from conserved model systems	NATURE			English	Article							PLURIPOTENT STEM-CELLS; IN-VITRO; DEFINITIVE ENDODERM; FATE; MOUSE; DIFFERENTIATION; MICE; SPECIFICATION; INDUCTION; DYNAMICS	Human primordial germ cells (hPGCs), the precursors of sperm and eggs, originate during weeks 2-3 of early post-implantation development(1). Using in vitro models of hPGC induction(2-4), recent studies have suggested that there are marked mechanistic differences in the specification of human and mouse PGCs(5). This may be due in part to the divergence in their pluripotency networks and early post-implantation development(6-8). As early human embryos are not accessible for direct study, we considered alternatives including porcine embryos that, as in humans, develop as bilaminar embryonic discs. Here we show that porcine PGCs originate from the posterior pre-primitive-streak competent epiblast by sequential upregulation of SOX17 and BLIMP1 in response to WNT and BMP signalling. We use this model together with human and monkey in vitro models simulating peri-gastrulation development to show the conserved principles of epiblast development for competency for primordial germ cell fate. This process is followed by initiation of the epigenetic program(9-11) and regulated by a balanced SOX17-BLIMP1 gene dosage. Our combinatorial approach using human, porcine and monkey in vivo and in vitro models provides synthetic insights into early human development.	[Kobayashi, Toshihiro; Tang, Walfred W. C.; Irie, Naoko; Sybirna, Anastasiya; Dietmann, Sabine; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England; [Kobayashi, Toshihiro; Tang, Walfred W. C.; Irie, Naoko; Sybirna, Anastasiya; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England; [Zhang, Haixin; Withey, Sarah; Klisch, Doris; Contreras, David A.; Webb, Robert; Alberio, Ramiro] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; [Sybirna, Anastasiya; Dietmann, Sabine] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England; [Allegrucci, Cinzia] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Contreras, David A.] CEIEPAA FMVZ UNAM, Tequisquiapan 76790, Queretaro, Mexico	University of Cambridge; University of Cambridge; University of Nottingham; University of Cambridge; University of Nottingham	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.; Surani, MA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.; Alberio, R (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.	Ramiro.Alberio@nottingham.ac.uk; a.surani@gurdon.cam.ac.uk	Withey, Sarah L/A-3460-2019; Alberio, Ramiro/G-5955-2011	Withey, Sarah L/0000-0003-0520-0290; Alberio, Ramiro/0000-0001-6560-3919; Zhang, Haixin/0000-0002-8840-053X; Dietmann, Sabine./0000-0001-6672-8457; Allegrucci, Cinzia/0000-0001-8517-2423; Sybirna, Anastasiya/0000-0002-8665-7112; Kobayashi, Toshihiro/0000-0001-8019-0008	JSPS; Uehara Foundation; Kanae Foundation; CSC; CONACYT; BBSRC [BB/M001466/1]; MRC [MR/P009948/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M001466/1] Funding Source: researchfish; Medical Research Council [MC_PC_12009, MR/P009948/1] Funding Source: researchfish; Rosetrees Trust [M603] Funding Source: researchfish	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Foundation(Uehara Memorial Foundation); Kanae Foundation; CSC; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust)	We thank R. Campbell and C. Lee for help with animals and hPSCs, A. Riddell for FACS and T. Otani for advice on cmPSCs. T.K. was supported by JSPS, the Uehara and Kanae Foundations; H.Z. by CSC; D.A.C. by CONACYT. The work was funded by BBSRC grant to R. A., C. A. and M.A.S (BB/M001466/1). M.A.S is a Wellcome Investigator.	Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Carter AM, 2016, THERIOGENOLOGY, V86, P278, DOI 10.1016/j.theriogenology.2016.04.041; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davidson KC, 2015, DEVELOPMENT, V142, P3090, DOI 10.1242/dev.116061; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Klisch K, 2011, REPRODUCTION, V142, P667, DOI 10.1530/REP-11-0007; Kuckenberg P, 2012, REPROD BIOMED ONLINE, V25, P12, DOI 10.1016/j.rbmo.2012.02.015; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lin IY, 2014, STEM CELL REP, V2, P189, DOI 10.1016/j.stemcr.2013.12.009; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Sasaki K, 2016, DEV CELL, V39, P169, DOI 10.1016/j.devcel.2016.09.007; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Sugawa F, 2015, EMBO J, V34, P1009, DOI 10.15252/embj.201488049; Surani M. A., 2017, PROTOC EXCH; Tang WWC, 2016, NAT REV GENET, V17, P585, DOI 10.1038/nrg.2016.88; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Magana GV, 2014, DEV BIOL, V387, P15, DOI 10.1016/j.ydbio.2014.01.008; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; Wang H, 2015, STEM CELLS DEV, V24, P2536, DOI 10.1089/scd.2015.0018; Wu J, 2016, CELL, V165, P1572, DOI 10.1016/j.cell.2016.05.043; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yoshida M, 2016, DEV DYNAM, V245, P67, DOI [10.1002/DVDY.24352, 10.1002/dvdy.24352]	39	155	159	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					416	+		10.1038/nature22812	http://dx.doi.org/10.1038/nature22812			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28607482	Green Accepted			2022-12-28	WOS:000403250900037
J	Qian, HW; Zhao, X; Cao, PP; Lei, JL; Yan, N; Gong, X				Qian, Hongwu; Zhao, Xin; Cao, Pingping; Lei, Jianlin; Yan, Nieng; Gong, Xin			Structure of the Human Lipid Exporter ABCA1	CELL			English	Article							BINDING CASSETTE TRANSPORTER; APOLIPOPROTEIN-A-I; EXTRACELLULAR DOMAIN; CHOLESTEROL EFFLUX; P-GLYCOPROTEIN; CELL-SURFACE; CONFORMATIONAL-CHANGES; PHOSPHOLIPID EFFLUX; CRYSTAL-STRUCTURES; TANGIER-DISEASE	ABCA1, an ATP-binding cassette (ABC) subfamily A exporter, mediates the cellular efflux of phospholipids and cholesterol to the extracellular acceptor apolipoprotein A-I (apoA-I) for generation of nascent high-density lipoprotein (HDL). Mutations of human ABCA1 are associated with Tangier disease and familial HDL deficiency. Here, we report the cryo-EM structure of human ABCA1 with nominal resolutions of 4.1 angstrom for the overall structure and 3.9 angstrom for the massive extracellular domain. The nucleotide-binding domains (NBDs) display a nucleotide-free state, while the two transmembrane domains (TMDs) contact each other through a narrow interface in the intracellular leaflet of the membrane. In addition to TMDs and NBDs, two extracellular domains of ABCA1 enclose an elongated hydrophobic tunnel. Structural mapping of dozens of disease-related mutations allows potential interpretation of their diverse pathogenic mechanisms. Structural-based analysis suggests a plausible "lateral access'' mechanism for ABCA1-mediated lipid export that may be distinct from the conventional alternating-access paradigm.	[Qian, Hongwu; Zhao, Xin; Cao, Pingping; Yan, Nieng; Gong, Xin] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Qian, Hongwu; Zhao, Xin; Cao, Pingping; Lei, Jianlin; Yan, Nieng; Gong, Xin] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Qian, Hongwu; Zhao, Xin; Cao, Pingping; Lei, Jianlin; Gong, Xin] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing 100084, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Sch Life Sci, Technol Ctr Prot Sci, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, N; Gong, X (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.; Yan, N; Gong, X (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Gong, X (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn; gongx@mail.tsinghua.edu.cn	Qian, Hongwu/AAL-7468-2021; Qian, Hongwu/GPT-1612-2022; Gong, Xin/W-6531-2018		Ministry of Science and Technology of China [2015CB910101, 2016YFA0500402, 2014ZX09507003-006, 2016YFA0501100]; National Natural Science Foundation of China [31621092, 31630017, 31611130036]; Tsinghua-Peking Center for Life Sciences postdoctoral fellowship; Advanced Innovation Fellowship from Beijing Advanced Innovation Center for Structural Biology; International Early Career Scientist grant from the Howard Hughes Medical Institute; endowed professorship from Bayer HealthCare	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences postdoctoral fellowship; Advanced Innovation Fellowship from Beijing Advanced Innovation Center for Structural Biology; International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); endowed professorship from Bayer HealthCare	We thank Xiaomei Li and Xiaomin Li for technical support during EM image acquisition. We thank Qiang Zhou for critical discussions. We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the cryo-EM facility support. We thank the computational facility support on the cluster of Bio-Computing Platform (Tsinghua University Branch of China National Center for Protein Sciences Beijing) and the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology of China (2015CB910101, 2016YFA0500402, 2014ZX09507003-006, and 2016YFA0501100) and the National Natural Science Foundation of China (projects 31621092, 31630017, and 31611130036). X.G. was supported by the Tsinghua-Peking Center for Life Sciences postdoctoral fellowship and Advanced Innovation Fellowship from Beijing Advanced Innovation Center for Structural Biology. N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and an endowed professorship from Bayer HealthCare.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Biswas-Fiss EE, 2010, J BIOL CHEM, V285, P19372, DOI 10.1074/jbc.M110.112896; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; DeLano W.L, PYMOL MOL GRAPHICS S; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Gulshan K, 2016, CIRC RES, V119, P827, DOI 10.1161/CIRCRESAHA.116.308856; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hozoji M, 2009, J BIOL CHEM, V284, P11293, DOI 10.1074/jbc.M900580200; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Knight HM, 2009, AM J HUM GENET, V85, P833, DOI 10.1016/j.ajhg.2009.11.003; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lin DYW, 2015, NATURE, V523, P425, DOI 10.1038/nature14623; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Nagao K, 2012, BBA-MOL CELL BIOL L, V1821, P530, DOI 10.1016/j.bbalip.2011.06.024; Nagao K, 2012, J LIPID RES, V53, P126, DOI 10.1194/jlr.M019976; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Nagao K, 2009, J LIPID RES, V50, P1165, DOI 10.1194/jlr.M800597-JLR200; Oldham ML, 2016, NATURE, V529, P537, DOI 10.1038/nature16506; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2001, J LIPID RES, V42, P1173; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rigot W, 2002, J LIPID RES, V43, P2077, DOI 10.1194/jlr.M200279-JLR200; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Singaraja RR, 2006, CIRC RES, V99, P389, DOI 10.1161/01.RES.0000237920.70451.ad; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang SH, 2014, BIOFACTORS, V40, P547, DOI 10.1002/biof.1187; Wang SH, 2013, ARTERIOSCL THROM VAS, V33, P1197, DOI 10.1161/ATVBAHA.112.301195; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zheng S., 2016, ANISOTROPIC CORRECTI	93	158	168	5	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1228	+		10.1016/j.cell.2017.05.020	http://dx.doi.org/10.1016/j.cell.2017.05.020			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28602350	Bronze			2022-12-28	WOS:000403332400012
J	Zhang, K; Foster, HE; Rondelet, A; Lacey, SE; Bahi-Buisson, N; Bird, AW; Carter, AP				Zhang, Kai; Foster, Helen E.; Rondelet, Arnaud; Lacey, Samuel E.; Bahi-Buisson, Nadia; Bird, Alexander W.; Carter, Andrew P.			Cryo-EM Reveals How Human Cytoplasmic Dynein Is Auto-inhibited and Activated	CELL			English	Article							CARGO ADAPTER COMPLEXES; DYNACTIN COMPLEX; LIGHT-CHAIN; IN-VITRO; TRANSPORT; PROCESSIVITY; RECONSTITUTION; MICROTUBULES; INITIATION; MOTILITY	Cytoplasmic dynein-1 binds dynactin and cargo adaptor proteins to form a transport machine capable of long-distance processive movement along microtubules. However, it is unclear why dynein-1 moves poorly on its own or how it is activated by dynactin. Here, we present a cryoelectron microscopy structure of the complete 1.4-megadalton human dynein-1 complex in an inhibited state known as the phi-particle. We reveal the 3D structure of the cargo binding dynein tail and show how self-dimerization of the motor domains locks them in a conformation with low microtubule affinity. Disrupting motor dimerization with structure-based mutagenesis drives dynein-1 into an open form with higher affinity for both microtubules and dynactin. We find the open form is also inhibited for movement and that dynactin relieves this by reorienting the motor domains to interact correctly with microtubules. Our model explains how dynactin binding to the dynein-1 tail directly stimulates its motor activity.	[Zhang, Kai; Foster, Helen E.; Lacey, Samuel E.; Carter, Andrew P.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [Rondelet, Arnaud; Bird, Alexander W.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Bahi-Buisson, Nadia] Univ Paris 05, Imaging Inst, Dept Pediat Neurol, INSERM U781, Paris, France	MRC Laboratory Molecular Biology; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Carter, AP (corresponding author), MRC, Lab Mol Biol, Cambridge CB2 0QH, England.	cartera@mrc-lmb.cam.ac.uk	Bahi-Buisson, Nadia/H-5207-2017	Bahi-Buisson, Nadia/0000-0002-5352-0929; Foster, Helen/0000-0002-4691-5746; Zhang, Kai/0000-0001-8617-2855; Lacey, Samuel/0000-0002-3807-8888; Bird, Alexander/0000-0002-1061-0799; Carter, Andrew/0000-0001-7292-5430	Wellcome Trust [WT100387]; Medical Research Council, UK [MC_UP_A025_1011]; Worldwide Cancer Research project [16-0093]; MRC [MC_UP_A025_1011] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1011] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Worldwide Cancer Research project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Scheres for cryo-EM advice; S. Chen, G. McMullan, C. Savva, J. Grimmett, and T. Darling for technical support at the MRC-LMB; D. Clare (Diamond Light Source, UK electron Bio-Imaging Center: EM13361), T. Boesen, J. Song, M. Dong (Aarhus University), and J. Novacek (CEITEC) for help with data collection; S. Maffini (MPI-Dortmund) for help with live-cell microscopy; S. Bullock, D. Barford, C. Lau, and J. Carter for comments on the manuscript. This work was funded by grants from the Wellcome Trust (WT100387) and the Medical Research Council, UK (MC_UP_A025_1011) to A.P.C. and the Worldwide Cancer Research project (16-0093) to A.W.B.	AMOS LA, 1989, J CELL SCI, V93, P19; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Belyy V, 2016, NAT CELL BIOL, V18, P1018, DOI 10.1038/ncb3393; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hertecant J, 2016, META GENE, V9, P124, DOI 10.1016/j.mgene.2016.05.004; Hoang HT, 2017, P NATL ACAD SCI USA, V114, pE1597, DOI 10.1073/pnas.1620141114; Imai H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9179; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; McKenney RJ, 2016, EMBO J, V35, P1175, DOI 10.15252/embj.201593071; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Nicholas MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7206; Nirschl JJ, 2016, CELL REP, V14, P2637, DOI 10.1016/j.celrep.2016.02.046; Olenick MA, 2016, J BIOL CHEM, V291, P18239, DOI 10.1074/jbc.M116.738211; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schiavo G, 2013, TRENDS NEUROSCI, V36, P641, DOI 10.1016/j.tins.2013.08.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Siglin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059453; Song J, 2005, J MOL BIOL, V354, P1043, DOI 10.1016/j.jmb.2005.10.017; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Strickland AV, 2015, J NEUROL, V262, P2124, DOI 10.1007/s00415-015-7727-2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Toropova K, 2017, NAT STRUCT MOL BIOL, V24, P461, DOI 10.1038/nsmb.3391; Tripathy SK, 2014, NAT CELL BIOL, V16, P1192, DOI 10.1038/ncb3063; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; van Heesbeen RGHP, 2014, CELL REP, V8, P948, DOI 10.1016/j.celrep.2014.07.015; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003	56	123	124	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1303	+		10.1016/j.cell.2017.05.025	http://dx.doi.org/10.1016/j.cell.2017.05.025			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28602352	Green Published, hybrid			2022-12-28	WOS:000403332400018
J	Wareham, S				Wareham, Sue			Bryan Furnass OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2017	357								j2889	10.1136/bmj.j2889	http://dx.doi.org/10.1136/bmj.j2889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UT	28615191				2022-12-28	WOS:000403753400011
J	Reinhardt, U				Reinhardt, Uwe			Where Does the Health Insurance Premium Dollar Go?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Reinhardt, Uwe] Princeton Univ, Polit Econ, Princeton, NJ 08544 USA; [Reinhardt, Uwe] Princeton Univ, Econ, Princeton, NJ 08544 USA; [Reinhardt, Uwe] Princeton Univ, Griswold Ctr Econ Policy Studies, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Reinhardt, U (corresponding author), Princeton Univ, Polit Econ, Princeton, NJ 08544 USA.; Reinhardt, U (corresponding author), Princeton Univ, Econ, Princeton, NJ 08544 USA.; Reinhardt, U (corresponding author), Princeton Univ, Griswold Ctr Econ Policy Studies, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2269	2270		10.1001/jama.2017.6200	http://dx.doi.org/10.1001/jama.2017.6200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609523	Bronze			2022-12-28	WOS:000403149900002
J	Palm, W; Thompson, CB				Palm, Wilhelm; Thompson, Craig B.			Nutrient acquisition strategies of mammalian cells	NATURE			English	Review							EPIDERMAL-GROWTH-FACTOR; RAS-TRANSFORMED CELLS; PROTEIN-KINASE AMPK; TRANSCRIPTION FACTOR; GLUTAMINE-METABOLISM; TUMOR METABOLISM; PHOSPHOINOSITIDE 3-KINASE; EXTRACELLULAR PROTEIN; PYRUVATE-CARBOXYLASE; CELLULAR ADAPTATION	Mammalian cells are surrounded by diverse nutrients, such as glucose, amino acids, various macromolecules and micronutrients, which they can import through transmembrane transporters and endolysosomal pathways. By using different nutrient sources, cells gain metabolic flexibility to survive periods of starvation. Quiescent cells take up sufficient nutrients to sustain homeostasis. However, proliferating cells depend on growth-factor-induced increases in nutrient uptake to support biomass formation. Here, we review cellular nutrient acquisition strategies and their regulation by growth factors and cell-intrinsic nutrient sensors. We also discuss how oncogenes and tumour suppressors promote nutrient uptake and thereby support the survival and growth of cancer cells.	[Palm, Wilhelm; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	thompsonc@mskcc.org	Palm, Wilhelm/AAS-6255-2021		Genentech Foundation Hope Funds for Cancer Research Fellowship; NCI [R01 CA201318]; Cancer Center Support Grant [P30CA008748]; NATIONAL CANCER INSTITUTE [R01CA201318, P30CA008748, P01CA104838] Funding Source: NIH RePORTER	Genentech Foundation Hope Funds for Cancer Research Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Thompson laboratory and in particular L. Finley and T. Lindsten for discussions. W.P. is the recipient of the Genentech Foundation Hope Funds for Cancer Research Fellowship. Work in the Thompson laboratory is supported by a grant from NCI to C.B.T. (R01 CA201318) and Cancer Center Support Grant P30CA008748.	Abbud W, 2000, ARCH BIOCHEM BIOPHYS, V380, P347, DOI 10.1006/abbi.2000.1935; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; BAILEY JM, 1964, P SOC EXP BIOL MED, V115, P747; Barnes K, 2002, J CELL SCI, V115, P2433; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bloomfield G, 2016, J CELL SCI, V129, P2697, DOI 10.1242/jcs.176149; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BRUNK U, 1976, EXP CELL RES, V103, P295, DOI 10.1016/0014-4827(76)90266-4; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Davidson SM, 2017, NAT MED, V23, P235, DOI 10.1038/nm.4256; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; DAVIS RJ, 1986, EMBO J, V5, P653, DOI 10.1002/j.1460-2075.1986.tb04263.x; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Krajcovic M, 2013, MOL BIOL CELL, V24, P3736, DOI 10.1091/mbc.E13-07-0408; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lewis WH, 1931, B JOHNS HOPKINS HOSP, V49, P17; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1566, DOI 10.1016/j.bbalip.2013.07.008; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Muranen T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13989; NECKERS LM, 1983, P NATL ACAD SCI-BIOL, V80, P3494, DOI 10.1073/pnas.80.11.3494; Nelson D. L, 2012, LEHNINGER PRINCIPLES; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Palmada M, 2005, BIOCHEM BIOPH RES CO, V331, P272, DOI 10.1016/j.bbrc.2005.03.159; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Stehle G, 1997, CRIT REV ONCOL HEMAT, V26, P77, DOI 10.1016/S1040-8428(97)00015-2; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Sun Q, 2014, CELL RES, V24, P1299, DOI 10.1038/cr.2014.138; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tardito S, 2015, NAT CELL BIOL, V17, P1556, DOI 10.1038/ncb3272; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Warburg O, 1924, BIOCHEM Z, V152, P309; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432	112	206	207	8	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					234	242		10.1038/nature22379	http://dx.doi.org/10.1038/nature22379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593971	Green Accepted			2022-12-28	WOS:000402823400027
J	Rubin, EJ				Rubin, Eric J.			Reviving a Drug for Tuberculosis?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ETHIONAMIDE		[Rubin, Eric J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.							Blondiaux N, 2017, SCIENCE, V355, P1206, DOI 10.1126/science.aag1006; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Willand N, 2009, NAT MED, V15, P537, DOI 10.1038/nm.1950	3	4	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2292	2294		10.1056/NEJMcibr1703502	http://dx.doi.org/10.1056/NEJMcibr1703502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW8WG	28591540				2022-12-28	WOS:000402798200017
J	Vijayalakshmi, AA; Anand, S				Vijayalakshmi, Arun A.; Anand, Shrutiraaj			Mondor's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vijayalakshmi, Arun A.; Anand, Shrutiraaj] Armed Forces Med Coll, Pune, Maharashtra, India	Armed Forces Medical College	Vijayalakshmi, AA (corresponding author), Armed Forces Med Coll, Pune, Maharashtra, India.	arunva5407@gmail.com		SHRUTIRAAJ, KUMAR ANAND/0000-0002-2382-2352					0	5	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					E47	E47		10.1056/NEJMicm1611550	http://dx.doi.org/10.1056/NEJMicm1611550			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW8WG	28591532				2022-12-28	WOS:000402798200011
J	Goldstein, RF; Abell, SK; Ranasinha, S; Misso, M; Boyle, JA; Black, MH; Li, N; Hu, G; Corrado, F; Rode, L; Kim, YJ; Haugen, M; Song, WO; Kim, MH; Bogaerts, A; Devlieger, R; Chung, JH; Teede, HJ				Goldstein, Rebecca F.; Abell, Sally K.; Ranasinha, Sanjeeva; Misso, Marie; Boyle, Jacqueline A.; Black, Mary Helen; Li, Nan; Hu, Gang; Corrado, Francesco; Rode, Line; Kim, Young Ju; Haugen, Margaretha; Song, Won O.; Kim, Min Hyoung; Bogaerts, Annick; Devlieger, Roland; Chung, Judith H.; Teede, Helena J.			Association of Gestational Weight Gain With Maternal and Infant Outcomes A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BODY-MASS INDEX; ADVERSE PREGNANCY OUTCOMES; LOW-BIRTH-WEIGHT; OBESE WOMEN; PRETERM BIRTH; PERINATAL OUTCOMES; RISK; IMPACT	IMPORTANCE Body mass index (BMI) and gestational weight gain are increasing globally. In 2009, the Institute of Medicine (IOM) provided specific recommendations regarding the ideal gestational weight gain. However, the association between gestational weight gain consistent with the IOM guidelines and pregnancy outcomes is unclear. OBJECTIVE To perform a systematic review, meta-analysis, and metaregression to evaluate associations between gestational weight gain above or below the IOM guidelines (gain of 12.5-18 kg for underweight women [BMI <18.5]; 11.5-16 kg for normal-weight women [BMI 18.5-24.9]; 7-11 kg for overweight women [BMI 25-29.9]; and 5-9 kg for obese women [BMI >= 30]) and maternal and infant outcomes. DATA SOURCES AND STUDY SELECTION Search of EMBASE, Evidence-Based Medicine Reviews, MEDLINE, and MEDLINE In-Process between January 1, 1999, and February 7, 2017, for observational studies stratified by prepregnancy BMI category and total gestational weight gain. DATA EXTRACTION AND SYNTHESIS Data were extracted by 2 independent reviewers. Odds ratios (ORs) and absolute risk differences (ARDs) per live birth were calculated using a random-effects model based on a subset of studies with available data. MAIN OUTCOMES AND MEASURES Primary outcomes were small for gestational age (SGA), preterm birth, and large for gestational age (LGA). Secondary outcomes were macrosomia, cesarean delivery, and gestational diabetes mellitus. RESULTS Of 5354 identified studies, 23 (n = 1 309 136 women) met inclusion criteria. Gestational weight gain was below or above guidelines in 23% and 47% of pregnancies, respectively. Gestational weight gain below the recommendations was associated with higher risk of SGA (OR, 1.53 [95% CI, 1.44-1.64]; ARD, 5%[95% CI, 4%-6%]) and preterm birth (OR, 1.70 [1.32-2.20]; ARD, 5%[3%-8%]) and lower risk of LGA (OR, 0.59 [0.55-0.64]; ARD, -2% [-10% to -6%]) and macrosomia (OR, 0.60 [0.52-0.68]; ARD, -2%[-3% to -1%]); cesarean delivery showed no significant difference (OR, 0.98 [0.96-1.02]; ARD, 0%[-2% to 1%]). Gestational weight gain above the recommendations was associated with lower risk of SGA (OR, 0.66 [0.63-0.69]; ARD, -3%; [-4% to -2%]) and preterm birth (OR, 0.77 [0.69-0.86]; ARD, -2%[-2% to -1%]) and higher risk of LGA (OR, 1.85 [1.76-1.95]; ARD, 4%[2%-5%]), macrosomia (OR, 1.95 [1.79-2.11]; ARD, 6%[4%-9%]), and cesarean delivery (OR, 1.30 [1.25-1.35]; ARD, 4%[3%-6%]). Gestational diabetes mellitus could not be evaluated because of the nature of available data. CONCLUSIONS AND RELEVANCE In this systematic review andmeta-analysis of more than 1 million pregnant women, 47% had gestational weight gain greater than IOM recommendations and 23% had gestational weight gain less than IOM recommendations. Gestational weight gain greater than or less than guideline recommendations, compared with weight gain within recommended levels, was associated with higher risk of adverse maternal and infant outcomes.	[Goldstein, Rebecca F.; Abell, Sally K.; Ranasinha, Sanjeeva; Misso, Marie; Boyle, Jacqueline A.; Teede, Helena J.] Monash Univ, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia; [Goldstein, Rebecca F.; Abell, Sally K.; Teede, Helena J.] Monash Hlth, Monash Diabet Unit, Clayton, Vic, Australia; [Goldstein, Rebecca F.; Abell, Sally K.; Teede, Helena J.] Monash Hlth, Monash Endocrine Unit, Clayton, Vic, Australia; [Black, Mary Helen] Kaiser Permanente, Los Angeles, CA USA; [Black, Mary Helen] Ambry Genet, Aliso Viejo, CA USA; [Li, Nan] Tianjin Womens & Childrens Hlth Ctr, Tianjin, Peoples R China; [Hu, Gang] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Corrado, Francesco] Univ Hosp, Messina, Italy; [Rode, Line] Rigshosp, Copenhagen Univ Hosp, Dept Biochem, Copenhagen, Denmark; [Kim, Young Ju] Ewha Womans Univ, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea; [Haugen, Margaretha] Norwegian Inst Publ Hlth, Oslo, Norway; [Song, Won O.] Michigan State Univ, E Lansing, MI 48824 USA; [Kim, Min Hyoung] Dankook Univ, Coll Med, Seoul, South Korea; [Bogaerts, Annick] Univ Leuven, KU Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Bogaerts, Annick] Univ Antwerp, Ctr Res & Innovat Care, Fac Med & Hlth Sci, Antwerp, Belgium; [Bogaerts, Annick] UC Leuven Limburg, Res Unit Hlth Living, Fac Hlth & Social Work, Leuven, Belgium; [Devlieger, Roland] Univ Hosp KU Leuven, Dept Obstet & Gynaecol, Leuven, Belgium; [Devlieger, Roland] GZA Campus Sint Augustinus, Dept Obstet Gynaecol & Fertil, Antwerp, Belgium; [Chung, Judith H.] Univ Calif Irvine, Irvine, CA USA	Monash University; Kaiser Permanente; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; AOU Policlinico Gaetano Martino; Rigshospitalet; University of Copenhagen; Ewha Womans University; Norwegian Institute of Public Health (NIPH); Michigan State University; Dankook University; KU Leuven; University of Antwerp; KU Leuven; University Hospital Leuven; University of California System; University of California Irvine	Teede, HJ (corresponding author), Monash Univ, 43-51 Kanooka Dr, Melbourne, Vic 3168, Australia.	helena.teede@monash.edu	Rode, Line/P-7625-2018; Boyle, Jacqueline/AAD-3246-2019; Hu, Gang/N-1971-2017; Bogaerts, Annick/W-9674-2018; Devlieger, Roland/AAS-9181-2020; Hu, Gang/V-7947-2019; Kim, Young Ju/P-1853-2014	Rode, Line/0000-0002-9080-3389; Hu, Gang/0000-0002-6172-8017; Devlieger, Roland/0000-0001-7837-4684; Hu, Gang/0000-0002-6172-8017; Bogaerts, Annick/0000-0003-2718-4682; Teede, Helena/0000-0001-7609-577X; Black, Mary Jane/0000-0002-9253-3773; Kim, Young Ju/0000-0002-3153-3008; Boyle, Jacqueline/0000-0002-3616-1637; ranasinha, sanjeeva/0000-0003-1323-4917	Research Training Program scholarship from the Department of Education and Training; National Health and Medical Research Council	Research Training Program scholarship from the Department of Education and Training; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Dr Goldstein is supported by a Research Training Program scholarship from the Department of Education and Training. Dr Abell is supported by a scholarship from the National Health and Medical Research Council. Drs Boyle and Teede are supported by fellowships from the National Health and Medical Research Council.	[Anonymous], 2014, CASE ACTION PROPOSAL; [Anonymous], 2014, EV SYNTH PROGR TEMPL; Badon SE, 2014, OBESITY, V22, P1731, DOI 10.1002/oby.20742; Billionnet C, 2017, DIABETOLOGIA, V60, P636, DOI 10.1007/s00125-017-4206-6; Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Bogaerts A, 2015, OBSTET GYNECOL, V126, P452, DOI 10.1097/AOG.0000000000000988; Bogaerts A, 2015, OBSTET GYNECOL, V125, P566, DOI 10.1097/AOG.0000000000000677; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Chihara I, 2014, MATERN CHILD HLTH J, V18, P1123, DOI 10.1007/s10995-013-1342-6; Di Benedetto A, 2012, DIABETES METAB, V38, P63, DOI 10.1016/j.diabet.2011.07.005; Durst JK, 2016, AM J PERINAT, V33, P849, DOI 10.1055/s-0036-1579650; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enomoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157081; Faucher MA, 2016, BJOG-INT J OBSTET GY, V123, P199, DOI 10.1111/1471-0528.13797; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Gavard JA, 2014, MATERN CHILD HLTH J, V18, P1038, DOI 10.1007/s10995-013-1356-0; Han Z, 2011, ACTA OBSTET GYN SCAN, V90, P935, DOI 10.1111/j.1600-0412.2011.01185.x; Harrison CL, 2013, OBESITY, V21, P904, DOI 10.1002/oby.20163; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, P201, DOI DOI 10.1186/1471-2393-14-201; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hrolfsdottir L, 2015, INT J OBESITY, V39, P671, DOI 10.1038/ijo.2014.179; Institute of Medicine, 1990, NUTR PREGN 1; Kapadia MZ, 2015, OBES REV, V16, P189, DOI 10.1111/obr.12238; Kapadia MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132650; Kominiarek MA, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.035; Lederman S A, 1998, Matern Child Health J, V2, P123; Lee Joung Min, 2014, Obstet Gynecol Sci, V57, P442, DOI 10.5468/ogs.2014.57.6.442; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; McDonald SD, 2011, J OBSTET GYNAECOL CA, V33, P1223, DOI 10.1016/S1701-2163(16)35107-6; Naderpoor N, 2016, HUM REPROD UPDATE, V22, P408, DOI 10.1093/humupd/dmv063; Nicholas LM, 2013, FASEB J, V27, P3786, DOI 10.1096/fj.13-227918; Nohr EA, 2008, AM J CLIN NUTR, V88, P1705, DOI 10.3945/ajcn.2008.26939; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Park JH, 2011, J OBSTET GYNAECOL RE, V37, P138, DOI 10.1111/j.1447-0756.2010.01332.x; Park S, 2011, MATERN CHILD HLTH J, V15, P289, DOI 10.1007/s10995-010-0596-5; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Rode L, 2007, OBSTET GYNECOL, V109, P1309, DOI 10.1097/01.AOG.0000266556.69952.de; Ruifrok AE, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-131; Savitz DA, 2011, ANN EPIDEMIOL, V21, P78, DOI 10.1016/j.annepidem.2010.06.009; Shin D, 2015, J MATERN-FETAL NEO M, V28, P1679, DOI 10.3109/14767058.2014.964675; Simas TAM, 2012, J WOMENS HEALTH, V21, P410, DOI 10.1089/jwh.2011.2810; Swank ML, 2014, OBSTET GYNECOL, V124, P1105, DOI 10.1097/AOG.0000000000000553; Hung TH, 2016, TAIWAN J OBSTET GYNE, V55, P575, DOI 10.1016/j.tjog.2016.06.016; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Vesco KK, 2011, OBSTET GYNECOL, V117, P812, DOI 10.1097/AOG.0b013e3182113ae4; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Wen TY, 2015, INT J CLIN EXP MED, V8, P2881; World Health Organisation, 2016, WHO REC ANT CAR POS; Xiong C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37168; Xu Z, 2017, J MATERN-FETAL NEO M, V30, P357, DOI 10.3109/14767058.2016.1173029; Yang SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130101; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	56	711	756	9	193	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2207	2225		10.1001/jama.2017.3635	http://dx.doi.org/10.1001/jama.2017.3635			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586887	Green Published, Bronze			2022-12-28	WOS:000402706100017
J	Viner, R; White, B; Christie, D				Viner, Russell; White, Billy; Christie, Deborah			Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden	LANCET			English	Review							BODY-MASS INDEX; BARIATRIC SURGERY; DEPRESSIVE SYMPTOMS; QUALITATIVE-ANALYSIS; INSULIN-RESISTANCE; GLYCEMIC CONTROL; YOUNG ADULTHOOD; DOUBLE-BLIND; RISK-FACTORS; WEIGHT-LOSS	Type 2 diabetes in adolescence manifests as a severe progressive form of diabetes that frequently presents with complications, responds poorly to treatment, and results in rapid progression of microvascular and macrovascular complications. Although overall still a rare disease, adolescent type 2 diabetes now poses major challenges to paediatric and adult diabetes services in many countries. Therapeutic options are heavily curtailed by a dearth of knowledge about the condition, with low numbers of participants and poor trial recruitment impeding research. Together with lifestyle modification, metformin remains the first-line therapy for adolescents with type 2 diabetes, although the majority rapidly progress to treatment failure and insulin therapy. Early bariatric surgery is controversial but has great potential to transform outcomes. Health systems must respond by both concentrating patients in specialist clinical services integrated with translational research programmes, but also by joining up with local health and social care services to improve engagement and uptake of services.	[Viner, Russell; White, Billy] UCL, Inst Child Hlth, Great Ormond St, London WC1N 1EH, England; [Viner, Russell; White, Billy; Christie, Deborah] UCL Hosp NHS Fdn Trust, Child & Adolescent Diabet Serv, London, England; [Christie, Deborah] UCL, Inst Epidemiol & Healthcare, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London	Viner, R (corresponding author), UCL, Inst Child Hlth, Great Ormond St, London WC1N 1EH, England.	r.viner@ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247	Medtronic Ltd; Eli Lilly; OmniaMed	Medtronic Ltd(Medtronic); Eli Lilly(Eli Lilly); OmniaMed	RV has attended meals funded by Medtronic Ltd related to clinical training in insulin pump use. DC has accepted speaker's fees from Eli Lilly, and other from Pfizer, Medtronic, and Novo Nordisk for presentations relating to psychological issues in diabetes. BW has received speaker's fees from Eli Lilly and OmniaMed for presentations on transition in diabetes.	Alsafar H, 2012, INT J DIABETES DEV C, V32, P25, DOI 10.1007/s13410-012-0062-6; [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; Arslanian S, 2013, DIABETES CARE, V36, P1749, DOI 10.2337/dc12-2393; Bagdure D, 2013, PEDIATR DIABETES, V14, P18, DOI 10.1111/j.1399-5448.2012.00897.x; Beckles ZL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i139; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bjornstad P, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0708-0; Black JA, 2013, OBES REV, V14, P634, DOI 10.1111/obr.12037; Brackney DE, 2015, J SCH NURS, V31, P6, DOI 10.1177/1059840514535445; Brouwer AM, 2012, CLIN PEDIATR, V51, P1130, DOI 10.1177/0009922812460914; Chernausek SD, 2016, DIABETES CARE, V39, P110, DOI 10.2337/dc15-1557; Christensen ML, 2015, J CLIN PHARMACOL, V55, P731, DOI 10.1002/jcph.497; Copeland KC, 2013, PEDIATRICS, V131, P364, DOI 10.1542/peds.2012-3494; Copeland KC, 2011, J CLIN ENDOCR METAB, V96, P159, DOI 10.1210/jc.2010-1642; Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; Danne T, 2017, J PEDIATR-US, V181, P146, DOI 10.1016/j.jpeds.2016.10.076; Dart AB, 2014, DIABETES CARE, V37, P436, DOI 10.2337/dc13-0954; Dawed AY, 2016, DIABETES CARE, V39, P1902, DOI 10.2337/dc15-2464; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Diabet Children Adolescents Work G, 2004, PEDIATRICS, V114, P259; Dujic T, 2016, DIABETES CARE, V39, P1896, DOI 10.2337/dc16-0706; Eppens MC, 2006, DIABETES CARE, V29, P1300, DOI 10.2337/dc05-2470; Eriksson JG, 2015, J INTERN MED, V278, P219, DOI 10.1111/joim.12354; Farsani SF, 2013, DIABETOLOGIA, V56, P1471, DOI 10.1007/s00125-013-2915-z; Galling B, 2016, JAMA PSYCHIAT, V73, P247, DOI 10.1001/jamapsychiatry.2015.2923; Geloneck MM, 2015, OPHTHALMOLOGY, V122, P2457, DOI 10.1016/j.ophtha.2015.07.010; Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4; Hannon TS, 2006, PEDIATR RES, V60, P759, DOI 10.1203/01.pdr.0000246097.73031.27; Hannon TS, 2015, ANN NY ACAD SCI, V1353, P113, DOI 10.1111/nyas.12939; Hannon TS, 2013, PEDIATR DIABETES, V14, P497, DOI 10.1111/pedi.12035; Inge TH, 2016, NEW ENGL J MED, V374, P113, DOI 10.1056/NEJMoa1506699; Katz LEL, 2005, PEDIATR DIABETES, V6, P84, DOI 10.1111/j.1399-543X.2005.00105.x; Kaulfers AMD, 2011, PEDIATRICS, V127, pE956, DOI 10.1542/peds.2010-0785; Khanolkar AR, 2016, J ADOLESCENT HEALTH, V59, P354, DOI 10.1016/j.jadohealth.2016.05.012; Klein DJ, 2014, DIABETES TECHNOL THE, V16, P679, DOI 10.1089/dia.2013.0366; Klingensmith GJ, 2016, PEDIATR DIABETES, V17, P266, DOI 10.1111/pedi.12281; Klingensmith GJ, 2016, DIABETES CARE, V39, P122, DOI 10.2337/dc15-1206; Laffel L, 2012, PEDIATR DIABETES, V13, P385, DOI 10.1111/j.1399-5448.2011.00846.x; Lawrence JM, 2006, PEDIATRICS, V117, P1348, DOI 10.1542/peds.2005-1398; Lee JM, 2011, DIABETES CARE, V34, P2597, DOI 10.2337/dc11-0827; Lee Jung Hyun, 2015, Ann Pediatr Endocrinol Metab, V20, P206, DOI 10.6065/apem.2015.20.4.206; Levitsky LL, 2013, DIABETES CARE, V36, P1772, DOI 10.2337/dc12-2387; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Mayer-Davis EJ, 2012, DIABETIC MED, V29, P1148, DOI 10.1111/j.1464-5491.2012.03591.x; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; Mayer-Davis EJ, 2009, METAB SYNDR RELAT D, V7, P89, DOI 10.1089/met.2008.0046; Miras AD, 2013, NAT REV GASTRO HEPAT, V10, P575, DOI 10.1038/nrgastro.2013.119; Morgan AR, 2012, CURR DIABETES REP, V12, P88, DOI 10.1007/s11892-011-0245-4; Mulvaney SA, 2006, DIABETES CARE, V29, P993, DOI 10.2337/dc05-2099; Nadeau K, 2011, J ADOLESCENT HEALTH, V49, P90, DOI 10.1016/j.jadohealth.2010.10.005; Nadeau KJ, 2016, DIABETES CARE, V39, P1635, DOI 10.2337/dc16-1066; Nambam B, 2017, PEDIATR DIABETES, V18, P222, DOI 10.1111/pedi.12377; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute for Health and Care Excellence (NICE), 2016, DIAB TYP 1 TYP 2 CHI; Nguyen TT, 2014, J ADOLESCENT HEALTH, V54, P247, DOI 10.1016/j.jadohealth.2013.08.017; Oester IMB, 2016, PEDIATR DIABETES, V17, P368, DOI 10.1111/pedi.12291; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Pihoker C, 2013, J CLIN ENDOCR METAB, V98, P4055, DOI 10.1210/jc.2013-1279; Pramyothin P, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0623-4; Praveen PA, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0571-4; Pulgaron Elizabeth Rose, 2015, Int J Adolesc Med Health, V27, P271, DOI 10.1515/ijamh-2014-0021; Rani F, 2008, PEDIATRICS, V121, P1002, DOI 10.1542/peds.2007-2008; Royal College of Paediatrics and Child Health, 2017, TYP 2 DIAB CHILDH UK; Royal College of Paediatrics and Child Health, 2016, NAT PAED DIAB AUD 20; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Salamon KS, 2012, DIABETES EDUCATOR, V38, P543, DOI 10.1177/0145721712445214; Shah AS, 2016, DIABETES CARE, V39, P934, DOI 10.2337/dc16-0067; Shield JPH, 2009, ARCH DIS CHILD, V94, P206, DOI 10.1136/adc.2008.143313; Silverstein J, 2015, DIABETES CARE, V38, P2341, DOI 10.2337/dc15-0982; Suglia SF, 2016, AM J EPIDEMIOL, V183, P269, DOI 10.1093/aje/kwv149; Tryggestad JB, 2015, J DIABETES COMPLICAT, V29, P307, DOI 10.1016/j.jdiacomp.2014.10.009; Turner KM, 2015, DIABETIC MED, V32, P250, DOI 10.1111/dme.12577; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; Viner RM, 2005, ARCH DIS CHILD, V90, P10, DOI 10.1136/adc.2003.036467; Walders-Abramson N, 2014, J PEDIATR-US, V165, P504, DOI 10.1016/j.jpeds.2014.05.020; Wei GS, 2015, DIABETES CARE, V38, P2042, DOI 10.2337/dc14-2770; Wittmeier KDM, 2012, PAED CHILD HEALT-CAN, V17, P129, DOI 10.1093/pch/17.3.129; Wong K, 2010, DIABETES CARE, V33, P512, DOI 10.2337/dc09-1333; Yeung RO, 2014, LANCET DIABETES ENDO, V2, P935, DOI 10.1016/S2213-8587(14)70137-8; Zeitler P, 2014, PEDIATR DIABETES, V15, P26, DOI 10.1111/pedi.12179; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	81	82	85	2	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2252	2260		10.1016/S0140-6736(17)31371-5	http://dx.doi.org/10.1016/S0140-6736(17)31371-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW5JC	28589895	Green Submitted			2022-12-28	WOS:000402540800033
J	Peters, S; Camidge, DR; Shaw, AT; Gadgeel, S; Ahn, JS; Kim, DW; Ou, SHI; Perol, M; Dziadziuszko, R; Rosell, R; Zeaiter, A; Mitry, E; Golding, S; Balas, B; Noe, J; Morcos, PN; Mok, T				Peters, Solange; Camidge, D. Ross; Shaw, Alice T.; Gadgeel, Shirish; Ahn, Jin S.; Kim, Dong-Wan; Ou, Sai-Hong I.; Perol, Maurice; Dziadziuszko, Rafal; Rosell, Rafael; Zeaiter, Ali; Mitry, Emmanuel; Golding, Sophie; Balas, Bogdana; Noe, Johannes; Morcos, Peter N.; Mok, Tony		ALEX Trial Investigators	Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHIBITOR ALECTINIB; ANTITUMOR-ACTIVITY; CHEMOTHERAPY; RESISTANT; MODELS	BACKGROUND Alectinib, a highly selective inhibitor of anaplastic lymphoma kinase (ALK), has shown systemic and central nervous system (CNS) efficacy in the treatment of ALK-positive non-small-cell lung cancer (NSCLC). We investigated alectinib as compared with crizotinib in patients with previously untreated, advanced ALK-positive NSCLC, including those with asymptomatic CNS disease. METHODS In a randomized, open-label, phase 3 trial, we randomly assigned 303 patients with previously untreated, advanced ALK-positive NSCLC to receive either alectinib (600 mg twice daily) or crizotinib (250 mg twice daily). The primary end point was investigator-assessed progression-free survival. Secondary end points were independent review committee-assessed progression-free survival, time to CNS progression, objective response rate, and overall survival. RESULTS During a median follow-up of 17.6 months (crizotinib) and 18.6 months (alectinib), an event of disease progression or death occurred in 62 of 152 patients (41%) in the alectinib group and 102 of 151 patients (68%) in the crizotinib group. The rate of investigator-assessed progression-free survival was significantly higher with alectinib than with crizotinib (12-month event-free survival rate, 68.4% [95% confidence interval (CI), 61.0 to 75.9] with alectinib vs. 48.7% [95% CI, 40.4 to 56.9] with crizotinib; hazard ratio for disease progression or death, 0.47 [95% CI, 0.34 to 0.65]; P<0.001); the median progression-free survival with alectinib was not reached. The results for independent review committee-assessed progression-free survival were consistent with those for the primary end point. A total of 18 patients (12%) in the alectinib group had an event of CNS progression, as compared with 68 patients (45%) in the crizotinib group (cause-specific hazard ratio, 0.16; 95% CI, 0.10 to 0.28; P<0.001). A response occurred in 126 patients in the alectinib group (response rate, 82.9%; 95% CI, 76.0 to 88.5) and in 114 patients in the crizotinib group (response rate, 75.5%; 95% CI, 67.8 to 82.1) (P = 0.09). Grade 3 to 5 adverse events were less frequent with alectinib (41% vs. 50% with crizotinib). CONCLUSIONS As compared with crizotinib, alectinib showed superior efficacy and lower toxicity in primary treatment of ALK-positive NSCLC. (Funded by F. Hoffmann-La Roche; ALEX ClinicalTrials.gov number, NCT02075840.)	[Peters, Solange] Lausanne Univ Hosp, Lausanne, Switzerland; [Zeaiter, Ali; Mitry, Emmanuel; Golding, Sophie; Balas, Bogdana; Noe, Johannes] F Hoffmann La Roche, Basel, Switzerland; [Camidge, D. Ross] Univ Colorado, Denver, CO 80202 USA; [Shaw, Alice T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Gadgeel, Shirish] Univ Michigan, Ann Arbor, MI 48109 USA; [Ahn, Jin S.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Seoul, South Korea; [Ou, Sai-Hong I.] Univ Calif Irvine, Sch Med, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA; [Perol, Maurice] Leon Berard Canc Ctr, Dept Med Oncol, Lyon, France; [Dziadziuszko, Rafal] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland; [Rosell, Rafael] Catalan Inst Oncol, Barcelona, Spain; [Morcos, Peter N.] Roche Innovat Ctr, New York, NY USA; [Mok, Tony] Chinese Univ Hong Kong, State Key Lab South China, Hong Kong, Hong Kong, Peoples R China	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Roche Holding; University of Colorado System; University of Colorado Denver; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; University of California System; University of California Irvine; UNICANCER; Centre Leon Berard; Fahrenheit Universities; Medical University Gdansk; Catalan Institute of Oncology; Chinese University of Hong Kong	Mok, T (corresponding author), Chinese Univ Hong Kong, State Key Lab South China, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China.	tony@clo.cuhk.edu.hk	Tabernero, Josep/AAG-5026-2019; Curioni-Fontecedro, Alessandra/R-4950-2018; Mok, Tony Shu Kam/B-2310-2019; Cortot, Alexis B/F-7006-2019; Tiseo, Marcello/K-6119-2016; Provencio, Mariano/ABE-8586-2020; Ou, Sai-Hong/AAA-3389-2020; kose, fatih/G-4827-2016; Camidge, David Ross/AAG-9144-2019; de Azevedo, Sergio Jobim/P-5115-2015; Dziadziuszko, Rafal/U-7036-2018; peters, solange/ABF-2187-2020; Lwin, Zarnie/G-3305-2018; Kim, Dong-Wan/J-5391-2012	Tabernero, Josep/0000-0002-2495-8139; Mok, Tony Shu Kam/0000-0002-8251-0551; Cortot, Alexis B/0000-0003-0098-2238; Tiseo, Marcello/0000-0002-9553-8465; Provencio, Mariano/0000-0001-9053-9197; kose, fatih/0000-0002-0156-5973; Dziadziuszko, Rafal/0000-0001-8080-9843; MORO-SIBILOT, Denis/0000-0001-6776-8610; Rybkin, Igor/0000-0002-8434-1093; Bennouna, Jaafar/0000-0002-5034-1108; Favaretto, Adolfo/0000-0001-8175-7467; Provencio Pulla, Mariano/0000-0001-6315-7919; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; Stroyakovskiy, Daniil/0000-0003-1973-1092; Coudert, Bruno/0000-0001-9445-2216; Kowalski, Dariusz/0000-0002-9452-3229; Meldgaard, Peter/0000-0002-5788-4463	F. Hoffmann-La Roche; ALEX	F. Hoffmann-La Roche(Hoffmann-La Roche); ALEX	Funded by F. Hoffmann-La Roche; ALEX ClinicalTrials.gov number, NCT02075840.	Awad Mark M, 2014, Clin Adv Hematol Oncol, V12, P429; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gainor JF, 2016, CANCER DISCOV, V6, P1118, DOI 10.1158/2159-8290.CD-16-0596; Hida T, 2017, LANCET; Katayama R, 2015, CLIN CANCER RES, V21, P2227, DOI 10.1158/1078-0432.CCR-14-2791; Kodama T, 2014, CANCER CHEMOTH PHARM, V74, P1023, DOI 10.1007/s00280-014-2578-6; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; Lu S, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9058; Mologni L, 2015, ONCOTARGET, V6, P5720, DOI 10.18632/oncotarget.3122; Ou SHI, 2016, J CLIN ONCOL, V34, P661, DOI 10.1200/JCO.2015.63.9443; Rangachari D, 2015, LUNG CANCER, V88, P108, DOI 10.1016/j.lungcan.2015.01.020; Shaw AT, 2016, LANCET ONCOL, V17, P234, DOI 10.1016/S1470-2045(15)00488-X; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Soria JC, 2017, LANCET, V389, P917, DOI 10.1016/S0140-6736(17)30123-X; Toyokawa G, 2015, CANCER METAST REV, V34, P797, DOI 10.1007/s10555-015-9592-y; Toyokawa G, 2015, ONCOL RES TREAT, V38, P291, DOI 10.1159/000430852	16	1267	1324	4	149	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					829	838		10.1056/NEJMoa1704795	http://dx.doi.org/10.1056/NEJMoa1704795			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28586279	Green Published, Bronze			2022-12-28	WOS:000408626400006
J	Porcu, P; Sahu, J				Porcu, Pierluigi; Sahu, Joya			A positive randomised trial in cutaneous T-cell lymphoma	LANCET			English	Editorial Material							BRENTUXIMAB VEDOTIN; PHASE-II; LYMPHOPROLIFERATIVE DISORDERS; HODGKIN LYMPHOMA; PAPULOSIS; SGN-30; CD30		[Porcu, Pierluigi] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA; [Sahu, Joya] Thomas Jefferson Univ, Dept Dermatol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Porcu, P (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA.	pierluigi.porcu@jefferson.edu		Porcu, Pierluigi/0000-0002-8056-023X				Duvic M, 2015, J CLIN ONCOL, V33, P3759, DOI 10.1200/JCO.2014.60.3787; Duvic M, 2009, CLIN CANCER RES, V15, P6217, DOI 10.1158/1078-0432.CCR-09-0162; Forero-Torres A, 2009, BRIT J HAEMATOL, V146, P171, DOI 10.1111/j.1365-2141.2009.07740.x; Kempf W, 2011, BLOOD, V118, P4024, DOI 10.1182/blood-2011-05-351346; Kim YH, 2015, J CLIN ONCOL, V33, P3750, DOI 10.1200/JCO.2014.60.3969; Prince HM, 2015, J CLIN ONCOL, V33, P3691, DOI 10.1200/JCO.2015.61.9486; Prince HM, 2017, LANCET; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Senter PD, 2012, NAT BIOTECHNOL, V30, P631, DOI 10.1038/nbt.2289; Zinzani PL, 2017, BLOOD, V129, P2328, DOI 10.1182/blood-2017-01-764258	10	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					533	534		10.1016/S0140-6736(17)31473-3	http://dx.doi.org/10.1016/S0140-6736(17)31473-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC5BM	28600131				2022-12-28	WOS:000406855800004
J	Kolodziejczak, M; Andreotti, F; Kowalewski, M; Buffon, A; Ciccone, MM; Parati, G; Scicchitano, P; Uminska, JM; De Servi, S; Bliden, KP; Kubica, J; Bortone, A; Crea, F; Gurbel, P; Navarese, EP				Kolodziejczak, Michalina; Andreotti, Felicita; Kowalewski, Mariusz; Buffon, Antonino; Ciccone, Marco Matteo; Parati, Gianfranco; Scicchitano, Pietro; Uminska, Julia M.; De Servi, Stefano; Bliden, Kevin P.; Kubica, Jacek; Bortone, Alessandro; Crea, Filippo; Gurbel, Paul; Navarese, Eliano P.			Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; DILATED CARDIOMYOPATHY; PROPHYLACTIC USE; HEART-FAILURE; HIGH-RISK; TIME; AMIODARONE; SURVIVAL; HEPARIN	Background: Implantable cardioverter-defibrillators (ICDs) have a role in preventing cardiac arrest in patients at risk for life-threatening ventricular arrhythmias. Purpose: To compare ICD therapy with conventional care for the primary prevention of death of various causes in adults with ischemic or nonischemic cardiomyopathy. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, Google Scholar, and EMBASE databases, as well as several Web sites, from 1 April 1976 through 31 March 2017. Study Selection: Randomized controlled trials, published in any language, comparing ICD therapy with conventional care and reporting mortality outcomes (all-cause, sudden, any cardiac, or noncardiac) in the primary prevention setting. Data Extraction: 2 independent investigators extracted study data and assessed risk of bias. Data Synthesis: Included were 11 trials involving 8716 patients: 4 (1781 patients) addressed nonischemic cardiomyopathy, 6 (4414 patients) ischemic cardiomyopathy, and 1 (2521 patients) both types of cardiomyopathy. Mean follow-up was 3.2 years. An overall reduction in all-cause mortality, from 28.26% with conventional care to 21.37% with ICD therapy (hazard ratio [HR], 0.81 [95% CI, 0.70 to 0.94]; P = 0.043), was found. The magnitude of reduction was similar in the cohorts with nonischemic (HR, 0.81 [CI, 0.72 to 0.91]) and ischemic (HR, 0.82 [CI, 0.63 to 1.06]) disease, although the latter estimate did not reach statistical significance. The rate of sudden death fell from 12.15% with conventional care to 4.39% with ICD therapy (HR, 0.41 [CI, 0.30 to 0.56]), with a similar magnitude of reduction in patients with ischemic (HR, 0.39 [CI, 0.23 to 0.68]) and those with nonischemic disease (HR, 0.44 [CI, 0.17 to 1.12]). Noncardiac and any cardiac deaths did not differ significantly by treatment. Limitation: Heterogeneous timing of ICD placement; heterogeneous pharmacologic and resynchronization co-interventions; trials conducted in different eras; adverse events and complications not reviewed. Conclusion: Overall, primary prevention with ICD therapy versus conventional care reduced the incidence of sudden and allcause death.	Coll Med Bydgoszcz, Systemat Invest & Res Intervent & Outcomes SIRIO, Bydgoszcz, Poland; Dr Antoni Jurasz Mem Univ Hosp, Bydgoszcz, Poland; Nicolaus Copernicus Univ, Bydgoszcz, Poland; Univ Nicolaus Copernicus, Torun, Poland; Catholic Univ, Rome, Italy; Univ Bari, Bari, Italy; Inova Heart & Vasc Inst, Falls Church, VA USA; SIRIO MEDICINE Res Network, Falls Church, VA USA; George Mason Univ, Fairfax, VA USA	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universita degli Studi di Bari Aldo Moro; Inova Fairfax Hospital; George Mason University	Navarese, EP (corresponding author), Inova Heart & Vasc Inst, Inova Ctr Thrombosis Res & Drug Dev, 3300 Gallows Rd, Falls Church, VA 22042 USA.	elianonavarese@gmail.com	De+Servi, Stefano/AAT-2631-2021; Kowalewski, Mariusz/AAA-6845-2020; Kubica, Jacek/D-6906-2014; Ciccone, Marco M/C-5271-2013; Kołodziejczak, Michalina/AAL-3968-2020; Andreotti, Felicita/A-9962-2019; Parati, Gianfranco/K-7151-2016	Kubica, Jacek/0000-0001-8250-754X; Ciccone, Marco M/0000-0002-5710-4228; Kołodziejczak, Michalina/0000-0001-5969-6055; Andreotti, Felicita/0000-0002-1456-6430; Parati, Gianfranco/0000-0001-9402-7439; Navarese, Eliano/0000-0002-2355-4589; Uminska, Julia/0000-0003-2309-2369; Buffon, Antonino/0000-0001-8144-6597				Adabag AS, 2008, JAMA-J AM MED ASSOC, V300, P2022, DOI 10.1001/jama.2008.553; Al-Khatib SM, 2017, JAMA CARDIOL, V2, P685, DOI 10.1001/jamacardio.2017.0630; Bansch D, 2002, CIRCULATION, V105, P1453, DOI 10.1161/01.CIR.0000012350.99718.AD; Bardy G, 2012, HEART RHYTHM, V9, P1579, DOI [10.1016/j.hrthm.2012.06.018, DOI 10.1016/J.HRTHM.2012.06.018]; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Barra S, 2015, EUROPACE, V17, P174, DOI 10.1093/europace/euu296; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Goldberger JJ, 2014, J AM COLL CARDIOL, V63, P1879, DOI 10.1016/j.jacc.2013.12.021; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McMurray JJV, 2016, NEW ENGL J MED, V375, P1283, DOI 10.1056/NEJMe1609826; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Navarese EP, 2011, J THROMB HAEMOST, V9, P1902, DOI 10.1111/j.1538-7836.2011.04445.x; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; Navarese EP, 2015, JACC-CARDIOVASC INTE, V8, P201, DOI 10.1016/j.jcin.2014.10.003; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Piccini JP, 2011, HEART RHYTHM, V8, P393, DOI 10.1016/j.hrthm.2010.11.033; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Strickberger SA, 2003, J AM COLL CARDIOL, V41, P1707, DOI 10.1016/S0735-1097(03)00297-3; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; Yancy CW, 2016, CIRCULATION, V134, pE282, DOI 10.1161/CIR.0000000000000435; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	31	39	41	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					103	111		10.7326/M17-0120	http://dx.doi.org/10.7326/M17-0120			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28632280				2022-12-28	WOS:000405573400016
J	Bialas, AR; Presumey, J; Das, A; van der Poel, CE; Lapchak, PH; Mesin, L; Victora, G; Tsokos, GC; Mawrin, C; Herbst, R; Carroll, MC				Bialas, Allison R.; Presumey, Jessy; Das, Abhishek; van der Poel, Cees E.; Lapchak, Peter H.; Mesin, Luka; Victora, Gabriel; Tsokos, George C.; Mawrin, Christian; Herbst, Ronald; Carroll, Michael C.			RETRACTED: Microglia-dependent synapse loss in type I interferon-mediated lupus (Retracted article. See vol. 578, pg. 177, 2020)	NATURE			English	Article; Retracted Publication							B-CELL TOLERANCE; BLOOD-BRAIN; NEUROPSYCHIATRIC MANIFESTATIONS; ERYTHEMATOSUS; RECEPTOR; DIAGNOSIS; ALPHA; PATHOGENESIS; ANTIBODY; PROFILE	Systemic lupus erythematosus (SLE) is an incurable autoimmune disease characterized by autoantibody deposition in tissues such as kidney, skin and lungs. Notably, up to 75% of patients with SLE experience neuropsychiatric symptoms that range from anxiety, depression and cognitive impairment to seizures and, in rare cases, psychosis-collectively this is referred to as central nervous system (CNS) lupus(1-4). In some cases, certain autoantibodies, such as anti-NMDAR or anti-phospholipid antibodies(5,6), promote CNS lupus. However, in most patients, the mechanisms that underlie these symptoms are unknown. CNS lupus typically presents at lupus diagnosis or within the first year, suggesting that early factors contributing to peripheral autoimmunity may promote CNS lupus symptoms. Here we report behavioural phenotypes and synapse loss in lupus-prone mice that are prevented by blocking type I interferon (IFN) signalling. Furthermore, we show that type I IFN stimulates microglia to become reactive and engulf neuronal and synaptic material in lupus-prone mice. These findings and our observation of increased type I IFN signalling in post-mortem hippocampal brain sections from patients with SLE may instruct the evaluation of ongoing clinical trials of anifrolumab(7), a type I IFN-receptor antagonist. Moreover, identification of IFN-driven microglia-dependent synapse loss, along with microglia transcriptome data, connects CNS lupus with other CNS diseases and provides an explanation for the neurological symptoms observed in some patients with SLE.	[Bialas, Allison R.; Presumey, Jessy; Das, Abhishek; van der Poel, Cees E.; Carroll, Michael C.] Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Bialas, Allison R.; Presumey, Jessy; Das, Abhishek; van der Poel, Cees E.; Carroll, Michael C.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Lapchak, Peter H.; Tsokos, George C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; [Mesin, Luka; Victora, Gabriel] Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY USA; [Mawrin, Christian] Univ Magdeburg, Dept Neuropathol, Magdeburg, Germany; [Mawrin, Christian] Otto von Guericke Univ, Ctr Behav Brain Sci CBBS, Magdeburg, Germany; [Herbst, Ronald] MedImmune LLC, Dept Canc Biol, Gaithersburg, MD 20878 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Rockefeller University; Otto von Guericke University; Otto von Guericke University; AstraZeneca; Medimmune	Carroll, MC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Carroll, MC (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	michael.carroll@childrens.harvard.edu	tsokos, george C/O-3360-2013; Lapchak, Peter H./B-3559-2009	tsokos, george C/0000-0001-9589-2360; Lapchak, Peter/0000-0001-8597-088X; Victora, Gabriel/0000-0001-8807-348X	Alliance for Lupus Research [A.L.R.-332527]; NIH [AI039246, AI42269]; MedImmune LLC; NIH T32 training grant [AI74549]; Jeffrey Modell Foundation	Alliance for Lupus Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MedImmune LLC(AstraZenecaMedimmune); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jeffrey Modell Foundation	We thank members of the M.C.C. and G.C.T. laboratories for helpful comments on experimental design and feedback on the manuscript; M. Tsokos, B. Volpe, P. Crow, B. Stevens and S. McCarroll for helpful discussions; E. M. Carroll for assistance and L. Prince-Wright for technical support; the HMS Rodent Histopathology core, and M. Ericsson and E. Benecchi from the HMS Electron Microscopy core; L. Konnikova and S. Snapper for advice and assistance with RNAscope; B. Caldarone at the Harvard NeuroDiscovery Center's NeuroBehavior Laboratory Core for guidance; the Boston Children's Hospital PCMM Optical Microscopy and flow cytometry cores and the Whitehead Institute Genome Technology Core; K. Holton from the HMS Bioinformatics core and S. Bradley for assistance with RNA-seq analysis, and C. Usher for help with editing the manuscript. This research was supported by the Alliance for Lupus Research (A.L.R.-332527); NIH (AI039246) and MedImmune LLC (M. C. C.), and by the NIH (AI42269) (G.C.T.). A.R.B. was supported by a NIH T32 training grant (AI74549) and the Jeffrey Modell Foundation.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Baccala R, 2012, J IMMUNOL, V189, P5976, DOI 10.4049/jimmunol.1201477; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Chatterjee P, 2013, EUR J IMMUNOL, V43, P2441, DOI 10.1002/eji.201343412; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crupi R, 2010, BIOL PSYCHIAT, V67, P558, DOI 10.1016/j.biopsych.2009.12.008; Das A, 2017, IMMUNITY, V46, P106, DOI 10.1016/j.immuni.2016.12.014; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; DUBOIS EL, 1966, J AMER MED ASSOC, V195, P285, DOI 10.1001/jama.195.4.285; FEINGLASS EJ, 1976, MEDICINE, V55, P323, DOI 10.1097/00005792-197607000-00004; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Hanly JG, 2007, ARTHRITIS RHEUM-US, V56, P265, DOI 10.1002/art.22305; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Mondal TK, 2008, BRAIN BEHAV IMMUN, V22, P949, DOI 10.1016/j.bbi.2008.01.013; MORI S, 1969, J COMP NEUROL, V135, P57, DOI 10.1002/cne.901350104; Pan WH, 1997, J NEUROIMMUNOL, V76, P105, DOI 10.1016/S0165-5728(97)00034-9; Popescu A, 2011, CURR NEUROPHARMACOL, V9, P449, DOI 10.2174/157015911796557984; SAKIC B, 1992, BRAIN BEHAV IMMUN, V6, P265; Sanna G, 2003, J RHEUMATOL, V30, P985; Santer DM, 2009, J IMMUNOL, V182, P1192, DOI 10.4049/jimmunol.182.2.1192; Schafer DP, 2014, JOVE-J VIS EXP, DOI 10.3791/51482; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Trysberg E, 2000, LUPUS, V9, P498, DOI 10.1177/096120330000900704; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; VANDAM AP, 1991, RHEUMATOL INT, V11, P1; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	39	120	122	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					539	+		10.1038/nature22821	http://dx.doi.org/10.1038/nature22821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28614301				2022-12-28	WOS:000403814100040
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Towards a GP consensus on the future of UK general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2017, GP              0518; BMA, 2017, CHAAND NAGP SPEECH B; Chan S, 2015, GP              0701; Clews G, 2016, GP              0715; Everington S, 2016, KINGS FUND      1018; Gayle D, 2016, GUARDIAN; Gutierrez-Gutierrez B, 2016, ANTIMICROB AGENTS CH, V60, P4159, DOI 10.1128/AAC.00365-16; Iacobucci G, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1713; Jones D, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6800; King's Fund, 2016, UND PRESS GEN PRACT; Lewis D, 2016, GP; Lind S, 2016, PULSE, V357; Marshall M, 2015, GP              1214; Millett D, 2016, GP; National Association of Primary Care, PRIM CAR HOM RAP TES; Rimmer A., 2017, BMJ CAREERS; Rosen R, 2015, TRANSFORMING GEN PRA; Royal College of General Practitioners, 2017, GP FORW VIEW INT ASS; Royal College of General Practitioners, 2013, 2022 GP VIS GEN PRAC; Royal College of General Practitioners, 2017, GP PARTN MOD STILL R; Sansom A, 2016, BMJ OPEN, V357, DOI 10.1136/bmjopen-2015-010592pmid:26895989; Thomas R, 2017, HLTH SERV J, V357; Trivedi S., 2014, HLTH SERV J, V357	23	1	1	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2017	357								j2949	10.1136/bmj.j2949	http://dx.doi.org/10.1136/bmj.j2949			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YT	28634249	Green Published, Bronze			2022-12-28	WOS:000404210000005
J	Rubin, AE; Cooper, KM; Till, CB; Kent, AJR; Costa, F; Bose, M; Gravley, D; Deering, C; Cole, J				Rubin, Allison E.; Cooper, Kari M.; Till, Christy B.; Kent, Adam J. R.; Costa, Fidel; Bose, Maitrayee; Gravley, Darren; Deering, Chad; Cole, Jim			Rapid cooling and cold storage in a silicic magma reservoir recorded in individual crystals	SCIENCE			English	Article							OKATAINA VOLCANIC COMPLEX; NEW-ZEALAND; ZIRCON; RESOLUTION; RHYOLITE; ERUPTION; TEPHROCHRONOLOGY; SYSTEM	Silicic volcanic eruptions pose considerable hazards, yet the processes leading to these eruptions remain poorly known. A missing link is knowledge of the thermal history of magma feeding such eruptions, which largely controls crystallinity and therefore eruptability. We have determined the thermal history of individual zircon crystals from an eruption of the Taupo Volcanic Zone, New Zealand. Results show that although zircons resided in the magmatic system for 10(3) to 10(5) years, they experienced temperatures >650 degrees to 750 degrees C for only years to centuries. This implies near-solidus long-term crystal storage, punctuated by rapid heating and cooling. Reconciling these data with existing models of magma storage requires considering multiple small intrusions and multiple spatial scales, and our approach can help to quantify heat input to and output from magma reservoirs.	[Rubin, Allison E.; Cooper, Kari M.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Till, Christy B.; Bose, Maitrayee] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Kent, Adam J. R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Costa, Fidel] Nanyang Technol Univ, Earth Observ Singapore, Singapore, Singapore; [Costa, Fidel] Nanyang Technol Univ, Asian Sch Environm, Singapore, Singapore; [Gravley, Darren; Cole, Jim] Univ Canterbury, Dept Geol Sci, Christchurch, New Zealand; [Deering, Chad] Michigan Technol Univ, Geol & Min Engn Sci, Houghton, MI 49931 USA	University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe; Oregon State University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Canterbury; Michigan Technological University	Cooper, KM (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	kmcooper@ucdavis.edu	Cooper, Kari M/G-8261-2012; Kent, Adam/ABC-1641-2021; Costa, Fidel/B-7035-2011; Till, Christy/Y-1173-2019; Till, Christy/D-7771-2012	Kent, Adam/0000-0003-3564-6285; Costa, Fidel/0000-0002-1409-5325; Till, Christy/0000-0001-8924-2206; Deering, Chad/0000-0002-3768-2258	NSF [ARRA-960334, EAR-1352996, EAR-1144945, EAR-1426858, EAR-1425491]; Singapore Ministry of Education [MoE2014-T2-2-041]; Division Of Earth Sciences [1426858] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Singapore Ministry of Education(Ministry of Education, Singapore); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The full data set for this paper is available in tables S1 to S3 and data S1. We thank C. Hitzman for developing Li analytical protocols for the NanoSIMS instrument at Stanford University and for assistance with running analyses. The Arizona State University (ASU) facility is supported by NSF awards ARRA-960334 and EAR-1352996, and support for the ASU analyses was provided by the facility. This work was partially supported by NSF awards EAR-1144945 and EAR-1426858 to K.M.C. and EAR-1425491 to A.J.R.K. and by Singapore Ministry of Education grant MoE2014-T2-2-041 to F.C.	Annen C, 2009, EARTH PLANET SC LETT, V284, P409, DOI 10.1016/j.epsl.2009.05.006; Annen C, 2015, LITHOS, V230, P206, DOI 10.1016/j.lithos.2015.05.008; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; Barboni M, 2016, P NATL ACAD SCI USA, V113, P13959, DOI 10.1073/pnas.1616129113; Bergantz GW, 2015, NAT GEOSCI, V8, P793, DOI [10.1038/NGEO2534, 10.1038/ngeo2534]; Burgisser A, 2011, NATURE, V471, P212, DOI 10.1038/nature09799; Caricchi L, 2014, NATURE, V511, P457, DOI 10.1038/nature13532; Cherniak DJ, 2010, CONTRIB MINERAL PETR, V160, P383, DOI 10.1007/s00410-009-0483-5; Cole JW, 2014, EARTH-SCI REV, V128, P1, DOI 10.1016/j.earscirev.2013.10.008; Cooper KM, 2014, NATURE, V506, P480, DOI 10.1038/nature12991; Danisik M, 2012, EARTH PLANET SC LETT, V349, P240, DOI 10.1016/j.epsl.2012.06.041; Degruyter W, 2014, EARTH PLANET SC LETT, V403, P117, DOI 10.1016/j.epsl.2014.06.047; Gelman SE, 2013, GEOLOGY, V41, P759, DOI 10.1130/G34241.1; Graeter KA, 2015, AM MINERAL, V100, P1778, DOI 10.2138/am-2015-5135; HALLIDAY AN, 1989, EARTH PLANET SC LETT, V94, P274, DOI 10.1016/0012-821X(89)90146-5; HUPPERT HE, 1988, J PETROL, V29, P599, DOI 10.1093/petrology/29.3.599; Jaxybulatov K, 2014, SCIENCE, V346, P617, DOI 10.1126/science.1258582; Kaiser JF, 2017, EARTH PLANET SC LETT, V457, P73, DOI 10.1016/j.epsl.2016.09.048; Kent AJR, 2007, GEOLOGY, V35, P231, DOI 10.1130/G22809A.1; Klemetti EW, 2011, EARTH PLANET SC LETT, V305, P185, DOI 10.1016/j.epsl.2011.02.054; MAHOOD GA, 1990, EARTH PLANET SC LETT, V99, P395, DOI 10.1016/0012-821X(90)90145-N; Rubin A, 2016, CONTRIB MINERAL PETR, V171, DOI 10.1007/s00410-015-1216-6; Schleicher JM, 2016, GEOPHYS RES LETT, V43, P1543, DOI 10.1002/2015GL067372; Schmitt AK, 2011, CONTRIB MINERAL PETR, V162, P1215, DOI 10.1007/s00410-011-0648-x; Shane P, 2012, LITHOS, V140, P1, DOI 10.1016/j.lithos.2012.01.012; Storm S, 2014, CONTRIB MINERAL PETR, V167, DOI 10.1007/s00410-014-1000-z; Trail D, 2016, CONTRIB MINERAL PETR, V171, DOI 10.1007/s00410-016-1238-8; Ushikubo T, 2008, EARTH PLANET SC LETT, V272, P666, DOI 10.1016/j.epsl.2008.05.032; Vazquez JA, 2012, EARTH PLANET SC LETT, V357, P54, DOI 10.1016/j.epsl.2012.09.013; Wilson CJN, 2009, STUDIES IN VOLCANOLOGY: THE LEGACY OF GEORGE WALKER, P225	30	105	109	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1154	1156		10.1126/science.aam8720	http://dx.doi.org/10.1126/science.aam8720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619940				2022-12-28	WOS:000403327400032
J	Levine, AG; Medoza, A; Hemmers, S; Moltedo, B; Niec, RE; Schizas, M; Hoyos, BE; Putintseva, EV; Chaudhry, A; Dikiy, S; Fujisawa, S; Chudakov, DM; Treuting, PM; Rudensky, AY				Levine, Andrew G.; Medoza, Alejandra; Hemmers, Saskia; Moltedo, Bruno; Niec, Rachel E.; Schizas, Michail; Hoyos, Beatrice E.; Putintseva, Ekaterina V.; Chaudhry, Ashutosh; Dikiy, Stanislav; Fujisawa, Sho; Chudakov, Dmitriy M.; Treuting, Piper M.; Rudensky, Alexander Y.			Stability and function of regulatory T cells expressing the transcription factor T-bet	NATURE			English	Article							ROR-GAMMA-T; DIFFERENTIATION; EFFECTOR; IMMUNITY; HOMEOSTASIS; GENERATION; INFECTION	Adaptive immune responses are tailored to different types of pathogens through differentiation of naive CD4 T cells into functionally distinct subsets of effector T cells (T helper 1 (T(H)1), T(H)2, and T(H)17) defined by expression of the key transcription factors T-bet, GATA3, and ROR gamma t, respectively(1). Regulatory T (T-reg) cells comprise a distinct anti-inflammatory lineage specified by the X-linked transcription factor Foxp3 (refs 2, 3). Paradoxically, some activated T-reg cells express the aforementioned effector CD4 T cell transcription factors, which have been suggested to provide T-reg cells with enhanced suppressive capacity(4-6). Whether expression of these factors in T-reg cells-as in effector T cells-is indicative of heterogeneity of functionally discrete and stable differentiation states, or conversely may be readily reversible, is unknown. Here we demonstrate that expression of the T(H)1-associated transcription factor T-bet in mouse T-reg cells, induced at steady state and following infection, gradually becomes highly stable even under non-permissive conditions. Loss of function or elimination of T-bet-expressing T-reg cells-but not of T-bet expression in T-reg cells-resulted in severe T(H)1 autoimmunity. Conversely, following depletion of T-bet-T-reg cells, the remaining T-bet(+) cells specifically inhibited T(H)1 and CD8 T cell activation consistent with their co-localization with T-bet(+) effector T cells. These results suggest that T-bet(+) T-reg cells have an essential immunosuppressive function and indicate that T-reg cell functional heterogeneity is a critical feature of immunological tolerance.	[Levine, Andrew G.; Medoza, Alejandra; Hemmers, Saskia; Moltedo, Bruno; Niec, Rachel E.; Schizas, Michail; Hoyos, Beatrice E.; Chaudhry, Ashutosh; Dikiy, Stanislav; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Immunol Program, New York, NY 10065 USA; [Levine, Andrew G.; Medoza, Alejandra; Hemmers, Saskia; Moltedo, Bruno; Niec, Rachel E.; Schizas, Michail; Hoyos, Beatrice E.; Chaudhry, Ashutosh; Dikiy, Stanislav; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Fujisawa, Sho] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10065 USA; [Putintseva, Ekaterina V.; Chudakov, Dmitriy M.] Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Miklukho Maklaya 16-10, Moscow 117997, Russia; [Putintseva, Ekaterina V.; Chudakov, Dmitriy M.] Masaryk Univ, Cent European Inst Technol, Kamenice 753-5, Brno 62500, Czech Republic; [Chudakov, Dmitriy M.] Pirogov Russian Natl Res Med Univ, Ostrovityanova 1, Moscow 117997, Russia; [Treuting, Piper M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Masaryk University Brno; Pirogov Russian National Research Medical University; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Immunol Program, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA.	rudenska@mskcc.org	Chudakov, Dmitriy M/G-7741-2014; Treuting, Piper M./AAB-2721-2019; Dikiy, Stanislav/HIR-5027-2022; Dikiy, Stanislav/GWR-2104-2022	Chudakov, Dmitriy M/0000-0003-0430-790X; Treuting, Piper M./0000-0002-1812-1519; Dikiy, Stanislav/0000-0002-8287-6561; Niec, Rachel/0000-0002-8525-3693	NIH Medical Scientist Training Program [T32GM07739]; Frank Lappin Horsfall Jr Student Fellowship; NIH [R37AI034206]; Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative; NIH/NCI Cancer Center Support Grant [P30 CA008748]; Russian Science Foundation [14-14-00533]; RFBR [16-34-60178]; Russian Science Foundation [17-14-00050] Funding Source: Russian Science Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank Lappin Horsfall Jr Student Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative; NIH/NCI Cancer Center Support Grant; Russian Science Foundation(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Arpaia, I. Leiner, and members of the Rudensky laboratory for discussions; J. Sun for providing L. monocytogenes stocks; and A. H. Bravo, S. E. Lee, and M. B. Faire for experimental support. This work was supported by an NIH Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (A.G.L.); the Frank Lappin Horsfall Jr Student Fellowship (A.G.L.); NIH grant R37AI034206 (A.Y.R.), the Ludwig Center at Memorial Sloan Kettering Cancer Center, and the Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation and Ludwig Cancer Research) (A.Y.R.); the NIH/NCI Cancer Center Support Grant P30 CA008748; the Russian Science Foundation project 14-14-00533 (E.V.P. and D.M.C.) and the RFBR fellowship grant 16-34-60178 (E.V.P.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Colbeck EJ, 2015, ONCOTARGET, V6, P24649, DOI 10.18632/oncotarget.5584; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lahl K, 2009, J IMMUNOL, V183, P5662, DOI 10.4049/jimmunol.0803762; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson RC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00069; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sawant DV, 2014, J IMMUNOL, V192, P2904, DOI 10.4049/jimmunol.1202502; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smith KA, 2016, MUCOSAL IMMUNOL, V9, P428, DOI 10.1038/mi.2015.73; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	31	195	198	7	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					421	+		10.1038/nature22360	http://dx.doi.org/10.1038/nature22360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28607488	Green Accepted			2022-12-28	WOS:000403250900038
J	Persson, M; Cnattingius, S; Villamor, E; Soderling, J; Pasternak, B; Stephansson, O; Neovius, M				Persson, Martina; Cnattingius, Sven; Villamor, Eduardo; Soderling, Jonas; Pasternak, Bjorn; Stephansson, Olof; Neovius, Martin			Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1.2 million singletons	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; HEART-DEFECTS; PREPREGNANCY OBESITY; INFANT-MORTALITY; EARLY-PREGNANCY; BIRTH-DEFECTS; FETAL; POPULATION; ASSOCIATION; ANOMALIES	OBJECTIVE To estimate the risks of major congenital malformations in the offspring of mothers who are underweight (body mass index (BMI) <18.5), overweight (BMI 25 to <30), or in obesity classes I (BMI 30 to <35), II (35 to <40), or III (>= 40) compared with offspring of normal weight mothers (BMI 18.5 to <25) in early pregnancy. DESIGN Population based cohort study. SETTING Nationwide Swedish registries. PARTICIPANTS 1 243 957 liveborn singleton infants from 2001 to 2014 in Sweden. Data on maternal and pregnancy characteristics were obtained by individual record linkages. EXPOSURE Maternal BMI at the first prenatal visit. MAIN OUTCOME MEASURES Offspring with any major congenital malformation, and subgroups of organ specific malformations diagnosed during the first year of life. Risk ratios were estimated using generalised linear models adjusted for maternal factors, sex of offspring, and birth year. RESULTS A total of 43 550 (3.5%) offspring had any major congenital malformation, and the most common subgroup was for congenital heart defects (n=20 074; 1.6%). Compared with offspring of normal weight mothers (risk of malformations 3.4%), the proportions and adjusted risk ratios of any major congenital malformation among the offspring of mothers with higher BMI were: overweight, 3.5% and 1.05 (95% confidence interval 1.02 to 1.07); obesity class I, 3.8% and 1.12 (1.08 to 1.15), obesity class II, 4.2% and 1.23 (1.17 to 1.30), and obesity class III, 4.7% and 1.37 (1.26 to 1.49). The risks of congenital heart defects, malformations of the nervous system, and limb defects also progressively increased with BMI from overweight to obesity class III. The largest organ specific relative risks related to maternal overweight and increasing obesity were observed for malformations of the nervous system. Malformations of the genital and digestive systems were also increased in offspring of obese mothers. CONCLUSIONS Risks of any major congenital malformation and several subgroups of organ specific malformations progressively increased with maternal overweight and increasing severity of obesity. For women who are planning pregnancy, efforts should be encouraged to reduce adiposity in those with a BMI above the normal range.	[Persson, Martina; Cnattingius, Sven; Villamor, Eduardo; Soderling, Jonas; Pasternak, Bjorn; Stephansson, Olof; Neovius, Martin] Karolinska Inst, Dept Med, Solna Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Persson, Martina] Soder Sjukhuset, Sachsska Childrens Hosp, Dept Diabet & Endocrinol, Stockholm, Sweden; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Villamor, Eduardo] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Pasternak, Bjorn] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Statens Serum Institut; Karolinska Institutet	Persson, M (corresponding author), Karolinska Inst, Dept Med, Solna Clin Epidemiol Unit, SE-17176 Stockholm, Sweden.; Persson, M (corresponding author), Soder Sjukhuset, Sachsska Childrens Hosp, Dept Diabet & Endocrinol, Stockholm, Sweden.	Martina.Persson@ki.se	Pasternak, Bjorn/H-5739-2012; Persson, Martina/B-7667-2015	Pasternak, Bjorn/0000-0002-2097-8466; Persson, Martina/0000-0003-2268-3159; Stephansson, Olof/0000-0003-1528-4563; Neovius, Martin/0000-0003-2300-3055	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK105948]; Swedish Research Council for Health, Working Life and Welfare [2014-0073]; Karolinska Institutet; Stockholm County Council; Swedish Research Council [2013-2429, 2013-3770]; Danish Medical Research Council; National Institutes of Health [R01DK105948]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105948] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number R01DK105948. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders were not involved in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript. This study was also funded by the Swedish Research Council for Health, Working Life and Welfare (grant No 2014-0073) and an unrestricted grant from Karolinska Institutet (distinguished professor award to SC). MP was supported by Stockholm County Council (clinical post-doctoral position). OS was supported by the Swedish Research Council (grant No 2013-2429). BP was supported by the Danish Medical Research Council. MN was supported by the Swedish Research Council (grant No 2013-3770) and the National Institutes of Health (award No R01DK105948).	Bodnar LM, 2015, AM J CLIN NUTR, V102, P858, DOI 10.3945/ajcn.115.112250; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Brite J, 2014, INT J OBESITY, V38, P878, DOI 10.1038/ijo.2013.244; Cai GJ, 2014, AM J OBSTET GYNECOL, V211, P91, DOI 10.1016/j.ajog.2014.03.028; Carmichael SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138549; Catalano P, 2015, INT J OBESITY, V39, P642, DOI 10.1038/ijo.2015.15; Cedergren M, 2002, ACTA PAEDIATR, V91, P222, DOI 10.1080/080352502317285252; Cedergren MI, 2002, SCAND J WORK ENV HEA, V28, P12, DOI 10.5271/sjweh.641; Cedergren MI, 2003, OBES RES, V11, P1065, DOI 10.1038/oby.2003.146; Cnattingius S, 2016, LANCET, V387, P558, DOI 10.1016/S0140-6736(15)00990-3; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dashe JS, 2009, J ULTRAS MED, V28, P1025, DOI 10.7863/jum.2009.28.8.1025; De-Regil LM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub3; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; ERIKSSON UJ, 1993, DIABETES, V42, P411, DOI 10.2337/diabetes.42.3.411; Feng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08506; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Glinianaia SV, 2008, HUM REPROD, V23, P1306, DOI 10.1093/humrep/den104; Gutierrez-Adan A, 2006, REPROD DOMEST ANIM, V41, P54, DOI 10.1111/j.1439-0531.2006.00769.x; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; HANSON U, 1990, DIABETOLOGIA, V33, P100, DOI 10.1007/BF00401047; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Johansson S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6572; Kitzmiller JL, 1996, DIABETES CARE, V19, P514, DOI 10.2337/diacare.19.5.514; Leite M, 2014, ACTA OBSTET GYN SCAN, V93, P825, DOI 10.1111/aogs.12433; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Masho SW, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1002-0; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Pasternak B, 2013, JAMA-J AM MED ASSOC, V310, P1601, DOI 10.1001/jama.2013.278343; Perez-Crespo M, 2005, MOL REPROD DEV, V72, P502, DOI 10.1002/mrd.20366; Persson M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001648; Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656; Scherer PE, 2016, DIABETES, V65, P1452, DOI 10.2337/db16-0339; Sewell MF, 2007, J REPROD MED, V52, P907; Shaw GM, 2003, AM J CLIN NUTR, V78, P972, DOI 10.1093/ajcn/78.5.972; Shaw GM, 2002, AM J MED GENET, V107, P253, DOI 10.1002/ajmg.10164; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Suhonen L, 2000, DIABETOLOGIA, V43, P79, DOI 10.1007/s001250050010; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Thomas-Valdes S, 2017, CRIT REV FOOD SCI, V57, P3332, DOI 10.1080/10408398.2015.1117413; TIFFIN GJ, 1991, J REPROD FERTIL, V93, P125; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Villamor E, 2015, ANN HUM BIOL, V42, P507, DOI 10.3109/03014460.2014.969488; Waller DK, 2007, ARCH PEDIAT ADOL MED, V161, P745, DOI 10.1001/archpedi.161.8.745; Watkins ML, 2001, EPIDEMIOLOGY, V12, P439, DOI 10.1097/00001648-200107000-00014; Yoon PW, 1997, ARCH PEDIAT ADOL MED, V151, P1096, DOI 10.1001/archpedi.1997.02170480026004	53	116	121	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2017	357								j2563	10.1136/bmj.j2563	http://dx.doi.org/10.1136/bmj.j2563			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UT	28615173	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000403753400001
J	Dexter, E				Dexter, Eric			Research on a razor's edge	SCIENCE			English	Editorial Material									[Dexter, Eric] Washington State Univ, Environm & Nat Resource Sci, Vancouver, WA 98686 USA	Washington State University	Dexter, E (corresponding author), Washington State Univ, Environm & Nat Resource Sci, Vancouver, WA 98686 USA.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1094	1094		10.1126/science.356.6342.1094	http://dx.doi.org/10.1126/science.356.6342.1094			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596368				2022-12-28	WOS:000402871700057
J	Goldthau, A				Goldthau, Andreas			The G20 must govern the shift to low-carbon energy	NATURE			English	Editorial Material									[Goldthau, Andreas] Royal Holloway Univ London, Ctr Int Publ Policy, London, England	University of London; Royal Holloway University London	Goldthau, A (corresponding author), Royal Holloway Univ London, Ctr Int Publ Policy, London, England.	andreas.goldthau@rhul.ac.uk						[Anonymous], 2011, UNB CARB; [Anonymous], 2017, ANN REP EX FED BUDG; Channell J., 2015, ENERGY DARWINISM; Goldthau A, 2012, ENERG POLICY, V41, P232, DOI 10.1016/j.enpol.2011.10.042; IEA, 2017, PERSP EN TRANS INV N; IRENA, 2016, REN EN BEN MEAS EC; Kraemer R.A., 2017, GREEN SHIFT SUSTAINA; MANLEY D, 2017, 34 OXF CTR AN RES RI; McGlade C, 2015, NATURE, V517, P187, DOI 10.1038/nature14016; World Trade Organization, 2016, WORLD TRAD STAT REV	10	29	29	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					203	205		10.1038/546203a	http://dx.doi.org/10.1038/546203a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9FY	28593983	Bronze			2022-12-28	WOS:000402823400011
J	Snyder, A				Snyder, Alison			George E Palade Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV-DEC	2008	372	9653					1876	1876		10.1016/S0140-6736(08)61800-0	http://dx.doi.org/10.1016/S0140-6736(08)61800-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379IA	28581435				2022-12-28	WOS:000261388700013
J	O'Mathuna, D; Siriwardhana, C				O'Mathuna, Donal; Siriwardhana, Chesmal			Research ethics and evidence for humanitarian health	LANCET			English	Editorial Material									[O'Mathuna, Donal] Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland; [Siriwardhana, Chesmal] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London, England	Dublin City University; University of London; London School of Hygiene & Tropical Medicine	O'Mathuna, D (corresponding author), Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland.	donal.omathuna@dcu.ie	O'Mathúna, Dónal/AAL-7625-2020	O'Mathúna, Dónal/0000-0001-5331-3340				Blanchet K, 2017, LANCET; Checchi F, 2017, LANCET; COLOMBO S, 2017, LANCET; Council for International Organizations of Medical Sciences, 2016, INT ETH GUID HLTH RE; Department for International Development (UK), 2012, PROM INN EV BAS APPR; Hunt M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157142; O'Mathuna Donal, 2015, J Evid Based Med, V8, P31, DOI 10.1111/jebm.12136; Siribaddana S, 2010, ASIAN BIOETHICS REV, V2, P162; Siriwardhana C., 2015, ASIAN BIOETHICS REV, V7, P188, DOI DOI 10.1353/ASB.2015.0015; Spiegel PB., 2017, LANCET	10	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2228	2229		10.1016/S0140-6736(17)31276-X	http://dx.doi.org/10.1016/S0140-6736(17)31276-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602560				2022-12-28	WOS:000415645700011
J	Beets, G				Beets, Geerard			Improving quality of life after treatment for rectal cancer	LANCET			English	Editorial Material							THERAPY; TRIAL		[Beets, Geerard] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Beets, Geerard] Maastricht Univ, Maastricht, Netherlands	Netherlands Cancer Institute; Maastricht University	Beets, G (corresponding author), Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands.; Beets, G (corresponding author), Maastricht Univ, Maastricht, Netherlands.	g.beets@nki.nl	Beets, Geerard/G-2682-2013	Beets, Geerard/0000-0002-1671-9912				Beets GL, 2015, EJSO-EUR J SURG ONC, V41, P1562, DOI 10.1016/j.ejso.2015.09.008; Beets GL, 2017, ANNU REV MED, V68, P169, DOI 10.1146/annurev-med-062915-021419; Ma B, 2017, INT J CANCER, V141, P1052, DOI 10.1002/ijc.30805; Pucciarelli S, 2013, DIS COLON RECTUM, V56, P1349, DOI 10.1097/DCR.0b013e3182a2303e; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; Rullier E, 2017, LANCET; Verseveld M, 2015, BRIT J SURG, V102, P853, DOI 10.1002/bjs.9809	7	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					432	434		10.1016/S0140-6736(17)31545-3	http://dx.doi.org/10.1016/S0140-6736(17)31545-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB9MO	28601341	Green Submitted			2022-12-28	WOS:000406463400005
J	Bose, R; Karthaus, WR; Armenia, J; Abida, W; Iaquinta, PJ; Zhang, ZD; Wongvipat, J; Wasmuth, EV; Shah, N; Sullivan, PS; Doran, MG; Wang, P; Patruno, A; Zhao, YL; Zheng, DY; Schultz, N; Sawyers, CL				Bose, Rohit; Karthaus, Wouter R.; Armenia, Joshua; Abida, Wassim; Iaquinta, Phillip J.; Zhang, Zeda; Wongvipat, John; Wasmuth, Elizabeth V.; Shah, Neel; Sullivan, Patrick S.; Doran, Michael G.; Wang, Ping; Patruno, Anna; Zhao, Yilin; Zheng, Deyou; Schultz, Nikolaus; Sawyers, Charles L.		Int SU2C PCF Prostate Canc Dream T	ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis	NATURE			English	Article							ANDROGEN RECEPTOR CISTROME; ORGANOID CULTURES; CANCER; TUMORIGENESIS; GENES; CELLS; NEUROENDOCRINE; EPITHELIUM; PROTEIN; TMPRSS2	Half of all prostate cancers are caused by the TMPRSS2-ERG gene-fusion, which enables androgens to drive expression of the normally silent E26 transformation-specific (ETS) transcription factor ERG in prostate cells(1,2). Recent genomic landscape studies of such cancers3-8 have reported recurrent point mutations and focal deletions of another ETS member, the ETS2 repressor factor ERF9. Here we show these ERF mutations cause decreased protein stability and mostly occur in tumours without ERG upregulation. ERF loss recapitulates the morphological and phenotypic features of ERG gain in normal mouse prostate cells, including expansion of the androgen receptor transcriptional repertoire, and ERF has tumour suppressor activity in the same genetic background of Pten loss that yields oncogenic activity by ERG. In the more common scenario of ERG upregulation, chromatin immunoprecipitation followed by sequencing indicates that ERG inhibits the ability of ERF to bind DNA at consensus ETS sites both in normal and in cancerous prostate cells. Consistent with a competition model, ERF overexpression blocks ERG-dependent tumour growth, and ERF loss rescues TMPRSS2-ERG-positive prostate cancer cells from ERG dependency. Collectively, these data provide evidence that the oncogenicity of ERG is mediated, in part, by competition with ERF and they raise the larger question of whether other gain-of-function oncogenic transcription factors might also inactivate endogenous tumour suppressors.	[Bose, Rohit; Karthaus, Wouter R.; Armenia, Joshua; Iaquinta, Phillip J.; Zhang, Zeda; Wongvipat, John; Wasmuth, Elizabeth V.; Shah, Neel; Sullivan, Patrick S.; Doran, Michael G.; Schultz, Nikolaus; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA; [Bose, Rohit; Abida, Wassim; Patruno, Anna] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA; [Armenia, Joshua; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, 1275 York Ave, New York, NY 10065 USA; [Zhang, Zeda] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Wang, Ping; Zhao, Yilin; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA.; Sawyers, CL (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20185 USA.	sawyersc@mskcc.org	Bose, Rohit/O-9825-2018; Sigaras, Alexandros/AAF-7111-2019; Mateo, Joaquin/AAG-9213-2019; Zhang, Zeda/AAV-8644-2021; Perez-Lopez, Raquel/AAH-1978-2019; Schultz, Nikolaus/ABE-6347-2020	Bose, Rohit/0000-0002-6785-0697; Sigaras, Alexandros/0000-0002-7607-559X; Zhang, Zeda/0000-0002-7225-534X; Wasmuth, Elizabeth/0000-0003-1474-4935; Perez-Lopez, Raquel/0000-0002-9176-0130; Karthaus, Wouter R./0000-0002-9234-9044; Dvinge, Heidi/0000-0003-1741-0738; Zheng, Deyou/0000-0003-4354-5337; Vats, Pankaj/0000-0001-8441-7732	American Society of Clinical Oncology (ASCO); Department of Defense Physician Training Award; Prostate Cancer Foundation; ASCO; Howard Hughes Medical Institute (HHMI) Summer Medical Fellowship; National Institutes of Health [CA155169, CA19387, CA092629, CA008748]; NATIONAL CANCER INSTITUTE [R01CA193837, P30CA008748, P50CA092629, P50CA097186, R01CA155169] Funding Source: NIH RePORTER	American Society of Clinical Oncology (ASCO); Department of Defense Physician Training Award; Prostate Cancer Foundation; ASCO; Howard Hughes Medical Institute (HHMI) Summer Medical Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Heguy, H. Hieronymous, J. Li, Y. Liang, E. Peguero, M. Pirun, N. Socci, P. Watson, A. Viale, Y. Zhang, Memorial Sloan Kettering Cancer Center core facilities, and the members of the Sawyers laboratory for comments. R.B. was supported by an American Society of Clinical Oncology (ASCO) Young Investigator Award, a Department of Defense Physician Training Award, and a Prostate Cancer Foundation Young Investigator Award. W.A. was supported by an ASCO Young Investigator Award and Prostate Cancer Foundation Young Investigator Award. M.G.D. was supported by a Howard Hughes Medical Institute (HHMI) Summer Medical Fellowship. N. Sch. is supported by the Prostate Cancer Foundation. C.L.S. is an investigator of the HHMI and this project was supported by National Institutes of Health grants CA155169, CA19387, CA092629, and CA008748.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; International Cancer Genome Consortium, 2016, PROST CANC AD; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mounir Z, 2015, ONCOGENE, V34, P3815, DOI 10.1038/onc.2014.308; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Regan MC, 2013, P NATL ACAD SCI USA, V110, P13374, DOI 10.1073/pnas.1301726110; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rockowitz S, 2015, NUCLEIC ACIDS RES, V43, P5730, DOI 10.1093/nar/gkv514; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Twigg SRF, 2013, NAT GENET, V45, P308, DOI 10.1038/ng.2539; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287	32	45	45	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					671	+		10.1038/nature22820	http://dx.doi.org/10.1038/nature22820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28614298	Green Accepted			2022-12-28	WOS:000404332000051
J	Zhu, S; Ding, SY; Wang, PH; Wei, Z; Pan, W; Palm, NW; Yang, Y; Yu, H; Li, HB; Wang, G; Lei, XQ; de Zoete, MR; Zhao, J; Zheng, YJ; Chen, HW; Zhao, YJ; Jurado, KA; Feng, NG; Shan, L; Kluger, Y; Lu, J; Abraham, C; Fikrig, E; Greenberg, HB; Flavell, RA				Zhu, Shu; Ding, Siyuan; Wang, Penghua; Wei, Zheng; Pan, Wen; Palm, Noah W.; Yang, Yi; Yu, Hua; Li, Hua-Bing; Wang, Geng; Lei, Xuqiu; de Zoete, Marcel R.; Zhao, Jun; Zheng, Yunjiang; Chen, Haiwei; Zhao, Yujiao; Jurado, Kellie A.; Feng, Ningguo; Shan, Liang; Kluger, Yuval; Lu, Jun; Abraham, Clara; Fikrig, Erol; Greenberg, Harry B.; Flavell, Richard A.			Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells	NATURE			English	Article							DOUBLE-STRANDED-RNA; HETEROLOGOUS ROTAVIRUS; AIM2 INFLAMMASOME; IMMUNE-RESPONSES; CASPASE-1; REPLICATION; SECRETION; FLAGELLIN; INNATE; DEATH	Rotavirus, a leading cause of severe gastroenteritis and diarrhoea in young children, accounts for around 215,000 deaths annually worldwide(1). Rotavirus specifically infects the intestinal epithelial cells in the host small intestine and has evolved strategies to antagonize interferon and NF-kappa B signalling(2-5), raising the question as to whether other host factors participate in antiviral responses in intestinal mucosa. The mechanism by which enteric viruses are sensed and restricted in vivo, especially by NOD-like receptor (NLR) inflammasomes, is largely unknown. Here we uncover and mechanistically characterize the NLR Nlrp9b that is specifically expressed in intestinal epithelial cells and restricts rotavirus infection. Our data show that, via RNA helicase Dhx9, Nlrp9b recognizes short double-stranded RNA stretches and forms inflammasome complexes with the adaptor proteins Asc and caspase-1 to promote the maturation of interleukin (Il)-18 and gasdermin D (Gsdmd)-induced pyroptosis. Conditional depletion of Nlrp9b or other inflammasome components in the intestine in vivo resulted in enhanced susceptibility of mice to rotavirus replication. Our study highlights an important innate immune signalling pathway that functions in intestinal epithelial cells and may present useful targets in the modulation of host defences against viral pathogens.	[Zhu, Shu; Wei, Zheng; Palm, Noah W.; Yang, Yi; Yu, Hua; Li, Hua-Bing; Wang, Geng; Lei, Xuqiu; de Zoete, Marcel R.; Zhao, Jun; Zheng, Yunjiang; Chen, Haiwei; Shan, Liang; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Ding, Siyuan; Feng, Ningguo; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Ding, Siyuan; Feng, Ningguo; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ding, Siyuan; Greenberg, Harry B.] VA Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA; [Wang, Penghua; Zhao, Yujiao] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Pan, Wen; Lu, Jun] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Zhao, Jun; Kluger, Yuval] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Jurado, Kellie A.; Abraham, Clara; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Fikrig, Erol; Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; New York Medical College; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	richard.flavell@yale.edu	Li, Huabing/M-5390-2013; Zhao, Jun/AAT-2086-2021; Zhu, Shu/P-6163-2018; Yang, Yi/GPX-3687-2022; Shan, Liang/ABB-9210-2021; de Zoete, Marcel/ABA-7918-2021; Ding, Siyuan/G-2718-2017; de Zoete, Marcel R/O-3012-2014; wang, Penghua/AAL-4011-2020	Li, Huabing/0000-0003-3573-6803; Zhu, Shu/0000-0002-8163-0869; Yang, Yi/0000-0002-5200-0614; Zhao, Yujiao/0000-0001-9142-4332; Yu, Hua/0000-0002-1691-2763; greenberg, harry/0000-0002-2128-9080; Palm, Noah/0000-0001-7262-9455; Ding, Siyuan/0000-0002-5338-260X; de Zoete, Marcel/0000-0002-6561-5810	Helen Hay Whitney Foundation-Howard Hughes Medical Institute; Walter V. and Idun Berry Postdoctoral Fellowship; Thrasher Research Fund; VA Merit Review grant [I01BX000158]; NIH [R01AI021362, U19AI116484];  [R21AI103807];  [R01DK099097];  [R01DK106593];  [R01AI120369];  [U19AI089992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI116484, R21AI103807, R01AI120369, U19AI089992, R01AI125249, R56AI021362, R01AI127865, T32AI007019, R01AI021362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099097, R01DK106593] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000158] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation-Howard Hughes Medical Institute(Howard Hughes Medical Institute); Walter V. and Idun Berry Postdoctoral Fellowship; Thrasher Research Fund; VA Merit Review grant(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank C. Jin, B. Hu, A. Solis, P. Bielecki, R. Nowarski, R. Jackson, W. Bailis, A. Rongvaux, J. Henao-Mejia, A. Williams, E. Elinav, T. Strowig, J. Alderman, C. Lieber, J. Stein, C. Hughes, L. Evangelisti, L. Borelli, P. Ranney and other members of Flavell laboratory for technical help and helpful discussion. S.Z. is supported by a fellowship from Helen Hay Whitney Foundation-Howard Hughes Medical Institute. S.D. is supported by the Walter V. and Idun Berry Postdoctoral Fellowship and an Early Career Award from the Thrasher Research Fund. P. W. is supported by R21AI103807. C. A. is supported by R01DK099097, R01DK106593 and R01AI120369. H.B.G. is supported by VA Merit Review grant I01BX000158, and NIH grants R01AI021362 and U19AI116484. R.A.F. and E.F. are investigators of the Howard Hughes Medical Institute, and are supported by U19AI089992.	Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; BURNS JW, 1995, VIROLOGY, V207, P143, DOI 10.1006/viro.1995.1060; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Deal EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000931; Ding SY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005929; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; EYDELLOTH RS, 1984, J VIROL, V50, P947, DOI 10.1128/JVI.50.3.947-950.1984; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; FENG NG, 1994, J VIROL, V68, P7766, DOI 10.1128/JVI.68.12.7766-7773.1994; Feng NG, 2013, J VIROL, V87, P8307, DOI 10.1128/JVI.00619-13; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Halasz P, 2010, J GEN VIROL, V91, P2007, DOI 10.1099/vir.0.018275-0; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hu B, 2016, SCIENCE, V354, P765, DOI 10.1126/science.aaf7532; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lin JD, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005600, 10.1371/journal.ppat.1005726]; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; Sen A, 2014, J VIROL, V88, P41, DOI 10.1128/JVI.01501-13; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; SHERIDAN JF, 1983, INFECT IMMUN, V39, P917, DOI 10.1128/IAI.39.2.917-927.1983; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tate JE, 2016, CLIN INFECT DIS, V62, pS208, DOI 10.1093/cid/civ1016; Uchiyama R, 2015, INNATE IMMUN-LONDON, V21, P416, DOI 10.1177/1753425914547435; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	41	201	215	9	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					667	+		10.1038/nature22967	http://dx.doi.org/10.1038/nature22967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28636595	Green Accepted, Green Submitted			2022-12-28	WOS:000404332000050
J	Voelker, R				Voelker, Rebecca			Antioxidant Drug Approved for ALS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2363	2363		10.1001/jama.2017.6974	http://dx.doi.org/10.1001/jama.2017.6974			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632852				2022-12-28	WOS:000403654600003
J	Hemenway, D				Hemenway, David			Fight the silencing of gun research	NATURE			English	Editorial Material							DEATH; FIREARMS; SUICIDE; RATES		[Hemenway, David] Harvard Univ, Hlth Policy, Cambridge, MA 02138 USA	Harvard University	Hemenway, D (corresponding author), Harvard Univ, Hlth Policy, Cambridge, MA 02138 USA.	hemenway@hsph.harvard.edu						Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; Barber C, 2017, JAMA INTERN MED, V177, P5, DOI 10.1001/jamainternmed.2016.6712; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hemenway David, 2017, Inj Epidemiol, V4, P11, DOI 10.1186/s40621-017-0109-8; Nagata T, 2008, INJURY PREV, V14, P19, DOI 10.1136/ip.2007.015719; Parmet WE, 2017, NEW ENGL J MED, V376, P1901, DOI 10.1056/NEJMp1702516; Reisch T, 2013, AM J PSYCHIAT, V170, P977, DOI 10.1176/appi.ajp.2013.12091256; Shope JT, 2007, J SAFETY RES, V38, P165, DOI 10.1016/j.jsr.2007.02.004; Stark DE, 2017, JAMA-J AM MED ASSOC, V317, P84, DOI 10.1001/jama.2016.16215; Tsai M C, 1999, Inj Prev, V5, P290; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337	11	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					345	347		10.1038/546345a	http://dx.doi.org/10.1038/546345a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28617476	Bronze			2022-12-28	WOS:000403250900012
J	Sieving, PA				Sieving, Paul A.			NIH competition to create 'eye in a dish'	NATURE			English	Letter									[Sieving, Paul A.] NEI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sieving, PA (corresponding author), NEI, Bethesda, MD 20892 USA.	paulsieving@nei.nih.govand							0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					352	352		10.1038/546352b	http://dx.doi.org/10.1038/546352b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617468	Bronze			2022-12-28	WOS:000403250900016
J	Marty, B; Altwegg, K; Balsiger, H; Bar-Nun, A; Bekaert, DV; Berthelier, JJ; Bieler, A; Briois, C; Calmonte, U; Combi, M; De Keyser, J; Fiethe, B; Fuselier, SA; Gasc, S; Gombosi, TI; Hansen, KC; Hassig, M; Jackel, A; Kopp, E; Korth, A; Le Roy, L; Mall, U; Mousis, O; Owen, T; Reme, H; Rubin, M; Semon, T; Tzou, CY; Waite, JH; Wurz, P				Marty, B.; Altwegg, K.; Balsiger, H.; Bar-Nun, A.; Bekaert, D. V.; Berthelier, J. -J.; Bieler, A.; Briois, C.; Calmonte, U.; Combi, M.; De Keyser, J.; Fiethe, B.; Fuselier, S. A.; Gasc, S.; Gombosi, T. I.; Hansen, K. C.; Haessig, M.; Jaeckel, A.; Kopp, E.; Korth, A.; Le Roy, L.; Mall, U.; Mousis, O.; Owen, T.; Reme, H.; Rubin, M.; Semon, T.; Tzou, C. -Y.; Waite, J. H.; Wurz, P.			Xenon isotopes in 67P/Churyumov-Gerasimenko show that comets contributed to Earth's atmosphere	SCIENCE			English	Article							NOBLE-GASES; SOLAR; ABUNDANCES; ELEMENTS; MISSION; ORIGINS; SYSTEM; WATER	The origin of cometary matter and the potential contribution of comets to inner-planet atmospheres are long-standing problems. During a series of dedicated low-altitude orbits, the Rosetta Orbiter Spectrometer for Ion and Neutral Analysis (ROSINA) on the Rosetta spacecraft analyzed the isotopes of xenon in the coma of comet 67P/Churyumov-Gerasimenko. The xenon isotopic composition shows deficits in heavy xenon isotopes and matches that of a primordial atmospheric component. The present-day Earth atmosphere contains 22 +/- 5% cometary xenon, in addition to chondritic (or solar) xenon.	[Marty, B.; Bekaert, D. V.] Univ Lorraine, CNRS, Ctr Rech Petrog & Geochim, 15 Rue Notre Dame Pauvres,BP 20, F-54501 Vandoeuvre Les Nancy, France; [Altwegg, K.; Balsiger, H.; Bieler, A.; Calmonte, U.; Gasc, S.; Haessig, M.; Jaeckel, A.; Kopp, E.; Le Roy, L.; Rubin, M.; Semon, T.; Tzou, C. -Y.; Wurz, P.] Univ Bern, Phys Inst, Sidlerstr 5, CH-3012 Bern, Switzerland; [Altwegg, K.] Univ Bern, Ctr Space & Habitabil, Sidlerstr 5, CH-3012 Bern, Switzerland; [Bar-Nun, A.] Tel Aviv Univ, Dept Geosci, Tel Aviv, Israel; [Berthelier, J. -J.] Univ Paris 06, CNRS, Inst Pierre Simon Laplace, Lab Atmospheres Milieux Observat Spati LATMOS, 4 Ave Neptune, F-94100 St Maur, France; [Bieler, A.; Combi, M.; Gombosi, T. I.; Hansen, K. C.] Univ Michigan, Dept Climate & Space Sci & Engn, 2455 Hayward St, Ann Arbor, MI 48109 USA; [Briois, C.] Univ Orleans, CNRS, UMR 6115, Lab Phys & Chim Environnement & Espace LPC2E, Orleans, France; [De Keyser, J.] Inst Royal Aeron Spatiale Belg BIRA IASB, Koninklijk Belgisch Inst Ruimte Aeron, Ringlaan 3, B-1180 Brussels, Belgium; [Fiethe, B.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Comp & Network Engn IDA, Hans Sommer Str 66, D-38106 Braunschweig, Germany; [Fuselier, S. A.; Haessig, M.; Waite, J. H.] Southwest Res Inst, Dept Space Sci, 6220 Culebra Rd, San Antonio, TX 78228 USA; [Korth, A.; Mall, U.] Max Planck Inst Sonnensystemforsch MPS, Justus von Liebig Weg 3, D-37077 Gottingen, Germany; [Mousis, O.] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, F-13388 Marseille, France; [Owen, T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Reme, H.] Univ Paul Sabatier, Observ Midi Pyrenees, CNRS, Inst Rech Astrophys & Planetol, 9 Ave Colonel Roche, F-31028 Toulouse 4, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Bern; University of Bern; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Braunschweig University of Technology; Southwest Research Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Hawaii System; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Marty, B (corresponding author), Univ Lorraine, CNRS, Ctr Rech Petrog & Geochim, 15 Rue Notre Dame Pauvres,BP 20, F-54501 Vandoeuvre Les Nancy, France.	bmarty@crpg.cnrs-nancy.fr	Mousis, Olivier/X-2712-2019; Wurz, Peter/R-2273-2017; Rubin, Martin/I-7777-2013; briois, christelle/B-2170-2015; Gombosi, Tamas I/G-4238-2011; Combi, Michael/J-1697-2012	Wurz, Peter/0000-0002-2603-1169; Rubin, Martin/0000-0001-6549-3318; Gombosi, Tamas I/0000-0001-9360-4951; Combi, Michael/0000-0002-9805-0078; Marty, Bernard/0000-0001-7936-1519; BRIOIS, Christelle/0000-0002-5616-0180; De Keyser, Johan/0000-0003-4805-5695; Calmonte, Ursina/0000-0002-0982-7501; Altwegg, Kathrin/0000-0002-2677-8238; Le Roy, Lena/0000-0002-5984-6153	State of Bern; Swiss National Science Foundation; European Space Agency (ESA) PRODEX program (Programme de Developpement d'Experiences Scientifiques); Max-Planck Society; Federal Ministry for Economic Affairs and Energy [50QP1302]; NASA's Jet Propulsion Laboratory [1496541, NAS703001TONMO710889]; NASA [JPL-1266313]; French National Research Agency [ANR-11-IDEX-0001-02]; Centre National d'Etudes Spatiales grants at Institut de Recherche en Astrophysique et Planetologie; LATMOS; LPC2ELaboratoire d'Astrophysique de Marseille; Centre de Recherches Petrographiques et Geochimiques; European Research Council [267255, 69618]; Belgian Science Policy Office through PRODEX/ROSINA PRODEX Experiment Arrangement [90020]	State of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Space Agency (ESA) PRODEX program (Programme de Developpement d'Experiences Scientifiques); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Federal Ministry for Economic Affairs and Energy; NASA's Jet Propulsion Laboratory; NASA(National Aeronautics & Space Administration (NASA)); French National Research Agency(French National Research Agency (ANR)); Centre National d'Etudes Spatiales grants at Institut de Recherche en Astrophysique et Planetologie; LATMOS; LPC2ELaboratoire d'Astrophysique de Marseille; Centre de Recherches Petrographiques et Geochimiques; European Research Council(European Research Council (ERC)European Commission); Belgian Science Policy Office through PRODEX/ROSINA PRODEX Experiment Arrangement	We thank Y. Marrocchi for comments and G. Avice for help in compiling solar system xenon data. Work was funded at the University of Bern by the State of Bern, the Swiss National Science Foundation, and the European Space Agency (ESA) PRODEX program (Programme de Developpement d'Experiences Scientifiques); at MPS by the Max-Planck Society and the Federal Ministry for Economic Affairs and Energy (contract 50QP1302); at Southwest Research Institute by NASA's Jet Propulsion Laboratory (subcontract 1496541 and JPL subcontract to J.H.W. NAS703001TONMO710889); at the University of Michigan by NASA (contract JPL-1266313); through the A*MIDEX project by the French National Research Agency (grant no. ANR-11-IDEX-0001-02); by Centre National d'Etudes Spatiales grants at Institut de Recherche en Astrophysique et Planetologie, LATMOS, LPC2E, Laboratoire d'Astrophysique de Marseille and Centre de Recherches Petrographiques et Geochimiques; by the European Research Council (grants no. 267255 and 69618 to B.M.); and at BIRA-IASB by the Belgian Science Policy Office through PRODEX/ROSINA PRODEX Experiment Arrangement 90020. ROSINA would not produce results without the work of the many engineers, technicians, and scientists involved with the mission, the Rosetta spacecraft, and the ROSINA instrument team over the past 20 years, whose contributions are gratefully acknowledged. These measurements could only be performed thanks to the skillful maneuvering of the spacecraft close to the comet by the operations team in Darmstadt, Germany. Rosetta is an ESA mission with contributions from its member states and NASA. We acknowledge the work of the whole ESA Rosetta team. ROSINA data are publicly available at ESA's Planetary Science Archive at www.cosmos.esa.int/web/psa/rosetta and NASA's Planetary Data System at https://pdssbn.astro.umd.edu/data_sb/missions/rosetta/index.shtml. M.R. and K.A. performed data reduction. M.R., K.A., and B.M. analyzed the data. B.M. interpreted the data and wrote the paper. K.A., M.R., and H.B. contributed to data interpretation and the supplementary materials. All authors contributed to the ROSINA instrument and commented on and revised the manuscript.	Altwegg K, 2015, SCIENCE, V347, DOI 10.1126/science.1261952; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Balsiger H, 2007, SPACE SCI REV, V128, P745, DOI 10.1007/s11214-006-8335-3; Balsiger H, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500377; Bockelee-Morvan D, 2015, SPACE SCI REV, V197, P47, DOI 10.1007/s11214-015-0156-9; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Brugger B, 2016, ASTROPHYS J LETT, V831, DOI 10.3847/2041-8205/831/2/L16; Busemann H, 2000, METEORIT PLANET SCI, V35, P949, DOI 10.1111/j.1945-5100.2000.tb01485.x; Gilmour JD, 2007, ASTROPHYS J, V657, P600, DOI 10.1086/510881; HUSS GR, 1994, METEORITICS, V29, P811, DOI 10.1111/j.1945-5100.1994.tb01095.x; Marrocchi Y, 2011, GEOCHIM COSMOCHIM AC, V75, P6255, DOI 10.1016/j.gca.2011.07.048; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; Meshik A, 2014, GEOCHIM COSMOCHIM AC, V127, P326, DOI 10.1016/j.gca.2013.11.030; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Notesco G, 1999, ICARUS, V142, P298, DOI 10.1006/icar.1999.6202; Ozima M., 2022, NOBLE GAS GEOCHEMIST; Pepin RO, 2000, SPACE SCI REV, V92, P371, DOI 10.1023/A:1005236405730; Tissot FLH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501400; Vacher LG, 2016, ASTROPHYS J LETT, V827, DOI 10.3847/2041-8205/827/1/L1; WETHERILL GW, 1975, ANNU REV NUCL PART S, V25, P283, DOI 10.1146/annurev.ns.25.120175.001435	25	125	126	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1069	+		10.1126/science.aal3496	http://dx.doi.org/10.1126/science.aal3496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596364	Green Published			2022-12-28	WOS:000402871700052
J	Wagner, N; Hochkirch, A; Martin, H; Matenaar, D; Rohde, K; Wacht, F; Wesch, C; Wirtz, S; Klein, R; Lotters, S; Proelss, A; Veith, M				Wagner, Norman; Hochkirch, Axel; Martin, Henrike; Matenaar, Daniela; Rohde, Katja; Wacht, Frank; Wesch, Charlotte; Wirtz, Sarah; Klein, Roland; Lotters, Stefan; Proelss, Alexander; Veith, Michael			De-extinction, nomenclature, and the law	SCIENCE			English	Editorial Material									[Wagner, Norman; Hochkirch, Axel; Matenaar, Daniela; Rohde, Katja; Wesch, Charlotte; Wirtz, Sarah; Klein, Roland; Lotters, Stefan; Veith, Michael] Univ Trier, Dept Biogeog, Univ Sring 15, D-54296 Trier, Germany; [Martin, Henrike; Wacht, Frank; Proelss, Alexander] Univ Trier, Inst Environm & Technol Law, D-54296 Trier, Germany; [Matenaar, Daniela] Stuttgart State Museum Nat Hist, Dept Entomol, D-70191 Stuttgart, Germany; [Matenaar, Daniela] Hess Landesmuseum Darmstadt, D-64283 Darmstadt, Germany	Universitat Trier; Universitat Trier	Hochkirch, A (corresponding author), Univ Trier, Dept Biogeog, Univ Sring 15, D-54296 Trier, Germany.	hochkirch@uni-trier.de	Hochkirch, Axel/A-4092-2008; Wagner, Norman/AFR-9091-2022	Hochkirch, Axel/0000-0002-4475-0394; Wagner, Norman/0000-0001-9565-619X	German Science Foundation, Deutsche Forschungsgemeinschaft [GRK 1319]	German Science Foundation, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors were funded by the German Science Foundation, Deutsche Forschungsgemeinschaft (GRK 1319).	Bennett JR, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0053; Carlin N. F., 2014, STANFORD ENV LAW J, V33, P3; Folch J, 2009, THERIOGENOLOGY, V71, P1026, DOI 10.1016/j.theriogenology.2008.11.005; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Ogden LE, 2014, BIOSCIENCE, V64, P469, DOI 10.1093/biosci/biu063; Park M., 2014, THESIS; Seddon PJ, 2014, TRENDS ECOL EVOL, V29, P140, DOI 10.1016/j.tree.2014.01.007; Shapiro B, 2017, FUNCT ECOL, V31, P996, DOI 10.1111/1365-2435.12705; Sherkow JS, 2013, SCIENCE, V340, P32, DOI 10.1126/science.1236965; SSC of the IUCN, 2016, GUID PRINC CREAT PRO; Yong E., 2013, RESURRECTING EXTINCT; Zielinski P, 2013, MOL ECOL, V22, P1884, DOI 10.1111/mec.12225	12	5	5	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1016	1017		10.1126/science.aal4012	http://dx.doi.org/10.1126/science.aal4012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596329				2022-12-28	WOS:000402871700034
J	Collins, C; Dyer, MS; Pitcher, MJ; Whitehead, GFS; Zanella, M; Mandal, P; Claridge, JB; Darling, GR; Rosseinsky, MJ				Collins, C.; Dyer, M. S.; Pitcher, M. J.; Whitehead, G. F. S.; Zanella, M.; Mandal, P.; Claridge, J. B.; Darling, G. R.; Rosseinsky, M. J.			Accelerated discovery of two crystal structure types in a complex inorganic phase field	NATURE			English	Article							STRUCTURE PREDICTION; ATOMISTIC SIMULATION; POWDER-DIFFRACTION; STRONTIUM GALLATE; SOLID-SOLUTIONS; TERNARY OXIDES; PEROVSKITE; REFINEMENT; ALGORITHM; CHEMISTRY	The discovery of new materials is hampered by the lack of efficient approaches to the exploration of both the large number of possible elemental compositions for such materials, and of the candidate structures at each composition(1). For example, the discovery of inorganic extended solid structures has relied on knowledge of crystal chemistry coupled with time-consuming materials synthesis with systematically varied elemental ratios(2,3). Computational methods have been developed to guide synthesis by predicting structures at specific compositions(4-6) and predicting compositions for known crystal structures(7,8), with notable successes(9,10). However, the challenge of finding qualitatively new, experimentally realizable compounds, with crystal structures where the unit cell and the atom positions within it differ from known structures, remains for compositionally complex systems. Many valuable properties arise from substitution into known crystal structures, but materials discovery using this approach alone risks both missing best-in-class performance and attempting design with incomplete knowledge(8,11). Here we report the experimental discovery of two structure types by computational identification of the region of a complex inorganic phase field that contains them. This is achieved by computing probe structures that capture the chemical and structural diversity of the system and whose energies can be ranked against combinations of currently known materials. Subsequent experimental exploration of the lowest-energy regions of the computed phase diagram affords two materials with previously unreported crystal structures featuring unusual structural motifs. This approach will accelerate the systematic discovery of new materials in complex compositional spaces by efficiently guiding synthesis and enhancing the predictive power of the computational tools through expansion of the knowledge base underpinning them.	[Collins, C.; Dyer, M. S.; Pitcher, M. J.; Whitehead, G. F. S.; Zanella, M.; Mandal, P.; Claridge, J. B.; Darling, G. R.; Rosseinsky, M. J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England	University of Liverpool	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	rossein@liverpool.ac.uk	Pitcher, Michael J/B-7157-2019; Dyer, Matthew S/Q-2762-2019; Claridge, John B/I-7395-2012; Dyer, Matthew S/E-8633-2017; Whitehead, George F S/E-6639-2017	Pitcher, Michael J/0000-0003-2044-6774; Dyer, Matthew S/0000-0002-4923-3003; Claridge, John B/0000-0003-4849-6714; Dyer, Matthew S/0000-0002-4923-3003; Whitehead, George F S/0000-0003-1949-4250; Darling, George/0000-0001-9329-9993; Collins, Christopher/0000-0002-0101-4426	EPSRC [EP/N004884]; Materials Chemistry Consortium [EPSRC: EP/L000202]; PRACE-3IP project [FP7 RI-312763]; UK's investment in e-infrastructure; EPSRC [EP/N004884/1, EP/L000202/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N004884/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Materials Chemistry Consortium; PRACE-3IP project; UK's investment in e-infrastructure; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank EPSRC for funding under EP/N004884. M.J.R. is a Royal Society Research Professor. We thank the Materials Chemistry Consortium (EPSRC: EP/L000202) and the PRACE-3IP project (FP7 RI-312763) for provision of computer time on the ARCHER UK National Supercomputing Service, and the N8 consortium (EPSRC: EP/K000225/1) and the University of Liverpool for access to local high-performance computing resources. We thank ISIS and Diamond Light Source for provision of beamtime and C. Tang, C. Murray and D. Fortes for assistance on the I11 and HRPD instruments. We acknowledge use of Hartree Centre resources in this work; the STFC Hartree Centre is a collaborative research laboratory in association with IBM providing high-performance computing platforms funded by the UK's investment in e-infrastructure. We thank R. Seshadri and T.A. Strom (Materials Research Laboratory and Department of Materials, University of California, Santa Barbara) for measurement of the phosphor quantum yield. We are also grateful to K. Dawson, from the Centre for Materials and Structures at the University of Liverpool, for sample preparation with the Focussed Ion Beam.	Agilent, 2011, CRYSALIS PRO; [Anonymous], 2007, POWD DIFFR FIL PDF 2; [Anonymous], 2006, XPERT HIGHSCORE PLUS; [Anonymous], 2015, ICSD WEB; Antic-Fidancev E, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195108; BAETZOLD RC, 1988, PHYS REV B, V38, P11304, DOI 10.1103/PhysRevB.38.11304; Barr G, 2004, J APPL CRYSTALLOGR, V37, P243, DOI 10.1107/S0021889804000391; BARRY TL, 1967, J INORG NUCL CHEM, V29, P1243, DOI 10.1016/0022-1902(67)80365-8; BERTAUT EF, 1959, ACTA CRYSTALLOGR, V12, P149, DOI 10.1107/S0365110X59000433; BILYI AI, 1986, KRISTALLOGRAFIYA+, V31, P1217; BUSH TS, 1994, J MATER CHEM, V4, P831, DOI 10.1039/jm9940400831; BUTTNER RH, 1992, ACTA CRYSTALLOGR B, V48, P764, DOI 10.1107/S010876819200510X; Cerqueira TFT, 2015, CHEM MATER, V27, P4562, DOI 10.1021/acs.chemmater.5b00716; Cheetham AK, 2014, NAT MATER, V13, P760, DOI 10.1038/nmat4044; Chen HL, 2012, J AM CHEM SOC, V134, P19619, DOI 10.1021/ja3040834; Chtoun E, 1997, EUR J SOL STATE INOR, V34, P553; DEISEROTH HJ, 1973, Z ANORG ALLG CHEM, V402, P201, DOI 10.1002/zaac.19734020211; DEISEROTH HJ, 1971, Z ANORG ALLG CHEM, V382, P149, DOI 10.1002/zaac.19713820206; deMello JC, 1997, ADV MATER, V9, P230, DOI 10.1002/adma.19970090308; Demont A, 2010, CHEM MATER, V22, P6598, DOI 10.1021/cm102475n; DICK BG, 1958, PHYS REV, V112, P90, DOI 10.1103/PhysRev.112.90; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Dyer MS, 2013, SCIENCE, V340, P847, DOI 10.1126/science.1226558; FALLON GD, 1983, J SOLID STATE CHEM, V49, P59, DOI 10.1016/0022-4596(83)90216-5; FAUCHER M, 1980, ACTA CRYSTALLOGR B, V36, P3209, DOI 10.1107/S0567740880011351; FENG M, 1994, EUR J SOL STATE INOR, V31, P663; Gale JD, 2003, MOL SIMULAT, V29, P291, DOI 10.1080/0892702031000104887; Gautier R, 2015, NAT CHEM, V7, P308, DOI [10.1038/NCHEM.2207, 10.1038/nchem.2207]; GELLER S, 1975, ACTA CRYSTALLOGR B, V31, P2770, DOI 10.1107/S0567740875008862; GELLER S, 1960, J CHEM PHYS, V33, P676, DOI 10.1063/1.1731237; Ghebouli MA, 2011, J ALLOY COMPD, V509, P1440, DOI 10.1016/j.jallcom.2010.11.097; Hautier G, 2011, INORG CHEM, V50, P656, DOI 10.1021/ic102031h; HOFMEISTER W, 1984, ACTA CRYSTALLOGR C, V40, P1510, DOI 10.1107/S0108270184008544; HUANG Q, 1992, PHYS REV B, V45, P9611, DOI 10.1103/PhysRevB.45.9611; ISHIHARA T, 1994, J AM CHEM SOC, V116, P3801, DOI 10.1021/ja00088a016; Jansen M, 2002, ANGEW CHEM INT EDIT, V41, P3747, DOI 10.1002/1521-3773(20021018)41:20<3746::AID-ANIE3746>3.0.CO;2-2; Kahlenberg V, 2005, J SOLID STATE CHEM, V178, P1429, DOI 10.1016/j.jssc.2005.02.009; Kahlenberg V, 2001, J SOLID STATE CHEM, V160, P421, DOI 10.1006/jssc.2001.9259; Kahlenberg V, 2001, Z KRISTALLOGR, V216, P210, DOI 10.1524/zkri.216.4.210.23254; Kahlenberg V, 2001, Z KRISTALLOGR, V216, P206, DOI 10.1524/zkri.216.4.206.23257; Kahlenberg V, 2000, J SOLID STATE CHEM, V153, P294, DOI 10.1006/jssc.2000.8768; KOBAYASHI H, 1994, NIPPON SERAM KYO GAK, V102, P583, DOI 10.2109/jcersj.102.583; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kuang X, 2008, NAT MATER, V7, P498, DOI 10.1038/nmat2201; Kuang XJ, 2002, CHEM MATER, V14, P4359, DOI 10.1021/cm020374m; LIU LG, 1971, J APPL PHYS, V42, P3702, DOI 10.1063/1.1659673; Lyakhov AO, 2013, COMPUT PHYS COMMUN, V184, P1172, DOI 10.1016/j.cpc.2012.12.009; Maglia F, 2006, J PHYS CHEM B, V110, P6561, DOI 10.1021/jp055713o; McKittrick J, 2014, J AM CERAM SOC, V97, P1327, DOI 10.1111/jace.12943; Morris AJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.224106; MUMME WG, 1968, ACTA CRYSTALL B-STRU, VB 24, P1327, DOI 10.1107/S0567740868004243; NAKATSUKA A, 1995, ACTA CRYSTALLOGR B, V51, P737, DOI 10.1107/S0108768194014813; OKEEFFE M, 1980, PHILOS T R SOC A, V295, P553, DOI 10.1098/rsta.1980.0150; Ong SP, 2013, COMP MATER SCI, V68, P314, DOI 10.1016/j.commatsci.2012.10.028; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Petricek V, 2014, Z KRIST-CRYST MATER, V229, P345, DOI 10.1515/zkri-2014-1737; Ruiz-Trejo E, 1999, SOLID STATE IONICS, V123, P121, DOI 10.1016/S0167-2738(99)00092-2; SABINE TM, 1982, ACTA CRYSTALLOGR B, V38, P701, DOI 10.1107/S0567740882003896; Schon JC, 2014, Z ANORG ALLG CHEM, V640, P2717, DOI 10.1002/zaac.201400374; SCHRODER KP, 1992, CHEM PHYS LETT, V188, P320, DOI 10.1016/0009-2614(92)90030-Q; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Siegrist T, 2003, EUR J INORG CHEM, P1483; Skakle JMS, 1999, POWDER DIFFR, V14, P195, DOI 10.1017/S0885715600010526; Szymanik B, 1998, SOLID STATE IONICS, V109, P223, DOI 10.1016/S0167-2738(98)00087-3; TILLMANNS E, 1971, INORG NUCL CHEM LETT, V7, P1169, DOI 10.1016/0020-1650(71)80059-4; TILLMANNS E, 1969, ACTA CRYSTALL B-STRU, VB 25, P1444, DOI 10.1107/S0567740869004195; TILLMANNS E, 1974, ACTA CRYSTALLOGR B, V30, P2894, DOI 10.1107/S0567740874008405; VANBEEST BWH, 1990, PHYS REV LETT, V64, P1955, DOI 10.1103/PhysRevLett.64.1955; Vanderah TA, 1996, J SOLID STATE CHEM, V121, P38, DOI 10.1006/jssc.1996.0006; Wales D. J., 1999, SCIENCE, V1368, P285, DOI DOI 10.1126/SCIENCE.285.5432.1368; Wang YC, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/20/203203; Woodley SM, 2008, NAT MATER, V7, P937, DOI 10.1038/nmat2321; Woodley SM, 1999, PHYS CHEM CHEM PHYS, V1, P2535, DOI 10.1039/a901227c; WU KK, 1973, ACTA CRYSTALLOGR B, V29, P2009, DOI 10.1107/S0567740873005959; Zhu Q, 2012, ACTA CRYSTALLOGR B, V68, P215, DOI 10.1107/S0108768112017466	77	42	42	3	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					280	+		10.1038/nature22374	http://dx.doi.org/10.1038/nature22374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593963				2022-12-28	WOS:000402823400035
J	Berens, P				Berens, Pamela			Antenatal milk expression for women with diabetes in pregnancy	LANCET			English	Editorial Material									[Berens, Pamela] Univ Texas Houston, Hlth Sci Ctr, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Berens, P (corresponding author), Univ Texas Houston, Hlth Sci Ctr, McGovern Med Sch, Houston, TX 77030 USA.	pamela.d.berens@uth.tmc.edu						American College of Obstetricians and Gynecologists Committee on Practice BulletinsObstetrics, 2016, Obstet Gynecol, V128, pe155, DOI 10.1097/AOG.0000000000001711; East CE, 2014, COCHRANE DB SYST REV, V30; Forster D, 2017, LANCET, V389, P2204, DOI 10.1016/S0140-6736(17)31373-9; Forster DA, 2011, MIDWIFERY, V27, P209, DOI 10.1016/j.midw.2009.05.009; Oza-Frank R, 2016, J HUM LACT, V32, P658, DOI 10.1177/0890334416663196; Soltani H, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-18	6	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2167	2168		10.1016/S0140-6736(17)31505-2	http://dx.doi.org/10.1016/S0140-6736(17)31505-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589882				2022-12-28	WOS:000402540800006
J	Samarasekera, U; Horton, R				Samarasekera, Udani; Horton, Richard			Improving evidence for health in humanitarian crises	LANCET			English	Editorial Material									[Samarasekera, Udani] Lancet Child & Adolescent Hlth, London EC2Y 5AS, England; [Horton, Richard] The Lancet, London EC2Y 5AS, England		Samarasekera, U (corresponding author), Lancet Child & Adolescent Hlth, London EC2Y 5AS, England.							ACAPS, 2016, CRIS OV 2016 HUM TRE; Blanchet K, 2017, LANCET; Checchi F, 2017, LANCET; COLOMBO S, 2017, LANCET; Elamein M, 2017, LANCET; Spiegel PB., 2017, LANCET	6	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2223	2224		10.1016/S0140-6736(17)31353-3	http://dx.doi.org/10.1016/S0140-6736(17)31353-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602559				2022-12-28	WOS:000415645700008
J	Jairam, AP; Timmermans, L; Eker, HH; Pierik, REGJM; van Klaveren, D; Steyerberg, EW; Timman, R; van der Ham, AC; Dawson, I; Charbon, JA; Schuhmacher, C; Mihaljevic, A; Izbicki, JR; Fikatas, P; Knebel, P; Fortelny, RH; Kleinrensink, GJ; Lange, JF; Jeekel, HJ				Jairam, An P.; Timmermans, Lucas; Eker, Hasan H.; Pierik, Robert E. G. J. M.; van Klaveren, David; Steyerberg, Ewout W.; Timman, Reinier; van der Ham, Arie C.; Dawson, Imro; Charbon, Jan A.; Schuhmacher, Christoph; Mihaljevic, Andre; Izbicki, Jakob R.; Fikatas, Panagiotis; Knebel, Philip; Fortelny, Rene H.; Kleinrensink, Gert-Jan; Lange, Johan F.; Jeekel, Hans J.		PRIMA Trialist Grp	Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial	LANCET			English	Article							ABDOMINAL AORTIC-ANEURYSM; COMPARING PRIMARY SUTURE; SURGICAL SITE INFECTION; QUALITY-OF-LIFE; PARASTOMAL HERNIA; POLYGLACTIN MESH; FIBRIN SEALANT; CLINICAL-TRIAL; RISK-FACTORS; REPAIR	Background Incisional hernia is a frequent long-term complication after abdominal surgery, with a prevalence greater than 30% in high-risk groups. The aim of the PRIMA trial was to evaluate the effectiveness of mesh reinforcement in high-risk patients, to prevent incisional hernia. Methods We did a multicentre, double-blind, randomised controlled trial at 11 hospitals in Austria, Germany, and the Netherlands. We included patients aged 18 years or older who were undergoing elective midline laparotomy and had either an abdominal aortic aneurysm or a body-mass index (BMI) of 27 kg/m(2) or higher. We randomly assigned participants using a computer-generated randomisation sequence to one of three treatment groups: primary suture; onlay mesh reinforcement; or sublay mesh reinforcement. The primary endpoint was incidence of incisional hernia during 2 years of follow-up, analysed by intention to treat. Adjusted odds ratios (ORs) were estimated by logistic regression. This trial is registered at ClinicalTrials.gov, number NCT00761475. Findings Between March, 2009, and December, 2012, 498 patients were enrolled to the study, of whom 18 were excluded before randomisation. Therefore, we included 480 patients in the primary analysis: 107 were assigned primary suture only, 188 were allocated onlay mesh reinforcement, and 185 were assigned sublay mesh reinforcement. 92 patients were identified with an incisional hernia, 33 (30%) who were allocated primary suture only, 25 (13%) who were assigned onlay mesh reinforcement, and 34 (18%) who were assigned sublay mesh reinforcement (onlay mesh reinforcement vs primary suture, OR 0.37, 95% CI 0.20-0.69; p=0.0016; sublay mesh reinforcement vs primary suture, 0.55, 0.30-1.00; p=0.05). Seromas were more frequent in patients allocated onlay mesh reinforcement (34 of 188) than in those assigned primary suture (five of 107; p=0.002) or sublay mesh reinforcement (13 of 185; p=0.002). The incidence of wound infection did not differ between treatment groups (14 of 107 primary suture; 25 of 188 onlay mesh reinforcement; and 19 of 185 sublay mesh reinforcement). Interpretation A significant reduction in incidence of incisional hernia was achieved with onlay mesh reinforcement compared with sublay mesh reinforcement and primary suture only. Onlay mesh reinforcement has the potential to become the standard treatment for high-risk patients undergoing midline laparotomy.	[Jairam, An P.; Timmermans, Lucas; Eker, Hasan H.; Lange, Johan F.] Erasmus Univ, Med Ctr, Dept Surg, NL-3000 CA Rotterdam, Netherlands; [van Klaveren, David; Steyerberg, Ewout W.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Timman, Reinier] Erasmus Univ, Med Ctr, Dept Med Psychol, Rotterdam, Netherlands; [Kleinrensink, Gert-Jan; Jeekel, Hans J.] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands; [Timmermans, Lucas] Maasstad Ziekenhuis, Dept Surg, Rotterdam, Netherlands; [Eker, Hasan H.] Vrije Univ Amsterdam, Dept Surg, Amsterdam, Netherlands; [Pierik, Robert E. G. J. M.] Isala Clin, Dept Surg, Zwolle, Netherlands; [van der Ham, Arie C.] St Franciscus Gasthuis, Dept Surg, Rotterdam, Netherlands; [Dawson, Imro] IJsselland Ziekenhuis, Dept Surg, Capelle aan den IJssel, Netherlands; [Charbon, Jan A.] Maxima Med Ctr, Dept Surg, Veldhoven, Netherlands; [Schuhmacher, Christoph] Tech Univ Munich, Dept Surg, Munich, Germany; [Mihaljevic, Andre] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Izbicki, Jakob R.] Univ Klinikum Hamburg Eppendorf, Dept Surg, Hamburg, Germany; [Fikatas, Panagiotis] Charite, Dept Surg, Berlin, Germany; [Knebel, Philip] Univ Klinikum Heidelberg, Dept Surg, Heidelberg, Germany; [Fortelny, Rene H.] Wilhelminenspital Stadt Wien, Dept Surg, Vienna, Austria	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital; Vrije Universiteit Amsterdam; Isala Clinics; Franciscus Gasthuis; Maxima Medical Center; Technical University of Munich; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Wilhelminenspital	Jairam, AP (corresponding author), Erasmus Univ, Med Ctr, Dept Surg, NL-3000 CA Rotterdam, Netherlands.	a.jairam@erasmusmc.nl	van Klaveren, David/ABF-3020-2021; Fortelny, René/AAD-5922-2021	van Klaveren, David/0000-0002-2096-606X; Fortelny, René/0000-0002-0066-7716; Fikatas, Panagiotis/0000-0003-0703-8207; Mihaljevic, Andre/0000-0003-1902-657X	Baxter; B Braun Surgical SA	Baxter; B Braun Surgical SA	Baxter; B Braun Surgical SA.	Abo-Ryia MH, 2013, OBES SURG, V23, P1571, DOI 10.1007/s11695-013-0915-1; Al Chalabi H, 2015, INT J SURG, V20, P65, DOI 10.1016/j.ijsu.2015.05.050; Antoniou GA, 2011, J VASC SURG, V54, P1175, DOI 10.1016/j.jvs.2011.02.065; Awaiz A, 2015, HERNIA, V19, P449, DOI 10.1007/s10029-015-1351-z; Bevis PM, 2010, BRIT J SURG, V97, P1497, DOI 10.1002/bjs.7137; Bloemen A, 2012, HERNIA, V16, P53, DOI 10.1007/s10029-011-0865-2; Burger JWA, 2004, ANN SURG, V240, P578; Caro-Tarrago A, 2014, WORLD J SURG, V38, P2223, DOI 10.1007/s00268-014-2510-6; Curro G, 2011, OBES SURG, V21, P1559, DOI 10.1007/s11695-010-0282-0; Deerenberg EB, 2015, LANCET, V386, P1254, DOI 10.1016/S0140-6736(15)60459-7; Diener MK, 2010, ANN SURG, V251, P843, DOI 10.1097/SLA.0b013e3181d973e4; Dumville JC, 2006, BMJ-BRIT MED J, V332, P969, DOI 10.1136/bmj.332.7547.969; Fink C, 2014, BRIT J SURG, V101, P51, DOI 10.1002/bjs.9364; Fortelny RH, 2012, SURG ENDOSC, V26, P1803, DOI 10.1007/s00464-012-2156-0; Franchi M, 2001, OBSTET GYNECOL, V97, P696, DOI 10.1016/S0029-7844(01)01192-9; Henriksen NA, 2013, J VASC SURG, V57, P1524, DOI 10.1016/j.jvs.2012.11.119; Holihan JL, 2016, WORLD J SURG, V40, P89, DOI 10.1007/s00268-015-3252-9; Lau H, 2005, ANN SURG, V242, P670, DOI 10.1097/01.sla.0000186440.02977.de; Little R. J. A., 1987, STAT ANAL MISSING DA; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Murray BW, 2011, AM J SURG, V202, P558, DOI 10.1016/j.amjsurg.2011.06.014; Muysoms FE, 2015, HERNIA, V19, P1, DOI 10.1007/s10029-014-1342-5; Muysoms FE, 2016, ANN SURG, V263, P638, DOI 10.1097/SLA.0000000000001369; Nieuwenhuizen J, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-48; Pans A, 1995, ACTA CHIR BELG, V95, P265; Pans A, 1998, WORLD J SURG, V22, P479, DOI 10.1007/s002689900420; Rogmark P, 2016, ANN SURG, V263, P244, DOI 10.1097/SLA.0000000000001305; Sarr MG, 2014, SURGERY, V156, P902, DOI 10.1016/j.surg.2014.06.022; Sauerland S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007781.pub2; Schug-Pass C, 2012, SURG ENDOSC, V26, P3282, DOI 10.1007/s00464-012-2339-8; Seiler CM, 2009, ANN SURG, V249, P576, DOI 10.1097/SLA.0b013e31819ec6c8; Sorensen LT, 2005, ARCH SURG-CHICAGO, V140, P119, DOI 10.1001/archsurg.140.2.119; Strzelczyk JM, 2006, BRIT J SURG, V93, P1347, DOI 10.1002/bjs.5512; Timmermans L, 2015, ANN SURG, V261, P276, DOI 10.1097/SLA.0000000000000798; Timmermans L, 2013, DIGEST SURG, V30, P401, DOI 10.1159/000355956; Timmermans L, 2014, SURGERY, V155, P178, DOI 10.1016/j.surg.2013.06.014; Togo S, 2008, J GASTROINTEST SURG, V12, P1115, DOI 10.1007/s11605-008-0469-z; van Dijk SM, 2015, WORLD J SURG, V39, P2595, DOI 10.1007/s00268-015-3107-4; van Ramshorst GH, 2012, AM J SURG, V204, P144, DOI 10.1016/j.amjsurg.2012.01.012; van't Riet M, 2002, BRIT J SURG, V89, P1350, DOI 10.1046/j.1365-2168.2002.02258.x; Wason JMS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-364	42	147	148	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					567	576		10.1016/S0140-6736(17)31332-6	http://dx.doi.org/10.1016/S0140-6736(17)31332-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC5BM	28641875				2022-12-28	WOS:000406855800021
J	Jones, I				Jones, Ian			Post-partum depression-a glimpse of light in the darkness?	LANCET			English	Editorial Material							PERINATAL MENTAL-HEALTH; PERIOD		[Jones, Ian] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Natl Ctr Mental Hlth, Cardiff CF24 4HQ, S Glam, Wales	Cardiff University	Jones, I (corresponding author), Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Natl Ctr Mental Hlth, Cardiff CF24 4HQ, S Glam, Wales.	Jonesir1@cf.ac.uk	Jones, Ian R/B-4925-2009	Jones, Ian R/0000-0001-5821-5889				Bauer A, 2014, COSTS PERINATAL MENT; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Howard LM, 2014, LANCET, V384, P1723, DOI 10.1016/S0140-6736(14)62040-7; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Kanes S, 2017, LANCET; National Institute for Health and Care Excellence, 2015, ANT POSTN MENT HLTH	6	1	1	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					434	435		10.1016/S0140-6736(17)31546-5	http://dx.doi.org/10.1016/S0140-6736(17)31546-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB9MO	28619475				2022-12-28	WOS:000406463400006
J	Le, DT; Durham, JN; Smith, KN; Wang, H; Bartlett, BR; Aulakh, LK; Lu, S; Kemberling, H; Wilt, C; Luber, BS; Wong, F; Azad, NS; Rucki, AA; Laheru, D; Donehower, R; Zaheer, A; Fisher, GA; Crocenzi, TS; Lee, JJ; Greten, TF; Duffy, AG; Ciombor, KK; Eyring, AD; Lam, BH; Joe, A; Kang, SP; Holdhoff, M; Danilova, L; Cope, L; Meyer, C; Zhou, SB; Goldberg, RM; Armstrong, DK; Bever, KM; Fader, AN; Taube, J; Housseau, F; Spetzler, D; Xiao, NQ; Pardoll, DM; Papadopoulos, N; Kinzler, KW; Eshleman, JR; Vogelstein, B; Anders, RA; Diaz, LA				Le, Dung T.; Durham, Jennifer N.; Smith, Kellie N.; Wang, Hao; Bartlett, Bjarne R.; Aulakh, Laveet K.; Lu, Steve; Kemberling, Holly; Wilt, Cara; Luber, Brandon S.; Wong, Fay; Azad, Nilofer S.; Rucki, Agnieszka A.; Laheru, Dan; Donehower, Ross; Zaheer, Atif; Fisher, George A.; Crocenzi, Todd S.; Lee, James J.; Greten, Tim F.; Duffy, Austin G.; Ciombor, Kristen K.; Eyring, Aleksandra D.; Lam, Bao H.; Joe, Andrew; Kang, S. Peter; Holdhoff, Matthias; Danilova, Ludmila; Cope, Leslie; Meyer, Christian; Zhou, Shibin; Goldberg, Richard M.; Armstrong, Deborah K.; Bever, Katherine M.; Fader, Amanda N.; Taube, Janis; Housseau, Franck; Spetzler, David; Xiao, Nianqing; Pardoll, Drew M.; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Eshleman, James R.; Vogelstein, Bert; Anders, Robert A.; Diaz, Luis A., Jr.			Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade	SCIENCE			English	Article							LONG-TERM SAFETY; CELL LUNG-CANCER; MICROSATELLITE INSTABILITY; COLORECTAL CARCINOMAS; RECEIVING NIVOLUMAB; CHECKPOINT BLOCKADE; SURVIVAL; IMMUNOTHERAPY; LYMPHOCYTES; NEOANTIGENS	The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed that colorectal cancers with mismatch repair deficiency were sensitive to immune checkpoint blockade with antibodies to programmed death receptor-1 (PD-1). We have now expanded this study to evaluate the efficacy of PD-1 blockade in patients with advanced mismatch repair-deficient cancers across 12 different tumor types. Objective radiographic responses were observed in 53% of patients, and complete responses were achieved in 21% of patients. Responses were durable, with median progression-free survival and overall survival still not reached. Functional analysis in a responding patient demonstrated rapid in vivo expansion of neoantigen-specific T cell clones that were reactive to mutant neopeptides found in the tumor. These data support the hypothesis that the large proportion of mutant neoantigens in mismatch repair-deficient cancers make them sensitive to immune checkpoint blockade, regardless of the cancers' tissue of origin.	[Le, Dung T.; Durham, Jennifer N.; Smith, Kellie N.; Azad, Nilofer S.; Rucki, Agnieszka A.; Danilova, Ludmila; Cope, Leslie; Zhou, Shibin; Taube, Janis; Housseau, Franck; Pardoll, Drew M.; Vogelstein, Bert; Anders, Robert A.; Diaz, Luis A., Jr.] Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD 21287 USA; [Le, Dung T.; Durham, Jennifer N.; Bartlett, Bjarne R.; Aulakh, Laveet K.; Lu, Steve; Wong, Fay; Diaz, Luis A., Jr.] Swim Amer Lab Johns Hopkins, Baltimore, MD 21287 USA; [Le, Dung T.; Durham, Jennifer N.; Smith, Kellie N.; Wang, Hao; Kemberling, Holly; Wilt, Cara; Luber, Brandon S.; Azad, Nilofer S.; Rucki, Agnieszka A.; Laheru, Dan; Donehower, Ross; Holdhoff, Matthias; Danilova, Ludmila; Cope, Leslie; Meyer, Christian; Zhou, Shibin; Armstrong, Deborah K.; Bever, Katherine M.; Taube, Janis; Housseau, Franck; Pardoll, Drew M.; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Anders, Robert A.; Diaz, Luis A., Jr.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA; [Bartlett, Bjarne R.; Aulakh, Laveet K.; Lu, Steve; Wong, Fay; Zhou, Shibin; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert] Ludwig Ctr & Howard Hughes Med Inst Johns Hopkins, Baltimore, MD 21287 USA; [Zaheer, Atif] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21287 USA; [Fisher, George A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Crocenzi, Todd S.] Providence Canc Ctr Providence Hlth & Serv, Portland, OR 97213 USA; [Lee, James J.] Univ Pittsburgh, Sch Med, Dept Med, Canc Inst, Pittsburgh, PA 15232 USA; [Greten, Tim F.; Duffy, Austin G.] NIH, Gastrointestinal Malignancies Sect, Thoracic GI Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Ciombor, Kristen K.] Ohio State Univ, Ctr Comprehens Canc, Div Med Oncol, Columbus, OH 43210 USA; [Eyring, Aleksandra D.; Lam, Bao H.; Joe, Andrew; Kang, S. Peter] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Goldberg, Richard M.] West Virginia Univ, Canc Inst, Morgantown, WV 26506 USA; [Fader, Amanda N.] Johns Hopkins Med, Dept Gynecol & Obstet, Baltimore, MD 21287 USA; [Spetzler, David; Xiao, Nianqing] Caris Life Sci, Phoenix, AZ 85040 USA; [Eshleman, James R.; Anders, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Diaz, Luis A., Jr.] Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, New York, NY 10065 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Merck & Company; West Virginia University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Memorial Sloan Kettering Cancer Center	Diaz, LA (corresponding author), Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD 21287 USA.; Diaz, LA (corresponding author), Swim Amer Lab Johns Hopkins, Baltimore, MD 21287 USA.; Diaz, LA (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA.; Diaz, LA (corresponding author), Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, New York, NY 10065 USA.	ldiaz@mskcc.org	Bartlett, Bjarne/AAI-7358-2021; Goldberg, Richard/O-1871-2017; Greten, Tim F/B-3127-2015	Bartlett, Bjarne/0000-0001-8579-0379; Goldberg, Richard/0000-0003-3713-6895; Greten, Tim F/0000-0002-0806-2535; Diaz, Luis/0000-0002-7079-8914; Aulakh, Laveet/0000-0002-3782-0673	Swim Across America Laboratory at Johns Hopkins; Ludwig Center for Cancer Genetics and Therapeutics; Howard Hughes Medical Institutes; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins; Stand Up to Cancer Colon Cancer Dream Team; Commonwealth Fund; Banyan Gate Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Bloomberg Foundation; Sol Goldman Pancreatic Cancer Research Center; Merck Co. Inc.; Gastrointestinal SPORE grant [P50CA062924]; NIH [P30CA006973, CA163672, CA43460, CA203891, CA67941, CA16058, CA57345]; NATIONAL CANCER INSTITUTE [U01CA067941, ZIABC011343, P50CA098252, R37CA043460, P30CA006973, P50CA062924, R01CA057345, R01CA067941, R01CA203891, K23CA163672, R37CA057345, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Swim Across America Laboratory at Johns Hopkins; Ludwig Center for Cancer Genetics and Therapeutics; Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins; Stand Up to Cancer Colon Cancer Dream Team; Commonwealth Fund; Banyan Gate Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Bloomberg Foundation; Sol Goldman Pancreatic Cancer Research Center; Merck Co. Inc.(Merck & Company); Gastrointestinal SPORE grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The data reported are tabulated in the main text and supplementary materials. The raw TCR RNA sequence data have been deposited into the ImmuneACCESS project repository of the Adaptive Biotech database, under the following link: https://clients.adaptivebiotech.com/pub/diaz-2017-science. We thank K. Helwig for administrative support, C. Blair for outstanding technical assistance, and E. H. Rubin, R. Dansey, and R. Perlmutter at Merck & Co. Inc. (Kenilworth, NJ) for supporting this research. Funded by the Swim Across America Laboratory at Johns Hopkins, the Ludwig Center for Cancer Genetics and Therapeutics, the Howard Hughes Medical Institutes, the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, the 2017 Stand Up to Cancer Colon Cancer Dream Team, the Commonwealth Fund, the Banyan Gate Foundation, the Lustgarten Foundation for Pancreatic Cancer Research, the Bloomberg Foundation, the Sol Goldman Pancreatic Cancer Research Center, Merck & Co. Inc., Gastrointestinal SPORE grant P50CA062924, and NIH grants P30CA006973, CA163672, CA43460, CA203891, CA67941, CA16058, and CA57345. L.D., D.L., B.V., N.P., and K.W.K. are inventors on a patent application (PCT/US2015/060331 or WO 2016077553 A1) submitted by Johns Hopkins University that covers checkpoint blockade and microsatellite instability. L.D., B.V., N.P., and K.W.K. are founders of PapGene and Personal Genome Diagnostics (PGDx). L.D. is a consultant for Merck, Illumina, PGDx, and Cell Design Labs. PGDx and PapGene, as well as other companies, have licensed technologies from Johns Hopkins University, on which L.D., B.V., N.P., and K.W.K. are inventors. Some of these licenses and relationships are associated with equity or royalty payments. The terms of these arrangements are being managed by Johns Hopkins and Memorial Sloan Kettering in accordance with its conflict-of-interest policies.	Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hugo W, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.010; KIM HG, 1994, AM J PATHOL, V145, P148; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; McDermott DF, 2015, J CLIN ONCOL, V33, P2013, DOI 10.1200/JCO.2014.58.1041; Overman MJ, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.519; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Smyrk TC, 2001, CANCER, V91, P2417, DOI 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.3.CO;2-L; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ward JP, 2016, ADV IMMUNOL, V130, P25, DOI 10.1016/bs.ai.2016.01.001; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	23	3509	3661	26	528	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					409	413		10.1126/science.aan6733	http://dx.doi.org/10.1126/science.aan6733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28596308	Green Accepted			2022-12-28	WOS:000406362300047
J	Bassat, E; Mutlak, YE; Genzelinakh, A; Shadrin, IY; Umansky, KB; Yifa, O; Kain, D; Rajchman, D; Leach, J; Bassat, DR; Udi, Y; Sarig, R; Sagi, I; Martin, JF; Bursac, N; Cohen, S; Tzahor, E				Bassat, Elad; Mutlak, Yara Eid; Genzelinakh, Alex; Shadrin, Ilya Y.; Umansky, Kfir Baruch; Yifa, Oren; Kain, David; Rajchman, Dana; Leach, John; Bassat, Daria Riabov; Udi, Yael; Sarig, Rachel; Sagi, Irit; Martin, James F.; Bursac, Nenad; Cohen, Shenhav; Tzahor, Eldad			The extracellular matrix protein agrin promotes heart regeneration in mice	NATURE			English	Article							RECEPTOR; CARDIOMYOCYTES; IDENTIFICATION; PROLIFERATION; DYSTROGLYCAN; MATURATION; BINDING	The adult mammalian heart is non-regenerative owing to the post-mitotic nature of cardiomyocytes. The neonatal mouse heart can regenerate, but only during the first week of life. Here we show that changes in the composition of the extracellular matrix during this week can affect cardiomyocyte growth and differentiation in mice. We identify agrin, a component of neonatal extracellular matrix, as required for the full regenerative capacity of neonatal mouse hearts. In vitro, recombinant agrin promotes the division of cardiomyocytes that are derived from mouse and human induced pluripotent stem cells through a mechanism that involves the disassembly of the dystrophin-glycoprotein complex, and Yap-and ERK-mediated signalling. In vivo, a single administration of agrin promotes cardiac regeneration in adult mice after myocardial infarction, although the degree of cardiomyocyte proliferation observed in this model suggests that there are additional therapeutic mechanisms. Together, our results uncover a new inducer of mammalian heart regeneration and highlight fundamental roles of the extracellular matrix in cardiac repair.	[Bassat, Elad; Genzelinakh, Alex; Umansky, Kfir Baruch; Yifa, Oren; Kain, David; Rajchman, Dana; Sarig, Rachel; Tzahor, Eldad] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Mutlak, Yara Eid; Cohen, Shenhav] Technion, Fac Biol, IL-32000 Haifa, Israel; [Shadrin, Ilya Y.; Bursac, Nenad] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Leach, John; Martin, James F.] Baylor Coll Med, Houston, TX 77030 USA; [Leach, John; Martin, James F.] Texas Heart Inst, Houston, TX 77030 USA; [Bassat, Daria Riabov; Udi, Yael; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Duke University; Baylor College of Medicine; Texas Heart Institute; Weizmann Institute of Science	Tzahor, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	eldad.tzahor@weizmann.ac.il	TZAHOR, ELDAD/AAD-9886-2021; Bursac, Nenad/AAU-5548-2021; Udi, Yael/ABA-8740-2020; Cohen, Shenhav/B-5946-2019	Bursac, Nenad/0000-0002-5688-6061; Cohen, Shenhav/0000-0001-8307-466X; Bassat, Elad/0000-0001-5851-052X; Leach, John/0000-0002-0779-8583; kain, david/0000-0002-8410-9390; Udi, Yael/0000-0001-8451-2246; Shadrin, Ilya/0000-0002-4501-0400	European Research Council; Israel Science Foundation; Britain Israel Research and Academic Exchange (BIRAX); Foundation LeDucq; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126524, F30HL122079, U01HL134764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Britain Israel Research and Academic Exchange (BIRAX); Foundation LeDucq(Leducq Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to E.T. from the European Research Council, Israel Science Foundation and the Britain Israel Research and Academic Exchange (BIRAX). E.T., J.F.M. and N.B. are supported by Foundation LeDucq and NIH funding. We thank R. Burgess for providing the Agrn<SUP>fl/fl</SUP> mice. We thank Y. Levin, head of de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, for protein profiling. We thank E. T. and I.S. laboratory members, A. Navon, K. Yaniv and P Riley for fruitful discussions, O. Goresh and B. Siani for animal husbandry, and N. Akron, D. Gorelik, R. Levine, S. Goldsmith, C. Raanan and M. Osin for genotyping and histology.	Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bian WN, 2014, BIOMATERIALS, V35, P3819, DOI 10.1016/j.biomaterials.2014.01.045; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Burden SJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009167; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Constantin B, 2013, BIOCHIM BIOPHYS ACTA, V1838, P635; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Jackman CP, 2016, BIOMATERIALS, V111, P66, DOI 10.1016/j.biomaterials.2016.09.024; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Mazzon C, 2012, BLOOD, V119, P5502, DOI 10.1182/blood-2011-09-382812; Morikawa Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005781; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Reischauer S, 2014, CIRC RES, V115, P845, DOI 10.1161/CIRCRESAHA.115.304356; Richardson GD, 2015, STEM CELLS DEV, V24, P1672, DOI 10.1089/scd.2014.0495; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wang C, 2016, AM J CANCER RES, V6, P27; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yahalom-Ronen Y, 2015, ELIFE, V4, DOI [10.7554/eLife.07455.001, 10.7554/eLife.07455]; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026	30	330	348	13	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					179	+		10.1038/nature22978	http://dx.doi.org/10.1038/nature22978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28581497	Green Accepted			2022-12-28	WOS:000405314500031
J	Sulzer, D; Alcalay, RN; Garretti, F; Cote, L; Kanter, E; Agin-Liebes, J; Liong, C; McMurtrey, C; Hildebrand, WH; Mao, XB; Dawson, VL; Dawson, TM; Oseroff, C; Pham, J; Sidney, J; Dillon, MB; Carpenter, C; Weiskopf, D; Phillips, E; Mallal, S; Peters, B; Frazier, A; Arlehamn, CSL; Sette, A				Sulzer, David; Alcalay, Roy N.; Garretti, Francesca; Cote, Lucien; Kanter, Ellen; Agin-Liebes, Julian; Liong, Christopher; McMurtrey, Curtis; Hildebrand, William H.; Mao, Xiaobo; Dawson, Valina L.; Dawson, Ted M.; Oseroff, Carla; Pham, John; Sidney, John; Dillon, Myles B.; Carpenter, Chelsea; Weiskopf, Daniela; Phillips, Elizabeth; Mallal, Simon; Peters, Bjoern; Frazier, April; Arlehamn, Cecilia S. Lindestam; Sette, Alessandro			T cells from patients with Parkinson's disease recognize alpha-synuclein peptides	NATURE			English	Article							BINDING REPERTOIRES; MOUSE MODEL; ACTIVATION; CLEAVAGE; NEURODEGENERATION; AGGREGATION; ASSOCIATION; CONTRIBUTES; EXPRESSION; TRUNCATION	Genetic studies have shown the association of Parkinson's disease with alleles of the major histocompatibility complex(1-3). Here we show that a defined set of peptides that are derived from a-synuclein, a protein aggregated in Parkinson's disease(4), act as antigenic epitopes displayed by these alleles and drive helper and cytotoxic T cell responses in patients with Parkinson's disease. These responses may explain the association of Parkinson's disease with specific major histocompatibility complex alleles.	[Sulzer, David; Garretti, Francesca; Kanter, Ellen; Agin-Liebes, Julian] Columbia Univ, Dept Psychiat, Div Molcular Therapeut, New York State Psychiat Inst, New York, NY 10032 USA; [Sulzer, David; Alcalay, Roy N.; Cote, Lucien; Liong, Christopher] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Sulzer, David] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [McMurtrey, Curtis; Hildebrand, William H.] Univ Oklahoma, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Mao, Xiaobo; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Mao, Xiaobo; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mao, Xiaobo; Dawson, Valina L.; Dawson, Ted M.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Dawson, Valina L.] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Oseroff, Carla; Pham, John; Sidney, John; Dillon, Myles B.; Carpenter, Chelsea; Weiskopf, Daniela; Peters, Bjoern; Frazier, April; Arlehamn, Cecilia S. Lindestam; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Phillips, Elizabeth; Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA 6150, Australia; [Phillips, Elizabeth; Mallal, Simon] Vanderbilt Univ, Sch Med, Nashville, TN 37235 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; La Jolla Institute for Immunology; Murdoch University; Vanderbilt University	Sulzer, D (corresponding author), Columbia Univ, Dept Psychiat, Div Molcular Therapeut, New York State Psychiat Inst, New York, NY 10032 USA.; Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.; Sulzer, D (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.; Sette, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	ds43@cumc.columbia.edu; alex@lji.org	Sette, Alessandro/AFO-8916-2022; Mao, Xiaobo/A-7362-2010; Mallal, Simon Alexander/HDM-9561-2022; Dawson, Valina/Y-9757-2019	Mao, Xiaobo/0000-0001-6587-556X; Mallal, Simon Alexander/0000-0002-7036-1309; Garretti, Francesca/0000-0002-6609-8034; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002; Weiskopf, Daniela/0000-0003-2968-7371	JPB's Foundation; William F. Richter's Foundation; Michael J. Fox's Foundation; Parkinson's Foundation; NIH/NINDS [P50 NS38377]; NIA [ADRC P50AG005146]; AHMMRF Parkinson's disease program [M-2014]; JHH Parkinson's disease program [M-2014]; JHUSOM Parkinson's disease program [M-2014]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS067525, P50NS038377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	JPB's Foundation; William F. Richter's Foundation; Michael J. Fox's Foundation; Parkinson's Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHMMRF Parkinson's disease program; JHH Parkinson's disease program; JHUSOM Parkinson's disease program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the JPB (D.S., T.M.D), William F. Richter (D.S.), Michael J. Fox (A.S., D.S.) and Parkinson's Foundations (A.S., D.S.). X.M., V.L.D. and T.M.D. are supported by NIH/NINDS grant P50 NS38377. X.M. is supported by NIA ADRC P50AG005146. T.M.D. is the Abramson Professor. X.M., V.L.D. and T.M.D. acknowledge joint support by AHMMRF, JHH and JHUSOM Parkinson's disease program, M-2014.	Alcalay RN, 2015, BRAIN, V138, P2648, DOI 10.1093/brain/awv179; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Atik A, 2016, BRAIN PATHOL, V26, P410, DOI 10.1111/bpa.12370; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Brahmachari S, 2016, J CLIN INVEST, V126, P2970, DOI 10.1172/JCI85456; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cebrian C, 2015, CURR TOP BEHAV NEURO, V22, P237, DOI 10.1007/7854_2014_356; Cebrian C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4633; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; de Marquesini LGP, 2010, DIABETOLOGIA, V53, P1451, DOI 10.1007/s00125-010-1739-3; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Foix C, 1925, CEREBRALE NOYAUZ GRI; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593; Hossain S, 2001, J ALZHEIMERS DIS, V3, P577, DOI 10.3233/JAD-2001-3608; Hughes AJ, 2001, NEUROLOGY, V57, pS34; Kannarkat GT, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.2; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kim KS, 2012, J BIOL CHEM, V287, P24862, DOI 10.1074/jbc.M112.348128; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Marrack P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007765; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; McKinney DM, 2015, HUM IMMUNOL, V76, P917, DOI 10.1016/j.humimm.2015.04.007; Mor F, 2003, J IMMUNOL, V170, P628, DOI 10.4049/jimmunol.170.1.628; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405; Paul S, 2015, J IMMUNOL, V194, P6164, DOI 10.4049/jimmunol.1403074; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney J, 2010, J IMMUNOL, V185, P4189, DOI 10.4049/jimmunol.1001006; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang W, 2016, P NATL ACAD SCI USA, V113, P9587, DOI 10.1073/pnas.1610099113; Wissemann WT, 2013, AM J HUM GENET, V93, P984, DOI 10.1016/j.ajhg.2013.10.009	44	397	404	10	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					656	+		10.1038/nature22815	http://dx.doi.org/10.1038/nature22815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28636593	Green Accepted			2022-12-28	WOS:000404332000048
J	Schwartz, RS; Erban, JK				Schwartz, Robert S.; Erban, John K.			Timing of Metastasis in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schwartz, Robert S.; Erban, John K.] Tufts Univ, Boston, MA 02111 USA	Tufts University	Schwartz, RS (corresponding author), Tufts Univ, Boston, MA 02111 USA.							Harper KL, 2016, NATURE; Hosseini H., 2016, NATURE; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106	5	35	40	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2486	2488		10.1056/NEJMcibr1701388	http://dx.doi.org/10.1056/NEJMcibr1701388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY2BW	28636861				2022-12-28	WOS:000403774400014
J	Budenholzer, B				Budenholzer, Brian			Guideline: USPSTF makes no recommendation for pelvic exams to screen for gynecologic conditions in asymptomatic women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Budenholzer, Brian] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Eastern Virginia Medical School	Budenholzer, B (corresponding author), Eastern Virginia Med Sch, Norfolk, VA 23501 USA.							Verghese A, 2015, AM J MED, V128, P1322, DOI 10.1016/j.amjmed.2015.06.004	1	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC63	JC63		10.7326/ACPJC-2017-166-12-063	http://dx.doi.org/10.7326/ACPJC-2017-166-12-063			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630975				2022-12-28	WOS:000403579000004
J	Kruger, P; Eikelboom, J				Kruger, Paul; Eikelboom, John			Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kruger, Paul; Eikelboom, John] McMaster Univ, Hamilton, ON, Canada	McMaster University	Kruger, P (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285				Hankey GJ, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0480-9; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Shoamanesh A., 2016, NOACS STROKE PREVENT	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC70	JC70		10.7326/ACPJC-2017-166-12-070	http://dx.doi.org/10.7326/ACPJC-2017-166-12-070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630982				2022-12-28	WOS:000403579000011
J	Abbott, A				Abbott, Alison			The time machine reconstructing ancient Venices social networks	NATURE			English	Editorial Material																			0	12	12	11	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					341	344		10.1038/546341a	http://dx.doi.org/10.1038/546341a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28617482	Bronze			2022-12-28	WOS:000403250900011
J	Despreaux, T; Saint-Lary, O; Danzin, F; Descatha, A				Despreaux, Thomas; Saint-Lary, Olivier; Danzin, Florence; Descatha, Alexis			10-MINUTE CONSULTATION Stress at work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS		[Despreaux, Thomas; Danzin, Florence; Descatha, Alexis] Univ Hosp Poincare Site, Occupat Hlth Unit, Garches, France; [Despreaux, Thomas] Versailles St Quentin Univ, Versailles, France; [Despreaux, Thomas] INSERM, CESP, U1018, Villejuif, France; [Saint-Lary, Olivier] Fac Hlth Sci Simone Veil, Dept Family Med, Montigny Le Bretonneux, France; Univ Paris Sud, Univ Paris Saclay, Villejuif, France; [Danzin, Florence] Charcot Psychiat Hosp, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Saint-Lary, O (corresponding author), Fac Hlth Sci Simone Veil, Dept Family Med, Montigny Le Bretonneux, France.	olivier.saint-lary@uvsq.fr						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Fraser L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005093; Harvey SB, 2017, OCCUP ENVIRON MED, V74, P301, DOI 10.1136/oemed-2016-104015; Joosen MCW, 2015, OCCUP ENVIRON MED, V72, P313, DOI 10.1136/oemed-2013-101626; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Mediouni Z, 2012, J OCCUP ENVIRON MED, V54, P1439, DOI 10.1097/JOM.0b013e31827942e0; Nielsen MB, 2016, SCAND J WORK ENV HEA, V42, P246, DOI 10.5271/sjweh.3554; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Rugulies R, 2017, SCAND J WORK ENV HEA, V43, P294, DOI 10.5271/sjweh.3632; Theorell T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1954-4; Van den Broeck K, 2016, J AFFECT DISORDERS, V200, P189, DOI 10.1016/j.jad.2016.04.044; van der Klink JJL, 2003, SCAND J WORK ENV HEA, V29, P478, DOI 10.5271/sjweh.756; Virtanen M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7772; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X	15	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2489	10.1136/bmj.j2489	http://dx.doi.org/10.1136/bmj.j2489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28619763	hybrid, Green Published			2022-12-28	WOS:000403753800001
J	Law, YXT; Long, W; Lee, KCJ				Law, Yu Xi Terence; Long, Welras; Lee, King Chien Joe			SPOT DIAGNOSIS An unusual pelvis radiograph	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Law, Yu Xi Terence; Lee, King Chien Joe] Natl Univ Singapore Hosp, Singapore, Singapore; [Long, Welras] Natl Univ Singapore, Singapore, Singapore	National University of Singapore; National University of Singapore	Law, YXT (corresponding author), Natl Univ Singapore Hosp, Singapore, Singapore.	terencelaw83@gmail.com	Joe, Chien Lee/E-4570-2019					Grayson DE, 2002, RADIOGRAPHICS, V22, P543, DOI 10.1148/radiographics.22.3.g02ma06543; Pickard R., 2016, EUROPEAN ASS UROLOGY; Quint HJ, 1992, J UROLOGY, V357, P134; Thomas AA, 2007, BJU INT, V100, P17, DOI 10.1111/j.1464-410X.2007.06930.x; Toyota N, 2011, ACTA MED OKAYAMA, V65, P129	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2593	10.1136/bmj.j2593	http://dx.doi.org/10.1136/bmj.j2593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28620010				2022-12-28	WOS:000403753800005
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Remember that doctors are more trusted than journalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Abel GA, 2017, BRIT J GEN PRACT, V67, pE377, DOI 10.3399/bjgp17X690869; Borland S, 2017, DAILY MAIL; Ipsos MORI, 2016, POL STILL TRUST LESS; Jackson J., 2017, GUARDIAN; Livingston G, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002252; Woloshin S, 2008, KNOW YOUR CHANCES UN; Woloshin S, 2007, ANN INTERN MED, V146, P256, DOI 10.7326/0003-4819-146-4-200702200-00004	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2017	357								j2608	10.1136/bmj.j2608	http://dx.doi.org/10.1136/bmj.j2608			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UJ	28607152	Bronze, Green Published			2022-12-28	WOS:000403752200001
J	Banerjee, A; Yan, JQ; Knolle, J; Bridges, CA; Stone, MB; Lumsden, MD; Mandrus, DG; Tennant, DA; Moessner, R; Nagler, SE				Banerjee, Arnab; Yan, Jiaqiang; Knolle, Johannes; Bridges, Craig A.; Stone, Matthew B.; Lumsden, Mark D.; Mandrus, David G.; Tennant, David A.; Moessner, Roderich; Nagler, Stephen E.			Neutron scattering in the proximate quantum spin liquid alpha-RuCl3	SCIENCE			English	Article							ANYONS; EXCITATIONS; SYSTEMS; IRIDATE; MAGNET	The Kitaev quantum spin liquid (KQSL) is an exotic emergent state of matter exhibiting Majorana fermion and gauge flux excitations. The magnetic insulator alpha-RuCl3 is thought to realize a proximate KQSL. We used neutron scattering on single crystals of alpha-RuCl3 to reconstruct dynamical correlations in energy-momentum space. We discovered highly unusual signals, including a column of scattering over a large energy interval around the Brillouin zone center, which is very stable with temperature. This finding is consistent with scattering from the Majorana excitations of a KQSL. Other, more delicate experimental features can be transparently associated with perturbations to an ideal model. Our results encourage further study of this prototypical material and may open a window into investigating emergent magnetic Majorana fermions in correlated materials.	[Banerjee, Arnab; Stone, Matthew B.; Lumsden, Mark D.; Nagler, Stephen E.] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA; [Yan, Jiaqiang; Mandrus, David G.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Knolle, Johannes] Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England; [Bridges, Craig A.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; [Mandrus, David G.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Tennant, David A.] Oak Ridge Natl Lab, Neutron Sci Directorate, Oak Ridge, TN 37831 USA; [Moessner, Roderich] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Cambridge; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; Max Planck Society	Banerjee, A; Nagler, SE (corresponding author), Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA.	banerjeea@ornl.gov; naglerse@ornl.gov	Lumsden, Mark/F-5366-2012; Nagler, Stephen E/E-4908-2010; Tennant, David A/Q-2497-2015; Banerjee, Arnab/AAY-5819-2021; Stone, Matthew/G-3275-2011	Lumsden, Mark/0000-0002-5472-9660; Nagler, Stephen E/0000-0002-7234-2339; Tennant, David A/0000-0002-9575-3368; Stone, Matthew/0000-0001-7884-9715; Banerjee, Arnab/0000-0002-3088-6071; Yan, Jiaqiang/0000-0001-6625-4706	U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), Scientific User Facilities Division; DOE, Office of Science, BES, Materials Sciences and Engineering Division; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4416]; Deutsche Forschungsgemeinschaft [SFB 1143]; German Academic Exchange Service (DAAD)	U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), Scientific User Facilities Division(United States Department of Energy (DOE)); DOE, Office of Science, BES, Materials Sciences and Engineering Division; Gordon and Betty Moore Foundation's EPiQS Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We thank C. Batista, K. Burch, H. Cao, B. Chakoumakos, G. Jackeli, G. Khalliulin, J. Leiner, P. Kelley, R. Valenti, and S. Winter for valuable discussions and O. Garlea for assistance with the measurement on HYSPEC. J.K. and R.M. particularly thank J. Chalker and D. Kovrizhin for collaboration on closely related work. The work at Oak Ridge National Laboratory's Spallation Neutron Source was supported by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), Scientific User Facilities Division. Part of the research was supported by the DOE, Office of Science, BES, Materials Sciences and Engineering Division (J.Y. and C.A.B.). D.G.M. acknowledges support from the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4416. The work at the Max Planck Institute for the Physics of Complex Systems, Dresden, Germany, and the collaboration as a whole were partially supported by Deutsche Forschungsgemeinschaft grant SFB 1143 (J.K. and R.M.) and by a fellowship within the postdoc program of the German Academic Exchange Service (DAAD) (J.K.). The data presented in this manuscript are available from the coauthors upon request.	Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Banerjee A, 2016, NAT MATER, V15, P733, DOI [10.1038/NMAT4604, 10.1038/nmat4604]; Barkeshli M, 2014, SCIENCE, V346, P722, DOI 10.1126/science.1253251; Baskaran G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247201; Biffin A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.197201; Cao HB, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.134423; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Choi SK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127204; Chun SH, 2015, NAT PHYS, V11, P462, DOI [10.1038/NPHYS3322, 10.1038/nphys3322]; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Jackeli G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017205; Johnson RD, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.235119; Kim BH, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.187201; Kim H. S., 2016, PHYS REV B, V93, DOI DOI 10.1103/PHYSREVB.93.155143; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Knolle J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115127; Knolle J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.207203; Modic KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5203; Nasu J, 2016, NAT PHYS, V12, P912, DOI [10.1038/nphys3809, 10.1038/NPHYS3809]; Nasu J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115122; Nasu J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.197205; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Plumb KW, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.041112; Rau JG, 2016, ANNU REV CONDEN MA P, V7, P195, DOI 10.1146/annurev-conmatphys-031115-011319; Rau JG, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.077204; Sandilands LJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.147201; SCALAPINO DJ, 1975, PHYS REV B, V11, P2042, DOI 10.1103/PhysRevB.11.2042; Winter S. M., 2017, ARXIV170208466; Winter SM, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.214431; Yoshitake J, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.157203	34	390	393	6	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1055	1058		10.1126/science.aah6015	http://dx.doi.org/10.1126/science.aah6015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596361	Green Submitted			2022-12-28	WOS:000402871700049
J	d'Ischia, M; Messersmith, PB				d'Ischia, Marco; Messersmith, Phillip B.			From sequence to color	SCIENCE			English	Editorial Material							ABSORPTION; EUMELANIN		[d'Ischia, Marco] Univ Naples Federico II, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy; [Messersmith, Phillip B.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Messersmith, Phillip B.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of Naples Federico II; University of California System; University of California Berkeley; University of California System; University of California Berkeley	d'Ischia, M (corresponding author), Univ Naples Federico II, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy.							Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Chen CT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4859; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h; Lampel A, 2017, SCIENCE, V356, P1064, DOI 10.1126/science.aal5005; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Micillo R, 2017, SCI REP-UK, V7, DOI 10.1038/srep41532; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Rosei MA, 2001, HISTOL HISTOPATHOL, V16, P931, DOI 10.14670/HH-16.931; Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h	11	9	9	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1011	1012		10.1126/science.aan5198	http://dx.doi.org/10.1126/science.aan5198			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596326				2022-12-28	WOS:000402871700030
J	Laha, B; Stafford, BK; Huberman, AD				Laha, Bireswar; Stafford, Ben K.; Huberman, Andrew D.			Regenerating optic pathways from the eye to the brain	SCIENCE			English	Review							RETINAL GANGLION-CELLS; PROMOTING AXON REGENERATION; NERVE REGENERATION; NOGO RECEPTOR; STEM-CELLS; ADULT CNS; GROWTH; NEURONS; CONNECTIVITY; INHIBITION	Humans are highly visual. Retinal ganglion cells (RGCs), the neurons that connect the eyes to the brain, fail to regenerate after damage, eventually leading to blindness. Here, we review research on regeneration and repair of the optic system. Intrinsic developmental growth programs can be reactivated in RGCs, neural activity can enhance RGC regeneration, and functional reformation of eye-to-brain connections is possible, even in the adult brain. Transplantation and gene therapy may serve to replace or resurrect dead or injured retinal neurons. Retinal prosthetics that can restore vision in animal models may too have practical power in the clinical setting. Functional restoration of sight in certain forms of blindness is likely to occur in human patients in the near future.	[Laha, Bireswar; Stafford, Ben K.; Huberman, Andrew D.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Huberman, Andrew D.] Stanford Univ, Dept Ophthalmol, Sch Med, Stanford, CA 94305 USA; [Huberman, Andrew D.] Stanford Univ, BioX, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Huberman, AD (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.; Huberman, AD (corresponding author), Stanford Univ, Dept Ophthalmol, Sch Med, Stanford, CA 94305 USA.; Huberman, AD (corresponding author), Stanford Univ, BioX, Sch Med, Stanford, CA 94305 USA.	adh1@stanford.edu			National Eye Institute; Glaucoma Research Foundation; McKnight Foundation; Pew Charitable Trusts; E. Matilda Ziegler Foundation for the Blind; NATIONAL EYE INSTITUTE [R01EY026100, R01EY027713] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Glaucoma Research Foundation; McKnight Foundation; Pew Charitable Trusts; E. Matilda Ziegler Foundation for the Blind; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Work in the laboratory of these authors was supported by the National Eye Institute, the Glaucoma Research Foundation, the McKnight Foundation, the Pew Charitable Trusts, and the E. Matilda Ziegler Foundation for the Blind.	AGUAYO AJ, 1987, ANN NY ACAD SCI, V495, P1, DOI 10.1111/j.1749-6632.1987.tb23661.x; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cantrup R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032795; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gall C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156134; Goetz GA, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/9/096701; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Goldberg JL, 2004, J NEUROSCI, V24, P4989, DOI 10.1523/JNEUROSCI.4390-03.2004; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Harvey P, 2010, P NATL ACAD SCI USA, V107, P11585, DOI 10.1073/pnas.1003287107; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; King CE, 2003, EXP NEUROL, V183, P593, DOI 10.1016/S0014-4886(03)00211-5; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Li S, 2016, P NATL ACAD SCI USA, V113, P1937, DOI 10.1073/pnas.1523645113; Li YQ, 2017, P NATL ACAD SCI USA, V114, pE209, DOI 10.1073/pnas.1616811114; Lim JHA, 2016, NAT NEUROSCI, V19, P1073, DOI 10.1038/nn.4340; Luo XT, 2013, EXP NEUROL, V247, P653, DOI 10.1016/j.expneurol.2013.03.001; Magri L, 2013, CELL MOL LIFE SCI, V70, P2887, DOI 10.1007/s00018-012-1196-x; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Narushima M, 2016, NEURON, V91, P1097, DOI 10.1016/j.neuron.2016.07.035; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Picaud S, 2014, CR BIOL, V337, P214, DOI 10.1016/j.crvi.2014.01.001; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Tanaka T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08344; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Ueki Y, 2015, P NATL ACAD SCI USA, V112, P13717, DOI 10.1073/pnas.1510595112; Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	48	67	68	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1031	1034		10.1126/science.aal5060	http://dx.doi.org/10.1126/science.aal5060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596336	Green Accepted			2022-12-28	WOS:000402871700042
J	Archilli, F; Bettler, MO; Owen, P; Petridis, KA				Archilli, F.; Bettler, M. -O.; Owen, P.; Petridis, K. A.			Flavour-changing neutral currents making and breaking the standard model	NATURE			English	Review							MU(+) MU(-); R-K; PHYSICS	The standard model of particle physics is our best description yet of fundamental particles and their interactions, but it is known to be incomplete. As yet undiscovered particles and interactions might exist. One of the most powerful ways to search for new particles is by studying processes known as flavour-changing neutral current decays, whereby a quark changes its flavour without altering its electric charge. One example of such a transition is the decay of a beauty quark into a strange quark. Here we review some intriguing anomalies in these decays, which have revealed potential cracks in the standard model-hinting at the existence of new phenomena.	[Archilli, F.] Nat Inst Subat Phys Nikhef, Amsterdam, Netherlands; [Bettler, M. -O.] European Org Nucl Res, CERN, Geneva, Switzerland; [Owen, P.] Univ Zurich, Phys Inst, Zurich, Switzerland; [Petridis, K. A.] Univ Bristol, HH Wills Phys Lab, Bristol, Avon, England	European Organization for Nuclear Research (CERN); University of Zurich; University of Bristol	Owen, P (corresponding author), Univ Zurich, Phys Inst, Zurich, Switzerland.	patrick.haworth.owen@cern.ch		Archilli, Flavio/0000-0002-1779-6813	European Science and Technology Facilities Council [ST/K001256/1]; Netherlands Foundation for Fundamental Research of Matter (FOM); Netherlands Foundation of Scientific Research Institutes (NWO-I); CERN; Swiss National Science Foundation [BSSGI0_155990]	European Science and Technology Facilities Council; Netherlands Foundation for Fundamental Research of Matter (FOM)(FOM (The Netherlands)); Netherlands Foundation of Scientific Research Institutes (NWO-I); CERN; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	K.A.P. acknowledges support from the European Science and Technology Facilities Council under grant number ST/K001256/1; F.A. acknowledges support from the Netherlands Foundation for Fundamental Research of Matter (FOM) and the Netherlands Foundation of Scientific Research Institutes (NWO-I); M.-O.B. acknowledges support from CERN; and P.O. acknowledges support from the Swiss National Science Foundation under grant number BSSGI0_155990.	Aad G, 2016, EUR PHYS J C, V76, DOI [10.1140/epjc/s10052-016-3978-z, 10.1140/epjc/s10052-016-4344-x, 10.1140/epjc/s10052-016-4338-8]; Aad G., 2008, JINST, V3, DOI DOI 10.1088/1748-0221/3/08/S08003; Aaij R, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2016)104; Aaij R, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2015)179; Aaij R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.151601; Aaij R, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2014)133; Abashian A, 2002, NUCL INSTRUM METH A, V479, P117, DOI 10.1016/S0168-9002(01)02013-7; Altmannshofer W, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2016)106; Altmannshofer W, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3602-7; Altmannshofer W, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.095033; Altmannshofer W, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2646-9; AUBERT JJ, 1974, PHYS REV LETT, V33, P1404, DOI 10.1103/PhysRevLett.33.1404; AUGUSTIN JE, 1974, PHYS REV LETT, V33, P1406, DOI 10.1103/PhysRevLett.33.1406; BaBar Collaboration, 2014, PHYS REV LETT, V112; BaBar Collaboration, 2002, NUCL I METH A, V479, P1; Babu KS, 2000, PHYS REV LETT, V84, P228, DOI 10.1103/PhysRevLett.84.228; Bauer M, 2016, PHYS REV LETT, V116, DOI [10.1140/epjc/s10052-021-09843-w, 10.1103/PhysRevLett.116.141802]; Bazavov A, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.114506; Beaujean F, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2897-0; Bell C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.226802; Belle collaboration, 2017, PHYS REV LETT, V118, DOI DOI 10.1103/PHYSREVLETT.118.111801; Belle II Collaboration, 2010, BELL II TECHN DES RE; BJORKEN BJ, 1964, PHYS LETT, V11, P255, DOI 10.1016/0031-9163(64)90433-0; Blake T, 2017, PROG PART NUCL PHYS, V92, P50, DOI 10.1016/j.ppnp.2016.10.001; Bobeth C, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.074014; Bobeth C, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/12/040; Bobeth C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.101801; Bordone M, 2016, EUR PHYS J C, V76, DOI 10.1140/epjc/s10052-016-4274-7; CABIBBO N, 1963, PHYS REV LETT, V10, P531, DOI 10.1103/PhysRevLett.10.531; Chatrchyan S, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08004; Choudhury SR, 1999, PHYS LETT B, V451, P86, DOI 10.1016/S0370-2693(99)00203-8; Crivellin A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.151801; Datta A, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.071501; Descotes-Genon S, 2016, J HIGH ENERGY PHYS, P1, DOI 10.1007/JHEP06(2016)092; Descotes-Genon S, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2014)125; Descotes-Genon S, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.074002; Descotes-Genon S, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2013)137; Ellis J, 2007, NATURE, V448, P297, DOI 10.1038/nature06079; Evans L, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08001; Fajfer S, 2016, PHYS LETT B, V755, P270, DOI 10.1016/j.physletb.2016.02.018; Gauld R, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2014)069; GLASHOW SL, 1970, PHYS REV D, V2, P1285, DOI 10.1103/PhysRevD.2.1285; Gripaios B, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2015)006; HPQCD Collaboration, 2012, PHYS REV D, V86; Huang CS, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.011701; Hurth T, 2016, NUCL PHYS B, V909, P737, DOI 10.1016/j.nuclphysb.2016.05.022; Hurth T, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2014)097; Iwasaki M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.092005; Jager S, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2013)043; Khodjamirian A, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2013)010; Khodjamirian A, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2010)089; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; Lees J.P., 2012, PHYS REV D, V86; LHCb collaboration, 2016, JHEP, V11; LHCb collaboration, 2008, JINST, V3, DOI DOI 10.1088/1748-0221/3/08/S08005; Lyon J., 2014, RESONANCES GONE TOPS; Mahmoudi F, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2927-y; PATI JC, 1975, PHYS REV D, V11, P703, DOI 10.1103/PhysRevD.11.703.2; Pich A., 1998, PROBING STANDARD M 1, P949; RBC-UKQCD Collaborations, 2013, AIP C P, V1560, P368; WILSON KG, 1972, COMMUN MATH PHYS, V24, P87, DOI 10.1007/BF01878448	61	3	3	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					221	226		10.1038/nature21721	http://dx.doi.org/10.1038/nature21721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593964				2022-12-28	WOS:000402823400025
J	Dechartres, A; Trinquart, L; Atal, I; Moher, D; Dickersin, K; Boutron, I; Perrodeau, E; Altman, DG; Ravaud, P				Dechartres, Agnes; Trinquart, Ludovic; Atal, Ignacio; Moher, David; Dickersin, Kay; Boutron, Isabelle; Perrodeau, Elodie; Altman, Douglas G.; Ravaud, Philippe			Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REDUCING WASTE; QUALITY; JOURNALS; DESIGN; IMPACT	Objective To examine how poor reporting and inadequate methods for key methodological features in randomised controlled trials (RCTs) have changed over the past three decades. Design Mapping of trials included in Cochrane reviews. Data sources Data from RCTs included in all Cochrane reviews published between March 2011 and September 2014 reporting an evaluation of the Cochrane risk of bias items: sequence generation, allocation concealment, blinding, and incomplete outcome data. Data extraction For each RCT, we extracted consensus on risk of bias made by the review authors and identified the primary reference to extract publication year and journal. We matched journal names with Journal Citation Reports to get 2014 impact factors. Main outcomes measures We considered the proportions of trials rated by review authors at unclear and high risk of bias as surrogates for poor reporting and inadequate methods, respectively. Results We analysed 20 920 RCTs (from 2001 reviews) published in 3136 journals. The proportion of trials with unclear risk of bias was 48.7% for sequence generation and 57.5% for allocation concealment; the proportion of those with high risk of bias was 4.0% and 7.2%, respectively. For blinding and incomplete outcome data, 30.6% and 24.7% of trials were at unclear risk and 33.1% and 17.1% were at high risk, respectively. Higher journal impact factor was associated with a lower proportion of trials at unclear or high risk of bias. The proportion of trials at unclear risk of bias decreased over time, especially for sequence generation, which fell from 69.1% in 1986-1990 to 31.2% in 2011-14 and for allocation concealment (70.1% to 44.6%). After excluding trials at unclear risk of bias, use of inadequate methods also decreased over time: from 14.8% to 4.6% for sequence generation and from 32.7% to 11.6% for allocation concealment. Conclusions Poor reporting and inadequate methods have decreased over time, especially for sequence generation and allocation concealment. But more could be done, especially in lower impact factor journals.	[Dechartres, Agnes; Trinquart, Ludovic; Atal, Ignacio; Boutron, Isabelle; Perrodeau, Elodie; Ravaud, Philippe] INSERM, U1153, Paris, France; Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Perrodeau, Elodie] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Paris, France; [Dechartres, Agnes; Trinquart, Ludovic; Atal, Ignacio; Boutron, Isabelle; Ravaud, Philippe] Cochrane France, Paris, France; [Moher, David] Univ Ottawa, Canadian EQUATOR Ctr, Sch Epidemiol Publ Hlth & Prevent Med, Clin Epidemiol Program,Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Altman, Douglas G.] Ctr Stat Med, Oxford, England; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Ottawa; Ottawa Hospital Research Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; Columbia University	Dechartres, A (corresponding author), INSERM, U1153, Paris, France.; Dechartres, A (corresponding author), Cochrane France, Paris, France.	agnes.dechartres@htd.aphp.fr	Moher, David/I-3408-2019; Trinquart, Ludovic/H-4961-2019; ravaud, philippe/C-1694-2009	Moher, David/0000-0003-2434-4206; Trinquart, Ludovic/0000-0002-3028-4900; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206; Atal, Ignacio/0000-0002-7323-6511	Cochrane France; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10131] Funding Source: researchfish	Cochrane France; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The researchers did not receive external funding. This work was internally funded by Cochrane France. The funding source had no role in the design, conduct, writing, or submission of this article.	Agha RA, 2014, EUR J PLAST SURG, V37, P55, DOI 10.1007/s00238-013-0893-5; Altman DG, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0575-7; Bala MM, 2013, J CLIN EPIDEMIOL, V66, P286, DOI 10.1016/j.jclinepi.2012.10.005; Barnes C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0460-y; Bryant J, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0094-z; Bunn F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19280; Callaway E, 2016, NATURE, V535, P210, DOI 10.1038/nature.2016.20224; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan Leighton, 2014, J Rehabil Res Dev, V51, pvii; Chen BY, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-128; Chen X, 2014, EUR SPINE J, V23, P1606, DOI 10.1007/s00586-014-3283-1; Chen ZW, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0677-2; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Davoli M, 2015, ADDICTION, V110, P891, DOI 10.1111/add.12788; Dechartres A, 2016, J CLIN EPIDEMIOL, V77, P24, DOI 10.1016/j.jclinepi.2016.04.005; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Delgado-Rodriguez M, 2001, J EPIDEMIOL COMMUN H, V55, P569, DOI 10.1136/jech.55.8.569; deMelo VV, 2005, C ADV LOG BAS INT SY; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Glujovsky D, 2015, FERTIL STERIL, V103, P236, DOI 10.1016/j.fertnstert.2014.10.024; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4178; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Kim KH, 2014, BMJ OPEN, V357, DOI [10.1136/bmjopen-2014, DOI 10.1136/BMJOPEN-2014]; Kloukos D, 2015, J ORAL REHABIL, V42, P914, DOI 10.1111/joor.12325; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Lee SY, 2013, J TRAUMA ACUTE CARE, V75, P562, DOI 10.1097/TA.0b013e3182a5399e; Lempesi E, 2014, J EVID-BASED DENT PR, V14, P46, DOI 10.1016/j.jebdp.2013.12.001; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Page MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159267; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Reveiz L, 2015, J CLIN EPIDEMIOL, V68, P1036, DOI 10.1016/j.jclinepi.2014.06.001; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Samaan Z, 2013, J MULTIDISCIP HEALTH, V6, P169, DOI 10.2147/JMDH.S43952; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shamseer L, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1408-z; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Turner L, 2012, COCHRANE DB SYST REV, V357; Van Noorden R, 2016, NATURE, V540, P325, DOI 10.1038/nature.2016.21131; Yao AC, 2014, EYE, V28, P1341, DOI 10.1038/eye.2014.206; Yordanov Y, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h809, 10.1136/bmj.h809]; Zhai X, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001083; Zhuang LX, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-151	55	84	84	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2017	357								j2490	10.1136/bmj.j2490	http://dx.doi.org/10.1136/bmj.j2490			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RE	28596181	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000403221600003
J	Hublin, JJ; Ben-Ncer, A; Bailey, SE; Freidline, SE; Neubauer, S; Skinner, MM; Bergmann, I; Le Cabec, A; Benazzi, S; Harvati, K; Gunz, P				Hublin, Jean-Jacques; Ben-Ncer, Abdelouahed; Bailey, Shara E. .; Freidline, Sarah E.; Neubauer, Simon; Skinner, Matthew M.; Bergmann, Inga; Le Cabec, Adeline; Benazzi, Stefano; Harvati, Katerina; Gunz, Philipp			New fossils from Jebel Irhoud, Morocco and the pan-African origin of Homo sapiens	NATURE			English	Article							MODERN HUMANS; FACIAL MORPHOLOGY; GENOME SEQUENCE; DENTAL REMAINS; LOWER MOLARS; NEANDERTHAL; EVOLUTION; HOMINID; SPAIN; SITE	Fossil evidence points to an African origin of Homo sapiens from a group called either H. heidelbergensis or H. rhodesiensis. However, the exact place and time of emergence of H. sapiens remain obscure because the fossil record is scarce and the chronological age of many key specimens remains uncertain. In particular, it is unclear whether the present day 'modern' morphology rapidly emerged approximately 200 thousand years ago (ka) among earlier representatives of H. sapiens(1) or evolved gradually over the last 400 thousand years(2). Here we report newly discovered human fossils from Jebel Irhoud, Morocco, and interpret the affinities of the hominins from this site with other archaic and recent human groups. We identified a mosaic of features including facial, mandibular and dental morphology that aligns the Jebel Irhoud material with early or recent anatomically modern humans and more primitive neurocranial and endocranial morphology. In combination with an age of 315 +/- 34 thousand years (as determined by thermoluminescence dating)(3), this evidence makes Jebel Irhoud the oldest and richest African Middle Stone Age hominin site that documents early stages of the H. sapiens clade in which key features of modern morphology were established. Furthermore, it shows that the evolutionary processes behind the emergence of H. sapiens involved the whole African continent.	[Hublin, Jean-Jacques; Freidline, Sarah E.; Neubauer, Simon; Bergmann, Inga; Le Cabec, Adeline; Gunz, Philipp] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany; [Hublin, Jean-Jacques] Coll France, Chaire Int Paleoanthropol, Paris, France; [Ben-Ncer, Abdelouahed] Inst Natl Sci Archeol & Patrimoine, Rabat, Morocco; [Bailey, Shara E. .] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Skinner, Matthew M.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Benazzi, Stefano] Univ Bologna, Dept Cultural Heritage, I-48121 Ravenna, Italy; [Harvati, Katerina] Eberhard Karls Univ Tubingen, Paleoanthropol, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [Harvati, Katerina] Eberhard Karls Univ Tubingen, DFG Ctr Adv Studies Words Bones Genes Tools, Tubingen, Germany	Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; College de France; New York University; University of Kent; University of Bologna; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Eberhard Karls University of Tubingen	Hublin, JJ; Gunz, P (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.; Hublin, JJ (corresponding author), Coll France, Chaire Int Paleoanthropol, Paris, France.	hublin@eva.mpg.de; gunz@eva.mpg.de	Neubauer, Simon/D-1317-2010; Benazzi, Stefano/AAH-3923-2020; Freidline, Sarah/GLR-6151-2022; Harvati, Katerina/A-5197-2008; Gunz, Philipp/C-7748-2009; LE CABEC, Adeline/I-1661-2019; Skinner, Matthew/D-1104-2010	Neubauer, Simon/0000-0001-9113-5063; Freidline, Sarah/0000-0003-4872-4924; Gunz, Philipp/0000-0002-2350-4450; LE CABEC, Adeline/0000-0001-6948-4726; Skinner, Matthew/0000-0001-8321-3543; Bailey, Shara/0000-0002-4626-9262	Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology	Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology	The research program at Jebel Irhoud is jointly conducted and supported by the Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine and the Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology. We are grateful to the many curators and colleagues who, over the years, gave us access to recent and fossil hominin specimens for computed tomography scanning or analysis, to E. Trinkaus for providing comparative data and to C. Kiarie, M. Lui, C. Piot, D. Plotzki, A. Buchenau and H. Temming for their technical assistance.	AMANI F, 1993, CR ACAD SCI II, V316, P847; Anderson J. E., 1968, The Prehistory of Nubia, V2, P996; ARAMBOURG C, 1956, AM J PHYS ANTHROPOL, V14, P467, DOI 10.1002/ajpa.1330140321; Arambourg C., 1963, GISEMENT TERNIFINE, V1; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Bailey S.E., 2002, THESIS; Bailey SE, 2014, AM J PHYS ANTHROPOL, V154, P104, DOI 10.1002/ajpa.22477; BARYOSEF O, 1991, SQUELETTE MOUSTERIEN, V2; Benazzi S, 2012, AM J PHYS ANTHROPOL, V149, P537, DOI 10.1002/ajpa.22155; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; de Castro JMB, 2014, ANTHROPOL SCI, V122, P149, DOI 10.1537/ase.140827; Beucher S., 1979, REAL TIM EDG MOT DET, P12, DOI citeulike-article-id:4083187.; Blake CC., 1867, ANTHROPOL REV, V5, P294; Bookstein F L, 1997, Med Image Anal, V1, P225; Brauer G, 2008, EVOL ANTHROPOL, V17, P22, DOI 10.1002/evan.20157; BRAUER G, 1988, AM J PHYS ANTHROPOL, V75, P69, DOI 10.1002/ajpa.1330750108; Bruner E, 2013, ANTHROPOL SCI, V121, P31, DOI 10.1537/ase.120927; Condemi S, 2001, NEANDERTALIENS CHAIS; Condemi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059781; Corrain C, 1968, MEMORIE MUSEO CIVICO, V16, P97; Crevecoeur I., 2004, ANTHROPOLOGIE, V42, P203; Crevecoeur I., 2006, THESIS; Crognier E., 1974, PALEORIENT, V2, P103; Daura J, 2005, J HUM EVOL, V49, P56, DOI 10.1016/j.jhevol.2005.03.004; De Lumley M. A., 1972, ETUDES QUATERNAIRES, V1, P375; DEBENATH A, 1980, CR ACAD SCI D NAT, V290, P851; DECASTRO JMB, 1986, J HUM EVOL, V15, P265; Drozdova E., 2001, ARCHEOL ROZHL, V53, P452; Dutour O., 1992, PREHISTOIRE ANTHR ME, V1, P73; Ennouchi E, 1962, ANTHROPOLOGIE, V66, P279; Ennouchi E., 1968, ANN PALEONTOLOGIE VE, P117; Formicola V., 1986, REV ANTROPOL, V64, P271; Freidline SE, 2012, J HUM EVOL, V63, P723, DOI 10.1016/j.jhevol.2012.08.002; Gambier D., 1990, AM J PHYS ANTHROPOL, V22, P9; Gambier D., 1990, ANTIQUITES NATL, V22, P9; Geraads D, 2013, QUATERNARY RES, V80, P552, DOI 10.1016/j.yqres.2013.08.003; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Grine Frederick Edward, 1994, Courier Forschungsinstitut Senckenberg, V171, P75; Grun R, 1996, NATURE, V382, P500, DOI 10.1038/382500a0; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Gunz P, 2012, J HUM EVOL, V62, P300, DOI 10.1016/j.jhevol.2011.11.013; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Harvati K, 2007, J HUM EVOL, V53, P732, DOI 10.1016/j.jhevol.2007.09.009; Harvati K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024024; HEIM JL, 1974, ANTHROPOLOGIE, V78, P321; HENKE W, 1984, Zeitschrift fuer Morphologie und Anthropologie, V75, P27; HERSHKOVITZ I, AM J PHYS ANTHR, V96, P215; Hooton E.A., 1953, ANCIENT PALESTINIAN, V17, P5; Hublin J.-J., 1981, ASPECTS HUMAN EVOLUT, V21, P167; HUBLIN JJ, 1992, PHILOS T ROY SOC B, V337, P185, DOI 10.1098/rstb.1992.0096; HUBLIN JJ, 1987, B MEM SOC ANTHRO PAR, V4, P115, DOI 10.3406/bmsap.1987.1625; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; Le Cabec A, 2013, J HUM EVOL, V64, P169, DOI 10.1016/j.jhevol.2012.08.011; Leguebe A., 1988, MANDIBULE CUBITUS NA, V15; Leroi-Gourhan A., 1958, ETUDE RESTES HUMAINS; Martin H, 1923, HOMME FOSSILE QUINA; Martin H., 1912, B SOC PREHISTORIQUE, V9, P700; MARTIN HENRI, 1927, BULL ET MEM SOC ANTHROP PARIS, V8, P103; MARTIN HENRI, 1926, HOMME PRIHIST, V13, P3; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; Odano A. M., 1978, B ARCHEOLOGIE MAROCA, V11, P25; Pap I., 1996, ANNAL HISTORICO NATU, V88, P233; Protsch R. R. R., 1981, ARCHAOLOGISCHEN ANTH; R Development Core Team, 2012, R LANG ENV STAT COMP; Richter D., 2017, NATURE; RIGHTMIRE GP, 1991, J HUM EVOL, V20, P131, DOI 10.1016/0047-2484(91)90054-Y; RIGHTMIRE GP, 1980, AM J PHYS ANTHROPOL, V53, P225, DOI 10.1002/ajpa.1330530207; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Sanchez F., 1999, Human Evolution, V14, P125, DOI 10.1007/BF02436200; SAUSSE F, 1975, ANTHROPOLOGIE, V79, P81; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Sladek V., 2000, DOLNI VESTONICE STUD, V5, P1; Smith F.H., 1992, CONTINUITY REPLACEME, P145; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Soficaru A, 2006, P NATL ACAD SCI USA, V103, P17196, DOI 10.1073/pnas.0608443103; Sollas WJ, 1927, J R ANTHROPOL INST G, V57, P89, DOI 10.2307/2843679; Spoor F, 2015, NATURE, V519, P83, DOI 10.1038/nature14224; Stewart T. D, 1962, ANN REPORT SMITHSONI, P521; STEWART TD, 1977, P AM PHILOS SOC, V121, P121; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Stringer C, 2011, ORIGIN OUR SPECIES; Stringer C.B., 1978, P395; TeschlerNicola M, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P1, DOI 10.1007/978-3-211-49294-9; THOMA A, 1984, J HUM EVOL, V13, P287, DOI 10.1016/S0047-2484(84)80014-7; Tillier AM, 1991, SQUELETTE MOUSTERIEN, V2, P97; Tixier J., 2001, ACTES 1ERES JOURNE E, V1, P149; Topinard P., 1886, REV ANTROPOL, V15, P385; TRINKAUS E, 1978, J HUM EVOL, V7, P369, DOI 10.1016/S0047-2484(78)80087-6; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Trinkaus E., 1983, SHANIDAR NEANDERTHAL; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; Vercellotti G, 2008, J ANTHROPOL SCI, V86, P143; Vlcek E., 1993, WEIMARER MONOGRAPHIE, V30; Walker MJ, 2010, AM J PHYS ANTHROPOL, V142, P261, DOI 10.1002/ajpa.21223; Weaver TD, 2012, J HUM EVOL, V63, P121, DOI 10.1016/j.jhevol.2012.04.003; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wollny G, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-20; WOOD BA, 1986, AM J PHYS ANTHROPOL, V69, P117, DOI 10.1002/ajpa.1330690113	106	462	484	7	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					289	+		10.1038/nature22336	http://dx.doi.org/10.1038/nature22336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593953	Green Submitted, Green Accepted			2022-12-28	WOS:000402823400037
J	Tollefson, J				Tollefson, Jeff			POLITICS Trump says no to climate pact	NATURE			English	News Item																			0	16	18	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					198	198		10.1038/nature.2017.22096	http://dx.doi.org/10.1038/nature.2017.22096			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593981	Bronze			2022-12-28	WOS:000402823400009
J	Singh, JA; Saag, KG				Singh, Jasvinder A.; Saag, Kenneth G.			Management of Gout	ANNALS OF INTERNAL MEDICINE			English	Letter							CLINICAL-PRACTICE GUIDELINE; AMERICAN-COLLEGE; PHYSICIANS		[Singh, Jasvinder A.; Saag, Kenneth G.] Univ Alabama Birmingham, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Singh, JA (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.		Singh, Jasvinder/R-6172-2019	Singh, Jasvinder/0000-0003-3485-0006				Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; FERRAZ MB, 1995, J RHEUMATOL, V22, P908; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]	5	1	1	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					855	855		10.7326/L17-0211	http://dx.doi.org/10.7326/L17-0211			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28586901				2022-12-28	WOS:000402700200017
J	Reich, K; Papp, KA; Blauvelt, A; Tyring, SK; Sinclair, R; Thaci, D; Nograles, K; Mehta, A; Cichanowitz, N; Li, Q; Liu, K; La Rosa, C; Green, S; Kimball, AB				Reich, Kristian; Papp, Kim A.; Blauvelt, Andrew; Tyring, Stephen K.; Sinclair, Rodney; Thaci, Diamant; Nograles, Kristine; Mehta, Anish; Cichanowitz, Nicole; Li, Qing; Liu, Kenneth; La Rosa, Carmen; Green, Stuart; Kimball, Alexa B.			Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials	LANCET			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; DOUBLE-BLIND; MODERATE; SAFETY; EFFICACY; USTEKINUMAB; SECUKINUMAB; GUSELKUMAB; BRODALUMAB; ADALIMUMAB	Background Tildrakizumab is a high-affinity, humanised, IgG1. antibody targeting interleukin 23 p19 that represents an evolving treatment strategy in chronic plaque psoriasis. Previous research suggested clinical improvement with inhibition of interleukin 23 p19. We did two phase 3 trials to investigate whether tildrakizumab is superior to placebo and etanercept in the treatment of chronic plaque psoriasis. Methods We did two three-part, parallel group, double-blind, randomised controlled studies, reSURFACE 1 (at 118 sites in Australia, Canada, Japan, the UK, and the USA) and reSURFACE 2 (at 132 sites in Europe, Israel, and the USA). Participants aged 18 years or older with moderate-to-severe chronic plaque psoriasis (body surface area involvement >= 10%, Physician's Global Assessment [PGA] score = 3, and Psoriasis Area and Severity Index [PASI] score = 12) were randomised (via interactive voice and web response system) to tildrakizumab 200 mg, tildrakizumab 100 mg, or placebo in reSURFACE 1 (2: 2: 1), or to tildrakizumab 200 mg, tildrakizumab 100 mg, placebo, or etanercept 50 mg (2: 2: 1: 2). Randomisation was done by region and stratified for bodyweight (<= 90 kg or >90 kg) and previous exposure to biologics therapy for psoriasis. Investigators, participants, and study personnel were blinded to group allocation and remained blinded until completion of the studies. Assigned medication was identical in appearance and packaging. Tildrakizumab was administered subcutaneously at weeks 0 and 4 during part 1 and at week 16 during part 2 (weeks 12 and 16 for participants re-randomised from placebo to tildrakizumab; etanercept was given twice weekly in part 1 of reSURFACE 2 and once weekly during part 2). The co-primary endpoints were the proportion of patients achieving PASI 75 and PGA response (score of 0 or 1 with = 2 grade score reduction from baseline) at week 12. Safety was assessed in the all-participants-as-treated population, and efficacy in the full-analysis set. These trials are registered with ClinicalTrials.gov, numbers NCT01722331 (reSURFACE 1) and NCT01729754 (reSURFACE 2). These studies are completed, but extension studies are ongoing. Findings reSURFACE 1 ran from Dec 10, 2012, to Oct 28, 2015. reSURFACE 2 ran from Feb 12, 2013, to Sept 28, 2015. In reSURFACE 1, 772 patients were randomly assigned, 308 to tildrakizumab 200 mg, 309 to tildrakizumab 100 mg, and 155 to placebo. At week 12, 192 patients (62%) in the 200 mg group and 197 patients (64%) in the 100 mg group achieved PASI 75, compared with 9 patients (6%) in the placebo group (p<0.0001 for comparisons of both tildrakizumab groups vs placebo). 182 patients (59%) in the 200 mg group and 179 patients (58%) in the 100 mg group achieved PGA responses, compared with 11 patients (7%) in the placebo group (p<0.0001 for comparisons of both tildrakizumab groups vs placebo). In reSURFACE 2, 1090 patients were randomly assigned, 314 to tildrakizumab 200 mg, 307 to tildrakizumab 100 mg, 156 to placebo, and 313 to etanercept. At week 12, 206 patients (66%) in the 200 mg group, and 188 patients (61%) in the 100 mg group achieved PASI 75, compared with 9 patients (6%) in the placebo group and 151 patients (48%) in the etanercept group (p< 0.0001 for comparisons of both tildrakizumab groups vs placebo; p< 0.0001 for 200 mg vs etanercept and p= 0.0010 for 100 mg vs etanercept). 186 patients (59%) in the 200 mg group, and 168 patients (55%) in the 100 mg group achieved a PGA response, compared with 7 patients (4%) in the placebo group and 149 patients (48%) in the etanercept group (p< 0.0001 for comparisons of both tildrakizumab groups vs placebo; p= 0.0031 for 200 mg vs etanercept and p= 0.0663 for 100 mg vs etanercept). Serious adverse events were similar and low in all groups in both trials. One patient died in reSURFACE 2, in the tildrakizumab 100 mg group; the patient had alcoholic cardiomyopathy and steatohepatitis, and adjudication was unable to determine the cause of death. Interpretation In two phase 3 trials, tildrakizumab 200 mg and 100 mg were efficacious compared with placebo and etanercept and were well tolerated in the treatment of patients with moderate-to-severe chronic plaque psoriasis.	[Reich, Kristian] SCIderm Res Inst & Dermatol Hamburg, Hamburg, Germany; [Papp, Kim A.] Prob Med Res, Waterloo, ON, Canada; [Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA; [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA; [Sinclair, Rodney] Univ Melbourne, Epworth Hosp, Dept Dermatol, Melbourne, Vic, Australia; [Thaci, Diamant] Univ Lubeck, Univ Med Sch Schleswig Holstein, Comprehens Ctr Inflammat Med, Lubeck, Germany; [Nograles, Kristine; Mehta, Anish; Cichanowitz, Nicole; Li, Qing; Liu, Kenneth; La Rosa, Carmen; Green, Stuart] Merck & Co Inc, Kenilworth, NJ USA; [Kimball, Alexa B.] Harvard Med Sch, Boston, MA USA	Dermatologikum Hamburg; University of Texas System; University of Texas Health Science Center Houston; University of Melbourne; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Merck & Company; Harvard University; Harvard Medical School	Reich, K (corresponding author), Dermatol Hamburg, Stephanspl 5, D-20354 Hamburg, Germany.	kreich@dermatologikum.de	Kimball, Alexandra B./M-6347-2019; Sinclair, Rodney/AAI-8355-2020; Nograles, Kristine/V-3648-2019; Thaci, Diamant/AAE-7310-2022	Kimball, Alexandra B./0000-0001-9405-0479; Sinclair, Rodney/0000-0001-6751-1428; Thaci, Diamant/0000-0001-8513-550X; Papp, Kim A./0000-0001-9557-3642	Merck Co	Merck Co(Merck & Company)	Merck & Co.	Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Blauvelt A, 2016, EXPERT OPIN DRUG SAF, V15, P1413, DOI 10.1080/14740338.2016.1221923; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Christophers E, 2001, CLIN EXP DERMATOL, V26, P314, DOI 10.1046/j.1365-2230.2001.00832.x; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Gordon KB, 2015, NEW ENGL J MED, V373, P136, DOI 10.1056/NEJMoa1501646; Gordon KB, 2012, J INVEST DERMATOL, V132, P304, DOI 10.1038/jid.2011.304; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Kimball AB, 2005, AM J CLIN DERMATOL, V6, P383, DOI 10.2165/00128071-200506060-00005; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Krueger JG, 2015, J ALLERGY CLIN IMMUN, V136, P116, DOI 10.1016/j.jaci.2015.01.018; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lewis-Beck C, 2013, PATIENT PREFER ADHER, V7, P199, DOI 10.2147/PPA.S39887; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Luger T, 2016, J EUR ACAD DERMATOL, V30, P1730, DOI 10.1111/jdv.13673; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Menter A, 2007, J AM ACAD DERMATOL, V56, P31, DOI 10.1016/j.jaad.2006.07.017; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Papp K, 2015, BRIT J DERMATOL, V173, P930, DOI 10.1111/bjd.13932; Papp KA, 2016, BRIT J DERMATOL, V175, P273, DOI 10.1111/bjd.14493; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042; Reich K, 2017, J AM ACAD DERMATOL, V76, P441, DOI 10.1016/j.jaad.2016.10.027; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Saunte DM, 2017, BRIT J DERMATOL, V177, P47, DOI 10.1111/bjd.15015; Schmidt C, 2015, NAT BIOTECHNOL, V33, P894, DOI 10.1038/nbt0915-894b; Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; van de Kerkhof PCM, 2016, J AM ACAD DERMATOL, V75, P83, DOI 10.1016/j.jaad.2016.03.024; Zhao YM, 2008, J INVEST DERMATOL, V128, P2190, DOI 10.1038/jid.2008.81	46	358	368	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					276	288		10.1016/S0140-6736(17)31279-5	http://dx.doi.org/10.1016/S0140-6736(17)31279-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA5IZ	28596043				2022-12-28	WOS:000405477900028
J	Jaiswal, S; Natarajan, P; Silver, AJ; Gibson, CJ; Bick, AG; Shvartz, E; McConkey, M; Gupta, N; Gabriel, S; Ardissino, D; Baber, U; Mehran, R; Fuster, V; Danesh, J; Frossard, P; Saleheen, D; Melander, O; Sukhova, GK; Neuberg, D; Libby, P; Kathiresan, S; Ebert, BL				Jaiswal, S.; Natarajan, P.; Silver, A. J.; Gibson, C. J.; Bick, A. G.; Shvartz, E.; McConkey, M.; Gupta, N.; Gabriel, S.; Ardissino, D.; Baber, U.; Mehran, R.; Fuster, V.; Danesh, J.; Frossard, P.; Saleheen, D.; Melander, O.; Sukhova, G. K.; Neuberg, D.; Libby, P.; Kathiresan, S.; Ebert, B. L.			Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; TET2 LOSS; MACROPHAGES; DESIGN; HYPERCHOLESTEROLEMIA; LEUKOCYTOSIS; INFLAMMATION; MUTATIONS; MONOCYTES; ADHESION	BACKGROUND Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of an expanded somatic blood-cell clone in persons without other hematologic abnormalities, is common among older persons and is associated with an increased risk of hematologic cancer. We previously found preliminary evidence for an association between CHIP and atherosclerotic cardiovascular disease, but the nature of this association was unclear. METHODS We used whole-exome sequencing to detect the presence of CHIP in peripheral-blood cells and associated such presence with coronary heart disease using samples from four case-control studies that together enrolled 4726 participants with coronary heart disease and 3529 controls. To assess causality, we perturbed the function of Tet2, the second most commonly mutated gene linked to clonal hematopoiesis, in the hematopoietic cells of atherosclerosis-prone mice. RESULTS In nested case-control analyses from two prospective cohorts, carriers of CHIP had a risk of coronary heart disease that was 1.9 times as great as in noncarriers (95% confidence interval [CI], 1.4 to 2.7). In two retrospective case-control cohorts for the evaluation of early-onset myocardial infarction, participants with CHIP had a risk of myocardial infarction that was 4.0 times as great as in noncarriers (95% CI, 2.4 to 6.7). Mutations in DNMT3A, TET2, ASXL1, and JAK2 were each individually associated with coronary heart disease. CHIP carriers with these mutations also had increased coronary-artery calcification, a marker of coronary atherosclerosis burden. Hypercholesterolemia-prone mice that were engrafted with bone marrow obtained from homozygous or heterozygous Tet2 knockout mice had larger atherosclerotic lesions in the aortic root and aorta than did mice that had received control bone marrow. Analyses of macrophages from Tet2 knockout mice showed elevated expression of several chemokine and cytokine genes that contribute to atherosclerosis. CONCLUSIONS The presence of CHIP in peripheral-blood cells was associated with nearly a doubling in the risk of coronary heart disease in humans and with accelerated atherosclerosis in mice. (Funded by the National Institutes of Health and others.)	[Jaiswal, S.; Silver, A. J.; McConkey, M.; Ebert, B. L.] Brigham & Womens Hosp, Dept Med, Div Hematol, 77 Ave Louis Pasteur,HIM 423, Boston, MA 02115 USA; [Sukhova, G. K.; Libby, P.; Ebert, B. L.] Harvard Med Sch, Boston, MA USA; [Shvartz, E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Jaiswal, S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Natarajan, P.; Kathiresan, S.] Massachusetts Gen Hosp, Ctr Genom Med, CPZN 5-830,185 Cambridge St, Boston, MA 02114 USA; [Natarajan, P.; Kathiresan, S.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Natarajan, P.; Kathiresan, S.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Bick, A. G.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Gibson, C. J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Neuberg, D.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Natarajan, P.; Bick, A. G.; Gupta, N.; Gabriel, S.; Kathiresan, S.] Broad Inst Harvard & Massachusetts Inst Technol, Program Med & Populat Genet, Cambridge, MA USA; [Ardissino, D.] Univ Hosp, Dept Cardiol, Parma, Italy; [Baber, U.; Mehran, R.; Fuster, V.] Mt Sinai Sch Med, Div Cardiol, Dept Med, New York, NY USA; [Fuster, V.] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Danesh, J.] Univ Cambridge, Med Res Council, British Heart Fdn, Cardiovasc Epidemiol Unit, Cambridge, England; [Danesh, J.] Univ Cambridge, Natl Inst Hlth Res, Blood & Transplant Res Unit Donor Hlth & Genom, Dept Publ Hlth & Primary Care, Cambridge, England; [Danesh, J.] Univ Cambridge, British Heart Fdn, Cambridge Ctr Excellence, Dept Med, Cambridge, England; [Danesh, J.] Wellcome Trust Res Labs, Sanger Inst, Genome Campus, Hinxton, England; [Frossard, P.; Saleheen, D.] Ctr Noncommunicable Dis, Karachi, Pakistan; [Saleheen, D.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Melander, O.] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Parma; University Hospital of Parma; Icahn School of Medicine at Mount Sinai; Centro Nacional de Investigaciones Cardiovasculares (CNIC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Pennsylvania; Lund University	Ebert, BL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, 77 Ave Louis Pasteur,HIM 423, Boston, MA 02115 USA.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, CPZN 5-830,185 Cambridge St, Boston, MA 02114 USA.	sekar@broadinstitute.org; bebert@partners.org	Ardissino, Diego/AAC-4041-2022; Natarajan, Pradeep/H-9764-2019; Libby, Peter/AAY-6404-2021; Mehran, Roxana/ABF-4160-2021; Fuster, Valentin/H-4319-2015	Natarajan, Pradeep/0000-0001-8402-7435; Libby, Peter/0000-0002-1502-502X; Fuster, Valentin/0000-0002-9043-9986; Sukhova, Galina/0000-0002-1421-9455; Bick, Alexander/0000-0001-5824-9595; Silver, Alexander/0000-0001-8255-3140; Melander, Olle/0000-0002-2581-484X; solinas, emilia/0000-0003-3532-1317	National Institutes of Health; MRC [G0800270, MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1, G0800270] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; Novo Nordisk Fonden [NNF17OC0026936, NNF13OC0005339, NNF14OC0009819] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [RC1TW008485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, R01HL080472, RC2HL101834, T32HL116324] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by the National Institutes of Health and others.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Carobbio A, 2007, BLOOD, V109, P2310, DOI 10.1182/blood-2006-09-046342; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen E, 2015, BLOOD, V125, P327, DOI 10.1182/blood-2014-04-567024; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kruth HS, 2011, CURR OPIN LIPIDOL, V22, P386, DOI 10.1097/MOL.0b013e32834adadb; Landolfi R, 2007, BLOOD, V109, P2446, DOI 10.1182/blood-2006-08-042515; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Muntendam P, 2010, AM HEART J, V160, P49, DOI 10.1016/j.ahj.2010.02.021; Saleheen D, 2009, EUR J EPIDEMIOL, V24, P329, DOI 10.1007/s10654-009-9334-y; SCHWARTZ D, 1994, J CLIN INVEST, V94, P1968, DOI 10.1172/JCI117548; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; SMITH EB, 1990, EUR HEART J, V11, P72, DOI 10.1093/eurheartj/11.suppl_E.72; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	37	1073	1087	5	125	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					111	121		10.1056/NEJMoa1701719	http://dx.doi.org/10.1056/NEJMoa1701719			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28636844	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000405282300005
J	Miller, R; Beaumont, O; van Oldenrijk, J				Miller, Robert; Beaumont, Oliver; van Oldenrijk, Jakob			CASE REVIEW Knee pain in a 15 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Miller, Robert; Beaumont, Oliver] NHS Fdn Trust, Oxford Univ Hosp, Oxford, England; [van Oldenrijk, Jakob] Erasmus Univ, Med Ctr, Rotterdam, Netherlands	Oxford University Hospitals NHS Foundation Trust; Erasmus University Rotterdam; Erasmus MC	Miller, R (corresponding author), NHS Fdn Trust, Oxford Univ Hosp, Oxford, England.	robmiller90@gmail.com		Miller, Robert/0000-0001-7090-2710				Bachmann LM, 2004, ANN INTERN MED, V140, P121, DOI 10.7326/0003-4819-140-5-200403020-00013; Batra Sumit, 2014, J Clin Orthop Trauma, V5, P245, DOI 10.1016/j.jcot.2014.09.006; Bonnefoy O, 2006, EUR RADIOL, V16, P2542, DOI 10.1007/s00330-006-0319-x; Dahill M, 2014, BULL HOSP JT DIS, V72, P284; Dejour H, 1994, KNEE SURG SPORT TR A, V2, P19, DOI [DOI 10.1007/BF01552649, 10.1007/BF01552649]; Fithian DC, 2004, AM J SPORT MED, V32, P1114, DOI 10.1177/0363546503260788; Gwinner C, 2016, GMS INTERDISCIP PLAS, V5, DOI 10.3205/iprs000080; Lazaro LE, 2013, J ORTHOP TRAUMA, V27, P336, DOI 10.1097/BOT.0b013e318270dfe7; Mackay HE, 2006, INJURY, V37, P513, DOI 10.1016/j.injury.2006.02.008; NIETOSVAARA Y, 1994, J PEDIATR ORTHOPED, V14, P513, DOI 10.1097/01241398-199407000-00018; Petri M, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.29301; Scolaro J, 2011, CLIN ORTHOP RELAT R, V469, P1213, DOI 10.1007/s11999-010-1537-8; Seeley MA, 2013, J PEDIATR ORTHOPED, V33, P511, DOI 10.1097/BPO.0b013e318288b7a0; Stanitski CL, 1998, AM J SPORT MED, V26, P52, DOI 10.1177/03635465980260012501; Verma A, 2001, ACAD RADIOL, V8, P392, DOI 10.1016/S1076-6332(03)80546-9	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2017	357								j2749	10.1136/bmj.j2749	http://dx.doi.org/10.1136/bmj.j2749			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YZ	28642236				2022-12-28	WOS:000404210800004
J	Araki, E; Saffer, DM; Kopf, AJ; Wallace, LM; Kimura, T; Machida, Y; Ide, S; Davis, E				Araki, Eiichiro; Saffer, Demian M.; Kopf, Achim J.; Wallace, Laura M.; Kimura, Toshinori; Machida, Yuya; Ide, Satoshi; Davis, Earl		Expedition 365 Shipboard Scientist	Recurring and triggered slow-slip events near the trench at the Nankai Trough subduction megathrust	SCIENCE			English	Article							LOW-FREQUENCY EARTHQUAKES; SEA-FLOOR; DEFORMATION; TREMOR; ZONE; SEISMICITY; NETWORK; JAPAN; FIELD	The discovery of slow earthquakes has revolutionized the field of earthquake seismology. Defining the locations of these events and the conditions that favor their occurrence provides important insights into the slip behavior of tectonic faults. We report on a family of recurring slow-slip events (SSEs) on the plate interface immediately seaward of repeated historical moment magnitude (Mw) 8 earthquake rupture areas offshore of Japan. The SSEs continue for days to several weeks, include both spontaneous and triggered slip, recur every 8 to 15 months, and are accompanied by swarms of low-frequency tremors. We can explain the SSEs with 1 to 4 centimeters of slip along the megathrust, centered 25 to 35 kilometers (km) from the trench (4 to 10 km depth). The SSEs accommodate 30 to 55% of the plate motion, indicating frequent release of accumulated strain near the trench.	[Araki, Eiichiro; Kimura, Toshinori; Machida, Yuya] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Natsushima Cho 2-15, Yokosuka, Kanagawa 2370061, Japan; [Saffer, Demian M.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Saffer, Demian M.] Penn State Univ, Ctr Geomech Geofluids & Geohazards, University Pk, PA 16802 USA; [Kopf, Achim J.] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen, Germany; [Wallace, Laura M.] GNS Sci, Lower Hutt, New Zealand; [Wallace, Laura M.] Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA; [Ide, Satoshi] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan; [Davis, Earl] Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC, Canada	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bremen; GNS Science - New Zealand; University of Texas System; University of Texas Austin; University of Tokyo; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Araki, E (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Natsushima Cho 2-15, Yokosuka, Kanagawa 2370061, Japan.; Saffer, DM (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.; Saffer, DM (corresponding author), Penn State Univ, Ctr Geomech Geofluids & Geohazards, University Pk, PA 16802 USA.	araki@jamstec.go.jp; demian@psu.edu	IDE, SATOSHI/G-4887-2014; Wallace, Laura/AAR-1862-2021	IDE, SATOSHI/0000-0003-0063-548X; Roesner, Alexander/0000-0002-8278-4376; Wallace, Laura/0000-0003-2070-0891	Japan Society for the Promotion of Science KAKENHI [JP15H05717]; NSF [NSF-OCE 0623633, NSF-OCE 1334436]; Deutsche Forschungsgemeinschaft [KO2109/25-1]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Japan Society for the Promotion of Science KAKENHI grant JP15H05717, NSF grants NSF-OCE 0623633 and NSF-OCE 1334436, and Deutsche Forschungsgemeinschaft grant KO2109/25-1. The borehole pore-fluid pressure data used for this research are openly available from JAMSTEC (join-web.jamstec.go.jp/join-portal/en/) and The Pennsylvania State University (offshore.geosc.psu.edu); the data set is also available from the National Environmental Information Center. Seafloor seismometer data are available from JAMSTEC on request.	Beroza GC, 2011, ANNU REV EARTH PL SC, V39, P271, DOI 10.1146/annurev-earth-040809-152531; Davis E, 2013, EARTH PLANET SC LETT, V368, P110, DOI 10.1016/j.epsl.2013.03.009; Davis EE, 2015, EARTH PLANET SC LETT, V410, P117, DOI 10.1016/j.epsl.2014.11.015; DeSantis Angelo, 2015, SEAFLOOR OBSERVATORI, P643, DOI [DOI 10.1007/978-3-642-11374-1_25, 10.1007/978-3-642-11374-1_25]; Dixon TH, 2014, P NATL ACAD SCI USA, V111, P17039, DOI 10.1073/pnas.1412299111; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Freed AM, 2005, ANNU REV EARTH PL SC, V33, P335, DOI 10.1146/annurev.earth.33.092203.122505; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Gomberg J, 1996, J GEOPHYS RES-SOL EA, V101, P733, DOI 10.1029/95JB03250; Itaba S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049593; Ito Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025270; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Kikuchi M., 2014, EARTH PLANETS SPACE, V55; Kopf A., 2016, EXPEDITION 365 PERLI; Kopf A., 2011, P IODP, DOI [10.2204/iodp.proc.332.2011, DOI 10.2204/IODP.PROC.332.2011]; Liu YJ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004930; Miyazaki S, 2001, J GEOPHYS RES-SOL EA, V106, P4305, DOI 10.1029/2000JB900312; Obana K, 2009, EARTH PLANET SC LETT, V287, P168, DOI 10.1016/j.epsl.2009.08.005; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2016, SCIENCE, V353, P253, DOI 10.1126/science.aaf1512; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Ozawa S., 2008, EARTH PLANETS SPACE, V59; Saffer DM, 2015, NAT GEOSCI, V8, P594, DOI [10.1038/ngeo2490, 10.1038/NGEO2490]; Schwartz SY, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000208; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Sugioka H, 2012, NAT GEOSCI, V5, P414, DOI [10.1038/NGEO1466, 10.1038/ngeo1466]; Suzuki K, 2016, TECTONOPHYSICS, V680, P90, DOI 10.1016/j.tecto.2016.05.012; To A, 2015, PHYS EARTH PLANET IN, V245, P40, DOI 10.1016/j.pepi.2015.04.007; Uchida N, 2016, SCIENCE, V351, P488, DOI 10.1126/science.aad3108; Wallace LM, 2016, J GEOPHYS RES-SOL EA, V121, P8338, DOI 10.1002/2016JB013417; Wallace LM, 2016, SCIENCE, V352, P701, DOI 10.1126/science.aaf2349; Yamashita Y, 2015, SCIENCE, V348, P676, DOI 10.1126/science.aaa4242; Yokota Y, 2016, NATURE, V534, P374, DOI 10.1038/nature17632	34	163	164	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1157	1160		10.1126/science.aan3120	http://dx.doi.org/10.1126/science.aan3120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619941				2022-12-28	WOS:000403327400033
J	Warren, P				Warren, Penny			Jeffrey Tate OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												penny.warren@btinternet.com						TATE J, PUBLICATION LIST, P65198	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2017	357								j2937	10.1136/bmj.j2937	http://dx.doi.org/10.1136/bmj.j2937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1VB	28623235				2022-12-28	WOS:000403754300005
J	Gulland, A				Gulland, Anne			Chaand Nagpaul: a calm and persuasive negotiator	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Iacobucci G, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2424; Iacobucci G, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2297; Nagpaul C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2066	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2877	10.1136/bmj.j2877	http://dx.doi.org/10.1136/bmj.j2877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28619749				2022-12-28	WOS:000403753800012
J	Chan, KK				Chan, K. K.			John Richard Newton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									[Chan, K. K.] Univ Birmingham, Obstet & Gynaecol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Chan, KK (corresponding author), Univ Birmingham, Obstet & Gynaecol, Birmingham B15 2TT, W Midlands, England.							NEWTON JR, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2017	357								j2758	10.1136/bmj.j2758	http://dx.doi.org/10.1136/bmj.j2758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UJ	28606916				2022-12-28	WOS:000403752200002
J	Sharma, DC				Sharma, Dinesh C.			Cyclone Mora devastates south Asia	LANCET			English	Editorial Material																			0	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2273	2273		10.1016/S0140-6736(17)31580-5	http://dx.doi.org/10.1016/S0140-6736(17)31580-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28612738				2022-12-28	WOS:000402872700010
J	Sultan, S; Malhotra, A				Sultan, Shahnaz; Malhotra, Ashish			Irritable Bowel Syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHARMACOLOGICAL MANAGEMENT; DIAGNOSTIC-VALUE; DOUBLE-BLIND; CONSTIPATION; SYMPTOMS; BIOMARKERS; THERAPY; IBS; ELUXADOLINE; PREVALENCE		[Sultan, Shahnaz] Univ Minnesota, Minneapolis, MN 55455 USA; Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Sultan, S (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.			Sultan, Shahnaz/0000-0002-5867-8741	American College of Physicians	American College of Physicians	American College of Physicians.	Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barbara G, 2009, GUT, V58, P1571, DOI 10.1136/gut.2008.169672; Begtrup LM, 2013, CLIN GASTROENTEROL H, V11, P956, DOI 10.1016/j.cgh.2012.12.038; Bengtsson M, 2006, PATIENT EDUC COUNS, V62, P118, DOI 10.1016/j.pec.2005.06.015; Bensoussan A, 2015, CLIN GASTROENTEROL H, V13, P1946, DOI 10.1016/j.cgh.2015.06.022; Camilleri M, 2015, ALIMENT PHARM THER, V42, P818, DOI 10.1111/apt.13351; Camilleri M, 2013, NEW ENGL J MED, V368, P578, DOI 10.1056/NEJMc1214185; Cash BD, 2011, GASTROENTEROLOGY, V141, P1187, DOI [10.1053/J.GASTRO.2011.06.084, 10.1053/j.gastro.2011.06.084]; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Chang L, 2014, GASTROENTEROLOGY, V147, P1149, DOI 10.1053/j.gastro.2014.09.002; Dove LS, 2013, GASTROENTEROLOGY, V145, P329, DOI 10.1053/j.gastro.2013.04.006; Drossman DA, 2009, ALIMENT PHARM THER, V29, P329, DOI 10.1111/j.1365-2036.2008.03881.x; Drossman D.A., 2016, GASTROENTEROLOGY; Efskind PS, 1996, SCAND J GASTROENTERO, V31, P463, DOI 10.3109/00365529609006766; Eswaran S, 2011, GASTROENTEROL CLIN N, V40, P141, DOI 10.1016/j.gtc.2010.12.012; Ford AC, 2014, AM J GASTROENTEROL, V109, P1547, DOI 10.1038/ajg.2014.202; Ford AC, 2014, AM J GASTROENTEROL, V109, P1350, DOI 10.1038/ajg.2014.148; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P401, DOI 10.1016/j.cgh.2009.07.020; Foxx-Orenstein AE, 2016, THER ADV GASTROENTER, V9, P354, DOI 10.1177/1756283X16633050; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gibson PR, 2010, J GASTROEN HEPATOL, V25, P252, DOI 10.1111/j.1440-1746.2009.06149.x; Grundmann O, 2014, WORLD J GASTROENTERO, V20, P346, DOI 10.3748/wjg.v20.i2.346; Guagnozzi D, 2016, ALIMENT PHARM THER, V43, P851, DOI 10.1111/apt.13573; Hilpusch F, 2017, SCAND J GASTROENTERO, V52, P173, DOI 10.1080/00365521.2016.1242025; Khalif IL, 2009, J GASTROINTEST LIVER, V18, P17; Khanna R, 2014, J CLIN GASTROENTEROL, V48, P505, DOI 10.1097/MCG.0b013e3182a88357; LAVO B, 1987, SCAND J GASTROENTERO, V22, P77, DOI 10.3109/00365528709091003; Lembo AJ, 2016, NEW ENGL J MED, V374, P242, DOI 10.1056/NEJMoa1505180; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Madisch A, 2004, ALIMENT PHARM THER, V19, P271, DOI 10.1111/j.1365-2036.2004.01859.x; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Mazurak N, 2015, J NEUROGASTROENTEROL, V21, P471, DOI 10.5056/jnm15071; Menees SB, 2015, AM J GASTROENTEROL, V110, P444, DOI 10.1038/ajg.2015.6; Moayyedi P, 2014, AM J GASTROENTEROL, V109, P1367, DOI 10.1038/ajg.2014.195; National Institute for Health and Care Excellence, 2013, HLTH CARE EXCELLENCE, V61; Ottillinger B, 2013, WIEN MED WOCHENSCHR, V163, P65, DOI 10.1007/s10354-012-0169-x; Ruepert L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003460.pub3, 10.1002/14651858.CD003460]; Sallon S, 2002, DIGESTION, V65, P161, DOI 10.1159/000064936; Schumann D, 2016, CLIN GASTROENTEROL H, V14, P1720, DOI 10.1016/j.cgh.2016.04.026; Shanahan F, 2014, GASTROENTEROLOGY, V146, P1554, DOI 10.1053/j.gastro.2014.01.050; Soh JS, 2015, AM J GASTROENTEROL, V110, P1197, DOI 10.1038/ajg.2015.153; Sood R, 2014, NAT REV GASTRO HEPAT, V11, P683, DOI 10.1038/nrgastro.2014.127; TALLEY NJ, 1990, GUT, V31, P77, DOI 10.1136/gut.31.1.77; Thompson WG, 1999, GUT, V45, P43; Tong K, 2013, THER ADV GASTROENTER, V6, P344, DOI 10.1177/1756283X13491798; Villoria A, 2006, AM J GASTROENTEROL, V101, P2552, DOI 10.1111/j.1572-0241.2006.00873.x; Weinberg DS, 2014, GASTROENTEROLOGY, V147, P1146, DOI 10.1053/j.gastro.2014.09.001	48	29	31	3	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					ITC81	ITC95		10.7326/AITC201706060	http://dx.doi.org/10.7326/AITC201706060			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28586906				2022-12-28	WOS:000402700200002
J	Taran, S; Detsky, AS				Taran, Shaurya; Detsky, Allan S.			It's a Beautiful Thing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Taran, Shaurya; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Detsky, AS (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, Toronto, ON, Canada.; Detsky, AS (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	allan.detsky@sinaihealthsystem.ca	Taran, Shaurya/ABF-1571-2020					McCabe K., 1989, WASHINGTONIAN    AUG	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2165	2166		10.1001/jama.2017.3102	http://dx.doi.org/10.1001/jama.2017.3102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586891				2022-12-28	WOS:000402706100009
J	Green, A				Green, Andrew			Cholera outbreak in the horn of Africa	LANCET			English	Editorial Material																			0	7	6	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2179	2179		10.1016/S0140-6736(17)31541-6	http://dx.doi.org/10.1016/S0140-6736(17)31541-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589885				2022-12-28	WOS:000402540800013
J	Greene, JA; Padula, WV				Greene, Jeremy A.; Padula, William V.			Perspective Targeting Unconscionable Prescription-Drug Prices Maryland's Anti-Price-Gouging Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENERIC DRUGS		[Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA; [Padula, William V.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA.		Padula, Bill/AGB-4625-2022					Alpern JD, 2014, NEW ENGL J MED, V371, P1859, DOI 10.1056/NEJMp1408376; [Anonymous], 2016, SUDD PRIC SPIK OFF P; Berndt ER, 2007, HEALTH AFFAIR, V26, P790, DOI 10.1377/hlthaff.26.3.790; Korobkin Russell, 2004, U HAW L REV, V26, P458; Tribble S. J., 2017, WASHINGTON POST	5	19	19	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					101	103		10.1056/NEJMp1704907	http://dx.doi.org/10.1056/NEJMp1704907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA2PC	28591520				2022-12-28	WOS:000405282300001
J	Camp, JG; Sekine, K; Gerber, T; Loeffler-Wirth, H; Binder, H; Gac, M; Kanton, S; Kageyama, J; Damm, G; Seehofer, D; Belicova, L; Bickle, M; Barsacchi, R; Okuda, R; Yoshizawa, E; Kimura, M; Ayabe, H; Taniguchi, H; Takebe, T; Treutlein, B				Camp, J. Gray; Sekine, Keisuke; Gerber, Tobias; Loeffler-Wirth, Henry; Binder, Hans; Gac, Malgorzata; Kanton, Sabina; Kageyama, Jorge; Damm, Georg; Seehofer, Daniel; Belicova, Lenka; Bickle, Marc; Barsacchi, Rico; Okuda, Ryo; Yoshizawa, Emi; Kimura, Masaki; Ayabe, Hiroaki; Taniguchi, Hideki; Takebe, Takanori; Treutlein, Barbara			Multilineage communication regulates human liver bud development from pluripotency	NATURE			English	Article							FUNCTIONAL HUMAN LIVER; EXPRESSION; SIGNALS; CELLS; GENERATION; TISSUES	Conventional two-dimensional differentiation from pluripotency fails to recapitulate cell interactions occurring during organogenesis. Three-dimensional organoids generate complex organ-like tissues(1); however, it is unclear how heterotypic interactions affect lineage identity. Here we use single-cell RNA sequencing(2,3) to reconstruct hepatocyte-like lineage progression from pluripotency in two-dimensional culture. We then derive three-dimensional liver bud organoids(4) by reconstituting hepatic, stromal, and endothelial interactions, and deconstruct heterogeneity during liver bud development. We find that liver bud hepatoblasts diverge from the two-dimensional lineage, and express epithelial migration signatures characteristic of organ budding. We benchmark three-dimensional liver buds against fetal and adult human liver single-cell RNA sequencing data, and find a striking correspondence between the three-dimensional liver bud and fetal liver cells. We use a receptor-ligand pairing analysis and a high-throughput inhibitor assay to interrogate signalling in liver buds, and show that vascular endothelial growth factor (VEGF) crosstalk potentiates endothelial network formation and hepatoblast differentiation. Our molecular dissection reveals interlineage communication regulating organoid development, and illuminates previously inaccessible aspects of human liver development.	[Camp, J. Gray; Gerber, Tobias; Gac, Malgorzata; Kanton, Sabina; Kageyama, Jorge; Treutlein, Barbara] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany; [Sekine, Keisuke; Okuda, Ryo; Yoshizawa, Emi; Kimura, Masaki; Ayabe, Hiroaki; Taniguchi, Hideki; Takebe, Takanori] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan; [Loeffler-Wirth, Henry; Binder, Hans] Univ Leipzig, Interdisciplinary Ctr Bioinformat, 16 Hartelstr, D-04107 Leipzig, Germany; [Damm, Georg; Seehofer, Daniel] Univ Hosp Leipzig, Dept Hepatobiliary & Transplantat Surg, Liebigstr 20, D-04103 Leipzig, Germany; [Damm, Georg; Seehofer, Daniel] Univ Leipzig, Saxonian Incubator Clin Translat SIKT, 55 Philipp Rosenthal Str, D-04103 Leipzig, Germany; [Belicova, Lenka; Bickle, Marc; Barsacchi, Rico; Treutlein, Barbara] Max Planck Inst Mol Cell Biol & Genet, 108 Pfotenhauerstr, D-01307 Dresden, Germany; [Takebe, Takanori] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA	Max Planck Society; Yokohama City University; Leipzig University; Leipzig University; Leipzig University; Max Planck Society; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Treutlein, B (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany.; Sekine, K; Takebe, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.; Treutlein, B (corresponding author), Max Planck Inst Mol Cell Biol & Genet, 108 Pfotenhauerstr, D-01307 Dresden, Germany.; Takebe, T (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	ksekine@yokohama-cu.ac.jp; Takanori.Takebe@cchmc.org; barbara_treutlein@eva.mpg.de	Belicova, Lenka/AAZ-5111-2021; Damm, Georg/ABD-7372-2021; Seehofer, Daniel/X-1933-2019; Binder, Hans/U-5519-2018	Belicova, Lenka/0000-0002-6687-630X; Damm, Georg/0000-0002-2104-8076; Loeffler-Wirth, Henry/0000-0001-8239-440X; Sekine, Keisuke/0000-0001-5133-0876; Binder, Hans/0000-0002-2242-4678; Takebe, Takanori/0000-0002-6989-3041; Treutlein, Barbara/0000-0002-3299-5597; Gerber, Tobias/0000-0001-8456-5495	Max Planck Society; PRESTO Japan Science and Technology Agency; Ministry of Education Culture and Sports of Japan [15H04922, 15KK0314]; AMED Research Center Network for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [16K15597] Funding Source: KAKEN	Max Planck Society(Max Planck Society); PRESTO Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED Research Center Network for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Paabo, K. Kohler, A. Weigert, B. Hober, A. Weihmann, B. Vernot, K. Pfufer, G. Renaud, M. Dannemann, J. Kelso of Max Planck Institute for Evolutionary Anthropology, M. Zerial of the Max Planck Institute of Molecular Cell Biology and Genetics, and T. Tamura, S. Tsuzuki, and C. Kaneko of Yokohama for their help with this project. This work was supported by the Max Planck Society (B. T.), PRESTO Japan Science and Technology Agency (T. T.), grants-in-aid 15H04922 and 15KK0314 from the Ministry of Education Culture and Sports of Japan (K. S.), and the AMED Research Center Network for Realization of Regenerative Medicine (H.T.). T. T. is a New York Stem Cell Foundation - Robertson Investigator.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; D'Amico G, 2014, J CLIN INVEST, V124, P824, DOI 10.1172/JCI68897; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kamiya A, 2004, HEPATOLOGY, V40, P527, DOI 10.1002/hep.20362; Kegel V, 2016, JOVE-J VIS EXP, DOI 10.3791/53069; Kim DH, 2015, CELL STEM CELL, V16, P88, DOI 10.1016/j.stem.2014.11.005; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Margagliotti S, 2007, DEV BIOL, V311, P579, DOI 10.1016/j.ydbio.2007.09.013; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Rankin SA, 2011, DEV BIOL, V351, P297, DOI 10.1016/j.ydbio.2010.11.037; Renaud G, 2015, BIOINFORMATICS, V31, P770, DOI 10.1093/bioinformatics/btu719; Renaud G, 2013, BIOINFORMATICS, V29, P1208, DOI 10.1093/bioinformatics/btt117; Rodriguez-Seguel E, 2013, GENE DEV, V27, P1932, DOI 10.1101/gad.220244.113; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Toronen P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-307; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wirth H, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-18; Wirth H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-306; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	46	274	278	19	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					533	+		10.1038/nature22796	http://dx.doi.org/10.1038/nature22796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28614297				2022-12-28	WOS:000403814100039
J	Shalev, A; Liberzon, I; Marmar, C				Shalev, Arieh; Liberzon, Israel; Marmar, Charles			Post-Traumatic Stress Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PREFRONTAL CORTEX; FEAR EXTINCTION; PTSD; RISK; TRAUMA; PHARMACOTHERAPY; PSYCHOTHERAPY; COMORBIDITY; ASSOCIATION; EXPOSURE		[Shalev, Arieh; Marmar, Charles] NYU, Sch Med, Dept Psychiat, Steven & Alexandra Cohen Vet Ctr Posttraumat Stre, New York, NY USA; [Liberzon, Israel] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Liberzon, Israel] Vet Affairs Ann Arbor Hlth Syst, Mental Hlth Serv, Ann Arbor, MI USA	New York University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Marmar, C (corresponding author), NYU, Sch Med, 1 Pk Ave,Rm 8-214, New York, NY 10016 USA.	charles.marmar@nyumc.org	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607; Shalev, Arieh/0000-0001-9425-050X	ARMGO Pharmaceuticals; Cohen Veterans Bioscience; Sunovion Pharmaceuticals	ARMGO Pharmaceuticals; Cohen Veterans Bioscience; Sunovion Pharmaceuticals	Dr. Liberzon reports receiving grant support and consulting fees from ARMGO Pharmaceuticals, grant support and honoraria from Cohen Veterans Bioscience, and consulting fees from Sunovion Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Admon R, 2013, CEREB CORTEX, V23, P28, DOI 10.1093/cercor/bhr369; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Amos T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006239.pub2; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; Bernal M, 2007, J AFFECT DISORDERS, V101, P27, DOI 10.1016/j.jad.2006.09.018; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bryant RA, 2010, BIOL PSYCHIAT, V67, P1217, DOI 10.1016/j.biopsych.2010.03.016; Clark C, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0621-x; Cloitre M, 2002, J CONSULT CLIN PSYCH, V70, P1067, DOI 10.1037//0022-006X.70.5.1067; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Eraly SA, 2014, JAMA PSYCHIAT, V71, P423, DOI 10.1001/jamapsychiatry.2013.4374; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Feder A, 2014, JAMA PSYCHIAT, V71, P681, DOI 10.1001/jamapsychiatry.2014.62; Felmingham KL, 2013, BIOL PSYCHIAT, V73, P1059, DOI 10.1016/j.biopsych.2012.10.033; Gartlehner G, 2013, INTERVENTIONS PREVEN; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hoge CW, 2016, JAMA PSYCHIAT, V73, P750, DOI 10.1001/jamapsychiatry.2016.0647; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Jonas D. E., 2013, PSYCHOL PHARM TREATM; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Karam EG, 2014, DEPRESS ANXIETY, V31, P130, DOI 10.1002/da.22169; Kendler KS, 2016, JAMA PSYCHIAT, V73, P1082, DOI 10.1001/jamapsychiatry.2016.1976; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Khachatryan D, 2016, GEN HOSP PSYCHIAT, V39, P46, DOI 10.1016/j.genhosppsych.2015.10.007; Lang S, 2009, EUR J NEUROSCI, V29, P823, DOI 10.1111/j.1460-9568.2009.06624.x; Lanius RA, 2007, PSYCHIAT RES-NEUROIM, V155, P45, DOI 10.1016/j.pscychresns.2006.11.006; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; Logue MW, 2015, NEUROPSYCHOPHARMACOL, V40, P2287, DOI 10.1038/npp.2015.118; Markowitz JC, 2015, AM J PSYCHIAT, V172, P430, DOI 10.1176/appi.ajp.2014.14070908; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Marshall AJ, 2014, J NEUROSCI, V34, P11754, DOI 10.1523/JNEUROSCI.0478-14.2014; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Metcalf O, 2016, J TRAUMA STRESS, V29, P88, DOI 10.1002/jts.22070; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Minassian A, 2015, JAMA PSYCHIAT, V72, P979, DOI 10.1001/jamapsychiatry.2015.0922; Mohamed S, 2008, J CLIN PSYCHIAT, V69, P959, DOI 10.4088/JCP.v69n0611; Nadorff MR, 2014, INT REV PSYCHIATR, V26, P225, DOI 10.3109/09540261.2014.888989; Nazarian D, 2012, J TRAUMA STRESS, V25, P220, DOI 10.1002/jts.21690; Ori R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007803.pub2; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Polusny MA, 2015, JAMA-J AM MED ASSOC, V314, P456, DOI 10.1001/jama.2015.8361; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Reiter K, 2016, J NERV MENT DIS, V204, P69, DOI 10.1097/NMD.0000000000000418; Roberts NP, 2015, CLIN PSYCHOL REV, V38, P25, DOI 10.1016/j.cpr.2015.02.007; Roberts NP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007944.pub2; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; Rougemont-Bucking A, 2011, CNS NEUROSCI THER, V17, P227, DOI 10.1111/j.1755-5949.2010.00152.x; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Schlenger WE, 2015, AM J EPIDEMIOL, V182, P980, DOI 10.1093/aje/kwv217; Schnyder U, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.28186; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shalev AY, 2016, J CLIN PSYCHIAT, V77, pE580, DOI 10.4088/JCP.15m09932; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smoller JW, 2016, NEUROPSYCHOPHARMACOL, V41, P297, DOI 10.1038/npp.2015.266; Spoont MR, 2015, JAMA-J AM MED ASSOC, V314, P501, DOI 10.1001/jama.2015.7877; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; van den Berg DPG, 2015, JAMA PSYCHIAT, V72, P259, DOI 10.1001/jamapsychiatry.2014.2637; Yarnell Stephanie, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.15r01786; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001	77	330	345	9	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2459	2469		10.1056/NEJMra1612499	http://dx.doi.org/10.1056/NEJMra1612499			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY2BW	28636846				2022-12-28	WOS:000403774400009
J	Hawkes, N				Hawkes, Nigel			Are new hepatitis C drugs all they're cracked up to be?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2017, GUARDIAN, P28; Gulland A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2809; Jakobsen JC, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012143.pub2, 10.1002/14651858.CD012143.pub3]; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Public Health England, HEP C ENGL 2017 REP	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2017	357								j2961	10.1136/bmj.j2961	http://dx.doi.org/10.1136/bmj.j2961			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YX	28637671				2022-12-28	WOS:000404210400005
J	Matthews, RAJ				Matthews, Robert A. J.			Heterogeneity in Treatment Effects	ANNALS OF INTERNAL MEDICINE			English	Letter							N-OF-1 TRIALS		[Matthews, Robert A. J.] Aston Univ, Birmingham, W Midlands, England	Aston University	Matthews, RAJ (corresponding author), Aston Univ, Birmingham, W Midlands, England.			Matthews, Robert/0000-0002-1253-6107				Davidoff F, 2017, ANN INTERN MED, V166, P141, DOI 10.7326/M16-1721; Kent DM, 2016, INT J EPIDEMIOL; Kravitz RL, 2008, MILBANK Q, V86, P533, DOI 10.1111/j.1468-0009.2008.00533.x; Senn S, 2004, BMJ-BRIT MED J, V329, P966, DOI 10.1136/bmj.329.7472.966; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					914	914		10.7326/L17-0155	http://dx.doi.org/10.7326/L17-0155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630984				2022-12-28	WOS:000403579000026
J	Somerville, S				Somerville, Simon			Guideline: In low back pain, non-pharmacologic treatments are recommended	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Somerville, Simon] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	Keele University	Somerville, S (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.							National Institute for Health and Care Excellence (NICE), 2016, LOW BACK PAIN SCIAT	1	1	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC62	JC62		10.7326/ACPJC-2017-166-12-062	http://dx.doi.org/10.7326/ACPJC-2017-166-12-062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630974				2022-12-28	WOS:000403579000003
J	Wagner, B				Wagner, Brent			In adults at risk for contrast-induced nephropathy, no prophylactic hydration was noninferior to hydration	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Wagner, Brent] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Wagner, B (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.		Wagner, Brent/AAA-8291-2020	Wagner, Brent/0000-0002-7063-0142				Katzberg RW, 2010, RADIOLOGY, V256, P21, DOI 10.1148/radiol.10092000; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Pannu N, 2006, JAMA-J AM MED ASSOC, V295, P2765, DOI 10.1001/jama.295.23.2765; Wilhelm-Leen E, 2017, J AM SOC NEPHROL, V28, P653, DOI 10.1681/ASN.2016010021	4	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC66	JC66		10.7326/ACPJC-2017-166-12-066	http://dx.doi.org/10.7326/ACPJC-2017-166-12-066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630978				2022-12-28	WOS:000403579000007
J	Johnson, CW; Fu, YN; Burgmann, R				Johnson, Christopher W.; Fu, Yuning; Burgmann, Roland			Seasonal water storage, stress modulation, and California seismicity	SCIENCE			English	Article							SAN-ANDREAS FAULT; EARTHQUAKE OCCURRENCE; PLATE BOUNDARY; DEFORMATION; TIDES; NORTHERN; STRAIN; UPLIFT; GPS	Establishing what controls the timing of earthquakes is fundamental to understanding the nature of the earthquake cycle and critical to determining time-dependent earthquake hazard. Seasonal loading provides a natural laboratory to explore the crustal response to a quantifiable transient force. In California, water storage deforms the crust as snow and water accumulates during the wet wintermonths. We used 9 years of global positioning system (GPS) vertical deformation time series to constrain models of monthly hydrospheric loading and the resulting stress changes on fault planes of small earthquakes. The seasonal loading analysis reveals earthquakes occurring more frequently during stress conditions that favor earthquake rupture. We infer that California seismicity rates are modestly modulated by natural hydrological loading cycles.	[Johnson, Christopher W.; Burgmann, Roland] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Johnson, Christopher W.; Burgmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Fu, Yuning] Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University System of Ohio; Bowling Green State University	Johnson, CW (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA.; Johnson, CW (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	cwj@seismo.berkeley.edu	Burgmann, Roland/AAE-5138-2022	Burgmann, Roland/0000-0002-3560-044X; Johnson, Christopher/0000-0002-2589-7593; Fu, Yuning/0000-0002-9226-3857	U.S. Geological Survey National Earthquake Hazards Reduction Program [G15AP00106]; Southern California Earthquake Center; National Science Foundation Graduate Research Fellowship [DGE1106400]; National Science Foundation [EAR-0350028, EAR-0732947]	U.S. Geological Survey National Earthquake Hazards Reduction Program(United States Geological Survey); Southern California Earthquake Center; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	Funding for this project was provided by the U.S. Geological Survey National Earthquake Hazards Reduction Program (G15AP00106) and the Southern California Earthquake Center. This material is based on work supported by the National Science Foundation Graduate Research Fellowship under grant number DGE1106400 for C.W.J. GPS data were collected by the Plate Boundary Observatory operated by UNAVCO for EarthScope (www.earthscope.org) and supported by National Science Foundation grant no. EAR-0350028 and EAR-0732947. The data were processed using the GIPSY OASIS II software provided by the Jet Propulsion Laboratory. Waveform data, metadata, or data products for this study were accessed through the Northern California Earthquake Data Center (NCEDC), doi:10.7932/NCEDC. The monthly water-loading estimates and earthquake catalog with the calculated stresses are all available in the supplementary materials.	Ader TJ, 2014, GEOPHYS J INT, V198, P385, DOI 10.1093/gji/ggu144; Amos CB, 2014, NATURE, V509, P483, DOI 10.1038/nature13275; Argus DF, 2014, GEOPHYS RES LETT, V41, P1971, DOI 10.1002/2014GL059570; Beeler NM, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001518; Ben-Zion Y, 2013, EARTH PLANET SC LETT, V379, P120, DOI 10.1016/j.epsl.2013.08.024; Bettinelli P, 2008, EARTH PLANET SC LETT, V266, P332, DOI 10.1016/j.epsl.2007.11.021; Bollinger L, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029192; Borsa AA, 2014, SCIENCE, V345, P1587, DOI 10.1126/science.1260279; Carpenter BM, 2011, NAT GEOSCI, V4, P251, DOI [10.1038/ngeo1089, 10.1038/NGEO1089]; Chanard K, 2014, J GEOPHYS RES-SOL EA, V119, P5097, DOI 10.1002/2013JB010451; Christiansen LB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028634; Cochran ES, 2004, SCIENCE, V306, P1164, DOI 10.1126/science.1103961; Dutilleul P, 2015, J GEOPHYS RES-SOL EA, V120, P8494, DOI 10.1002/2015JB012467; FARRELL WE, 1972, REV GEOPHYS SPACE GE, V10, P761, DOI 10.1029/RG010i003p00761; Felzer K. R., 2013, 20131165 US GEOL SUR, P1; Field E. H., 2013, SO CALIFORNIA EARTHQ, V1792; Fu YN, 2015, J GEOPHYS RES-SOL EA, V120, P552, DOI 10.1002/2014JB011415; Fu YN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008925; Gao SS, 2000, NATURE, V406, P500, DOI 10.1038/35020045; Hainzl S, 2013, J GEOPHYS RES-SOL EA, V118, P5442, DOI 10.1002/jgrb.50387; Hardebeck JL, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003239; Heki K, 2003, EARTH PLANET SC LETT, V207, P159, DOI 10.1016/S0012-821X(02)01148-2; Johnson CW, 2016, GEOPHYS RES LETT, V43, P6196, DOI 10.1002/2016GL069546; Page BM, 1998, GEOL SOC AM BULL, V110, P846, DOI 10.1130/0016-7606(1998)110<0846:OLCTOT>2.3.CO;2; Pollitz FF, 2013, J GEOPHYS RES-SOL EA, V118, P2445, DOI 10.1002/jgrb.50181; Provost AS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001123; Shelly DR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049336; Titus SJ, 2011, GEOL SOC AM BULL, V123, P794, DOI 10.1130/B30150.1; Vidale JE, 1998, J GEOPHYS RES-SOL EA, V103, P24567, DOI 10.1029/98JB00594; Yang WZ, 2013, GEOPHYS J INT, V194, P100, DOI 10.1093/gji/ggt113; Zhuang J, 2002, J AM STAT ASSOC, V97, P369, DOI 10.1198/016214502760046925	31	93	98	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1161	1164		10.1126/science.aak9547	http://dx.doi.org/10.1126/science.aak9547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619942	Green Submitted			2022-12-28	WOS:000403327400034
J	Baik, S; Kim, DW; Park, Y; Lee, TJ; Bhang, SH; Pang, C				Baik, Sangyul; Kim, Da Wan; Park, Youngjin; Lee, Tae-Jin; Bhang, Suk Ho; Pang, Changhyun			A wet-tolerant adhesive patch inspired by protuberances in suction cups of octopi	NATURE			English	Article							POLYMER; MOLD	Adhesion strategies that rely on mechanical interlocking or molecular attractions between surfaces can suffer when coming into contact with liquids(1,2). Thus far, artificial wet and dry adhesives have included hierarchical mushroom-shaped or porous structures that allow suction or capillarity(3-6), supramolecular structures comprising nanoparticles(7), and chemistry-based attractants that use various protein polyelectrolytes(8-10). However, it is challenging to develop adhesives that are simple to make and also perform well- and repeatedly-under both wet and dry conditions, while avoiding non-chemical contamination on the adhered surfaces(11). Here we present an artificial, biologically inspired, reversible wet/dry adhesion system that is based on the dome-like protuberances found in the suction cups of octopi. To mimic the architecture of these protuberances(12-14), we use a simple, solution-based, air-trap technique that involves fabricating a patterned structure as a polymeric master, and using it to produce a reversed architecture, without any sophisticated chemical syntheses or surface modifications. The micrometre-scale domes in our artificial adhesive enhance the suction stress. This octopus-inspired system exhibits strong, reversible, highly repeatable adhesion to silicon wafers, glass, and rough skin surfaces under various conditions (dry, moist, under water and under oil). To demonstrate a potential application, we also used our adhesive to transport a large silicon wafer in air and under water without any resulting surface contamination.	[Baik, Sangyul; Kim, Da Wan; Park, Youngjin; Lee, Tae-Jin; Bhang, Suk Ho; Pang, Changhyun] Sungkyunkwan Univ, Sch Chem Engn, Suwon 16419, Kyunggi Do, South Korea; [Pang, Changhyun] Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Suwon 16419, Kyunggi Do, South Korea; [Pang, Changhyun] Sungkyunkwan Univ, SAIHST, Suwon 16419, Kyunggi Do, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Pang, C (corresponding author), Sungkyunkwan Univ, Sch Chem Engn, Suwon 16419, Kyunggi Do, South Korea.; Pang, C (corresponding author), Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Suwon 16419, Kyunggi Do, South Korea.; Pang, C (corresponding author), Sungkyunkwan Univ, SAIHST, Suwon 16419, Kyunggi Do, South Korea.	chpang@skku.edu	Pang, Changhyun/AAS-9096-2020	Pang, Changhyun/0000-0001-8339-7880	National Research Foundation of Korea [NRF-2014R1A1A1007162, NRF-2016H1A2A1908670]; Korea Health Technology RD Project [HI17C1728]; Institute for Information and Communications Technology Promotion; Korea government [B0132-15-1003]; National Research Foundation of Korea; Ministry of Science, ICT and Future Planning [NRF-2015R1C1A1A01055224]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology RD Project; Institute for Information and Communications Technology Promotion; Korea government(Korean Government); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	We acknowledge support from the National Research Foundation of Korea (grants NRF-2014R1A1A1007162 and NRF-2016H1A2A1908670). This research was partially supported by a grant from the Korea Health Technology R&D Project (grant HI17C1728), and by a grant from the Institute for Information and Communications Technology Promotion, funded by the Korea government (grant B0132-15-1003, 'The development of skin adhesive patches for the monitoring and prediction of mental disorders'). S.H.B. was partially supported by the National Research Foundation of Korea, funded by the Ministry of Science, ICT and Future Planning (grant NRF-2015R1C1A1A01055224). We thank D. G. Jo for animal experiments.	Afferrante L, 2013, TRIBOL LETT, V52, P439, DOI 10.1007/s11249-013-0227-6; Bullock J. M. R, 2010, BIOMECHANICS FIBRILL; Chen Y, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0273; Choi SJ, 2004, J AM CHEM SOC, V126, P7744, DOI 10.1021/ja048972k; Heepe L, 2011, J R SOC INTERFACE, V8, P585, DOI 10.1098/rsif.2010.0420; Jeong HE, 2009, P NATL ACAD SCI USA, V106, P5639, DOI 10.1073/pnas.0900323106; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kovalev AE, 2012, SOFT MATTER, V8, P7560, DOI 10.1039/c2sm25431j; Laulicht B, 2012, P NATL ACAD SCI USA, V109, P18803, DOI 10.1073/pnas.1216071109; Lee SB, 2015, BIOMACROMOLECULES, V16, P2265, DOI 10.1021/acs.biomac.5b00451; Rose S, 2014, NATURE, V505, P382, DOI 10.1038/nature12806; Smith AM, 1996, J EXP BIOL, V199, P949; Tramacere F, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0050; Tramacere F, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0816; Tramacere F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065074; White JD, 2011, MACROMOLECULES, V44, P5085, DOI 10.1021/ma201044x; Xue LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7621; Yang SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2715; Yoo PJ, 2004, CHEM MATER, V16, P5000, DOI 10.1021/cm049068u; Zhao Q, 2016, NAT MATER, V15, P407, DOI [10.1038/NMAT4539, 10.1038/nmat4539]	20	250	260	70	539	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					396	+		10.1038/nature22382	http://dx.doi.org/10.1038/nature22382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617467				2022-12-28	WOS:000403250900033
J	Russell-Jones, R				Russell-Jones, Robin			Air pollution in the UK: better ways to solve the problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Russell-Jones, Robin] Help Rescue Planet, Stoke Poges, Bucks, England		Russell-Jones, R (corresponding author), Help Rescue Planet, Stoke Poges, Bucks, England.	info@robinrussell-jones.com			Ebsworth Enterprises, a limited company	Ebsworth Enterprises, a limited company	I have read and understood BMJ policy on declaration of interests and declare that I am on the board of Ebsworth Enterprises, a limited company dedicated to developing and funding environmentally friendly technologies. I was involved with the Campaign for Lead-Free Air from 1981 to 1989. I am the author of a book on society's attitude to the environment throughout history (The Gilgamesh Gene).	[Anonymous], 2014, WHOHISHISGHE20147; Defra, 2015, DRAFT PLANS IMPR AIR; Department for Environment Food and Rural Affairs Department for Transport, 2017, TACKL NITR DIOX OUT; European Environment Agency, 2016, AIR QUAL EUR 2016 RE; INRIX, 2016, GLOB TRAFF SCOR; International Monetary Fund, 2015, IMF SURV COUNT COST; Lawson D, 2015, SUNDAY TIMES; Majewski WA, 2001, DIESELNET TECHNOLOGY; Margolis AE, 2016, J CHILD PSYCHOL PSYC, V57, P851, DOI 10.1111/jcpp.12548; NICE, 2016, AIR POLL OUTD AIR QU; Perera F, 2014, J PUBLIC HEALTH POL, V35, P327, DOI 10.1057/jphp.2014.14; Peterson BS, 2015, JAMA PSYCHIAT, V72, P531, DOI 10.1001/jamapsychiatry.2015.57; Pubic Health England, 2010, COMEAP 2010 MORT EFF; Ridley M., 2017, TIMES, P26; Rohde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135749; Russell-Jones R., 2015, FINANCIAL TIMES; Russell-Jones Robin, 2016, BMJ, V355, pi6726, DOI 10.1136/bmj.i6726; The Institution of Environmental Sciences, 2017, NEW CLEAN AIR ACT WH; Wood HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0109121	19	4	4	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2713	10.1136/bmj.j2713	http://dx.doi.org/10.1136/bmj.j2713			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28615170				2022-12-28	WOS:000403753800006
J	Lian, Z; Bhawal, BN; Yu, P; Morandi, B				Lian, Zhong; Bhawal, Benjamin N.; Yu, Peng; Morandi, Bill			Palladium-catalyzed carbon-sulfur or carbon-phosphorus bond metathesis by reversible arylation	SCIENCE			English	Article							ARYL SULFIDES; C-S; ACTIVATION; REAGENTS; INTERCHANGE; EFFICIENT; CLEAVAGE; EXCHANGE	Compounds bearing aryl-sulfur and aryl-phosphorus bonds have found numerous applications in drug development, organic materials, polymer science, and homogeneous catalysis. We describe palladium-catalyzed metathesis reactions of both compound classes, each of which proceeds through a reversible arylation manifold. The synthetic power and immediate utility of this approach are demonstrated in several applications that would be challenging to achieve by means of traditional cross-coupling methods. The C(sp(2))-S bond metathesis protocol was used in the depolymerization of a commercial thermoplastic polymer and in the late-stage derivatization of a drug. The C(sp(2))-P variant led to the convenient preparation of a variety of phosphorus heterocycles, including a potential chiral ligand and fluorescent organic materials, via a ring-closing transformation.	[Lian, Zhong; Bhawal, Benjamin N.; Yu, Peng; Morandi, Bill] Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany	Max Planck Society	Morandi, B (corresponding author), Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany.	morandi@kofo.mpg.de		Lian, Zhong/0000-0003-2533-3066; Bhawal, Benjamin Niladri/0000-0002-8552-1547; Morandi, Bill/0000-0003-3968-1424	Carlsberg Foundation; Leverhulme Trust; China Scholarship Council; Max Planck Society; Max-Planck-Institut fur Kohlenforschung; Otto Rohm Gedachtnisstiftung; Fonds der Chemischen Industrie	Carlsberg Foundation(Carlsberg Foundation); Leverhulme Trust(Leverhulme Trust); China Scholarship Council(China Scholarship Council); Max Planck Society(Max Planck SocietyFoundation CELLEX); Max-Planck-Institut fur Kohlenforschung; Otto Rohm Gedachtnisstiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Supported by a Carlsberg Foundation fellowship (Z.L.), a Leverhulme Trust fellowship (B.N.B.), a China Scholarship Council fellowship (P.Y.), the Max Planck Society, the Max-Planck-Institut fur Kohlenforschung, the Otto Rohm Gedachtnisstiftung, and Fonds der Chemischen Industrie. We thank R. H. Grubbs and Z. K. Wickens for critical proofreading, our MS and HPLC departments for technical assistance, B. List and H. Tuysuz for sharing analytical equipment, K. Chen for technical assistance with UV/Vis and PL spectrophotometry, and X. Zhang for helpful discussions. Experimental procedures, optimization data, UV/Vis data, chiral HPLC data, <SUP>1</SUP>H NMR spectra, <SUP>13</SUP>C NMR spectra, and MS data are available in the supplementary materials. Z.L., B.N.B., P.Y., and B.M. are inventors on patent application DE102017203746.6 submitted by the Studiengesellschaft Kohle mbH that covers catalytic C-X bond metathesis reactions through reversible arylation.	ABATJOGLOU AG, 1984, ORGANOMETALLICS, V3, P932, DOI 10.1021/om00084a019; Arisawa M, 2008, PURE APPL CHEM, V80, P993, DOI 10.1351/pac200880050993; Baba K, 2013, ANGEW CHEM INT EDIT, V52, P11892, DOI 10.1002/anie.201307115; Baker EL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11554; BARANANO D, 1995, J AM CHEM SOC, V117, P2937, DOI 10.1021/ja00115a033; Barbero N, 2012, ORG LETT, V14, P796, DOI 10.1021/ol2033306; Baumgartner T, 2006, CHEM REV, V106, P4681, DOI 10.1021/cr040179m; Baumgartner T, 2014, ACCOUNTS CHEM RES, V47, P1613, DOI 10.1021/ar500084b; Beletskaya IP, 2011, CHEM REV, V111, P1596, DOI 10.1021/cr100347k; Bell CM, 2007, ANGEW CHEM INT EDIT, V46, P761, DOI 10.1002/anie.200603588; BERTRAND G, 1994, CHEM REV, V94, P1161, DOI 10.1021/cr00029a600; Boyd DA, 2016, ANGEW CHEM INT EDIT, V55, P15486, DOI 10.1002/anie.201604615; Cornella J, 2014, CHEM SOC REV, V43, P8081, DOI 10.1039/c4cs00206g; Crabtree RH, 2015, CHEM REV, V115, P127, DOI 10.1021/cr5004375; Enthaler S, 2014, ANGEW CHEM INT EDIT, V53, P2716, DOI 10.1002/anie.201309299; Fernandez-Rodriguez MA, 2006, CHEM-EUR J, V12, P7782, DOI 10.1002/chem.200600949; Furstner A, 2000, ANGEW CHEM INT EDIT, V39, P3012; GOEL AB, 1984, INORG CHIM A-ART LET, V86, pL77, DOI 10.1016/S0020-1693(00)83758-5; Goodson FE, 1997, J AM CHEM SOC, V119, P12441, DOI 10.1021/ja972554g; Grubbs R. H., 2003, HDB METATHESIS; Haibach MC, 2012, ACCOUNTS CHEM RES, V45, P947, DOI 10.1021/ar3000713; Hartwig J. F., 2009, ORGANOTRANSITION MET, P668; Hie L, 2015, NATURE, V524, P79, DOI 10.1038/nature14615; Hwang LK, 2005, ANGEW CHEM INT EDIT, V44, P6166, DOI 10.1002/anie.200501582; Ilardi EA, 2014, J MED CHEM, V57, P2832, DOI 10.1021/jm401375q; Johnson T. W., 1984, U. S. Patent, Patent No. 4426500; Kasahara T, 2014, ANGEW CHEM INT EDIT, V53, P9637, DOI 10.1002/anie.201405594; Kwong FY, 2001, J AM CHEM SOC, V123, P8864, DOI 10.1021/ja005875s; Kwong FY, 2000, CHEM COMMUN, P1069, DOI 10.1039/b002656p; Ludwig JR, 2016, NATURE, V533, P374, DOI 10.1038/nature17432; Ma LN, 2016, ANGEW CHEM INT EDIT, V55, P10410, DOI 10.1002/anie.201604349; Marcoux D, 2008, J ORG CHEM, V73, P590, DOI 10.1021/jo702355c; Pan F, 2014, ACS CATAL, V4, P280, DOI 10.1021/cs400985m; Rahate AS, 2013, REV CHEM ENG, V29, P471, DOI 10.1515/revce-2012-0021; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Stolar M, 2014, CHEM-ASIAN J, V9, P1212, DOI 10.1002/asia.201301670; Sugahara T, 2014, ANGEW CHEM INT EDIT, V53, P9329, DOI 10.1002/anie.201404355; Vinogradova EV, 2015, NATURE, V526, P687, DOI 10.1038/nature15739; Wagner AM, 2014, J ORG CHEM, V79, P2263, DOI 10.1021/jo402567b; Wang CS, 2012, B CHEM SOC JPN, V85, P136, DOI 10.1246/bcsj.20110255; Wauters I, 2014, BEILSTEIN J ORG CHEM, V10, P1064, DOI 10.3762/bjoc.10.106; WENKERT E, 1979, J CHEM SOC CHEM COMM, P637, DOI 10.1039/c39790000637; Wurz RP, 2005, J AM CHEM SOC, V127, P12234, DOI 10.1021/ja053277d; Xie JH, 2008, ACCOUNTS CHEM RES, V41, P581, DOI 10.1021/ar700137z; Yavari K, 2013, CHEM-EUR J, V19, P9939, DOI 10.1002/chem.201300844	45	141	141	7	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1059	1063		10.1126/science.aam9041	http://dx.doi.org/10.1126/science.aam9041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596362				2022-12-28	WOS:000402871700050
J	Berwick, DM				Berwick, Donald M.			ESSAY Understanding the American healthcare reform debate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, Cambridge, MA 02138 USA.	dberwick@ihi.org							0	3	3	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2017	357								j2718	10.1136/bmj.j2718	http://dx.doi.org/10.1136/bmj.j2718			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RC	28592416				2022-12-28	WOS:000403221400003
J	Chew, EY				Chew, Emily Y.			Dietary Intake of Omega-3 Fatty Acids From Fish and Risk of Diabetic Retinopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; FATTY-ACIDS; MEDITERRANEAN DIET		[Chew, Emily Y.] NEI, Div Epidemiol & Clin Applicat, Clin Trials Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chew, EY (corresponding author), NIH, 10 Ctr Dr,MSC 1204, Bethesda, MD 20892 USA.	echew@nei.nih.gov			Intramural NIH HHS [Z99 EY999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Burckhardt M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009002.pub3; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Diaz-Lopez A, 2015, DIABETES CARE, V38, P2134, DOI 10.2337/dc15-1117; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, P151, DOI 10.1161/01.ATV.0000057393.97337.AE; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Sala-Vila A, 2016, JAMA OPHTHALMOL, V134, P1142, DOI 10.1001/jamaophthalmol.2016.2906; Sapieha P, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.10	10	7	7	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2226	2227		10.1001/jama.2017.1926	http://dx.doi.org/10.1001/jama.2017.1926			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586878	Green Accepted			2022-12-28	WOS:000402706100018
J	Burki, TK				Burki, Talha Khan			Medical research in the UK party manifestos	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2180	2180		10.1016/S0140-6736(17)31542-8	http://dx.doi.org/10.1016/S0140-6736(17)31542-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589886				2022-12-28	WOS:000402540800014
J	Lane, R				Lane, Richard			Elizabeth Mayer-Davis: leader in adolescent diabetes	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2184	2184		10.1016/S0140-6736(17)31493-9	http://dx.doi.org/10.1016/S0140-6736(17)31493-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589888				2022-12-28	WOS:000402540800017
J	[Anonymous]				[Anonymous]			Diabetes: a dynamic disease	LANCET			English	Editorial Material																			0	21	22	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2163	2163		10.1016/S0140-6736(17)31537-4	http://dx.doi.org/10.1016/S0140-6736(17)31537-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589879				2022-12-28	WOS:000402540800002
J	Li, LX; Geraghty, OC; Mehta, Z; Rothwell, PM				Li, Linxin; Geraghty, Olivia C.; Mehta, Ziyah; Rothwell, Peter M.		Oxford Vasc Study	Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study	LANCET			English	Article							LOW-DOSE ASPIRIN; ACUTE CORONARY SYNDROMES; PROTON PUMP INHIBITORS; ISCHEMIC-STROKE; CLOPIDOGREL; PREVENTION; METAANALYSIS; HEMORRHAGE; MORTALITY; THERAPY	Background Lifelong antiplatelet treatment is recommended after ischaemic vascular events, on the basis of trials done mainly in patients younger than 75 years. Upper gastrointestinal bleeding is a serious complication, but had low case fatality in trials of aspirin and is not generally thought to cause long-term disability. Consequently, although co-prescription of proton-pump inhibitors (PPIs) reduces upper gastrointestinal bleeds by 70-90%, uptake is low and guidelines are conflicting. We aimed to assess the risk, time course, and outcomes of bleeding on antiplatelet treatment for secondary prevention in patients of all ages. Methods We did a prospective population-based cohort study in patients with a first transient ischaemic attack, ischaemic stroke, or myocardial infarction treated with antiplatelet drugs (mainly aspirin based, without routine PPI use) after the event in the Oxford Vascular Study from 2002 to 2012, with follow-up until 2013. We determined type, severity, outcome (disability or death), and time course of bleeding requiring medical attention by face-to-face follow-up for 10 years. We estimated age-specific numbers needed to treat (NNT) to prevent upper gastrointestinal bleeding with routine PPI co-prescription on the basis of Kaplan-Meier risk estimates and relative risk reduction estimates from previous trials. Findings 3166 patients (1582 [50%] aged >= 75 years) had 405 first bleeding events (n=218 gastrointestinal, n=45 intracranial, and n=142 other) during 13 509 patient-years of follow-up. Of the 314 patients (78%) with bleeds admitted to hospital, 117 (37%) were missed by administrative coding. Risk of non-major bleeding was unrelated to age, but major bleeding increased steeply with age (>= 75 years hazard ratio [HR] 3.10, 95% CI 2.27-4.24; p<0.0001), particularly for fatal bleeds (5.53, 2.65-11.54; p<0.0001), and was sustained during long-term follow-up. The same was true of major upper gastrointestinal bleeds (>= 75 years HR 4.13, 2.60-6.57; p<0.0001), particularly if disabling or fatal (10.26, 4.37-24.13; p<0.0001). At age 75 years or older, major upper gastrointestinal bleeds were mostly disabling or fatal (45 [62%] of 73 patients vs 101 [47%] of 213 patients with recurrent ischaemic stroke), and outnumbered disabling or fatal intracerebral haemorrhage (n=45 vs n=18), with an absolute risk of 9.15 (95% CI 6.67-12.24) per 1000 patient-years. The estimated NNT for routine PPI use to prevent one disabling or fatal upper gastrointestinal bleed over 5 years fell from 338 for individuals younger than 65 years, to 25 for individuals aged 85 years or older. Interpretation In patients receiving aspirin-based antiplatelet treatment without routine PPI use, the long-term risk of major bleeding is higher and more sustained in older patients in practice than in the younger patients in previous trials, with a substantial risk of disabling or fatal upper gastrointestinal bleeding. Given that half of the major bleeds in patients aged 75 years or older were upper gastrointestinal, the estimated NNT for routine PPI use to prevent such bleeds is low, and co-prescription should be encouraged.	[Li, Linxin; Geraghty, Olivia C.; Mehta, Ziyah; Rothwell, Peter M.; Oxford Vasc Study] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Ctr Prevent Stroke & Dementia, Oxford OX3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Ctr Prevent Stroke & Dementia, Oxford OX3 9DU, England.	peter.rothwell@ndcn.ox.ac.uk	Rothwell, Peter/ABE-5913-2020; Li, Linxin/AAB-7774-2020	Rothwell, Peter/0000-0001-9739-9211; Li, Linxin/0000-0002-3636-8355	Wellcome Trust; Wolfson Foundation; British Heart Foundation; Dunhill Medical Trust; National Institute of Health Research (NIHR); NIHR Oxford Biomedical Research Centre; NIHR Senior Investigator Award; Wellcome Trust Senior Investigator Award	Wellcome Trust(Wellcome TrustEuropean Commission); Wolfson Foundation; British Heart Foundation(British Heart Foundation); Dunhill Medical Trust(Dunhill Medical Trust); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Senior Investigator Award; Wellcome Trust Senior Investigator Award(Wellcome Trust)	Wellcome Trust, Wolfson Foundation, British Heart Foundation, Dunhill Medical Trust, National Institute of Health Research (NIHR), and the NIHR Oxford Biomedical Research Centre.; The Oxford Vascular Study has been funded by Wellcome Trust, Wolfson Foundation, British Heart Foundation, Dunhill Medical Trust, National Institute of Health Research (NIHR), and the NIHR Oxford Biomedical Research Centre. PMR is in receipt of an NIHR Senior Investigator Award and a Wellcome Trust Senior Investigator Award.	Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Altman DG, 1999, BMJ-BRIT MED J, V319, P1492; [Anonymous], BR J CARDIOL; Asberg S, 2013, INT J STROKE, V8, P80, DOI 10.1111/j.1747-4949.2011.00718.x; Bhatt DL, 2008, CIRCULATION, V118, P1891; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Soriano LC, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00126; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; de Jong HJI, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003044; Ducrocq G, 2010, EUR HEART J, V31, P1257, DOI 10.1093/eurheartj/ehq021; Dumbleton JS, 2015, EBIOMEDICINE, V2, P1200, DOI 10.1016/j.ebiom.2015.07.012; Garcia Rodriguez LA, 2016, PLOS ONE, V11; Gomm W, 2016, JAMA NEUROL, V73, P410, DOI 10.1001/jamaneurol.2015.4791; Greenwald DA, 2004, AM J MED S5A, V117, p8S; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lambert AA, 2015, PLOS ONE, V10; Lovelock CE, 2007, LANCET NEUROL, V6, P487, DOI 10.1016/S1474-4422(07)70107-2; Merino EM, 2013, AM J CARDIOL, V112, P1075, DOI 10.1016/j.amjcard.2013.05.051; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Mo C, 2015, WORLD J GASTROENTERO, V21, P5382, DOI 10.3748/wjg.v21.i17.5382; Moayyedi P, 2012, NAT REV GASTRO HEPAT, V9, P132, DOI 10.1038/nrgastro.2011.272; Othman F, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5813; Park CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112558; Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Soriano LC, 2013, THROMB HAEMOSTASIS, V110, P1298; Steinhubl SR, 2007, AM HEART J, V154, P3, DOI 10.1016/j.ahj.2007.04.009; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005; Yang G, 2005, J AM COLL CARDIOL, V46, P1490, DOI 10.1016/j.jacc.2005.06.072; Yusuf S, 2001, NEW ENGL J MED, V345, P494	36	213	223	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					490	499		10.1016/S0140-6736(17)30770-5	http://dx.doi.org/10.1016/S0140-6736(17)30770-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28622955	Green Published, hybrid			2022-12-28	WOS:000406463400030
J	James, ND; de Bono, JS; Spears, MR; Clarke, NW; Mason, MD; Dearnaley, DP; Ritchie, AWS; Amos, CL; Gilson, C; Jones, RJ; Matheson, D; Miliman, R; Attard, G; Chowdhury, S; Cross, WR; Gillessen, S; Parker, CC; Russell, JM; Berthold, DR; Brawley, C; Adab, F; Aung, S; Birtle, AJ; Bowen, J; Brock, S; Chakraborti, P; Ferguson, C; Gale, J; Gray, E; Hingorani, M; Hoskin, PJ; Lester, JF; Malik, ZI; McKinna, F; McPhail, N; Money-Kyrle, J; O'Sullivan, J; Parikh, O; Protheroe, A; Robinson, A; Srihari, NN; Thomas, C; Wagstaff, J; Wylie, J; Zarkar, A; Parmar, MKB; Sydes, MR				James, N. D.; de Bono, J. S.; Spears, M. R.; Clarke, N. W.; Mason, M. D.; Dearnaley, D. P.; Ritchie, A. W. S.; Amos, C. L.; Gilson, C.; Jones, R. J.; Matheson, D.; Miliman, R.; Attard, G.; Chowdhury, S.; Cross, W. R.; Gillessen, S.; Parker, C. C.; Russell, J. M.; Berthold, D. R.; Brawley, C.; Adab, F.; Aung, S.; Birtle, A. J.; Bowen, J.; Brock, S.; Chakraborti, P.; Ferguson, C.; Gale, J.; Gray, E.; Hingorani, M.; Hoskin, P. J.; Lester, J. F.; Malik, Z. I.; McKinna, F.; McPhail, N.; Money-Kyrle, J.; O'Sullivan, J.; Parikh, O.; Protheroe, A.; Robinson, A.; Srihari, N. N.; Thomas, C.; Wagstaff, J.; Wylie, J.; Zarkar, A.; Parmar, M. K. B.; Sydes, M. R.		STAMPEDE Investigators	Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ZOLEDRONIC ACID; PLUS PREDNISONE; STAMPEDE TRIAL; CONTROL ARM; OPEN-LABEL; SURVIVAL; MULTISTAGE; DOCETAXEL; MULTIARM	BACKGROUND Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial design. METHODS We randomly assigned patients in a 1: 1 ratio to receive ADT alone or ADT plus abiraterone acetate (1000 mg daily) and prednisolone (5 mg daily) (combination therapy). Local radiotherapy was mandated for patients with node-negative, nonmetastatic disease and encouraged for those with positive nodes. For patients with nonmetastatic disease with no radiotherapy planned and for patients with metastatic disease, treatment continued until radiologic, clinical, or prostate-specific antigen (PSA) progression; otherwise, treatment was to continue for 2 years or until any type of progression, whichever came first. The primary outcome measure was overall survival. The intermediate primary outcome was failure-free survival (treatment failure was defined as radiologic, clinical, or PSA progression or death from prostate cancer). RESULTS A total of 1917 patients underwent randomization from November 2011 through January 2014. The median age was 67 years, and the median PSA level was 53 ng per milliliter. A total of 52% of the patients had metastatic disease, 20% had node-positive or node-indeterminate nonmetastatic disease, and 28% had node-negative, nonmetastatic disease; 95% had newly diagnosed disease. The median follow-up was 40 months. There were 184 deaths in the combination group as compared with 262 in the ADT-alone group (hazard ratio, 0.63; 95% confidence interval [CI], 0.52 to 0.76; P<0.001); the hazard ratio was 0.75 in patients with nonmetastatic disease and 0.61 in those with metastatic disease. There were 248 treatment-failure events in the combination group as compared with 535 in the ADT-alone group (hazard ratio, 0.29; 95% CI, 0.25 to 0.34; P<0.001); the hazard ratio was 0.21 in patients with nonmetastatic disease and 0.31 in those with metastatic disease. Grade 3 to 5 adverse events occurred in 47% of the patients in the combination group (with nine grade 5 events) and in 33% of the patients in the ADT-alone group (with three grade 5 events). CONCLUSIONS Among men with locally advanced or metastatic prostate cancer, ADT plus abiraterone and prednisolone was associated with significantly higher rates of overall and failure-free survival than ADT alone.	[James, N. D.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Zarkar, A.] Univ Hosp Birmingham, Birmingham, W Midlands, England; [de Bono, J. S.; Dearnaley, D. P.; Attard, G.] Inst Canc Res, London, England; [Spears, M. R.; Amos, C. L.; Gilson, C.; Brawley, C.; Parmar, M. K. B.; Sydes, M. R.] UCL, MRC, Clin Trials Unit, London, England; [Chowdhury, S.] Kings Coll London, London, England; [Chowdhury, S.] Guys & St Thomas NHS Fdn Trust, London, England; [Parker, C. C.] Royal Marsden NHS Fdn Trust, London, England; [Clarke, N. W.] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Mason, M. D.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Lester, J. F.] Velindre Canc Ctr, Cardiff, S Glam, Wales; [Ritchie, A. W. S.] Gloucestershire Royal Hosp, Gloucester, England; [Bowen, J.] Gloucestershire Hosp NHS Fdn Trust, Gloucester, England; [Jones, R. J.; Russell, J. M.] Univ Glasgow, Glasgow, Lanark, Scotland; [Cross, W. R.] St James Univ Hosp, Leeds, W Yorkshire, England; [Adab, F.] Univ Hosp North Midlands, Stoke On Trent, Staffs, England; [Aung, S.] Royal Devon & Exeter Hosp NHS Fdn Trust Exeter, Exeter, Devon, England; [Birtle, A. J.] Royal Preston Hosp, Rosemere Canc Ctr, Preston, Lancs, England; [Brock, S.] Poole Hosp, Dorset Canc Ctr, Poole, Dorset, England; [Chakraborti, P.] Royal Derby Hosp, Derby, England; [Ferguson, C.] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Gale, J.] Queen Alexandra Hosp, Portsmouth Oncol Ctr, Portsmouth, Hants, England; [Gray, E.] Musgrove Pk Hosp, Taunton, Somerset, England; [Hingorani, M.] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England; [Hoskin, P. J.] Mt Vernon Canc Ctr, Northwood, Middx, England; [Malik, Z. I.] Clatterbridge Canc Ctr, Wirral, Merseyside, England; [McKinna, F.] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Robinson, A.] Royal Sussex Cty Hosp, Sussex Canc Ctr, Brighton, E Sussex, England; [McPhail, N.] NHS Highland, Inverness, Scotland; [Money-Kyrle, J.] Royal Surrey Cty Hosp, Guildford, Surrey, England; [O'Sullivan, J.] Northern Ireland Canc & Queens Univ, Belfast, Antrim, North Ireland; [Parikh, O.] Lancashire Teaching Hosp NHS Trust, Preston, Lancs, England; [Protheroe, A.] Churchill Hosp, Oxford, England; [Srihari, N. N.] Shrewsbury & Telford Hosp NHS Trust, Shrewsbury, Salop, England; [Thomas, C.] East Kent Hosp NHS Trust, Canterbury, Kent, England; [Wagstaff, J.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Wylie, J.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Gillessen, S.] Kantonsspital St Gallen, Dept Med Oncol, St Gallen, Switzerland; [Berthold, D. R.] Univ Lausanne Hosp, Lausanne, Switzerland	University of Birmingham; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Salford Royal NHS Foundation Trust; Cardiff University; Velindre Cancer Centre; Gloucestershire Royal Hospital; Gloucestershire Hospitals NHS Foundation Trust; University of Glasgow; Saint James's University Hospital; Royal Preston Hospital; Poole Hospital; University of Nottingham; Weston Park Hospital; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Musgrove Park Hospital; Mount Vernon Cancer Centre; Clatterbridge Cancer Centre; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Brighton; Royal Surrey County Hospital; University of Oxford; Swansea University; Christie NHS Foundation Trust; Kantonsspital St. Gallen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	James, ND (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England.	mrcctu.stampede_publications@ucl.ac.uk	Hingorani, M./AAQ-3416-2020; Sydes, Matthew/C-3373-2008; James, Nick/AAL-6802-2020; Dearnaley, David P/J-2318-2014; Mason, Malcolm D/H-6979-2013; Gillessen, Silke/C-6093-2019	Hingorani, M./0000-0003-4877-5174; Sydes, Matthew/0000-0002-9323-1371; Dearnaley, David P/0000-0002-3954-2806; Wagstaff, John/0000-0002-1140-5981; de Bono, Johann S/0000-0002-2034-595X; O'Sullivan, Joe/0000-0001-6999-2739; Hoskin, Peter/0000-0001-8323-9567; Gillessen, Silke/0000-0001-5746-6555; James, Nicholas/0000-0002-7314-8204; Brawley, Christopher/0000-0003-3641-278X	Cancer Research U.K.; Cancer Research UK [3804] Funding Source: researchfish; Medical Research Council [MC_UU_12023/25] Funding Source: researchfish	Cancer Research U.K.(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by Cancer Research U.K. and others; STAMPEDE ClinicalTrials.gov number, NCT00268476, and Current Controlled Trials number, ISRCTN78818544.	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Barthel FMS, 2009, STATA J, V9, P505, DOI 10.1177/1536867X0900900401; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Fitzpatrick JM, 2014, EUR UROL, V65, P1198, DOI 10.1016/j.eururo.2013.07.022; Fizazi K, 2017, NEW ENGL J MED, V377, P352, DOI 10.1056/NEJMoa1704174; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Gravis G, 2016, EUR UROL, V70, P256, DOI 10.1016/j.eururo.2015.11.005; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; James ND, 2016, JAMA ONCOL, V2, P348, DOI 10.1001/jamaoncol.2015.4350; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; James ND, 2009, BJU INT, V103, P464, DOI 10.1111/j.1464-410X.2008.08034.x; James ND, 2015, EUR UROL, V67, P1028, DOI 10.1016/j.eururo.2014.09.032; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Mason MD, 2017, J CLIN ONCOL, V35, P1530, DOI 10.1200/JCO.2016.69.0677; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Parmar MKB, 2008, JNCI-J NATL CANCER I, V100, P1204, DOI 10.1093/jnci/djn267; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ryan CJ, 2015, LANCET ONCOL, V16, P152, DOI 10.1016/S1470-2045(14)71205-7; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Sydes M.R., 2011, TRIALS, Vvol. 12, pA3; Sydes MR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-168; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Vale CL, 2016, LANCET ONCOL, V17, P243, DOI 10.1016/S1470-2045(15)00489-1	29	958	973	2	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					338	351		10.1056/NEJMoa1702900	http://dx.doi.org/10.1056/NEJMoa1702900			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28578639	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000406295000006
J	Gates, SN; Yokom, AL; Lin, J; Jackrel, ME; Rizo, AN; Kendsersky, NM; Buell, CE; Sweeny, EA; Mack, KL; Chuang, E; Torrente, MP; Su, M; Shorter, J; Southworth, DR				Gates, Stephanie N.; Yokom, Adam L.; Lin, JiaBei; Jackrel, Meredith E.; Rizo, Alexandrea N.; Kendsersky, Nathan M.; Buell, Courtney E.; Sweeny, Elizabeth A.; Mack, Korrie L.; Chuang, Edward; Torrente, Mariana P.; Su, Min; Shorter, James; Southworth, Daniel R.			Ratchet-like polypeptide translocation mechanism of the AAA plus disaggregase Hsp104	SCIENCE			English	Article							PROTEIN DISAGGREGATION; 26S PROTEASOME; INSIGHTS; CLPB; CHAPERONE; HELICASE	Hsp100 polypeptide translocases are conserved members of the AAA+ family (adenosine triphosphatases associated with diverse cellular activities) that maintain proteostasis by unfolding aberrant and toxic proteins for refolding or proteolytic degradation. The Hsp104 disaggregase from Saccharomyces cerevisiae solubilizes stress-induced amorphous aggregates and amyloids. The structural basis for substrate recognition and translocation is unknown. Using a model substrate (casein), we report cryo-electron microscopy structures at near-atomic resolution of Hsp104 in different translocation states. Substrate interactions aremediated by conserved, pore-loop tyrosines that contact an 80-angstrom-long unfolded polypeptide along the axial channel. Two protomers undergo a ratchet-like conformational change that advances pore loop-substrate interactions by two amino acids. These changes are coupled to activation of specific nucleotide hydrolysis sites and, when transmitted around the hexamer, reveal a processive rotary translocation mechanism and substrate-responsive flexibility during Hsp104-catalyzed disaggregation.	[Gates, Stephanie N.; Yokom, Adam L.; Su, Min; Southworth, Daniel R.] Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gates, Stephanie N.; Yokom, Adam L.; Rizo, Alexandrea N.; Southworth, Daniel R.] Univ Michigan, Inst Life Sci, Grad Program Chem Biol, Ann Arbor, MI 48109 USA; [Lin, JiaBei; Jackrel, Meredith E.; Kendsersky, Nathan M.; Buell, Courtney E.; Sweeny, Elizabeth A.; Mack, Korrie L.; Chuang, Edward; Torrente, Mariana P.; Shorter, James] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kendsersky, Nathan M.; Chuang, Edward; Shorter, James] Univ Penn, Pharmacol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mack, Korrie L.; Shorter, James] Univ Penn, Biochem & Mol Biophys Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Torrente, Mariana P.] CUNY Brooklyn Coll, Chem Dept, New York, NY 10016 USA; [Torrente, Mariana P.] CUNY, PhD Program Chem, Grad Ctr, New York, NY 10016 USA; [Torrente, Mariana P.] CUNY, PhD Program Biochem, Grad Ctr, New York, NY 10016 USA; [Torrente, Mariana P.] CUNY, PhD Program Biol, Grad Ctr, New York, NY 10016 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System	Southworth, DR (corresponding author), Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA.; Southworth, DR (corresponding author), Univ Michigan, Inst Life Sci, Grad Program Chem Biol, Ann Arbor, MI 48109 USA.	dsouth@umich.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Kendsersky, Nathan/0000-0003-0132-8748; Jackrel, Meredith/0000-0003-4406-9504; Sweeny, Elizabeth/0000-0001-7818-9112; LIN, JIABEI/0000-0001-8863-1859; Chuang, Edward/0000-0002-6380-7317	American Heart Association (AHA) predoctoral fellowship; Target Amyotrophic Lateral Sclerosis (ALS) Springboard Fellowship; AHA predoctoral fellowship; NIH [T32GM008275, T32GM008076, K12GM081259, K22NS09131401, R01GM099836, R01GM109896, R01GM077430, R01GM110001A]; NSF Graduate Research Fellowship [DGE-1321851]; Muscular Dystrophy Association Research Award [MDA277268]; Life Extension Foundation; Packard Center for ALS Research at Johns Hopkins University; Target ALS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597, R01GM110001, R01GM109896, R01GM099836, K12GM081259, T32GM008275, R01GM077430, T32GM008076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS091314] Funding Source: NIH RePORTER	American Heart Association (AHA) predoctoral fellowship; Target Amyotrophic Lateral Sclerosis (ALS) Springboard Fellowship; AHA predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Muscular Dystrophy Association Research Award(Muscular Dystrophy Association); Life Extension Foundation; Packard Center for ALS Research at Johns Hopkins University(Johns Hopkins University); Target ALS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Smith and L. Rice for discussion of the manuscript and F. DiMaio for help with Rosetta. A.L.Y. is supported by an American Heart Association (AHA) predoctoral fellowship. M.E.J. is supported by a Target Amyotrophic Lateral Sclerosis (ALS) Springboard Fellowship. E.A.S. is supported by an AHA predoctoral fellowship and NIH grant T32GM008275. E.C. is supported by NIH grant T32GM008076. M.P.T. is supported by NIH grants K12GM081259 and K22NS09131401. K.L.M. is supported by an NSF Graduate Research Fellowship (DGE-1321851). J.S. is supported by NIH grant R01GM099836, a Muscular Dystrophy Association Research Award (MDA277268), the Life Extension Foundation, the Packard Center for ALS Research at Johns Hopkins University, and Target ALS. D.R.S. is supported by NIH grants R01GM109896, R01GM077430, and R01GM110001A. Cryo-EM maps and models are deposited in the Electron Microscopy and Protein Data Banks (EMDB and PDB, respectively): Hsp104:casein closed state (EMDB: 8697, PDB: 5VJH), extended state (EMDB: 8746, PDB: 5VYA), and middle-domain conformation (EMDB: 8745, PDB: 5VY9); and Hsp104-ADP (EMDB: 8744, PDB: 5VY8).	Abid Ali Ferdos, 2016, Nat Commun, V7, P10708, DOI 10.1038/ncomms10708; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Heuck A, 2016, ELIFE, V5, DOI 10.7554/eLife.21516; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Li T, 2015, BIOCHEM J, V470, P39, DOI 10.1042/BJ20141457; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lyubimov AY, 2012, P NATL ACAD SCI USA, V109, P11999, DOI 10.1073/pnas.1209406109; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Wehmer M, 2016, INT J BIOCHEM CELL B, V79, P437, DOI 10.1016/j.biocel.2016.08.008; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	27	168	168	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					273	279		10.1126/science.aan1052	http://dx.doi.org/10.1126/science.aan1052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28619716	Green Accepted			2022-12-28	WOS:000405901600034
J	Rossfeld, ZM; Wright, NR				Rossfeld, Zachary M.; Wright, Nathan R.			Hyperammonemia After Blood Transfusion	ANNALS OF INTERNAL MEDICINE			English	Letter							HEPATIC-ENCEPHALOPATHY		[Rossfeld, Zachary M.; Wright, Nathan R.] Ohio State Univ, Columbus, OH 43210 USA	Ohio State University	Rossfeld, ZM (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.		Rossfeld, Zach/GWR-2587-2022					Apushkin M, 2013, TRANSFUS APHER SCI, V49, P459, DOI 10.1016/j.transci.2013.05.002; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Clay AS, 2007, CHEST, V132, P1368, DOI 10.1378/chest.06-2940; Lockwood AH, 2004, METAB BRAIN DIS, V19, P345, DOI 10.1023/B:MEBR.0000043980.74574.eb; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210	5	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					143	144		10.7326/L17-0093	http://dx.doi.org/10.7326/L17-0093			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28605806				2022-12-28	WOS:000405573400026
J	Bayeh, L; Le, PQ; Tambar, UK				Bayeh, Liela; Le, Phong Q.; Tambar, Uttam K.			Catalytic allylic oxidation of internal alkenes to a multifunctional chiral building block	NATURE			English	Article							ACID CATALYSIS; ENE REACTIONS; OLEFINS; AMINATION; FUNCTIONALIZATION; ACETYLENES; REAGENTS; STRATEGY; BONDS	The stereoselective oxidation of hydrocarbons is one of the most notable advances in synthetic chemistry over the past fifty years(1-3). Inspired by nature, enantioselective dihydroxylations, epoxidations and other oxidations of unsaturated hydrocarbons have been developed. More recently, the catalytic enantioselective allylic carbon-hydrogen oxidation of alkenes has streamlined the production of pharmaceuticals, natural products, fine chemicals and other functional materials(4-7). Allylic functionalization provides a direct path to chiral building blocks with a newly formed stereocentre from petrochemical feedstocks while preserving the olefin functionality as a handle for further chemical elaboration. Various metal-based catalysts have been discovered for the enantioselective allylic carbon-hydrogen oxidation of simple alkenes with cyclic or terminal double bonds(8-16). However, a general and selective allylic oxidation using the more common internal alkenes remains elusive. Here we report the enantioselective, regioselective and E/Z-selective allylic oxidation of unactivated internal alkenes via a catalytic hetero-ene reaction with a chalcogen-based oxidant. Our method enables non-symmetric internal alkenes to be selectively converted into allylic functionalized products with high stereoselectivity and regioselectivity. Stereospecific transformations of the resulting multifunctional chiral building blocks highlight the potential for rapidly converting internal alkenes into a broad range of enantioenriched structures that can be used in the synthesis of complex target molecules.	[Bayeh, Liela; Le, Phong Q.; Tambar, Uttam K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Tambar, UK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Uttam.Tambar@utsouthwestern.edu		Romero, Liela/0000-0001-5532-756X; Le, Phong/0000-0003-3259-5136	W. W. Caruth Jr Endowed Scholarship; Robert A. Welch Foundation [I-1748]; National Institutes of Health [R01GM102604]; National Science Foundation CAREER Award [1150875]; Sloan Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102604] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1150875] Funding Source: National Science Foundation	W. W. Caruth Jr Endowed Scholarship; Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Financial support was provided by the W. W. Caruth Jr Endowed Scholarship, the Robert A. Welch Foundation (Grant I-1748), the National Institutes of Health (R01GM102604), the National Science Foundation CAREER Award (1150875), and the Sloan Research Fellowship. We thank V. Lynch for X-ray structural analysis.	Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Andrus M., 2011, STEREOSELECTIVE SYNT; Andrus MB, 2002, J AM CHEM SOC, V124, P8806, DOI 10.1021/ja026266i; Bonini C, 2002, TETRAHEDRON, V58, P4981, DOI 10.1016/S0040-4020(02)00440-4; Collet F, 2011, CHEM SOC REV, V40, P1926, DOI 10.1039/c0cs00095g; Collins KD, 2013, NAT CHEM, V5, P597, DOI [10.1038/NCHEM.1669, 10.1038/nchem.1669]; Covell DJ, 2008, ANGEW CHEM INT EDIT, V47, P6448, DOI 10.1002/anie.200802106; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Eames J, 2001, ANGEW CHEM INT EDIT, V40, P3567, DOI 10.1002/1521-3773(20011001)40:19<3567::AID-ANIE3567>3.0.CO;2-C; Grennberg H., 2008, TRANSITION METALS OR, P243; HORI T, 1978, J ORG CHEM, V43, P1456, DOI 10.1021/jo00401a035; Huang Y, 2003, NATURE, V424, P146, DOI 10.1038/424146a; HUBERT AJ, 1967, J CHEM SOC C, P1984, DOI 10.1039/j39670001984; Ishibashi H, 2002, CHEM REC, V2, P177, DOI 10.1002/tcr.10020; Johannsen M, 1998, CHEM REV, V98, P1689, DOI 10.1021/cr970343o; Johnston JN, 2010, ANGEW CHEM INT EDIT, V49, P2290, DOI 10.1002/anie.200904828; Lauer AM, 2011, J AM CHEM SOC, V133, P9119, DOI 10.1021/ja202954b; Liu GS, 2010, TOP CURR CHEM, V292, P195, DOI 10.1007/128_2009_16; Ojima I., 2010, CATALYTIC ASYMMETRIC; Page P. C. B., 1991, COMPREHENSIVE ORGANI, V7, P83, DOI [DOI 10.1016/B978-0-08-052349-1.00184-0, 10.1016/B978-0-08-052349-1.00184-0]; Ramirez TA, 2012, CHEM SOC REV, V41, P931, DOI 10.1039/c1cs15104e; SCHONBERGER N, 1975, LIEBIGS ANN CHEM, P1725; Sharma A, 2013, J AM CHEM SOC, V135, P17983, DOI 10.1021/ja409995w; SHARPLESS KB, 1976, J AM CHEM SOC, V98, P269, DOI 10.1021/ja00417a062; SHARPLESS KB, 1976, J ORG CHEM, V41, P176, DOI 10.1021/jo00863a051; SHARPLESS KB, 1972, J AM CHEM SOC, V94, P7154, DOI 10.1021/ja00775a050; Surendra K, 2012, J AM CHEM SOC, V134, P11992, DOI 10.1021/ja305851h; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Trost BM, 2015, J AM CHEM SOC, V137, P2776, DOI 10.1021/jacs.5b00786; WHITESELL JK, 1987, J AM CHEM SOC, V109, P2839, DOI 10.1021/ja00243a055; Yamamoto H, 2005, ANGEW CHEM INT EDIT, V44, P1924, DOI 10.1002/anie.200460394; Zalatan DN, 2010, TOP CURR CHEM, V292, P347, DOI 10.1007/128_2009_19	32	48	48	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					196	+		10.1038/nature22805	http://dx.doi.org/10.1038/nature22805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28636605	Green Accepted			2022-12-28	WOS:000405314500034
J	Tyler, DS; Vappiani, J; Caneque, T; Lam, EYN; Ward, A; Gilan, O; Chan, YC; Hienzsch, A; Rutkowska, A; Werner, T; Wagner, AJ; Lugo, D; Gregory, R; Molina, CR; Garton, N; Wellaway, CR; Jackson, S; MacPherson, L; Figueiredo, M; Stolzenburg, S; Bell, CC; House, C; Dawson, SJ; Hawkins, ED; Drewes, G; Prinjha, RK; Rodriguez, R; Grandi, P; Dawson, MA				Tyler, Dean S.; Vappiani, Johanna; Caneque, Tatiana; Lam, Enid Y. N.; Ward, Aoife; Gilan, Omer; Chan, Yih-Chih; Hienzsch, Antje; Rutkowska, Anna; Werner, Thilo; Wagner, Anne J.; Lugo, Dave; Gregory, Richard; Molina, Cesar Ramirez; Garton, Neil; Wellaway, Christopher R.; Jackson, Susan; MacPherson, Laura; Figueiredo, Margarida; Stolzenburg, Sabine; Bell, Charles C.; House, Colin; Dawson, Sarah-Jane; Hawkins, Edwin D.; Drewes, Gerard; Prinjha, Rab K.; Rodriguez, Raphal; Grandi, Paola; Dawson, Mark A.			Click chemistry enables preclinical evaluation of targeted epigenetic therapies	SCIENCE			English	Article							BET BROMODOMAIN INHIBITION; ACUTE MYELOID-LEUKEMIA; BRD4; RECRUITMENT; SELECTIVITY; CHROMATIN; PROTEINS; PROBES; DRUGS; CELLS	The success of new therapies hinges on our ability to understand their molecular and cellular mechanisms of action. We modified BET bromodomain inhibitors, an epigenetic-based therapy, to create functionally conserved compounds that are amenable to click chemistry and can be used as molecular probes in vitro and in vivo. We used click proteomics and click sequencing to explore the gene regulatory function of BRD4 (bromodomain containing protein 4) and the transcriptional changes induced by BET inhibitors. In our studies of mouse models of acute leukemia, we used high-resolution microscopy and flow cytometry to highlight the heterogeneity of drug activity within tumor cells located in different tissue compartments. We also demonstrate the differential distribution and effects of BET inhibitors in normal and malignant cells in vivo. This study provides a potential framework for the preclinical assessment of a wide range of drugs.	[Tyler, Dean S.; Lam, Enid Y. N.; Gilan, Omer; Chan, Yih-Chih; Jackson, Susan; MacPherson, Laura; Figueiredo, Margarida; Stolzenburg, Sabine; Bell, Charles C.; House, Colin; Dawson, Sarah-Jane; Dawson, Mark A.] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia; [Tyler, Dean S.; Lam, Enid Y. N.; Gilan, Omer; MacPherson, Laura; Bell, Charles C.; Dawson, Sarah-Jane; Dawson, Mark A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Vappiani, Johanna; Ward, Aoife; Rutkowska, Anna; Werner, Thilo; Wagner, Anne J.; Drewes, Gerard; Grandi, Paola] GlaxoSmithKline, Cellzome GmbH, Meyerhofstr 1, Heidelberg, Germany; [Caneque, Tatiana; Hienzsch, Antje; Rodriguez, Raphal] Paris Sci & Lettres Res Univ, Inst Curie, Chem Cell Biol Grp, 26 Rue Ulm, F-75248 Paris 05, France; [Caneque, Tatiana; Hienzsch, Antje; Rodriguez, Raphal] CNRS, UMR3666, F-75005 Paris, France; [Caneque, Tatiana; Hienzsch, Antje; Rodriguez, Raphal] INSERM, U1143, F-75005 Paris, France; [Lugo, Dave; Gregory, Richard; Molina, Cesar Ramirez; Garton, Neil; Wellaway, Christopher R.; Prinjha, Rab K.] GlaxoSmithKline, Epigenet Discovery Performance Unit, Immunoinflammat Therapy Area Unit, Stevenage, Herts, England; [Dawson, Sarah-Jane; Dawson, Mark A.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Hawkins, Edwin D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Dawson, Mark A.] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; GlaxoSmithKline; Cellzome GmbH; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GlaxoSmithKline; University of Melbourne; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center	Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.; Grandi, P (corresponding author), GlaxoSmithKline, Cellzome GmbH, Meyerhofstr 1, Heidelberg, Germany.; Dawson, MA (corresponding author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia.	paola.x.grandi@gsk.com; mark.dawson@petermac.org	Dawson, Mark A/B-9317-2017; Cobo, Tatiana Cañeque/AAA-2675-2020	Dawson, Mark A/0000-0002-5464-5029; Cobo, Tatiana Cañeque/0000-0002-1110-0643; Drewes, Gerard/0000-0003-0575-6766; Vappiani, Johanna/0000-0002-6768-1432; Ward Gahlawat, Aoife/0000-0001-7854-7207; MacPherson, Laura/0000-0003-3422-4478; Dawson, Sarah-Jane/0000-0002-8276-0374; L A Figueiredo, Margarida/0000-0003-4883-9940; Hawkins, Edwin/0000-0002-3686-8261; Wagner, Anne/0000-0001-7078-2878; Bell, Charles/0000-0003-2194-8311; Lam, Enid Yi Ni/0000-0001-5843-7836	National Health and Medical Research Council of Australia [1106444, 1085015, 1106447]; Senior Leukaemia Foundation Australia Fellowship; VESKI Innovation Fellowship; Leukaemia Foundation Australia; Victoria Cancer Agency; European Union [BLUEPRINT/282510]; Emergence Ville de Paris Program; European Research Council under the European Union's Horizon 2020 research and innovation program [647973]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Leukaemia Foundation Australia Fellowship; VESKI Innovation Fellowship; Leukaemia Foundation Australia; Victoria Cancer Agency; European Union(European Commission); Emergence Ville de Paris Program; European Research Council under the European Union's Horizon 2020 research and innovation program	Work in the Dawson laboratory is supported by the National Health and Medical Research Council of Australia (grants 1106444, 1085015, and 1106447 to M.A.D.). M.A.D. is currently supported by a Senior Leukaemia Foundation Australia Fellowship and a VESKI Innovation Fellowship. D.S.T. and O.G. are respectively supported by a Ph.D. scholarship and a postdoctoral fellowship from Leukaemia Foundation Australia. E.Y.N.L. and L.M. are supported by fellowships from the Victoria Cancer Agency. Work performed at Cellzome was supported in part by funding from the European Union (FP7 Project BLUEPRINT/282510). We thank V. Benes and the European Molecular Biology Laboratory GeneCore facility for DNA sequencing. Research in the Rodriguez laboratory is supported by the Emergence Ville de Paris Program and funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement 647973). Reagents JQ1-TCO, JQ1-PA, IBET762-TCO, and IBET151 and plasmids for BRD4 are available from the corresponding authors under a material transfer agreement with Institut Curie, GlaxoSmithKline, and Peter MacCallum Cancer Centre. GlaxoSmithKline holds patent WO 2011054846 A1, which covers IBET151. The ChIP-seq, click-seq, and RNA-seq data are available from the National Center for Biotechnology Information Gene Expression Omnibus repository under accession number GSE88751.	Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Caneque T, 2015, NAT CHEM, V7, P744, DOI [10.1038/NCHEM.2302, 10.1038/nchem.2302]; Dawson MA, 2017, SCIENCE, V355, P1147, DOI 10.1126/science.aam7304; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dittmann A, 2014, ACS CHEM BIOL, V9, P495, DOI 10.1021/cb400789e; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Gilan O, 2016, NAT STRUCT MOL BIOL, V23, P673, DOI 10.1038/nsmb.3249; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Leroy G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r68; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Rodriguez R, 2014, NAT REV GENET, V15, P783, DOI 10.1038/nrg3796; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Rutkowska A, 2016, ACS CHEM BIOL, V11, P2541, DOI 10.1021/acschembio.6b00346; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	21	75	77	4	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1397	1401		10.1126/science.aal2066	http://dx.doi.org/10.1126/science.aal2066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28619718	Green Accepted			2022-12-28	WOS:000404351500042
J	Dharmarajan, K; Qin, L; Bierlein, M; Choi, JES; Lin, ZQ; Desai, NR; Spatz, ES; Krumholz, HM; Venkatesh, AK				Dharmarajan, Kumar; Qin, Li; Bierlein, Maggie; Choi, Jennie E. S.; Lin, Zhenqiu; Desai, Nihar R.; Spatz, Erica S.; Krumholz, Harlan M.; Venkatesh, Arjun K.			Outcomes after observation stays among older adult Medicare beneficiaries in the USA: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; DEPARTMENT OBSERVATION UNIT; EMERGENCY-DEPARTMENT; HEART-FAILURE; READMISSION RATES; OBSERVATION SERVICES; HOSPITAL STRATEGIES; 30-DAY READMISSION; TRANSITIONAL CARE; DISCHARGE	OBJECTIVE To characterize rates and trends over time of emergency department treatment-and-discharge stays, repeat observation stays, inpatient stays, any hospital revisit, and death within 30 days of discharge from observation stays. DESIGN Retrospective cohort study. SETTING 4750 hospitals in the USA. PARTICIPANTS Nationally representative sample of Medicare fee for service beneficiaries aged 65 or over discharged after 363 037 index observation stays, 2 540 000 index emergency department treatment-and-discharge stays, and 2 667 525 index inpatient stays from 2006-11. MAIN OUTCOME MEASURES Rates of emergency department treatment-and-discharge stays, observation stays, inpatient stays, any hospital revisit, and death within 30 days of discharge from index observation stays. Rates were compared with corresponding outcomes within 30 days of discharge from both index emergency department treatment-and-discharge stays and index inpatient stays. RESULTS Among 363 037 index observation stays resulting in discharge from 2006-11, 30 day rates of emergency department treatment-and-discharge stays were 8.4%, repeat observation stays were 2.9%, inpatient stays were 11.2%, any hospital revisit was 20.1%, and death was 1.8%. Of all revisits, 49.7% were for inpatient stays. Revisit rates for emergency department treatment-and-discharge stays, repeat observation stays, and any hospital revisit increased from 2006-11 (P<0.001 for trend), while 30 day rates of inpatient stays (P=0.054 for trend) and 30 day mortality (P=0.091 for trend) were both unchanged. Averaged over the study period, 30 day rates of any hospital revisit were similar after discharge from index emergency department treatment-and-discharge stays (19.9%) and index observation stays (20.1%), as was 30 day mortality (1.8% for both). Rates of any hospital revisit (21.8%) and death (5.2%) were highest after discharge from index inpatient stays. CONCLUSIONS Hospital revisits are common after discharge from observation stays, frequently result in inpatient hospitalizations, and have increased over time among Medicare beneficiaries. As revisit rates are similar after emergency department and observation stays, strategies shown to enhance emergency department transitional care may be reasonable starting points to improve post-observation outcomes.	[Dharmarajan, Kumar; Desai, Nihar R.; Spatz, Erica S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, 333 Cedar St, New Haven, CT 06510 USA; [Qin, Li; Lin, Zhenqiu] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Bierlein, Maggie] United Healthcare, Winooski, VT USA; [Choi, Jennie E. S.] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA; [Venkatesh, Arjun K.] Yale Univ, Sch Med, Dept Emergency Med, 333 Cedar St, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Dharmarajan, K (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, 333 Cedar St, New Haven, CT 06510 USA.	kumar.dharmarajan@yale.edu	, Harlan/AAI-2875-2020		National Institute on Aging [K23AG048331]; American Federation for Aging Research through the Paul B Beeson career development award program; Yale Claude D Pepper Older Americans Independence Center [P30AG021342]; Agency for Healthcare Research and Quality [K12HS023000]; Emergency Medicine Foundation health policy grant; Centers for Medicare & Medicaid innovation transforming clinical practice initiative [1L1CMS333479-01-00]; Emergency Medicine Foundation health policy scholar award; CTSA grant from the National Center for Advancing Translational Science, a component of the National Institutes of Health [UL1TR000142]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862, UL1TR001863] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B Beeson career development award program; Yale Claude D Pepper Older Americans Independence Center; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Emergency Medicine Foundation health policy grant; Centers for Medicare & Medicaid innovation transforming clinical practice initiative; Emergency Medicine Foundation health policy scholar award; CTSA grant from the National Center for Advancing Translational Science, a component of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	KD is supported by grant K23AG048331 from the National Institute on Aging and the American Federation for Aging Research through the Paul B Beeson career development award program. He is also supported by grant P30AG021342 from the Yale Claude D Pepper Older Americans Independence Center. NRD, ESS, and HMK are supported by grant K12HS023000 from the Agency for Healthcare Research and Quality. AKV is supported by an Emergency Medicine Foundation health policy grant to study emergency department and hospital utilization by Medicare beneficiaries and by the Centers for Medicare & Medicaid innovation transforming clinical practice initiative (contract 1L1CMS333479-01-00) for work seeking to improve the use of observation stays and inpatient hospital stays for chest pain. At the time this research was initially performed, AKV was also supported by an Emergency Medicine Foundation health policy scholar award and by CTSA grant UL1TR000142 from the National Center for Advancing Translational Science, a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views or policies of the Department of Health and Human Services, the National Institutes of Health, the American Federation for Aging Research, the Agency for Healthcare Research and Quality, or the National Quality Forum. The funders did not play a role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abbass I, 2015, WEST J EMERG MED, V16, P395, DOI 10.5811/westjem.2015.2.24281; Abbass IM, 2014, CLIN CARDIOL, V37, P591, DOI 10.1002/clc.22319; Abraham J., 2013, SP05 PHUSE; Agency for Healthcare Research and Quality, HCUP METH SER; American College of Emergency Physicians Transitions of Care Task Force, 2012, TRANS CAR TASK FORC; Bradley EH, 2015, J GEN INTERN MED, V30, P605, DOI 10.1007/s11606-014-3105-5; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Cafardi SG, 2016, AM J EMERG MED, V34, P16, DOI 10.1016/j.ajem.2015.08.049; Centers for Medicare and Medicaid Services (CMS), 2015, FED REGISTER, V80, P49325; Centers for Medicare & Medicaid Services, REC AUD PROGR; Centers for Medicare & Medicaid Services, CMS ROADM OV; Centers for Medicare & Medicaid Services, MED HOSP COMP; Centers for Medicare & Medicaid Services, AC INP PPS; Centers for Medicare & Medicaid Services, ORG PROC ORG REP COM; Centers for Medicare & Medicaid Services, STAND AN FIL; Centers for Medicare & Medicaid Services, HOSP OUTP PPS; College of Emergency Medicine, 2013, SYST BENCHM REC; Cooke MW, 2003, EMERG MED J, V20, P138, DOI 10.1136/emj.20.2.138; Cubanski J, 2010, HEALTH AFFAIR, V29, P1725, DOI 10.1377/hlthaff.2009.0962; Department of Health & Human Services, 2005, CMS MAN SYST PUB 100; Dharmarajan K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h411; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Duseja R, 2015, ANN INTERN MED, V162, P750, DOI 10.7326/M14-1616; England NHS, 2013, EV BAS URG EM CAR RE; Feltner C, 2014, ANN INTERN MED, V160, P774, DOI 10.7326/M14-0083; Feng ZL, 2014, MED CARE, V52, P796, DOI 10.1097/MLR.0000000000000179; Feng ZL, 2012, HEALTH AFFAIR, V31, P1251, DOI 10.1377/hlthaff.2012.0129; Gabayan GZ, 2015, J AM GERIATR SOC, V63, P39, DOI 10.1111/jgs.13185; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Gabayan GZ, 2011, ANN EMERG MED, V58, P551, DOI 10.1016/j.annemergmed.2011.07.001; Guttman A, 2004, ACAD EMERG MED, V11, P1318, DOI 10.1197/j.aem.2004.07.006; Harrison Jeffrey P, 2013, J Health Care Finance, V39, P1; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kaiser Health News. FAQ, KAISER HLTH NEWS; Katz EB, 2012, ANN EMERG MED, V60, P12, DOI 10.1016/j.annemergmed.2012.02.025; Kenny RA, 2015, EUROPACE, V17, P1325, DOI 10.1093/europace/euv115; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Kociol RD, 2012, CIRC-HEART FAIL, V5, P680, DOI 10.1161/CIRCHEARTFAILURE.112.967406; Medicare Rights Center, DIFF OR MED MED ADV; Miro O, 2016, EUR HEART J ACUTE CA; Misch F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098097; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Nuffield Trust, 2014, NHS HOSP PRESS TREND; Office of Inspector General, HOSP US OBS STAYS SH; Penumetsa SC, 2012, ARCH INTERN MED, V172, P873, DOI 10.1001/archinternmed.2012.940; Purdy S., 2010, AVOIDING HOSP ADMISS; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Rising KL, 2015, ANN EMERG MED, V65, P377, DOI 10.1016/j.annemergmed.2014.07.015; Robin DW, 2010, J AM GERIATR SOC, V58, P1576, DOI 10.1111/j.1532-5415.2010.02974.x; Ross MA, 2003, ANN EMERG MED, V41, P668, DOI 10.1067/mem.2003.153; Ross MA, 2010, ANN EMERG MED, V56, P34, DOI 10.1016/j.annemergmed.2010.02.012; Sabbatini AK, 2016, JAMA-J AM MED ASSOC, V315, P663, DOI 10.1001/jama.2016.0649; Schrager J, 2013, ACAD EMERG MED, V20, P554, DOI 10.1111/acem.12147; Schuur JD, 2013, HEALTH AFFAIR, V32, P2129, DOI 10.1377/hlthaff.2013.0730; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; US Centers for Medicare and Medicaid Services, WHATS MED; Venkatesh A, 2014, ANN INTERN MED, V161, pS76, DOI 10.7326/M13-3014; Venkatesh AK, 2017, ACAD EMERG MED, V24, P422, DOI 10.1111/acem.13140; Venkatesh AK, 2016, MED CARE, V55, P1070, DOI 10.1097/MLR.0000000000000601; Venkatesh AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024326; Wright B, 2015, HEALTH AFFAIR, V34, P1730, DOI 10.1377/hlthaff.2014.1474; Zhao L, 2013, 201310 AARP PUBL POL	64	18	18	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2017	357								j2616	10.1136/bmj.j2616	http://dx.doi.org/10.1136/bmj.j2616			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY7YT	28634181	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000404210000001
J	Gupta, A; Yek, C; Hendler, RS				Gupta, Arjun; Yek, Christina; Hendler, Robert S.			Phenytoin Toxicity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INPATIENT MEDICATION RECONCILIATION; EVENTS		[Gupta, Arjun; Yek, Christina; Hendler, Robert S.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Hendler, Robert S.] Parkland Hlth & Hosp Syst, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Hendler, RS (corresponding author), Parkland Hlth & Hosp Syst, Profess & Acad Affairs, 5201 Harry Hines Blvd, Dallas, TX 75235 USA.	robert.hendler@phhs.org						Agency for Healthcare Research and Quality U.S. Department of Health and Human Services,, 2012, AHRQ PUBLICATION; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Craig S, 2005, NEUROCRIT CARE, V3, P161, DOI 10.1385/NCC:3:2:161; Greenwald JL, 2010, J HOSP MED, V5, P477, DOI 10.1002/jhm.849; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Siu Henry K, 2015, Hosp Pract (1995), V43, P65, DOI 10.1080/21548331.2015.1023159; The Joint Commission, 2017, 2017 NAT PAT SAF GOA	9	4	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2445	2446		10.1001/jama.2017.6881	http://dx.doi.org/10.1001/jama.2017.6881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632869				2022-12-28	WOS:000403654600017
J	Hamer, DH; Chen, LH; Libman, M; Grobusch, MP; Esposito, DH				Hamer, Davidson H.; Chen, Lin H.; Libman, Michael; Grobusch, Martin P.; Esposito, Douglas H.			Travel-Associated Zika Virus Disease RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							INFECTION		[Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Chen, Lin H.] Mt Auburn Hosp, Cambridge, MA USA; [Libman, Michael] McGill Univ, Montreal, PQ, Canada; [Grobusch, Martin P.] Univ Amsterdam, Amsterdam, Netherlands; [Esposito, Douglas H.] Ctr Dis Control & Prevent, Atlanta, GA USA	Boston University; Harvard University; Mount Auburn Hospital; McGill University; University of Amsterdam; Centers for Disease Control & Prevention - USA	Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.		Hamer, Davidson Howes/J-2020-2019; Chen, Lin/ADS-6751-2022	Hamer, Davidson Howes/0000-0002-4700-1495; 				Centers for Disease Control and Prevention, 2017, CLIN GUID PREGN TRAV; Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207; Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789; Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z; Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					913	914		10.7326/L17-0195	http://dx.doi.org/10.7326/L17-0195			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630988				2022-12-28	WOS:000403579000025
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLON-CANCER; CONDITIONAL SURVIVAL; ADJUVANT CHEMOTHERAPY; MISSING DATA; POPULATION; PROGNOSIS; DIAGNOSIS; MODEL; STAGE; IMPUTATION	OBJECTIVE To develop and externally validate risk prediction equations to estimate absolute and conditional survival in patients with colorectal cancer. DESIGN Cohort study. SETTING General practices in England providing data for the QResearch database linked to the national cancer registry. PARTICIPANTS 44 145 patients aged 15-99 with colorectal cancer from 947 practices to derive the equations. The equations were validated in 15 214 patients with colorectal cancer from 305 different QResearch practices and 437 821 patients with colorectal cancer from the national cancer registry. MAIN OUTCOME MEASURES The primary outcome was all cause mortality and secondary outcome was colorectal cancer mortality. METHODS Cause specific hazards models were used to predict risks of colorectal cancer mortality and other cause mortality accounting for competing risks, and these risk estimates were combined to obtain risks of all cause mortality. Separate equations were derived for men and women. Several variables were tested: age, ethnicity, deprivation score, cancer stage, cancer grade, surgery, chemotherapy, radiotherapy, smoking status, alcohol consumption, body mass index, family history of bowel cancer, anaemia, liver function test result, comorbidities, use of statins, use of aspirin, clinical values for anaemia, and platelet count. Measures of calibration and discrimination were determined in both validation cohorts at 1, 5, and 10 years. RESULTS The final models included the following variables in men and women: age, deprivation score, cancer stage, cancer grade, smoking status, colorectal surgery, chemotherapy, family history of bowel cancer, raised platelet count, abnormal liver function, cardiovascular disease, diabetes, chronic renal disease, chronic obstructive pulmonary disease, prescribed aspirin at diagnosis, and prescribed statins at diagnosis. Improved survival in women was associated with younger age, earlier stage of cancer, well or moderately differentiated cancer grade, colorectal cancer surgery (adjusted hazard ratio 0.50), family history of bowel cancer (0.62), and prescriptions for statins (0.77) and aspirin (0.83) at diagnosis, with comparable results for men. The risk equations were well calibrated, with predicted risks closely matching observed risks. Discrimination was good in men and women in both validation cohorts. For example, the five year survival equations on the QResearch validation cohort explained 45.3% of the variation in time to colorectal cancer death for women, the D statistic was 1.86, and Harrell's C statistic was 0.80 (both measures of discrimination, indicating that the scores are able to distinguish between people with different levels of risk). The corresponding results for all cause mortality were 42.6%, 1.77, and 0.79. CONCLUSIONS Risk prediction equations were developed and validated to estimate overall and conditional survival of patients with colorectal cancer accounting for an individual's clinical and demographic characteristics. These equations can provide more individualised accurate information for patients with colorectal cancer to inform decision making and follow-up.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Univ Pk, Nottingham NG2 7RD, England	University of Nottingham	Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Anderson JR, 2008, J CLIN ONCOL, V26, P3913, DOI 10.1200/JCO.2008.16.1000; Bains SJ, 2016, J CLIN ONCOL, V34, P2501, DOI 10.1200/JCO.2015.65.3519; Bastiaannet E, 2012, BRIT J CANCER, V106, P1564, DOI 10.1038/bjc.2012.101; Cai HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126944; Chang GJ, 2009, J CLIN ONCOL, V27, P5938, DOI 10.1200/JCO.2009.23.1860; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Gill S, 2011, CANCER-AM CANCER SOC, V117, P4155, DOI 10.1002/cncr.26003; Hancock K, 2007, PALLIATIVE MED, V21, P507, DOI 10.1177/0269216307080823; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hieke S, 2015, CLIN CANCER RES, V21, P1530, DOI 10.1158/1078-0432.CCR-14-2154; Hippisley-Cox J, 2016, PROTOCOL FOR DEVELOP; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007825; Hippisley-Cox J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003482; Hippisley-Cox J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616346; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; Howlader Nadia, 2014, Journal of the National Cancer Institute Monographs, P255, DOI 10.1093/jncimonographs/lgu022; Kalbfleisch J, 2002, THE STATISTICAL ANAL, DOI [10.1002/9781118032985, DOI 10.1002/9781118032985]; Majeed Azeem, 2004, Health Stat Q, P5; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; McPhail S, 2015, BRIT J CANCER, V112, pS108, DOI 10.1038/bjc.2015.49; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Reljic T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014661; Renfro LA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju333; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sanoff HK, 2012, J CLIN ONCOL, V30, P2624, DOI 10.1200/JCO.2011.41.1140; Sarfati D, 2010, INT J EPIDEMIOL, V39, P598, DOI 10.1093/ije/dyp392; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sobin LH, 2009, TNM CLASSIFICATION O; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Townsend P, 1982, THE BLACK REPORT; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Wise PH, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5792; Yu XQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-460	49	23	23	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2497	10.1136/bmj.j2497	http://dx.doi.org/10.1136/bmj.j2497			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28620089	Green Published, hybrid			2022-12-28	WOS:000403753800002
J	Ryan, AM; Krinsky, S; Maurer, KA; Dimick, JB				Ryan, Andrew M.; Krinsky, Sam; Maurer, Kristin A.; Dimick, Justin B.			Changes in Hospital Quality Associated with Hospital Value-Based Purchasing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGIONAL-VARIATIONS; OF-CARE; PAY; PROGRAM; IMPROVEMENT; MORTALITY; MODEL; COST	BACKGROUND Starting in fiscal year 2013, the Hospital Value-Based Purchasing (HVBP) program introduced quality performance-based adjustments of up to 1% to Medicare reimbursements for acute care hospitals. METHODS We evaluated whether quality improved more in acute care hospitals that were exposed to HVBP than in control hospitals (Critical Access Hospitals, which were not exposed to HVBP). The measures of quality were composite measures of clinical process and patient experience (measured in units of standard deviations, with a value of 1 indicating performance that was 1 standard deviation [SD] above the hospital mean) and 30-day risk-standardized mortality among patients who were admitted to the hospital for acute myocardial infarction, heart failure, or pneumonia. The changes in quality measures after the introduction of HVBP were assessed for matched samples of acute care hospitals (the number of hospitals included in the analyses ranged from 1364 for mortality among patients admitted for acute myocardial infarction to 2615 for mortality among patients admitted for pneumonia) and control hospitals (number of hospitals ranged from 31 to 617). Matching was based on preintervention performance with regard to the quality measures. We evaluated performance over the first 4 years of HVBP. RESULTS Improvements in clinical-process and patient-experience measures were not significantly greater among hospitals exposed to HVBP than among control hospitals, with difference-in-differences estimates of 0.079 SD (95% confidence interval [CI], -0.140 to 0.299) for clinical process and -0.092 SD (95% CI, -0.307 to 0.122) for patient experience. HVBP was not associated with significant reductions in mortality among patients who were admitted for acute myocardial infarction (difference-in-differences estimate, -0.282 percentage points [95% CI, -1.715 to 1.152]) or heart failure (-0.212 percentage points [95% CI, -0.532 to 0.108]), but it was associated with a significant reduction in mortality among patients who were admitted for pneumonia (-0.431 percentage points [95% CI, -0.714 to -0.148]). CONCLUSIONS In our study, HVBP was not associated with improvements in measures of clinical process or patient experience and was not associated with significant reductions in two of three mortality measures. (Funded by the National Institute on Aging.)	[Ryan, Andrew M.; Krinsky, Sam; Maurer, Kristin A.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Dimick, Justin B.] Univ Michigan, Dept Surg, Med Sch, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ryan, AM (corresponding author), Univ Michigan, Sch Publ Hlth, 1415 Washington Hts,SPH 2,Rm M3124, Ann Arbor, MI 48109 USA.	amryan@umich.edu			National Institute on Aging; NATIONAL INSTITUTE ON AGING [R01AG039434, R01AG047932] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging.	[Anonymous], 2016, DAT PROGR REP; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Calikoglu S, 2012, HEALTH AFFAIR, V31, P2649, DOI 10.1377/hlthaff.2012.0357; Colla CH, 2016, HEALTH AFFAIR, V35, P431, DOI 10.1377/hlthaff.2015.0919; Doran T, 2017, ANNU REV PUBL HEALTH, V38, P449, DOI 10.1146/annurev-publhealth-032315-021457; Figueroa JF, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2214; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; Hussey PS, 2013, ANN INTERN MED, V158, P27, DOI 10.7326/0003-4819-158-1-201301010-00006; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Leuven E, PSMATCH2 STATA MODUL; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Ryan AM, 2015, HEALTH SERV RES, V50, P1211, DOI 10.1111/1475-6773.12270; Ryan AM, 2015, HEALTH SERV RES, V50, P81, DOI 10.1111/1475-6773.12206; Ryan AM, 2013, HEALTHCARE-J DEL SCI, V1, P42, DOI 10.1016/j.hjdsi.2013.04.006; Ryan AM, 2012, HEALTH AFFAIR, V31, P797, DOI 10.1377/hlthaff.2011.0626; Ryan AM, 2012, HEALTH AFFAIR, V31, P585, DOI 10.1377/hlthaff.2011.0719; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; StataCorp, 2015, STAT STAT SOFTW REL; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	30	84	85	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2358	2366		10.1056/NEJMsa1613412	http://dx.doi.org/10.1056/NEJMsa1613412			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28614675	Green Accepted, Bronze			2022-12-28	WOS:000403230800009
J	Gray, B; Vandergrift, J; Lipner, RS; Green, MM				Gray, Bradley; Vandergrift, Jonathan; Lipner, Rebecca S.; Green, Marianne M.			Comparison of Content on the American Board of Internal Medicine Maintenance of Certification Examination With Conditions Seen in Practice by General Internists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Success on the internal medicine (IM) examination is a central requirement of the American Board of Internal Medicine's (ABIM's) Maintenance of Certification program (MOC). Therefore, it is important to understand the degree to which this examination reflects conditions seen in practice, one dimension of content validity, which focuses on the match between content in the discipline and the topics on the examination questions. OBJECTIVE To assess whether the frequency of questions on IM-MOC examinations were concordant with the frequency of conditions seen in practice. DESIGN, SETTING, AND PARTICIPANTS The 2010-2013 IM-MOC examinations were used to calculate the percentage of questions for 186 medical condition categories from the examination blueprint, which balances examination content by considering importance and frequency of conditions seen in practice. Nationally representative estimates of conditions seen in practice by general internists were estimated from the primary diagnosis for 13 832 office visits (2010-2013 National Ambulatory Medical Care Surveys) and 108 472 hospital stays (2010 National Hospital Discharge Survey). EXPOSURES Prevalence of conditions included on the IM-MOC examination questions. MAIN OUTCOMES AND MEASURES The outcome measure was the concordance between the percentages of IM-MOC examination questions and the percentages of conditions seen in practice during either office visits or hospital stays for each of 186 condition categories (eg, diabetes mellitus, ischemic heart disease, liver disease). The concordance thresholds were 0.5 SD of the weighted mean percentages of the applicable 186 conditions seen in practice (0.74% for office visits; 0.51% for hospital stays). If the absolute differences between the percentages of examination questions and the percentages of office visit conditions or hospital stay conditions seen were less than the applicable concordance threshold, then the condition category was judged to be concordant. RESULTS During the 2010-2013 IM-MOC examination periods, 3600 questions (180 questions per examination form) were administered and 3461 questions (96.1%) were mapped into the 186 study conditions (mean, 18.6 questions per condition). Comparison of the percentages of 186 categories of medical conditions seen in 13 832 office visits and 108 472 hospital stays with the percentages of 3461 questions on IM-MOC examinations revealed that 2389 examination questions (69.0%; 95% CI, 67.5%-70.6% involving 158 conditions) were categorized as concordant. For concordance between questions and office visits only, 2010 questions (58.08%; 95% CI, 56.43%-59.72% of all examination questions) involving 145 conditions were categorized as concordant. For concordance between questions and hospital stays only, 1456 questions (42.07%; 95% CI, 40.42%-43.71% of all examination questions) involving 122 conditions were categorized as concordant. CONCLUSIONS AND RELEVANCE Among questions on IM-MOC examinations from 2010-2013, 69% were concordant with conditions seen in general internal medicine practices, although some areas of discordance were identified.	[Gray, Bradley; Vandergrift, Jonathan; Lipner, Rebecca S.] Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA; [Green, Marianne M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA	American Board of Internal Medicine; Northwestern University; Feinberg School of Medicine	Gray, B (corresponding author), Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	bgray@abim.org			ABIM	ABIM	Financial and material support was provided by the ABIM.	American Medical Association, 2013, STAT MED LIC REQ STA; Centor RM, 2014, ANN INTERN MED, V161, P226, DOI 10.7326/M14-1014; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook DA, 2016, ACAD MED, V91, P785, DOI 10.1097/ACM.0000000000001114; Coutinho AJ, 2015, JAMA-J AM MED ASSOC, V314, P2364, DOI 10.1001/jama.2015.13734; Downing SM, 2006, HDB TEST DEV; Gray B, 2013, HEALTH SERV RES, V48, P1096, DOI 10.1111/1475-6773.12011; Holmboe ES, 2008, JAMA-J AM MED ASSOC, V299, P338, DOI 10.1001/jama.299.3.338; Lane S., 2006, ED MEASUREMENT, P1; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; US Census Bureau, 2016, NAMCS252 US CENS BUR	11	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2317	2324		10.1001/jama.2017.6853	http://dx.doi.org/10.1001/jama.2017.6853			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609535	Bronze, Green Published			2022-12-28	WOS:000403149900018
J	Moore, A				Moore, Alia			Gray Areas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Moore, Alia] Univ Colorado, Sch Med, Div Gen Internal Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Moore, A (corresponding author), Univ Colorado, Sch Med, Div Gen Internal Med, Aurora, CO 80045 USA.	alia.moore@ucdenver.edu						Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Binswanger IA, 2012, J URBAN HEALTH, V89, P98, DOI 10.1007/s11524-011-9614-1; Graff Gilda, 2015, J Psychohist, V43, P120; Wang EA, 2008, AM J PUBLIC HEALTH, V98, P2182, DOI 10.2105/AJPH.2007.119669	5	0	0	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2281	2282		10.1001/jama.2017.1657	http://dx.doi.org/10.1001/jama.2017.1657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609538				2022-12-28	WOS:000403149900011
J	Burmester, GR; Pope, JE				Burmester, Gerd R.; Pope, Janet E.			Novel treatment strategies in rheumatoid arthritis	LANCET			English	Article							ADALIMUMAB PLUS METHOTREXATE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EARLY INFLAMMATORY ARTHRITIS; RANDOMIZED CONTROLLED-TRIAL; NECROSIS-FACTOR INHIBITORS; LOW DISEASE-ACTIVITY; DOUBLE-BLIND; PHASE-III; UNDIFFERENTIATED ARTHRITIS; MYOCARDIAL-INFARCTION	New treatment strategies have substantially changed the course of rheumatoid arthritis. Many patients can achieve remission if the disease is recognised early and is treated promptly and continuously; however, some individuals do not respond adequately to treatment. Rapid diagnosis and a treat-to-target approach with tight monitoring and control, can increase the likelihood of remission in patients with rheumatoid arthritis. In this Series paper, we describe new insights into the management of rheumatoid arthritis with targeted therapy approaches using classic and novel medications, and outline the potential effects of precision medicine in this challenging disease. Articles are included that investigate the treat-to-target approach, which includes adding or de-escalating treatment. Rheumatoid arthritis treatment is impeded by delayed diagnosis, problematic access to specialists, and difficulties adhering to treat-to-target principles. Clinical management goals in rheumatoid arthritis include enabling rapid access to optimum diagnosis and care and the well informed use of multiple treatments approved for this disease.	[Burmester, Gerd R.] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Pope, Janet E.] Western Univ, St Josephs Hosp, Div Rheumatol, London, ON, Canada	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University; Western University (University of Western Ontario)	Burmester, GR (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany.	gerd.burmester@charite.de	Burmester, Gerd R./AAY-7514-2020; Pope, Janet/G-3342-2011	Pope, Janet/0000-0003-1479-5302	AbbVie; Bristol-Myers Squibb; Pfizer; Roche; UCB; MSD; AstraZeneca; Actelion; Amgen; Bayer; Celgene; Genzyme; GlaxoSmithKline; Janssen; Lilly; Merck; Novartis; Regeneron; Sanofi; Genentech	AbbVie(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Roche(Roche Holding); UCB(UCB Pharma SA); MSD; AstraZeneca(AstraZeneca); Actelion; Amgen(Amgen); Bayer(Bayer AG); Celgene(Bristol-Myers SquibbCelgene Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly(Eli Lilly); Merck(Merck & Company); Novartis(Novartis); Regeneron(Regeneron); Sanofi; Genentech(Roche HoldingGenentech)	GRB reports grants and personal fees from AbbVie, Bristol-Myers Squibb, Pfizer, Roche, and UCB; and personal fees from MSD and AstraZeneca. JEP has received consulting fees for AbbVie, Actelion, Amgen, Bayer, Bristol-Myers Squibb, Celgene, Genzyme, GlaxoSmithKline, Janssen, Lilly, Merck, Novartis, Pfizer, Roche, Regeneron, Sanofi, UCB; and reports research grants from AbbVie, Actelion, Amgen, Bayer, Bristol-Myers Squibb, Genentech, Merck, Pfizer, Roche, Regeneron, and UCB.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Bartlett SJ, 2016, AM COLL RHEUM ANN M, P3068; Bijlsma JWJ, 2016, LANCET, V388, P343, DOI 10.1016/S0140-6736(16)30363-4; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bos WH, 2010, ANN RHEUM DIS, V69, P571, DOI 10.1136/ard.2008.105767; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Buch MH, 2017, RHEUMATOLOGY, V56, P58, DOI 10.1093/rheumatology/kew357; Buckley Felicity, 2015, J Manag Care Spec Pharm, V21, P409; Burmester GR, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210310; Burmester GR, 2016, ANN RHEUM DIS, V75, P1081, DOI 10.1136/annrheumdis-2015-207628; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Burmester GR, NAT REV RHE IN PRESS; Canadian Rheumatology Association, 2017, CAN RHEUM ASS POS ST; Chatzidionysiou K, 2017, ANN RHEUM DIS, V76, P1102, DOI 10.1136/annrheumdis-2016-210711; Chingcuanco F, 2016, ANN INTERN MED, V165, P565, DOI 10.7326/M16-0428; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Cohen J, 2014, GABI J, V3, P108, DOI DOI 10.5639/GABIJ.2014.0303.028; Cohen SB, 2017, ANN RHEUM DIS, V76, P1253, DOI 10.1136/annrheumdis-2016-210457; Combe B, 2017, ANN RHEUM DIS, V76, P948, DOI 10.1136/annrheumdis-2016-210602; Curtis JR, 2016, ANN RHEUM DIS, V75, P1843, DOI 10.1136/annrheumdis-2016-209131; Dale J, 2014, ARTHRIT CARE RES, V66, P19, DOI 10.1002/acr.22218; Detert J, 2013, ANN RHEUM DIS, V72, P844, DOI 10.1136/annrheumdis-2012-201612; Dorner T, 2016, ANN RHEUM DIS, V75, P974, DOI 10.1136/annrheumdis-2016-209166; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Elnady BM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004336; Emamikia S, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2016-000323; Emery P, 2017, ANN RHEUM DIS, V76, P96, DOI 10.1136/annrheumdis-2015-209057; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2015, ANN RHEUM DIS, V74, P19, DOI 10.1136/annrheumdis-2014-206106; Emery P, 2009, ARTHRITIS RHEUM-US, V60, P2272, DOI 10.1002/art.24638; European Medicines Agency, 2017, SUMM OPT IN AUTH XEL; European Medicines Agency, BIOS MED; European Medicines Agency, SUMM OP IN AUTH OL B; Feist E, 2013, OXFORD TXB RHEUMATOL; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fleischmann R, LANCET IN PRESS; FLEISCHMANN R, 2017, RMD OPEN, V3, DOI DOI 10.1136/rmdopen-2016-000371; Fleischmann R, 2017, ARTHRITIS RHEUMATOL, V69, P506, DOI 10.1002/art.39953; Food and Drug Administration, 2015, INF CONS BIOS; Gabay C, 2015, RHEUMATOLOGY, V54, P1664, DOI 10.1093/rheumatology/kev019; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Genovese MC, 2016, NEW ENGL J MED, V374, P1243, DOI 10.1056/NEJMoa1507247; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; Gerlag DM, 2016, RHEUMATOLOGY, V55, P607, DOI 10.1093/rheumatology/kev347; Gerlag DM, 2016, AM COLL RHEUM ANN M, P3028; Giles JT, 2016, AM COLL RHEUM ANN M, p3L; Haavardsholm EA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4205; Hazlewood GS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010227.pub2; Hazlewood GS, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1777; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hitchon CA, 2016, RHEUMATOLOGY, V55, P1751, DOI 10.1093/rheumatology/kew061; Jorgensen KK, 2017, LANCET, V389, P2304, DOI 10.1016/S0140-6736(17)30068-5; Katchamart W, 2010, ARTHRIT CARE RES, V62, P1128, DOI 10.1002/acr.20188; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Louder AM, 2016, AM HEALTH DRUG BENEF, V9, P84; Machold KP, 2010, ANN RHEUM DIS, V69, P495, DOI 10.1136/ard.2009.122473; Mankia K, 2016, CURR OPIN RHEUMATOL, V28, P260, DOI 10.1097/BOR.0000000000000268; Marzo-Ortega H, 2007, ARTHRIT RHEUM-ARTHR, V57, P154, DOI 10.1002/art.22467; McInnes IB, 2017, LANCET, V389, P2328, DOI 10.1016/S0140-6736(17)31472-1; Meissner Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1077-z; Mercer LK, 2017, ANN RHEUM DIS, V76, P386, DOI 10.1136/annrheumdis-2016-209285; Moreland LW, 2010, ARTHRITIS RHEUM, V64, P2824; Nam JL, 2014, ANN RHEUM DIS, V73, P1027, DOI 10.1136/annrheumdis-2013-204882; Nam JL, 2016, ANN RHEUM DIS, V75, P2060, DOI 10.1136/annrheumdis-2015-208235; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; Pope J, 2016, ANN EUR C RHEUM LOND; Pope JE, 2014, ANN RHEUM DIS, V73, P2144, DOI 10.1136/annrheumdis-2013-203684; Porter D, 2016, LANCET, V388, P239, DOI 10.1016/S0140-6736(16)00380-9; Quinn MA, 2005, BEST PRACT RES CL RH, V19, P1, DOI 10.1016/j.berh.2004.08.001; Ramiro S, 2017, ANN RHEUM DIS, V76, P1093, DOI 10.1136/annrheumdis-2016-210708; Ravindran V, 2009, RHEUMATOLOGY, V48, P807, DOI 10.1093/rheumatology/kep096; Remy A, 2011, CLIN EXP RHEUMATOL, V29, P96; Roubille C, 2015, J RHEUMATOL, V42, P1767, DOI 10.3899/jrheum.141112; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Saleem B, 2008, ANN RHEUM DIS, V67, P1178, DOI 10.1136/ard.2007.084269; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; SCHUMACHER HR, 1993, PRIMER RHEUMATIC DIS; Singh JA, 2016, ANN RHEUM DIS, V68, P1; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Smolen JS, 2016, LANCET, V388, P2763, DOI 10.1016/S0140-6736(16)31651-8; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Sokka T, 2009, ANN RHEUM DIS, V68, P1666, DOI 10.1136/ard.2009.109983; Stoffer MA, 2016, ANN RHEUM DIS, V75, P16, DOI 10.1136/annrheumdis-2015-207526; Strangfeld A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2904; Tak PP, 2011, ANN RHEUM DIS, V70, P39, DOI 10.1136/ard.2010.137703; Tanaka Y, 2013, CLIN EXP RHEUMATOL, V31, pS22; Tanaka Y, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1264-6; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; Tedeschi SK, 2016, SEMIN ARTHRITIS RHEU, DOI [10.1016/j, DOI 10.1016/J]; Teitsma XM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1108-9; Thompson AE, 2011, ARTHRITIS RHEUM-US, V63, P1479, DOI 10.1002/art.30310; van Aken J, 2014, ANN RHEUM DIS, V73, P396, DOI 10.1136/annrheumdis-2012-202967; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; van Nies JAB, 2015, ANN RHEUM DIS, V74, P806, DOI 10.1136/annrheumdis-2014-206047; van Nies JAB, 2014, ANN RHEUM DIS, V73, P861, DOI 10.1136/annrheumdis-2012-203130; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; van Walsem A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0554-0; Verschueren P, 2015, ANN RHEUM DIS, V74, P27, DOI 10.1136/annrheumdis-2014-205489; Verstappen SMM, 2010, ANN RHEUM DIS, V69, P503, DOI 10.1136/ard.2009.119149; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711; Weng HH, 2010, J RHEUMATOL, V37, P550, DOI 10.3899/jrheum.090818; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Widdifield J, 2015, ARTHRIT CARE RES, V67, P1047, DOI 10.1002/acr.22553; Yamaoka K, 2016, DRUG SAFETY, V39, P823, DOI 10.1007/s40264-016-0430-0; Yamaoka K, 2016, CURR OPIN CHEM BIOL, V32, P29, DOI 10.1016/j.cbpa.2016.03.006; Zhang YQ, 2017, ANN RHEUM DIS, V76, P408, DOI 10.1136/annrheumdis-2015-209058; Zink A, 2014, ANN RHEUM DIS, V73, P1673, DOI 10.1136/annrheumdis-2013-203341	111	450	499	40	238	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2338	2348		10.1016/S0140-6736(17)31491-5	http://dx.doi.org/10.1016/S0140-6736(17)31491-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW9XM	28612748				2022-12-28	WOS:000402872700028
J	Lampel, A; McPhee, SA; Park, HA; Scott, GG; Humagain, S; Hekstra, DR; Yoo, B; Frederix, PWJM; Li, TD; Abzalimov, RR; Greenbaum, SG; Tuttle, T; Hu, CH; Bettinger, CJ; Ulijn, RV				Lampel, Ayala; McPhee, Scott A.; Park, Hang-Ah; Scott, Gary G.; Humagain, Sunita; Hekstra, Doeke R.; Yoo, Barney; Frederix, Pim W. J. M.; Li, Tai-De; Abzalimov, Rinat R.; Greenbaum, Steven G.; Tuttle, Tell; Hu, Chunhua; Bettinger, Christopher J.; Ulijn, Rein V.			Polymeric peptide pigments with sequence-encoded properties	SCIENCE			English	Article							BIOMATERIALS; NANOTUBES; EUMELANIN; HYDROGELS	Melanins are a family of heterogeneous polymeric pigments that provide ultraviolet (UV) light protection, structural support, coloration, and free radical scavenging. Formed by oxidative oligomerization of catecholic small molecules, the physical properties of melanins are influenced by covalent and noncovalent disorder. We report the use of tyrosine-containing tripeptides as tunable precursors for polymeric pigments. In these structures, phenols are presented in a (supra-)molecular context dictated by the positions of the amino acids in the peptide sequence. Oxidative polymerization can be tuned in a sequence-dependent manner, resulting in peptide sequence-encoded properties such as UV absorbance, morphology, coloration, and electrochemical properties over a considerable range. Short peptides have low barriers to application and can be easily scaled, suggesting near-term applications in cosmetics and biomedicine.	[Lampel, Ayala; McPhee, Scott A.; Li, Tai-De; Abzalimov, Rinat R.; Ulijn, Rein V.] CUNY, Grad Ctr, Adv Sci Res Ctr, 85 St Nicholas Terrace, New York, NY 10031 USA; [Park, Hang-Ah; Bettinger, Christopher J.] Carnegie Mellon Univ, Dept Mat Sci & Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Scott, Gary G.; Tuttle, Tell] Univ Strathclyde, WestCHEM, 295 Cathedral St, Glasgow G1 1XL, Lanark, Scotland; [Scott, Gary G.; Tuttle, Tell] Univ Strathclyde, Dept Pure & Appl Chem, 295 Cathedral St, Glasgow G1 1XL, Lanark, Scotland; [Humagain, Sunita; Greenbaum, Steven G.] CUNY, Hunter Coll, Dept Phys & Astron, 695 Pk Ave, New York, NY 10065 USA; [Humagain, Sunita; Greenbaum, Steven G.; Ulijn, Rein V.] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA; [Humagain, Sunita; Greenbaum, Steven G.; Ulijn, Rein V.] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA; [Humagain, Sunita; Greenbaum, Steven G.; Ulijn, Rein V.] CUNY, Grad Ctr, PhD Program Phys, New York, NY 10016 USA; [Hekstra, Doeke R.] Harvard Univ, Sch Engn & Appl Sci, Dept Mol & Cellular Biol, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Yoo, Barney; Ulijn, Rein V.] CUNY, Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10065 USA; [Frederix, Pim W. J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Hu, Chunhua] Silver Ctr Arts & Sci, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA; [Bettinger, Christopher J.] Carnegie Mellon Univ, Dept Biomed Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Bettinger, Christopher J.] McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA	City University of New York (CUNY) System; Carnegie Mellon University; University of Strathclyde; University of Strathclyde; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Harvard University; City University of New York (CUNY) System; Hunter College (CUNY); University of Groningen; Carnegie Mellon University	Ulijn, RV (corresponding author), CUNY, Grad Ctr, Adv Sci Res Ctr, 85 St Nicholas Terrace, New York, NY 10031 USA.; Ulijn, RV (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA.; Ulijn, RV (corresponding author), CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA.; Ulijn, RV (corresponding author), CUNY, Grad Ctr, PhD Program Phys, New York, NY 10016 USA.; Ulijn, RV (corresponding author), CUNY, Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10065 USA.	rein.ulijn@asrc.cuny.edu	Abzalimov, Rinat/C-1113-2018; Lampel, Ayala/ABC-6216-2021; Greenbaum, Steven G/I-6904-2016; Abzalimov, Rinat/ABE-1915-2020; Abzalimov, Rinat R/F-9780-2010	Lampel, Ayala/0000-0003-2733-9197; Frederix, Pim/0000-0002-6892-5611; Li, Tai-De/0000-0003-0515-5135; Hekstra, Doeke/0000-0003-2332-9223; Abzalimov, Rinat/0000-0003-2110-1532; Scott, Gary George/0000-0003-2177-0373	U.S. Air Force Office of Scientific Research [FA9550-15-1-0192]; Planning and Budget Committee of the Israeli Council for Higher Education; Netherlands Organization for Scientific Research (Veni program) [722.015.005]; Materials Research Science and Engineering Center program of the National Science Foundation (NSF) [DMR-0820341, DMR-1420073]; NSF [CHE-1346572]; U.S. DOE [DE-AC02-06CH11357]; City University of New York; NSF; National Institute on Minority Health and Health Disparities (NIMHD) of the NIH; Engineering and Physical Sciences Research Council [EP/K000586/1]; Division Of Chemistry [1346572] Funding Source: National Science Foundation; EPSRC [EP/K000586/1] Funding Source: UKRI	U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Planning and Budget Committee of the Israeli Council for Higher Education; Netherlands Organization for Scientific Research (Veni program); Materials Research Science and Engineering Center program of the National Science Foundation (NSF)(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF(National Science Foundation (NSF)); U.S. DOE(United States Department of Energy (DOE)); City University of New York; NSF(National Science Foundation (NSF)); National Institute on Minority Health and Health Disparities (NIMHD) of the NIH; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research leading to these results has received funding from the U.S. Air Force Office of Scientific Research (grant FA9550-15-1-0192). A.L. is funded by the Planning and Budget Committee of the Israeli Council for Higher Education. P.W.J.M.F. is funded by the Netherlands Organization for Scientific Research (Veni program, grant number 722.015.005). The authors are grateful for support from the Materials Research Science and Engineering Center program of the National Science Foundation (NSF) under award numbers DMR-0820341 and DMR-1420073 and for the assistance of C.-H. (J.) Chen at the University of Indiana and Y.-S. Chen at the ChemMatCARS Sector 15 of the Advanced Photon Source (APS), which is principally supported by the NSF (grant number CHE-1346572). Use of the APS, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. We thank A. Bykov (Department of Physics, City College of New York) for help with WAXS analysis and J. Gu and V. M. Menon (Department of Physics, City College of New York) for help with UV-Vis analysis. Hunter Mass Spectrometry is supported by the City University of New York, the NSF, and the National Institute on Minority Health and Health Disparities (NIMHD) of the NIH. Results were obtained using the Engineering and Physical Sciences Research Council-funded ARCHIE-WeSt High Performance Computer (www.archie-west.ac.uk; grant number EP/K000586/1). The City University of New York has filed a provisional patent application (serial number 62/385,544) for technology related to this work.	Adler-Abramovich L, 2014, CHEM SOC REV, V43, P6881, DOI 10.1039/c4cs00164h; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Bellesia G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2739547; Boekhoven J, 2015, SCIENCE, V349, P1075, DOI 10.1126/science.aac6103; d'Ischia M, 2014, ACCOUNTS CHEM RES, V47, P3541, DOI 10.1021/ar500273y; Fichman G, 2014, ACS NANO, V8, P7220, DOI 10.1021/nn502240r; Frederix PWJM, 2015, NAT CHEM, V7, P30, DOI [10.1038/NCHEM.2122, 10.1038/nchem.2122]; Gao J, 2011, SOFT MATTER, V7, P10443, DOI 10.1039/c1sm06192e; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Gorbitz CH, 2001, CHEM-EUR J, V7, P5153, DOI 10.1002/1521-3765(20011203)7:23<5153::AID-CHEM5153>3.0.CO;2-N; Hirst AR, 2010, NAT CHEM, V2, P1089, DOI [10.1038/nchem.861, 10.1038/NCHEM.861]; Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b; Kim YJ, 2016, ADV MATER, V28, P3173, DOI 10.1002/adma.201504650; Kim YJ, 2013, P NATL ACAD SCI USA, V110, P20912, DOI 10.1073/pnas.1314345110; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee OS, 2011, J AM CHEM SOC, V133, P3677, DOI 10.1021/ja110966y; Marchesan S, 2012, NANOSCALE, V4, P6752, DOI 10.1039/c2nr32006a; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Pappas CG, 2016, NAT NANOTECHNOL, V11, P960, DOI [10.1038/NNANO.2016.169, 10.1038/nnano.2016.169]; Park HA, 2016, POLYM INT, V65, P1331, DOI 10.1002/pi.5184; Partlow BP, 2016, BIOMACROMOLECULES, V17, P3570, DOI 10.1021/acs.biomac.6b01086; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Shillingford C, 2016, ACS APPL MATER INTER, V8, P4314, DOI 10.1021/acsami.5b11933; Trausel F, 2016, ACCOUNTS CHEM RES, V49, P1440, DOI 10.1021/acs.accounts.6b00137; Webber MJ, 2016, NAT MATER, V15, P13, DOI [10.1038/NMAT4474, 10.1038/nmat4474]; Xiao M, 2015, ACS NANO, V9, P5454, DOI 10.1021/acsnano.5b01298; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhao H, 2016, NAT NANOTECHNOL, V11, P82, DOI [10.1038/NNANO.2015.256, 10.1038/nnano.2015.256]	29	193	195	16	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1064	1068		10.1126/science.aal5005	http://dx.doi.org/10.1126/science.aal5005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596363	Green Accepted, Green Submitted			2022-12-28	WOS:000402871700051
J	Blanchet, K; Ramesh, A; Frison, S; Warren, E; Hossain, M; Smith, J; Knight, A; Post, N; Lewis, C; Woodward, A; Dahab, M; Ruby, A; Sistenich, V; Pantuliano, S; Roberts, B				Blanchet, Karl; Ramesh, Anita; Frison, Severine; Warren, Emily; Hossain, Mazeda; Smith, James; Knight, Abigail; Post, Nathan; Lewis, Christopher; Woodward, Aniek; Dahab, Maysoon; Ruby, Alexander; Sistenich, Vera; Pantuliano, Sara; Roberts, Bayard			Evidence on public health interventions in humanitarian crises	LANCET			English	Article							MENTAL-HEALTH; EVIDENCE BASE; RANDOMIZED INTERVENTION; COMPLEX EMERGENCIES; REFUGEE CAMPS; CONFLICT; EPIDEMIOLOGY; MORTALITY; DISASTER; IMPACT	Recognition of the need for evidence-based interventions to help to improve the effectiveness and efficiency of humanitarian responses has been increasing. However, little is known about the breadth and quality of evidence on health interventions in humanitarian crises. We describe the findings of a systematic review with the aim of examining the quantity and quality of evidence on public health interventions in humanitarian crises to identify key research gaps. We identified 345 studies published between 1980 and 2014 that met our inclusion criteria. The quantity of evidence varied substantially by health topic, from communicable diseases (n=131), nutrition (n=77), to non-communicable diseases (n=8), and water, sanitation, and hygiene (n=6). We observed common study design and weaknesses in the methods, which substantially reduced the ability to determine causation and attribution of the interventions. Considering the major increase in health-related humanitarian activities in the past three decades and calls for a stronger evidence base, this paper highlights the limited quantity and quality of health intervention research in humanitarian contexts and supports calls to scale up this research.	[Blanchet, Karl; Smith, James; Knight, Abigail] London Sch Hyg & Trop Med, Hlth Humanitarian Crises Ctr, London, England; [Hossain, Mazeda; Post, Nathan; Woodward, Aniek; Dahab, Maysoon; Ruby, Alexander; Roberts, Bayard] London Sch Hyg & Trop Med, ECOHOST Ctr Hlth & Social Change, London, England; [Ramesh, Anita; Frison, Severine; Warren, Emily] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England; [Ramesh, Anita; Frison, Severine; Warren, Emily] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Lewis, Christopher] Dept Int Dev, London, England; [Sistenich, Vera] Harvard Sch Publ Hlth, Boston, MA USA; [Pantuliano, Sara] Overseas Dev Inst, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Roberts, B (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England.	Bayard.roberts@lshtm.ac.uk	Hossain, Mazeda/AAL-3202-2020	Hossain, Mazeda/0000-0002-1878-8145; Post, Nathan/0000-0003-3250-7933; Warren, Emily/0000-0002-9117-844X; Roberts, Bayard/0000-0003-4482-5859	Research for Health in Humanitarian Crises (R2HC) Programme - DFID; Wellcome Trust	Research for Health in Humanitarian Crises (R2HC) Programme - DFID; Wellcome Trust(Wellcome Trust)	The work for this systematic review was funded through the Research for Health in Humanitarian Crises (R2HC) Programme funded by DFID and the Wellcome Trust and commissioned by Enhancing Learning and Research for Humanitarian Assistance (ELRHA).	Ager A, 2014, SCIENCE, V345, P1290, DOI 10.1126/science.1254164; ALNAP, 2014, ACT LEARN NETW ACC P; ARMENIAN HK, 1989, SOC SCI MED, V28, P643, DOI 10.1016/0277-9536(89)90211-6; Bailar J. C., 2012, MED USES STAT; Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Bellos Anna, 2010, Confl Health, V4, P3, DOI 10.1186/1752-1505-4-3; Betancourt TS, 2013, J CHILD PSYCHOL PSYC, V54, P17, DOI 10.1111/j.1469-7610.2012.02620.x; Birch M, 2005, BRIT MED J, V330, P1199, DOI 10.1136/bmj.330.7501.1199; Blanchet K, 2014, EVIDENCE REV RES HLT; Blanchet K, 2014, DISABIL REHABIL, V36, P1494, DOI 10.3109/09638288.2013.790489; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; Bostoen K, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-13; Bradt D, 2009, EVIDENCE BASED DECIS; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Bruckner Catherine, 2011, Confl Health, V5, P13, DOI 10.1186/1752-1505-5-13; Buttenheim A, 2009, IMPACT EVALUATION PO; CASEY SE, 2015, CONFL HEALTH S1, V9; Checchi F, 2005, INTERPRETING USING M; Checchi F, PUBLIC HLTH CRISIS A; Cochrane Collaboration, 2014, NONR CONTR STUD NRS; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Cred, 2015, HUM COST NAT DIS 201; CRED, 2013, PEOPL AFF CONFL HUM; Culbert H, 2007, PLOS MED, V4, P794, DOI 10.1371/journal.pmed.0040129; Curry D, 2013, ETHICAL FRAMEWORK DE; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Darcy J, 2007, REV LINKS NEEDS ASSE; Darcy J., 2013, USE EVIDENCE HUMANIT; Dewachi O, 2014, LANCET, V383, P449, DOI 10.1016/S0140-6736(13)62299-0; Dijkzeul D, 2013, DISASTERS, V37, pS1, DOI 10.1111/disa.12009; Duffield A, 2005, LANCET, V365, P842, DOI 10.1016/S0140-6736(05)71034-5; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Ford Nathan, 2009, Confl Health, V3, P7, DOI 10.1186/1752-1505-3-7; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Frerks G, EVALUATION HUMANITAR; Garfield R, 2000, NUTR REV, V58, P269, DOI 10.1111/j.1753-4887.2000.tb01880.x; GLASS RI, 1977, SCIENCE, V197, P638, DOI 10.1126/science.197.4304.638; Grais Rebecca F, 2011, Confl Health, V5, P21, DOI 10.1186/1752-1505-5-21; Griekspoor A, 2001, BRIT MED J, V323, P740, DOI 10.1136/bmj.323.7315.740; Haan N, 2005, REV EMERGENCY FOOD S; Haelterman E, 1996, TROP MED INT HEALTH, V1, P385, DOI 10.1046/j.1365-3156.1996.d01-49.x; Hall A., 2011, IMPACT EFFECTIVENESS; Hofmann C, 2004, MEASURING IMPACT HUM; IASC, 2012, OP GUID COORD ASS HU; IASC, 2009, HLTH CLUST GUID PRAC; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khader A, 2012, TROP MED INT HEALTH, V17, P1569, DOI 10.1111/j.1365-3156.2012.03097.x; Kilpatrick DG, 2004, J TRAUMA STRESS, V17, P361, DOI 10.1023/B:JOTS.0000048961.75301.74; Kimbrough W, 2012, LANCET INFECT DIS, V12, P950, DOI 10.1016/S1473-3099(12)70225-6; Leaning J, 2001, LANCET, V357, P1432, DOI 10.1016/S0140-6736(00)04572-4; LOGUE JN, 1981, EPIDEMIOL REV, V3, P140, DOI 10.1093/oxfordjournals.epirev.a036231; Mills EJ, 2005, BMJ-BRIT MED J, V331, P1485, DOI 10.1136/bmj.331.7531.1485; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nickerson JW, 2012, PREHOSP DISASTER MED, V27, P184, DOI 10.1017/S1049023X12000556; Noji EK, 1997, DISASTERS, V21, P366, DOI 10.1111/1467-7717.00068; Overseas Development Institute, 2009, HUM DIAGN US INF AN; Palmer JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002003; PARRISH HM, 1964, PUBLIC HEALTH REP, V79, P863, DOI 10.2307/4592266; Pitt C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-9; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Proudlock K, 2009, IMPROVING HUMANITARI; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; Puri J, WHAT METHODS MAY BE; Roberts L, 2001, B WORLD HEALTH ORGAN, V79, P280; Roberts Les, 2004, Emerg Themes Epidemiol, V1, P3, DOI 10.1186/1742-7622-1-3; Roberts L, 2007, PREHOSPITAL DISASTER, V22, P384, DOI 10.1017/S1049023X00005094; Robertson DW, 2002, LANCET, V360, P330, DOI 10.1016/S0140-6736(02)09558-2; Rowland M, 2001, ANN TROP MED PARASIT, V95, P741, DOI 10.1080/00034980120103405; Salama P, 2005, LANCET, V365, P1848, DOI 10.1016/S0140-6736(05)66613-5; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; SHARE Research Consortium, 2012, EV REV RES PRIOR WAT; SOMMER A, 1972, LANCET, V1, P1029; Spiegel P B, 2006, Glob Public Health, V1, P147, DOI 10.1080/17441690600679764; Spiegel P, 2014, LANCET ONCOL, V15, pE290, DOI 10.1016/S1470-2045(14)70067-1; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Spiegel PB, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-12; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; Stern E., 2012, 38 DFID; The Sphere Project, 2011, SPHER HDB HUM CHART; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; Tomashek KM, 2001, AM J TROP MED HYG, V64, P164, DOI 10.4269/ajtmh.2001.64.164; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; UNHCR, 2004, REP INT GLOB EV REPR; United Nations, 2005, HUM RESP REV; van der Haar G, 2013, DISASTERS, V37, pS20, DOI 10.1111/disa.12010; Wingfield-digby PK, 2010, RAPID ASSESSMENT SAM; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; Woodruff B, 2014, USE EPIDEMIOLOGICAL; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3	94	98	99	2	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2287	2296		10.1016/S0140-6736(16)30768-1	http://dx.doi.org/10.1016/S0140-6736(16)30768-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602563	Green Accepted			2022-12-28	WOS:000415645700027
J	Checchi, F; Warsame, A; Treacy-Wong, V; Polonsky, J; van Ommeren, M; Prudhon, C				Checchi, Francesco; Warsame, Abdihamid; Treacy-Wong, Victoria; Polonsky, Jonathan; van Ommeren, Mark; Prudhon, Claudine			Public health information in crisis-affected populations: a review of methods and their use for advocacy and action	LANCET			English	Review							UPPER ARM CIRCUMFERENCE; WEIGHT-FOR-HEIGHT; MENTAL-HEALTH; ACUTE MALNUTRITION; SEXUAL VIOLENCE; CLUSTER SURVEYS; MORTALITY; PREVALENCE; NUTRITION; ASSOCIATION	Valid and timely information about various domains of public health underpins the effectiveness of humanitarian public health interventions in crises. However, obstacles including insecurity, insufficient resources and skills for data collection and analysis, and absence of validated methods combine to hamper the quantity and quality of public health information available to humanitarian responders. This paper, the second in a Series of four papers, reviews available methods to collect public health data pertaining to different domains of health and health services in crisis settings, including population size and composition, exposure to armed attacks, sexual and gender-based violence, food security and feeding practices, nutritional status, physical and mental health outcomes, public health service availability, coverage and effectiveness, and mortality. The paper also quantifies the availability of a minimal essential set of information in large armed conflict and natural disaster crises since 2010: we show that information was available and timely only in a small minority of cases. On the basis of this observation, we propose an agenda for methodological research and steps required to improve on the current use of available methods. This proposition includes setting up a dedicated interagency service for public health information and epidemiology in crises.	[Checchi, Francesco; Treacy-Wong, Victoria] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Checchi, Francesco; Warsame, Abdihamid; Prudhon, Claudine] Save Children, Humanitarian Dept, London, England; [Polonsky, Jonathan] WHO, Dept Hlth Emergency Informat & Risk Assessment, Geneva, Switzerland; [van Ommeren, Mark] WHO, Dept Mental Hlth & Subst Abuse, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Save the Children; World Health Organization; World Health Organization	Checchi, F (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.	francesco.checchi@lshtm.ac.uk		Polonsky, Jonathan/0000-0002-8634-4255; Checchi, Francesco/0000-0001-9030-5382	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ager A, 2014, SCIENCE, V345, P1290, DOI 10.1126/science.1254164; Alcorn T, 2014, LANCET, V383, P2034, DOI 10.1016/S0140-6736(14)60970-3; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Altare C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109022; [Anonymous], 1999, COM ESCL HIST GUAT; [Anonymous], 2015, CMAM REP COMPR MON R; Asgary R, 2013, INT HEALTH, V5, P85, DOI 10.1093/inthealth/iht009; Ball P, 2002, REPORT ITN CRIMINAL; Bamrah S, 2013, PREHOSP DISASTER MED, V28, P43, DOI 10.1017/S1049023X12001665; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Bilukha O, 2012, FOOD NUTR BULL, V33, P169, DOI 10.1177/156482651203300211; Bilukha OO, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-25; Blanchet K, 2017, LANCET; Blanton CJ, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-8; Bowden Sarah, 2012, Confl Health, V6, P11, DOI 10.1186/1752-1505-6-11; Briend A., 2016, BMC NUTR, V2, P63, DOI [10.1186/s40795-016-0101-7, DOI 10.1186/S40795-016-0101-7, 10.1186/s40795-016, DOI 10.1186/S40795-016]; Briend A, 2013, LANCET, V382, P1549, DOI 10.1016/S0140-6736(13)62315-6; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; Cairns KL, 2009, DISASTERS, V33, P503, DOI 10.1111/j.1467-7717.2008.01085.x; Caleo GM, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-18; Chan E Y Y, 2007, Asia Pac J Public Health, V19 Spec No, P45; Chandramohan D, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-22; Checchi F., 2011, EVALUATION DIS EARLY; Checchi F, 2007, 61 HPN; Checchi F, 2006, HUMANITARIAN EXCHANG, V36, P7; Checchi F, 2008, PLOS MED, V5, P1025, DOI 10.1371/journal.pmed.0050146; Checchi F, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-4; Church LJ, 2010, DATA CTR IDPS N KIVU; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Cooperative for Assistance and Relief Everywhere Inc. (CARE), 2010, INF YOUNG CHILD FEED; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; CRED, 2013, PEOPL AFF CONFL 2013; Crowe S, 2014, PEERJ, V2, DOI 10.7717/peerj.380; Dale NM, 2013, PUBLIC HEALTH NUTR, V16, P858, DOI 10.1017/S1368980012003345; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; Deitchler M, 2007, INT J EPIDEMIOL, V36, P858, DOI 10.1093/ije/dym092; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; DHS Program, 2015, DEM HLTH SURV PROGR; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Emergency Nutrition Network, 2012, MID UPP CIRC WEIGHT; FAO and FEWS NET, 2013, MORT POP SO CENTR SO; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Food and Nutrition Technical Assistance Project, 1999, FOOD SEC IND FRAM US; Frison S, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0048-9; Frison S, 2015, AM J CLIN NUTR, V102, P1176, DOI 10.3945/ajcn.115.108282; Garenne M, 2013, PUBLIC HEALTH NUTR, V16, P1533, DOI 10.1017/S136898001200448X; Global Health Cluster, 2009, HERAMS HLTH RES AV M; Global Health Cluster, 2017, STAND PUBL HLGH INF; Global Nutrition Cluster, 2011, RES MAT TRAIN NUTR E; Global Water Sanitation and Hygiene (WASH) Cluster, 2015, GLOB WAT SAN HYG WAS; Grais RF, 2006, DISASTERS, V30, P364, DOI 10.1111/j.0361-3666.2005.00326.x; Grais Rebecca F, 2009, Confl Health, V3, P8, DOI 10.1186/1752-1505-3-8; Grellety E., 2016, BMC NUTR, V2, P1173, DOI [10.1038/ng.3097, DOI 10.1038/NG.3097, DOI 10.1186/S40795-016-0049-7]; Grellety E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062767; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Guha-Sapir D., 2016, EM DAT CRED OFDA INT; Hagopian A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001533; Harrell-Bond B., 1992, Journal of Refugee Studies, V5, P205, DOI 10.1093/jrs/5.3-4.205; Hassan G, 2015, CULTURE CONTEXT MENT; Henderson A, 2009, USING DELPHI METHOD; Heudtlass P, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0082-9; Hicks MHR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000415; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hillbruner C, 2012, GLOB FOOD SECUR-AGR, V1, P20, DOI 10.1016/j.gfs.2012.08.001; Human Rights Watch, 2015, SAF HLTH CONFL; Human Security Centre, 2005, HUM SEC REP 2005 WAR; IASC RG MHPSS, 2015, IASC REF GROUP MENT; IASC RG MHPSS, 2012, IASC REF GROUP MENT; ICRC, 2011, HLTH CAR DANG MAK CA; ICRC, 2008, GUID ASS EM GEN; IFE Core Group, 2007, INF YOUNG CHILD FEED; Integrated Food Security Phase Classification, 2015, EVID STAND BETT FOOD; Inter-Agency Standing Committee (IASC), 2012, WHO IS DOING WHAT 4W; Johnson Kirsten, 2014, Confl Health, V8, P2, DOI 10.1186/1752-1505-8-2; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Kerac M, 2009, MANAGEMENT ACUTE MAL; Kerac M, 2011, ARCH DIS CHILD, V96, P1008, DOI 10.1136/adc.2010.191882; Kersten R, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20311; Keygnaert I, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-32; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Koedam A, 2012, RAPID ESTIMATION AFF; Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI 10.1056/NEJMra1109877; Lessler J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001110; Llosa AE, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1154-5; Lopriore C, 2007, PUBLIC HEALTH NUTR, V10, P79, DOI 10.1017/S1368980007219676; Luquero FJ, 2008, NEW ENGL J MED, V359, P432; Mackey TK, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19410; Mathers C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000265; Minetti A, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-6; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Moszynski P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8198; Myatt M, 2015, SEMIQUANTITATIVE EVA; Myatt M, 2009, ANN HUM BIOL, V36, P5, DOI 10.1080/03014460802471205; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Nickerson JW, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0045-6; NutVal, 2015, PLANN CALC MON APPL; Parcesepe A, 2016, VIOLENCE AGAINST WOM, V22, P798, DOI 10.1177/1077801215613852; Pezzoli L, 2010, TROP MED INT HEALTH, V15, P540, DOI 10.1111/j.1365-3156.2010.02482.x; Pinto A, 2007, LECT NOTES GEOINF CA, P271, DOI 10.1007/978-3-540-71318-0_20; PRICE M, 2015, SIGNIFICANCE, V12, P14, DOI DOI 10.1111/J.1740-9713.2015.00811.X; Price M, 2014, UPDATED STAT ANAL DO; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Prudhon C, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-57; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; Puttkammer NH, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24572; Rahim M, 2010, East Mediterr Health J, V16 Suppl, pS114; Reproductive Health Response in Conflict Consortium, 2004, GEND BAS VIOL TOOLS; Roberts B, 2015, ADDICTION, V110, P889, DOI 10.1111/add.12869; Roberts B, 2010, INT J EPIDEMIOL, V39, P1584, DOI 10.1093/ije/dyq188; Roberts Les, 2004, Emerg Themes Epidemiol, V1, P3, DOI 10.1186/1742-7622-1-3; Robinson C., 2003, DEMOGRAPHIC METHODS; Rodin D, 2009, INT J EPIDEMIOL, V38, P1045, DOI 10.1093/ije/dyp203; Save the Children and The Food Economy Group, 2008, PRACT GUID HOUS EC A; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Schopper D, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0002-3; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Siddiqi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113258; Slama S, 2017, LANCET, V389, P326, DOI 10.1016/S0140-6736(16)31404-0; Sollom R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001007; Spiegel PB, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-12; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; Spirer H.F., 2008, STAT METHODS HUMAN R, P195; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; Stark L, 2010, J EPIDEMIOL COMMUN H, V64, P1056, DOI 10.1136/jech.2009.093799; Stark Lindsay, 2013, Confl Health, V7, P20, DOI 10.1186/1752-1505-7-20; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Sundberg R, 2011, UNDERSTANDING PEACE RESEARCH: METHODS AND CHALLENGES, P91; Telford J, 1997, COUNTING IDENTIFICAT; The National Research Council, 2007, TOOLS METH EST POP R; Thoms Oskar Nt, 2007, Confl Health, V1, P11, DOI 10.1186/1752-1505-1-11; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; Treacy-Wong V, 2011, POPULATION ESTIMATIO; UNICEF, 2020, MULT IND CLUST SURV; United Nations High Commissioner for Refugees, 2015, UN HIGH COMM REF TWI; United Nations High Commissioner for Refugees, 2015, STAND EXP NUTR SURV; United Nations Office for the Coordination of Humanitarian Affairs, 2015, UN OFF COORD HUM AFF; United Nations Office for the Coordination of Humanitarian Affairs, 2015, UN OFF COORD HUM AFF; Uppsala Conflict Data Program, 2016, UCDP BATTL REL DEATH; van Ommeren M, 2005, BRIT MED J, V330, P1160, DOI 10.1136/bmj.330.7501.1160; van Ommeren M, 2003, LANCET, V362, P574, DOI 10.1016/S0140-6736(03)14123-2; WFP, 2006, DESK REV EST POP SIZ; WHO, 2011, EARL WARN SURV RESP; WHO, 2013, UPD MAN SEV MANLN IN; WHO, 2012, OUTBR SURV RESP HUM; WHO, 2009, EARL WARN SURV RESP; WHO, 2010, PAN AM HLTH ORG CULT; WHO, 2012, UN HIGH COMM REF ASS; World Food Programme, 2015, FOOD SEC AN VULN ASS; WORLD FOOD PROGRAMME [WFP], 2009, EM FOOD SEC ASS HDB; World Health Organization, 2000, MAN NUTR MAJ EM; World Health Organization, 2012, 65 WORLD HLTH ASS CL; World Health Organization, 2008, IND ASS INF YOUNG CH; World Health Organization, 2007, WHO ETHICAL SAFETY R; World Health Organization (WHO), 2013, EM RESP FRAM; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3; Young H, 2006, 56 HPN OV DEV I; Zeger SL, 2007, SIGNIFICANCE, V4, P54	160	58	58	5	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2297	2313		10.1016/S0140-6736(17)30702-X	http://dx.doi.org/10.1016/S0140-6736(17)30702-X			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602558	Green Accepted			2022-12-28	WOS:000415645700028
J	Rullier, E; Rouanet, P; Tuech, JJ; Valverde, A; Lelong, B; Rivoire, M; Faucheron, JL; Jafari, M; Portier, G; Meunier, B; Sileznieff, I; Prudhomme, M; Marchal, F; Pocard, M; Pezet, D; Rullier, A; Vendrely, V; Denost, Q; Asselineau, J; Doussau, A				Rullier, Eric; Rouanet, Philippe; Tuech, Jean-Jacques; Valverde, Alain; Lelong, Bernard; Rivoire, Michel; Faucheron, Jean-Luc; Jafari, Mehrdad; Portier, Guillaume; Meunier, Bernard; Sileznieff, Igor; Prudhomme, Michel; Marchal, Frederic; Pocard, Marc; Pezet, Denis; Rullier, Anne; Vendrely, Veronique; Denost, Quentin; Asselineau, Julien; Doussau, Adelaide			Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial	LANCET			English	Article							TOTAL MESORECTAL EXCISION; TRANSANAL ENDOSCOPIC MICROSURGERY; CLINICAL COMPLETE RESPONSE; PREOPERATIVE RADIOTHERAPY; NEOADJUVANT CHEMORADIOTHERAPY; CHEMORADIATION THERAPY; LOCAL EXCISION	Background Organ preservation is a concept proposed for patients with rectal cancer after a good clinical response to neoadjuvant chemotherapy, to potentially avoid morbidity and side-effects of rectal excision. The objective of this study was to compare local excision and total mesorectal excision in patients with a good response after chemoradiotherapy for lower rectal cancer. Methods We did a prospective, randomised, open-label, multicentre, phase 3 trial at 15 tertiary centres in France that were experts in the treatment of rectal cancer. Patients aged 18 years and older with stage T2T3 lower rectal carcinoma, of maximum size 4 cm, who had a good clinical response to neoadjuvant chemoradiotherapy (residual tumour <= 2 cm) were centrally randomly assigned by the surgeon before surgery to either local excision or total mesorectal excision surgery. Randomisation, which was done via the internet, was not stratified and used permuted blocks of size eight. In the local excision group, a completion total mesorectal excision was required if tumour stage was ypT2-3. The primary endpoint was a composite outcome of death, recurrence, morbidity, and side-effects at 2 years after surgery, to show superiority of local excision over total mesorectal excision in the modified intention-to-treat (ITT) population (expected proportions of patients having at least one event were 25% vs 60% for superiority). This trial was registered with ClinicalTrials.gov, number NCT00427375. Findings From March 1, 2007, to Sept 24, 2012, 186 patients received chemoradiotherapy and were enrolled in the study. 148 good clinical responders were randomly assigned to treatment, three were excluded (because they had metastatic disease, tumour >8 cm from anal verge, and withdrew consent), and 145 were analysed: 74 in the local excision group and 71 in the total mesorectal excision group. In the local excision group, 26 patients had a completion total mesorectal excision. At 2 years in the modified ITT population, one or more events from the composite primary outcome occurred in 41 (56%) of 73 patients in the local excision group and 33 (48%) of 69 in the total mesorectal excision group (odds ratio 1.33, 95% CI 0.62-2.86; p=0.43). In the modified ITT analysis, there was no difference between the groups in all components of the composite outcome, and superiority was not shown for local excision over total mesorectal excision. Interpretation We failed to show superiority of local excision over total mesorectal excision, because many patients in the local excision group received a completion total mesorectal excision that probably increased morbidity and side-effects, and compromised the potential advantages of local excision. Better patient selection to avoid unnecessary completion total mesorectal excision could improve the strategy.	[Rullier, Eric; Denost, Quentin] CHU Bordeaux, Dept Colorectal Surg, Montpellier, France; [Vendrely, Veronique] CHU Bordeaux, Serv Radiotherapie, Montpellier, France; [Rouanet, Philippe] Haut Leveque Hosp, CHU Bordeaux, Bordeaux, France; [Tuech, Jean-Jacques] CHU Charles Nicolle, Serv Chirurg Digest, Rouen, France; [Valverde, Alain] Grp Hosp Diaconesses Croix St Simon, Serv Chirurg Digest, Paris, France; [Lelong, Bernard] Inst Paoli Calmette Marseille, Dept Chirurg Oncol, Marseille, France; [Prudhomme, Michel] Ctr Leon Berard, Dept Chirurg Oncol, Lyon, France; [Faucheron, Jean-Luc] Hop A Michallon, Serv Chirurg Digest, La Tronche, France; [Jafari, Mehrdad] Ctr Oscar Lambret, Dept Chirurg Oncol, Lille, France; [Portier, Guillaume] Hop Purpan, Serv Chirurg Digest, Toulouse, France; [Sileznieff, Igor] CHU Timone, Serv Chirurg Digest, Marseille, France; [Prudhomme, Michel] Univ Caremeau, Dept Chirurg, Nimes, France; [Marchal, Frederic] Univ Lorraine, CNRS, UMR 7039, CRAN, Vandoeuvre Les Nancy, France; [Pocard, Marc] Hop Lariboisiere, Dept Med Chirurg Pathol Digest, Paris, France; [Pezet, Denis] Hop Hotel Dieu, Clermont Ferrand, France; [Rullier, Anne] CHU Bordeaux, Hop Pellegrin, Bordeaux, France	CHU Bordeaux; CHU Bordeaux; Universite de Montpellier; CHU Bordeaux; CHU de Rouen; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Leon Berard; CHU Grenoble Alpes; UNICANCER; Centre Oscar Lambret; CHU de Toulouse; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Nimes; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; CHU Bordeaux	Rullier, E (corresponding author), CHU Bordeaux, Dept Colorectal Surg, Montpellier, France.	eric.rullier@chu-bordeaux.fr	Portier, Guillaume/AAI-9411-2021; meunier, bernard/K-9938-2018	Portier, Guillaume/0000-0002-1764-8677; lelong, bernard/0000-0003-1642-2913	National Cancer Institute of France; Sanofi; Roche Pharma	National Cancer Institute of France; Sanofi(Sanofi-Aventis); Roche Pharma	National Cancer Institute of France, Sanofi, Roche Pharma.	Appelt AL, 2015, LANCET ONCOL, V16, P919, DOI 10.1016/S1470-2045(15)00120-5; Baxter NN, 2007, J CLIN ONCOL, V25, P1014, DOI 10.1200/JCO.2006.09.7840; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Bujko K, 2005, RADIOTHER ONCOL, V76, P234, DOI 10.1016/j.radonc.2005.04.004; Bujko K, 2009, RADIOTHER ONCOL, V92, P195, DOI 10.1016/j.radonc.2009.02.013; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Edge SB, 2009, AJCC CANC STAGING MA, V7; Garcia-Aguilar J, 2015, LANCET ONCOL, V16, P1537, DOI 10.1016/S1470-2045(15)00215-6; Gerard JP, 2015, RADIOTHER ONCOL, V115, P246, DOI 10.1016/j.radonc.2015.04.003; Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376; Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32; Lezoche E, 2012, BRIT J SURG, V99, P1211, DOI 10.1002/bjs.8821; Maas M, 2015, ANN SURG ONCOL, V22, P3873, DOI 10.1245/s10434-015-4687-9; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Martens MH, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw171; Pahlman L, 2007, BRIT J SURG, V94, P1285, DOI 10.1002/bjs.5679; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Pucciarelli S, 2013, DIS COLON RECTUM, V56, P1349, DOI 10.1097/DCR.0b013e3182a2303e; Renehan AG, 2016, LANCET ONCOL, V17, P174, DOI 10.1016/S1470-2045(15)00467-2; Rodel C, 2006, J CLIN ONCOL, V24, P8688; Rullier E, 2011, COLORECTAL DIS, V13, P37, DOI 10.1111/j.1463-1318.2011.02777.x; Schell SR, 2002, J AM COLL SURGEONS, V194, P584, DOI 10.1016/S1072-7515(02)01128-6; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Smart CJ, 2016, BRIT J SURG, V103, P1069, DOI 10.1002/bjs.10171; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Verseveld M, 2015, BRIT J SURG, V102, P853, DOI 10.1002/bjs.9809; Washington MK, 2009, ARCH PATHOL LAB MED, V133, P1539, DOI 10.1043/1543-2165-133.10.1539	29	170	193	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					469	479		10.1016/S0140-6736(17)31056-5	http://dx.doi.org/10.1016/S0140-6736(17)31056-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28601342				2022-12-28	WOS:000406463400028
J	Song, J; Li, Z; Wang, PF; Meyer, T; Mao, CD; Ke, YG				Song, Jie; Li, Zhe; Wang, Pengfei; Meyer, Travis; Mao, Chengde; Ke, Yonggang			Reconfiguration of DNA molecular arrays driven by information relay	SCIENCE			English	Article							SINGLE-STRANDED-DNA; CONDUCTIVE NANOWIRES; FORCE SPECTROSCOPY; NANOSCALE SHAPES; FOLDING DNA; ORIGAMI; TILES; CRYSTALS; NANOPARTICLES; NANOACTUATOR	Information relay at the molecular level is an essential phenomenon in numerous chemical and biological processes, such as intricate signaling cascades. One key challenge in synthetic molecular self-assembly is to construct artificial structures that imitate these complex behaviors in controllable systems. We demonstrated prescribed, long-range information relay in an artificial molecular array assembled from modular DNA structural units. The dynamic DNA molecular array exhibits transformations with programmable initiation, propagation, and regulation. The transformation of the array can be initiated at selected units and then propagated, without addition of extra triggers, to neighboring units and eventually the entire array. The specific information pathways by which this transformation occurs can be controlled by altering the design of individual units and the arrays.	[Song, Jie; Wang, Pengfei; Meyer, Travis; Ke, Yonggang] Emory Univ, Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Song, Jie; Wang, Pengfei; Meyer, Travis; Ke, Yonggang] Georgia Inst Technol, Atlanta, GA 30322 USA; [Song, Jie] Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Dept Instrument Sci & Engn, Shanghai 200240, Peoples R China; [Li, Zhe; Mao, Chengde] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Ke, Yonggang] Emory Univ, Dept Chem, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Shanghai Jiao Tong University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Emory University	Song, J; Ke, YG (corresponding author), Emory Univ, Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.; Song, J; Ke, YG (corresponding author), Georgia Inst Technol, Atlanta, GA 30322 USA.; Song, J (corresponding author), Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Dept Instrument Sci & Engn, Shanghai 200240, Peoples R China.; Mao, CD (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.; Ke, YG (corresponding author), Emory Univ, Dept Chem, Atlanta, GA 30322 USA.	sjie@sjtu.edu.cn; mao@purdue.edu; yonggang.ke@emory.edu	Mao, Chengde/GPP-1546-2022	Wang, Pengfei/0000-0002-3125-763X; Meyer, Travis/0000-0002-8047-4649; Mao, Chengde/0000-0001-7516-8666	NSF CAREER Award [DMR-1654485]; Wallace H. Coulter Department of Biomedical Engineering Startup Fund; Billi and Bernie Marcus Research Award; Office of Naval Research [N00014-15-1-2707]; NSF [CMMI-1437301]; National Natural Scientific Foundation of China [21605102]; Directorate For Engineering [1437301] Funding Source: National Science Foundation	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Wallace H. Coulter Department of Biomedical Engineering Startup Fund; Billi and Bernie Marcus Research Award; Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank M. Dai, S. Jiang, M. Dong, B. Wei, H. Yan, and P. Yin for technical assistance and discussion. This work was supported by NSF CAREER Award DMR-1654485, the Wallace H. Coulter Department of Biomedical Engineering Startup Fund, a Billi and Bernie Marcus Research Award to Y.K., Office of Naval Research grant N00014-15-1-2707 and NSF grant CMMI-1437301 to C.M., and a National Natural Scientific Foundation of China Grant 21605102 to J.S. All data are reported in the main text and supplementary materials.	Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Burns JR, 2016, NAT NANOTECHNOL, V11, P152, DOI [10.1038/NNANO.2015.279, 10.1038/nnano.2015.279]; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHANGEUX JP, 1961, COLD SPRING HARB SYM, V26, P313, DOI 10.1101/SQB.1961.026.01.037; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; DU SM, 1992, BIOCHEMISTRY-US, V31, P10955, DOI 10.1021/bi00160a003; Endo M, 2014, ANGEW CHEM INT EDIT, V53, P7484, DOI 10.1002/anie.201402973; Feng LP, 2003, ANGEW CHEM INT EDIT, V42, P4342, DOI 10.1002/anie.200351818; Gerling T, 2015, SCIENCE, V347, P1446, DOI 10.1126/science.aaa5372; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y., 2005, ANGEW CHEM, V117, P6852, DOI DOI 10.1002/ANGE.200502193; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Ke YG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10935; Ke YG, 2014, NAT CHEM, V6, P994, DOI [10.1038/NCHEM.2083, 10.1038/nchem.2083]; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Liu MH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3127; Liu WY, 2016, NAT CHEM, V8, P867, DOI [10.1038/NCHEM.2540, 10.1038/nchem.2540]; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Marras AE, 2015, P NATL ACAD SCI USA, V112, P713, DOI 10.1073/pnas.1408869112; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Miick SM, 1997, P NATL ACAD SCI USA, V94, P9080, DOI 10.1073/pnas.94.17.9080; Nickels PC, 2016, SCIENCE, V354, P305, DOI 10.1126/science.aah5974; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Park SH, 2005, NANO LETT, V5, P693, DOI 10.1021/nl050108i; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schueler-Furman O, 2016, CURR OPIN STRUC BIOL, V41, P159, DOI 10.1016/j.sbi.2016.06.017; Schulman R, 2007, P NATL ACAD SCI USA, V104, P15236, DOI 10.1073/pnas.0701467104; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Song J, 2012, J AM CHEM SOC, V134, P9844, DOI 10.1021/ja3017939; Veneziano R, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4388; Wang PF, 2016, J AM CHEM SOC, V138, P7733, DOI 10.1021/jacs.6b03966; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Wickham SFJ, 2011, NAT NANOTECHNOL, V6, P166, DOI [10.1038/nnano.2010.284, 10.1038/NNANO.2010.284]; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan L, 2017, P NATL ACAD SCI USA, V114, P2526, DOI 10.1073/pnas.1615536114; Yin P, 2004, ANGEW CHEM INT EDIT, V43, P4906, DOI 10.1002/anie.200460522; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	60	118	118	9	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349							eaan3377	10.1126/science.aan3377	http://dx.doi.org/10.1126/science.aan3377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28642234				2022-12-28	WOS:000406362300036
J	Ovadnevaite, J; Zuend, A; Laaksonen, A; Sanchez, KJ; Roberts, G; Ceburnis, D; Decesari, S; Rinaldi, M; Hodas, N; Facchini, MC; Seinfeld, JH; O'Dowd, C				Ovadnevaite, Jurgita; Zuend, Andreas; Laaksonen, Ari; Sanchez, Kevin J.; Roberts, Greg; Ceburnis, Darius; Decesari, Stefano; Rinaldi, Matteo; Hodas, Natasha; Facchini, Maria Cristina; Seinfeld, John H.; O'Dowd, Colin			Surface tension prevails over solute effect in organic-influenced cloud droplet activation	NATURE			English	Article							THERMODYNAMIC MODEL; HYGROSCOPIC GROWTH; COASTAL AEROSOL; PARTICLES; NUCLEUS; IMPACT; CCN	The spontaneous growth of cloud condensation nuclei (CCN) into cloud droplets under supersaturated water vapour conditions is described by classic Kohler theory(1,2). This spontaneous activation of CCN depends on the interplay between the Raoult effect, whereby activation potential increases with decreasing water activity or increasing solute concentration, and the Kelvin effect, whereby activation potential decreases with decreasing droplet size or increases with decreasing surface tension, which is sensitive to surfactants(1). Surface tension lowering caused by organic surfactants, which diminishes the Kelvin effect, is expected to be negated by a concomitant reduction in the Raoult effect, driven by the displacement of surfactant molecules from the droplet bulk to the droplet-vapour interface(3,4). Here we present observational and theoretical evidence illustrating that, in ambient air, surface tension lowering can prevail over the reduction in the Raoult effect, leading to substantial increases in cloud droplet concentrations. We suggest that consideration of liquid-liquid phase separation, leading to complete or partial engulfing of a hygroscopic particle core by a hydrophobic organic-rich phase, can explain the lack of concomitant reduction of the Raoult effect, while maintaining substantial lowering of surface tension, even for partial surface coverage. Apart from the importance of particle size and composition in droplet activation, we show by observation and modelling that incorporation of phase-separation effects into activation thermodynamics can lead to a CCN number concentration that is up to ten times what is predicted by climate models, changing the properties of clouds. An adequate representation of the CCN activation process is essential to the prediction of clouds in climate models, and given the effect of clouds on the Earth's energy balance, improved prediction of aerosol-cloud-climate interactions is likely to result in improved assessments of future climate change.	[Ovadnevaite, Jurgita; Ceburnis, Darius; O'Dowd, Colin] Natl Univ Ireland Galway, Sch Phys, Galway, Ireland; [Ovadnevaite, Jurgita; Ceburnis, Darius; O'Dowd, Colin] Natl Univ Ireland Galway, Ctr Climate & Air Pollut Studies, Galway, Ireland; [Zuend, Andreas] McGill Univ, Dept Atmospher & Ocean Sci, Montreal, PQ, Canada; [Laaksonen, Ari] Finnish Meteorol Inst, Helsinki, Finland; [Laaksonen, Ari] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Sanchez, Kevin J.; Roberts, Greg] Ctr Natl Rech Meteorol, 42 Ave Gaspard Coriolis, F-31057 Toulouse, France; [Roberts, Greg] Scripps Inst Oceanog, 9500 Gilman Dr,0221, La Jolla, CA 92093 USA; [Decesari, Stefano; Rinaldi, Matteo; Facchini, Maria Cristina] CNR, Inst Sci Atmosfera, I-40129 Bologna, Italy; [Hodas, Natasha; Seinfeld, John H.] CALTECH, Div Chem & Chem Engn, Mail Code 210-41, Pasadena, CA 91125 USA; [Hodas, Natasha] Portland State Univ, Dept Environm Sci & Management, Portland, OR 97201 USA	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; McGill University; Finnish Meteorological Institute; University of Eastern Finland; University of California System; University of California San Diego; Scripps Institution of Oceanography; Consiglio Nazionale delle Ricerche (CNR); California Institute of Technology; Portland State University	O'Dowd, C (corresponding author), Natl Univ Ireland Galway, Sch Phys, Galway, Ireland.; O'Dowd, C (corresponding author), Natl Univ Ireland Galway, Ctr Climate & Air Pollut Studies, Galway, Ireland.	colin.odowd@nuigalway.ie	Roberts, Greg/GWV-5653-2022; rinaldi, matteo/K-6083-2012; Ovadnevaite, Jurgita/B-6203-2018; Laaksonen, Ari/B-5094-2011; FACCHINI, MARIA CRISTINA/O-1230-2015; Facchini, Maria Cristina/B-3369-2014; Zuend, Andreas/O-1552-2019; Ceburnis, Darius/C-1293-2012; O'Dowd, Colin D/K-8904-2012; Facchini, Maria Cristina/AAA-1592-2019	Roberts, Greg/0000-0002-3636-8590; rinaldi, matteo/0000-0001-6543-4000; Ovadnevaite, Jurgita/0000-0001-7201-0118; Laaksonen, Ari/0000-0002-1657-2383; FACCHINI, MARIA CRISTINA/0000-0003-4833-9305; Facchini, Maria Cristina/0000-0003-4833-9305; Zuend, Andreas/0000-0003-3101-8521; Ceburnis, Darius/0000-0003-0231-5324; O'Dowd, Colin D/0000-0002-3068-2212; Facchini, Maria Cristina/0000-0003-4833-9305; Sanchez, Kevin/0000-0003-4456-0918	European Union [603445]; Irish Environmental Protection Agency; HEA PRTLI4 project; Academy of Finland Center of Excellence programme [272041]; CNR (Italy) under AirSEaLab: Progetto Laboratori Congiunti; US Office of Naval Research; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/04315-2014]; National Science Foundation Atmospheric and Geospace Sciences Postdoctoral Research Fellowship [14433246]; ICER [1450657] Funding Source: National Science Foundation	European Union(European Commission); Irish Environmental Protection Agency; HEA PRTLI4 project; Academy of Finland Center of Excellence programme(Academy of Finland); CNR (Italy) under AirSEaLab: Progetto Laboratori Congiunti; US Office of Naval Research(Office of Naval Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation Atmospheric and Geospace Sciences Postdoctoral Research Fellowship; ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research leading to these results received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) project BACCHUS under grant agreement number 603445, the Irish Environmental Protection Agency, the HEA PRTLI4 project and the Academy of Finland Center of Excellence programme (grant number 272041). The work was further supported by the CNR (Italy) under AirSEaLab: Progetto Laboratori Congiunti, the US Office of Naval Research, and the Natural Sciences and Engineering Research Council of Canada (NSERC, grant RGPIN/04315-2014). N.H. was supported by a National Science Foundation Atmospheric and Geospace Sciences Postdoctoral Research Fellowship (award number 14433246).	Bialek J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044013; DeCarlo PF, 2006, ANAL CHEM, V78, P8281, DOI 10.1021/ac061249n; Facchini MC, 2000, ATMOS ENVIRON, V34, P4853, DOI 10.1016/S1352-2310(00)00237-5; Gerard V, 2016, ENVIRON SCI TECHNOL, V50, P2974, DOI 10.1021/acs.est.5b05809; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Kleefeld C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000262; Kohler H, 1936, T FARADAY SOC, V32, P1152, DOI 10.1039/tf9363201152; Li ZD, 1998, J ATMOS SCI, V55, P1859, DOI 10.1175/1520-0469(1998)055<1859:IOSSPO>2.0.CO;2; Liu XH, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044010; McFiggans G, 2006, ATMOS CHEM PHYS, V6, P2593, DOI 10.5194/acp-6-2593-2006; McLafferty F. W., 1993, INTERPRETATION MASS; Monahan C, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/689763; Noziere B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4335; O'Dowd C, 2014, ATMOS CHEM PHYS, V14, P10687, DOI 10.5194/acp-14-10687-2014; Ovadnevaite J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048869; Petters MD, 2007, ATMOS CHEM PHYS, V7, P1961, DOI 10.5194/acp-7-1961-2007; Prisle NL, 2010, ATMOS CHEM PHYS, V10, P5663, DOI 10.5194/acp-10-5663-2010; Prisle NL, 2008, TELLUS B, V60, P416, DOI 10.1111/j.1600-0889.2008.00352.x; Rinaldi M, 2009, ATMOS CHEM PHYS, V9, P9635, DOI 10.5194/acp-9-9635-2009; Roberts GC, 2005, AEROSOL SCI TECH, V39, P206, DOI 10.1080/027868290913988; Ruehl CR, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053706; Ruehl CR, 2016, SCIENCE, V351, P1447, DOI 10.1126/science.aad4889; Ruehl CR, 2014, J PHYS CHEM A, V118, P3952, DOI 10.1021/jp502844g; Sareen N, 2013, P NATL ACAD SCI USA, V110, P2723, DOI 10.1073/pnas.1204838110; Song MJ, 2013, FARADAY DISCUSS, V165, P289, DOI 10.1039/c3fd00049d; Sorjamaa R, 2004, ATMOS CHEM PHYS, V4, P2107, DOI 10.5194/acp-4-2107-2004; Sorjamaa R, 2006, J AEROSOL SCI, V37, P1730, DOI 10.1016/j.jaerosci.2006.07.004; Sun JM, 2006, ATMOS ENVIRON, V40, P795, DOI 10.1016/j.atmosenv.2005.05.052; VARGAFTIK NB, 1983, J PHYS CHEM REF DATA, V12, P817, DOI 10.1063/1.555688; Zuend A, 2008, ATMOS CHEM PHYS, V8, P4559, DOI 10.5194/acp-8-4559-2008; Zuend A, 2011, ATMOS CHEM PHYS, V11, P9155, DOI 10.5194/acp-11-9155-2011	31	164	167	13	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					637	641		10.1038/nature22806	http://dx.doi.org/10.1038/nature22806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28636594	Green Submitted			2022-12-28	WOS:000404332000044
J	Nusbaum, NJ				Nusbaum, Neil J.			Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Letter									[Nusbaum, Neil J.] West Texas VA Hlth Care Syst, Big Spring, TX 79720 USA		Nusbaum, NJ (corresponding author), West Texas VA Hlth Care Syst, Big Spring, TX 79720 USA.							McQuade CN, 2017, ANN INTERN MED, V166, P180, DOI 10.7326/M16-1468	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					915	915		10.7326/L17-0193	http://dx.doi.org/10.7326/L17-0193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630986				2022-12-28	WOS:000403579000028
J	Voelker, R				Voelker, Rebecca			Immunotherapy for Bladder Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2363	2363		10.1001/jama.2017.6976	http://dx.doi.org/10.1001/jama.2017.6976			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MT	28632853				2022-12-28	WOS:000426799500003
J	Makani, J; Ofori-Acquah, SF; Tluway, F; Mulder, N; Wonkam, A				Makani, Julie; Ofori-Acquah, Solomon F.; Tluway, Furahini; Mulder, Nicola; Wonkam, Ambroise			Sickle cell disease: tipping the balance of genomic research to catalyse discoveries in Africa	LANCET			English	Editorial Material									[Makani, Julie; Tluway, Furahini] Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Dar Es Salaam, Tanzania; [Ofori-Acquah, Solomon F.] Univ Pittsburgh, Vasc Med Inst, Ctr Translat & Int Hematol, Pittsburgh, PA 15260 USA; [Ofori-Acquah, Solomon F.] Univ Ghana, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Korle Bu, Accra, Ghana; [Mulder, Nicola] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Computat Biol Grp,Dept Integrat Biomed Sci, Cape Town, South Africa; [Wonkam, Ambroise] Univ Cape Town, Fac Hlth Sci, Div Human Genet, Cape Town, South Africa; [Wonkam, Ambroise] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa	Muhimbili University of Health & Allied Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Ghana; University of Cape Town; University of Cape Town; University of Cape Town	Makani, J (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Dar Es Salaam, Tanzania.	jmakani@blood.ac.tz	Wonkam, Ambroise/AFU-6901-2022; Makani, Julie/N-9370-2013	Mulder, Nicola J/0000-0003-4905-0941; Makani, Julie/0000-0002-4801-6250; Ofori-Acquah, Solomon/0000-0001-5000-3048	NHLBI NIH HHS [U24 HL135600, U24 HL135881] Funding Source: Medline; Wellcome Trust [093727] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U24HL135881, U24HL135600] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Society of Hematology, 2016, STAT SICKL CELL DIS; Makani J, 2017, BRIT J HAEMATOL, V177, P838, DOI 10.1111/bjh.14644; Makani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014699; Mtatiro SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111464; Mulder NJ, 2016, GENOME RES, V26, P271, DOI 10.1101/gr.196295.115; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Quinlan J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00026; Ranque B, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.779.779; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; Seguin B, 2008, NAT REV GENET, V9, P487, DOI 10.1038/nrg2379; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; WHO, 2011, BRAZZ DECL NON COMM; Wonkam A, 2014, AM J HEMATOL, V89, P664, DOI 10.1002/ajh.23711; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	15	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2355	2358		10.1016/S0140-6736(17)31615-X	http://dx.doi.org/10.1016/S0140-6736(17)31615-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	28635598	Green Accepted			2022-12-28	WOS:000403334400010
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			Supply of promising T cell therapy is strained	SCIENCE			English	News Item																			0	12	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343								10.1126/science.356.6343.1112	http://dx.doi.org/10.1126/science.356.6343.1112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619895				2022-12-28	WOS:000403327400010
J	Krall, AS; Christofk, HR				Krall, Abigail S.; Christofk, Heather R.			CELL CYCLE Division enzyme regulates metabolism	NATURE			English	Editorial Material							CANCER; KINASE		[Krall, Abigail S.; Christofk, Heather R.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Krall, Abigail S.; Christofk, Heather R.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Christofk, HR (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA.; Christofk, HR (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	hchristofk@mednet.ucla.edu						Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang SH, 2017, NATURE, V544, P460, DOI 10.1038/nature22032; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	12	20	20	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					357	358		10.1038/nature22504	http://dx.doi.org/10.1038/nature22504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28607481				2022-12-28	WOS:000403250900022
J	Warren, P				Warren, Penny			Brian Webb OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		WEBB B, PUBLICATION LIST	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2017	357								j2829	10.1136/bmj.j2829	http://dx.doi.org/10.1136/bmj.j2829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UJ	28607122				2022-12-28	WOS:000403752200006
J	Berger, RE; Rivers, E; Levy, MM				Berger, Rebecca E.; Rivers, Emanuel; Levy, Mitchell M.			Management of Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GOAL-DIRECTED THERAPY; VENOUS OXYGEN-SATURATION; SEVERE SEPSIS; RESUSCITATION; MORTALITY		[Rivers, Emanuel] Henry Ford Hosp, Dept Emergency Med, Detroit, MI 48202 USA; [Levy, Mitchell M.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Levy, Mitchell M.] Rhode Isl Hosp, Providence, RI USA	Henry Ford Health System; Henry Ford Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital								Boulain T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0609-7; Engoren Milo, 2012, J Intensive Care Med, V27, P112, DOI 10.1177/0885066610394326; Grissom CK, 2009, CRIT CARE MED, V37, P2720, DOI 10.1097/CCM.0b013e3181a59532; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Mark DG, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0496-y; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1288-3; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rowan KM, 2017, NEW ENGL J MED, V376, P2223, DOI 10.1056/NEJMoa1701380; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	13	15	15	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2282	2285		10.1056/NEJMclde1705277	http://dx.doi.org/10.1056/NEJMclde1705277			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW8WG	28591533				2022-12-28	WOS:000402798200015
J	Chan, EYY; Murray, V				Chan, Emily Y. Y.; Murray, Virginia			What are the health research needs for the Sendai Framework?	LANCET			English	Editorial Material							DISASTER RISK		[Chan, Emily Y. Y.] Univ Oxford, Collaborating Ctr, Oxford, England; [Chan, Emily Y. Y.] Chinese Univ Hong Kong, Chinese Univ Hong Kong Disaster & Med Humanitaria, Prince Wales Hosp, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Murray, Virginia] Publ Hlth England, London, England	University of Oxford; Chinese University of Hong Kong; Prince of Wales Hospital; Public Health England	Chan, EYY (corresponding author), Univ Oxford, Collaborating Ctr, Oxford, England.	emily.chan@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093				Aitsi-Selmi A, 2015, B WORLD HEALTH ORGAN, V93, P362, DOI 10.2471/BLT.15.157362; Chan EYY, 2013, NAT GEOSCI, V6, P327, DOI 10.1038/ngeo1815; Chan Emily Ying Yang, 2009, Am J Disaster Med, V4, P107; Lo STT, 2017, INT J DISAST RISK SC, V8, P145, DOI 10.1007/s13753-017-0122-0; Maini R, 2017, INT J DISAST RISK SC, V8, P150, DOI 10.1007/s13753-017-0120-2; Poljansek K., 2017, SCI DISASTER RISK MA, DOI DOI 10.2788/842809; The Lancet, 2016, LANCET, V385, P2016; Tsutsumi A, 2015, LANCET PSYCHIAT, V2, P679, DOI 10.1016/S2215-0366(15)00278-3; UNDRR, 2015, AUST J EMERG MANAG; UNISDR, 2016, BANGK PRINC IMPL HLT; UNISDR, 2017, CANC HIGH LEV COMM E; Wahlstrom M, 2015, INT J DISAST RISK SC, V6, P200, DOI 10.1007/s13753-015-0057-2; World Health Organization, 2015, HOSP SAF IND GUID EV	13	28	28	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2017	390	10106					E35	E36		10.1016/S0140-6736(17)31670-7	http://dx.doi.org/10.1016/S0140-6736(17)31670-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK9HW	28641876				2022-12-28	WOS:000413823200002
J	Pardo, JD; Szostakiwskyj, M; Ahlberg, PE; Anderson, JS				Pardo, Jason D.; Szostakiwskyj, Matt; Ahlberg, Per E.; Anderson, Jason S.			Hidden morphological diversity among early tetrapods	NATURE			English	Article							CRANIAL MORPHOLOGY; COMPUTED-TOMOGRAPHY; DEVONIAN TETRAPOD; EAST KIRKTON; LEPOSPONDYLI; EVOLUTION; SCOTLAND; AMPHIBIANS; ANATOMY; GENUS	Phylogenetic analysis of early tetrapod evolution has resulted in a consensus across diverse data sets(1-3) in which the tetrapod stem group is a relatively homogenous collection of medium-to large-sized animals showing a progressive loss of 'fish' characters as they become increasingly terrestrial(4,5), whereas the crown group demonstrates marked morphological diversity and disparity(6). The oldest fossil attributed to the tetrapod crown group is the highly specialized astopod Lethiscus stocki(7,8), which shows a small size, extreme axial elongation, loss of limbs, spool-shaped vertebral centra, and a skull with reduced centres of ossification, in common with an otherwise disparate group of small animals known as lepospondyls. Here we use micro-computed tomography of the only known specimen of Lethiscus to provide new information that strongly challenges this consensus. Digital dissection reveals extremely primitive cranial morphology, including a spiracular notch, a large remnant of the notochord within the braincase, an open ventral cranial fissure, an anteriorly restricted parasphenoid element, and Meckelian ossifications. The braincase is elongate and lies atop a dorsally projecting septum of the parasphenoid bone, similar to stem tetrapods such as embolomeres. This morphology is consistent in a second astopod, Coloraderpeton, although the details differ. Phylogenetic analysis, including critical new braincase data, places astopods deep on the tetrapod stem, whereas another major lepospondyl lineage is displaced into the amniotes. These results show that stem group tetrapods were much more diverse in their body plans than previously thought. Our study requires a change in commonly used calibration dates for molecular analyses, and emphasizes the importance of character sampling for early tetrapod evolutionary relationships.	[Pardo, Jason D.; Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, 3330 Hosp Dr, Calgary, AB T2N 4N1, Canada; [Szostakiwskyj, Matt] Univ Calgary, Dept Biol Sci, 2500 Univ Dr, Calgary, AB T2N 1N4, Canada; [Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden	University of Calgary; University of Calgary; Uppsala University	Anderson, JS (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, 3330 Hosp Dr, Calgary, AB T2N 4N1, Canada.	janders@ucalgary.ca		Anderson, Jason/0000-0002-4503-8657; Ahlberg, Per/0000-0001-9054-2900	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank S. Pierce, J. Cundiff, the late F. A. Jenkins, C. Schaff, the late W. Amaral, D. Berman, A. Henrici, P. Holroyd, A. C. Milner, J. A. Clack, J. Bolt and W. Simpson for access to specimens, and J. Bolt, R. Carroll, J. A. Clack, M. Coates, N. Frobisch, D. Germain, A. Huttenlocker, M. Laurin, H. Maddin, D. Marjanovi, J. Olori, R. R. Reisz, and R. Schoch for discussions. We particularly thank D. Germain for first suggesting reanalysis of the Lethiscus data set with current computational tools. This research was supported in part by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to J.S.A.	Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson JS, 2003, J VERTEBR PALEONTOL, V23, P532, DOI 10.1671/1752; Anderson JS, 2003, CAN J EARTH SCI, V40, P1071, DOI 10.1139/E03-023; Anderson JS, 2002, J PALEONTOL, V76, P1029, DOI 10.1666/0022-3360(2002)076<1029:ROTAGP>2.0.CO;2; Anderson PSL, 2013, INTEGR COMP BIOL, V53, P197, DOI 10.1093/icb/ict006; Beaumont EH, 1998, ZOOL J LINN SOC-LOND, V122, P187, DOI 10.1006/zjls.1997.0118; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Carroll R. L., 1968, American Museum Novitates, VNo. 2337, P1; Carroll RL, 1998, ZOOL J LINN SOC-LOND, V122, P143, DOI 10.1006/zjls.1997.0116; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 2002, NATURE, V418, P72, DOI 10.1038/nature00824; Clack JA, 2012, PALAEONTOLOGY, V55, P73, DOI 10.1111/j.1475-4983.2011.01117.x; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Dawson J.W, 1863, AIR BREATHERS COAL P; HOLMES R, 1984, PHILOS T ROY SOC B, V306, P431, DOI 10.1098/rstb.1984.0103; Huttenlocker AK, 2013, J VERTEBR PALEONTOL, V33, P540, DOI 10.1080/02724634.2013.728998; Maddin Hillary C., 2012, Fieldiana-Life and Earth Sciences, V5, P59; Maddin HC, 2011, J MORPHOL, V272, P722, DOI 10.1002/jmor.10946; MILNER AR, 1994, T ROY SOC EDIN-EARTH, V84, P331; PANCHEN AL, 1985, PHILOS T ROY SOC B, V309, P505, DOI 10.1098/rstb.1985.0095; Pardo JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161823; Porro LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118882; REISZ RR, 1981, SPEC PUBL MUS NAT HI, V7, P1; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; SMITHSON TR, 1985, ZOOL J LINN SOC-LOND, V85, P317, DOI 10.1111/j.1096-3642.1985.tb01517.x; SMITHSON TR, 1994, T ROY SOC EDIN-EARTH, V84, P383, DOI 10.1017/S0263593300006192; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; VAUGHN PETER PAUL, 1962, AMER MIDLAND NAT, V67, P79, DOI 10.2307/2422819; WELLSTEAD CF, 1982, PALAEONTOLOGY, V25, P193	30	80	81	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					642	+		10.1038/nature22966	http://dx.doi.org/10.1038/nature22966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28636600	Green Accepted			2022-12-28	WOS:000404332000045
J	Kuchay, S; Giorgi, C; Simoneschi, D; Pagan, J; Missiroli, S; Saraf, A; Florens, L; Washburn, MP; Collazo-Lorduy, A; Castillo-Martin, M; Cordon-Cardo, C; Sebti, SM; Pinton, P; Pagano, M				Kuchay, Shafi; Giorgi, Carlotta; Simoneschi, Daniele; Pagan, Julia; Missiroli, Sonia; Saraf, Anita; Florens, Laurence; Washburn, Michael P.; Collazo-Lorduy, Ana; Castillo-Martin, Mireia; Cordon-Cardo, Carlos; Sebti, Said M.; Pinton, Paolo; Pagano, Michele			PTEN counteracts FBXL2 to promote IP3R3-and Ca2+-mediated apoptosis limiting tumour growth	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; F-MEDIATED DEGRADATION; LIVER EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM; TRISPHOSPHATE RECEPTORS; CALCIUM-RELEASE; DOWN-REGULATION; CANCER-THERAPY; CA2+ RELEASE; ER	In response to environmental cues that promote IP3 (inositol 1,4,5-trisphosphate) generation, IP3 receptors (IP3Rs) located on the endoplasmic reticulum allow the 'quasisynaptical' feeding of calcium to the mitochondria to promote oxidative phosphorylation(1). However, persistent Ca2+ release results in mitochondrial Ca2+ overload and consequent apoptosis(2). Among the three mammalian IP3Rs, IP3R3 appears to be the major player in Ca2+-dependent apoptosis. Here we show that the F-box protein FBXL2 (the receptor subunit of one of 69 human SCF (SKP1, CUL1, F-box protein) ubiquitin ligase complexes(3)) binds IP3R3 and targets it for ubiquitin-, p97- and proteasome-mediated degradation to limit Ca2+ influx into mitochondria. FBXL2-knockdown cells and FBXL2-insensitive IP3R3 mutant knock-in clones display increased cytosolic Ca2+ release from the endoplasmic reticulum and sensitization to Ca2+-dependent apoptotic stimuli. The phosphatase and tensin homologue (PTEN) gene is frequently mutated or lost in human tumours and syndromes that predispose individuals to cancer(4). We found that PTEN competes with FBXL2 for IP3R3 binding, and the FBXL2-dependent degradation of IP3R3 is accelerated in Pten(-/-) mouse embryonic fibroblasts and PTEN-null cancer cells. Reconstitution of PTEN-null cells with either wild-type PTEN or a catalytically dead mutant stabilizes IP3R3 and induces persistent Ca2+ mobilization and apoptosis. IP3R3 and PTEN protein levels directly correlate in human prostate cancer. Both in cell culture and xenograft models, a non-degradable IP3R3 mutant sensitizes tumour cells with low or no PTEN expression to photodynamic therapy, which is based on the ability of photosensitizer drugs to cause Ca2+-dependent cytotoxicity after irradiation with visible light(5,6). Similarly, disruption of FBXL2 localization with GGTi-2418, a geranylgeranyl transferase inhibitor(7), sensitizes xenotransplanted tumours to photodynamic therapy. In summary, we identify a novel molecular mechanism that limits mitochondrial Ca2+ overload to prevent cell death. Notably, we provide proof-of-principle that inhibiting IP3R3 degradation in PTEN-deregulated cancers represents a valid therapeutic strategy.	[Kuchay, Shafi; Giorgi, Carlotta; Simoneschi, Daniele; Pagan, Julia; Pagano, Michele] NYU, Sch Med, Dept Biochem & Mol Pharmacol, 522 First Ave,SRB 1107, New York, NY 10016 USA; [Kuchay, Shafi; Giorgi, Carlotta; Simoneschi, Daniele; Pagan, Julia; Pagano, Michele] NYU, Sch Med, Perlmutter Canc Ctr, 522 First Ave,SRB 1107, New York, NY 10016 USA; [Kuchay, Shafi; Pagan, Julia; Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, 522 First Ave,SRB 1107, New York, NY 10016 USA; [Giorgi, Carlotta; Missiroli, Sonia; Pinton, Paolo] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Lab Technol Adv Therapies LTTA, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Collazo-Lorduy, Ana; Castillo-Martin, Mireia; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Collazo-Lorduy, Ana] Spanish Soc Med Oncol, Madrid, Spain; [Castillo-Martin, Mireia] Champalimaud Ctr Unknown, Dept Pathol, Lisbon, Portugal; [Sebti, Said M.] Univ S Florida, Moffitt Canc Ctr, Drug Discovery Dept, Tampa, FL 33612 USA; [Sebti, Said M.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA	New York University; New York University; Howard Hughes Medical Institute; New York University; University of Ferrara; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Icahn School of Medicine at Mount Sinai; Fundacao Champalimaud; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Pagano, M (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 522 First Ave,SRB 1107, New York, NY 10016 USA.; Pagano, M (corresponding author), NYU, Sch Med, Perlmutter Canc Ctr, 522 First Ave,SRB 1107, New York, NY 10016 USA.; Pagano, M (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 522 First Ave,SRB 1107, New York, NY 10016 USA.; Pinton, P (corresponding author), Univ Ferrara, Sect Pathol Oncol & Expt Biol, Lab Technol Adv Therapies LTTA, Dept Morphol Surg & Expt Med, Ferrara, Italy.	paolo.pinton@unife.it; michele.pagano@nyumc.org	Giorgi, Carlotta/K-4649-2016; Missiroli, Sonia/K-5769-2016; Pagan, Julia/O-1929-2016; Pinton, Paolo/J-8025-2012	Pagan, Julia/0000-0002-7079-6388; Pinton, Paolo/0000-0001-7108-6508; pagano, michele/0000-0003-3210-2442; Florens, Laurence/0000-0002-9310-6650; Simoneschi, Daniele/0000-0003-0448-4295; Missiroli, Sonia/0000-0003-4530-617X	NIH; AIRC [IG-18624, MFAG-13521]; Ferrara's University; Italian Ministry of Health; Cariplo; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R35CA197731, R01CA076584, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC(Fondazione AIRC per la ricerca sul cancro); Ferrara's University; Italian Ministry of Health(Ministry of Health, Italy); Cariplo(Fondazione Cariplo); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank W. Dai, R. Parsons, M. Phillips and K. Tanaka for reagents; E. DeMarchi, C. Espiritu, G. Rona and E. Schenkein for their contribution to this study, and L. Cantley and B. Neel for advice. M. P. and P. P. are grateful to T. M. Thor and C. degli. Scrovegni, respectively, for continuous support. This work was funded by grants from the NIH to MP, and grants from AIRC (IG-18624 and MFAG-13521), funds from Ferrara's University (5x1000), the Italian Ministry of Health, and Cariplo to S.M., C. G. and P. P. A.S., L.F. and M. P. W. are supported by the Stowers Institute for Medical Research. M. P. is an Investigator with the Howard Hughes Medical Institute.	Alzayady KJ, 2013, J BIOL CHEM, V288, P29772, DOI 10.1074/jbc.M113.502203; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Barber AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098786; Bittremieux M, 2016, BBA-MOL CELL RES, V1863, P1364, DOI 10.1016/j.bbamcr.2016.01.002; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Bononi A, 2013, CELL DEATH DIFFER, V20, P1631, DOI 10.1038/cdd.2013.77; Bonora M, 2013, NAT PROTOC, V8, P2105, DOI 10.1038/nprot.2013.127; Brown SB, 2004, LANCET ONCOL, V5, P497, DOI 10.1016/S1470-2045(04)01529-3; Castillo-Martin M, 2016, METHODS MOL BIOL, P23, DOI 10.1007/978-1-4939-3299-3_3; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Dankert JF, 2016, MOL CELL, V64, P507, DOI 10.1016/j.molcel.2016.09.010; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Giorgi C, 2015, CELL CYCLE, V14, P933, DOI 10.1080/15384101.2015.1010973; Giorgi C, 2015, ONCOTARGET, V6, P1435, DOI 10.18632/oncotarget.2935; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Kazi A, 2009, MOL CELL BIOL, V29, P2254, DOI 10.1128/MCB.01029-08; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45; Marchi S, 2008, BIOCHEM BIOPH RES CO, V375, P501, DOI 10.1016/j.bbrc.2008.07.153; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004; Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112	44	147	151	11	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					554	+		10.1038/nature22965	http://dx.doi.org/10.1038/nature22965			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28614300	Green Submitted, Green Accepted			2022-12-28	WOS:000403814100043
J	Cleaver, G				Cleaver, Gavin			Access to abortion in the USA-the legal battle	LANCET			English	Editorial Material																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2361	2362		10.1016/S0140-6736(17)31663-X	http://dx.doi.org/10.1016/S0140-6736(17)31663-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	28635601				2022-12-28	WOS:000403334400013
J	Horton, R				Horton, Richard			Offline: The Donald Trump Promise	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2360	2360		10.1016/S0140-6736(17)31657-4	http://dx.doi.org/10.1016/S0140-6736(17)31657-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	28635600	Bronze			2022-12-28	WOS:000403334400012
J	Le, T; Van Kinh, N; Cuc, NTK; Tung, NLN; Lam, NT; Thuy, PTT; Cuong, DD; Phuc, PTH; Vinh, VH; Hanh, DTH; Van Tam, V; Thanh, NT; Thuy, TP; Hang, NT; Long, HB; Nhan, HT; Wertheim, HFL; Merson, L; Shikuma, C; Day, JN; Chau, NVV; Farrar, J; Thwaites, G; Wolbers, M				Thuy Le; Nguyen Van Kinh; Cuc, Ngo T. K.; Tung, Nguyen L. N.; Lam, Nguyen T.; Thuy, Pham T. T.; Cuong, Do D.; Phuc, Pham T. H.; Vinh, Vu H.; Hanh, Doan T. H.; Vu Van Tam; Thanh, Nguyen T.; Thuy, Tran P.; Hang, Nguyen T.; Long, Hoang B.; Nhan, Ho T.; Wertheim, Heiman F. L.; Merson, Laura; Shikuma, Cecilia; Day, Jeremy N.; Chau, Nguyen V. V.; Farrar, Jeremy; Thwaites, Guy; Wolbers, Marcel		IVAP Investigators	A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PENICILLIUM-MARNEFFEI INFECTION; CRYPTOCOCCAL MENINGITIS; VIETNAM; SERIES	BACKGROUND Talaromyces marneffei infection is a major cause of human immunodeficiency virus (HIV)-related death in South and Southeast Asia. Guidelines recommend initial treatment with amphotericin B deoxycholate, but this drug has substantial side effects, a high cost, and limited availability. Itraconazole is available in oral form, is associated with fewer unacceptable side effects than amphotericin, and is widely used in place of amphotericin; however, clinical trials comparing these two treatments are lacking. METHODS In this open-label, noninferiority trial, we randomly assigned 440 HIV-infected adults who had talaromycosis, confirmed by either microscopy or culture, to receive either intravenous amphotericin B deoxycholate (amphotericin) (219 patients), at a dose of 0.7 to 1.0 mg per kilogram of body weight per day, or itraconazole capsules (221 patients), at a dose of 600 mg per day for 3 days, followed by 400 mg per day, for 11 days; thereafter, all the patients received maintenance therapy with itraconazole. The primary outcome was all-cause mortality at week 2. Secondary outcomes included all-cause mortality at week 24, the time to clinical resolution of talaromycosis, early fungicidal activity, relapse of talaromycosis, development of the immune reconstitution inflammatory syndrome (IRIS), and the side-effect profile. RESULTS The risk of death at week 2 was 6.5% in the amphotericin group and 7.4% in the itraconazole group (absolute risk difference, 0.9 percentage points; 95% confidence interval [CI], -3.9 to 5.6; P < 0.001 for noninferiority); however, the risk of death at week 24 was 11.3% in the amphotericin group and 21.0% in the itraconazole group (absolute risk difference, 9.7 percentage points; 95% CI, 2.8 to 16.6; P = 0.006). Treatment with amphotericin was associated with significantly faster clinical resolution and fungal clearance and significantly lower rates of relapse and IRIS than itraconazole. The patients who received amphotericin had significantly higher rates of infusion-related reactions, renal failure, hypokalemia, hypomagnesemia, and anemia than patients in the itraconazole group. CONCLUSIONS Amphotericin was superior to itraconazole as initial treatment for talaromycosis with respect to 6-month mortality, clinical response, and fungicidal activity. (Funded by the Medical Research Council and others; IVAP Current Controlled Trials number, ISRCTN59144167.)	[Thuy Le; Lam, Nguyen T.; Thuy, Tran P.; Hang, Nguyen T.; Long, Hoang B.; Nhan, Ho T.; Wertheim, Heiman F. L.; Day, Jeremy N.; Farrar, Jeremy; Thwaites, Guy; Wolbers, Marcel] Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, 764 Vo Van Kiet,Ward 1,Dist 5, Ho Chi Minh City, Vietnam; [Cuc, Ngo T. K.; Tung, Nguyen L. N.; Chau, Nguyen V. V.] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Nguyen Van Kinh; Lam, Nguyen T.] Natl Hosp Trop Dis, Hanoi, Vietnam; [Thuy, Pham T. T.; Cuong, Do D.] Bach Mai Hosp, Hanoi, Vietnam; [Phuc, Pham T. H.; Vinh, Vu H.] Viet Tiep Hosp, Hai Phong, Vietnam; [Hanh, Doan T. H.; Vu Van Tam] Vietnam Sweden Uong Bi Hosp, Quang Ninh, Vietnam; [Thuy Le; Day, Jeremy N.; Thwaites, Guy; Wolbers, Marcel] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Merson, Laura] Univ Oxford, Worldwide Antimalarial Resistance Network, Oxford, England; [Wertheim, Heiman F. L.] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands; [Thuy Le; Shikuma, Cecilia] Univ Hawaii Manoa, Hawaii Ctr AIDS, Honolulu, HI 96822 USA	National Hospital of Tropical Diseases; University of Oxford; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN); Radboud University Nijmegen; University of Hawaii System; University of Hawaii Manoa	Le, T (corresponding author), Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, 764 Vo Van Kiet,Ward 1,Dist 5, Ho Chi Minh City, Vietnam.	thuyl@oucru.org	Hoang, Long Bao/L-7676-2017; Thwaites, Guy E/R-4993-2019; HAI, Vinh VU/AAT-2844-2021; Wertheim, Heiman FL/F-3338-2016; van Doorn, H. Rogier/H-3080-2019; Farrar, Jeremy J./HGA-7610-2022; Larsson, Mattias/C-6434-2017	Hoang, Long Bao/0000-0002-2829-3875; Thwaites, Guy E/0000-0002-2858-2087; HAI, Vinh VU/0000-0001-6130-7864; Wertheim, Heiman FL/0000-0002-5003-5565; van Doorn, H. Rogier/0000-0002-9807-1821; Larsson, Mattias/0000-0002-0514-7445; Gray, Alastair/0000-0003-0239-7278; Do Duy, Cuong/0000-0002-1565-642X; Merson, Laura/0000-0002-4168-1960	Medical Research Council; Medical Research Council [G1100682] Funding Source: researchfish; MRC [G1100682] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Medical Research Council and others; IVAP Current Controlled Trials number, ISRCTN59144167.	Angus BJ, 2011, HIV MED, V12, P88, DOI 10.1111/j.1468-1293.2011.00944_11.x; Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024; Bicanic T, 2015, ANTIMICROB AGENTS CH, V59, P7224, DOI 10.1128/AAC.01698-15; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.18; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hai VV, 2010, REV MED INTERNE, V31, P812, DOI 10.1016/j.revmed.2010.07.019; Hu YX, 2013, MYCOPATHOLOGIA, V175, P57, DOI 10.1007/s11046-012-9577-0; Larsson M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-24; Livermore J, 2014, MBIO, V5, DOI 10.1128/mBio.00725-13; Muzoora CK, 2012, J INFECTION, V64, P76, DOI 10.1016/j.jinf.2011.10.014; R CORE TEAM, 2016, R LANG ENV STAT COMP; Ranjana KH, 2002, J INFECTION, V45, P268, DOI 10.1053/jinf.2002.1062; Sirisanthana T, 1998, CLIN INFECT DIS, V26, P1107, DOI 10.1086/520280; Son VT, 2014, MED MALADIES INFECT, V44, P495, DOI 10.1016/j.medmal.2014.09.008; SUPPARATPINYO K, 1992, CLIN INFECT DIS, V14, P871, DOI 10.1093/clinids/14.4.871; SUPPARATPINYO K, 1994, LANCET, V344, P110, DOI 10.1016/S0140-6736(94)91287-4; Thuy L, 2011, CLIN INFECT DIS, V52, P945, DOI 10.1093/cid/cir028; Tran VTN, 2012, T ROY SOC TROP MED H, V106, P26, DOI 10.1016/j.trstmh.2011.10.004; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Viet Nam Authority of HIV/AIDS Control, 2014, ANN UPD HIV EP VIETN; World Health Organization, 2011, RAP ADV DIAGN PREV M; Wu T. C., 2008, Hong Kong Medical Journal, V14, P103	25	81	100	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2329	2340		10.1056/NEJMoa1613306	http://dx.doi.org/10.1056/NEJMoa1613306			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4UQ	28614691	Bronze, Green Published			2022-12-28	WOS:000403230800006
J	Weis, S; Carlos, AR; Moita, MR; Singh, S; Blankenhaus, B; Cardoso, S; Larsen, R; Rebelo, S; Schauble, S; Del Barrio, L; Mithieux, G; Rajas, F; Lindig, S; Bauer, M; Soares, MP				Weis, Sebastian; Carlos, Ana Rita; Moita, Maria Raquel; Singh, Sumnima; Blankenhaus, Birte; Cardoso, Silvia; Larsen, Rasmus; Rebelo, Sofia; Schaeuble, Sascha; Del Barrio, Laura; Mithieux, Gilles; Rajas, Fabienne; Lindig, Sandro; Bauer, Michael; Soares, Miguel P.			Metabolic Adaptation Establishes Disease Tolerance to Sepsis	CELL			English	Article							GLUCOSE-6-PHOSPHATASE GENE-EXPRESSION; IRON STORAGE; FERRITIN H; HEME; LIVER; INFLAMMATION; BINDING; MICE; HOMEOSTASIS; PREDICTION	Sepsis is an often lethal syndrome resulting from maladaptive immune and metabolic responses to infection, compromising host homeostasis. Disease tolerance is a defense strategy against infection that preserves host homeostasis without exerting a direct negative impact on pathogens. Here, we demonstrate that induction of the iron-sequestering ferritin H chain (FTH) in response to polymicrobial infections is critical to establish disease tolerance to sepsis. The protective effect of FTH is exerted via a mechanism that counters iron-driven oxidative inhibition of the liver glucose-6-phosphatase (G6Pase), and in doing so, sustains endogenous glucose production via liver gluconeogenesis. This is required to prevent the development of hypoglycemia that otherwise compromises disease tolerance to sepsis. FTH overexpression or ferritin administration establish disease tolerance therapeutically. In conclusion, disease tolerance to sepsis relies on a crosstalk between adaptive responses controlling iron and glucose metabolism, required to maintain blood glucose within a physiologic range compatible with host survival.	[Weis, Sebastian; Carlos, Ana Rita; Moita, Maria Raquel; Singh, Sumnima; Blankenhaus, Birte; Cardoso, Silvia; Larsen, Rasmus; Rebelo, Sofia; Del Barrio, Laura; Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Weis, Sebastian; Lindig, Sandro; Bauer, Michael] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, D-07747 Jena, Germany; [Schaeuble, Sascha] Friedrich Schiller Univ, Language & Informat Engn Lab, D-07743 Jena, Germany; [Mithieux, Gilles; Rajas, Fabienne] Univ Claude Bernard Lyon, INSERM U1213, F-69100 Villeurbanne, France; [Lindig, Sandro; Bauer, Michael] Jena Univ Hosp, Ctr Sepsis Control & Care, D-07747 Jena, Germany	Instituto Gulbenkian de Ciencia; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Friedrich Schiller University of Jena	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt	Weis, Sebastian/P-9016-2014; Carlos, Ana Rita/N-1137-2016; Schäuble, Sascha/AAF-7809-2021; Carlos, Ana Rita/K-6014-2019; Barrio, Laura/B-3767-2017	Weis, Sebastian/0000-0003-3201-2375; Carlos, Ana Rita/0000-0002-6953-1163; Carlos, Ana Rita/0000-0002-6953-1163; Barrio, Laura/0000-0001-9203-3296; Cardoso, Silvia/0000-0003-4639-698X; Gilles, Mithieux/0000-0003-3579-8529; Singh, Sumnima/0000-0002-1826-0180; Moita, Maria Raquel/0000-0002-4624-8154; Bauer, Michael/0000-0002-1521-3514; Soares, Miguel/0000-0002-9314-4833; Blankenhaus, Birte/0000-0003-0987-5228; Rebelo, Sofia/0000-0001-8399-0262	Fundacao para a Ciencia e Tecnologia [PTDC/SAU-TOX/116627/2010, HMSP-ICT/0018/2011, SFRH/BPD/101608/2014]; European Community 7th Framework [ERC-2011-AdG294709-DAMAGECONTROL]; Deutsche Forschungsgemeinschaft (DFG) [WE 4971/3]; German Federal Ministry of Education and Research (BMBF, Center for Sepsis Control and Care ) [01EO1002]; Meta-ZIK [03Z2J52]; German Ministry for Research and Education e:Med initiative GlioPATH [FKZ 01ZX1402C]; French National Research Agency [ANR-11-BSV1-009, ANR-15-CE14-0026-03]; Medical Research Foundation [DRM20101220448]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community 7th Framework; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF, Center for Sepsis Control and Care )(Federal Ministry of Education & Research (BMBF)); Meta-ZIK; German Ministry for Research and Education e:Med initiative GlioPATH; French National Research Agency(French National Research Agency (ANR)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Inflammation Group (IGC) for insightful discussions, Tania Carvalho and Jasmin Tischer for histopathological examination, Amandine Gautier-Stein (Universite Claude Bernard Lyon, France) for luciferase reporter constructs and advise, Luis F. Moita (IGC) and Rui Martins (Medical University, Vienna, Austria) for critical appraisal of the manuscript as well as Marta Monteiro (IGC, Flow Cytometry). Support was provided by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-TOX/116627/2010 and HMSP-ICT/0018/2011 to M.P.S. and SFRH/BPD/101608/2014 to A.R.C.), the European Community 7th Framework (ERC-2011-AdG294709-DAMAGECONTROL to M.P.S.), the Deutsche Forschungsgemeinschaft (DFG; WE 4971/3 to S.W.), the German Federal Ministry of Education and Research (BMBF; 01EO1002, Center for Sepsis Control and Care to M.B.), Meta-ZIK (03Z2J52 to M.B.), the German Ministry for Research and Education e:Med initiative GlioPATH (FKZ 01ZX1402C to S. Schauble), the French National Research Agency (ANR-11-BSV1-009 and ANR-15-CE14-0026-03 to F.R.), and the Medical Research Foundation (DRM20101220448 to G.M.).	Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clottes E, 1998, J BIOL CHEM, V273, P19391, DOI 10.1074/jbc.273.31.19391; Darshan D, 2009, HEPATOLOGY, V50, P852, DOI 10.1002/hep.23058; Deak M, 1999, NAT BIOTECHNOL, V17, P192, DOI 10.1038/6198; Deutschman CS, 1997, AM J PHYSIOL-REG I, V273, pR1709, DOI 10.1152/ajpregu.1997.273.5.R1709; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; Gozzelino R, 2014, ANTIOXID REDOX SIGN, V20, P1754, DOI 10.1089/ars.2013.5666; Gozzelino R, 2012, CELL HOST MICROBE, V12, P693, DOI 10.1016/j.chom.2012.10.011; Grempler R, 2004, BIOCHEM J, V382, P471, DOI 10.1042/BJ20040160; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c; Janz DR, 2013, CRIT CARE, V17, DOI 10.1186/cc13108; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Lee I, 2014, BBA-MOL BASIS DIS, V1842, P1579, DOI 10.1016/j.bbadis.2014.05.031; LIPINSKI P, 1991, INT J EXP PATHOL, V72, P623; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meyron-Holtz EG, 2011, J NEURAL TRANSM, V118, P337, DOI 10.1007/s00702-011-0582-0; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; Mutel E, 2011, J HEPATOL, V54, P529, DOI 10.1016/j.jhep.2010.08.014; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Okin D, 2016, CELL, V165, P343, DOI 10.1016/j.cell.2016.02.023; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pravda Jay, 2014, World J Crit Care Med, V3, P45, DOI 10.5492/wjccm.v3.i2.45; Raetzsch CF, 2009, HEPATOLOGY, V50, P592, DOI 10.1002/hep.22999; Rajas F, 2002, J BIOL CHEM, V277, P15736, DOI 10.1074/jbc.M200971200; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Soares MP, 2016, CURR OPIN IMMUNOL, V38, P94, DOI 10.1016/j.coi.2015.11.006; Soares MP, 2015, EMBO REP, V16, P1482, DOI 10.15252/embr.201540558; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; WITZLEBEN CL, 1962, J EXP MED, V115, P723, DOI 10.1084/jem.115.4.723; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; YKIJARVINEN H, 1989, J CLIN ENDOCR METAB, V69, P317, DOI 10.1210/jcem-69-2-317	53	145	149	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1263	+		10.1016/j.cell.2017.05.031	http://dx.doi.org/10.1016/j.cell.2017.05.031			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622511	Green Published, hybrid			2022-12-28	WOS:000403332400015
J	Moss, S; Mumford, D				Moss, Stasia; Mumford, David			Timothy Hugh Moss OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									[Moss, Stasia; Mumford, David] Frenchay Hosp, Bristol, Avon, England		Moss, S (corresponding author), Frenchay Hosp, Bristol, Avon, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2017	357								j2826	10.1136/bmj.j2826	http://dx.doi.org/10.1136/bmj.j2826			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UJ	28606899				2022-12-28	WOS:000403752200005
J	Kayani, M; Aslam, AM				Kayani, Mahaz; Aslam, Arif M.			CLINICAL UPDATES Bullous pemphigoid and pemphigus vulgaris	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; DIAGNOSIS		[Kayani, Mahaz] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Preston PR2 9HT, Lancs, England; [Aslam, Arif M.] St Helens & Knowsley Teaching Hosp NHS Trust, St Helens WA9 3DA, England	Royal Preston Hospital	Aslam, AM (corresponding author), St Helens & Knowsley Teaching Hosp NHS Trust, St Helens WA9 3DA, England.	a.aslam@doctors.org.uk						Ahmed AR, 2006, NEW ENGL J MED, V355, P1772, DOI 10.1056/NEJMoa062930; AHMED AR, 1990, P NATL ACAD SCI USA, V87, P7658, DOI 10.1073/pnas.87.19.7658; [Anonymous], 2011, CLIN EXP DERMATOL, V36, P927, DOI 10.1111/j.1365-2230.2011.04251.x; [Anonymous], 2011, CLIN EXP DERMATOL, V357, P449, DOI [10.1111/j.1365-2230.2011.04104.x, DOI 10.1111/J.1365-2230.2011.04104.X]; Atzmony L, 2015, J AM ACAD DERMATOL, V73, P264, DOI 10.1016/j.jaad.2015.04.038; Bastuji-Garin S, 2011, J INVEST DERMATOL, V131, P637, DOI 10.1038/jid.2010.301; Baum S, 2014, AUTOIMMUN REV, V13, P482, DOI 10.1016/j.autrev.2014.01.047; Beissert S, 2010, J INVEST DERMATOL, V130, P2041, DOI 10.1038/jid.2010.91; Brick KE, 2014, J AM ACAD DERMATOL, V71, P92, DOI 10.1016/j.jaad.2014.02.030; Carson PJ, 1996, J AM ACAD DERMATOL, V34, P645, DOI 10.1016/S0190-9622(96)80066-1; Chams-Davatchi C, 2013, J EUR ACAD DERMATOL, V27, P1285, DOI 10.1111/j.1468-3083.2012.04717.x; Cortes B, 2011, BRIT J DERMATOL, V165, P368, DOI 10.1111/j.1365-2133.2011.10413.x; GUILLAUME JC, 1993, ARCH DERMATOL, V129, P49, DOI 10.1001/archderm.129.1.49; Hertl M, 2015, J EUR ACAD DERMATOL, V29, P405, DOI 10.1111/jdv.12772; Heymann AD, 2007, ARCH DERMATOL, V143, P704, DOI 10.1001/archderm.143.6.704; Horvath B, 2012, BRIT J DERMATOL, V166, P405, DOI 10.1111/j.1365-2133.2011.10663.x; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Langan SM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a180; Lloyd-Lavery A, 2013, JAMA DERMATOL, V149, P58, DOI 10.1001/2013.jamadermatol.376; Mariotti F, 2004, BRIT J DERMATOL, V151, P1004, DOI 10.1111/j.1365-2133.2004.06245.x; Risser J, 2009, ARCH DERMATOL, V145, P1005, DOI 10.1001/archdermatol.2009.205; Roussel A, 2011, ARCH DERMATOL, V147, P293, DOI 10.1001/archdermatol.2011.21; Schmidt E, 2010, AUTOIMMUN REV, V10, P84, DOI 10.1016/j.autrev.2010.08.007; Sitaru C, 2005, EXP DERMATOL, V14, P861, DOI 10.1111/j.1600-0625.2005.00367.x; Sitaru C, 2007, EXP DERMATOL, V16, P770, DOI 10.1111/j.1600-0625.2007.00592.x; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Stavropoulos PG, 2014, J EUR ACAD DERMATOL, V28, P1133, DOI 10.1111/jdv.12366; Terra JB, 2014, J EUR ACAD DERMATOL, V28, P712, DOI 10.1111/jdv.12153; Venning VA, 2012, BRIT J DERMATOL, V167, P1200, DOI 10.1111/bjd.12072; Williams HC, 2017, LANCET, V389, P1630, DOI 10.1016/S0140-6736(17)30560-3	30	14	14	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2017	357								j2169	10.1136/bmj.j2169	http://dx.doi.org/10.1136/bmj.j2169			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RE	28596152				2022-12-28	WOS:000403221600001
J	Liu, JL; Li, L; Deng, K; Xu, C; Busse, JW; Vandvik, PO; Li, SY; Guyatt, GH; Sun, X				Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Busse, Jason W.; Vandvik, Per Olav; Li, Sheyu; Guyatt, Gordon H.; Sun, Xin			Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; GLP-1 RECEPTOR AGONISTS; DPP-4 INHIBITORS; CARDIOVASCULAR OUTCOMES; HEART-FAILURE; SGLT-2 INHIBITORS; BLOOD-PRESSURE; DOUBLE-BLIND; SITAGLIPTIN	OBJECTIVE To assess the impact of incretin based treatment on all cause mortality in patients with type 2 diabetes. DESIGN Systematic review and meta-analysis of randomised trials. DATA SOURCES Medline, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov. ELIGIBILITY CRITERIA Randomised controlled trials that compared glucagon-like peptide-1 (GLP-1) receptor agonists or dipeptidyl peptidase-4 (DPP-4) inhibitors with placebo or active anti-diabetic drugs in patients with type 2 diabetes. DATA COLLECTION AND ANALYSIS Paired reviewers independently screened citations, assessed risk of bias of included studies, and extracted data. Peto's method was used as the primary approach to pool effect estimates from trials, sensitivity analyses were carried out with other statistical approaches, and meta-regression was applied for six prespecified hypotheses to explore heterogeneity. The GRADE approach was used to rate the quality of evidence. RESULTS 189 randomised controlled trials (n=155 145) were included, all of which were at low to moderate risk of bias; 77 reported no events of death and 112 reported 3888 deaths among 151 614 patients. Meta-analysis of 189 trials showed no difference in all cause mortality between incretin drugs versus control (1925/84 136 v 1963/67 478; odds ratio 0.96, 95% confidence interval 0.90 to 1.02, I-2=0%; risk difference 3 fewer events (95% confidence interval 7 fewer to 1 more) per 1000 patients over five years; moderate quality evidence). Results suggested the possibility of a mortality benefit with GLP-1 agonists but not DPP-4 inhibitors, but the subgroup hypothesis had low credibility. Sensitivity analyses showed no important differences in the estimates of effects. CONCLUSIONS Current evidence does not support the suggestion that incretin based treatment increases all cause mortality in patients with type 2 diabetes. Further studies are warranted to examine if the effect differs between GLP-1 agonists versus DPP-4 inhibitors.	[Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Sun, Xin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China; [Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Sun, Xin] Sichuan Univ, West China Hosp, CREAT Grp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Sun, Xin] Collaborat Innovat Ctr, Chengdu 610041, Sichuan, Peoples R China; [Busse, Jason W.; Guyatt, Gordon H.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4K1, Canada; [Busse, Jason W.] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4K1, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON L8S 4K1, Canada; [Vandvik, Per Olav] Norwegian Knowledge Ctr Hlth Serv, N-0130 N- Oslo, Norway; [Vandvik, Per Olav] Innlandet Hosp Trust, Dept Med, N-2819 Gjovik, Norway; [Li, Sheyu] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610041, Sichuan, Peoples R China; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada	Sichuan University; Sichuan University; McMaster University; McMaster University; McMaster University; Norwegian Knowledge Centre for Health Services; Innlandet Hospital Trust; Sichuan University; McMaster University	Sun, X (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China.; Sun, X (corresponding author), Sichuan Univ, West China Hosp, CREAT Grp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.; Sun, X (corresponding author), Collaborat Innovat Ctr, Chengdu 610041, Sichuan, Peoples R China.	sunx26@gmail.com	Li, Sheyu/O-3242-2016; Busse, Jason/CAH-3696-2022	Li, Sheyu/0000-0003-0060-0287; Busse, Jason/0000-0002-0178-8712; Xu, Chang/0000-0002-2627-1250	National Natural Science Foundation of China [71573183, 81400811, 21534008]; "Thousand Youth Talents Plan" of China [D1024002]; "Thousand Youth Talents Plan" of Sichuan Province; Young Investigator Award of Sichuan University [2013SCU04A37]; Canadian Institutes of Health Research; Canadian Chiropractic Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Thousand Youth Talents Plan" of China; "Thousand Youth Talents Plan" of Sichuan Province; Young Investigator Award of Sichuan University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation	This study was supported by National Natural Science Foundation of China (grant No 71573183), "Thousand Youth Talents Plan" of China (grant No D1024002), and Sichuan Province, and Young Investigator Award of Sichuan University (grant No 2013SCU04A37). These funders had no role in the study design, writing of the manuscript, or decision to submit this or future manuscripts for publication. JWB is funded by a New Investigator Award from the Canadian Institutes of Health Research and Canadian Chiropractic Research Foundation. SL is funded by the National Natural Science Foundation of China (grant No 81400811 and 21534008).	Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Bailey TS, 2016, DIABETES OBES METAB, V18, P1191, DOI 10.1111/dom.12736; Bergenstal Richard M, 2012, Diabetes Ther, V3, P13, DOI 10.1007/s13300-012-0013-8; Boland CL, 2013, ANN PHARMACOTHER, V47, P490, DOI 10.1345/aph.1R444; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brunton S, 2014, INT J CLIN PRACT, V68, P557, DOI 10.1111/ijcp.12361; Charbonnel B, 2013, DIABETOLOGIA, V56, P1503, DOI 10.1007/s00125-013-2905-1; ClinicalTrials. gov, WHY SHOULD I REG SUB; de Wit HM, 2016, BRIT J CLIN PHARMACO, V82, P301, DOI 10.1111/bcp.12925; Ding S, 2016, INT J CARDIOL, V222, P957, DOI 10.1016/j.ijcard.2016.07.199; Esposito K, 2011, CURR MED RES OPIN, V27, P1519, DOI 10.1185/03007995.2011.590127; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Giorda CB, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007959; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Guyatt GH, MODIFICATION COCHRAN; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Karagiannis T, 2015, DIABETES OBES METAB, V17, P1065, DOI 10.1111/dom.12541; Karagiannis T, 2012, BMJ-BRIT MED J, V344, pe1369, DOI DOI 10.1136/BMJ.E1369; Katout M, 2014, AM J HYPERTENS, V27, P130, DOI 10.1093/ajh/hpt196; Kawalec P, 2014, DIABETES-METAB RES, V30, P269, DOI 10.1002/dmrr.2494; Kline Glaxo Smith, 2000, STUDY EFFICACY SAFET; Kline Glaxo Smith, 2000, EFFICACY SAFETY ALBI; Lisa Yanoff MD, SAXAGLIPTIN ASSESSME; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mogensen UM, 2014, DIABETES OBES METAB, V16, P1001, DOI 10.1111/dom.12314; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Monami M, 2014, DIABETES OBES METAB, V16, P38, DOI 10.1111/dom.12175; Monami M, 2010, NUTR METAB CARDIOVAS, V20, P224, DOI 10.1016/j.numecd.2009.03.015; Monami M, 2011, EXP DIABETES RES, DOI 10.1155/2011/215764; Morgan CL, 2014, DIABETES OBES METAB, V16, P977, DOI 10.1111/dom.12306; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Pratley R, 2011, INT J CLIN PRACT, V65, P397, DOI 10.1111/j.1742-1241.2011.02656.x; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Savarese G, 2016, INT J CARDIOL, V220, P595, DOI 10.1016/j.ijcard.2016.06.208; Savarese G, 2015, INT J CARDIOL, V181, P239, DOI 10.1016/j.ijcard.2014.12.017; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sun F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/157201; SUN X, 2010, BMJ-BRIT MED J, V340, DOI DOI 10.1136/BMJ.C117; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tricco AC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005752; [United BioSource CorporationTessella Inc. Berry Consultants Eli Lilly and Company], 2000, STUD LY2189265 COMP; Van Gaal L, 2014, J CLIN TRANSL ENDOCR, V1, P31, DOI 10.1016/j.jcte.2014.03.001; Velez M, 2015, J CARD FAIL, V21, P2, DOI 10.1016/j.cardfail.2014.10.012; Wang KL, 2014, INT J CARDIOL, V177, P86, DOI 10.1016/j.ijcard.2014.09.038; Weir DL, 2014, JACC-HEART FAIL, V2, P573, DOI 10.1016/j.jchf.2014.04.005; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wu SY, 2014, CARDIOVASC THER, V32, P147, DOI 10.1111/1755-5922.12075; Zang L, 2016, DIABETES OBES METAB, V18, P803, DOI 10.1111/dom.12674; Zhang XD, 2016, J HYPERTENS, V34, P167, DOI 10.1097/HJH.0000000000000782	55	43	46	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2017	357								j2499	10.1136/bmj.j2499	http://dx.doi.org/10.1136/bmj.j2499			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RE	28596247	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000403221600004
J	Yao, SY; Zhang, X; Zhou, W; Gao, R; Xu, WQ; Ye, YF; Lin, LL; Wen, XD; Liu, P; Chen, BB; Crumlin, E; Guo, JH; Zuo, ZJ; Li, WZ; Xie, JL; Lu, L; Kiely, CJ; Gu, L; Shi, C; Rodriguez, JA; Ma, D				Yao, Siyu; Zhang, Xiao; Zhou, Wu; Gao, Rui; Xu, Wenqian; Ye, Yifan; Lin, Lili; Wen, Xiaodong; Liu, Ping; Chen, Bingbing; Crumlin, Ethan; Guo, Jinghua; Zuo, Zhijun; Li, Weizhen; Xie, Jinglin; Lu, Li; Kiely, Christopher J.; Gu, Lin; Shi, Chuan; Rodriguez, Jose A.; Ma, Ding			Atomic-layered Au clusters on alpha-MoC as catalysts for the low-temperature water-gas shift reaction	SCIENCE			English	Article							NANOPARTICLES; CERIA; OXIDATION	The water-gas shift (WGS) reaction (where carbon monoxide plus water yields dihydrogen and carbon dioxide) is an essential process for hydrogen generation and carbon monoxide removal in various energy-related chemical operations. This equilibrium-limited reaction is favored at a low working temperature. Potential application in fuel cells also requires a WGS catalyst to be highly active, stable, and energy-efficient and to match the working temperature of on-site hydrogen generation and consumption units. We synthesized layered gold (Au) clusters on a molybdenum carbide (alpha-MoC) substrate to create an interfacial catalyst system for the ultralow-temperature WGS reaction. Water was activated over alpha-MoC at 303 kelvin, whereas carbon monoxide adsorbed on adjacent Au sites was apt to react with surface hydroxyl groups formed from water splitting, leading to a high WGS activity at low temperatures.	[Yao, Siyu; Lin, Lili; Li, Weizhen; Xie, Jinglin; Ma, Ding] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Yao, Siyu; Lin, Lili; Li, Weizhen; Xie, Jinglin; Ma, Ding] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Zhang, Xiao; Chen, Bingbing; Shi, Chuan] Dalian Univ Technol, Coll Chem, State Key Lab Fine Chem, Dalian 116024, Peoples R China; [Zhou, Wu] Chinese Acad Sci, Univ Chinese Acad Sci, Key Lab Vacuum Sci, Sch Phys Sci, Beijing 100049, Peoples R China; [Zhou, Wu] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Gao, Rui; Wen, Xiaodong] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, POB 165, Taiyuan 030001, Shanxi, Peoples R China; [Gao, Rui; Wen, Xiaodong] Synfuels China, Beijing 100195, Peoples R China; [Xu, Wenqian; Liu, Ping; Rodriguez, Jose A.] Brookhaven Natl Lab, Chem Div, Bldg 555,POB 5000, Upton, NY 11973 USA; [Ye, Yifan; Crumlin, Ethan; Guo, Jinghua] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Zuo, Zhijun] Taiyuan Univ Technol, Key Lab Coal Sci & Technol, Minist Educ & Shanxi Prov, Taiyuan 030024, Shanxi, Peoples R China; [Lu, Li; Kiely, Christopher J.] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA; [Gu, Lin] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China	Peking University; Peking University; Dalian University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Energy (DOE); Oak Ridge National Laboratory; Chinese Academy of Sciences; Institute of Coal Chemistry, CAS; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Taiyuan University of Technology; Lehigh University; Chinese Academy of Sciences; Institute of Physics, CAS	Ma, D (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.; Ma, D (corresponding author), Peking Univ, Coll Engn, Beijing 100871, Peoples R China.; Shi, C (corresponding author), Dalian Univ Technol, Coll Chem, State Key Lab Fine Chem, Dalian 116024, Peoples R China.; Rodriguez, JA (corresponding author), Brookhaven Natl Lab, Chem Div, Bldg 555,POB 5000, Upton, NY 11973 USA.	chuanshi@dlut.edu.cn; rodrigez@bnl.gov; dma@pku.edu.cn	Gu, Lin/D-9631-2011; Zhou, Wu/D-8526-2011; Guo, Jinghua/AAZ-6492-2020; Yao, Siyu/G-5865-2013; Crumlin, Ethan/AAZ-3087-2020	Gu, Lin/0000-0002-7504-031X; Zhou, Wu/0000-0002-6803-1095; Guo, Jinghua/0000-0002-8576-2172; Xu, Wenqian/0000-0002-4815-6253; Kiely, Christopher/0000-0001-5412-0970	973 Project [2017YFB0602200, 2013CB933100, 2011CB201402]; CAS Pioneer Hundred Talents Program; Natural Science Foundation of China [91645115, 21473003, 21222306, 21373037, 21577013, 91545121]; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division; Fundamental Research Funds for the Central Universities [DUT15TD49, DUT16ZD224]; DOE [DE-SC0012704]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; Advanced Light Source Doctoral Fellowship; U.S. National Science Foundation Major Research Instrumentation program [MRI/DMR-1040229]	973 Project(National Basic Research Program of China); CAS Pioneer Hundred Talents Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DOE(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); Advanced Light Source Doctoral Fellowship; U.S. National Science Foundation Major Research Instrumentation program(National Science Foundation (NSF))	This work received financial support from the 973 Project (grants 2017YFB0602200, 2013CB933100, and 2011CB201402), the CAS Pioneer Hundred Talents Program, and the Natural Science Foundation of China (grants 91645115, 21473003, 21222306, 21373037, 21577013, and 91545121). The electron microscopy work was also supported in part by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division (to W.Z.), and through a user project at Oak Ridge National Laboratory's Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. The x-ray absorption spectroscopy experiments were conducted at the Shanghai Synchrotron Radiation Facility and the Beijing Synchrotron Radiation Facility. We also acknowledge the National Thousand Young Talents Program of China, the Shanxi Hundred Talents Program, and the Fundamental Research Funds for the Central Universities (grants DUT15TD49 and DUT16ZD224). The research done at Brookhaven National Laboratory (BNL) was financed under contract no. DE-SC0012704 with the DOE. Some of the theoretical calculations were done at the Center for Functional Nanomaterials on the BNL campus. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract no. DE-AC02-05CH11231. Y.Y. acknowledges the support of the Advanced Light Source Doctoral Fellowship. C.J.K. gratefully acknowledges funding from the U.S. National Science Foundation Major Research Instrumentation program (grant MRI/DMR-1040229). D.M. thanks L. Peng and M. Wang for help with <SUP>17</SUP>O NMR experiments. All data are reported in the main text and supplementary materials. C.S. and X.Z. are inventors on a patent application (ZL 2015 1 0253637.6) held by Dalian University of Technology that covers the preparation of Au/a-MoC. D.M., C.S., and J.A.R. designed the study. X.Z. and S.Y. performed most of the reactions. W.Z., L.Lu, C.J.K., and L.G. performed the electron microscopy study. R.G., X.W., P.L., and Z.Z. finished the DFT calculations. S.Y., W.X., and W.L. performed the x-ray structure characterization and analysis. S.Y., D.M., W.Z., and J.A.R. wrote the paper. Other authors provided reagents, performed certain experiments, and revised the paper.	Andreeva D, 1996, J CATAL, V158, P354, DOI 10.1006/jcat.1996.0035; Beale AM, 2010, PHYS CHEM CHEM PHYS, V12, P5562, DOI 10.1039/b925206a; Deng WL, 2007, TOP CATAL, V44, P199, DOI 10.1007/S11244-007-0293-9; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Hedley N., 1968, CHEMISTRY CYANADATIO; LAINE RM, 1977, J AM CHEM SOC, V99, P252, DOI 10.1021/ja00443a049; LEE JS, 1987, J CATAL, V106, P125, DOI 10.1016/0021-9517(87)90218-1; Li Y, 2000, APPL CATAL B-ENVIRON, V27, P179, DOI 10.1016/S0926-3373(00)00147-8; Lin J, 2013, J AM CHEM SOC, V135, P15314, DOI 10.1021/ja408574m; OYAMA ST, 1992, CATAL TODAY, V15, P179, DOI 10.1016/0920-5861(92)80175-M; Qian K, 2013, CATAL SCI TECHNOL, V3, P679, DOI 10.1039/c2cy20481a; Ratnasamy C, 2009, CATAL REV, V51, P325, DOI 10.1080/01614940903048661; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; Rodriguez JA, 2014, ANGEW CHEM INT EDIT, V53, P11270, DOI 10.1002/anie.201407208; Rodriguez JA, 2009, ANGEW CHEM INT EDIT, V48, P8047, DOI 10.1002/anie.200903918; Sabnis KD, 2015, J CATAL, V331, P162, DOI 10.1016/j.jcat.2015.08.017; Schweitzer NM, 2011, J AM CHEM SOC, V133, P2378, DOI 10.1021/ja110705a; Si R, 2008, ANGEW CHEM INT EDIT, V47, P2884, DOI 10.1002/anie.200705828; Veith GM, 2009, J CATAL, V262, P92, DOI 10.1016/j.jcat.2008.12.005; Yang M, 2014, SCIENCE, V346, P1498, DOI 10.1126/science.1260526; Yang M, 2013, J AM CHEM SOC, V135, P3768, DOI 10.1021/ja312646d; Zhai YP, 2010, SCIENCE, V329, P1633, DOI 10.1126/science.1192449; Zugic B, 2014, J AM CHEM SOC, V136, P3238, DOI 10.1021/ja4123889	24	401	411	76	1072	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					389	+		10.1126/science.aah4321	http://dx.doi.org/10.1126/science.aah4321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28642235	Green Accepted, Green Submitted			2022-12-28	WOS:000406362300042
J	Geller, AM				Geller, Aaron M.			Stellar siblings grow closer with age	NATURE			English	Editorial Material							BINARY; STARS	High-mass stars often pair up to form binary systems. Observations reveal that the stars in such systems are born farther apart than was formerly thought, casting fresh light on an enduring debate about star formation.	[Geller, Aaron M.] Northwestern Univ, CIERA, Evanston, IL 60208 USA; [Geller, Aaron M.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Geller, Aaron M.] Adler Planetarium, Chicago, IL 60605 USA	Northwestern University; Northwestern University	Geller, AM (corresponding author), Northwestern Univ, CIERA, Evanston, IL 60208 USA.; Geller, AM (corresponding author), Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA.; Geller, AM (corresponding author), Adler Planetarium, Chicago, IL 60605 USA.	a-geller@northwestern.edu						Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.061102; Bosch G, 2001, ASTRON ASTROPHYS, V380, P137, DOI 10.1051/0004-6361:20011427; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Kobulnicky HA, 2014, ASTROPHYS J SUPPL S, V213, DOI 10.1088/0067-0049/213/2/34; Kraus S, 2010, NATURE, V466, P339, DOI 10.1038/nature09174; Paxton B, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/4; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Sana H, 2014, ASTROPHYS J SUPPL S, V215, DOI 10.1088/0067-0049/215/1/15; Sana H., 2017, ASTROPHYSICS, V599, P9; Tokovinin A, 2006, ASTRON ASTROPHYS, V450, P681, DOI 10.1051/0004-6361:20054427; Zinnecker H, 2007, ANNU REV ASTRON ASTR, V45, P481, DOI 10.1146/annurev.astro.44.051905.092549	11	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					41	42		10.1038/nature23092	http://dx.doi.org/10.1038/nature23092			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28636598				2022-12-28	WOS:000404839900027
J	Gregorio, GG; Masureel, M; Hilger, D; Terry, DS; Juette, M; Zhao, H; Zhou, Z; Perez-Aguilar, JM; Hauge, M; Mathiasen, S; Javitch, JA; Weinstein, H; Kobilka, BK; Blanchard, SC				Gregorio, G. Glenn; Masureel, Matthieu; Hilger, Daniel; Terry, Daniel S.; Juette, Manuel; Zhao, Hong; Zhou, Zhou; Perez-Aguilar, Jose Manuel; Hauge, Maria; Mathiasen, Signe; Javitch, Jonathan A.; Weinstein, Harel; Kobilka, Brian K.; Blanchard, Scott C.			Single-molecule analysis of ligand efficacy in beta(2)AR-G-protein activation	NATURE			English	Article							CONFORMATIONAL DYNAMICS; STRUCTURAL INSIGHTS; NUCLEOTIDE EXCHANGE; RECEPTOR; TRANSDUCIN; MECHANISM; GPCR; RHODOPSIN; AGONISTS; BETA(2)	G-protein-coupled receptor (GPCR)-mediated signal transduction is central to human physiology and disease intervention, yet the molecular mechanisms responsible for ligand-dependent signalling responses remain poorly understood. In class A GPCRs, receptor activation and G-protein coupling entail outward movements of transmembrane helix 6 (TM6). Here, using single-molecule fluorescence resonance energy transfer imaging, we examine TM6 movements in the beta(2) adrenergic receptor (beta(2)AR) upon exposure to orthosteric ligands with different efficacies, in the absence and presence of the G(s) heterotrimer. We show that partial and full agonists differentially affect TM6 motions to regulate the rate at which GDP-bound beta(2)AR-G(s) complexes are formed and the efficiency of nucleotide exchange leading to G(s) activation. These data also reveal transient nucleotide-bound beta(2)AR-G(s) species that are distinct from known structures, and provide single-molecule perspectives on the allosteric link between ligand-and nucleotide-binding pockets that shed new light on the G-protein activation mechanism.	[Gregorio, G. Glenn; Terry, Daniel S.; Juette, Manuel; Zhao, Hong; Zhou, Zhou; Perez-Aguilar, Jose Manuel; Weinstein, Harel; Blanchard, Scott C.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Masureel, Matthieu; Hilger, Daniel; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Hauge, Maria; Mathiasen, Signe; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA; [Hauge, Maria; Mathiasen, Signe; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Hauge, Maria] Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Mol Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Hauge, Maria] Univ Copenhagen, NNF Ctr Basic Metab Res, Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA; [Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Perez-Aguilar, Jose Manuel] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY USA	Cornell University; Stanford University; Columbia University; New York State Psychiatry Institute; University of Copenhagen; University of Copenhagen; Columbia University; Cornell University; International Business Machines (IBM)	Blanchard, SC (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.; Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu; scb2005@med.cornell.edu	Juette, Manuel/E-2320-2013; Blanchard, Scott C./A-5804-2009; Hilger, Daniel/C-7297-2019; WEINSTEIN, HAREL/O-8245-2019	Juette, Manuel/0000-0002-8760-8080; Blanchard, Scott C./0000-0003-2717-9365; Hilger, Daniel/0000-0001-5179-1357; WEINSTEIN, HAREL/0000-0003-3473-9818; Mathiasen, Signe/0000-0001-6854-0044; Kobilka, Brian/0000-0001-5958-3990; Javitch, Jonathan/0000-0001-7395-2967; Hauge Pedersen, Maria/0000-0003-0034-5837; Gregorio, Gabriel Glenn/0000-0001-8677-133X; Perez-Aguilar, Jose Manuel/0000-0002-9893-5992	University of Texas at Austin [TG MCB120008]; Oak Ridge Leadership Computing Facility (ALCC) at the Oak Ridge National Laboratory by Office of Science of the US Department of Energy [BIP109, DE-AC05-00OR22725]; National Institutes of Health (NIH) [GM098859, R21DA0354585, K05DA022413, R01 MH54137, R01GM083118, R01NS028471, U54GM087519]; German Academic Exchange Service (DAAD); American Heart Association [15POST22700020]; Novo Nordisk Foundation Center for Basic Metabolic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM083118, R01GM098859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS102694, R01NS028471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, P01DA012408, P01DA012923, R21DA035485, R01DA015170] Funding Source: NIH RePORTER	University of Texas at Austin; Oak Ridge Leadership Computing Facility (ALCC) at the Oak Ridge National Laboratory by Office of Science of the US Department of Energy; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); American Heart Association(American Heart Association); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Howarth for the gift of trans-divalent streptavidin, and C. Stern in the laboratory of J. Chodera for constructing the CHARMM-consistent parameters for the dyes used in the molecular dynamics simulations. Computational resources are gratefully acknowledged: an XSEDE allocation at the Texas Advanced Computing Center at the University of Texas at Austin (Stampede supercomputer, project TG MCB120008), support from resources at the Oak Ridge Leadership Computing Facility (ALCC allocation BIP109) at the Oak Ridge National Laboratory that is supported by the Office of Science of the US Department of Energy under contract no. DE-AC05-00OR22725; and the resources of the David A. Cofrin Center for Biomedical Information in the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine at Weill Cornell Medicine. This work was supported in part by National Institutes of Health (NIH) grants GM098859 (S.C.B.), R21DA0354585 (J. A. J., S.C.B. and G.G.G.), K05DA022413 and R01 MH54137 (J. A. J.), R01GM083118 and R01NS028471 (B.K.K.), and U54GM087519 (H.W. and J. M. P.-A.), the German Academic Exchange Service (DAAD) (D.H.), the American Heart Association Postdoctoral fellowship (15POST22700020) (M. M.), and the Novo Nordisk Foundation Center for Basic Metabolic Research (M.H.).	Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Ceruso MA, 2004, J MOL BIOL, V338, P469, DOI 10.1016/j.jmb.2004.02.064; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ferguson A, 2015, MOL CELL, V60, P475, DOI 10.1016/j.molcel.2015.09.013; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kaya AI, 2014, J BIOL CHEM, V289, P24475, DOI 10.1074/jbc.M114.572875; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kim HD, 2002, P NATL ACAD SCI USA, V99, P4284, DOI 10.1073/pnas.032077799; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; MURAYAMA T, 1984, J BIOL CHEM, V259, P761; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vafabakhsh R, 2015, NATURE, V524, P497, DOI 10.1038/nature14679; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	34	166	167	9	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					68	+		10.1038/nature22354	http://dx.doi.org/10.1038/nature22354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28607487	Green Accepted, Green Submitted			2022-12-28	WOS:000404839900032
J	Edwards, ST; Dorr, DA; Landon, BE				Edwards, Samuel T.; Dorr, David A.; Landon, Bruce E.			Can Personalized Care Planning Improve Primary Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LONG-TERM CONDITIONS; MANAGEMENT		[Edwards, Samuel T.] Vet Affairs VA Portland Hlth Care Syst, Sect Gen Internal Med, Portland, OR USA; [Edwards, Samuel T.] Oregon Hlth & Sci Univ, Div Gen Internal Med & Geriatr, Portland, OR 97201 USA; [Dorr, David A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Landon, Bruce E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Edwards, ST (corresponding author), VA Portland Hlth Care Syst, Sect Gen Internal Med, 3710 SW US Vet Hosp Rd,R&D199, Portland, OR 97239 USA.	samuel.edwards@va.gov			Research Triangle Institute International; UpToDate Inc; Evidera; American Board of Internal Medicine; Freedman Healthcare Consulting	Research Triangle Institute International; UpToDate Inc; Evidera; American Board of Internal Medicine; Freedman Healthcare Consulting	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Landon reported receiving travel support from the Meyers-JDC Brookdale Institute and EagleDream Health; receiving personal fees from Research Triangle Institute International, UpToDate Inc, Evidera, the American Board of Internal Medicine, and Freedman Healthcare Consulting; and serving as a member of the Newton, Massachusetts, Healthcare Advisory Committee. No other authors reported disclosures.	Agency for Healthcare Research and Quality (AHRQ), INT BEH HLTH PRIM CA; Baker A, 2017, MAKING COMPREHENSIVE; Centers for Medicare & Medicaid Services (CMS). HHS, 2014, FED REGISTER, V79, P67547; Chase Dian A, 2014, AMIA Annu Symp Proc, V2014, P1718; Coulter A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010523.pub2; Edwards ST, 2014, NEW ENGL J MED, V371, P2049, DOI 10.1056/NEJMp1410790; Newbould J, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-71; Reeves D, 2014, BRIT J GEN PRACT, V64, pE568, DOI 10.3399/bjgp14X681385; Tinetti ME, 2016, JAMA CARDIOL, V1, P9, DOI 10.1001/jamacardio.2015.0248	9	22	22	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					25	26		10.1001/jama.2017.6953	http://dx.doi.org/10.1001/jama.2017.6953			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28594991				2022-12-28	WOS:000404717700009
J	Cao, BC; Bray, F; Beltran-Sanchez, H; Ginsburg, O; Soneji, S; Soerjomataram, I				Cao, Bochen; Bray, Freddie; Beltran-Sanchez, Hiram; Ginsburg, Ophira; Soneji, Samir; Soerjomataram, Isabelle			Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL VARIATION; GASTRIC-CANCER; SMOKING PREVALENCE; GENDER-DIFFERENCES; UNITED-STATES; TOBACCO USE; LOW-INCOME; BURDEN; DEATHS; WORLD	Objective To quantify the impact of cancer (all cancers combined and major sites) compared with cardiovascular disease (CVD) on longevity worldwide during 1981-2010. Design Retrospective demographic analysis using aggregated data. Setting National civil registration systems in member states of the World Health Organization. Participants 52 populations with moderate to high quality data on cause specific mortality. Main outcome measures Disease specific contributions to changes in life expectancy in ages 40-84 (LE40-84) over time in populations grouped by two levels of Human Development Index (HDI) values. Results Declining CVD mortality rates during 1981-2010 contributed to, on average, over half of the gains in LE40-84; the corresponding gains were 2.3 (men) and 1.7 (women) years, and 0.5 (men) and 0.8 (women) years in very high and medium and high HDI populations, respectively. Declines in cancer mortality rates contributed to, on average, 20% of the gains in LE40-84, or 0.8 (men) and 0.5 (women) years in very high HDI populations, and to over 10% or 0.2 years (both sexes) in medium and high HDI populations. Declining lung cancer mortality rates brought about the largest LE40-84 gain in men in very high HDI populations (up to 0.7 years in the Netherlands), whereas in medium and high HDI populations its contribution was smaller yet still positive. Among women, declines in breast cancer mortality rates were largely responsible for the improvement in longevity, particularly among very high HDI populations (up to 0.3 years in the United Kingdom). In contrast, losses in LE40-84 were observed in many medium and high HDI populations as a result of increasing breast cancer mortality rates. Conclusions The control of CVD has led to substantial gains in LE40-84 worldwide. The inequality in improvement in longevity attributed to declining cancer mortality rates reflects inequities in implementation of cancer control, particularly in less resourced populations and in women. Global actions are needed to revitalize efforts for cancer control, with a specific focus on less resourced countries.	[Cao, Bochen; Bray, Freddie; Soerjomataram, Isabelle] Int Agcy Res Canc, Sect Canc Surveillance, F-69372 Lyon 08, France; [Beltran-Sanchez, Hiram] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Beltran-Sanchez, Hiram] Univ Calif Los Angeles, Calif Ctr Populat Res, Los Angeles, CA USA; [Ginsburg, Ophira] NYU, Dept Populat Hlth, Laura & Isaac Perlmutter Canc Ctr, Langone Med Ctr, New York, NY USA; [Soneji, Samir] Dartmouth Coll, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA	World Health Organization; International Agency for Research on Cancer (IARC); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University; NYU Langone Medical Center; Dartmouth College	Cao, BC (corresponding author), Int Agcy Res Canc, Sect Canc Surveillance, F-69372 Lyon 08, France.	CaoB@fellows.iarc.fr		Ginsburg, Ophira/0000-0002-1384-2675; Bray, Freddie/0000-0002-3248-7787				Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; [Anonymous], 1994, IARC MONOGR EVAL CAR, V61, P1; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; CALDWELL JC, 1976, POPUL DEV REV, V2, P321, DOI 10.2307/1971615; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Danilova I, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0078-0; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Department of Health Statistics and Information Systems WHO, 2016, WHO METH DAT SOURC G; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gelband H, 2015, DIS CONTROL PRIORITI, V3, DOI [10.1596/9781-46480349-9, DOI 10.1596/978-1-4648-0349-9]; Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; Graham H, 1996, SOC SCI MED, V43, P243, DOI 10.1016/0277-9536(95)00369-X; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; International Agency for Research on Cancer (IARC), 2012, GLOBOCAN, P3; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Janssen F, 2004, B WHO; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Klenk J, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0089-x; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Maurice J, 2015, LANCET, V386, P1121, DOI 10.1016/S0140-6736(15)00251-2; Mesle F, 2012, MORTALITY CAUSES DEA, P131, DOI DOI 10.1007/978-94-007-2433-4_9; OFDT, 2013, DROG ADD DONN ESS, DOI [10.3917/lcd.056.0143, DOI 10.3917/LCD.056.0143]; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Pampel Fred C, 2006, Int J Comp Sociol, V47, P466, DOI 10.1177/0020715206070267; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Preston SH, 2000, DEMOGRAPHY MEASURING, DOI [10.2307/1535065, DOI 10.2307/1535065]; Samet J, 2001, WOMEN TOBACCO EPIDEM; Schaap MM, 2009, SOC SCI MED, V68, P1271, DOI 10.1016/j.socscimed.2009.01.007; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Soneji S, 2014, J CLIN ONCOL, V32, P444, DOI 10.1200/JCO.2013.50.8952; Strasser-Weippl K, 2015, LANCET ONCOL, V16, P1405, DOI 10.1016/S1470-2045(15)00218-1; Thomson GW, 2002, TOB CONTROL, V11, P372, DOI 10.1136/tc.11.4.372; Torre LA, 2014, CANCER EPIDEM BIOMAR, V23, P1025, DOI 10.1158/1055-9965.EPI-13-1220; Townsend N, 2016, EUR HEART J, V37, P3232, DOI [10.1093/eurheartj/ehw334, 10.1093/eurheartj/ehy342]; United Nations, 2015, WORLD POP PROSP POP; United Nations Development Programme, 2015, HUMAN DEV REPORT; WALDRON I, 1991, SOC SCI MED, V32, P989, DOI 10.1016/0277-9536(91)90157-8; WALDRON I, 1988, SOC SCI MED, V27, P1269, DOI 10.1016/0277-9536(88)90357-7; Wild CP, 2014, LANCET, V384, P1502, DOI 10.1016/S0140-6736(14)61918-8; World Bank, 2022, WORLD BANK COUNTR LE, DOI DOI 10.1596/36370; World Health Organization, 2015, 19 WHO MOD LIST ESS, P1; World Health Organization, 2013, WHO REPORT GLOBAL TO, V5, P106; World Health Organization, 2014, WHO MORT DAT; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yamaguchi N, 2001, LANCET ONCOL, V2, P88, DOI 10.1016/S1470-2045(00)00225-4	61	32	34	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2017	357								j2765	10.1136/bmj.j2765	http://dx.doi.org/10.1136/bmj.j2765			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY7YX	28637656	Green Published, hybrid			2022-12-28	WOS:000404210400002
J	Wu, PE; Morris, AM				Wu, Peter E.; Morris, Andrew M.			Review: Lung ultrasonography had varied sensitivity and specificity for diagnosing pneumonia in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ULTRASOUND		[Wu, Peter E.] Univ Hlth Network, Toronto, ON, Canada; [Morris, Andrew M.] Univ Hlth Network, Sinai Hlth Syst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto	Wu, PE (corresponding author), Univ Hlth Network, Toronto, ON, Canada.							Chavez MA, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-50; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Solomon SD, 2014, NEW ENGL J MED, V370, P1083, DOI 10.1056/NEJMp1311944; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC69	JC69		10.7326/ACPJC-2017-166-12-069	http://dx.doi.org/10.7326/ACPJC-2017-166-12-069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630981				2022-12-28	WOS:000403579000010
J	Elkhatib, N; Bresteau, E; Baschieri, F; Rioja, AL; van Niel, G; Vassilopoulos, S; Montagnac, G				Elkhatib, Nadia; Bresteau, Enzo; Baschieri, Francesco; Rioja, Alba Lopez; van Niel, Guillaume; Vassilopoulos, Stephane; Montagnac, Guillaume			Tubular clathrin/AP-2 lattices pinch collagen fibers to support 3D cell migration	SCIENCE			English	Article							ENDOCYTIC TRAFFICKING; DEPENDENT ENDOCYTOSIS; ADHESIONS; DYNAMICS; EXOCYTOSIS; INTEGRINS; DAB2	Migrating cells often use focal adhesions in order to move. Focal adhesions are less prominent in cells migrating in three-dimensional (3D) as compared with 2D environments. We looked for alternative adhesion structures supporting cell migration. We analyzed the dynamics of clathrin-coated pits in cells migrating in a 3D environment of collagen fibers. Both topological cues and local engagement of integrins triggered the accumulation of clathrin-coated structures on fibers. Clathrin/adaptor protein 2 (AP-2) lattices pinched collagen fibers by adopting a tube-like morphology and regulated adhesion to fibers in an endocytosis-independent manner. During migration, tubular clathrin/AP-2 lattices stabilized cellular protrusions by providing anchoring points to collagen fibers. Thus, tubular clathrin/AP-2 lattices promote cell adhesion that, in coordination with focal adhesions, supports cell migration in 3D.	[Elkhatib, Nadia; Bresteau, Enzo; Baschieri, Francesco; Rioja, Alba Lopez; Montagnac, Guillaume] Univ Paris Saclay, Gustave Roussy Inst, INSERM, U1170, Villejuif, France; [van Niel, Guillaume] Univ Rech Paris Sci & Lettres, Inst Curie, Ctr Univ, UMR144, Paris, France; [Vassilopoulos, Stephane] Univ Paris 06, INSERM, UMR S974, Inst Myol, Paris, France; [van Niel, Guillaume] Univ Paris, INSERM, Ctr Psychiat & Neurosci, U894, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Elkhatib, N; Montagnac, G (corresponding author), Univ Paris Saclay, Gustave Roussy Inst, INSERM, U1170, Villejuif, France.	nadia.elkhatib@gustaveroussy.fr; guillaume.montagnac@gustaveroussy.fr	Baschieri, Francesco/J-9525-2014; vassilopoulos, stephane/AAF-3865-2021; van Niel, Guillaume/HCI-8445-2022; vassilopoulos, stéphane/F-6041-2014; baschieri, francesco/AAE-7780-2021; van Niel, Guillaume/A-6585-2011	vassilopoulos, stephane/0000-0003-0172-330X; baschieri, francesco/0000-0003-0218-5320; van Niel, Guillaume/0000-0002-8651-9705; Bresteau, Enzo/0000-0001-9469-2578	ATIP/Avenir Program; Gustave Roussy Institute; INSERM; Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche [ANR-15-CE15-0005-03, ANR-14-CE12-0001-01]	ATIP/Avenir Program; Gustave Roussy Institute; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors thank M. Piel, B. Ladoux, P. Chavrier, and J. Ivaska for critical comments on the manuscript. We thank the Gustave Roussy imaging facility for help with image acquisition and the Electron Microscopy Facility of the Institut de Biologie Paris-Seine (IBPS). Core funding for this work was provided by the Gustave Roussy Institute and INSERM, and additional support was provided by grants from ATIP/Avenir Program and la Ligue Nationale Contre le Cancer and from the Agence Nationale de la Recherche (ANR-15-CE15-0005-03) to G.M. and a young researcher grant (ANR-14-CE12-0001-01) to S.V. N.E. designed and performed experiments, analyzed results, and wrote the manuscript. E.B., F.B., and A.L.R. performed experiments. G.V.N. designed and performed electron microscopy analyses in the 3D environment. S.V. designed and performed metal-replica electron microscopy analyses and wrote the manuscript. G.M. supervised the study, designed experiments, and wrote the manuscript. Data described can be found in the main figures and supplementary materials. The authors declare no competing financial interests.	Batchelder EM, 2010, MOL BIOL CELL, V21, P3070, DOI 10.1091/mbc.E09-12-1044; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Geraldo S, 2012, EUR J CELL BIOL, V91, P930, DOI 10.1016/j.ejcb.2012.07.005; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hong SH, 2015, CELL REP, V12, P2121, DOI 10.1016/j.celrep.2015.08.048; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Lampe M, 2016, J STRUCT BIOL, V196, P48, DOI 10.1016/j.jsb.2016.07.009; Liu AP, 2009, BIOPHYS J, V97, P1038, DOI 10.1016/j.bpj.2009.06.003; Maritzen T, 2015, CELL MOL LIFE SCI, V72, P2119, DOI 10.1007/s00018-015-1855-9; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Montagnac G, 2013, NATURE, V502, P567, DOI 10.1038/nature12571; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paul NR, 2015, CURR BIOL, V25, pR1092, DOI 10.1016/j.cub.2015.09.049; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pietuch A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130084; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Pucadyil TJ, 2016, MOL BIOL CELL, V27, P3156, DOI 10.1091/mbc.E16-06-0399; TAWIL N, 1993, J CELL BIOL, V120, P261, DOI 10.1083/jcb.120.1.261; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002	32	57	57	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343							eaal4713	10.1126/science.aal4713	http://dx.doi.org/10.1126/science.aal4713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619886				2022-12-28	WOS:000403327400026
J	Garber, K				Garber, Ken			In a major shift, cancer drugs go 'tissue-agnostic'	SCIENCE			English	News Item																			0	16	18	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1111	1112		10.1126/science.356.6343.1111	http://dx.doi.org/10.1126/science.356.6343.1111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619894				2022-12-28	WOS:000403327400009
J	Ubbink, J				Ubbink, Job			There's more to a meal	SCIENCE			English	Book Review									[Ubbink, Job] Calif Polytech State Univ San Luis Obispo, Dept Food Sci & Nutr, San Luis Obispo, CA 93407 USA	California State University System; California Polytechnic State University San Luis Obispo	Ubbink, J (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Food Sci & Nutr, San Luis Obispo, CA 93407 USA.	jubbink@calpoly.edu						Barham P, 2010, CHEM REV, V110, P2313, DOI 10.1021/cr900105w; McGee H, 2004, FLAVORING PLANTS HER	2	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1129	1129		10.1126/science.aan4039	http://dx.doi.org/10.1126/science.aan4039			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619904				2022-12-28	WOS:000403327400019
J	Seo, D; Southard, KM; Kim, JW; Lee, HJ; Farlow, J; Lee, JU; Litt, DB; Haas, T; Alivisatos, AP; Cheon, J; Gartner, ZJ; Jun, YW				Seo, Daeha; Southard, Kaden M.; Kim, Ji-wook; Lee, Hyun Jung; Farlow, Justin; Lee, Jung-uk; Litt, David B.; Haas, Thomas; Alivisatos, A. Paul; Cheon, Jinwoo; Gartner, Zev J.; Jun, Young-wook			A Mechanogenetic Toolkit for Interrogating Cell Signaling in Space and Time (vol 165, pg 1507, 2016)	CELL			English	Correction												zev.gartner@ucsf.edu; young-wook.jun@ucsf.edu		Jun, Young-wook/0000-0003-3182-5366; gartner, zev/0000-0001-7803-1219	NICHD NIH HHS [DP2 HD080351] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD080351] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Seo D, 2016, CELL, V165, P1507, DOI 10.1016/j.cell.2016.04.045	1	5	5	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1357	1357		10.1016/j.cell.2017.06.005	http://dx.doi.org/10.1016/j.cell.2017.06.005			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622515	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000403332400022
J	Bhan, I; Kedrin, D; Richter, JM				Bhan, Irun; Kedrin, Dmitriy; Richter, James M.			Acute Lower Gastrointestinal Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Bhan, Irun; Richter, James M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kedrin, Dmitriy] Elliot Hosp, Manchester, NH USA	Harvard University; Massachusetts General Hospital	Bhan, I (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	ibhan1@mgh.harvard.edu	Bhan, Irun/HDO-1888-2022					Fisher ORT, 2014, GASTROINTEST ENDOSC, V79, P317, DOI 10.1016/j.gie.2013.09.004; Gralnek IM, 2017, NEW ENGL J MED, V376, P1054, DOI 10.1056/NEJMcp1603455; Kouanda AM, 2017, GASTROINTEST EN 0204; Strate LL, 2010, CLIN GASTROENTEROL H, V8, P333, DOI 10.1016/j.cgh.2009.12.017	4	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					E50	E50		10.1056/NEJMc1705188	http://dx.doi.org/10.1056/NEJMc1705188			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW8WG	28594156				2022-12-28	WOS:000402798200031
J	Patorno, E; Huybrechts, KF; Bateman, BT; Cohen, JM; Desai, RJ; Mogun, H; Cohen, LS; Hernandez-Diaz, S				Patorno, Elisabetta; Huybrechts, Krista F.; Bateman, Brian T.; Cohen, Jacqueline M.; Desai, Rishi J.; Mogun, Helen; Cohen, Lee S.; Hernandez-Diaz, Sonia			Lithium Use in Pregnancy and the Risk of Cardiac Malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-UTERO EXPOSURE; BIPOLAR DISORDER; TRICUSPID-VALVE; NEWBORN-INFANT; 1ST TRIMESTER; CARBONATE; WOMEN; OUTCOMES; DEFECTS; THERAPY	BACKGROUND There has been concern that exposure to lithium early in pregnancy may be associated with a marked increase in the risk of Ebstein's anomaly (a right ventricular outflow tract obstruction defect) in infants and overall congenital cardiac defects, but data are conflicting and limited. METHODS We conducted a cohort study involving 1,325,563 pregnancies in women who were enrolled in Medicaid and who delivered a live-born infant between 2000 and 2010. We examined the risk of cardiac malformations among infants exposed to lithium during the first trimester as compared with unexposed infants and, in secondary analyses, with infants exposed to another commonly used mood stabilizer, lamotrigine. Risk ratios and 95% confidence intervals were estimated with control for psychiatric and medical conditions, medications, and other potential confounders. RESULTS Cardiac malformations were present in 16 of the 663 infants exposed to lithium (2.41%), 15,251 of the 1,322,955 nonexposed infants (1.15%), and 27 of the 1945 infants exposed to lamotrigine (1.39%). The adjusted risk ratio for cardiac malformations among infants exposed to lithium as compared with unexposed infants was 1.65 (95% confidence interval [CI], 1.02 to 2.68). The risk ratio was 1.11 (95% CI, 0.46 to 2.64) for a daily dose of 600 mg or less, 1.60 (95% CI, 0.67 to 3.80) for 601 to 900 mg, and 3.22 (95% CI, 1.47 to 7.02) for more than 900 mg. The prevalence of right ventricular outflow tract obstruction defects was 0.60% among lithium-exposed infants versus 0.18% among unexposed infants (adjusted risk ratio, 2.66; 95% CI, 1.00 to 7.06). Results were similar when lamotrigine-exposed infants were used as the reference group. CONCLUSIONS Maternal use of lithium during the first trimester was associated with an increased risk of cardiac malformations, including Ebstein's anomaly; the magnitude of this effect was smaller than had been previously postulated.	[Patorno, Elisabetta; Huybrechts, Krista F.; Bateman, Brian T.; Desai, Rishi J.; Mogun, Helen] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Cohen, Jacqueline M.; Hernandez-Diaz, Sonia] Harvard Med Sch, Dept Epidemiol, Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Cohen, Lee S.] Massachusetts Gen Hosp, Ctr Womens Mental Hlth, Dept Psychiat, Boston, MA 02114 USA; [Patorno, Elisabetta] Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Patorno, E (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.; Patorno, E (corresponding author), Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	epatorno@bwh.harvard.edu	Cohen, Jacqueline M./H-6517-2019; Desai, Rishi/AAH-8988-2021	Cohen, Jacqueline M./0000-0002-7300-0488; 	National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100216, K01MH099141] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by the National Institute of Mental Health.	ALLAN LD, 1982, LANCET, V2, P875; [Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; [Anonymous], 2002, PHYS DESK REFERENCE; ARNON RG, 1981, AM J DIS CHILD, V135, P941, DOI 10.1001/archpedi.1981.02130340047016; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Boden R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7085; Briggs G.C., 2002, DRUGS PREGNANCY LACT; COHEN LS, 1994, JAMA-J AM MED ASSOC, V271, P146, DOI 10.1001/jama.271.2.146; CORREAVILLASENOR A, 1994, TERATOLOGY, V50, P137, DOI 10.1002/tera.1420500208; CZEIZEL A, 1990, TERATOLOGY, V42, P505, DOI 10.1002/tera.1420420507; Desai RJ, 2017, EPIDEMIOLOGY, V28, P249, DOI 10.1097/EDE.0000000000000595; Diav-Citrin O, 2014, AM J PSYCHIAT, V171, P785, DOI 10.1176/appi.ajp.2014.12111402; EDMONDS L D, 1990, Teratology, V41, P551; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; JACOBSON SJ, 1992, LANCET, V339, P530, DOI 10.1016/0140-6736(92)90346-5; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; KALLEN B, 1988, TERATOLOGY, V38, P597, DOI 10.1002/tera.1420380608; KALLEN B, 1983, ACTA PSYCHIAT SCAND, V68, P134, DOI 10.1111/j.1600-0447.1983.tb06991.x; Kallen B, 1991, LITHIUM BIOL MED NEW, P121; Kramer A, 2003, EUR NEUROPSYCHOPHARM, V13, pS246, DOI 10.1016/S0924-977X(03)91879-7; Licht RW, 2010, BIPOLAR DISORD, V12, P483, DOI 10.1111/j.1399-5618.2010.00836.x; Long W A, 1984, Am J Perinatol, V1, P182, DOI 10.1055/s-2007-999999; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; NORA JJ, 1974, LANCET, V2, P594; Palmsten K, 2014, PHARMACOEPIDEM DR S, V23, P646, DOI 10.1002/pds.3627; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; PARK JM, 1980, AM J DIS CHILD, V134, P703, DOI 10.1001/archpedi.1980.02130190069018; RANE A, 1978, J PEDIATR-US, V93, P296, DOI 10.1016/S0022-3476(78)80527-7; Reis M, 2008, J CLIN PSYCHOPHARM, V28, P279, DOI 10.1097/JCP.0b013e318172b8d5; SCHOU M, 1973, BMJ-BRIT MED J, V2, P135, DOI 10.1136/bmj.2.5859.135; SIPEK A, 1989, COR VASA, V31, P149; SMITHBERG M, 1982, TERATOLOGY, V26, P239, DOI 10.1002/tera.1420260304; SZABO KT, 1970, NATURE, V225, P73, DOI 10.1038/225073a0; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; Weinstein M.R., 1980, LITHIUM TREATMENT WO; WEINSTEIN MR, 1975, AM J PSYCHIAT, V132, P529; Yacobi S, 2008, ISR J PSYCHIATR REL, V45, P95; Yonkers KA, 2004, AM J PSYCHIAT, V161, P608, DOI 10.1176/appi.ajp.161.4.608; ZALZSTEIN E, 1990, AM J CARDIOL, V65, P817, DOI 10.1016/0002-9149(90)91398-P	40	97	98	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2245	2254		10.1056/NEJMoa1612222	http://dx.doi.org/10.1056/NEJMoa1612222			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW8WG	28591541	Green Accepted, Bronze			2022-12-28	WOS:000402798200008
J	Fleischmann, R; Mysler, E; Hall, S; Kivitz, AJ; Moots, RJ; Luo, Z; DeMasi, R; Soma, K; Zhang, R; Takiya, L; Tatulych, S; Mojcik, C; Krishnaswami, S; Menon, S; Smolen, JS				Fleischmann, Roy; Mysler, Eduardo; Hall, Stephen; Kivitz, Alan J.; Moots, Robert J.; Luo, Zhen; DeMasi, Ryan; Soma, Koshika; Zhang, Richard; Takiya, Liza; Tatulych, Svitlana; Mojcik, Christopher; Krishnaswami, Sriram; Menon, Sujatha; Smolen, Josef S.		ORAL Strategy Investigators	Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; JANUS KINASE INHIBITOR; LONG-TERM SAFETY; INADEQUATE RESPONSE; PLUS METHOTREXATE; AMERICAN-COLLEGE; NECROSIS-FACTOR; OPEN-LABEL; COMBINATION; PLACEBO	Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the comparative efficacy of tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate for the treatment of rheumatoid arthritis in patients with a previous inadequate response to methotrexate. Methods ORAL Strategy was a 1 year, double-blind, phase 3b/4, head-to-head, non-inferiority, randomised controlled trial in patients aged 18 years or older with active rheumatoid arthritis despite methotrexate therapy. Patients were randomly assigned (1: 1: 1) to receive oral tofacitinib (5 mg twice daily) monotherapy, oral tofacitinib (5 mg twice daily) plus methotrexate, or subcutaneous adalimumab (40 mg every other week) plus methotrexate at 194 centres in 25 countries. Eligible patients received live zoster vaccine at investigators' discretion. The primary endpoint was the proportion of patients who attained an American College of Rheumatology response of at least 50% (ACR50) at month 6 in the full analysis set (patients who were randomly assigned to a group and received at least one dose of the study treatment). Non-inferiority between groups was shown if the lower bound of the 98.34% CI of the difference between comparators was larger than -13.0%. This trial is registered with ClinicalTrials.gov, number NCT02187055. Findings 1146 patients received treatment (384 had tofacitinib monotherapy; 376 had tofacitinib and methotrexate; and 386 had adalimumab and methotrexate). At 6 months, ACR50 response was attained in 147 (38%) of 384 patients with tofacitinib monotherapy, 173 (46%) of 376 patients with tofacitinib and methotrexate, and 169 (44%) of 386 patients with adalimumab and methotrexate. Non-inferiority was declared for tofacitinib and methotrexate versus adalimumab and methotrexate (difference 2% [98.34% CI -6 to 11]) but not for tofacitinib monotherapy versus either adalimumab and methotrexate (-6 [-14 to 3]) or tofacitinib and methotrexate (-8 [-16 to 1]). In total, 23 (6%) of 384 patients receiving tofacitinib monotherapy, 26 (7%) of 376 patients receiving tofacitinib plus methotrexate, and 36 (9%) of 386 patients receiving adalimumab plus methotrexate discontinued due to adverse events. Two (1%) of the 384 patients receiving tofacitinib monotherapy died. No new or unexpected safety issues were reported for either treatment in this study for up to 1 year. Interpretation Tofacitinib and methotrexate combination therapy was non-inferior to adalimumab and methotrexate combination therapy in the treatment of rheumatoid arthritis in patients with an inadequate response to methotrexate in this trial. Tofacitinib monotherapy was not shown to be non-inferior to either combination.	[Fleischmann, Roy] Univ Texas Southwestern Med Ctr, Dallas, TX USA; [Fleischmann, Roy] Metroplex Clin Res Ctr, Dallas, TX USA; [Mysler, Eduardo] Org Med Invest, Buenos Aires, DF, Argentina; [Hall, Stephen] Monash Univ, Dept Med, Malvern, Vic, Australia; [Kivitz, Alan J.] Altoona Ctr Clin Res, Duncansville, PA USA; [Moots, Robert J.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England; [Luo, Zhen] Pfizer Inc, Shanghai, Peoples R China; [DeMasi, Ryan; Takiya, Liza] Pfizer Inc, Collegeville, PA USA; [Soma, Koshika; Tatulych, Svitlana; Krishnaswami, Sriram; Menon, Sujatha] Pfizer Inc, Groton, CT 06340 USA; [Zhang, Richard; Mojcik, Christopher] Pfizer Inc, New York, NY USA; [Smolen, Josef S.] Med Univ Vienna, Dept Med 3, Vienna, Austria	University of Texas System; University of Texas Southwestern Medical Center Dallas; Metroplex Clinical Research Center; Monash University; Altoona Center for Clinical Research; University of Liverpool; Pfizer; Pfizer; Pfizer; Pfizer; Medical University of Vienna	Fleischmann, R (corresponding author), Univ Texas Southwestern Med Ctr, Dallas, TX USA.	rfleischmann@arthdocs.com	Moots, Robert/AAM-8091-2020; Prochazkova, Leona/ABH-3762-2020; Batalov, Anastas/J-4921-2019; Fernandez-Nebro, Antonio/K-7628-2012; Yakushin, Sergey/N-4165-2013	Prochazkova, Leona/0000-0001-7685-5767; Batalov, Anastas/0000-0001-8857-0574; Pacheco-Tena, Cesar/0000-0002-0793-8988; Wei, James Cheng-Chung/0000-0002-1235-0679; Fernandez-Nebro, Antonio/0000-0002-2962-9844; Gomez-Reino, Juan/0000-0001-5229-6294; Yakushin, Sergey/0000-0001-7202-742X; Menshikova, Irina/0000-0003-3181-5272; ANCUTA, CODRINA MIHAELA/0000-0002-1777-8121; Abud-Mendoza, Carlos/0000-0002-3749-5831; Mihailova, Anna/0000-0003-2541-4296; DEMIN, Aleksandr/0000-0003-1052-1451	Pfizer Inc.; National Institute for Health Research [NF-SI-0508-10299, NF-SI-0513-10139, RC-PG-0407-10054] Funding Source: researchfish; Versus Arthritis [20639, 18475] Funding Source: researchfish	Pfizer Inc.(Pfizer); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	Pfizer Inc.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Burmester GR, 2017, ANN RHEUM DIS, V76, P414, DOI 10.1136/annrheumdis-2016-209322; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Cohen SB, 2017, ANN RHEUM DIS, V76, P1253, DOI 10.1136/annrheumdis-2016-210457; Curtis JR, 2016, ANN RHEUM DIS, V75, P1843, DOI 10.1136/annrheumdis-2016-209131; Machado MAD, 2013, REV BRAS REUMATOL, V53, P419, DOI 10.1590/S0482-50042013000500009; Fleischmann R, 2017, ARTHRITIS RHEUMATOL, V69, P506, DOI 10.1002/art.39953; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Keystone EC, 2004, ARTHRITIS RHEUM, V50; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Merck, 2017, ZOSTAVAX PRESCR INF; Singh JA, 2016, ANN RHEUM DIS, V68, P1; Smolen J, 2016, ARTHRITIS RHEUMA S10, V68; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2013, ANN RHEUM DIS, V72, P3, DOI 10.1136/annrheumdis-2012-202361; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Winthrop K, 2015, ARTHRITIS RHEUMATOL, V67; Wollenhaupt J, 2016, ARTHRITIS RHEUMA S10, V68; Wollenhaupt J, 2014, J RHEUMATOL, V41, P837, DOI 10.3899/jrheum.130683; Yamanaka H, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0932-2	30	249	272	3	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					457	468		10.1016/S0140-6736(17)31618-5	http://dx.doi.org/10.1016/S0140-6736(17)31618-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28629665				2022-12-28	WOS:000406463400027
J	Morikawa, Y; Heallen, T; Each, JL; Xiao, Y; Martin, JF				Morikawa, Yuka; Heallen, Todd; Each, John L.; Xiao, Yang; Martin, James F.			Dystrophin-glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ADULT HEART REGENERATION; IN-VIVO; PRESSURE-OVERLOAD; MOUSE MODEL; MUSCLE; GENE; MICE	The regenerative capacity of the adult mammalian heart is limited, because of the reduced ability of cardiomyocytes to progress through mitosis(1). Endogenous cardiomyocytes have regenerative capacity at birth but this capacity is lost postnatally, with subsequent organ growth occurring through cardiomyocyte hypertrophy(2,3). The Hippo pathway, a conserved kinase cascade, inhibits cardiomyocyte proliferation in the developing heart to control heart size and prevents regeneration in the adult heart(4,5). The dystrophingly-coprotein complex (DGC), a multicomponent transmembrane complex linking the actin cytoskeleton to extracellular matrix, is essential for cardiomyocyte homeostasis. DGC deficiency in humans results in muscular dystrophy, including the lethal Duchenne muscular dystrophy. Here we show that the DGC component dystroglycan 1 (Dag1) directly binds to the Hippo pathway effector Yap to inhibit cardiomyocyte proliferation in mice. The Yap-Dag1 interaction was enhanced by Hippo-induced Yap phosphorylation, revealing a connection between Hippo pathway function and the DGC. After injury, Hippo-deficient postnatal mouse hearts maintained organ size control by repairing the defect with correct dimensions, whereas postnatal hearts deficient in both Hippo and the DGC showed cardiomyocyte overproliferation at the injury site. In the hearts of mature Mdx mice (which have a point mutation in Dmd)-a model of Duchenne muscular dystrophy-Hippo deficiency protected against overload-induced heart failure.	[Morikawa, Yuka; Heallen, Todd; Xiao, Yang; Martin, James F.] Texas Heart Inst, Cardiomyocyte Renewal Lab, Houston, TX 77030 USA; [Each, John L.; Martin, James F.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Martin, James F.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Martin, James F.] Baylor Coll Med, Houston, TX 77030 USA	Texas Heart Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Martin, JF (corresponding author), Texas Heart Inst, Cardiomyocyte Renewal Lab, Houston, TX 77030 USA.; Martin, JF (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.; Martin, JF (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Martin, JF (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	jfmartin@bcm.edu	Morikawa, Yuka/E-3092-2010; Morikawa, Yuka/AAP-8917-2021; Morikawa, Yuka/ABH-6969-2020	Morikawa, Yuka/0000-0002-4571-8409; Morikawa, Yuka/0000-0002-4571-8409; Leach, John/0000-0002-0779-8583; Xiao, Yang/0000-0002-9297-0973; Heallen, Todd/0000-0002-6003-8743	Intellectual and Developmental Disability Research Center grant from Eunice Kennedy Shriver National Institute of Child Health & Human Development [1U54 HD083092]; Mouse Phenotyping Core at Baylor College of Medicine; National Institutes of Health [U54 HG006348, DE 023177, HL 127717, HL 130804, HL 118761]; Vivian L. Smith Foundation; Transatlantic Network of Excellence Award LeDucq Foundation Transatlantic Networks of Excellence in Cardiovascular Research [14CVD01]; American Heart Association [16SDG26460001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127717, R01HL118761, R01HL130804] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023177] Funding Source: NIH RePORTER	Intellectual and Developmental Disability Research Center grant from Eunice Kennedy Shriver National Institute of Child Health & Human Development; Mouse Phenotyping Core at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vivian L. Smith Foundation; Transatlantic Network of Excellence Award LeDucq Foundation Transatlantic Networks of Excellence in Cardiovascular Research; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported in part by an Intellectual and Developmental Disability Research Center grant (1U54 HD083092) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; the Mouse Phenotyping Core at Baylor College of Medicine with funding from the National Institutes of Health (U54 HG006348); and grants from the National Institutes of Health (DE 023177, HL 127717, HL 130804, and HL 118761 to J.F.M.) and the Vivian L. Smith Foundation (to J.F.M.). J.F.M. was supported by the Transatlantic Network of Excellence Award LeDucq Foundation Transatlantic Networks of Excellence in Cardiovascular Research 14CVD01. T.H. was supported by the American Heart Association Scientist Development Grant (16SDG26460001). We thank N. Stancel of the Texas Heart Institute for editorial assistance.	Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; di Vignano AT, 2000, FEBS LETT, V471, P229, DOI 10.1016/S0014-5793(00)01400-9; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Houtchens GR, 2008, J BIOMECH, V41, P762, DOI 10.1016/j.jbiomech.2007.11.027; Kamogawa Y, 2001, CARDIOVASC RES, V50, P509, DOI 10.1016/S0008-6363(01)00205-X; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Morikawa Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005781; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Richardson GD, 2016, JOVE-J VIS EXP, DOI 10.3791/53979; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; van Westering TLE, 2015, MOLECULES, V20, P8823, DOI 10.3390/molecules20058823; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	21	165	171	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					227	+		10.1038/nature22979	http://dx.doi.org/10.1038/nature22979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28581498	Green Accepted			2022-12-28	WOS:000405314500041
J	von Minckwitz, G; Procter, M; de Azambuja, E; Zardavas, D; Benyunes, M; Viale, G; Suter, T; Arahmani, A; Rouchet, N; Clark, E; Knott, A; Lang, I; Levy, C; Yardley, DA; Bines, J; Gelber, RD; Piccart, M; Baselga, J				von Minckwitz, Gunter; Procter, Marion; de Azambuja, Evandro; Zardavas, Dimitrios; Benyunes, Mark; Viale, Giuseppe; Suter, Thomas; Arahmani, Amal; Rouchet, Nathalie; Clark, Emma; Knott, Adam; Lang, Istvan; Levy, Christelle; Yardley, Denise A.; Bines, Jose; Gelber, Richard D.; Piccart, Martine; Baselga, Jose		APHINITY Steering Comm	Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLUS DOCETAXEL; CHEMOTHERAPY; EFFICACY	BACKGROUND Pertuzumab increases the rate of pathological complete response in the preoperative context and increases overall survival among patients with metastatic disease when it is added to trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. In this trial, we investigated whether pertuzumab, when added to adjuvant trastuzumab and chemotherapy, improves outcomes among patients with HER2-positive early breast cancer. METHODS We randomly assigned patients with node-positive or high-risk node-negative HER2-positive, operable breast cancer to receive either pertuzumab or placebo added to standard adjuvant chemotherapy plus 1 year of treatment with trastuzumab. We assumed a 3-year invasive-disease-free survival rate of 91.8% with pertuzumab and 89.2% with placebo. RESULTS In the trial population, 63% of the patients who were randomly assigned to receive pertuzumab (2400 patients) or placebo (2405 patients) had node-positive disease and 36% had hormone-receptor-negative disease. Disease recurrence occurred in 171 patients (7.1%) in the pertuzumab group and 210 patients (8.7%) in the placebo group (hazard ratio, 0.81; 95% confidence interval [CI], 0.66 to 1.00; P = 0.045). The estimates of the 3-year rates of invasive-disease-free survival were 94.1% in the pertuzumab group and 93.2% in the placebo group. In the cohort of patients with node-positive disease, the 3-year rate of invasive-disease-free survival was 92.0% in the pertuzumab group, as compared with 90.2% in the placebo group (hazard ratio for an invasive-disease event, 0.77; 95% CI, 0.62 to 0.96; P = 0.02). In the cohort of patients with node-negative disease, the 3-year rate of invasive-disease-free survival was 97.5% in the pertuzumab group and 98.4% in the placebo group (hazard ratio for an invasive-disease event, 1.13; 95% CI, 0.68 to 1.86; P = 0.64). Heart failure, cardiac death, and cardiac dysfunction were infrequent in both treatment groups. Diarrhea of grade 3 or higher occurred almost exclusively during chemotherapy and was more frequent with pertuzumab than with placebo (9.8% vs. 3.7%). CONCLUSIONS Pertuzumab significantly improved the rates of invasive-disease-free survival among patients with HER2-positive, operable breast cancer when it was added to trastuzumab and chemotherapy. Diarrhea was more common with pertuzumab than with placebo. (Funded by F. Hoffmann-La Roche/Genentech; APHINITY ClinicalTrials.gov number, NCT01358877.)	[von Minckwitz, Gunter] German Breast Grp, Neu Isenburg, Germany; [Procter, Marion] Frontier Sci Scotland, Kincraig, Scotland; [de Azambuja, Evandro; Rouchet, Nathalie] Breast European Adjuvant Study Team BrEAST, Ctr Data, Brussels, Belgium; [Zardavas, Dimitrios; Arahmani, Amal] Breast Int Grp, Brussels, Belgium; [Piccart, Martine] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium; [Benyunes, Mark; Clark, Emma; Knott, Adam] Roche Pharma, Bern, Switzerland; [Suter, Thomas] Bern Univ Hosp, Dept Cardiol, Cardiooncol, Bern, Switzerland; [Viale, Giuseppe] Univ Milan, European Inst Oncol, Dept Pathol, Milan, Italy; [Lang, Istvan] Natl Inst Oncol, Budapest, Hungary; [Levy, Christelle] Ctr Francois Baclesse, Caen, France; [Yardley, Denise A.] Sarah Cannon Res Inst, Nashville, TN USA; [Yardley, Denise A.] Tennessee Oncol, Nashville, TN USA; [Bines, Jose] Inst Nacl Canc, Rio De Janeiro, Brazil; [Gelber, Richard D.] Harvard Med Sch, Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA USA; [Gelber, Richard D.] Frontier Sci & Technol Res Fdn Inc, Boston, MA USA; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	German Breast Group; Breast International Group; Institut Jules Bordet; Universite Libre de Bruxelles; University of Bern; University Hospital of Bern; IRCCS European Institute of Oncology (IEO); University of Milan; National Institute of Oncology Hungary; UNICANCER; Centre Francois Baclesse; Sarah Cannon Research Institute; Tennessee Oncology; National Cancer Institute (Inca); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; Memorial Sloan Kettering Cancer Center	von Minckwitz, G (corresponding author), GBG Forschungs, German Breast Grp, Martin Behaim Str 12, D-63263 Neu Isenburg, Germany.; Baselga, J (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	gunter.vonminckwitz@gbg.de; baselgaj@mskcc.org	Watanabe, Junichiro/AAI-8481-2021; Khasraw, Mustafa/ABH-5962-2020; Garcia-Saenz, Jose Angel/AAW-8662-2020; Loi, Sherene/H-1979-2016; Viale, Giuseppe/AAE-8921-2019; Wardley, Andrew/N-8135-2015; Perren, Timothy/D-5387-2013	Watanabe, Junichiro/0000-0001-9226-895X; Khasraw, Mustafa/0000-0003-3249-9849; Garcia-Saenz, Jose Angel/0000-0001-6880-0301; Loi, Sherene/0000-0001-6137-9171; Wardley, Andrew/0000-0002-9639-0888; Biganzoli, Laura/0000-0001-7989-8658; Pienkowski, Tadeusz/0000-0002-0110-5950; Di Leo, Angelo/0000-0002-3665-9056; Fernandez-Morales, Luis Antonio/0000-0003-2120-6457; Bedard, Philippe/0000-0002-6771-2999; Perren, Timothy/0000-0001-8472-8856; Horvath, Zsolt/0000-0002-5376-7737; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702; Coudert, Bruno/0000-0001-9445-2216; Bliss, Judith/0000-0001-7957-7424; LEVY, Christelle/0000-0003-0572-5222; Antolin Novoa, Silvia/0000-0002-0110-3349; Hennessy, Bryan/0000-0002-7871-6477	F. Hoffmann-La Roche/Genentech; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; Cancer Research UK [15955] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10107] Funding Source: researchfish	F. Hoffmann-La Roche/Genentech(Hoffmann-La RocheRoche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by F. Hoffmann-La Roche/Genentech; APHINITY ClinicalTrials.gov number, NCT01358877.	[Anonymous], 2016, LANCET ONCOL, V17, P791; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; De Mattos-Arruda L, 2016, NAT REV CLIN ONCOL, V13, P566, DOI 10.1038/nrclinonc.2016.35; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Swain SM, 2013, ONCOLOGIST, V18, P257, DOI 10.1634/theoncologist.2012-0448; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Zardavas D, 2015, BREAST, V24, pS143, DOI 10.1016/j.breast.2015.07.034	14	639	648	8	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					122	131		10.1056/NEJMoa1703643	http://dx.doi.org/10.1056/NEJMoa1703643			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28581356	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000405282300006
J	Suzuki, K; Nosyreva, E; Hunt, KW; Kavalali, ET; Monteggia, LM				Suzuki, Kanzo; Nosyreva, Elena; Hunt, Kevin W.; Kavalali, Ege T.; Monteggia, Lisa M.			Effects of a ketamine metabolite on synaptic NMDAR function	NATURE			English	Letter							RAPID ANTIDEPRESSANT; RECEPTORS; MEMANTINE		[Suzuki, Kanzo; Nosyreva, Elena; Kavalali, Ege T.; Monteggia, Lisa M.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Hunt, Kevin W.] Univ Texas Southwestern Med Ctr Dallas, Biopharmaceut Prod Dev, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Monteggia, LM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lisa.monteggia@utsouthwestern.edu						Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Collingridge GL, 2017, BIOL PSYCHIAT, V81, pE65, DOI 10.1016/j.biopsych.2016.06.029; Gideons ES, 2014, P NATL ACAD SCI USA, V111, P8649, DOI 10.1073/pnas.1323920111; Kotermanski SE, 2009, J PHYSIOL-LONDON, V587, P4589, DOI 10.1113/jphysiol.2009.176297; LUKAS G, 1971, J PHARMACOL EXP THER, V178, P562; Moaddel R, 2013, EUR J PHARMACOL, V698, P228, DOI 10.1016/j.ejphar.2012.11.023; Nosyreva E, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00094; Nosyreva E, 2013, J NEUROSCI, V33, P6990, DOI 10.1523/JNEUROSCI.4998-12.2013; Singh JB, 2016, BIOL PSYCHIAT, V80, P424, DOI 10.1016/j.biopsych.2015.10.018; Zanos P, 2017, BIOL PSYCHIAT, V81, pE69, DOI 10.1016/j.biopsych.2016.08.039; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998	13	106	109	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					E1	E3		10.1038/nature22084	http://dx.doi.org/10.1038/nature22084			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640258				2022-12-28	WOS:000403814100003
J	Gallus, A				Gallus, Alex			Simplified and original Wells rules plus age-adjusted D-dimer test were useful for ruling out suspected PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gallus, Alex] Flinders Univ S Australia, Adelaide, SA, Australia; [Gallus, Alex] Med Ctr, Adelaide, SA, Australia	Flinders University South Australia	Gallus, A (corresponding author), Flinders Univ S Australia, Adelaide, SA, Australia.; Gallus, A (corresponding author), Med Ctr, Adelaide, SA, Australia.			Gallus, Alexander/0000-0001-7347-9989				van Es N, 2016, ANN INTERN MED, V165, P253, DOI 10.7326/M16-0031; Yan ZH, 2017, RADIOLOGY, V282, P717, DOI 10.1148/radiol.2016151985	2	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC71	JC71		10.7326/ACPJC-2017-166-12-071	http://dx.doi.org/10.7326/ACPJC-2017-166-12-071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630983				2022-12-28	WOS:000403579000012
J	McDermott, J				McDermott, Jason			Drawing connections	SCIENCE			English	Editorial Material								At a recent scientific conference, someone I had never met looked at my nametag and said, "Oh, you're that comic guy." Now, I'm a researcher with more than 20 years of experience in my field, and part of me wishes that this was what I was recognized for. But after a chance doodle snowballed into a poster entirely in comic form, I am also "that comic guy." I am still getting used to this dual identity. After a bit of hesitation, though, I've decided to embrace the pleasures of my two pursuits- and their unexpected points of connection.	[McDermott, Jason] Pacif Northwest Natl Lab, Richland, WA 99354 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	McDermott, J (corresponding author), Pacif Northwest Natl Lab, Richland, WA 99354 USA.			McDermott, Jason/0000-0003-2961-2572					0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1202	1202		10.1126/science.356.6343.1202	http://dx.doi.org/10.1126/science.356.6343.1202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619947	Bronze			2022-12-28	WOS:000403327400044
J	Assawaworrarit, S; Yu, XF; Fan, SH				Assawaworrarit, Sid; Yu, Xiaofang; Fan, Shanhui			Robust wireless power transfer using a nonlinear parity-time-symmetric circuit	NATURE			English	Article							TRANSFER SYSTEM; MICROIMPLANTS; MICROCAVITIES; FREQUENCY; BREAKING; DESIGN; LASERS	Considerable progress in wireless power transfer has been made in the realm of non-radiative transfer, which employs magnetic-field coupling in the near field(1-4). A combination of circuit resonance and impedance transformation is often used to help to achieve efficient transfer of power over a predetermined distance of about the size of the resonators(3,4). The development of non-radiative wireless power transfer has paved the way towards real-world applications such as wireless powering of implantable medical devices and wireless charging of stationary electric vehicles(1,2,5-8). However, it remains a fundamental challenge to create a wireless power transfer system in which the transfer efficiency is robust against the variation of operating conditions. Here we propose theoretically and demonstrate experimentally that a parity-time-symmetric circuit incorporating a nonlinear gain saturation element provides robust wireless power transfer. Our results show that the transfer efficiency remains near unity over a distance variation of approximately one metre, without the need for any tuning. This is in contrast with conventional methods where high transfer efficiency can only be maintained by constantly tuning the frequency or the internal coupling parameters as the transfer distance or the relative orientation of the source and receiver units is varied. The use of a nonlinear parity-time-symmetric circuit should enable robust wireless power transfer to moving devices or vehicles(9,10).	[Assawaworrarit, Sid; Yu, Xiaofang; Fan, Shanhui] Stanford Univ, Dept Elect Engn, Ginzton Lab, Stanford, CA 94305 USA	Stanford University	Fan, SH (corresponding author), Stanford Univ, Dept Elect Engn, Ginzton Lab, Stanford, CA 94305 USA.	shanhui@stanford.edu	Fan, Shanhui/B-4659-2012; Yu, Xiaofang/E-7210-2011	Yu, Xiaofang/0000-0001-8359-4841; Assawaworrarit, Sid/0000-0001-7752-0870	TomKat Center for Sustainable Energy at Stanford	TomKat Center for Sustainable Energy at Stanford	Part of the work was supported by the TomKat Center for Sustainable Energy at Stanford. S.F. thanks R. Sassoon and A. Cerjan for discussions.	Bender CM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270401; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Brecher A., 2014, 0060 FTA; BROWN WC, 1984, IEEE T MICROW THEORY, V32, P1230, DOI 10.1109/TMTT.1984.1132833; Cerjan A, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.013840; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Ge L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24889; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Hassan AU, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063807; Haus HA, 1984, WAVES FIELDS OPTOELE, P197; Heetderks W. J., 1988, BIOMEDICAL ENG IEEE, V35, P323, DOI [10.1109/10.1388, DOI 10.1109/10.1388]; Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Huh J, 2011, IEEE T POWER ELECTR, V26, P3666, DOI 10.1109/TPEL.2011.2160972; Kim NY, 2012, ELECTRON LETT, V48, P452, DOI 10.1049/el.2012.0580; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Li SQ, 2015, IEEE J EM SEL TOP P, V3, P4, DOI 10.1109/JESTPE.2014.2319453; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Villa JL, 2009, APPL ENERG, V86, P355, DOI 10.1016/j.apenergy.2008.05.009; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Peng B, 2014, SCIENCE, V346, P328, DOI 10.1126/science.1258004; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Raab FH, 2002, IEEE T MICROW THEORY, V50, P814, DOI 10.1109/22.989965; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Sample AP, 2011, IEEE T IND ELECTRON, V58, P544, DOI 10.1109/TIE.2010.2046002; Schindler J, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444029; Shin J, 2014, IEEE T IND ELECTRON, V61, P1179, DOI 10.1109/TIE.2013.2258294; Siegman A. E., 1986, LASERS, P992; Tesla N., U.S. patent, Patent No. [1,119,732, 1119732]; TROYK PR, 1992, IEEE T BIO-MED ENG, V39, P589, DOI 10.1109/10.141197; Yu XF, 2013, AIP ADV, V3, DOI 10.1063/1.4809665; Zhou X, 2016, OPT EXPRESS, V24, P6916, DOI 10.1364/OE.24.006916; Zierhofer C.M., 1990, BIOMEDICAL ENG IEEE, V37, P716	34	330	345	54	396	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					387	+		10.1038/nature22404	http://dx.doi.org/10.1038/nature22404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617463				2022-12-28	WOS:000403250900031
J	Lien, CH; Lee, MD; Lin, CY				Lien, Chi-Hone; Lee, Ming-Dar; Lin, Chien-Yu			CASE REVIEW Purpura in a 5 year old girl	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lien, Chi-Hone; Lee, Ming-Dar; Lin, Chien-Yu] Hsinchu Mackay Mem Hosp, Dept Paediat, Hsinchu, Taiwan; Univ Edinburgh, Div Infect & Pathway Med, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland	Mackay Memorial Hospital; University of Edinburgh	Lin, CY (corresponding author), Hsinchu Mackay Mem Hosp, Dept Paediat, Hsinchu, Taiwan.	v1clin3@exseed.ed.ac.uk						Betrosian AP, 2006, AM J MED SCI, V332, P339, DOI 10.1097/00000441-200612000-00006; Campsall PA, 2013, CRIT CARE CLIN, V29, P393, DOI 10.1016/j.ccc.2013.03.001; Chalmers E, 2011, ARCH DIS CHILD, V96, P1066, DOI 10.1136/adc.2010.199919; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; McGill F, 2016, J INFECTION, V72, P405, DOI 10.1016/j.jinf.2016.01.007; Pace D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1554; Pathan N, 2003, ARCH DIS CHILD, V88, P601, DOI 10.1136/adc.88.7.601; Takada S, 2016, INTERNAL MED, V55, P567, DOI 10.2169/internalmedicine.55.3272; WONG VK, 1989, PEDIATR INFECT DIS J, V8, P224	10	0	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2530	10.1136/bmj.j2530	http://dx.doi.org/10.1136/bmj.j2530			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28619707				2022-12-28	WOS:000403753800004
J	Ryu, J; Lee, TH				Ryu, Jaewon; Lee, Thomas H.			The Waiting Game - Why Providers May Fail to Reduce Wait Times	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ryu, Jaewon] Geisinger Hlth Syst, Danville, PA 17822 USA; [Lee, Thomas H.] Press Ganey, Wakefield, MA USA; [Lee, Thomas H.] Harvard Med Sch, Boston, MA USA	Geisinger Health System; Harvard University; Harvard Medical School	Ryu, J (corresponding author), Geisinger Hlth Syst, Danville, PA 17822 USA.							Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158	1	19	22	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2309	2311		10.1056/NEJMp1704478	http://dx.doi.org/10.1056/NEJMp1704478			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28614684				2022-12-28	WOS:000403230800001
J	Schibler, U				Schibler, Ueli			Getting Surprising Answers to Unasked Questions	CELL			English	Editorial Material																			0	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1162	1167		10.1016/j.cell.2017.06.001	http://dx.doi.org/10.1016/j.cell.2017.06.001			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622500	Bronze			2022-12-28	WOS:000403332400003
J	Simkanin, C; Cawood, A				Simkanin, Christina; Cawood, Alison			Senior scientists as allies for equity	NATURE			English	Letter									[Simkanin, Christina; Cawood, Alison] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	Smithsonian Institution; Smithsonian Environmental Research Center	Simkanin, C (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	simkaninc@si.edu		Cawood, Alison/0000-0002-7849-0412					0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					352	352		10.1038/546352e	http://dx.doi.org/10.1038/546352e			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617459	Bronze			2022-12-28	WOS:000403250900019
J	Davis, MM; Hanauer, DA				Davis, Matthew M.; Hanauer, David A.			Online Measures of Physician Performance Moving Beyond Aggregation to Integration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RATING SITES; AWARENESS; CARE	IMPORTANCE Patient satisfaction is an increasingly important component of health care quality measures. Online reviews of physicians represent a promising platform for capturing patient perspectives of care. OBJECTIVE To identify qualitative themes associated with patient reviews of dermatologic care on consumer reporting websites. DESIGN, SETTING, AND PARTICIPANTS A qualitative analysis was conducted of patient-generated reviews of dermatology practices on 2 consumer review platforms. Yelp is an online consumer portal for users to review their experience with local businesses; ZocDoc is an online patient-scheduling portal that provides opportunity for patients to write reviews of physician practices. A total of 518 reviews from 45 dermatology practices on Yelp and 4921 reviews from 45 dermatology providers on ZocDoc were collected from 3 geographically diverse cities: Philadelphia, Pennsylvania; Houston, Texas; and Seattle, Washington. The study was conducted from January 15 to July 15, 2015. MAIN OUTCOMES AND MEASURES Reviews were separated into high-scoring and low-scoring groups. An inductive qualitative method was used to code and identify key themes associated with positive and negative patient experiences. Analysis was completed upon reaching thematic saturation. RESULTS Reported as mean (95% CI), the overall Yelp score for the 45 selected practices was 3.46 of 5 stars (3.17-3.75) and overall ZocDoc score for the 45 selected practices was 4.72 of 5 stars (4.47-4.80). The proportion of individual reviews giving a score of 5.0 was significantly higher on ZocDoc (3986 [81.0%]) than on Yelp (229 [44.2%]) (P<.001). Qualitative themes centered on characteristics of the physician and the practice. Themes that emerged from the high-scoring and low-scoring reviews were similar in content but opposite in valence. Physician-specific themes included temperament, knowledge and competency, physical examination, communication abilities, and mindfulness of cost. Practice-specific themes included scheduling, staff temperament, office cleanliness, waiting room, and insurance. Patients appreciated physicians who are kind, respectful, and thorough with the physical examination; empathetic about the emotional difficulty of skin disease; and cognizant of cost. Negative experiences were frequently affected by considerations outside of the physician-patient interaction, such as curt interactions with staff, difficulty with scheduling, practice cleanliness, and insurance problems. Patients reported relying on consumer websites to identify dermatology providers. CONCLUSIONS AND RELEVANCE Online consumer review websites are designed to facilitate instantaneous and public communication among patients. These platforms provide elaborate and timely data for dermatologists to garner insight into their patients' experiences. The themes identified in this study are consistent with past satisfaction studies and may aid dermatologists in optimizing the patient care experience.	[Davis, Matthew M.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Acad Gen Pediat & Primary Care, Chicago, IL 60611 USA; [Davis, Matthew M.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Davis, Matthew M.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Davis, Matthew M.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Hanauer, David A.] Univ Michigan Hlth Syst, Child Hlth Evaluat & Res Unit, Ann Arbor, MI USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Mary Ann & J Milburn Smith Child Hlth Res Program, 225 Chicago Ave,Mailstop 157, Chicago, IL 60611 USA.	mmdavis@luriechildrens.org						C. S. Mott Children's Hospital, MAN PAR WAR ONL RAT; Findlay SD, 2016, HEALTH AFFAIR, V35, P688, DOI 10.1377/hlthaff.2015.1654; Gray BM, 2015, JAMA INTERN MED, V175, P291, DOI 10.1001/jamainternmed.2014.6291; Hanauer DA, 2014, PEDIATRICS, V134, pE966, DOI 10.1542/peds.2014-0681; Hanauer DA, 2014, JAMA-J AM MED ASSOC, V311, P734, DOI 10.1001/jama.2013.283194; Merchant RM, 2016, JAMA-J AM MED ASSOC, V316, P2483, DOI 10.1001/jama.2016.16754; Smith RJ, 2016, JAMA DERMATOL, V152, P153, DOI 10.1001/jamadermatol.2015.3950	7	3	3	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2325	+		10.1001/jama.2017.3979	http://dx.doi.org/10.1001/jama.2017.3979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609521				2022-12-28	WOS:000403149900019
J	Roehr, B				Roehr, Bob			Amy Josephine Reed OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												bobroehr@aol.com						REED AJ, PUBLICATION LIST	1	1	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2017	357								j2827	10.1136/bmj.j2827	http://dx.doi.org/10.1136/bmj.j2827			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UL	28611212				2022-12-28	WOS:000403752500003
J	Oswalt, TD				Oswalt, T. D.			A centennial gift from Einstein	SCIENCE			English	Editorial Material									[Oswalt, T. D.] Embry Riddle Aeronaut Univ, Dept Phys Sci, 600 Clyde Morris Blvd, Daytona Beach, FL 32114 USA	Embry-Riddle Aeronautical University	Oswalt, TD (corresponding author), Embry Riddle Aeronaut Univ, Dept Phys Sci, 600 Clyde Morris Blvd, Daytona Beach, FL 32114 USA.	terry.oswalt@erau.edu						Althaus LG, 2010, ASTRON ASTROPHYS REV, V18, P471, DOI [10.1007/s00159-010-0033-1, 10.1007/s00159-010-0033-]; Chandrasekhar S, 1931, ASTROPHYS J, V74, P81, DOI 10.1086/143324; Davidson C., 1920, PHILOS T R SOC A, V220, P291, DOI DOI 10.1098/RSTA.1920.0009; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; Sahu KC, 2017, SCIENCE, V356, P1046, DOI 10.1126/science.aal2879; Will CM, 2014, LIVING REV RELATIV, V17, DOI 10.12942/lrr-2014-4	6	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1015	1015		10.1126/science.aan2996	http://dx.doi.org/10.1126/science.aan2996			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28592429				2022-12-28	WOS:000402871700033
J	Treister, E; Schawinski, K; Volonteri, M; Natarajan, P; Gawiser, E				Treister, Ezequiel; Schawinski, Kevin; Volonteri, Marta; Natarajan, Priyamvada; Gawiser, Eric			Black hole growth in the early Universe is self-regulated and largely hidden from view (vol 474, pg 356, 2011)	NATURE			English	Correction												etreiste@astro.puc.cl	Schawinski, Kevin/N-7057-2016; Natarajan, Priyamvada/AAG-2086-2021	Schawinski, Kevin/0000-0001-5464-0888; 				Cowie LL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/50; Treister E, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/130; Treister E, 2011, NATURE, V474, P356, DOI 10.1038/nature10103; Willott CJ, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/1/L8	4	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					316	316		10.1038/nature22810	http://dx.doi.org/10.1038/nature22810			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593956	Bronze			2022-12-28	WOS:000402823400043
J	Vassy, JL; Christensen, KD; Schonman, EF; Blout, CL; Robinson, JO; Krier, JB; Diamond, PM; Lebo, M; Machini, K; Azzariti, DR; Dukhovny, D; Bates, DW; MacRae, CA; Murray, MF; Rehm, HL; McGuire, AL; Green, RC				Vassy, J. L.; Christensen, K. D.; Schonman, E. F.; Blout, C. L.; Robinson, J. O.; Krier, J. B.; Diamond, P. M.; Lebo, M.; Machini, K.; Azzariti, D. R.; Dukhovny, D.; Bates, D. W.; MacRae, C. A.; Murray, M. F.; Rehm, H. L.; McGuire, A. L.; Green, R. C.		MedSeq Project	Whole-Genome Sequencing in Primary Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Vassy, Jason L./AAC-8220-2019	Vassy, Jason/0000-0001-6113-5564; Christensen, Kurt/0000-0003-4068-776X; Lebo, Matthew/0000-0002-9733-5207					0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					I20	I20		10.7326/P17-9040	http://dx.doi.org/10.7326/P17-9040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28632285				2022-12-28	WOS:000406631400001
J	Timbie, JW; Setodji, CM; Kress, A; Lavelle, TA; Friedberg, MW; Mendel, PJ; Chen, EK; Weidmer, BA; Buttorff, C; Malsberger, R; Kommareddi, M; Rastegar, A; Kofner, A; Hiatt, L; Mahmud, A; Giuriceo, K; Kahn, KL				Timbie, Justin W.; Setodji, Claude M.; Kress, Amii; Lavelle, Tara A.; Friedberg, Mark W.; Mendel, Peter J.; Chen, Emily K.; Weidmer, Beverly A.; Buttorff, Christine; Malsberger, Rosalie; Kommareddi, Mallika; Rastegar, Afshin; Kofner, Aaron; Hiatt, Lisa; Mahmud, Ammarah; Giuriceo, Katherine; Kahn, Katherine L.			Implementation of Medical Homes in Federally Qualified Health Centers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMBULATORY-CARE; PERFORMANCE; PROVIDERS; QUALITY; COST; TERM	BACKGROUND From 2011 through 2014, the Federally Qualified Health Center Advanced Primary Care Practice Demonstration provided care management fees and technical assistance to a nationwide sample of 503 federally qualified health centers to help them achieve the highest (level 3) medical-home recognition by the National Committee for Quality Assurance, a designation that requires the implementation of processes to improve access, continuity, and coordination. METHODS We examined the achievement of medical-home recognition and used Medicare claims and beneficiary surveys to measure utilization of services, quality of care, patients' experiences, and Medicare expenditures in demonstration sites versus comparison sites. Using difference-in-differences analyses, we compared changes in outcomes in the two groups of sites during a 3-year period. RESULTS Level 3 medical-home recognition was awarded to 70% of demonstration sites and to 11% of comparison sites. Although the number of visits to federally qualified health centers decreased in the two groups, smaller reductions among demonstration sites than among comparison sites led to a relative increase of 83 visits per 1000 beneficiaries per year at demonstration sites (P<0.001). Similar trends explained the higher performance of demonstration sites with respect to annual eye examinations and nephropathy tests (P<0.001 for both comparisons); there were no significant differences with respect to three other process measures. Demonstration sites had larger increases than comparison sites in emergency department visits (30.3 more per 1000 beneficiaries per year, P<0.001), inpatient admissions (5.7 more per 1000 beneficiaries per year, P = 0.02), and Medicare Part B expenditures ($37 more per beneficiary per year, P = 0.02). Demonstration-site participation was not associated with relative improvements in most measures of patients' experiences. CONCLUSIONS Demonstration sites had higher rates of medical-home recognition and smaller decreases in the number of patients' visits to federally qualified health centers than did comparison sites, findings that may reflect better access to primary care relative to comparison sites. Demonstration sites had larger increases in emergency department visits, inpatient admissions, and Medicare Part B expenditures. (Funded by the Centers for Medicare and Medicaid Services.)	[Timbie, Justin W.; Kress, Amii; Chen, Emily K.; Buttorff, Christine; Kofner, Aaron; Mahmud, Ammarah] RAND, 1200 S Hayes St, Arlington, VA 22202 USA; [Lavelle, Tara A.] Tufts Med Ctr, Boston, MA USA; [Friedberg, Mark W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Friedberg, Mark W.] Harvard Med Sch, Boston, MA USA; [Kahn, Katherine L.] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Giuriceo, Katherine] Ctr Medicare Serv, Baltimore, MD USA; [Giuriceo, Katherine] Ctr Medicaid Serv, Baltimore, MD USA	RAND Corporation; Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Timbie, JW (corresponding author), RAND, 1200 S Hayes St, Arlington, VA 22202 USA.	jtimbie@rand.org	Friedberg, Mark William/Y-2607-2019; Kahn, Katherine/AAE-2857-2020	Friedberg, Mark William/0000-0002-7907-8358; Kahn, Katherine/0000-0002-6605-1455	Centers for Medicare and Medicaid Services	Centers for Medicare and Medicaid Services	Funded by the Centers for Medicare and Medicaid Services.	Abrams MK, 2010, ENHANCING CAPACITY C; Agency for Healthcare Research and Quality, 2016, DEV PAT CTR MED HOM; Agency for Healthcare Research and Quality, 2016, CONS ASS HEALTHC PRO; Agency for Healthcare Research and Quality, 2001, GUID PREV QUAL IND H; Agency for Healthcare Research and Quality, 2015, MEAS SUMM UNPL READM; American Academy of Family Physicians, 2007, JOINT PRINC PAT CTR; [Anonymous], 2015, FQHC ADV PRIM CAR PR; [Anonymous], 2013, REP C MED HLTH CAR D; [Anonymous], 2006, FRAM HIGH PERF HLTH; Dale SB, 2016, NEW ENGL J MED, V374, P2345, DOI 10.1056/NEJMsa1414953; Department of Health and Human Services, 2014, PAT CTR MED HLTH HOM; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Goldman LE, 2012, AM J PREV MED, V43, P142, DOI 10.1016/j.amepre.2012.02.033; Health Resources and Services Administration, 2015, 2015 HLTH CTR DAT HL; Jones EB, 2014, HEALTH AFFAIR, V33, P1254, DOI 10.1377/hlthaff.2013.1274; Kahn KL, 2015, 2 RAND; Kahn KL, 2015, 1 RAND; Kahn KL, 2017, RR8862CMS RAND; Kangovi S, 2013, HEALTH AFFAIR, V32, P1196, DOI 10.1377/hlthaff.2012.0825; Maeng DD, 2012, AM J MANAG CARE, V18, P149; Moreno L, 2016, 2 MATH POL RES; National Association of Community Health Centers, 2008, SERV PAT LTD ENGL PR; National Association of Community Health Centers, 2016, SKETCH COMM HLTH CTR; Nichols D, 2016, 2 RTI INT; Peikes D, 2016, EVALUATION COMPREHEN; Puhani PA, 2012, ECON LETT, V115, P85, DOI 10.1016/j.econlet.2011.11.025; Quinn MT, 2013, ETHNIC DIS, V23, P356; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Rothkopf J, 2011, HEALTH AFFAIR, V30, P1335, DOI 10.1377/hlthaff.2011.0066; Shi LY, 2017, HEALTH SERV RES, V52, P984, DOI 10.1111/1475-6773.12523; Shi LY, 2015, MED CARE, V53, P389, DOI 10.1097/MLR.0000000000000331; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Sugarman JR, 2014, MED CARE, V52, pS1, DOI 10.1097/MLR.0000000000000207; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wright B, 2015, HEALTH AFFAIR, V34, P1147, DOI 10.1377/hlthaff.2014.0823; Wynia MK, 2010, J HEALTH COMMUN, V15, P102, DOI 10.1080/10810730.2010.499981	36	14	14	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					246	256		10.1056/NEJMsa1616041	http://dx.doi.org/10.1056/NEJMsa1616041			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9PI	28636834	Bronze			2022-12-28	WOS:000405777600008
J	Strom, AR; Emelyanov, AV; Mir, M; Fyodorov, DV; Darzacq, X; Karpen, GH				Strom, Amy R.; Emelyanov, Alexander V.; Mir, Mustafa; Fyodorov, Dmitry V.; Darzacq, Xavier; Karpen, Gary H.			Phase separation drives heterochromatin domain formation	NATURE			English	Article							LIVE CELLS; PROTEIN; COMPLEXITY; DROSOPHILA; SPECTROSCOPY; SEQUENCES	Constitutive heterochromatin is an important component of eukaryotic genomes that has essential roles in nuclear architecture, DNA repair and genome stability(1), and silencing of transposon and gene expression(2). Heterochromatin is highly enriched for repetitive sequences, and is defined epigenetically by methylation of histone H3 at lysine 9 and recruitment of its binding partner heterochromatin protein 1 (HP1). A prevalent view of heterochromatic silencing is that these and associated factors lead to chromatin compaction, resulting in steric exclusion of regulatory proteins such as RNA polymerase from the underlying DNA(3). However, compaction alone does not account for the formation of distinct, multi-chromosomal, membrane-less heterochromatin domains within the nucleus, fast diffusion of proteins inside the domain, and other dynamic features of heterochromatin. Here we present data that support an alternative hypothesis: that the formation of heterochromatin domains is mediated by phase separation, a phenomenon that gives rise to diverse non-membrane-bound nuclear, cytoplasmic and extracellular compartments(4). We show that Drosophila HP1a protein undergoes liquid-liquid demixing in vitro, and nucleates into foci that display liquid properties during the first stages of heterochromatin domain formation in early Drosophila embryos. Furthermore, in both Drosophila and mammalian cells, heterochromatin domains exhibit dynamics that are characteristic of liquid phase-separation, including sensitivity to the disruption of weak hydrophobic interactions, and reduced diffusion, increased coordinated movement and inert probe exclusion at the domain boundary. We conclude that heterochromatic domains form via phase separation, and mature into a structure that includes liquid and stable compartments. We propose that emergent biophysical properties associated with phase-separated systems are critical to understanding the unusual behaviours of heterochromatin, and how chromatin domains in general regulate essential nuclear functions.	[Strom, Amy R.; Karpen, Gary H.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Strom, Amy R.; Mir, Mustafa; Darzacq, Xavier; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Emelyanov, Alexander V.; Fyodorov, Dmitry V.] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Yeshiva University	Karpen, GH (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.; Karpen, GH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ghkarpen@lbl.gov		Mir, Mustafa/0000-0001-8280-2821	National Institute of Health [R01 GM117420, R01-GM074233, U54-DK107980, U01-EB021236]; California Institute for Regenerative Medicine (CIRM) [LA1-08013]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233, R01GM117420] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institute of Health grants R01 GM117420 (G.H.K.), R01-GM074233 (D.V.F.), and U54-DK107980 and U01-EB021236 (X.D.), and the California Institute for Regenerative Medicine (CIRM, LA1-08013, X.D.). We thank A. Dernburg for use of the spinning disk confocal, M. Scott for maintenance of the rastering confocal, S. Colmenares for cell lines, C. Robertson for introduction to RICS and N&B, A. Tangara for help in assembling and maintaining the LLSM, and A. Dernburg, S. Safran, M. Elbaum and the Karpen laboratory for helpful comments on the manuscript.	Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, BIOPHYS J, V96, P707, DOI 10.1016/j.bpj.2008.09.051; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Falahati H, 2016, CURR BIOL, V26, P277, DOI 10.1016/j.cub.2015.11.065; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Greil F, 2007, EMBO J, V26, P741, DOI 10.1038/sj.emboj.7601527; Hancock R, 2014, INT REV CEL MOL BIO, V307, P15, DOI 10.1016/B978-0-12-800046-5.00002-3; Hinde E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12001; HUBER G, 1991, PHYSICA A, V170, P463, DOI 10.1016/0378-4371(91)90001-S; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Iborra FJ, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-15; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larson A.G., 2017, NATURE; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Vasquez PA, 2016, NUCLEIC ACIDS RES, V44, P5540, DOI 10.1093/nar/gkw510; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Yuan K, 2016, GENE DEV, V30, P579, DOI 10.1101/gad.272237.115; Zhu L, 2015, CURR OPIN CELL BIOL, V34, P23, DOI 10.1016/j.ceb.2015.04.003	37	880	891	21	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					241	+		10.1038/nature22989	http://dx.doi.org/10.1038/nature22989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28636597	Green Accepted			2022-12-28	WOS:000405314500044
J	Hansen, SG; Piatak, M; Ventura, AB; Hughes, CM; Gilbride, RM; Ford, JC; Oswald, K; Shoemaker, R; Li, Y; Ewis, MSL; Gilliam, AN; Xu, GW; Whizin, N; Burwitz, BJ; Planer, SL; Turner, JM; Egasse, AWL; Axthelm, MK; Nelson, JA; Fruh, K; Sacha, JB; Estes, JD; Keele, BF; Edlefsen, PT; Ifson, JDL; Picker, LJ				Hansen, Scott G.; Piatak, Michael, Jr.; Ventura, Abigail B.; Hughes, Colette M.; Gilbride, Roxanne M.; Ford, Julia C.; Oswald, Kelli; Shoemaker, Rebecca; Li, Yuan; Ewis, Matthew S. L.; Gilliam, Awbrey N.; Xu, Guangwu; Whizin, Nathan; Burwitz, Benjamin J.; Planer, Shannon L.; Turner, John M.; Egasse, Alfred W. L.; Axthelm, Michael K.; Nelson, Jay A.; Fruh, Klaus; Sacha, Jonah B.; Estes, Jacob D.; Keele, Brandon F.; Edlefsen, Paul T.; Ifson, Jeffrey D. L.; Picker, Louis J.			Immune clearance of highly pathogenic SIV infection (vol 502, pg 100, 2013)	NATURE			English	Correction														Frueh, Klaus/0000-0001-8014-3877				Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; LIN PKT, 1992, NUCLEIC ACIDS RES, V20, P5149	2	34	34	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					123	124		10.1038/nature22984	http://dx.doi.org/10.1038/nature22984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28636599				2022-12-28	WOS:000404839900043
J	Holmes, D				Holmes, David			MARCHING TO A NEW BEAT	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					S6	S7		10.1038/546S6a	http://dx.doi.org/10.1038/546S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28636587	Bronze			2022-12-28	WOS:000403814100002
J	Sacks, CA				Sacks, Chana A.			Perirenal Extramedullary Hematopoiesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2470	2470		10.1056/NEJMicm1700379	http://dx.doi.org/10.1056/NEJMicm1700379			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY2BW	28636862				2022-12-28	WOS:000403774400010
J	Liao, PQ; Huang, NY; Zhang, WX; Zhang, JP; Chen, XM				Liao, Pei-Qin; Huang, Ning-Yu; Zhang, Wei-Xiong; Zhang, Jie-Peng; Chen, Xiao-Ming			Controlling guest conformation for efficient purification of butadiene	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; CARBON-DIOXIDE; ADSORPTION; 1,3-BUTADIENE; SEPARATION; SORPTION; DIMERIZATION; CAPTURE	Conventional adsorbents preferentially adsorb the small, high-polarity, and unsaturated 1,3-butadiene molecule over the other C-4 hydrocarbons from which it must be separated. We show from single-crystal x-ray diffraction and computational simulation that a hydrophilic metal-organic framework, [Zn-2(btm)(2)], where H(2)btm is bis(5-methyl-1H-1,2,4-triazol-3-yl) methane, has quasi-discrete pores that can induce conformational changes in the flexible guest molecules, weakening 1,3-butadiene adsorption through a large bending energy penalty. In a breakthrough operation at ambient temperature and pressure, this guest conformation-controlling adsorbent eluted 1,3-butadiene first, then butane, butene, and isobutene. Thus, 1,3-butadiene can be efficiently purified (>= 99.5%) while avoiding high-temperature conditions that can lead to its undesirable polymerization.	[Liao, Pei-Qin; Huang, Ning-Yu; Zhang, Wei-Xiong; Zhang, Jie-Peng; Chen, Xiao-Ming] Sun Yat Sen Univ, Sch Chem, MOE Key Lab Bioinorgan & Synthet Chem, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, JP (corresponding author), Sun Yat Sen Univ, Sch Chem, MOE Key Lab Bioinorgan & Synthet Chem, Guangzhou 510275, Guangdong, Peoples R China.	zhangjp7@mail.sysu.edu.cn	Zhang, Jie-Peng/G-5251-2011; Chen, Xiao-Ming/B-4551-2010; Zhang, Wei-Xiong/D-3365-2011; Liao, Pei-Qin/C-6724-2015	Chen, Xiao-Ming/0000-0002-3353-7918; Zhang, Wei-Xiong/0000-0003-0797-3465; Liao, Pei-Qin/0000-0001-5888-1283; Huang, Ning-Yu/0000-0003-1038-2260	973 Project [2014CB845602]; National Natural Science Foundation of China [21225105, 21290173, 21473260]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The data described in this paper are presented in the supplementary materials. This work was supported by the 973 Project (grant 2014CB845602) and the National Natural Science Foundation of China (grants 21225105, 21290173, and 21473260). Single-crystal x-ray diffraction structures have been deposited in the Cambridge Crystallographic Data Centre under accession numbers CCDC 1525534 to 1525538.	Aldeeb AA, 2004, J HAZARD MATER, V115, P51, DOI 10.1016/j.jhazmat.2004.06.019; Bae YS, 2012, ANGEW CHEM INT EDIT, V51, P1857, DOI 10.1002/anie.201107534; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Cadiau A, 2016, SCIENCE, V353, P137, DOI 10.1126/science.aaf6323; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Cavka JH, 2008, J AM CHEM SOC, V130, P13850, DOI 10.1021/ja8057953; Chen KJ, 2016, ANGEW CHEM INT EDIT, V55, P10268, DOI 10.1002/anie.201603934; Chui SSY, 1999, SCIENCE, V283, P1148, DOI 10.1126/science.283.5405.1148; Cui XL, 2016, SCIENCE, V353, P141, DOI 10.1126/science.aaf2458; Fukushima T, 2010, ANGEW CHEM INT EDIT, V49, P4820, DOI 10.1002/anie.201000989; Gucuyener C, 2010, J AM CHEM SOC, V132, P17704, DOI 10.1021/ja1089765; Herm ZR, 2013, SCIENCE, V340, P960, DOI 10.1126/science.1234071; Huang XC, 2006, ANGEW CHEM INT EDIT, V45, P1557, DOI 10.1002/anie.200503778; HUYBRECHTS G, 1977, INT J CHEM KINET, V9, P283, DOI 10.1002/kin.550090211; Kishida K., 2016, ANGEW CHEM, V128, P13988; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Liao PQ, 2016, CHEM SCI, V7, P6528, DOI 10.1039/c6sc00836d; Liao PQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9697; Liao PQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7350; Liao PQ, 2012, J AM CHEM SOC, V134, P17380, DOI 10.1021/ja3073512; Matar S., 2000, CHEM PETROCHEMICAL P, V2nd; Meyer G, 2003, U. S. Patent, Patent No. [20,030,181,772, 20030181772, 20,030,181,772 Al]; Nguyen NTT, 2014, ANGEW CHEM INT EDIT, V53, P10645, DOI 10.1002/anie.201403980; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Pires J, 2014, ACS APPL MATER INTER, V6, P12093, DOI 10.1021/am502686g; Rege SU, 1998, AICHE J, V44, P799, DOI 10.1002/aic.690440405; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Shekhah O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5228; Tsybulevski AM, 2012, IND ENG CHEM RES, V51, P7073, DOI 10.1021/ie202478c; WAGNER U, 1970, IND ENG CHEM, V62, P43, DOI 10.1021/ie50724a008; Yang SH, 2015, NAT CHEM, V7, P121, DOI 10.1038/nchem.2114; Zhang JP, 2014, CHEM SOC REV, V43, P5789, DOI 10.1039/c4cs00129j	32	426	434	50	436	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1193	1196		10.1126/science.aam7232	http://dx.doi.org/10.1126/science.aam7232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619946				2022-12-28	WOS:000403327400043
J	Latrubesse, EM; Arima, EY; Dunne, T; Park, E; Baker, VR; d'Horta, FM; Wight, C; Wittmann, F; Zuanon, J; Baker, PA; Ribas, CC; Norgaard, RB; Filizola, N; Ansar, A; Flyvbjerg, B; Stevaux, JC				Latrubesse, Edgardo M.; Arima, Eugenio Y.; Dunne, Thomas; Park, Edward; Baker, Victor R.; d'Horta, Fernando M.; Wight, Charles; Wittmann, Florian; Zuanon, Jansen; Baker, Paul A.; Ribas, Camila C.; Norgaard, Richard B.; Filizola, Naziano; Ansar, Atif; Flyvbjerg, Bent; Stevaux, Jose C.			Damming the rivers of the Amazon basin	NATURE			English	Article							SEDIMENT DISTRIBUTION PATTERNS; SUSPENDED SEDIMENT; HYDROPOWER; INFRASTRUCTURE; IMPACT; ANDES	More than a hundred hydropower dams have already been built in the Amazon basin and numerous proposals for further dam constructions are under consideration. The accumulated negative environmental effects of existing dams and proposed dams, if constructed, will trigger massive hydrophysical and biotic disturbances that will affect the Amazon basin's floodplains, estuary and sediment plume. We introduce a Dam Environmental Vulnerability Index to quantify the current and potential impacts of dams in the basin. The scale of foreseeable environmental degradation indicates the need for collective action among nations and states to avoid cumulative, far-reaching impacts. We suggest institutional innovations to assess and avoid the likely impoverishment of Amazon rivers.	[Latrubesse, Edgardo M.; Arima, Eugenio Y.; Park, Edward; Wight, Charles] Univ Texas Austin, Dept Geog & Environm, Austin, TX 78712 USA; [Latrubesse, Edgardo M.] Nanyang Technol Univ, Earth Observ Singapore, Singapore, Singapore; [Latrubesse, Edgardo M.] Nanyang Technol Univ, Asian Sch Environm, Singapore, Singapore; [Dunne, Thomas] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Baker, Victor R.] Univ Arizona, Dept Hydrol & Atmospher Sci, Tucson, AZ USA; [d'Horta, Fernando M.; Zuanon, Jansen] Natl Inst Amazonian Res INPA, Manaus, Amazonas, Brazil; [Wittmann, Florian] Karlsruhe Inst Technol, Inst Floodplain Ecol, Rastatt, Germany; [Baker, Paul A.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Baker, Paul A.] Yachay Tech, Geol Sci, Urcuqui, Ecuador; [Norgaard, Richard B.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Norgaard, Richard B.; Filizola, Naziano] Univ Fed Amazonas, Dept Geog, Manaus, Amazonas, Brazil; [Ansar, Atif; Flyvbjerg, Bent] Univ Oxford, Said Business Sch, Oxford, England; [Stevaux, Jose C.] State Univ Sao Paulo UNESP Rio Claro, Dept Appl Geol, Rio Claro, Brazil	University of Texas System; University of Texas Austin; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of California System; University of California Santa Barbara; University of Arizona; Institute Nacional de Pesquisas da Amazonia; Helmholtz Association; Karlsruhe Institute of Technology; Duke University; University of California System; University of California Berkeley; Universidade Federal de Amazonas; University of Oxford	Latrubesse, EM (corresponding author), Univ Texas Austin, Dept Geog & Environm, Austin, TX 78712 USA.; Latrubesse, EM (corresponding author), Nanyang Technol Univ, Earth Observ Singapore, Singapore, Singapore.; Latrubesse, EM (corresponding author), Nanyang Technol Univ, Asian Sch Environm, Singapore, Singapore.	latrubesse@austin.utexas.edu	Filizola, Naziano/AAK-3644-2021; Zuanon, Jansen A. S./E-5791-2013; Park, Edward/GZA-5944-2022; d'Horta, Fernando M/AFS-3304-2022; Ribas, Camila C/H-1769-2014	Filizola, Naziano/0000-0001-7285-7220; Zuanon, Jansen A. S./0000-0001-8354-2750; Park, Edward/0000-0002-1299-1724; Stevaux, Jose/0000-0001-6136-2556; Latrubesse, Edgardo/0000-0001-5592-302X; Ribas, Camila/0000-0002-9088-4828	NSF [FESD-1338694, EAR-1147954, DDRI-1558446]; NASA [NAG5-6120]; National Geographic Society-Research and Exploration Grant [8855-10]; LLILAS-Mellon; Brazilian Council for Scientific and Technological Development-CNPq; CAPES Foundation; Direct For Social, Behav & Economic Scie [1558446] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); National Geographic Society-Research and Exploration Grant(National Geographic Society); LLILAS-Mellon; Brazilian Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported in part by NSF grants (FESD-1338694, EAR-1147954 and DDRI-1558446), a NASA grant (NAG5-6120), a National Geographic Society-Research and Exploration Grant (8855-10), LLILAS-Mellon, the Brazilian Council for Scientific and Technological Development-CNPq and the CAPES Foundation.	[Anonymous], 2000, DAMS DEV NEW FRAM DE; Ansar A., 2016, BIG IS FRAGILE ATTEM; Ansar A, 2014, ENERG POLICY, V69, P43, DOI 10.1016/j.enpol.2013.10.069; Berardi U, 2015, PROCEDIA ENGINEER, V118, P128, DOI 10.1016/j.proeng.2015.08.411; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Constantine JA, 2014, NAT GEOSCI, V7, P899, DOI [10.1038/ngeo2282, 10.1038/NGEO2282]; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; de Sousa PT, 2011, NATURE, V478, P458, DOI 10.1038/478458b; Dunne T, 1998, GEOL SOC AM BULL, V110, P450, DOI 10.1130/0016-7606(1998)110<0450:EOSBTF>2.3.CO;2; Empresa de Pesquisa Energetica de Brasil (EPE), 2014, 1314 EPE; Empresa de Pesquisa energetica (EPE), 2008, REP MOD US HIDR; Fearnside PM, 2016, SCIENCE, V353, P746, DOI 10.1126/science.aag0254; Fearnside PM, 2013, WATER ALTERN, V6, P313; Fearnside PM, 2015, ENVIRON SCI POLICY, V50, P225, DOI 10.1016/j.envsci.2015.03.002; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Filizola N., 2015, IDBTN891; Filizola N, 2009, HYDROL PROCESS, V23, P3207, DOI 10.1002/hyp.7394; Flyvbjerg B, 2014, PROJ MANAG J, V45, P6, DOI 10.1002/pmj.21409; Grill G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/015001; Guyot JL, 1996, IAHS-AISH P, P55; Hess L., 2015, WETLANDS, V35, P1, DOI DOI 10.1007/S13157-015-0666-Y; IRENA, 2014, PER REN READ ASS 201; Junk, 2013, CENTRAL AMAZON FLOOD, V126; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Latrubesse EM, 2009, GEOMORPHOLOGY, V113, P239, DOI 10.1016/j.geomorph.2009.03.014; Latrubesse EM, 2008, GEOMORPHOLOGY, V101, P130, DOI 10.1016/j.geomorph.2008.05.035; Latrubesse EM, 2014, GEOMORPHOLOGY, V216, P225, DOI 10.1016/j.geomorph.2014.04.007; Latrubesse EM, 2005, GEOMORPHOLOGY, V70, P187, DOI 10.1016/j.geomorph.2005.02.005; Little P. E., 2014, MEGA DEV PROJECTS AM, P90; Malagueta D, 2014, RENEW ENERG, V68, P223, DOI 10.1016/j.renene.2014.01.050; MEADE RH, 1985, SCIENCE, V228, P488, DOI 10.1126/science.228.4698.488; Meisen P, 2009, RENEWABLE ENERGY POT; Molina Carpio J., 2006, ANALISIS ESTUDIOS IM, V2; Moura RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501252; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; NITTROUER CA, 1995, MAR GEOL, V125, P177, DOI 10.1016/0025-3227(95)00075-A; Nobre CA, 2009, GEOPHYS MONOGR SER, V186, P145, DOI 10.1029/2009GM000903; Park E, 2015, WATER RESOUR RES, V51, P6197, DOI 10.1002/2014WR016757; Park E, 2014, REMOTE SENS ENVIRON, V147, P232, DOI 10.1016/j.rse.2014.03.013; Pereira MG, 2012, RENEW SUST ENERG REV, V16, P3786, DOI 10.1016/j.rser.2012.03.024; Prado FA, 2016, RENEW SUST ENERG REV, V53, P1132, DOI 10.1016/j.rser.2015.09.050; Queiroz L., 2013, PEIXES RIO MADEIRA D, P1163; Rey O., 2012, SETOR ELETRICO BRASI, V21; Ritter CD, 2017, BIOL CONSERV, V206, P161, DOI 10.1016/j.biocon.2016.12.031; SALO J, 1986, NATURE, V322, P254, DOI 10.1038/322254a0; Schaeffer R, 2013, IEEE POWER ENERGY M, V11, P22, DOI 10.1109/MPE.2013.2245584; Scudder Thayer, 2012, FUTURE LARGE DAMS DE; Secretaria de Asuntos Estrategicos (SAE), 2013, REC HIDR FRONT TRANS, P144; Secretaria de Estado de Meio Ambiente (SEMA), 2012, PLAN EST REC HIDR AC; Sovacool BK, 2014, ENERGY, V74, P906, DOI 10.1016/j.energy.2014.07.070; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Stickler CM, 2013, P NATL ACAD SCI USA, V110, P9601, DOI 10.1073/pnas.1215331110; Stone R, 2011, SCIENCE, V333, P817, DOI 10.1126/science.333.6044.817; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; United Nations Environment Programme (UNEP), 2016, TRANSB RIV BAS STAT, P342; Vale MM, 2008, CONSERV BIOL, V22, P1006, DOI 10.1111/j.1523-1739.2008.00939.x; Vizy EK, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014049; Wade L, 2016, SCIENCE, V352, P1044, DOI 10.1126/science.352.6289.1044; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; World Database on Protected Areas (WDPA), 2004, WORLD CONS UN UNEP W; WWF, 2012, AL GRAND HIDR POL FO	61	360	377	21	388	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					363	369		10.1038/nature22333	http://dx.doi.org/10.1038/nature22333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617466	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000403250900026
J	Squazzoni, F; Grimaldo, F; Marusic, A				Squazzoni, Flaminio; Grimaldo, Francisco; Marusic, Ana			Journals could share peer-review data	NATURE			English	Letter									[Squazzoni, Flaminio] Univ Brescia, Brescia, Italy; [Grimaldo, Francisco] Univ Valencia, Valencia, Spain; [Marusic, Ana] Univ Split, Split, Croatia	University of Brescia; University of Valencia; University of Split	Squazzoni, F (corresponding author), Univ Brescia, Brescia, Italy.	flaminio.squazzoni@unibs.it							0	22	22	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					352	352		10.1038/546352a	http://dx.doi.org/10.1038/546352a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617464	Bronze			2022-12-28	WOS:000403250900015
J	Woodcock, A				Woodcock, Ashley			Commentary: View from the frontline of pragmatic trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Woodcock, Ashley] Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England	Wythenshawe Hospital NHS Foundation Trust	Woodcock, A (corresponding author), Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England.	ashley.woodcock@manchester.ac.uk		Woodcock, Ashley/0000-0002-5428-8578				Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Elkhenini HF, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0132-z; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Liu H, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0956-y; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Sulaiman I, 2017, AM J RESP CRIT CARE, V195, P1333, DOI 10.1164/rccm.201604-0733OC; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; Vestbo J, 2017, LANCET RESP MED, V5, P466, DOI 10.1016/S2213-2600(17)30177-7; Vestbo J, 2016, NEW ENGL J MED, V375, P1253, DOI 10.1056/NEJMoa1608033	10	2	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2017	357								j2837	10.1136/bmj.j2837	http://dx.doi.org/10.1136/bmj.j2837			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UT	28615287				2022-12-28	WOS:000403753400005
J	Taichman, DB; Sahni, P; Pinborg, A; Peiperl, L; Laine, C; James, A; Haileamlak, A; Gollogly, L; Godlee, F; Frizelle, FA; Florenzano, F; Drazen, JM; Bauchner, H; Baethge, C; Backus, J				Taichman, Darren B.; Sahni, Peush; Pinborg, Anja; Peiperl, Larry; Laine, Christine; James, Astrid; Haileamlak, Abraham; Gollogly, Laragh; Godlee, Fiona; Frizelle, Frank A.; Florenzano, Fernando; Drazen, Jeffrey M.; Bauchner, Howard; Baethge, Christopher; Backus, Joyce			Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors	LANCET			English	Editorial Material									[Backus, Joyce] Natl Lib Med, Lib Operat, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)		dtaichman@acponline.org		Pinborg, Anja/0000-0002-8340-104X	Public Library of Science	Public Library of Science	DBT is employed as an Editor by the Annals of Internal Medicine and the American College of Physicians. LP is Chief Editor of PLOS Medicine and receives a salary and benefits from Public Library of Science, a non-profit publisher and advocate of open access research, has received travel reimbursement from WHO to attend consultations on data sharing, and has received travel reimbursement from the Association of Healthcare Journalists to speak on data sharing. CL is employed as an Editor by the Annals of Internal Medicine and the American College of Physicians. AH is an employee of Jimma University in Ethiopia and the Editor of Ethiopian Journal of Health Sciences. LG is employed by WHO. PS, AP, AJ, S-TH, FG, FAF, FF, JMD, HB, CB, and JB declare no competing interests. PS's affiliation as representative and past president of the World Association of Medical Editors (WAME) does not imply endorsement by WAME member journals that are not part of the ICMJE.	Menikoff J, 2017, OFFICE HUMAN RES PRO; Taichman DB, 2016, ANN INTERN MED, V164, P505, DOI 10.7326/M15-2928	2	20	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					E12	E14		10.1016/S0140-6736(17)31282-5	http://dx.doi.org/10.1016/S0140-6736(17)31282-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28596041	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000402872700001
J	Fiennes, C				Fiennes, Caroline			We need a science of philanthropy	NATURE			English	Editorial Material									[Fiennes, Caroline] Giving Evidence, London, England		Fiennes, C (corresponding author), Giving Evidence, London, England.	caroline.fiennes@giving-evidence.com							0	7	7	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					187	187		10.1038/546187a	http://dx.doi.org/10.1038/546187a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9FY	28593975	Bronze			2022-12-28	WOS:000402823400004
J	Oliver, D				Oliver, David			David Oliver: Unproductive activity and NHS consultants	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1520; Ham C, 2017, ORG CARE NHS FRONT L; King's Fund, 2012, LEAD ENG IMPR NHS TO; Oliver D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4656	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2017	357								j2693	10.1136/bmj.j2693	http://dx.doi.org/10.1136/bmj.j2693			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4WM	28588008	Bronze, Green Published			2022-12-28	WOS:000426827800001
J	Petersen, M; Balzer, L; Kwarsiima, D; Sang, N; Chamie, G; Ayieko, J; Kabami, J; Owaraganise, A; Liegler, T; Mwangwa, F; Kadede, K; Jain, V; Plenty, A; Brown, L; Lavoy, G; Schwab, J; Black, D; van der Laan, M; Bukusi, EA; Cohen, CR; Clark, TD; Charlebois, E; Kamya, M; Havlir, D				Petersen, Maya; Balzer, Laura; Kwarsiima, Dalsone; Sang, Norton; Chamie, Gabriel; Ayieko, James; Kabami, Jane; Owaraganise, Asiphas; Liegler, Teri; Mwangwa, Florence; Kadede, Kevin; Jain, Vivek; Plenty, Albert; Brown, Lillian; Lavoy, Geoff; Schwab, Joshua; Black, Douglas; van der Laan, Mark; Bukusi, Elizabeth A.; Cohen, Craig R.; Clark, Tamara D.; Charlebois, Edwin; Kamya, Moses; Havlir, Diane			Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; ART; RETENTION; INFECTION; CASCADE; RNA	IMPORTANCE Antiretroviral treatment (ART) is now recommended for all HIV-positive persons. UNAIDS has set global targets to diagnose 90% of HIV-positive individuals, treat 90% of diagnosed individuals with ART, and suppress viral replication among 90% of treated individuals, for a population-level target of 73% of all HIV-positive persons with HIV viral suppression. OBJECTIVE To describe changes in the proportions of HIV-positive individuals with HIV viral suppression, HIV-positive individuals who had received a diagnosis, diagnosed individuals treated with ART, and treated individuals with HIV viral suppression, following implementation of a community-based testing and treatment program in rural East Africa. DESIGN, SETTING, AND PARTICIPANTS Observational analysis based on interim data from 16 rural Kenyan (n = 6) and Ugandan (n = 10) intervention communities in the SEARCH Study, an ongoing cluster randomized trial. Community residents who were 15 years or older (N = 77 774) were followed up for 2 years (2013-2014 to 2015-2016). HIV serostatus and plasma HIV RNA level were measured annually at multidisease health campaigns followed by home-based testing for nonattendees. All HIV-positive individuals were offered ART using a streamlined delivery model designed to reduce structural barriers, improve patient-clinician relationships, and enhance patient knowledge and attitudes about HIV. MAIN OUTCOMES AND MEASURES Primary outcome was viral suppression (plasma HIV RNA <500 copies/mL) among all HIV-positive individuals, assessed at baseline and after 1 and 2 years. Secondary outcomes included HIV diagnosis, ART among previously diagnosed individuals, and viral suppression among those who had initiated ART. RESULTS Among 77 774 residents (male, 45.3%; age 15-24 years, 35.1%), baseline HIV prevalence was 10.3%(7108 of 69 283 residents). The proportion of HIV-positive individuals with HIV viral suppression at baseline was 44.7%(95% CI, 43.5%-45.9%; 3464 of 7745 residents) and after 2 years of intervention was 80.2%(95% CI, 79.1%-81.2%; 5666 of 7068 residents), an increase of 35.5 percentage points (95% CI, 34.4-36.6). After 2 years, 95.9% of HIV-positive individuals had been previously diagnosed (95% CI, 95.3%-96.5%; 6780 of 7068 residents); 93.4% of those previously diagnosed had received ART (95% CI, 92.8%-94.0%; 6334 of 6780 residents); and 89.5% of those treated had achieved HIV viral suppression (95% CI, 88.6%-90.3%; 5666 of 6334 residents). CONCLUSIONS AND RELEVANCE Among individuals with HIV in rural Kenya and Uganda, implementation of community-based testing and treatment was associated with an increased proportion of HIV-positive adults who achieved viral suppression, along with increased HIV diagnosis and initiation of antiretroviral therapy. In these communities, the UNAIDS population-level viral suppression target was exceeded within 2 years after program implementation.	[Petersen, Maya; Schwab, Joshua; van der Laan, Mark] Univ Calif Berkeley, Sch Publ Hlth, 101 Haviland Hall, Berkeley, CA 94110 USA; [Balzer, Laura; Chamie, Gabriel; Liegler, Teri; Jain, Vivek; Plenty, Albert; Brown, Lillian; Black, Douglas; Cohen, Craig R.; Clark, Tamara D.; Charlebois, Edwin; Havlir, Diane] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Balzer, Laura] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Kwarsiima, Dalsone; Kabami, Jane; Owaraganise, Asiphas; Mwangwa, Florence; Lavoy, Geoff; Kamya, Moses] Infect Dis Res Collaborat, Kampala, Uganda; [Sang, Norton; Ayieko, James; Kadede, Kevin; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Kamya, Moses] Makerere Univ, Kampala, Uganda	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Kenya Medical Research Institute; Makerere University	Petersen, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 101 Haviland Hall, Berkeley, CA 94110 USA.	mayaliv@berkeley.edu		Owaraganise, Asiphas/0000-0002-5594-0310	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [UM1AI069502, U01AI099959, R01AI074345]; US President's Emergency Plan for AIDS Relief; Office of the Global AIDS Coordinator; Gilead Sciences (Truvada donation); Office of AIDS Research; University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for Aids Research [P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074345, UM1AI069502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of the Global AIDS Coordinator; Gilead Sciences (Truvada donation); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for Aids Research(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants UM1AI069502, U01AI099959 (both from Dr Havlir), and R01AI074345 (Dr van der Laan) from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health and by the US President's Emergency Plan for AIDS Relief, the Office of the Global AIDS Coordinator, Gilead Sciences (Truvada donation), and the Office of AIDS Research. The University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for Aids Research provided indirect funding through grant P30 AI027763 for laboratory infrastructure and Dr Liegler's support.	Adakun SA, 2013, JAIDS-J ACQ IMM DEF, V62, P317, DOI 10.1097/QAI.0b013e3182800daf; Ayieko J, 2016, INT AIDS C JUL 18 22; Balzer L, EVALUATION PROGR UNA; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Cherutich P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154318; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Grabowski M, 2017, C RETR OPP INF FEBR; Granich R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002253; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Jain V, 2017, LANCET HIV, V4, pE122, DOI 10.1016/S2352-3018(16)30220-X; Jain V, 2013, CLIN INFECT DIS, V56, P598, DOI 10.1093/cid/cis881; Justman J, 2017, C RETR OPP INF FEBR; Kranzer K, 2013, JAIDS-J ACQ IMM DEF, V63, P498, DOI 10.1097/QAI.0b013e318293ae48; Kwarisiima D, 2016, C RETR OPP INF FEBR; Larmarange J, 2016, C RETR OPP INF FEBR; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Lippman SA, 2016, JAIDS-J ACQ IMM DEF, V73, P91, DOI 10.1097/QAI.0000000000001026; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Maman D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20673; Maman D, 2015, AIDS, V29, P1557, DOI 10.1097/QAD.0000000000000741; Polley E., SUPERLEARNER SUPER L; Schwab J, LTMLE LONGITUDINAL T; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; Walensky RP, 2016, ANN INTERN MED, V165, P325, DOI 10.7326/M16-0799; World Health Organization, 2015, CONS GUID US ANT DRU	34	93	93	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2196	2206		10.1001/jama.2017.5705	http://dx.doi.org/10.1001/jama.2017.5705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586888	Green Published			2022-12-28	WOS:000402706100016
J	Shekelle, PG; Newberry, SJ				Shekelle, Paul G.; Newberry, Sydne J.			Management of Gout RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Shekelle, Paul G.] West Los Angeles VA Med Ctr, Los Angeles, CA 90073 USA; [Newberry, Sydne J.] RAND Corp, Santa Monica, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center; RAND Corporation	Shekelle, PG (corresponding author), West Los Angeles VA Med Ctr, Los Angeles, CA 90073 USA.							Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]	2	1	1	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					855	855		10.7326/L17-0212	http://dx.doi.org/10.7326/L17-0212			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28586902				2022-12-28	WOS:000402700200018
J	Voelker, R				Voelker, Rebecca			Liver Cancer Treatment Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2157	2157		10.1001/jama.2017.6339	http://dx.doi.org/10.1001/jama.2017.6339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586877				2022-12-28	WOS:000402706100006
J	Drummond, C				Drummond, Colin			Cuts to addiction services are a false economy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Drummond, Colin] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England	University of London; King's College London	Drummond, C (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.	colin.drummond@kcl.ac.uk	Drummond, Colin/O-9141-2019	Drummond, Colin/0000-0001-9379-5452	Medical Research Council [G0701681, G0701818] Funding Source: researchfish; National Institute for Health Research [13/86/03, NF-SI-0616-10077, RP-PG-0609-10162] Funding Source: researchfish; MRC [G0701818, G0701681] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2017, BBC; [Anonymous], 2017, THE GUARDIAN; Corrigan P., 2017, SENTINEL; Drummond, 2017, WORKFORCE STRATEGY A; Health Education England, 2015, HEE WORKF PLANN STRA; Middleton J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5259; Mohammadi D, 2014, LANCET PSYCHIAT, V1, P421, DOI 10.1016/S2215-0366(14)00015-7; NHS Digital, 2017, STAT DRUGS MIS ENGL; Office for National Statistics, 2016, DEATHS INV SUBST AR; Taylor J., 2016, LIVERPOOL ECHO  0825	10	27	27	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2017	357								j2704	10.1136/bmj.j2704	http://dx.doi.org/10.1136/bmj.j2704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4VU	28584061	Green Published			2022-12-28	WOS:000426826000002
J	Le, C; Liang, YF; Evans, RW; Li, XM; MacMillan, DWC				Le, Chip; Liang, Yufan; Evans, Ryan W.; Li, Ximing; MacMillan, David W. C.			Selective sp(3) C-H alkylation via polarity-match-based cross-coupling	NATURE			English	Article							LATE-STAGE FUNCTIONALIZATION; PHOTOREDOX CATALYSIS; ARYL HALIDES; ORGANIC-CHEMISTRY; BONDS; ALPHA; C(SP(3))-H; SECONDARY; COMPLEX; CARBON	The functionalization of carbon-hydrogen (C-H) bonds is one of the most attractive strategies for molecular construction in organic chemistry. The hydrogen atom is considered to be an ideal coupling handle, owing to its relative abundance in organic molecules and its availability for functionalization at almost any stage in a synthetic sequence1. Although many C-H functionalization reactions involve C(sp(3))-C(sp(2)) coupling, there is a growing demand for C-H alkylation reactions, wherein sp(3) C-H bonds are replaced with sp(3) C-alkyl groups. Here we describe a polarity-match-based selective sp(3) C-H alkylation via the combination of photoredox, nickel and hydrogen-atom transfer catalysis. This methodology simultaneously uses three catalytic cycles to achieve hydridic C-H bond abstraction (enabled by polarity matching), alkyl halide oxidative addition, and reductive elimination to enable alkyl-alkyl fragment coupling. The sp(3) C-H alkylation is highly selective for the alpha-C-H of amines, ethers and sulphides, which are commonly found in pharmaceutically relevant architectures. This cross-coupling protocol should enable broad synthetic applications in de novo synthesis and late-stage functionalization chemistry.	[Le, Chip; Liang, Yufan; Evans, Ryan W.; Li, Ximing; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Le, Chi/0000-0002-9614-365X; Liang, Yufan/0000-0002-0533-2982; Li, Ximing/0000-0003-0764-8451	NIH National Institute of General Medical Sciences [R01 GM078201-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH National Institute of General Medical Sciences (R01 GM078201-05) and gifts from Merck, Bristol-Myers Squibb, Eli Lilly and Johnson & Johnson. The authors thank T. Liu for assistance in preparing this manuscript.	Ackermann L, 2010, CHEM COMMUN, V46, P4866, DOI 10.1039/c0cc00778a; Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P6045, DOI 10.1002/anie.200902458; ADAMS J, 1989, TETRAHEDRON LETT, V30, P1749, DOI 10.1016/S0040-4039(00)99570-4; Aihara Y, 2013, J AM CHEM SOC, V135, P5308, DOI 10.1021/ja401344e; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Cheung MS, 2015, CHEM-EUR J, V21, P7480, DOI 10.1002/chem.201500110; Colby DA, 2012, ACCOUNTS CHEM RES, V45, P814, DOI 10.1021/ar200190g; Davies HML, 2003, J AM CHEM SOC, V125, P6462, DOI 10.1021/ja0290072; Davies HML, 2016, J ORG CHEM, V81, P343, DOI 10.1021/acs.joc.5b02818; DiRocco DA, 2014, ANGEW CHEM INT EDIT, V53, P4802, DOI 10.1002/anie.201402023; Doyle MP, 2010, CHEM REV, V110, P704, DOI 10.1021/cr900239n; Durandetti M, 1996, NEW J CHEM, V20, P659; Gutierrez O, 2015, J AM CHEM SOC, V137, P4896, DOI 10.1021/ja513079r; Ilies L, 2014, J AM CHEM SOC, V136, P13126, DOI 10.1021/ja5066015; Jeffrey JL, 2015, SCIENCE, V349, P1532, DOI 10.1126/science.aac8555; Karkas MD, 2016, CHEM REV, V116, P9683, DOI 10.1021/acs.chemrev.5b00760; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Roberts BP, 1999, CHEM SOC REV, V28, P25, DOI 10.1039/a804291h; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Shabashov D, 2010, J AM CHEM SOC, V132, P3965, DOI 10.1021/ja910900p; Shaw MH, 2016, J ORG CHEM, V81, P6898, DOI 10.1021/acs.joc.6b01449; Shaw MH, 2016, SCIENCE, V352, P1304, DOI 10.1126/science.aaf6635; Zhang SY, 2013, J AM CHEM SOC, V135, P12135, DOI 10.1021/ja406484v; Zhang XH, 2016, J AM CHEM SOC, V138, P13862, DOI 10.1021/jacs.6b09533; Zhang YH, 2009, ANGEW CHEM INT EDIT, V48, P6097, DOI 10.1002/anie.200902262; Zhu RY, 2014, J AM CHEM SOC, V136, P13194, DOI 10.1021/ja508165a; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	30	304	305	25	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					79	83		10.1038/nature22813	http://dx.doi.org/10.1038/nature22813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28636596	Green Accepted			2022-12-28	WOS:000404839900034
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Health inequality has to be political	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6; Osborne H., 2014, GUARDIAN; Understanding Glasgow (the Glasgow Indicators Project), NEIGHB MAL LIF EXP C	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2017	357								j2978	10.1136/bmj.j2978	http://dx.doi.org/10.1136/bmj.j2978			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YT	28634281	Bronze, Green Published			2022-12-28	WOS:000404210000012
J	Maffioli, SI; Zhang, Y; Degen, D; Carzaniga, T; Del Gatto, G; Serina, S; Monciardini, P; Mazzetti, C; Guglierame, P; Candiani, G; Chiriac, AI; Facchetti, G; Kaltofen, P; Sahl, HG; Deho, G; Donadio, S; Ebright, RH				Maffioli, Sonia I.; Zhang, Yu; Degen, David; Carzaniga, Thomas; Del Gatto, Giancarlo; Serina, Stefania; Monciardini, Paolo; Mazzetti, Carlo; Guglierame, Paola; Candiani, Gianpaolo; Chiriac, Alina Iulia; Facchetti, Giuseppe; Kaltofen, Petra; Sahl, Hans-Georg; Deho, Gianni; Donadio, Stefano; Ebright, Richard H.			Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase	CELL			English	Article							STRUCTURAL BASIS; TRANSCRIPTION INHIBITION; FLUCTUATION ANALYSIS; ACTIVE-CENTER; RPOB GENE; MUTATIONS; BINDING; RIFAMPICIN; TARGET; DNA	Drug-resistant bacterial pathogens pose an urgent public-health crisis. Here, we report the discovery, from microbial-extract screening, of a nucleoside-analog inhibitor that inhibits bacterial RNA polymerase (RNAP) and exhibits antibacterial activity against drug-resistant bacterial pathogens: pseudouridimycin (PUM). PUM is a natural product comprising a formamidinylated, N-hydroxylated Gly-Gln dipeptide conjugated to 6'-amino-pseudouridine. PUM potently and selectively inhibits bacterial RNAP in vitro, inhibits bacterial growth in culture, and clears infection in a mouse model of Streptococcus pyogenes peritonitis. PUM inhibits RNAP through a binding site on RNAP (the NTP addition site) and mechanism (competition with UTP for occupancy of the NTP addition site) that differ from those of the RNAP inhibitor and current antibacterial drug rifampin (Rif). PUM exhibits additive antibacterial activity when co-administered with Rif, exhibits no cross-resistance with Rif, and exhibits a spontaneous resistance rate an order-of-magnitude lower than that of Rif. PUM is a highly promising lead for antibacterial therapy.	[Maffioli, Sonia I.; Del Gatto, Giancarlo; Serina, Stefania; Monciardini, Paolo; Mazzetti, Carlo; Donadio, Stefano] NAICONS Srl, I-20139 Milan, Italy; [Maffioli, Sonia I.; Serina, Stefania; Monciardini, Paolo; Candiani, Gianpaolo; Facchetti, Giuseppe; Kaltofen, Petra; Donadio, Stefano] Vicuron Pharmaceut, I-21040 Gerenzano, Italy; [Zhang, Yu; Degen, David; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Zhang, Yu; Degen, David; Ebright, Richard H.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA; [Carzaniga, Thomas; Deho, Gianni] Univ Milan, Dept Biosci, I-20122 Milan, Italy; [Guglierame, Paola] NeED Pharma Srl, I-20139 Milan, Italy; [Chiriac, Alina Iulia; Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-53012 Bonn, Germany	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Milan; University of Bonn	Donadio, S (corresponding author), NAICONS Srl, I-20139 Milan, Italy.; Donadio, S (corresponding author), Vicuron Pharmaceut, I-21040 Gerenzano, Italy.; Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.; Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.	sdonadio@naicons.com; ebright@waksman.rutgers.edu	Carzaniga, Thomas/AAJ-3323-2021; Ebright, Richard/O-3321-2019; Monciardini, Paolo/AAF-5904-2020; maffioli, sonia/K-7575-2019; Zhang, Yu/AAV-5722-2021	Carzaniga, Thomas/0000-0002-4236-4019; Ebright, Richard/0000-0001-8915-7140; Zhang, Yu/0000-0002-1778-8389; Degen, David/0000-0002-2916-0564	NIH [GM041376, AI104660]; Italian Ministry of Research [30190679]; Regione Lombardia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by NIH grants GM041376 and AI104660 to R.H.E. and Italian Ministry of Research grant 30190679 and Regione Lombardia grants to NAICONS. We thank former colleagues at Vicuron Pharmaceuticals for early characterization of PUM; S. Parapini for cytotoxicity assays; W. Fenical for Sal; A. Berk and I. Grummt for plasmids; J. Silverman, NARSA, and BEI Resources for strains; and the Cornell High Energy Synchrotron Source for beamline access. S.I.M., S.S., P.M., and S.D. are employees and/or shareholders of NAICONS. Y.Z., S.I.M., S.S., P.M., P.G., G.C., S.D., and R.H.E. have patent filings. The other authors declare that no competing interests exist. (Vicuron Pharmaceuticals no longer is operational.)	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; Bae B, 2015, P NATL ACAD SCI USA, V112, pE4178, DOI 10.1073/pnas.1502368112; BARRY AL, 1993, EUR J CLIN MICROBIOL, V12, P548, DOI 10.1007/BF01970963; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Ciciliato I, 2004, J ANTIBIOT, V57, P210, DOI 10.7164/antibiotics.57.210; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; CLSI, 2009, METH DIL ANT SUSC TE, pM07; DEAN N, 1988, MOL CELL BIOL, V8, P3017, DOI 10.1128/MCB.8.8.3017; Degen D, 2014, ELIFE, V3, DOI 10.7554/eLife.02451; Donadio S, 2009, METHOD ENZYMOL, V458, P3, DOI 10.1016/S0076-6879(09)04801-0; Ebright R. H., 2005, RNA-Exit Channel: Target and Method for Inhibition of Bacterial RNA, Patent No. [WO 2005/001034, 2005001034]; Ebright R.H., 2012, WIPO Patent Application WO, Patent No. 2012037508; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feklistov A, 2008, P NATL ACAD SCI USA, V105, P14820, DOI 10.1073/pnas.0802822105; Feng Y, 2015, STRUCTURE, V23, P1470, DOI 10.1016/j.str.2015.06.009; FRALICK JA, 1994, J BACTERIOL, V176, P6404, DOI 10.1128/jb.176.20.6404-6406.1994; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Hein PP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-141; Ho MX, 2009, CURR OPIN STRUC BIOL, V19, P715, DOI 10.1016/j.sbi.2009.10.010; Holowachuk SA, 2003, J MICROBIOL METH, V55, P441, DOI 10.1016/S0167-7012(03)00190-8; Hudson BP, 2009, P NATL ACAD SCI USA, V106, P19830, DOI 10.1073/pnas.0908782106; IRSCHIK H, 1995, J ANTIBIOT, V48, P787, DOI 10.7164/antibiotics.48.787; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; IRSCHIK H, 1985, J ANTIBIOT, V38, P145, DOI 10.7164/antibiotics.38.145; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; Jovanovic M, 2011, J BIOL CHEM, V286, P14469, DOI 10.1074/jbc.M110.212902; KETTENRING J, 1991, J ANTIBIOT, V44, P702, DOI 10.7164/antibiotics.44.702; LANCINI G, 1969, J BACTERIOL, V97, P761, DOI 10.1128/JB.97.2.761-768.1969; LANCINI GC, 1968, EXPERIENTIA, V24, P1105, DOI 10.1007/BF02147783; Landwehr W, 2016, CURR TOP MICROBIOL, V398, P273, DOI 10.1007/82_2016_503; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; Leitner A, 2003, J MASS SPECTROM, V38, P891, DOI 10.1002/jms.477; Lin W, 2017, MOL CELL, V66, P169, DOI 10.1016/j.molcel.2017.03.001; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Maffioli SI, 2005, ORG LETT, V7, P5237, DOI 10.1021/ol052100l; Mariani R, 2009, CURR MED CHEM, V16, P430, DOI 10.2174/092986709787315559; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; MATTINGLY PG, 1980, J ORG CHEM, V45, P410, DOI 10.1021/jo01291a007; Mazza P, 2003, MICROBIAL ECOL, V45, P362, DOI 10.1007/s00248-002-2038-4; Mazzetti C, 2012, J NAT PROD, V75, P1044, DOI 10.1021/np300003n; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mukhopadhyay J, 2003, METHOD ENZYMOL, V371, P144; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PFLEIDERER C, 1990, NUCLEIC ACIDS RES, V18, P4727, DOI 10.1093/nar/18.16.4727; PLOESER JM, 1949, J BIOL CHEM, V178, P431; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; SAGITOV V, 1993, J BIOL CHEM, V268, P2195; Sambrook J., 2001, MOL CLONING LAB MANU; SANCAR A, 1980, P NATL ACAD SCI-BIOL, V77, P2611, DOI 10.1073/pnas.77.5.2611; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SERGIO S, 1975, J ANTIBIOT, V28, P543, DOI 10.7164/antibiotics.28.543; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; Srivastava A, 2012, ANTIMICROB AGENTS CH, V56, P6250, DOI 10.1128/AAC.01060-12; Srivastava A, 2011, CURR OPIN MICROBIOL, V14, P532, DOI 10.1016/j.mib.2011.07.030; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Summers BB, 2014, J PHARM PHARMACOL, V66, P1653, DOI 10.1111/jphp.12294; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Weinzierl ROJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-134; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Yuzenkova Y, 2012, TRANSCR-AUSTIN, V3, P115, DOI 10.4161/trns.19887; Zhang Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02450; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	81	87	90	6	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1240	+		10.1016/j.cell.2017.05.042	http://dx.doi.org/10.1016/j.cell.2017.05.042			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622509	Green Accepted, Bronze			2022-12-28	WOS:000403332400013
J	Savage, N				Savage, Neil			Patience for patients	NATURE			English	Editorial Material																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					S1	S3		10.1038/546S1a	http://dx.doi.org/10.1038/546S1a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28614292	Bronze			2022-12-28	WOS:000403250900001
J	Lane, R				Lane, Richard			Moses Massaquoi: health leader in humanitarian crises	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2232	2232		10.1016/S0140-6736(17)31569-6	http://dx.doi.org/10.1016/S0140-6736(17)31569-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602554				2022-12-28	WOS:000415645700014
J	Selvin, E; Sacks, DB				Selvin, Elizabeth; Sacks, David B.			Variability in the Relationship of Hemoglobin A(1c) and Average Glucose Concentrations: How Much Does Race Matter?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IRON-DEFICIENCY		[Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA; [Sacks, David B.] NIH, Bldg 10,Room 2C306,10 Ctr Dr, Bethesda, MD 20892 USA; [Selvin, Elizabeth] Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA	Selvin, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA.; Selvin, E (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA.	eselvin@jhu.edu		Sacks, David/0000-0003-3100-0735				Bergenstal RM, 2017, ANN INTERN MED, V167, P95, DOI 10.7326/M16-2596; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Cengiz E, 2009, DIABETES TECHNOL THE, V11, pS11, DOI 10.1089/dia.2009.0002; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Tarim O, 1999, PEDIATR INT, V41, P357; Welsh KJ, 2016, DIABETES CARE, V39, P1299, DOI 10.2337/dc15-2727	7	26	26	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					131	+		10.7326/M17-1231	http://dx.doi.org/10.7326/M17-1231			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28605752				2022-12-28	WOS:000405573400022
J	Lundeberg, MB; Gao, YD; Asgari, R; Tan, C; Van Duppen, B; Autore, M; Alonso-Gonzalez, P; Woessner, A; Watanabe, K; Taniguchi, T; Hillenbrand, R; Hone, J; Polini, M; Koppens, FHL				Lundeberg, Mark B.; Gao, Yuanda; Asgari, Reza; Tan, Cheng; Van Duppen, Ben; Autore, Marta; Alonso-Gonzalez, Pablo; Woessner, Achim; Watanabe, Kenji; Taniguchi, Takashi; Hillenbrand, Rainer; Hone, James; Polini, Marco; Koppens, Frank H. L.			Tuning quantum nonlocal effects in graphene plasmonics	SCIENCE			English	Article							OSCILLATIONS; EXCITATIONS; NANOSCOPY	The response of electron systems to electrodynamic fields that change rapidly in space is endowed by unique features, including an exquisite spatial nonlocality. This can reveal much about the materials' electronic structure that is invisible in standard probes that use gradually varying fields. Here, we use graphene plasmons, propagating at extremely slow velocities close to the electron Fermi velocity, to probe the nonlocal response of the graphene electron liquid. The near-field imaging experiments reveal a parameter-free match with the full quantum description of the massless Dirac electron gas, which involves three types of nonlocal quantum effects: single-particle velocity matching, interaction-enhanced Fermi velocity, and interaction-reduced compressibility. Our experimental approach can determine the full spatiotemporal response of an electron system.	[Lundeberg, Mark B.; Woessner, Achim; Koppens, Frank H. L.] Barcelona Inst Sci & Technol, ICFO Inst Cinecies Foton, Castelldefels 08860, Barcelona, Spain; [Gao, Yuanda; Tan, Cheng; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Asgari, Reza] Inst Res Fundamental Sci IPM, Sch Phys, Tehran 193955531, Iran; [Asgari, Reza] Inst Res Fundamental Sci IPM, Sch Nano Sci, Tehran 193955531, Iran; [Van Duppen, Ben] Univ Antwerp, Dept Phys, Groenenborgerlaan 171, B-2020 Antwerp, Belgium; [Autore, Marta; Alonso-Gonzalez, Pablo; Hillenbrand, Rainer] CIC NanoGUNE, E-20018 Donostia San Sebastian, Spain; [Alonso-Gonzalez, Pablo] Univ Oviedo, Dept Fis, E-33007 Oviedo, Spain; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Hillenbrand, Rainer] EHU UPV, E-20018 Donostia San Sebastian, Spain; [Hillenbrand, Rainer] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Polini, Marco] Ist Italiano Tecnol, Graphene Labs, Via Morego 30, I-16163 Genoa, Italy; [Koppens, Frank H. L.] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Columbia University; University of Antwerp; University of Oviedo; National Institute for Materials Science; University of Basque Country; Basque Foundation for Science; Istituto Italiano di Tecnologia - IIT; ICREA	Koppens, FHL (corresponding author), Barcelona Inst Sci & Technol, ICFO Inst Cinecies Foton, Castelldefels 08860, Barcelona, Spain.; Polini, M (corresponding author), Ist Italiano Tecnol, Graphene Labs, Via Morego 30, I-16163 Genoa, Italy.; Koppens, FHL (corresponding author), ICREA, Barcelona 08010, Spain.	marco.polini@iit.it; frank.koppens@icfo.es	Hillenbrand, Rainer/N-3428-2016; Hone, James C/E-1879-2011; Polini, Marco/L-3419-2013; Watanabe, Kenji/ABB-2135-2021; Alonso-González, Pablo/B-8101-2013; Woessner, Achim/N-1962-2014; Van Duppen, Ben/M-1630-2013	Hillenbrand, Rainer/0000-0002-1904-4551; Hone, James C/0000-0002-8084-3301; Watanabe, Kenji/0000-0003-3701-8119; Alonso-González, Pablo/0000-0002-4597-9326; Woessner, Achim/0000-0002-5024-4201; Van Duppen, Ben/0000-0003-0759-0931; Asgari, Reza/0000-0001-5163-4765	European Union [696656, 307806]; Fondazione Istituto Italiano di Tecnologia; project GRASP [FP7-ICT-2013-613024-GRASP]; Spanish Ministry of Economy and Competitiveness [SEV-2015-0522, MAT-2015-65525-R]; Fundacio Cellex Barcelona; CERCA Programme/Generalitat de Catalunya; Mineco [RYC-2012-12281, FIS2013-47161-P, FIS2014-59639-JIN]; Government of Catalonia through the SGR [2014-SGR-1535]; ERC [715496]; Elemental Strategy Initiative by the MEXT, Japan; JSPS KAKENHI [JP26248061, JP15K21722, JP25106006]; U. S. Office of Naval Research [N00014-13-1-0662]; Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; U. S. Department of Energy Office of Science Facility at Brookhaven National Laboratory [DE-SC0012704]; Flemish Science Foundation (FWO-Vl);  [FIS2014-60195-JIN];  [FA9550-11-C-0028]	European Union(European Commission); Fondazione Istituto Italiano di Tecnologia; project GRASP; Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); CERCA Programme/Generalitat de Catalunya; Mineco(Spanish Government); Government of Catalonia through the SGR; ERC(European Research Council (ERC)European Commission); Elemental Strategy Initiative by the MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); U. S. Office of Naval Research(Office of Naval Research); Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship; U. S. Department of Energy Office of Science Facility at Brookhaven National Laboratory(United States Department of Energy (DOE)); Flemish Science Foundation (FWO-Vl)(FWO); ; 	F.H.L.K., M.P., and R.H. acknowledge support by the European Union Seventh Framework Programme under grant agreement no. 696656 Graphene Flagship. M. P. acknowledges support by Fondazione Istituto Italiano di Tecnologia. F. H. L. K. acknowledges financial support from the European Union Seventh Framework Programme under the ERC starting grant (307806, CarbonLight) and project GRASP (FP7-ICT-2013-613024-GRASP). F. H. L. K. acknowledges support from the Spanish Ministry of Economy and Competitiveness, through the " Severo Ochoa" Programme for Centres of Excellence in R& D (SEV-2015-0522), support by Fundacio Cellex Barcelona, CERCA Programme/Generalitat de Catalunya, the Mineco grants Ramon y Cajal (RYC-2012-12281), Plan Nacional (FIS2013-47161-P and FIS2014-59639-JIN), and support from the Government of Catalonia through the SGR grant (2014-SGR-1535). R. H. acknowledges support from the Spanish Ministry of Economy and Competitiveness (national project MAT-2015-65525-R). P. A-G. acknowledges financial support from the national project FIS2014-60195-JIN and the ERC starting grant 715496, 2DNANOPTICA. K. W. and T. T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan, and JSPS KAKENHI grant numbers JP26248061, JP15K21722, and JP25106006. Y. G., C. T., and J. H. acknowledge support from the U. S. Office of Naval Research N00014-13-1-0662. C. T. was supported under contract FA9550-11-C-0028 and awarded by the Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a. This research used resources of the Center for Functional Nanomaterials, which is a U. S. Department of Energy Office of Science Facility at Brookhaven National Laboratory under contract no. DE-SC0012704. B. V. D. acknowledges support from the Flemish Science Foundation (FWO-Vl) by a postdoctoral fellowship. M. P. is extremely grateful for the financial support granted by ICFO during a visit in August 2016. This work used open source software (www. python. org, www. matplotlib. org, and www. blender. org). R. H. is cofounder of Neaspec GmbH, a company producing scattering-type scanning near-field optical microscope systems such as the ones used in this study. All other authors declare no competing financial interests.	Abedinpour SH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045429; Alonso-Gonzalez P, 2017, NAT NANOTECHNOL, V12, P31, DOI [10.1038/nnano.2016.185, 10.1038/NNANO.2016.185]; Basov DN, 2011, REV MOD PHYS, V83, P471, DOI 10.1103/RevModPhys.83.471; BOHM D, 1949, PHYS REV, V75, P1851, DOI 10.1103/PhysRev.75.1851; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; Das Sarma S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045425; Elias DC, 2011, NAT PHYS, V7, P701, DOI [10.1038/nphys2049, 10.1038/NPHYS2049]; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; GIRVIN SM, 1986, PHYS REV B, V33, P2481, DOI 10.1103/PhysRevB.33.2481; Giuliani G.F., 2005, QUANTUM THEORY ELECT; Hirjibehedin CF, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161309; Hofmann J, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.241402; Hwang EH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226801; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; KIRZHNIT.DA, 1973, J LOW TEMP PHYS, V10, P79, DOI 10.1007/BF00655243; KOHN W, 1961, PHYS REV, V123, P1242, DOI 10.1103/PhysRev.123.1242; Kukushkin IV, 2009, SCIENCE, V324, P1044, DOI 10.1126/science.1171472; Levitov LS, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.235403; Lundeberg MB, 2017, NAT MATER, V16, P204, DOI [10.1038/NMAT4755, 10.1038/nmat4755]; Pines D., 1966, THEORY QUANTUM LIQUI; Scholl JA, 2012, NATURE, V483, P421, DOI 10.1038/nature10904; Tame MS, 2013, NAT PHYS, V9, P329, DOI [10.1038/NPHYS2615, 10.1038/nphys2615]; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Woessner A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10783; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]; Wunsch B, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/318; Yu GL, 2013, P NATL ACAD SCI USA, V110, P3282, DOI 10.1073/pnas.1300599110; Zhu WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11495	30	196	199	9	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		187	190		10.1126/science.aan2735	http://dx.doi.org/10.1126/science.aan2735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28596312	Green Submitted			2022-12-28	WOS:000405391700042
J	Kandathil, AJ; Breitwieser, FP; Sachithanandham, J; Robinson, M; Mehta, SH; Timp, W; Salzberg, SL; Thomas, DL; Balagopal, A				Kandathil, Abraham J.; Breitwieser, Florian P.; Sachithanandham, Jaiprasath; Robinson, Matthew; Mehta, Shruti H.; Timp, Winston; Salzberg, Steven L.; Thomas, David L.; Balagopal, Ashwin			Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; HUMAN VIROME; GENERATION; ASSOCIATION; DIAGNOSIS; ALIGNMENT	Background: Next-generation metagenomic sequencing (NGMS) has opened new frontiers in microbial discovery but has been clinically characterized in only a few settings. Objective: To explore the plasma virome of persons who inject drugs and to characterize the sensitivity and accuracy of NGMS compared with quantitative clinical standards. Design: Longitudinal and cross-sectional studies. Setting: A clinical trial (ClinicalTrials.gov: NCT01285050) and a well-characterized cohort study of persons who have injected drugs. Participants: Persons co-infected with hepatitis C virus (HCV) and HIV. Measurements: Viral nucleic acid in plasma by NGMS and quantitative polymerase chain reaction (PCR). Results: Next-generation metagenomic sequencing generated a total of 600 million reads, which included the expected HIV and HCV RNA sequences. HIV and HCV reads were consistently identified only when samples contained more than 10 000 copies/mL or IU/mL, respectively, as determined by quantitative PCR. A novel RNA virus, human hepegivirus-1 (HHpgV-1), was also detected by NGMS in 4 samples from 2 persons in the clinical trial. Through use of a quantitative PCR assay for HHpgV-1, infection was also detected in 17 (10.9%) of 156 members of a cohort of persons who injected drugs. In these persons, HHpgV-1 viremia persisted for a median of at least 4538 days and was associated with detection of other bloodborne viruses, such as HCV RNA and SEN virus D. Limitation: The medical importance of HHpgV-1 infection is unknown. Conclusion: Although NGMS is insensitive for detection of viruses with relatively low plasma nucleic acid concentrations, it may have broad potential for discovery of new viral infections of possible medical importance, such as HHpgV-1.	Johns Hopkins Univ, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thomas, DL (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, 1830 East Monument St,Suite 437, Baltimore, MD 21287 USA.	dthomas@jhmi.edu	Sachithanandham, Jaiprasath/S-1156-2019; Timp, Winston/B-5215-2008; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Timp, Winston/0000-0003-2083-6027; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Breitwieser, Florian P/0000-0001-6192-0853; , Jaiprasath/0000-0001-7086-2990; Robinson, Matthew L/0000-0003-0376-8560	National Institutes of Health; FOGARTY INTERNATIONAL CENTER [R25TW009340] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007291, P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078, R01DA013806, U01DA023832, R37DA013806, R01DA012568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health.	Adams NJ, 1998, J GEN VIROL, V79, P1871, DOI 10.1099/0022-1317-79-8-1871; Balagopal A, 2014, HEPATOLOGY, V60, P477, DOI 10.1002/hep.27158; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berg MG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005325; Breitwieser FP, 2016, BIORXIV, DOI DOI 10.1101/084715; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Casadella M, 2016, VIRUS RES, DOI [10.1016/j.virusres.2016.10.019, DOI 10.1016/J.VIRUSRES]; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Eminaga Seda, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0417s103; Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15; Goldsmith CS, 2009, CLIN MICROBIOL REV, V22, P552, DOI 10.1128/CMR.00027-09; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627; Kandathil AJ, 2013, GASTROENTEROLOGY, V145, P1404, DOI 10.1053/j.gastro.2013.08.034; Kapoor A, 2015, MBIO, V6, DOI 10.1128/mBio.01466-15; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lefterova MI, 2015, J MOL DIAGN, V17, P623, DOI 10.1016/j.jmoldx.2015.07.004; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Lipkin WI, 2013, CURR OPIN VIROL, V3, P199, DOI 10.1016/j.coviro.2013.03.010; MAKINO S, 1987, NATURE, V329, P343, DOI 10.1038/329343a0; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rascovan N, 2016, ANNU REV MICROBIOL, V70, P125, DOI 10.1146/annurev-micro-102215-095431; Salzberg SL, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000251; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith DB, 2016, J GEN VIROL, V97, P2894, DOI 10.1099/jgv.0.000612; Stremlau MH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003631; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wilson LE, 2001, J INFECT DIS, V184, P1315, DOI 10.1086/324001; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	37	24	25	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2017	167	1					1	+		10.7326/M17-0085	http://dx.doi.org/10.7326/M17-0085			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ3DW	28586923	Green Accepted			2022-12-28	WOS:000404591600004
J	McGovern, N; Shin, A; Low, G; Low, D; Duan, KB; Yao, LJ; Msallam, R; Low, I; Shadan, NB; Sumatoh, HR; Soon, E; Lum, J; Mok, E; Hubert, S; See, P; Kunxiang, EH; Lee, YH; Janela, B; Choolani, M; Mattar, CNZ; Fan, YP; Lim, TKH; Chan, DKH; Tan, KK; Tam, JKC; Schuster, C; Elbe-Burger, A; Wang, XN; Bigley, V; Collin, M; Haniffa, M; Schlitzer, A; Poidinger, M; Albani, S; Larbi, A; Newell, EW; Chan, JKY; Ginhoux, F				McGovern, Naomi; Shin, Amanda; Low, Gillian; Low, Donovan; Duan, Kaibo; Yao, Leong Jing; Msallam, Rasha; Low, Ivy; Shadan, Nurhidaya Binte; Sumatoh, Hermi R.; Soon, Erin; Lum, Josephine; Mok, Esther; Hubert, Sandra; See, Peter; Kunxiang, Edwin Huang; Lee, Yie Hou; Janela, Baptiste; Choolani, Mahesh; Mattar, Citra Nurfarah Zaini; Fan, Yiping; Lim, Tony Kiat Hon; Chan, Dedrick Kok Hong; Tan, Ker-Kan; Tam, John Kit Chung; Schuster, Christopher; Elbe-Buerger, Adelheid; Wang, Xiao-nong; Bigley, Venetia; Collin, Matthew; Haniffa, Muzlifah; Schlitzer, Andreas; Poidinger, Michael; Albani, Salvatore; Larbi, Anis; Newell, Evan W.; Chan, Jerry Kok Yen; Ginhoux, Florent			Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2	NATURE			English	Article							MATERNAL HLA ANTIGENS; STEM-CELLS; EXPRESSION; TOLERANCE; RESPONSES; SURVIVAL; BEHAVIOR; TISSUES; SKIN; CCR7	During gestation the developing human fetus is exposed to a diverse range of potentially immune-stimulatory molecules including semi-allogeneic antigens from maternal cells(1,2), substances from ingested amniotic fluid(3,4), food antigens(5), and microbes(6). Yet the capacity of the fetal immune system, including antigen-presenting cells, to detect and respond to such stimuli remains unclear. In particular, dendritic cells, which are crucial for effective immunity and tolerance, remain poorly characterized in the developing fetus. Here we show that subsets of antigen-presenting cells can be identified in fetal tissues and are related to adult populations of antigen-presenting cells. Similar to adult dendritic cells, fetal dendritic cells migrate to lymph nodes and respond to toll-like receptor ligation; however, they differ markedly in their response to allogeneic antigens, strongly promoting regulatory T-cell induction and inhibiting T-cell tumour-necrosis factor-a production through arginase-2 activity. Our results reveal a previously unappreciated role of dendritic cells within the developing fetus and indicate that they mediate homeostatic immune-suppressive responses during gestation.	[McGovern, Naomi; Shin, Amanda; Low, Gillian; Low, Donovan; Duan, Kaibo; Msallam, Rasha; Low, Ivy; Shadan, Nurhidaya Binte; Sumatoh, Hermi R.; Soon, Erin; Lum, Josephine; Mok, Esther; Hubert, Sandra; See, Peter; Janela, Baptiste; Schlitzer, Andreas; Poidinger, Michael; Larbi, Anis; Newell, Evan W.; Chan, Jerry Kok Yen; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 3 & 4, Singapore 138648, Singapore; [Shin, Amanda] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Yao, Leong Jing; Albani, Salvatore] STIIC, 20 Coll Rd,Level 8 Discovery Tower, Singapore 169856, Singapore; [Kunxiang, Edwin Huang; Fan, Yiping; Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Lee, Yie Hou] KK Womens & Childrens Hosp, KK Res Ctr, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Lee, Yie Hou] Duke NUS Med Sch, OBGYN Acad Clin Program, Duke NUS, 8 Coll Rd, Singapore 169857, Singapore; [Choolani, Mahesh; Mattar, Citra Nurfarah Zaini] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, NUHS Tower Block,1E Kent Ridge Rd, Singapore 119228, Singapore; [Choolani, Mahesh; Mattar, Citra Nurfarah Zaini; Fan, Yiping; Chan, Jerry Kok Yen] Natl Univ Singapore, Yong Loo Lin Sch Med, Expt Fetal Med Grp, Singapore 119077, Singapore; [Lim, Tony Kiat Hon] Singapore Gen Hosp, Dept Pathol, 20 Coll Rd, Singapore 169856, Singapore; [Chan, Dedrick Kok Hong; Tan, Ker-Kan] Natl Univ Hlth Syst, Univ Surg Cluster, Div Colorectal Surg, Singapore 119074, Singapore; [Tan, Ker-Kan; Tam, John Kit Chung; Schlitzer, Andreas] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, 1E Kent Ridge Rd, Singapore 119228, Singapore; [Schuster, Christopher; Elbe-Buerger, Adelheid] Med Univ Vienna, DIAID, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; [Wang, Xiao-nong; Bigley, Venetia; Collin, Matthew; Haniffa, Muzlifah] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Schlitzer, Andreas] Univ Bonn, Myeloid Cell Biol Life & Med Sci Inst, D-53115 Bonn, Germany; [Schlitzer, Andreas] German Ctr Neurodegenerat Dis, Single Cell Genom & Epigen Unit, D-53175 Bonn, Germany; [Schlitzer, Andreas] Univ Bonn, D-53175 Bonn, Germany; [Chan, Jerry Kok Yen] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University; KK Women's & Children's Hospital; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; National University of Singapore; National University of Singapore; Medical University of Vienna; Newcastle University - UK; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; National University of Singapore	Chan, JKY; Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 3 & 4, Singapore 138648, Singapore.; Chan, JKY (corresponding author), KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore.; Chan, JKY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Expt Fetal Med Grp, Singapore 119077, Singapore.; Chan, JKY (corresponding author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 119077, Singapore.	jerrychan@duke.nus.edu.sg; Florent_Ginhoux@immunol.a-star.edu.sg	Bigley, Venetia/AAU-9738-2020; Chan, Dedrick/AAK-1440-2021; Tan, Ker Kan/K-2506-2017; Larbi, Anis/ABE-5868-2020; Chan, Dedrick/AAI-8469-2021; Schlitzer, Andreas/R-2237-2016; Newell, Evan W/F-9711-2012; Tam, John/B-6048-2012	Bigley, Venetia/0000-0002-3017-2474; Tan, Ker Kan/0000-0002-0410-0450; Chan, Dedrick/0000-0002-4237-8648; Schlitzer, Andreas/0000-0001-7662-3712; Newell, Evan W/0000-0002-2889-243X; Mattar, Citra Nurfarah/0000-0003-0068-6957; Leong, Jing Yao/0000-0002-8651-9801; Chan, Jerry Kok Yen/0000-0002-0246-2159; See, Peter/0000-0003-4428-7763; McGovern, Naomi/0000-0001-5200-2698; Soon, Erin/0000-0002-9115-9345; Poidinger, Michael/0000-0002-1047-2277	Singapore Immunology Network; Biomedical Research Council (BMRC); Austrian Science Fund [P19474-B13, W1248-B30]; BMRC [SPF2014/00]; Singapore Ministry of Health's National Medical Research Council [CSIRG/1383/2014, CSA(SI)/008/2016/]	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Austrian Science Fund(Austrian Science Fund (FWF)); BMRC(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This work was supported by Singapore Immunology Network core funding (F.G. and E.W.N.), Biomedical Research Council (BMRC) Young Investigator Grant (N.McG.), Austrian Science Fund (P19474-B13, W1248-B30 to A.E.-B.), BMRC SPF2014/00 (S.A.), and the Singapore Ministry of Health's National Medical Research Council (J.K.Y.C, CSIRG/1383/2014, CSA(SI)/008/2016/). We thank L. Robinson for manuscript editing.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; Campbell DE, 2015, CLIN EXP ALLERGY, V45, P844, DOI 10.1111/cea.12531; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; DEVRIES JIP, 1985, EARLY HUM DEV, V12, P99, DOI 10.1016/0378-3782(85)90174-4; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Ivarsson MA, 2013, J CLIN INVEST, V123, P3889, DOI 10.1172/JCI68989; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Morris SM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135pe27; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Polkinghorne J, 1989, REV GUIDANCE RES USE; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schuster C, 2015, AM J PATHOL, V185, P2563, DOI 10.1016/j.ajpath.2015.05.006; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Tong XL, 2013, J CHIN MED ASSOC, V76, P606, DOI 10.1016/j.jcma.2013.07.006; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Wang XN, 2014, J INVEST DERMATOL, V134, P965, DOI 10.1038/jid.2013.481	29	140	144	5	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					662	+		10.1038/nature22795	http://dx.doi.org/10.1038/nature22795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28614294	Green Submitted, Green Accepted			2022-12-28	WOS:000404332000049
J	Anderson, CS; Arima, H; Lavados, P; Billot, L; Hackett, ML; Olavarria, VV; Venturelli, PM; Brunser, A; Peng, B; Cui, L; Song, L; Rogers, K; Middleton, S; Lim, JY; Forshaw, D; Lightbody, CE; Woodward, M; Pontes-Neto, O; De Silva, HA; Lin, RT; Lee, TH; Pandian, JD; Mead, GE; Robinson, T; Watkins, C				Anderson, C. S.; Arima, H.; Lavados, P.; Billot, L.; Hackett, M. L.; Olavarria, V. V.; Munoz Venturelli, P.; Brunser, A.; Peng, B.; Cui, L.; Song, L.; Rogers, K.; Middleton, S.; Lim, J. Y.; Forshaw, D.; Lightbody, C. E.; Woodward, M.; Pontes-Neto, O.; De Silva, H. A.; Lin, R. -T.; Lee, T. -H.; Pandian, J. D.; Mead, G. E.; Robinson, T.; Watkins, C.		HeadPoST Investigators Coordinator	Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; BLOOD-FLOW-VELOCITY; CEREBRAL OXYGENATION; GUIDELINES; TELEPHONE; SCALE; CARE	BACKGROUND The role of supine positioning after acute stroke in improving cerebral blood flow and the countervailing risk of aspiration pneumonia have led to variation in head positioning in clinical practice. We wanted to determine whether outcomes in patients with acute ischemic stroke could be improved by positioning the patient to be lying flat (i.e., fully supine with the back horizontal and the face upwards) during treatment to increase cerebral perfusion. METHODS In a pragmatic, cluster-randomized, crossover trial conducted in nine countries, we assigned 11,093 patients with acute stroke (85% of the strokes were ischemic) to receive care in either a lying-flat position or a sitting-up position with the head elevated to at least 30 degrees, according to the randomization assignment of the hospital to which they were admitted; the designated position was initiated soon after hospital admission and was maintained for 24 hours. The primary outcome was degree of disability at 90 days, as assessed with the use of the modified Rankin scale (scores range from 0 to 6, with higher scores indicating greater disability and a score of 6 indicating death). RESULTS The median interval between the onset of stroke symptoms and the initiation of the assigned position was 14 hours (interquartile range, 5 to 35). Patients in the lying-flat group were less likely than patients in the sitting-up group to maintain the position for 24 hours (87% vs. 95%, P<0.001). In a proportional-odds model, there was no significant shift in the distribution of 90-day disability outcomes on the global modified Rankin scale between patients in the lying-flat group and patients in the sitting-up group (unadjusted odds ratio for a difference in the distribution of scores on the modified Rankin scale in the lying-flat group, 1.01; 95% confidence interval, 0.92 to 1.10; P = 0.84). Mortality within 90 days was 7.3% among the patients in the lying-flat group and 7.4% among the patients in the sitting-up group (P = 0.83). There were no significant between-group differences in the rates of serious adverse events, including pneumonia. CONCLUSIONS Disability outcomes after acute stroke did not differ significantly between patients assigned to a lying-flat position for 24 hours and patients assigned to a sitting-up position with the head elevated to at least 30 degrees for 24 hours. (Funded by the National Health and Medical Research Council of Australia; HeadPoST ClinicalTrials.gov number, NCT02162017.)	[Anderson, C. S.; Arima, H.; Billot, L.; Hackett, M. L.; Munoz Venturelli, P.; Rogers, K.; Lim, J. Y.; Woodward, M.] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Anderson, C. S.; Billot, L.; Hackett, M. L.; Song, L.; Rogers, K.; Lim, J. Y.; Woodward, M.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Anderson, C. S.] Sydney Hlth Partners, Royal Prince Alfred Hosp, Neurol Dept, Sydney, NSW, Australia; [Middleton, S.] St Vincents Hlth, Nursing Res Inst, Sydney, NSW, Australia; [Middleton, S.; Watkins, C.] Australian Catholic Univ, Sydney, NSW, Australia; [Anderson, C. S.; Song, L.] Peking Univ, Hlth Sci Ctr, George Inst China, Beijing, Peoples R China; [Peng, B.; Cui, L.] Beijing Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China; [Song, L.] 85 Hosp Peoples Liberat Army, Dept Neurol, Shanghai, Peoples R China; [Arima, H.] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka, Japan; [Lavados, P.; Olavarria, V. V.; Munoz Venturelli, P.; Brunser, A.] Clin Alemana De Santiago, Dept Neurol & Psychiat, Santiago, Chile; [Lavados, P.] Clin Alemana Univ Desarrollo, Fac Med, Santiago, Chile; [Lavados, P.] Univ Chile, Fac Med, Dept Ciencias Neurol, Santiago, Chile; [Hackett, M. L.; Forshaw, D.; Lightbody, C. E.; Watkins, C.] Univ Cent Lancashire, Coll Hlth & Wellbeing, Preston, Lancs, England; [Woodward, M.] Univ Oxford, George Inst Global Hlth, Edinburgh, Midlothian, Scotland; [Mead, G. E.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Robinson, T.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Robinson, T.] Univ Leicester, NIHR Biomed Res Unit, Leicester, Leics, England; [Woodward, M.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Pontes-Neto, O.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosci & Behav, Stroke Serv Neurol Div, Sao Paulo, Brazil; [De Silva, H. A.] Univ Kelaniya, Fac Med, Dept Pharmacol, Clin Trials Unit, Kelaniya, Sri Lanka; [Pandian, J. D.] Christian Med Coll & Hosp, Dept Neurol, Ludhiana, Punjab, India; [Lin, R. -T.] Kaohsiung Med Univ & Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lee, T. -H.] Chang Gung Univ, Linkou Chang Gung Mem Hosp & Coll Med, Stroke Ctr, Taoyuan, Taiwan; [Lee, T. -H.] Chang Gung Univ, Linkou Chang Gung Mem Hosp & Coll Med, Dept Neurol, Taoyuan, Taiwan	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Sydney; Australian Catholic University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Fukuoka University; Clinica Alemana; Universidad del Desarrollo; Universidad de Chile; University of Central Lancashire; University of Oxford; University of Edinburgh; University of Leicester; University of Leicester; Johns Hopkins University; Universidade de Sao Paulo; University Kelaniya; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung University; Chang Gung University	Anderson, CS (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth China, Ste 1801,Tower B,Horizon Tower,6 Zhichun Rd, Beijing 100088, Peoples R China.	canderson@georgeinstitute.org.cn	Pontes-Neto, Octavio Marques/G-4294-2012; Demchuk, Andrew M/E-1103-2012; Hackett, Maree L/O-8752-2016; Middleton, Sandy/J-5526-2015; Woodward, Mark/L-6817-2017; Song, Lili/AGY-5209-2022; Luvizutto, Gustavo/F-3709-2019; Lindley, Richard/B-8148-2013; Carbonera, Leonardo Augusto A/Q-5674-2018; Edwards, Taiza GS/F-9214-2012; Pandian, Jeyaraj Durai/AAV-5591-2020; Chen, Christopher/E-7023-2013; Billot, Laurent/Y-1241-2019; Shafras, Mohamed/O-3516-2018; Watkins, Caroline/E-6898-2013; Munoz Venturelli, Paula/O-6701-2018	Pontes-Neto, Octavio Marques/0000-0003-0317-843X; Demchuk, Andrew M/0000-0002-4930-7789; Hackett, Maree L/0000-0003-1211-9087; Middleton, Sandy/0000-0002-7201-4394; Song, Lili/0000-0002-6105-1720; Luvizutto, Gustavo/0000-0002-6914-7225; Lindley, Richard/0000-0002-0104-5679; Carbonera, Leonardo Augusto A/0000-0002-9313-7967; Edwards, Taiza GS/0000-0003-3033-2981; Chen, Christopher/0000-0002-1047-9225; Billot, Laurent/0000-0002-4975-9793; Woodward, Mark/0000-0001-9800-5296; Richardson, Carla/0000-0002-1774-7261; Lightbody, Elizabeth/0000-0001-5016-3471; Shafras, Mohamed/0000-0002-4827-0275; Watkins, Caroline/0000-0002-9403-3772; Forshaw, Denise/0000-0001-5725-3736; Anderson, Craig/0000-0002-7248-4863; Pandian, Jeyaraj/0000-0003-0028-1968; Blacker, David/0000-0003-0046-9776; Liu, Kuan-Ting/0000-0002-1355-5019; Jan, Stephen/0000-0003-2839-1405; Robinson, Thompson/0000-0003-2144-2468; Lim, Joyce Y/0000-0003-0659-1078; Munoz Venturelli, Paula/0000-0003-1869-2255; Emsley, Hedley/0000-0003-0129-4488; SEAK, CHEN-JUNE/0000-0003-0984-8385	National Health and Medical Research Council of Australia; National Institute for Health Research [NF-SI-0515-10116] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Health and Medical Research Council of Australia; HeadPoST ClinicalTrials.gov number, NCT02162017.	Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Billot L, 2017, INT J STROKE; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Cumbler E, 2014, STROKE, V45, P231, DOI 10.1161/STROKEAHA.113.003617; Dennis M, 2012, STROKE, V43, P851, DOI 10.1161/STROKEAHA.111.639708; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Hargroves D, 2008, AGE AGEING, V37, P581, DOI 10.1093/ageing/afn143; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Katzan IL, 2015, STROKE, V46, P1153, DOI 10.1161/STROKEAHA.115.009084; Mehagnoul-Schipper DJ, 2000, STROKE, V31, P1615, DOI 10.1161/01.STR.31.7.1615; Menon BK, 2016, STROKE, V47, P1972, DOI 10.1161/STROKEAHA.116.013829; Morgan KE, 2017, STAT MED, V36, P318, DOI 10.1002/sim.7137; Venturelli PM, 2015, J STROKE CEREBROVASC, V24, P1564, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.023; Munoz-Venturelli P, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0767-1; Olavarria VV, 2014, CEREBROVASC DIS, V37, P401, DOI 10.1159/000362533; Palazzo P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.425; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Quinn TJ, 2009, STROKE, V40, P3393, DOI [10.1161/STROKEAHA.109.557256, 10.1161/STROKEAHA.108.522516]; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Sutton CJ, 2013, INT J STROKE, V8, P566, DOI 10.1111/j.1747-4949.2012.00915.x; Turner RM, 2007, STAT MED, V26, P274, DOI 10.1002/sim.2537; Tyson SF, 2004, CLIN REHABIL, V18, P801, DOI 10.1191/0269215504cr744oa; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wojner-Alexander AW, 2005, NEUROLOGY, V64, P1354, DOI 10.1212/01.WNL.0000158284.41705.A5	30	95	104	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2437	2447		10.1056/NEJMoa1615715	http://dx.doi.org/10.1056/NEJMoa1615715			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY2BW	28636854	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000403774400007
J	Gaudi, BS; Stassun, KG; Collins, KA; Beatty, TG; Zhou, G; Latham, DW; Bieryla, A; Eastman, JD; Siverd, RJ; Crepp, JR; Gonzales, EJ; Stevens, DJ; Buchhave, LA; Pepper, J; Johnson, MC; Colon, KD; Jensen, ELN; Rodriguez, JE; Bozza, V; Novati, SC; D'Ago, G; Dumont, MT; Ellis, T; Gaillard, C; Jang-Condell, H; Kasper, DH; Fukui, A; Gregorio, J; Ito, A; Kielkopf, JF; Manner, M; Matt, K; Narita, N; Oberst, TE; Reed, PA; Scarpetta, G; Stephens, DC; Yeigh, RR; Zambelli, R; Fulton, BJ; Howard, AW; James, DJ; Penny, M; Bayliss, D; Curtis, IA; Depoy, DL; Esquerdo, GA; Gould, A; Joner, MD; Kuhn, RB; Labadie-Bartz, J; Lund, MB; Marshall, JL; McLeod, KK; Pogge, RW; Relles, H; Stockdale, C; Tan, TG; Trueblood, M; Trueblood, P				Gaudi, B. Scott; Stassun, Keivan G.; Collins, Karen A.; Beatty, Thomas G.; Zhou, George; Latham, David W.; Bieryla, Allyson; Eastman, Jason D.; Siverd, Robert J. .; Crepp, Justin R.; Gonzales, Erica J.; Stevens, Daniel J.; Buchhave, Lars A.; Pepper, Joshua; Johnson, Marshall C.; Colon, Knicole D.; Jensen, Eric L. N.; Rodriguez, Joseph E.; Bozza, Valerio; Novati, Sebastiano Calchi; D'Ago, Giuseppe; Dumont, Mary T.; Ellis, Tyler; Gaillard, Clement; Jang-Condell, Hannah; Kasper, David H.; Fukui, Akihiko; Gregorio, Joao; Ito, Ayaka; Kielkopf, John F.; Manner, Mark; Matt, Kyle; Narita, Norio; Oberst, Thomas E.; Reed, Phillip A.; Scarpetta, Gaetano; Stephens, Denice C.; Yeigh, Rex R.; Zambelli, Roberto; Fulton, B. J.; Howard, Andrew W.; James, David J.; Penny, Matthew; Bayliss, Daniel; Curtis, Ivan A.; Depoy, D. L.; Esquerdo, Gilbert A.; Gould, Andrew; Joner, Michael D.; Kuhn, Rudolf B.; Labadie-Bartz, Jonathan; Lund, Michael B.; Marshall, Jennifer L.; McLeod, Kim K.; Pogge, Richard W.; Relles, Howard; Stockdale, Christopher; Tan, T. G.; Trueblood, Mark; Trueblood, Patricia			A giant planet undergoing extreme-ultraviolet irradiation by its hot massive-star host	NATURE			English	Article							LINE-PROFILE TOMOGRAPHY; EXOPLANET TRANSITS; SHORT-PERIOD; ENGULFMENT; RADII; CANDIDATES; TELESCOPE; VELOCITY; JUPITERS; CATALOG	The amount of ultraviolet irradiation and ablation experienced by a planet depends strongly on the temperature of its host star. Of the thousands of extrasolar planets now known, only six have been found that transit hot, A-type stars (with temperatures of 7,300-10,000 kelvin), and no planets are known to transit the even hotter B-type stars. For example, WASP-33 is an A-type star with a temperature of about 7,430 kelvin, which hosts the hottest known transiting planet, WASP-33b (ref. 1); the planet is itself as hot as a red dwarf star of type M (ref. 2). WASP-33b displays a large heat differential between its dayside and nightside(2), and is highly inflated-traits that have been linked to high insolation(3,4). However, even at the temperature of its dayside, its atmosphere probably resembles the molecule-dominated atmospheres of other planets and, given the level of ultraviolet irradiation it experiences, its atmosphere is unlikely to be substantially ablated over the lifetime of its star. Here we report observations of the bright star HD 195689 (also known as KELT-9), which reveal a close-in (orbital period of about 1.48 days) transiting giant planet, KELT-9b. At approximately 10,170 kelvin, the host star is at the dividing line between stars of type A and B, and we measure the dayside temperature of KELT-9b to be about 4,600 kelvin. This is as hot as stars of stellar type K4 (ref. 5). The molecules in K stars are entirely dissociated, and so the primary sources of opacity in the dayside atmosphere of KELT-9b are probably atomic metals. Furthermore, KELT-9b receives 700 times more extreme-ultraviolet radiation (that is, with wavelengths shorter than 91.2 nanometres) than WASP-33b, leading to a predicted range of mass-loss rates that could leave the planet largely stripped of its envelope during the main-sequence lifetime of the host star(6).	[Gaudi, B. Scott; Stevens, Daniel J.; Johnson, Marshall C.; Penny, Matthew; Gould, Andrew; Pogge, Richard W.] Ohio State Univ, Dept Astron, 174 W 18Th Ave, Columbus, OH 43210 USA; [Stassun, Keivan G.; Collins, Karen A.; Lund, Michael B.] Vanderbilt Univ, Dept Phys & Astron, 6301 Stevenson Ctr, Nashville, TN 37235 USA; [Stassun, Keivan G.] Fisk Univ, Dept Phys, 1000 17th Ave North, Nashville, TN 37208 USA; [Beatty, Thomas G.] Penn State Univ, Ctr Exoplanets & Habitable Worlds, 525 Davey Lab, University Pk, PA 16802 USA; [Beatty, Thomas G.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Zhou, George; Latham, David W.; Bieryla, Allyson; Eastman, Jason D.; Rodriguez, Joseph E.; Esquerdo, Gilbert A.; Relles, Howard] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Siverd, Robert J. .] Las Cumbres Observ Global Telescope Network, 6740 Cortona Dr,Suite 102, Santa Barbara, CA 93117 USA; [Crepp, Justin R.; Gonzales, Erica J.] Univ Notre Dame, Dept Phys, 225 Nieuwland Sci Hall, Notre Dame, IN 46556 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, Juliane Maries Vej 30, DK-21S00 Copenhagen, Denmark; [Buchhave, Lars A.] Geol Museum, Ctr Star & Planet Format, Oster Voldgade 5, DK-1350 Copenhagen, Denmark; [Pepper, Joshua; Labadie-Bartz, Jonathan] Lehigh Univ, Dept Phys, 16 Mem Dr East, Bethlehem, PA 18015 USA; [Colon, Knicole D.] NASA, Ames Res Ctr, M-S 244-30, Moffett Field, CA 94035 USA; [Colon, Knicole D.] Bay Area Environm Res Inst, 625 2nd St Ste 209, Petaluma, CA 94952 USA; [Jensen, Eric L. N.] Swarthmore Coll, Dept Phys & Astron, Swarthmore, PA 19081 USA; [Bozza, Valerio; Novati, Sebastiano Calchi; Scarpetta, Gaetano] Univ Salerno, Dipartimento Fis ER Caianiello, Via Giovanni Paolo 2 132, I-84084 Fisciano, SA, Italy; [Bozza, Valerio] Ist Nazl Fis Nucl, Sez Napoli, I-80126 Naples, Italy; [Novati, Sebastiano Calchi; Scarpetta, Gaetano] CALTECH, IPAC, Mail Code 100-22,1200 East Calif Blvd, Pasadena, CA 91125 USA; [D'Ago, Giuseppe] IIASS, Via G Pellegrino 19, I-84019 Vietri Sul Mare, SA, Italy; [D'Ago, Giuseppe] INAF, Observ Capodimonte, Salita Moiariello 16, I-80131 Naples, Italy; [Dumont, Mary T.; Gaillard, Clement; Matt, Kyle; Stephens, Denice C.; Joner, Michael D.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA; [Dumont, Mary T.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Ellis, Tyler; Jang-Condell, Hannah; Kasper, David H.; Yeigh, Rex R.] Univ Wyoming, Dept Phys & Astron, 1000 East Univ, Laramie, WY 82071 USA; [Ellis, Tyler] Louisiana State Univ, Dept Phys & Astron, 202 Nicholson Hall, Baton Rouge, LA 70803 USA; [Fukui, Akihiko] NINS, Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; [Gregorio, Joao] Atalaia Grp, Portalegre, Portugal; [Gregorio, Joao] Crow Observ, Portalegre, Portugal; [Ito, Ayaka; Narita, Norio] NINS, Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan; [Ito, Ayaka] Hosei Univ, Grad Sch Sci & Engn, 3-7-2 Kajino Cho, Tokyo 1848584, Japan; [Kielkopf, John F.] Univ Louisville, Dept Phys & Astron, Louisville, KY 40292 USA; [Manner, Mark] Spot Observ, Nashville, TN 37206 USA; [Narita, Norio] Univ Tokyo, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Narita, Norio] NINS, Astrobiol Ctr, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan; [Oberst, Thomas E.] Westminster Coll, Dept Phys, New Wilmington, PA 16172 USA; [Reed, Phillip A.] Kutztown State Univ, Dept Phys Sci, Kutztown, PA 19530 USA; [Zambelli, Roberto] Soc Astron Lunae, I-19030 Castelnuovo Magra, Italy; [Fulton, B. J.; Howard, Andrew W.] Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA; [James, David J.] Univ Washington, Astron Dept, Box 351580, Seattle, WA 98195 USA; [Bayliss, Daniel] Univ Geneva, Observ Astron, 51 Chemin Maillettes, CH-1290 Chavannes Des Bois, Switzerland; [Curtis, Ivan A.] ICO, Adelaide, SA, Australia; [Depoy, D. L.; Marshall, Jennifer L.] Texas A&M Univ, George P & Cynthia Woods Mitchell Inst Fundamen P, College Stn, TX 77843 USA; [Depoy, D. L.; Marshall, Jennifer L.] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Gould, Andrew] Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany; [Kuhn, Rudolf B.] South African Astron Observ, POB 9, ZA-7935 Cape Town, South Africa; [McLeod, Kim K.] Wellesley Coll, 106 Cent St, Wellesley, MA 02481 USA; [Stockdale, Christopher] Hazelwood Observ, Churchill, Vic, Australia; [Tan, T. G.] Perth Exoplanet Survey Telescope, Perth, WA, Australia; [Trueblood, Mark; Trueblood, Patricia] Winer Observ, Sonoita, AZ 85637 USA	University System of Ohio; Ohio State University; Vanderbilt University; Fisk University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Notre Dame; University of Copenhagen; Niels Bohr Institute; Lehigh University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Swarthmore College; University of Salerno; Istituto Nazionale di Fisica Nucleare (INFN); California Institute of Technology; Istituto Nazionale Astrofisica (INAF); Brigham Young University; University of California System; University of California Santa Cruz; University of Wyoming; Louisiana State University System; Louisiana State University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Hosei University; University of Louisville; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Astrobiology Center (ABC); Westminster College Pennsylvania; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; University of Hawaii System; University of Washington; University of Washington Seattle; University of Geneva; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Max Planck Society; National Research Foundation - South Africa; South African Astronomical Observatory; Wellesley College	Gaudi, BS (corresponding author), Ohio State Univ, Dept Astron, 174 W 18Th Ave, Columbus, OH 43210 USA.	gaudi.1@osu.edu	Fukui, Akihiko/ABF-2092-2021; Fukui, Akihiko/ABE-4506-2020; Fukui, Akihiko/W-2238-2017; Buchhave, Lars A./ABF-2000-2020; Penny, Matthew/AGE-0251-2022; D'Ago, Giuseppe/N-8318-2016	Fukui, Akihiko/0000-0002-4909-5763; Buchhave, Lars A./0000-0003-1605-5666; D'Ago, Giuseppe/0000-0001-9697-7331; Reed, Phillip/0000-0002-5005-1215; Kuhn, Rudolf Bruwer/0000-0002-4236-9020; Kielkopf, John/0000-0003-0497-2651; Bieryla, Allyson/0000-0001-6637-5401; Pepper, Joshua/0000-0002-3827-8417; Gonzales, Erica/0000-0002-9329-2190; Stassun, Keivan/0000-0002-3481-9052; Ellis, Tyler/0000-0001-6584-9919; Latham, David/0000-0001-9911-7388; Penny, Matthew/0000-0001-7506-5640; Tan, Thiam-Guan/0000-0001-5603-6895; Labadie-Bartz, Jonathan/0000-0002-2919-6786; Fulton, Benjamin/0000-0003-3504-5316; Siverd, Robert/0000-0001-5016-3359; Beatty, Thomas/0000-0002-9539-4203; Calchi Novati, Sebastiano/0000-0002-7669-1069; Jensen, Eric/0000-0002-4625-7333; Lund, Michael/0000-0003-2527-1598	Ohio State University; Vanderbilt University; Lehigh University; NSF CAREER [AST-1056524]; NSF PAARE [AST-1358862]; Jet Propulsion Laboratory; Exoplanet Exploration Program of the National Aeronautics and Space Administration (NASA); National Science Foundation Graduate Research Fellowship [2014184874]; Harvard Future Faculty Leaders Postdoctoral fellowship; Japan Society for Promotion of Science (JSPS) KAKENHI [JP25247026]; W. M. Keck Foundation; NASA; Two Micron All Sky Survey; American Association of Variable Star Observers (AAVSO) Photometric All-Sky Survey (APASS); Robert Martin Ayers Sciences Fund; AAVSO Endowment	Ohio State University(Ohio State University); Vanderbilt University; Lehigh University; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF PAARE(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Jet Propulsion Laboratory; Exoplanet Exploration Program of the National Aeronautics and Space Administration (NASA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Harvard Future Faculty Leaders Postdoctoral fellowship; Japan Society for Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); W. M. Keck Foundation(W.M. Keck Foundation); NASA(National Aeronautics & Space Administration (NASA)); Two Micron All Sky Survey; American Association of Variable Star Observers (AAVSO) Photometric All-Sky Survey (APASS); Robert Martin Ayers Sciences Fund; AAVSO Endowment	This research was made possible by the KELT survey, the KELT Follow-Up Network, and support from The Ohio State University, Vanderbilt University and Lehigh University. Work by B. S. G. and D. J. S. was partially supported by NSF CAREER grant AST-1056524. K. G. S. and K. A. C. acknowledge partial support from NSF PAARE grant AST-1358862. B. S. G. acknowledges support by the Jet Propulsion Laboratory, operated by the California Institute of Technology, and the Exoplanet Exploration Program of the National Aeronautics and Space Administration (NASA). B. J. F. notes that this material is based upon work supported by the National Science Foundation Graduate Research Fellowship under grant no. 2014184874. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the National Science Foundation. Work performed by J. E. R. was supported by the Harvard Future Faculty Leaders Postdoctoral fellowship. K. K. M. acknowledges the purchase of SDSS filters for Whitin Observatory by the Theodore Dunham Jr Grant of the Fund for Astronomical Research. N. N. acknowledges support by the Japan Society for Promotion of Science (JSPS) KAKENHI Grant Number JP25247026. We acknowledge observations by M. Kunitomo, R. Hasegawa, B. Sato, H. Harakawa, T. Hirano and H. Izumiura on the Okayama 188 cm telescope (HIDES observations) and N. Kusakabe, M. Onitsuka and T. Ryu for MuSCAT observations. The NIRC2 AO data in this work were obtained at the W. M. Keck Observatory, which was financed by the W. M. Keck Foundation and is operated as a scientific partnership between the California Institute of Technology, the University of California and NASA. The authors wish to recognize and acknowledge the very significant cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. This work has made use of NASA's Astrophysics Data System, the Exoplanets Data Explorer at exoplanets. org, the Extrasolar Planet Encyclopedia at exoplanet. eu, the SIMBAD database operated at CDS, Strasbourg, France, and the VizieR catalogue access tool, CDS, Strasbourg, France. This publication makes use of data products from the Widefield Infrared Survey Explorer, which is a joint project of the University of California, Los Angeles; the Jet Propulsion Laboratory/California Institute of Technology, which is funded by NASA; the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by NASA; and the American Association of Variable Star Observers (AAVSO) Photometric All-Sky Survey (APASS), whose funding is provided by the Robert Martin Ayers Sciences Fund and the AAVSO Endowment (https://www. aavso. org/aavso-photometricall- sky-survey-data-release-1). We acknowledge input from T. Barman, J. Fortney, M. Marley and K. Zanhle.	Aguilera-Gomez C, 2016, ASTROPHYS J, V829, DOI 10.3847/0004-637X/829/2/127; Bieryla A, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/1/12; Borgniet S, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201628805; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Boue G, 2013, ASTRON ASTROPHYS, V550, DOI [10.1051/0004-6361/201210146, 10.1051/0004-6361/201220146]; Brown AGA, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629512; Cameron AC, 2007, MON NOT R ASTRON SOC, V380, P1230, DOI 10.1111/j.1365-2966.2007.12195.x; Cameron AC, 2010, MON NOT R ASTRON SOC, V407, P507, DOI 10.1111/j.1365-2966.2010.16922.x; Cameron AC, 2010, MON NOT R ASTRON SOC, V403, P151, DOI 10.1111/j.1365-2966.2009.16131.x; Casewell SL, 2015, MON NOT R ASTRON SOC, V447, P3218, DOI 10.1093/mnras/stu2721; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Cutri R.M, 2012, WISE ALL SKY DATA RE; Cutri R. M., 2003, 2MASS ALL SKY CATALO; Demarque P, 2004, ASTROPHYS J SUPPL S, V155, P667, DOI 10.1086/424966; Demory BO, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/12; Donati JF, 1997, MON NOT R ASTRON SOC, V291, P658, DOI 10.1093/mnras/291.4.658; Droege TF, 2006, PUBL ASTRON SOC PAC, V118, P1666, DOI 10.1086/510197; Galland F, 2005, ASTRON ASTROPHYS, V443, P337, DOI 10.1051/0004-6361:20052938; Gillon M, 2017, NATURE, V542, P456, DOI 10.1038/nature21360; Gray D.F., 2008, OBSERVATION ANAL STE; Hartman JD, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/6/197; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Hog E, 2000, ASTRON ASTROPHYS, V355, pL27; Johnson JA, 2007, ASTROPHYS J, V665, P785, DOI 10.1086/519677; Johnson MC, 2015, ASTROPHYS J LETT, V810, DOI 10.1088/2041-8205/810/2/L23; Komacek TD, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/1/16; Kunitomo M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/66; Kurucz R.L., 1992, P IAU S 149, P225; Lloyd JP, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L49; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; McLaughlin DB, 1924, ASTROPHYS J, V60, P22, DOI 10.1086/142826; Mermilliod J. C., 2006, HOMOGENEOUS MEANS UB; Metzger BD, 2012, MON NOT R ASTRON SOC, V425, P2778, DOI 10.1111/j.1365-2966.2012.21444.x; Murray-Clay RA, 2009, ASTROPHYS J, V693, P23, DOI 10.1088/0004-637X/693/1/23; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pecaut MJ, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/9; Pepper J, 2007, PUBL ASTRON SOC PAC, V119, P923, DOI 10.1086/521836; Pepper J, 2012, PUBL ASTRON SOC PAC, V124, P230, DOI 10.1086/665044; Privitera G, 2016, ASTRON ASTROPHYS, V593, DOI 10.1051/0004-6361/201628758; Rossiter RA, 1924, ASTROPHYS J, V60, P15, DOI 10.1086/142825; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schlaufman KC, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/143; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Siverd RJ, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/123; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Stassun KG, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa5df3; Thompson G. I., 2005, CATALOGUE STELLAR UL; Torres G, 2010, ASTRON ASTROPHYS REV, V18, P67, DOI 10.1007/s00159-009-0025-1; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Villaver E, 2007, ASTROPHYS J, V661, P1192, DOI 10.1086/516746; von Essen C, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201526202; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Zacharias N, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/44; Zacharias N., 2004, BAAS, V36, P1418; Zhou G, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa674a; Zhou G, 2016, MON NOT R ASTRON SOC, V460, P3376, DOI 10.1093/mnras/stw1107	57	145	148	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					514	+		10.1038/nature22392	http://dx.doi.org/10.1038/nature22392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28582774	Green Submitted, Green Accepted			2022-12-28	WOS:000403814100035
J	Kondo, T; Terada, K				Kondo, Takeshi; Terada, Kazuhiko			Coronary-Artery Vasospasm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kondo, Takeshi; Terada, Kazuhiko] Chiba Univ Hosp, Chiba, Japan	Chiba University	Kondo, T (corresponding author), Chiba Univ Hosp, Chiba, Japan.	reds_liverpool_2005@yahoo.co.jp	Kondo, Takeshi/GXG-4271-2022	Kondo, Takeshi/0000-0001-6285-4966					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					E52	E52		10.1056/NEJMicm1614640	http://dx.doi.org/10.1056/NEJMicm1614640			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY2BW	28636863				2022-12-28	WOS:000403774400011
J	Sabbah, S; Gemmer, JA; Bhatia-Lin, A; Manoff, G; Castro, G; Siegel, JK; Jeffery, N; Berson, DM				Sabbah, Shai; Gemmer, John A.; Bhatia-Lin, Ananya; Manoff, Gabrielle; Castro, Gabriel; Siegel, Jesse K.; Jeffery, Nathan; Berson, David M.			A retinal code for motion along the gravitational and body axes	NATURE			English	Article							GANGLION-CELLS; DIRECTION-SELECTIVITY; WIRING SPECIFICITY; RABBIT; IDENTIFICATION; ORIENTATION; MECHANISMS; CIRCUIT; MODELS; SYSTEM	Self-motion triggers complementary visual and vestibular reflexes supporting image-stabilization and balance. Translation through space produces one global pattern of retinal image motion (optic flow), rotation another. We examined the direction preferences of direction-sensitive ganglion cells (DSGCs) in flattened mouse retinas in vitro. Here we show that for each subtype of DSGC, direction preference varies topographically so as to align with specific translatory optic flow fields, creating a neural ensemble tuned for a specific direction of motion through space. Four cardinal translatory directions are represented, aligned with two axes of high adaptive relevance: the body and gravitational axes. One subtype maximizes its output when the mouse advances, others when it retreats, rises or falls. Two classes of DSGCs, namely, ON-DSGCs and ON-OFF-DSGCs, share the same spatial geometry but weight the four channels differently. Each subtype ensemble is also tuned for rotation. The relative activation of DSGC channels uniquely encodes every translation and rotation. Although retinal and vestibular systems both encode translatory and rotatory self-motion, their coordinate systems differ.	[Sabbah, Shai; Bhatia-Lin, Ananya; Manoff, Gabrielle; Castro, Gabriel; Siegel, Jesse K.; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Gemmer, John A.] Wake Forest Univ, Dept Math & Stat, Winston Salem, NC 27109 USA; [Jeffery, Nathan] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3GA, Merseyside, England	Brown University; Wake Forest University; University of Liverpool	Sabbah, S; Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	shai_sabbah@brown.edu; david_berson@brown.edu		Gemmer, John/0000-0002-7316-6082; Siegel, Jesse/0000-0003-3233-7276; Jeffery, Nathan/0000-0001-5166-2029; Sabbah, Shai/0000-0002-4752-3832	Banting Postdoctoral Fellowship of Canada; Sidney A. Fox and Dorothea Doctors Fox Postdoctoral Fellowship in Ophthalmology and Visual Sciences; NSF-RTG [DMS-1148284]; NIH [R01 EY12793]; Alcon Research Institute Award; NATIONAL EYE INSTITUTE [R01EY012793] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1148284] Funding Source: National Science Foundation	Banting Postdoctoral Fellowship of Canada; Sidney A. Fox and Dorothea Doctors Fox Postdoctoral Fellowship in Ophthalmology and Visual Sciences; NSF-RTG(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcon Research Institute Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Demb and W. Wei for providing us with Trhr-GFP and Drd4-GFP mice. Countless colleagues provided theoretical, data-analytic and technical advice, including imaging, electronics and device synchronization, intracranial and intraocular injections, electrophysiological recordings and statistical analysis. They included J. McIlwain, B. Borghuis, G. Williams, C. Deister, J. Voigts, C. Moore, D. Sheinberg, K. Briggman, M. Fogerson, M. E. Stabio, J. Renna, S. Cruikshank, S. Crandall, B. Connors, S. Guan, J. Sanes, W. Truccolo and C. Aizenman. D. Boghossian maintained the mouse colony and genotyped experimental mice. K. Boghossian, C. Papendorp and P.-N. Chiang contributed to digital image analysis. J. Murphy constructed microscope stages and retinal mounts. We thank V. Jayaraman, D. S. Kim, L. L. Looger and K. Svoboda from the GENIE Project, Janelia Research Campus, Howard Hughes Medical Institute for sharing their GCaMP6f calcium indicator. This project was supported by the Banting Postdoctoral Fellowship of Canada (S. S.), The Sidney A. Fox and Dorothea Doctors Fox Postdoctoral Fellowship in Ophthalmology and Visual Sciences (S. S.), NSF-RTG grant DMS-1148284 (J. A. G.), and NIH grant R01 EY12793 and an Alcon Research Institute Award (D. M. B.).	Angelaki DE, 2005, NAT REV NEUROSCI, V6, P966, DOI 10.1038/nrn1804; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chan YC, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.13; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Dai XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117570; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Ding HY, 2016, NATURE, V535, P105, DOI 10.1038/nature18609; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Ivanova E, 2013, JOVE-J VIS EXP, DOI 10.3791/51018; Kanjhan R, 2010, NEUROSCI LETT, V483, P105, DOI 10.1016/j.neulet.2010.07.071; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Nilsson DE, 2009, PHILOS T R SOC B, V364, P2833, DOI 10.1098/rstb.2009.0083; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Oommen BS, 2008, BRAIN RES, V1193, P57, DOI 10.1016/j.brainres.2007.11.053; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Park SJH, 2014, J NEUROSCI, V34, P3976, DOI 10.1523/JNEUROSCI.5017-13.2014; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; SIMPSON JI, 1988, ANN NY ACAD SCI, V545, P170; SIMPSON JI, 1988, J NEUROPHYSIOL, V60, P2055, DOI 10.1152/jn.1988.60.6.2055; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Vaney DI, 2001, MOTION VISION, P13; Venkataramani S, 2010, J NEUROSCI, V30, P15664, DOI 10.1523/JNEUROSCI.2081-10.2010; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; YANG G, 1994, J NEUROSCI, V14, P5267; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	42	64	65	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					492	+		10.1038/nature22818	http://dx.doi.org/10.1038/nature22818			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28607486	Green Accepted			2022-12-28	WOS:000403814100031
J	McQuade, CN; Umscheid, CA				McQuade, Casey N.; Umscheid, Craig A.			Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[McQuade, Casey N.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Umscheid, Craig A.] Univ Penn, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania	McQuade, CN (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.							Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE; Cournot M, 2007, AM J GERIATR CARDIOL, V16, P8, DOI 10.1111/j.1076-7460.2007.05297.x; Michtalik HJ, 2011, AM J CARDIOL, V107, P1191, DOI 10.1016/j.amjcard.2010.12.018; Shah MR, 2007, AM J CARDIOL, V100, P1427, DOI 10.1016/j.amjcard.2007.06.035; Valle R, 2011, HEART FAIL REV, V16, P519, DOI 10.1007/s10741-011-9244-4	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					916	916		10.7326/L17-0194	http://dx.doi.org/10.7326/L17-0194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630987				2022-12-28	WOS:000403579000029
J	Hanefeld, J; Vearey, J; Lunt, N				Hanefeld, Johanna; Vearey, Jo; Lunt, Neil		Researchers Migration Mobilit	A global research agenda on migration, mobility, and health	LANCET			English	Editorial Material									[Hanefeld, Johanna] London Sch Hyg & Trop Med, London WC1H 9SH, England; [Vearey, Jo] Univ Witwatersrand, Africa Ctr Migrat & Soc, Sch Social Sci, Johannesburg, South Africa; [Lunt, Neil] Univ York, Dept Social Policy & Social Work, York, N Yorkshire, England	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of York - UK	Hanefeld, J (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	johanna.hanefeld@lshtm.ac.uk	Vearey, Jo/A-6512-2018	Kamndaya, Mphatso/0000-0002-7597-3339; Vearey, Jo/0000-0002-6636-1322; Bell, Sadie/0000-0003-4381-0030; Ghilardi, Ludovica/0000-0001-8480-955X; Howard, Natasha/0000-0003-4174-7349; Lynch, Caroline Anita/0000-0003-0072-0473	Newton Fund; MRC [MR/M002160/1] Funding Source: UKRI; Medical Research Council [MR/M002160/1] Funding Source: researchfish	Newton Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors met at a workshop on migration, mobility, and health at the London School of Hygiene & Tropical Medicine (LSHTM), London, UK, in March, 2017, supported by the Newton Fund. We declare no other competing interests. This Comment is dedicated to the memory of Chesmal Siriwardhana.	Abubakar I, 2016, LANCET, V388, P1141, DOI 10.1016/S0140-6736(16)31581-1; Hanefeld J, 2015, SOC SCI MED, V124, P356, DOI 10.1016/j.socscimed.2014.05.016; Hanefeld J, 2017, WHO B, V95, P368; Hanefeld J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j771; International Organization of Migration, 2016, CONC NOT 2 GLOB CONS; Lynch C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001040; UN, 2016, STESASERA384 1N DEP; UN, 2015, 2030 AG SUST DEV; Vearey J, 2018, J IMMIGR MINOR HEALT, V20, P91, DOI 10.1007/s10903-016-0535-7; Wickramage K, 2017, MIGRATION HLTH RES A, V1; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034	11	26	27	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2358	2359		10.1016/S0140-6736(17)31588-X	http://dx.doi.org/10.1016/S0140-6736(17)31588-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	28635599				2022-12-28	WOS:000403334400011
J	Pena, CJ; Kronman, HG; Walker, DM; Cates, HM; Bagot, RC; Purushothaman, I; Issler, O; Loh, YHE; Leong, T; Kiraly, DD; Goodman, E; Neve, RL; Shen, L; Nestler, EJ				Pena, Catherine J.; Kronman, Hope G.; Walker, Deena M.; Cates, Hannah M.; Bagot, Rosemary C.; Purushothaman, Immanuel; Issler, Orna; Loh, Yong-Hwee Eddie; Leong, Tin; Kiraly, Drew D.; Goodman, Emma; Neve, Rachael L.; Shen, Li; Nestler, Eric J.			Early life stress confers lifelong stress susceptibility in mice via ventral tegmental area OTX2	SCIENCE			English	Article							MAJOR DEPRESSION; CHILDHOOD; RESPONSES; DOPAMINE; TRAUMA	Early life stress increases risk for depression. Here we establish a "two-hit" stress model in mice wherein stress at a specific postnatal period increases susceptibility to adult social defeat stress and causes long-lasting transcriptional alterations that prime the ventral tegmental area (VTA)-a brain reward region-to be in a depression-like state. We identify a role for the developmental transcription factor orthodenticle homeobox 2 (Otx2) as an upstream mediator of these enduring effects. Transient juvenile-but not adult-knockdown of Otx2 in VTA mimics early life stress by increasing stress susceptibility, whereas its overexpression reverses the effects of early life stress. This work establishes a mechanism by which early life stress encodes lifelong susceptibility to stress via long-lasting transcriptional programming in VTA mediated by Otx2.	[Pena, Catherine J.; Kronman, Hope G.; Walker, Deena M.; Cates, Hannah M.; Bagot, Rosemary C.; Purushothaman, Immanuel; Issler, Orna; Loh, Yong-Hwee Eddie; Leong, Tin; Kiraly, Drew D.; Goodman, Emma; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA; [Kiraly, Drew D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Bagot, Rosemary C.] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); McGill University	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Walker, Deena/GOE-5789-2022; Kiraly, Drew/X-2993-2019; Pena, Catherine Jensen/AAU-3014-2021; Bagot, Rosemary/V-4325-2019	Kiraly, Drew/0000-0002-4818-5169; Pena, Catherine Jensen/0000-0002-2884-5035; Kronman, Hope/0000-0002-2828-723X; Cates, Hannah/0000-0002-9413-0847	National Institute of Mental Health, NIH [P50MH096890]; Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH051399] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Mental Health, NIH (P50MH096890) and Hope for Depression Research Foundation. RNA-seq and ChIP-seq data are available at Gene Expression Omnibus, accession number GSE89692. Supplementary materials contain additional data.	Brake WG, 2004, EUR J NEUROSCI, V19, P1863, DOI 10.1111/j.1460-9568.2004.03286.x; CABIB S, 1993, BRAIN RES, V604, P232, DOI 10.1016/0006-8993(93)90374-V; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Hammen C, 2000, J CONSULT CLIN PSYCH, V68, P782, DOI 10.1037/0022-006X.68.5.782; Hanson JL, 2016, SOC COGN AFFECT NEUR, V11, P405, DOI 10.1093/scan/nsv124; Jonson-Reid M, 2012, PEDIATRICS, V129, P839, DOI 10.1542/peds.2011-2529; Kendler KS, 2004, PSYCHOL MED, V34, P1475, DOI 10.1017/S003329170400265X; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Rincon-Cortes M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00033; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Williams LM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.61; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Zhang ZY, 2016, BEHAV BRAIN RES, V306, P154, DOI 10.1016/j.bbr.2016.03.040	21	183	186	7	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1185	1188		10.1126/science.aan4491	http://dx.doi.org/10.1126/science.aan4491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619944	Green Accepted			2022-12-28	WOS:000403327400041
J	Kumar, KVSH; Singh, P				Kumar, K. V. S. Hari; Singh, Pratima			Seesaw Nystagmus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kumar, K. V. S. Hari; Singh, Pratima] Army Hosp, Delhi, India		Kumar, KVSH (corresponding author), Army Hosp, Delhi, India.	hariendo@-rediffmail.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					E51	E51		10.1056/NEJMicm1613244	http://dx.doi.org/10.1056/NEJMicm1613244			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28614692				2022-12-28	WOS:000403230800012
J	Lerosey, G				Lerosey, Geoffroy			APPLIED PHYSICS Wireless power on the move	NATURE			English	Editorial Material							SYMMETRY		[Lerosey, Geoffroy] CNRS, Langevin Inst, F-75005 Paris, France; [Lerosey, Geoffroy] ESPCI Paris, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Lerosey, G (corresponding author), CNRS, Langevin Inst, F-75005 Paris, France.; Lerosey, G (corresponding author), ESPCI Paris, F-75005 Paris, France.	geoffroy.lerosey@espci.fr						Assawaworrarit S, 2017, NATURE, V546, P387, DOI 10.1038/nature22404; Bender CM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270401; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Karalis A, 2008, ANN PHYS-NEW YORK, V323, P34, DOI 10.1016/j.aop.2007.04.017; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Song MZ, 2017, APPL PHYS REV, V4, DOI 10.1063/1.4981396; Tesla N., 1914, U.S. Patent, Patent No. 1119732; WHEELER LP, 1943, ELECTRON ENG, V62, P355	12	12	12	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					354	355		10.1038/546354a	http://dx.doi.org/10.1038/546354a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28617452				2022-12-28	WOS:000403250900020
J	Managi, S; Wakamatsu, M				Managi, Shunsuke; Wakamatsu, Mihoko			Pay countries to stop whaling	NATURE			English	Letter									[Managi, Shunsuke; Wakamatsu, Mihoko] Kyushu Univ, Fukuoka, Japan	Kyushu University	Managi, S (corresponding author), Kyushu Univ, Fukuoka, Japan.	managi@doc.kyushu-u.ac.jpevents	Managi, Shunsuke/G-1740-2013	Managi, Shunsuke/0000-0001-7883-1427; Wakamatsu, Mihoko/0000-0002-1340-8801	Grants-in-Aid for Scientific Research [26000001] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))			0	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					352	352		10.1038/546352c	http://dx.doi.org/10.1038/546352c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617462	Bronze			2022-12-28	WOS:000403250900017
J	Singh, S				Singh, Sonia			BECOMING A PHYSICIAN Morning Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Singh, Sonia] Stanford Hlth Care, Los Gatos, CA 95032 USA		Singh, S (corresponding author), Stanford Hlth Care, Los Gatos, CA 95032 USA.								0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2316	2317		10.1056/NEJMp1701939	http://dx.doi.org/10.1056/NEJMp1701939			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28614674				2022-12-28	WOS:000403230800004
J	Baston, J				Baston, John			Daphne Marsh Baston OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2017	357								j2887	10.1136/bmj.j2887	http://dx.doi.org/10.1136/bmj.j2887			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UL	28611059				2022-12-28	WOS:000403752500011
J	Richter, D; Grun, R; Joannes-Boyau, R; Steele, TE; Amani, F; Rue, M; Fernandes, P; Raynal, JP; Geraads, D; Ben-Ncer, A; Hublin, JJ; McPherron, SP				Richter, Daniel; Grun, Rainer; Joannes-Boyau, Renaud; Steele, Teresa E. .; Amani, Fethi; Rue, Mathieu; Fernandes, Paul; Raynal, Jean-Paul; Geraads, Denis; Ben-Ncer, Abdelouahed; Hublin, Jean-Jacques; McPherron, Shannon P.			The age of the hominin fossils from Jebel Irhoud, Morocco, and the origins of the Middle Stone Age	NATURE			English	Article							U-SERIES DISEQUILIBRIUM; EARLY HOMO-SAPIENS; BURNT FLINTS; PALEOLITHIC SITE; TOOTH ENAMEL; ESR/U-SERIES; TABUN CAVE; OMO I; LUMINESCENCE; ISRAEL	The timing and location of the emergence of our species and of associated behavioural changes are crucial for our understanding of human evolution. The earliest fossil attributed to a modern form of Homo sapiens comes from eastern Africa and is approximately 195 thousand years old(1,2), therefore the emergence of modern human biology is commonly placed at around 200 thousand years ago(3,4). The earliest Middle Stone Age assemblages come from eastern and southern Africa but date much earlier(5-7). Here we report the ages, determined by thermoluminescence dating, of fire-heated flint artefacts obtained from new excavations at the Middle Stone Age site of Jebel Irhoud, Morocco, which are directly associated with newly discovered remains of H. sapiens(8). A weighted average age places these Middle Stone Age artefacts and fossils at 315 +/- 34 thousand years ago. Support is obtained through the recalculated uranium series with electron spin resonance date of 286 +/- 32 thousand years ago for a tooth from the Irhoud 3 hominin mandible. These ages are also consistent with the faunal and microfaunal(9) assemblages and almost double the previous age estimates for the lower part of the deposits(10,11). The north African site of Jebel Irhoud contains one of the earliest directly dated Middle Stone Age assemblages, and its associated human remains are the oldest reported for H. sapiens. The emergence of our species and of the Middle Stone Age appear to be close in time, and these data suggest a larger scale, potentially pan-African, origin for both.	[Richter, Daniel; Steele, Teresa E. .; Raynal, Jean-Paul; Geraads, Denis; Hublin, Jean-Jacques; McPherron, Shannon P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany; [Richter, Daniel] Leuphana Univ Luneburg, Inst Ecol Subject Area Landscape Change, Scharnhorststr 1, D-21335 Luneburg, Germany; [Richter, Daniel] Freiberg Instruments GmbH, Delfterstr 6, D-09599 Freiberg, Germany; [Grun, Rainer; Joannes-Boyau, Renaud] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Grun, Rainer] Griffith Univ, Australian Res Ctr Human Evolut, Environm Futures Res Inst, Nathan, Qld 4111, Australia; [Joannes-Boyau, Renaud] Southern Cross Univ, Southern Cross GeoSci, Mil Rd, Lismore, NSW 2480, Australia; [Steele, Teresa E. .] Univ Calif Davis, Dept Anthropol, One Shields Ave, Davis, CA USA; [Amani, Fethi; Ben-Ncer, Abdelouahed] Minist Culture & Commun, Inst Natl Sci Archeol & Patrimoine, Angle Rues 5&7,BP 6828, Rabat, Morocco; [Rue, Mathieu; Fernandes, Paul] Paleotime, 6173 Rue Jean Seraphin Achard Picard, F-38250 Villard De Lans, France; [Rue, Mathieu] Univ Montpellier 3, MCC, CNRS, ASM,UMR 5140, Route Mende, F-34199 Montpellier 5, France; [Fernandes, Paul; Raynal, Jean-Paul] Univ Bordeaux, CNRS, UMR 5199, PACEA,MCC, Batiment B18,Allee Geoffroy St Hilaire,CS 500, F-33615 Pessac, France; [Geraads, Denis] Sorbonne Univ, UPMC, MNHN, CNRS,CR2P,UMR 7207, CP 38,8 Rue Buffon, F-75231 Paris 05, France; [Hublin, Jean-Jacques] Coll France, Chaire Int Paleoanthropol, Paris, France	Max Planck Society; Leuphana University Luneburg; Australian National University; Griffith University; Southern Cross University; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Paul-Valery; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; College de France	McPherron, SP (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	mcpherron@eva.mpg.de	Joannes-Boyau, Renaud/D-6058-2012; GERAADS, Denis/AAC-7241-2021; Geraads, Denis/AAY-6051-2020; Richter, Daniel G/A-1367-2011; Fernandes, Paul/H-2972-2013	Joannes-Boyau, Renaud/0000-0002-0452-486X; GERAADS, Denis/0000-0003-2475-8011; Richter, Daniel G/0000-0003-1681-727X; Fernandes, Paul/0000-0003-4135-115X; Rue, Mathieu/0000-0001-7948-9459; Steele, Teresa/0000-0002-3091-6488	Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology (MPI-EVA); Max Planck Society; ARC [DP0664144, DP140100919]	Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine; Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology (MPI-EVA); Max Planck Society(Max Planck SocietyFoundation CELLEX); ARC(Australian Research Council)	The Jebel Irhoud project is jointly conducted and supported by the Moroccan Institut National des Sciences de l'Archeologie et du Patrimoine and the Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology (MPI-EVA). We thank S. Albert (MPI-EVA) for sample preparation and for measuring the flint samples, E. Pernicka (Curt-Engelhorn-Zentrum Archaometrie, Mannheim) for neutron activation analysis and D. Degering (Verein fur Kernverfahrenstechnik und Analytik, Rossendorf) for performing gamma-ray spectrometry . The Max Planck Society funded the fieldwork and the thermoluminescence analysis. V. Aldeias (MPI-EVA) excavated the partial skull. B. Larmignat illustrated the stone artefacts. Philipp Gunz commented on the manuscript, and Les Kinsley (RSES, ANU) assisted with laser ablation measurements. Parts of the US/ESR research were funded by ARC discovery grants (DP0664144 to R.G.) and (DP140100919 to R.J.-B.)	Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Adler DS, 2014, SCIENCE, V345, P1609, DOI 10.1126/science.1256484; Aitken MJ, 1985, THERMOLUMINESCENCE D; Arambourg C., 1965, QUATERNARIA, VVII, P1; BERGER GW, 1985, CAN J EARTH SCI, V22, P704, DOI 10.1139/e85-076; Brown FH, 2012, J HUM EVOL, V63, P577, DOI 10.1016/j.jhevol.2012.05.014; Deino AL, 2002, J HUM EVOL, V42, P185, DOI 10.1006/jhev.2001.0517; Eggins S, 2003, QUATERNARY SCI REV, V22, P1373, DOI 10.1016/S0277-3791(03)00064-7; Ennouchi E., 1963, ACT 5 C PAN PREH EST, P53; Ennouchi E., 1968, ANN PALEONTOLOGIE VE, P117; Ennouchi E., 1966, SEANCES SOC GEOL FR, V10, P405; Falgueres C, 2013, J HUM EVOL, V65, P168, DOI 10.1016/j.jhevol.2013.05.005; Frouin M, 2014, J ARCHAEOL SCI, V52, P524, DOI 10.1016/j.jas.2014.09.012; Geraads D, 2013, QUATERNARY RES, V80, P552, DOI 10.1016/j.yqres.2013.08.003; Geraads D, 2010, QUATERN INT, V212, P159, DOI 10.1016/j.quaint.2009.06.002; Gran R., 2000, ANCIENT TL, V18, P1; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Grun R, 2008, GEOCHIM COSMOCHIM AC, V72, P5278, DOI 10.1016/j.gca.2008.08.007; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; GRUN R, 1991, ARCHAEOMETRY, V33, P153, DOI 10.1111/j.1475-4754.1991.tb00696.x; Grun R, 1996, NATURE, V382, P500, DOI 10.1038/382500a0; Grun R., 1994, ANCIENT TL, V12, P35; Grun R., 1987, ANCIENT TL, V5, P6; Guerin G., 2012, THESIS; Guerin G, 2012, GEOCHRONOMETRIA, V39, P40, DOI 10.2478/s13386-011-0056-z; Guibert P, 1998, RADIAT MEAS, V29, P561, DOI 10.1016/S1350-4487(98)00069-9; GUIBERT P, 1996, ANCIENT TL, V14, P7; Guibert P, 2009, RADIAT MEAS, V44, P223, DOI 10.1016/j.radmeas.2009.03.024; Hublin J.-J., 2017, NATURE; HUBLIN JJ, 1992, PHILOS T ROY SOC B, V337, P185, DOI 10.1098/rstb.1992.0096; HUBLIN JJ, 1987, B MEM SOC ANTHRO PAR, V4, P115, DOI 10.3406/bmsap.1987.1625; Joannes-Boyau R, 2011, QUAT GEOCHRONOL, V6, P82, DOI 10.1016/j.quageo.2010.09.001; Larrasoana J.C., 2012, MODERN ORIGINS N AFR, P19; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; McDougall I, 2008, J HUM EVOL, V55, P409, DOI 10.1016/j.jhevol.2008.05.012; MERCIER N, 1991, NUCL TRACKS RAD MEAS, V18, P77; Mercier N, 2003, J HUM EVOL, V45, P401, DOI 10.1016/j.jhevol.2003.09.004; MERCIER N, 1995, J ARCHAEOL SCI, V22, P495, DOI 10.1006/jasc.1995.0048; Mercier N., 1992, ANCIENT TL, V10, P28; Mercier N, 2013, J ARCHAEOL SCI, V40, P3011, DOI 10.1016/j.jas.2013.03.002; Michel V, 2013, QUAT GEOCHRONOL, V15, P20, DOI 10.1016/j.quageo.2012.12.008; Nathan R., 2003, ANC TL, V21, P79; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Prescott J., 1993, ANCIENT TL, V11, P1; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Ramos J, 2008, QUATERNARY SCI REV, V27, P2210, DOI 10.1016/j.quascirev.2008.08.030; Richter D, 2010, RADIAT PROT DOSIM, V141, P27, DOI 10.1093/rpd/ncq146; Richter D, 2007, GEOARCHAEOLOGY, V22, P671, DOI 10.1002/gea.20180; Richter D, 2015, J HUM EVOL, V89, P46, DOI 10.1016/j.jhevol.2015.06.003; Rink WJ, 2004, J ARCHAEOL SCI, V31, P15, DOI 10.1016/S0305-4403(03)00080-3; Sahle Y, 2014, QUATERN INT, V331, P6, DOI 10.1016/j.quaint.2013.03.010; Sanzelle S, 1996, RADIAT MEAS, V26, P631, DOI 10.1016/1350-4487(96)00003-0; Scheinfeldt LB, 2010, P NATL ACAD SCI USA, V107, P8931, DOI 10.1073/pnas.1002563107; Schmidt C, 2013, ARCHAEOMETRY, V55, P407, DOI 10.1111/j.1475-4754.2012.00690.x; SCHWARCZ HP, 1994, QUATERNARY SCI REV, V13, P601, DOI 10.1016/0277-3791(94)90084-1; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Tixier J., 2001, ACTES J NATL ARCHEOL, P149; Tribolo C, 2006, ARCHAEOMETRY, V48, P341, DOI 10.1111/j.1475-4754.2006.00260.x; Valladas G., 1978, PACT, V2, P141; VALLADAS H, 1987, NATURE, V330, P159, DOI 10.1038/330159a0; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; Valladas H., 1985, THESIS; Valladas H., 1982, PACT, V6, P171; Wagner GA, 2010, P NATL ACAD SCI USA, V107, P19726, DOI 10.1073/pnas.1012722107	65	237	248	5	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					293	+		10.1038/nature22335	http://dx.doi.org/10.1038/nature22335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EW9FY	28593967				2022-12-28	WOS:000402823400038
J	Witze, A				Witze, Alexandra			NASA's dark-energy probe faces cost crisis	NATURE			English	News Item																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					195	195		10.1038/546195a	http://dx.doi.org/10.1038/546195a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593984	Bronze			2022-12-28	WOS:000402823400006
J	Voelker, R				Voelker, Rebecca			New AML Therapy and Diagnostic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2157	2157		10.1001/jama.2017.6304	http://dx.doi.org/10.1001/jama.2017.6304			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586875				2022-12-28	WOS:000402706100004
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Prescribing incentives feel grubby because they are	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Dumbreck S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h949; Lind S., 2013, PULSE, V357; Oxfordshire CCG, 2017, PRESCR INC	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2017	357								j2695	10.1136/bmj.j2695	http://dx.doi.org/10.1136/bmj.j2695			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4VU	28584026	Bronze, Green Published			2022-12-28	WOS:000426826000001
J	Nutt, C; Adams, P				Nutt, Cameron; Adams, Patrick			Zika in Africa-the invisible epidemic?	LANCET			English	Editorial Material																			0	30	31	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2017	389	10079					1595	1596		10.1016/S0140-6736(17)31051-6	http://dx.doi.org/10.1016/S0140-6736(17)31051-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ES5EK	28593839				2022-12-28	WOS:000399560000010
J	Prince, HM; Kim, YH; Horwitz, SM; Dummer, R; Scarisbrick, J; Quaglino, P; Zinzani, PL; Wolter, P; Sanches, JA; Ortiz-Romero, PL; Akilov, OE; Geskin, L; Trotman, J; Taylor, K; Dalle, S; Weichenthal, M; Walewski, J; Fisher, D; Dreno, B; Stadler, R; Feldman, T; Kuzel, TM; Wang, YH; Palanca-Wessels, MC; Zagadailov, E; Trepicchio, WL; Zhang, WW; Lin, HM; Liu, Y; Huebner, D; Little, M; Whittaker, S; Duvic, M				Prince, H. Miles; Kim, Youn H.; Horwitz, Steven M.; Dummer, Reinhard; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Sanches, Jose A.; Ortiz-Romero, Pablo L.; Akilov, Oleg E.; Geskin, Larisa; Trotman, Judith; Taylor, Kerry; Dalle, Stephane; Weichenthal, Michael; Walewski, Jan; Fisher, David; Dreno, Brigitte; Stadler, Rudolf; Feldman, Tatyana; Kuzel, Timothy M.; Wang, Yinghui; Palanca-Wessels, Maria Corinna; Zagadailov, Erin; Trepicchio, William L.; Zhang, Wenwen; Lin, Hui-Min; Liu, Yi; Huebner, Dirk; Little, Meredith; Whittaker, Sean; Duvic, Madeleine		ALCANZA Study Grp	Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial	LANCET			English	Article							MYCOSIS FUNGOIDES/SEZARY-SYNDROME; QUALITY-OF-LIFE; SEZARY-SYNDROME; CONSENSUS RECOMMENDATIONS; ORAL BEXAROTENE; II TRIAL; EORTC; ORGANIZATION; PAPULOSIS; SOCIETY	Background Cutaneous T-cell lymphomas are rare, generally incurable, and associated with reduced quality of life. Present systemic therapies rarely provide reliable and durable responses. We aimed to assess efficacy and safety of brentuximab vedotin versus conventional therapy for previously treated patients with CD30-positive cutaneous T-cell lymphomas. Methods In this international, open-label, randomised, phase 3, multicentre trial, we enrolled adult patients with CD30-positive mycosis fungoides or primary cutaneous anaplastic large-cell lymphoma who had been previously treated. Patients were enrolled across 52 centres in 13 countries. Patients were randomly assigned (1:1) centrally by an interactive voice and web response system to receive intravenous brentuximab vedotin 1.8 mg/kg once every 3 weeks, for up to 16 3-week cycles, or physician's choice (oral methotrexate 5-50 mg once per week or oral bexarotene 300 mg/m(2) once per day) for up to 48 weeks. The primary endpoint was the proportion of patients in the intention-totreat population achieving an objective global response lasting at least 4 months per independent review facility. Safety analyses were done in all patients who received at least one dose of study drug. This trial was registered with ClinicalTrials.gov, number NCT01578499. Findings Between Aug 13, 2012, and July 31, 2015, 131 patients were enrolled and randomly assigned to a group (66 to brentuximab vedotin and 65 to physician's choice), with 128 analysed in the intention-to-treat population (64 in each group). At a median follow-up of 22.9 months (95% CI 18.4-26.1), the proportion of patients achieving an objective global response lasting at least 4 months was 56.3% (36 of 64 patients) with brentuximab vedotin versus 12.5% (eight of 64) with physician's choice, resulting in a between-group difference of 43.8% (95% CI 29.1-58.4; p<0.0001). Grade 3-4 adverse events were reported in 27 (41%) of 66 patients in the brentuximab vedotin group and 29 (47%) of 62 patients in the physician's choice group. Peripheral neuropathy was seen in 44 (67%) of 66 patients in the brentuximab vedotin group (n=21 grade 2, n=6 grade 3) and four (6%) of 62 patients in the physician's choice group. One of the four on-treatment deaths was deemed by the investigator to be treatment-related in the brentuximab vedotin group; no on-treatment deaths were reported in the physician's choice group. Interpretation Significant improvement in objective response lasting at least 4 months was seen with brentuximab vedotin versus physician's choice of methotrexate or bexarotene.	[Prince, H. Miles] Univ Melbourne, Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia; [Prince, H. Miles] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Prince, H. Miles] Univ Melbourne, Epworth Healthcare, Melbourne, Vic, Australia; [Kim, Youn H.] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Kim, Youn H.] Stanford Canc Inst, Stanford, CA USA; [Horwitz, Steven M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Dummer, Reinhard] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Scarisbrick, Julia] Univ Hosp Birmingham, Dept Dermatol, Birmingham, W Midlands, England; [Quaglino, Pietro] Univ Turin, Dept Med Sci, Dermatol Clin, Turin, Italy; [Zinzani, Pier Luigi] Univ Bologna, Inst Haematol, Bologna, Italy; [Wolter, Pascal] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium; [Sanches, Jose A.] Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil; [Ortiz-Romero, Pablo L.] Univ Complutense, Univ Hosp Octubre 12, Inst Med Sch I 12, Madrid, Spain; [Akilov, Oleg E.; Geskin, Larisa] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA; [Geskin, Larisa] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Trotman, Judith] Univ Sydney, Concord Repatriat Gen Hosp, Dept Haematol, Concord, NSW, Australia; [Taylor, Kerry] ICON Canc Care, South Brisbane, Qld, Australia; [Dalle, Stephane] Claude Bernard Lyon 1 Univ, Hosp Civils Lyon, Dept Dermatol, Lyon, France; [Weichenthal, Michael] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany; [Walewski, Jan] Maria Sklodowska Curie Inst, Warsaw, Poland; [Walewski, Jan] Oncol Ctr, Warsaw, Poland; [Fisher, David] Dana Farber Canc Inst, Boston, MA 02115 USA; [Dreno, Brigitte] Nantes Univ, Fac Med, Nantes, France; [Stadler, Rudolf] Johannes Wesling Med Ctr, Univ Clin Dermatol, Minden, Germany; [Feldman, Tatyana] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Kuzel, Timothy M.] Rush Univ, Dept Med, Div Hematol Oncol Cell Therapy, Chicago, IL 60612 USA; [Wang, Yinghui; Palanca-Wessels, Maria Corinna] Seattle Genet Inc, Bothell, WA USA; [Zagadailov, Erin; Trepicchio, William L.; Zhang, Wenwen; Lin, Hui-Min; Liu, Yi; Huebner, Dirk; Little, Meredith] Takeda Pharmaceut Co Ltd, Millennium Pharmaceut Inc, Cambridge, MA USA; [Whittaker, Sean] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London, England; [Duvic, Madeleine] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Stanford University; Stanford Cancer Institute; Memorial Sloan Kettering Cancer Center; University of Zurich; University Zurich Hospital; University of Birmingham; University of Turin; University of Bologna; KU Leuven; University Hospital Leuven; Universidade de Sao Paulo; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Concord Repatriation General Hospital; University of Sydney; ICON plc; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Kiel; Schleswig Holstein University Hospital; Maria Sklodowska-Curie National Research Institute of Oncology; Harvard University; Dana-Farber Cancer Institute; Nantes Universite; Ruhr University Bochum; Hackensack University Medical Center; Rush University; Seattle Genetics; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Texas System; UTMD Anderson Cancer Center	Prince, HM (corresponding author), Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic 8006, Australia.	Miles.Prince@petermac.org	Spina, Michele/ABE-6014-2020; Dalle, Stephane/E-4552-2018; SANCHES, JOSE ANTONIO/B-3250-2011; Cordeiro de Lima, Vladmir C/P-2559-2015; Quaglino, Pietro/AAC-6122-2022; Walewski, Jan/ABC-9523-2020; Akilov, Oleg/I-8753-2019; Illidge, Tim/M-3659-2015; ZINZANI, PIER LUIGI/J-9182-2016	Spina, Michele/0000-0001-6576-8182; Dalle, Stephane/0000-0002-3423-4548; SANCHES, JOSE ANTONIO/0000-0002-5709-092X; Cordeiro de Lima, Vladmir C/0000-0003-3955-1101; Akilov, Oleg/0000-0003-1339-5710; Illidge, Tim/0000-0003-3191-7324; Walewski, Jan/0000-0003-4247-2674; Trotman, Judith/0000-0001-8009-4593; QUAGLINO, Pietro/0000-0003-4185-9586; BOSI, ALBERTO/0000-0002-5486-4838; Beylot-Barry, Marie/0000-0001-6150-1229; Novelli, Silvana/0000-0001-8750-0195; ZINZANI, PIER LUIGI/0000-0002-2112-2651	Millennium Pharmaceuticals Inc; Seattle Genetics Inc.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Millennium Pharmaceuticals Inc(Takeda Pharmaceutical Company Ltd); Seattle Genetics Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Millennium Pharmaceuticals Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd), Seattle Genetics Inc.	Agar NS, 2010, J CLIN ONCOL, V28, P4730, DOI 10.1200/JCO.2009.27.7665; Assaf C, 2006, BRIT J DERMATOL, V155, P261, DOI 10.1111/j.1365-2133.2006.07329.x; Chren MM, 1997, ARCH DERMATOL, V133, P1433, DOI 10.1001/archderm.133.11.1433; Chren MM, 2012, SKINDEX 29 SKINDEX 1; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Diamandidou E, 1998, BLOOD; Dummer R, 2012, J CLIN ONCOL, V30, P4091, DOI 10.1200/JCO.2011.39.8065; Duvic M, 2001, J CLIN ONCOL, V19, P2456, DOI 10.1200/JCO.2001.19.9.2456; Duvic M, 2001, ARCH DERMATOL, V137, P581; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Duvic M, 2015, J CLIN ONCOL, V33, P3759, DOI 10.1200/JCO.2014.60.3787; European Medicines Agency, 2012, APP 1 GUID EV ANT ME; Food and Drug Administration, 2007, GUID IND CLIN TRIAL; Horwitz SM, 2016, J NATL COMPR CANC NE, V14, P1067, DOI 10.6004/jnccn.2016.0117; Hughes CFM, 2015, BLOOD, V125, P71, DOI 10.1182/blood-2014-07-588236; Kempf W, 2011, BLOOD, V118, P4024, DOI 10.1182/blood-2011-05-351346; Kim YH, 2016, 3 WORLD C CUT LYMPH; Kim YH, 2015, J CLIN ONCOL, V33, P3750, DOI 10.1200/JCO.2014.60.3969; Korgavkar K, 2013, JAMA DERMATOL, V149, P1295, DOI 10.1001/jamadermatol.2013.5526; Olsen EA, 2011, J CLIN ONCOL, V29, P2598, DOI 10.1200/JCO.2010.32.0630; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Pro B, 2012, J CLIN ONCOL; Quaglino P, 2016, 3 WORLD C CUT LYMPH; Sampogna F, 2009, BRIT J DERMATOL, V160, P815, DOI 10.1111/j.1365-2133.2008.08992.x; Trautinger F, 2006, EUR J CANCER, V42, P1014, DOI 10.1016/j.ejca.2006.01.025; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Willemze R, 2013, ANN ONCOL, V24, P149, DOI 10.1093/annonc/mdt242; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Zackheim HS, 2003, J AM ACAD DERMATOL, V49, P873, DOI 10.1016/S0190-9622(03)01591-3	30	311	320	3	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					555	566		10.1016/S0140-6736(17)31266-7	http://dx.doi.org/10.1016/S0140-6736(17)31266-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC5BM	28600132				2022-12-28	WOS:000406855800020
J	Jha, S; Rollins, MG; Fuchs, G; Procter, DJ; Hall, EA; Cozzolino, K; Sarnow, P; Savas, JN; Walsh, D				Jha, Sujata; Rollins, Madeline G.; Fuchs, Gabriele; Procter, Dean J.; Hall, Elizabeth A.; Cozzolino, Kira; Sarnow, Peter; Savas, Jeffrey N.; Walsh, Derek			Trans-kingdom mimicry underlies ribosome customization by a poxvirus kinase	NATURE			English	Article							TOBACCO-MOSAIC-VIRUS; TEMPERATURE-SENSITIVE MUTANTS; MESSENGER-RNA TRANSLATION; VACCINIA VIRUS; EUKARYOTIC RIBOSOME; MASS-SPECTROMETRY; INFECTED CELLS; B1 KINASE; IN-VIVO; PROTEIN	Ribosomes have the capacity to selectively control translation through changes in their composition that enable recognition of specific RNA elements(1). However, beyond differential subunit expression during development(2,3), evidence for regulated ribosome specification within individual cells has remained elusive(1). Here we report that a poxvirus kinase phosphorylates serine/threonine residues in the human small ribosomal subunit protein, receptor for activated C kinase (RACK1), that are not phosphorylated in uninfected cells or cells infected by other viruses. These modified residues cluster in an extended loop in RACK1, phosphorylation of which selects for translation of viral or reporter mRNAs with 5' untranslated regions that contain adenosine repeats, so-called polyA-leaders. Structural and phylogenetic analyses revealed that although RACK1 is highly conserved, this loop is variable and contains negatively charged amino acids in plants, in which these leaders act as translational enhancers. Phosphomimetics and interspecies chimaeras have shown that negative charge in the RACK1 loop dictates ribosome selectivity towards viral RNAs. By converting human RACK1 to a charged, plant-like state, poxviruses remodel host ribosomes so that adenosine repeats erroneously generated by slippage of the viral RNA polymerase(4) confer a translational advantage. Our findings provide insight into ribosome customization through trans-kingdom mimicry and the mechanics of species-specific leader activity that underlie poxvirus polyA-leaders(4).	[Jha, Sujata; Rollins, Madeline G.; Procter, Dean J.; Walsh, Derek] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Fuchs, Gabriele] SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA; [Hall, Elizabeth A.; Cozzolino, Kira; Savas, Jeffrey N.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Sarnow, Peter] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Northwestern University; Feinberg School of Medicine; Stanford University	Walsh, D (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	derek.walsh@northwestern.edu		Sarnow, Peter/0000-0002-2043-2770; Rollins, Madeline/0000-0002-7213-0467; Fuchs, Gabriele/0000-0002-6838-2100	National Institutes of Health (NIH) [R01AI127456, R21AI105330, R00DC013805, R01AI099506]; Chicago Biomedical Consortium [C-068];  [T32GM008061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127456, R01AI099506, R21AI105330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC013805] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health (NIH) R01AI127456 and R21AI105330 to D.W., R00DC013805 to J.N.S., R01AI099506 to P.S., and Catalyst Award C-068 from the Chicago Biomedical Consortium to J.N.S. M.G.R. was supported by training grant T32GM008061. We thank G. McFadden, R. Condit, P. Traktman, D. Evans and Y. Xiang for reagents.	Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Boyle KA, 2004, J VIROL, V78, P1992, DOI 10.1128/JVI.78.4.1992-2005.2004; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chen EI, 2008, ANAL CHEM, V80, P8694, DOI 10.1021/ac800606w; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; COCIORVA D, 2007, CURR PROTOC BIOINFOR; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GALLIE DR, 1988, NUCLEIC ACIDS RES, V16, P8675, DOI 10.1093/nar/16.17.8675; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Jan E, 2016, ANNU REV VIROL, V3, P283, DOI 10.1146/annurev-virology-100114-055014; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin YCJ, 2010, J VIROL, V84, P2432, DOI 10.1128/JVI.01998-09; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Majzoub K, 2014, CELL, V159, P1086, DOI 10.1016/j.cell.2014.10.041; Malikov V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7660; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; MOSS B, 2007, FIELDS VIROLOGY, P2849; Punjabi A, 2005, J VIROL, V79, P2171, DOI 10.1128/JVI.79.4.2171-2190.2005; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmitt K., 2016, MOL CELL BIOL; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shi Z, 2015, ANNU REV CELL DEV BI, V31, P31, DOI 10.1146/annurev-cellbio-100814-125346; Shirokikh NE, 2008, P NATL ACAD SCI USA, V105, P10738, DOI 10.1073/pnas.0804940105; SLEAT DE, 1987, GENE, V60, P217, DOI 10.1016/0378-1119(87)90230-7; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Thompson MK, 2016, ELIFE, V5, DOI 10.7554/eLife.11154; Walsh D, 2006, GENE DEV, V20, P461, DOI 10.1101/gad.1375006; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Wolf AS, 2015, RNA, V21, P935, DOI 10.1261/rna.049080.114; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010	52	49	51	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					651	+		10.1038/nature22814	http://dx.doi.org/10.1038/nature22814			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28636603	Green Accepted			2022-12-28	WOS:000404332000047
J	Zanos, P; Moaddel, R; Morris, PJ; Georgiou, P; Fischell, J; Elmer, GI; Alkondon, M; Yuan, PX; Pribut, HJ; Singh, NS; Dossou, KSS; Fang, YH; Huang, XP; Mayo, CL; Albuquerque, EX; Thompson, SM; Thomas, CJ; Zarate, CA; Gould, TD				Zanos, Panos; Moaddel, Ruin; Morris, Patrick J.; Georgiou, Polymnia; Fischell, Jonathan; Elmer, Greg I.; Alkondon, Manickavasagom; Yuan, Peixiong; Pribut, Heather J.; Singh, Nagendra S.; Dossou, Katina S. S.; Fang, Yuhong; Huang, Xi-Ping; Mayo, Cheryl L.; Albuquerque, Edson X.; Thompson, Scott M.; Thomas, Craig J.; Zarate, Carlos A., Jr.; Gould, Todd D.			Effects of a ketamine metabolite on synaptic NMDAR function Reply	NATURE			English	Letter							MECHANISMS; KINASE; INHIBITION; EEF2		[Zanos, Panos; Georgiou, Polymnia; Elmer, Greg I.; Pribut, Heather J.; Thompson, Scott M.; Gould, Todd D.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Moaddel, Ruin; Singh, Nagendra S.; Dossou, Katina S. S.] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Morris, Patrick J.; Fang, Yuhong; Thomas, Craig J.; Gould, Todd D.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20892 USA; [Fischell, Jonathan; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Elmer, Greg I.; Albuquerque, Edson X.; Gould, Todd D.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Elmer, Greg I.; Mayo, Cheryl L.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA; [Alkondon, Manickavasagom; Albuquerque, Edson X.] Univ Maryland, Sch Med, Div Translat Toxicol, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Yuan, Peixiong; Zarate, Carlos A., Jr.] NIMH, Expt Therapeut & Pathophysiol Branch, Intramural Res Program, NIH, Bethesda, MD 20814 USA; [Huang, Xi-Ping] Univ North Carolina Chapel Hill, Med Sch, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27516 USA; [Huang, Xi-Ping] Univ North Carolina Chapel Hill, Med Sch, Div Chem Biol & Med Chem, Chapel Hill, NC 27516 USA; [Albuquerque, Edson X.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Gould, Todd D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gould, TD (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA.; Gould, TD (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.; Gould, TD (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	gouldlab@me.com	Zarate, Carlos/ABD-6843-2021; Singh, Nagendra S/K-8966-2015; Thompson, Scott M/K-8921-2015; Zanos, Panos/ABD-8906-2021; Moaddel, Ruin/AAE-3378-2020; Singh, Nagendra/B-6646-2018; ZANOS, PANOS/AAX-4568-2020	Zanos, Panos/0000-0002-1968-8648; Morris, Patrick/0000-0003-2380-4178; Thomas, Craig/0000-0001-9386-9001; Zarate Jr., Carlos A./0000-0003-4442-7412; Moaddel, Ruin/0000-0002-6812-0127; Elmer, Greg/0000-0002-1483-3690; Georgiou, Polymnia/0000-0003-3171-9993	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086828, ZIAMH002857, ZIAMH002927, R01MH107615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000297] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA MH002857-12] Funding Source: Medline; NIMH NIH HHS [R01 MH107615, R01 MH086828] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Gideons ES, 2014, P NATL ACAD SCI USA, V111, P8649, DOI 10.1073/pnas.1323920111; Hizli AA, 2013, MOL CELL BIOL, V33, P596, DOI 10.1128/MCB.01270-12; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Moaddel R, 2013, EUR J PHARMACOL, V698, P228, DOI 10.1016/j.ejphar.2012.11.023; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Nosyreva E, 2013, J NEUROSCI, V33, P6990, DOI 10.1523/JNEUROSCI.4998-12.2013; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Suzuki K, 2017, NATURE, V546, pE1, DOI 10.1038/nature22084; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Yang B, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw080; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998	13	22	22	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					E4	E5		10.1038/nature22085	http://dx.doi.org/10.1038/nature22085			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640272	Green Accepted			2022-12-28	WOS:000403814100004
J	Voelker, R				Voelker, Rebecca			Mercury Risk at Day Care Center	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2272	2272		10.1001/jama.2017.6559	http://dx.doi.org/10.1001/jama.2017.6559			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609540				2022-12-28	WOS:000403149900006
J	Eming, SA; Wynn, TA; Martin, P				Eming, Sabine A.; Wynn, Thomas A.; Martin, Paul			Inflammation and metabolism in tissue repair and regeneration	SCIENCE			English	Review							MACROPHAGE POLARIZATION; SUCCINATE-DEHYDROGENASE; MEDIATED INFLAMMATION; PULMONARY-FIBROSIS; MECHANISMS; CELLS; ZEBRAFISH; DISTINCT; DISEASE; HEART	Tissue repair after injury is a complex, metabolically demanding process. Depending on the tissue's regenerative capacity and the quality of the inflammatory response, the outcome is generally imperfect, with some degree of fibrosis, which is defined by aberrant accumulation of collagenous connective tissue. Inflammatory cells multitask at the wound site by facilitating wound debridement and producing chemokines, metabolites, and growth factors. If this well-orchestrated response becomes dysregulated, the wound can become chronic or progressively fibrotic, with both outcomes impairing tissue function, which can ultimately lead to organ failure and death. Here we review the current understanding of the role of inflammation and cell metabolism in tissue-regenerative responses, highlight emerging concepts that may expand therapeutic perspectives, and briefly discuss where important knowledge gaps remain.	[Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany; [Wynn, Thomas A.] NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Martin, Paul] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Martin, Paul] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Martin, Paul] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Martin, Paul] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	University of Cologne; University of Cologne; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bristol; University of Bristol; Cardiff University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Eming, SA (corresponding author), Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany.; Eming, SA (corresponding author), Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.; Eming, SA (corresponding author), Univ Cologne, Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany.; Wynn, TA (corresponding author), NIAID, Immunopathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.; Martin, P (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.; Martin, P (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.; Martin, P (corresponding author), Cardiff Univ, Sch Med, Cardiff, S Glam, Wales.; Martin, P (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	sabine.eming@uni-koeln.de; twynn@niaid.nih.gov; pyxpm@bristol.ac.uk	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731; Martin, Paul/0000-0002-2665-5086	intramural research program of NIH's National Institute of Allergy and Infectious Diseases; Wellcome Trust; Cancer Research UK; Medical Research Council; Deutsche Forschungsgemeinschaft [SFB829, FOR 2240]; Deutsche Forschungsgemeinschaft (CECAD); Center for Molecular Medicine Cologne; Cancer Research UK [15936] Funding Source: researchfish; Medical Research Council [G0301048, MR/J002577/1] Funding Source: researchfish; Wellcome Trust [097791/Z/11/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001019] Funding Source: NIH RePORTER; MRC [MR/J002577/1, G0301048] Funding Source: UKRI	intramural research program of NIH's National Institute of Allergy and Infectious Diseases; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (CECAD)(German Research Foundation (DFG)); Center for Molecular Medicine Cologne; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank K. Vannella, T. Gieseck, K. Hart, H. Weavers, R. Richardson, and S. Willenborg for helpful comments. T.A.W. is supported by the intramural research program of NIH's National Institute of Allergy and Infectious Diseases. P.M. is supported by investigator/program grants from the Wellcome Trust, Cancer Research UK, and the Medical Research Council. S.A.E. is supported by grants from the Deutsche Forschungsgemeinschaft (SFB829, FOR 2240, and CECAD) and the Center for Molecular Medicine Cologne.	Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Barron L, 2011, AM J PHYSIOL-GASTR L, V300, pG723, DOI 10.1152/ajpgi.00414.2010; Borthwick LA, 2016, MUCOSAL IMMUNOL, V9, P38, DOI 10.1038/mi.2015.34; Charles ASD, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160102; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Ellett F, 2015, J LEUKOCYTE BIOL, V98, P975, DOI 10.1189/jlb.3MA0315-105R; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fabre T, 2014, J IMMUNOL, V193, P3925, DOI 10.4049/jimmunol.1400861; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gieseck RL, 2016, IMMUNITY, V45, P145, DOI 10.1016/j.immuni.2016.06.009; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jessup HK, 2008, J IMMUNOL, V181, P4311, DOI 10.4049/jimmunol.181.6.4311; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kyritsis N, 2014, TRENDS CELL BIOL, V24, P128, DOI 10.1016/j.tcb.2013.08.004; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Liu C, 2016, IMMUNITY, V44, P1162, DOI 10.1016/j.immuni.2016.03.008; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Metchnikoff E., 1968, LECT COMP PATHOLOGY; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Pase L, 2012, CURR BIOL, V22, P1818, DOI 10.1016/j.cub.2012.07.060; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Ramalingam TR, 2016, J PATHOL, V239, P344, DOI 10.1002/path.4733; Robertson AL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007672; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Telorack M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005800; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; Vannella KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004372; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Weavers H, 2016, CURR BIOL, V26, P1975, DOI 10.1016/j.cub.2016.06.012; Weavers H, 2016, CELL, V165, P1658, DOI 10.1016/j.cell.2016.04.049; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wood W, 2017, DEV CELL, V40, P221, DOI 10.1016/j.devcel.2017.01.001; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015	68	497	509	55	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1026	1030		10.1126/science.aam7928	http://dx.doi.org/10.1126/science.aam7928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596335	Green Submitted			2022-12-28	WOS:000402871700041
J	Carroll, RW; Katz, ML; Paul, E; Juppner, H				Carroll, Ryan W.; Katz, Michelle L.; Paul, Elahna; Juppner, Harald			Case 17-2017: A 14-Year-Old Boy with Acute Fear of Choking while Swallowing Pseudohypoparathyroidism type 1b.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATERNAL UNIPARENTAL DISOMY; AUTOSOMAL-DOMINANT; CHROMOSOME 20Q; IB; GNAS; DELETION; MUTATIONS; DEFECTS		[Carroll, Ryan W.; Katz, Michelle L.; Paul, Elahna; Juppner, Harald] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Carroll, Ryan W.; Katz, Michelle L.; Paul, Elahna; Juppner, Harald] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Katz, Michelle L.] Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	Carroll, RW (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Carroll, RW (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.				NIDDK NIH HHS [R01 DK046718] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046718] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2015, ENDOCRINOLOGY, P1147; Dixit A, 2013, J CLIN ENDOCR METAB, V98, pE103, DOI 10.1210/jc.2012-2639; Elli FM, 2014, J CLIN ENDOCR METAB, V99, pE724, DOI 10.1210/jc.2013-3704; JACOBSON MA, 1991, J CLIN ENDOCR METAB, V72, P1130, DOI 10.1210/jcem-72-5-1130; Juppner H, 1998, P NATL ACAD SCI USA, V95, P11798, DOI 10.1073/pnas.95.20.11798; Juppner H, 2005, AM J HUM GENET, V76, P804; Juppner H, 2013, PRIMER METABOLIC BON, P590; Liamis G, 2009, J BONE MINER METAB, V27, P635, DOI 10.1007/s00774-009-0119-x; Linglart A, 2007, CLIN ENDOCRINOL, V67, P822, DOI 10.1111/j.1365-2265.2007.02969.x; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Malloy PJ, 2010, ENDOCRIN METAB CLIN, V39, P333, DOI 10.1016/j.ecl.2010.02.004; Mantovani G, 2010, J CLIN ENDOCR METAB, V95, P651, DOI 10.1210/jc.2009-0176; Richard N, 2012, J CLIN ENDOCR METAB, V97, pE863, DOI 10.1210/jc.2011-2804; Schafer A, 2013, PRIMER METABOLIC BON, V8th, P573; Shoback D, 2008, NEW ENGL J MED, V359, P391, DOI 10.1056/NEJMcp0803050; Takatani R, 2016, J BONE MINER RES, V31, P796, DOI 10.1002/jbmr.2731; Takatani R, 2015, BONE, V79, P15, DOI 10.1016/j.bone.2015.05.011; Thiele S, 2011, HUM MUTAT, V32, P653, DOI 10.1002/humu.21489; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675	21	0	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2266	2275		10.1056/NEJMcpc1616019	http://dx.doi.org/10.1056/NEJMcpc1616019			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW8WG	28591527	Green Accepted			2022-12-28	WOS:000402798200012
J	Marin-Palomo, P; Kemal, JN; Karpov, M; Kordts, A; Pfeifle, J; Pfeiffer, MHP; Trocha, P; Wolf, S; Brasch, V; Anderson, MH; Rosenberger, R; Vijayan, K; Freude, W; Kippenberg, TJ; Koos, C				Marin-Palomo, Pablo; Kemal, Juned N.; Karpov, Maxim; Kordts, Arne; Pfeifle, Joerg; Pfeiffer, Martin H. P.; Trocha, Philipp; Wolf, Stefan; Brasch, Victor; Anderson, Miles H.; Rosenberger, Ralf; Vijayan, Kovendhan; Freude, Wolfgang; Kippenberg, Tobias J.; Koos, Christian			Microresonator-based solitons for massively parallel coherent optical communications	NATURE			English	Article							ORGANIC HYBRID SOH; FREQUENCY COMB; PHOTONIC WIRE; TRANSMISSION; GENERATION	Solitons are waveforms that preserve their shape while propagating, as a result of a balance of dispersion and nonlinearity(1,2). Soliton-based data transmission schemes were investigated in the 1980s and showed promise as a way of overcoming the limitations imposed by dispersion of optical fibres. However, these approaches were later abandoned in favour of wavelength-division multiplexing schemes, which are easier to implement and offer improved scalability to higher data rates. Here we show that solitons could make a comeback in optical communications, not as a competitor but as a key element of massively parallel wavelength-division multiplexing. Instead of encoding data on the soliton pulse train itself, we use continuous-wave tones of the associated frequency comb as carriers for communication. Dissipative Kerr solitons (DKSs)(3,4) (solitons that rely on a double balance of parametric gain and cavity loss, as well as dispersion and nonlinearity) are generated as continuously circulating pulses in an integrated silicon nitride microresonator(5) via four-photon interactions mediated by the Kerr nonlinearity, leading to low-noise, spectrally smooth, broadband optical frequency combs(6). We use two interleaved DKS frequency combs to transmit a data stream of more than 50 terabits per second on 179 individual optical carriers that span the entire telecommunication C and L bands (centred around infrared telecommunication wavelengths of 1.55 micrometres). We also demonstrate coherent detection of a wavelength-division multiplexing data stream by using a pair of DKS frequency combs-one as a multi-wavelength light source at the transmitter and the other as the corresponding local oscillator at the receiver. This approach exploits the scalability of microresonator-based DKS frequency comb sources for massively parallel optical communications at both the transmitter and the receiver. Our results demonstrate the potential of these sources to replace the arrays of continuous-wave lasers that are currently used in highspeed communications. In combination with advanced spatial multiplexing schemes(7,8) and highly integrated silicon photonic circuits(9), DKS frequency combs could bring chip-scale petabit-per-second transceivers into reach.	[Marin-Palomo, Pablo; Kemal, Juned N.; Pfeifle, Joerg; Trocha, Philipp; Wolf, Stefan; Rosenberger, Ralf; Vijayan, Kovendhan; Freude, Wolfgang; Koos, Christian] Karlsruhe Inst Technol, Inst Photon & Quantum Elect IPQ, D-76131 Karlsruhe, Germany; [Karpov, Maxim; Kordts, Arne; Pfeiffer, Martin H. P.; Brasch, Victor; Anderson, Miles H.; Kippenberg, Tobias J.] Ecole Polytech Fed Lausanne, LPQM, CH-1015 Lausanne, Switzerland; [Freude, Wolfgang; Koos, Christian] Karlsruhe Inst Technol, IMT, D-76131 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Helmholtz Association; Karlsruhe Institute of Technology	Koos, C (corresponding author), Karlsruhe Inst Technol, Inst Photon & Quantum Elect IPQ, D-76131 Karlsruhe, Germany.; Kippenberg, TJ (corresponding author), Ecole Polytech Fed Lausanne, LPQM, CH-1015 Lausanne, Switzerland.; Koos, C (corresponding author), Karlsruhe Inst Technol, IMT, D-76131 Karlsruhe, Germany.	tobias.kippenberg@epfl.ch; christian.koos@kit.edu	Freude, Wolfgang/P-9257-2015; Wolf, Stefan/B-1495-2016; Anderson, Miles/AFU-8173-2022; Koos, Christian/S-6310-2016; Vijayan, Kovendhan/F-9044-2019; Karpov, Maxim A./G-4688-2016; Kippenberg, T. J./B-3133-2013	Freude, Wolfgang/0000-0002-8797-7687; Anderson, Miles/0000-0003-0549-2385; Koos, Christian/0000-0003-2690-0691; Karpov, Maxim A./0000-0002-9304-3936; Kippenberg, T. J./0000-0002-3408-886X; Marin-Palomo, Pablo/0000-0003-4344-0594; Kordts, Arne/0000-0001-5826-2319; Brasch, Victor/0000-0002-0354-2847; Kemal, Juned N./0000-0003-4153-5880	European Research Council (ERC Starting Grant 'EnTeraPIC') [280145]; EU project BigPipes; Alfried Krupp von Bohlen und Halbach Foundation; Karlsruhe School of Optics and Photonics (KSOP); Helmholtz International Research School for Teratronics (HIRST); Erasmus Mundus doctorate programme Europhotonics [159224-1-2009-1-FR-ERA MUNDUS-EMJD]; Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center 'Wave Phenomena: Analysis and Numerics' [CRC 1173]; ESA PhD fellowship; Air Force Office of Scientific Research, Air Force Material Command, USAF [FA9550-15-1-0099]; Marie Curie FP7 ITN FACT; Swiss National Science Foundation via precoR [161537]; Defense Advanced Research Projects Agency (DARPA), Defense Sciences Office (DSO) [W911NF-11-1-0202]	European Research Council (ERC Starting Grant 'EnTeraPIC'); EU project BigPipes; Alfried Krupp von Bohlen und Halbach Foundation; Karlsruhe School of Optics and Photonics (KSOP); Helmholtz International Research School for Teratronics (HIRST); Erasmus Mundus doctorate programme Europhotonics; Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center 'Wave Phenomena: Analysis and Numerics'; ESA PhD fellowship; Air Force Office of Scientific Research, Air Force Material Command, USAF(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Marie Curie FP7 ITN FACT; Swiss National Science Foundation via precoR; Defense Advanced Research Projects Agency (DARPA), Defense Sciences Office (DSO)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the European Research Council (ERC Starting Grant 'EnTeraPIC', number 280145), the EU project BigPipes, the Alfried Krupp von Bohlen und Halbach Foundation, the Karlsruhe School of Optics and Photonics (KSOP), and the Helmholtz International Research School for Teratronics (HIRST). P.M.-P. is supported by the Erasmus Mundus doctorate programme Europhotonics (grant number 159224-1-2009-1-FR-ERA MUNDUS-EMJD). We acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center 'Wave Phenomena: Analysis and Numerics' (CRC 1173), project B3 'Frequency combs'. Si<INF>3</INF>N<INF>4</INF> devices were fabricated and grown in the Center of MicroNanoTechnology (CMi) at EPFL. EPFL acknowledges support by an ESA PhD fellowship (M.K.) and by the Air Force Office of Scientific Research, Air Force Material Command, USAF, number FA9550-15-1-0099. M.K. acknowledges funding support from Marie Curie FP7 ITN FACT. We also acknowledge the Swiss National Science Foundation via precoR, Grant No. 161537. This publication was supported by Contract W911NF-11-1-0202 (QuASAR) from the Defense Advanced Research Projects Agency (DARPA), Defense Sciences Office (DSO).	Akhmediev N., 2008, DISSIPATIVE SOLITONS; Ataie V, 2015, J LIGHTWAVE TECHNOL, V33, P694, DOI 10.1109/JLT.2015.2388579; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Brasch V, 2016, SCIENCE, V351, P357, DOI 10.1126/science.aad4811; Brasch V, 2017, LIGHT-SCI APPL, V6, DOI 10.1038/lsa.2016.202; Carmon T, 2004, OPT EXPRESS, V12, P4742, DOI 10.1364/OPEX.12.004742; Chang F, 2010, IEEE COMMUN MAG, V48, pS48, DOI 10.1109/MCOM.2010.5434378; Dai DX, 2014, NANOPHOTONICS-BERLIN, V3, P283, DOI 10.1515/nanoph-2013-0021; Dar R, 2016, EUR C OPT COMM W 1 D; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Guo H, 2017, NAT PHYS, V13, P94, DOI [10.1038/NPHYS3893, 10.1038/nphys3893]; Herr T, 2014, NAT PHOTONICS, V8, P145, DOI [10.1038/NPHOTON.2013.343, 10.1038/nphoton.2013.343]; Hesegawa A., 1995, SOLITONS OPTICAL COM; Hillerkuss D, 2011, NAT PHOTONICS, V5, P364, DOI [10.1038/NPHOTON.2011.74, 10.1038/nphoton.2011.74]; Hillerkuss D, 2012, J OPT COMMUN NETW, V4, P715, DOI 10.1364/JOCN.4.000715; Hu H., 2016, C LAS EL OPT JTH4C; Joshi C, 2016, OPT LETT, V41, P2565, DOI 10.1364/OL.41.002565; Jost JD, 2015, OPTICA, V2, P706, DOI 10.1364/OPTICA.2.000706; Karpov M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.103902; Kemal J., 2017, OPT FIB COMM C TH5C; Kemal JN, 2016, OPT EXPRESS, V24, P25432, DOI 10.1364/OE.24.025432; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Koos C, 2016, J LIGHTWAVE TECHNOL, V34, P256, DOI 10.1109/JLT.2015.2499763; Kordts A, 2016, OPT LETT, V41, P452, DOI 10.1364/OL.41.000452; Lauermann M, 2015, J LIGHTWAVE TECHNOL, V33, P1210, DOI 10.1109/JLT.2015.2394211; Levy JS, 2010, NAT PHOTONICS, V4, P37, DOI 10.1038/NPHOTON.2009.259; Liang D, 2010, NAT PHOTONICS, V4, P511, DOI [10.1038/NPHOTON.2010.167, 10.1038/nphoton.2010.167]; Liang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8957; Lindenmann N, 2012, OPT EXPRESS, V20, P17667, DOI 10.1364/OE.20.017667; LUGIATO LA, 1987, PHYS REV LETT, V58, P2209, DOI 10.1103/PhysRevLett.58.2209; Marin P, 2016, C LAS EL OPT STU1G 1; Marin P, 2016, EUR C OPT COMM PDP3; MOLLENAUER LF, 1980, PHYS REV LETT, V45, P1095, DOI 10.1103/PhysRevLett.45.1095; Nagarajan R, 2010, IEEE J SEL TOP QUANT, V16, P1113, DOI 10.1109/JSTQE.2009.2037828; NAKAZAWA M, 1991, ELECTRON LETT, V27, P1270, DOI 10.1049/el:19910796; Pfau T, 2009, J LIGHTWAVE TECHNOL, V27, P989, DOI 10.1109/JLT.2008.2010511; Pfeiffer MHP, 2017, PHYS REV APPL, V7, DOI 10.1103/PhysRevApplied.7.024026; Pfeiffer MHP, 2016, OPTICA, V3, P20, DOI 10.1364/OPTICA.3.000020; Pfeifle J, 2015, CONF LASER ELECTR; Pfeifle J, 2015, OPT EXPRESS, V23, P724, DOI 10.1364/OE.23.000724; Pfeifle J, 2014, NAT PHOTONICS, V8, P375, DOI 10.1038/nphoton.2014.57; Puttnam B. J., 2015, EUR C OPT COMM PDP3; Puttnam BJ, 2014, OPT EXPRESS, V22, P21185, DOI 10.1364/OE.22.021185; Sano A, OPT FIB COMM C PDP5C; Schmogrow R., 2012, PHOTONICS TECHNOLOGY, V24, P61, DOI DOI 10.1109/LPT.2011.2172405; Selvaraja SK, 2009, J LIGHTWAVE TECHNOL, V27, P4076, DOI 10.1109/JLT.2009.2022282; Suh MG, 2016, SCIENCE, V354, P600, DOI 10.1126/science.aah6516; Temprana E, 2015, SCIENCE, V348, P1445, DOI 10.1126/science.aab1781; Wang PH, 2016, OPT EXPRESS, V24, P10890, DOI 10.1364/OE.24.010890; Weimann C, 2014, OPT EXPRESS, V22, P3629, DOI 10.1364/OE.22.003629; Winzer PJ, 2010, J LIGHTWAVE TECHNOL, V28, P547, DOI 10.1109/JLT.2009.2031922; Xuan Y, 2016, OPTICA, V3, P1171, DOI 10.1364/OPTICA.3.001171; Yi X, 2015, OPTICA, V2, P1078, DOI 10.1364/OPTICA.2.001078; Yu M., 2016, PREPRINT	54	560	571	36	390	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					274	+		10.1038/nature22387	http://dx.doi.org/10.1038/nature22387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593968	Green Submitted			2022-12-28	WOS:000402823400034
J	Welch, HG; Fisher, ES				Welch, H. Gilbert; Fisher, Elliott S.			Income and Cancer Overdiagnosis - When Too Much Care Is Harmful	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Welch, H. Gilbert; Fisher, Elliott S.] Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA	Dartmouth College	Welch, HG (corresponding author), Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA.							Anderson Elizabeth, 1984, LANCET, V1, P1003; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Schwartz AL, 2015, JAMA INTERN MED, V175, P1815, DOI 10.1001/jamainternmed.2015.4525; Sirovich BE, 2011, ARCH INTERN MED, V171, P1582, DOI 10.1001/archinternmed.2011.437; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	5	38	40	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2208	2209		10.1056/NEJMp1615069	http://dx.doi.org/10.1056/NEJMp1615069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW8WG	28591536				2022-12-28	WOS:000402798200004
J	Hampton, T				Hampton, Tracy			Unfolding the Clinical Potential of DNA and Protein Origami	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2154	2155		10.1001/jama.2017.6288	http://dx.doi.org/10.1001/jama.2017.6288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586869				2022-12-28	WOS:000402706100002
J	Kenyon, S; Sanders, J; Middleton, L; Johnston, T				Kenyon, Sara; Sanders, Julia; Middleton, Lee; Johnston, Tracey			UNCERTAINTIES What is the best treatment to reduce the need for caesarean section in nulliparous women at term with delayed first stage of labour?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kenyon, Sara] Univ Birmingham, Inst Appl Hlth Res, Evidence Based Matern Care, Birmingham B15 2TT, W Midlands, England; [Sanders, Julia] Cardiff Univ, Healthcare Sci, Cardiff CF24 0AB, S Glam, Wales; [Middleton, Lee] Univ Birmingham, Birmingham Clin Trials Unit, Sch Canc Sci, Robert Aitken Inst, Birmingham, W Midlands, England; [Johnston, Tracey] Birmingham Womens & Childrens NHS Fdn Trust, Maternal & Fetal Med, Birmingham, W Midlands, England	University of Birmingham; Cardiff University; University of Birmingham	Kenyon, S (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Evidence Based Matern Care, Birmingham B15 2TT, W Midlands, England.	s.kenyon@bham.ac.uk	; Uldbjerg, Niels/O-2038-2016	Kenyon, Sara/0000-0002-0756-9617; Glavind, Julie/0000-0002-9856-6621; Uldbjerg, Niels/0000-0002-6449-6426; Middleton, Lee/0000-0003-4621-1922	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care in the West Midlands (CLAHRC WM); National Institute for Health Research [14/140/44] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care in the West Midlands (CLAHRC WM); National Institute for Health Research(National Institute for Health Research (NIHR))	SK was part funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care in the West Midlands (CLAHRC WM).	[Anonymous], 2014, Obstet Gynecol, V123, P693, DOI 10.1097/01.AOG.0000444441.04111.1d; Armstrong N, 2017, HEALTH-LONDON, V21, P223, DOI 10.1177/1363459315617311; Begley CM, 2014, MIDWIFERY, V30, P975, DOI 10.1016/j.midw.2014.06.005; Cheng YW, 2010, OBSTET GYNECOL, V116, P1127, DOI 10.1097/AOG.0b013e3181f5eaf0; Fawcus S, 2013, BEST PRACT RES CL OB, V27, P233, DOI 10.1016/j.bpobgyn.2012.08.018; Hayes EJ, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.039; Hinshaw K, 2008, BJOG-INT J OBSTET GY, V115, P1289, DOI 10.1111/j.1471-0528.2008.01819.x; Kenyon S, 2013, BJOG-INT J OBSTET GY, V120, P1403, DOI 10.1111/1471-0528.12331; Kenyon S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007201.pub3; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1380, DOI 10.1111/j.1471-0528.2007.01507.x; Kominiarek MA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.014; Lavender T, 1999, BIRTH-ISS PERINAT C, V26, P89, DOI 10.1046/j.1523-536x.1999.00089.x; Lavender T, 2006, OBSTET GYNECOL, V108, P295, DOI 10.1097/01.AOG.0000226862.78768.5c; Lee L, 2016, J OBSTET GYNAECOL CA, V38, P843, DOI 10.1016/j.jogc.2016.04.093; National Institute for Health and Care Excellence, 2014, CLIN GUID 190; Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2014, PROV ROUT INTR CAR A; Royal College of Obstetricians and Gynaecologists, 2015, GREEN TOP GUID 45 20; Steer PJ, 2015, BJOG-INT J OBSTET GY, V122, P1543, DOI 10.1111/1471-0528.13571; Williams FLR, 1998, J EPIDEMIOL COMMUN H, V52, P494, DOI 10.1136/jech.52.8.494; World Health Organization, 2014, REC AUGM LAB; Zhang JT, 2011, SPINE, V36, pE1004, DOI 10.1097/BRS.0b013e3181fef60f	21	2	2	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2017	357								j2469	10.1136/bmj.j2469	http://dx.doi.org/10.1136/bmj.j2469			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4QY	28588033	Green Published			2022-12-28	WOS:000403221000002
J	Harvin, JA; Kao, LS				Harvin, John A.; Kao, Lillian S.			PRIMA, non nocere	LANCET			English	Editorial Material							VENTRAL HERNIA REPAIR; INCISIONAL HERNIA; MESH		[Harvin, John A.; Kao, Lillian S.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kao, LS (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA.	lillian.s.kao@uth.tmc.edu	Kao, Lillian/GOV-7076-2022		Center for Clinical and Translational Sciences; National Institutes of Health Clinical and Translational Award from the National Center for Advancing Translational Sciences [KL2 TR000370]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000370] Funding Source: NIH RePORTER	Center for Clinical and Translational Sciences; National Institutes of Health Clinical and Translational Award from the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	JAH is supported by a grant from the Center for Clinical and Translational Sciences, which is funded by the National Institutes of Health Clinical and Translational Award KL2 TR000370 from the National Center for Advancing Translational Sciences. LSK declares no competing interests.	Antonescu I, 2014, SURGERY, V156, P319, DOI 10.1016/j.surg.2014.03.005; Baucom RB, 2014, AM SURGEON, V80, P720; Baucom RB, 2014, J AM COLL SURGEONS, V218, P363, DOI 10.1016/j.jamcollsurg.2013.12.007; Borab ZM, 2017, SURGERY, V161, P1149, DOI 10.1016/j.surg.2016.09.036; Broman KK, 2017, J AM COLL SURGEONS, V224, P35, DOI 10.1016/j.jamcollsurg.2016.09.016; Holihan JL, 2016, ANN SURG, V264, P585, DOI 10.1097/SLA.0000000000001865; Jairam A. P., 2017, LANCET; Pianka F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171548; Poulose BK, 2012, HERNIA, V16, P179, DOI 10.1007/s10029-011-0879-9; Timmermans L, 2015, ANN SURG, V261, P276, DOI 10.1097/SLA.0000000000000798	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					535	536		10.1016/S0140-6736(17)31616-1	http://dx.doi.org/10.1016/S0140-6736(17)31616-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC5BM	28641874				2022-12-28	WOS:000406855800005
J	Liao, JM; Schapira, MS; Navathe, AS; Mitra, N; Weissman, A; Asch, DA				Liao, Joshua M.; Schapira, Marilyn S.; Navathe, Amol S.; Mitra, Nandita; Weissman, Arlene; Asch, David A.			The Effect of Emphasizing Patient, Societal, and Institutional Harms of Inappropriate Antibiotic Prescribing on Physician Support of Financial Penalties: A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Letter									[Liao, Joshua M.; Schapira, Marilyn S.; Navathe, Amol S.; Mitra, Nandita; Asch, David A.] Univ Penn, Philadelphia, PA 19104 USA; [Schapira, Marilyn S.; Navathe, Amol S.; Asch, David A.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Weissman, Arlene] Amer Coll Physicians, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; American College of Physicians	Liao, JM (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X; Navathe, Amol/0000-0001-7182-4988	Leonard Davis Institute of Health Economics at the University of Pennsylvania	Leonard Davis Institute of Health Economics at the University of Pennsylvania	By the Leonard Davis Institute of Health Economics at the University of Pennsylvania, which had no role in the study design, data collection, analysis, or interpretation of results.	American Board of Internal Medicine Foundation, 2017, CHOOS WISELY; Berwick DM, 2017, LANCET, P32570, DOI [10.1016/S0140-6736, DOI 10.1016/S0140-6736]; Centers for Medicare & Medicaid Services, 2016, CMS RESP PUBL COMM N; Mafi JN, 2016, ANN INTERN MED, V165, P237, DOI 10.7326/M15-2152; Rosenberg A, 2015, JAMA INTERN MED, V175, P1913, DOI 10.1001/jamainternmed.2015.5441	5	14	14	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					215	216		10.7326/L17-0102	http://dx.doi.org/10.7326/L17-0102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28631001				2022-12-28	WOS:000406631400017
J	Toft, S; Zabl, J; Richard, J; Gallazzi, A; Zibetti, S; Prescott, M; Grillo, C; Man, AWS; Lee, NY; Gomez-Guijarro, C; Stockmann, M; Magdis, G; Steinhardt, CL				Toft, Sune; Zabl, Johannes; Richard, Johan; Gallazzi, Anna; Zibetti, Stefano; Prescott, Moire; Grillo, Claudio; Man, Allison W. S.; Lee, Nicholas Y.; Gomez-Guijarro, Carlos; Stockmann, Mikkel; Magdis, Georgios; Steinhardt, Charles L.			A massive, dead disk galaxy in the early Universe	NATURE			English	Article							SIMILAR-TO 2; ACTIVE GALACTIC NUCLEI; STAR-FORMING GALAXIES; COMPACT QUIESCENT GALAXIES; HUBBLE-SPACE-TELESCOPE; SAURON PROJECT; BILLION YEARS; C II; SPECTROSCOPY; KINEMATICS	At redshift z = 2, when the Universe was just three billion years old, half of the most massive galaxies were extremely compact and had already exhausted their fuel for star formation(1-4). It is believed that they were formed in intense nuclear starbursts and that they ultimately grew into the most massive local elliptical galaxies seen today, through mergers with minor companions(5,6), but validating this picture requires higher-resolution observations of their centres than is currently possible. Magnification from gravitational lensing offers an opportunity to resolve the inner regions of galaxies(7). Here we report an analysis of the stellar populations and kinematics of a lensed z = 2.1478 compact galaxy, which-surprisingly-turns out to be a fast-spinning, rotationally supported disk galaxy. Its stars must have formed in a disk, rather than in a merger-driven nuclear starburst(8). The galaxy was probably fed by streams of cold gas, which were able to penetrate the hot halo gas until they were cut off by shock heating from the dark matter halo(9). This result confirms previous indirect indications(10-13) that the first galaxies to cease star formation must have gone through major changes not just in their structure, but also in their kinematics, to evolve into present-day elliptical galaxies.	[Toft, Sune; Zabl, Johannes; Lee, Nicholas Y.; Gomez-Guijarro, Carlos; Stockmann, Mikkel; Magdis, Georgios; Steinhardt, Charles L.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, Juliane Maries Vej 32, DK-2100 Copenhagen O, Denmark; [Zabl, Johannes] Univ Toulouse, CNRS, UPS, IRAP, F-31400 Toulouse, France; [Richard, Johan] Univ Lyon 1, CNRS, Ens Lyon, Ctr Rech Astrophys Lyon,UMR5574, F-69230 St Genis Laval, France; [Gallazzi, Anna; Zibetti, Stefano] Osserv Astrofis Arcetri, Ist Nazl Astrofis, Largo Enrico Fermi 5, I-50125 Florence, Italy; [Prescott, Moire] New Mexico State Univ, Dept Astron, 1320 Frenger Mall, Las Cruces, NM 88003 USA; [Grillo, Claudio] Univ Milan, Dipartimento Fis, Via Celoria 16, I-20133 Milan, Italy; [Man, Allison W. S.] European Southern Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Magdis, Georgios] Natl Observ Athens, Inst Astron Astrophys Space Applicat & Remo, GR-15236+ Athens, Greece	University of Copenhagen; Niels Bohr Institute; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Istituto Nazionale Astrofisica (INAF); New Mexico State University; University of Milan; European Southern Observatory; National Observatory of Athens	Toft, S (corresponding author), Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, Juliane Maries Vej 32, DK-2100 Copenhagen O, Denmark.	sune@dark-cosmology.dk	Zibetti, Stefano/ABB-1480-2020; Zabl, Johannes/E-7979-2015; Magdis, Georgios/AAX-6804-2021; Magdis, Georgios/L-5366-2019; Gómez-Guijarro, Carlos/GSI-4743-2022; Magdis, Georgios/D-1276-2019; Stockmann, Mikkel/E-7722-2015	Zibetti, Stefano/0000-0003-1734-8356; Zabl, Johannes/0000-0002-9842-6354; Magdis, Georgios/0000-0002-4872-2294; Magdis, Georgios/0000-0002-4872-2294; Gómez-Guijarro, Carlos/0000-0002-4085-9165; Magdis, Georgios/0000-0002-4872-2294; Toft, Sune/0000-0003-3631-7176; Man, Allison/0000-0003-2475-124X; Stockmann, Mikkel/0000-0001-5983-6273; Gallazzi, Anna/0000-0002-9656-1800; Richard, Johan/0000-0001-5492-1049	ERC [648179]; VILLUM FONDEN Young Investigator Programme [10123, 13160]; Carlsberg Foundation; EU Marie Curie Career Integration Grant "SteMaGE" [PCIG12-GA-2012-326466]; OCEVU Labex - 'Investissements d'Avenir' French government [ANR-11-LABX-0060]; A*MIDEX project - 'Investissements d'Avenir' French government [ANR-11-IDEX-0001-02]; Villum Fonden [00010123] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); VILLUM FONDEN Young Investigator Programme(Villum Fonden); Carlsberg Foundation(Carlsberg Foundation); EU Marie Curie Career Integration Grant "SteMaGE"; OCEVU Labex - 'Investissements d'Avenir' French government(French National Research Agency (ANR)); A*MIDEX project - 'Investissements d'Avenir' French government(French National Research Agency (ANR)); Villum Fonden(Villum Fonden)	S.T., J.Z., G.M., N.Y.L., C.L.S., C.G.-G. and M.S. acknowledge support from the ERC Consolidator Grant funding scheme (project ConTExt, grant number 648179). C.G. acknowledges support from the VILLUM FONDEN Young Investigator Programme (grant number 10123). G.M. acknowledges support from the Carlsberg Foundation and from the VILLUM FONDEN Young Investigator Programme (grant number 13160). S.Z. and A. G. acknowledge support by the EU Marie Curie Career Integration Grant "SteMaGE" number PCIG12-GA-2012-326466 (call identifier FP7-PEOPLE-2012 CIG). J.Z. acknowledges support of the OCEVU Labex (ANR-11-LABX-0060) and the A*MIDEX project (ANR-11-IDEX-0001-02) funded by the 'Investissements d'Avenir' French government programme managed by the French National Research Agency (ANR). We thank M. Yun and R. Cybalski for providing the deep Spitzer data, and D. Watson and F. Valentino for discussions.	Barro G, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/145; Behroozi PS, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/57; Belli S, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/1/18; Cappellari M, 2017, MON NOT R ASTRON SOC, V466, P798, DOI 10.1093/mnras/stw3020; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; Christensen L, 2012, MON NOT R ASTRON SOC, V427, P1953, DOI 10.1111/j.1365-2966.2012.22006.x; Coe D, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/22; Comerford JM, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/112; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Ebeling H, 2001, ASTROPHYS J, V553, P668, DOI 10.1086/320958; Emsellem E, 2007, MON NOT R ASTRON SOC, V379, P401, DOI 10.1111/j.1365-2966.2007.11752.x; Geier S, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/87; Hill AR, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/1/74; Hopkins PF, 2009, MON NOT R ASTRON SOC, V398, P898, DOI 10.1111/j.1365-2966.2009.15062.x; Hopkins PF, 2009, ASTROPHYS J, V691, P1168, DOI 10.1088/0004-637X/691/2/1168; Hsu LY, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/92; Ilbert O, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321100; Jullo E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/447; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Kewley LJ, 2001, ASTROPHYS J, V556, P121, DOI 10.1086/321545; Lotz JM, 2010, MON NOT R ASTRON SOC, V404, P575, DOI 10.1111/j.1365-2966.2010.16268.x; Magdis GE, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/6; McGrath EJ, 2008, ASTROPHYS J, V682, P303, DOI 10.1086/589631; Monna A, 2017, MON NOT R ASTRON SOC, V466, P4094, DOI 10.1093/mnras/stx015; Muller-Sanchez F, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/69; Naab T, 2014, MON NOT R ASTRON SOC, V444, P3357, DOI 10.1093/mnras/stt1919; Newman AB, 2015, ASTROPHYS J LETT, V813, DOI 10.1088/2041-8205/813/1/L7; Oteo I, 2016, ASTROPHYS J, V827, DOI 10.3847/0004-637X/827/1/34; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Prescott MKM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/62; Puech M, 2008, ASTRON ASTROPHYS, V484, P173, DOI 10.1051/0004-6361:20079313; Puech M, 2007, ASTRON ASTROPHYS, V466, P83, DOI 10.1051/0004-6361:20065978; Riechers DA, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/84; SANDAGE A, 1986, ASTRON ASTROPHYS, V161, P89; Sarzi M, 2006, MON NOT R ASTRON SOC, V366, P1151, DOI 10.1111/j.1365-2966.2005.09839.x; Selsing J, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201527096; Stockton A, 2004, ASTROPHYS J, V605, P37, DOI 10.1086/382235; Szomoru D, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/121; Tacchella S, 2015, SCIENCE, V348, P314, DOI 10.1126/science.1261094; Toft S, 2007, ASTROPHYS J, V671, P285, DOI 10.1086/521810; Toft S, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/68; Toft S, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/3; Trujillo I, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L20; Valdes F, 2004, ASTROPHYS J SUPPL S, V152, P251, DOI 10.1086/386343; van de Sande J, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/85; van der Wel A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/28; Van der Wel A, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/38; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; van Dokkum PG, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/23; Whitaker KE, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/104; Wu Y, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015014; Wuyts S, 2010, ASTROPHYS J, V722, P1666, DOI 10.1088/0004-637X/722/2/1666; Yesuf HM, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/84; Zabl J, 2015, MON NOT R ASTRON SOC, V451, P2050, DOI 10.1093/mnras/stv1019; Zibetti S, 2017, MON NOT R ASTRON SOC, V468, P1902, DOI 10.1093/mnras/stx251; Zibetti S, 2009, MON NOT R ASTRON SOC, V400, P1181, DOI 10.1111/j.1365-2966.2009.15528.x; Zitrin A, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/117; Zitrin A, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/1/44	62	64	64	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					510	+		10.1038/nature22388	http://dx.doi.org/10.1038/nature22388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640271	Green Accepted, Green Submitted			2022-12-28	WOS:000403814100034
J	Reiling, J				Reiling, Jennifer			The Patent Laws and Patent Office Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2455	2455		10.1001/jama.2017.5056	http://dx.doi.org/10.1001/jama.2017.5056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632856				2022-12-28	WOS:000403654600025
J	Voelker, R				Voelker, Rebecca			Warnings for Anesthetic Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2363	2363		10.1001/jama.2017.6977	http://dx.doi.org/10.1001/jama.2017.6977			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MT	28632854				2022-12-28	WOS:000426799500004
J	Schar, D				Schar, Daniel			Unlikely allies	SCIENCE			English	Book Review									[Schar, Daniel] US Agcy Int Dev, Bangkok 10110, Thailand	United States Agency for International Development (USAID)	Schar, D (corresponding author), US Agcy Int Dev, Bangkok 10110, Thailand.	dlschar@gmail.com						Frobel Kai, 2016, Naturschutz und Landschaftsplanung, V48, P105; Hochkirch A, 2016, NATURE, V539, P141, DOI 10.1038/539141a; HOLDEN C, 1989, SCIENCE, V246, P754, DOI 10.1126/science.2814497; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; New TR, 1999, EUR J ENTOMOL, V96, P11; Noss RF, 1996, CONSERV BIOL, V10, P1, DOI 10.1046/j.1523-1739.1996.10010001.x; Weidemann G., 1977, VERH GES OK, V1976, P59	7	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1130	1130		10.1126/science.aan3832	http://dx.doi.org/10.1126/science.aan3832			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619905				2022-12-28	WOS:000403327400020
J	Hoeksma, J				Hoeksma, Jon			NHS cyberattack may prove to be a valuable wake up call	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jon@digitalhealth.net						Banerjee A, 2017, SPECIAL MEASURES CAU; Hawkes N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2464; Martin G, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2375	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2818	10.1136/bmj.j2818	http://dx.doi.org/10.1136/bmj.j2818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28620122				2022-12-28	WOS:000403753800009
J	Campbell, MK; Weijer, C; Goldstein, CE; Edwards, SJL				Campbell, Marion K.; Weijer, Charles; Goldstein, Cory E.; Edwards, Sarah J. L.			Do doctors have a duty to take part in pragmatic randomised trials?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Campbell, Marion K.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Weijer, Charles; Goldstein, Cory E.] Western Univ, Rotman Inst Philosophy, London, ON, Canada; [Edwards, Sarah J. L.] UCL, London, England	University of Aberdeen; Western University (University of Western Ontario); University of London; University College London	Campbell, MK (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland.; Weijer, C (corresponding author), Western Univ, Rotman Inst Philosophy, London, ON, Canada.	m.k.campbell@abdn.ac.uk; cweijer@uwo.ca	Weijer, Charles/ABC-5433-2020; Campbell, Marion/ABB-7063-2020	Weijer, Charles/0000-0002-5510-1074; Campbell, Marion/0000-0001-5386-4097; Goldstein, Cory E./0000-0002-0229-5039	Chief Scientist Office [HSRU1] Funding Source: researchfish	Chief Scientist Office		Cullati S, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0151-1; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Gelinas L, 2016, HASTINGS CENT REP, V46, P35, DOI 10.1002/hast.548; Harris J, 2005, J MED ETHICS, V31, P242, DOI 10.1136/jme.2005.011973; Haugen AS, 2015, ANN SURG, V261, P821, DOI 10.1097/SLA.0000000000000716; Hutton JL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-52; McCann S, 2013, J HEALTH SERV RES PO, V18, P233, DOI 10.1177/1355819613483126; Nayak RK, 2015, ANN INTERN MED, V163, P356, DOI 10.7326/M15-0817; Ross S, 1999, J CLIN EPIDEMIOL, V52, P1143, DOI 10.1016/S0895-4356(99)00141-9; Schaefer GO, 2009, JAMA-J AM MED ASSOC, V302, P67, DOI 10.1001/jama.2009.931; Sibbald B, 1998, BRIT MED J, V316, P201; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; United Nations, 1976, INTERNATIONAL COVENA	14	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2017	357								j2817	10.1136/bmj.j2817	http://dx.doi.org/10.1136/bmj.j2817			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UT	28615179	Green Published, Green Submitted			2022-12-28	WOS:000403753400003
J	Horton, R				Horton, Richard			Offline: Sweden seeks a renaissance in global health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2272	2272		10.1016/S0140-6736(17)31583-0	http://dx.doi.org/10.1016/S0140-6736(17)31583-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28612737				2022-12-28	WOS:000402872700009
J	Zarocostas, J				Zarocostas, John			Cholera outbreak in Haiti-from 2010 to today	LANCET			English	Editorial Material																			0	12	12	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2274	2275		10.1016/S0140-6736(17)31581-7	http://dx.doi.org/10.1016/S0140-6736(17)31581-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28612739				2022-12-28	WOS:000402872700011
J	Doppelt, MC				Doppelt, Martin C.			Ancient Brews: Rediscovered and Re-Created	SCIENCE			English	Book Review									[Doppelt, Martin C.] Univ Chicago, Dept Anthropol, Chicago, IL 60637 USA	University of Chicago	Doppelt, MC (corresponding author), Univ Chicago, Dept Anthropol, Chicago, IL 60637 USA.	mdoppelt@uchicago.edu						McGovern P.E., 2017, ANCIENT BREWS REDISC	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1004	1005		10.1126/science.aan3690	http://dx.doi.org/10.1126/science.aan3690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9XC	28596324				2022-12-28	WOS:000402871700020
J	Vesper, I				Vesper, Inga			POLICY Romanian science reforms spur boycott	NATURE			English	News Item																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					197	197		10.1038/546197a	http://dx.doi.org/10.1038/546197a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593978	Bronze			2022-12-28	WOS:000402823400008
J	Foucar, CE; Stein, BL				Foucar, Charles Elliott; Stein, Brady Lee			JAK2 V617F Mutation Testing in Patients Presenting With Hepatic and Portal Vein Thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA		[Foucar, Charles Elliott] Northwestern Univ, Feinberg Sch Med, Dept Internal Med, Chicago, IL 60611 USA; [Stein, Brady Lee] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, 645 N Michigan Ave,Ste 1020, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Stein, BL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, 645 N Michigan Ave,Ste 1020, Chicago, IL 60611 USA.	bstein@nmff.org						[Anonymous], 2015, HARRISONS PRINCIPLES; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bench AJ, 2013, BRIT J HAEMATOL, V160, P25, DOI 10.1111/bjh.12075; Busque L, 2016, AM J CLIN PATHOL, V146, P408, DOI [10.1093/ajcp/aqw131, 10.1093/AJCP/AQW131]; Cankovic M, 2009, AM J CLIN PATHOL, V132, P713, DOI 10.1309/AJCPFHUQZ9AGUEKA; Centers for Medicare & Medicaid Services, PHYS FEE SCHED; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Middeldorp S, 2008, BRIT J HAEMATOL, V143, P321, DOI 10.1111/j.1365-2141.2008.07339.x; Pardanani A, 2007, LEUKEMIA, V21, P1960, DOI 10.1038/sj.leu.2404810; Smalberg JH, 2012, BLOOD, V120, P4921, DOI 10.1182/blood-2011-09-376517	10	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2228	2229		10.1001/jama.2017.2329	http://dx.doi.org/10.1001/jama.2017.2329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586872				2022-12-28	WOS:000402706100019
J	Rutter, H; Savona, N; Glonti, K; Bibby, J; Cummins, S; Finegood, DT; Greaves, F; Harper, L; Hawe, P; Moore, L; Petticrew, M; Rehfuess, E; Shiell, A; Thomas, J; White, M				Rutter, Harry; Savona, Natalie; Glonti, Ketevan; Bibby, Jo; Cummins, Steven; Finegood, Diane T.; Greaves, Felix; Harper, Laura; Hawe, Penelope; Moore, Laurence; Petticrew, Mark; Rehfuess, Eva; Shiell, Alan; Thomas, James; White, Martin			The need for a complex systems model of evidence for public health	LANCET			English	Editorial Material							INTERVENTIONS; POLICY		[Rutter, Harry; Savona, Natalie; Glonti, Ketevan; Cummins, Steven; Petticrew, Mark] London Sch Hyg & Trop Med, London WC1H 9SH, England; [Bibby, Jo; Harper, Laura] Hlth Fdn, London, England; [Finegood, Diane T.] Simon Fraser Univ, Vancouver, BC, Canada; [Greaves, Felix] Publ Hlth England, London, England; [Hawe, Penelope] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Hawe, Penelope] Univ Sydney, Australian Prevent Partnership Ctr, Sydney, NSW, Australia; [Moore, Laurence] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Rehfuess, Eva] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Pettenkofer Sch Publ Hlth, Munich, Germany; [Shiell, Alan] La Trobe Univ, Australian Prevent Partnership Ctr, Melbourne, Vic, Australia; [Shiell, Alan] La Trobe Univ, Dept Publ Hlth, Melbourne, Vic, Australia; [Thomas, James] UCL, EPPI Ctr, London, England; [White, Martin] Univ Cambridge, Ctr Diet & Act Res, Epidemiol Unit, MRC, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine; Simon Fraser University; Public Health England; University of Sydney; University of Sydney; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Munich; La Trobe University; La Trobe University; University of London; University College London; UCL Institute of Education; University of Cambridge	Rutter, H (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	harry.rutter@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021; Rutter, Harry/HCI-8765-2022; Greaves, Felix/AAL-5891-2021; Rehfuess, Eva Annette/ABD-8167-2021; Greaves, Felix/A-1324-2012; Cummins, Steven/C-1230-2009; Shiell, Alan/AAL-4146-2020; Savona, Natalie/ABB-2397-2021	Greaves, Felix/0000-0001-9393-3122; Greaves, Felix/0000-0001-9393-3122; Cummins, Steven/0000-0002-3957-4357; Shiell, Alan/0000-0001-5914-1084; Savona, Natalie/0000-0002-3006-3681; White, Martin/0000-0002-1861-6757; Rutter, Harry/0000-0002-9322-0656; Moore, Laurence/0000-0003-2182-823X; Thomas, James/0000-0003-4805-4190	Health Foundation (London, UK); UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; UK Medical Research Council [MC_UU_12017/14]; Chief Scientist Office [SPHSU14]; UK NIHR; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12017/14, MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MC_UU_12017/14] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10019] Funding Source: researchfish	Health Foundation (London, UK); UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; UK NIHR(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a grant from The Health Foundation (London, UK) that supported HR, KG, and NS. HR was also supported by the UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. LM is supported by the UK Medical Research Council (MC_UU_12017/14) and the Chief Scientist Office (SPHSU14). MW is funded in part by the UK NIHR as Director of its Public Health Research Programme. The views expressed are those of the authors, and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health.	Adams J, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001990, 10.1371/journal.pmed.1002045]; Anderson LM, 2013, J CLIN EPIDEMIOL, V66, P1223, DOI 10.1016/j.jclinepi.2013.06.014; Batty M., 2013, NEW SCI CITIES; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Carey G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009002; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Dunning T., 2012, NATURAL EXPT SOCIAL; Finegood DT., 2011, HDB SOCIAL SCI OBESI, P208, DOI DOI 10.1093/OXFORDHB/9780199736362.013.0013; Fink DS., 2017, SYSTEMS SCI POPULATI, P25; Gerhardus A, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0112-5; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Hunter D., 2009, LEARNING LESSONS SHA; Lee BY, 2017, NUTR REV, V75, P94, DOI 10.1093/nutrit/nuw049; Maedows D, 1999, LEVERAGE POINTS PLAC; Marshall B.D., 2017, SYSTEMS SCI POPULATI, P87; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Parkhurst JO, 2016, SOC EPISTEMOL, V30, P665, DOI 10.1080/02691728.2016.1172365; Pearl J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1203; Petticrew M, 2004, J EPIDEMIOL COMMUN H, V58, P811, DOI 10.1136/jech.2003.015289; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1230, DOI 10.1016/j.jclinepi.2013.06.005; Petticrew M, 2013, EVID POLICY, V9, P87, DOI 10.1332/174426413X663742; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Rose G., 1992, STRATEGY PREVENTIVE; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X; The Academy of Medical Sciences, 2016, IMPR HLTH PUBL 2040; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P355, DOI 10.1016/0149-7189(89)90052-9; White M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002080; Whitty CJM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0544-8; Wutzke S, 2016, PUBLIC HEALTH RES PR, V26, DOI 10.17061/phrp2631632	34	438	439	7	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2602	2604		10.1016/S0140-6736(17)31267-9	http://dx.doi.org/10.1016/S0140-6736(17)31267-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	28622953	Green Submitted, Green Accepted			2022-12-28	WOS:000417493300029
J	Robson, M; Im, SA; Senkus, E; Xu, BH; Domchek, SM; Masuda, N; Delaloge, S; Li, W; Tung, N; Armstrong, A; Wu, WT; Goessl, C; Runswick, S; Conte, P				Robson, Mark; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Delaloge, Suzette; Li, Wei; Tung, Nadine; Armstrong, Anne; Wu, Wenting; Goessl, Carsten; Runswick, Sarah; Conte, Pierfranco			Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL CONSENSUS GUIDELINES; ABC 3; CARRIERS; PHASE-2; SCORES; TRIAL	BACKGROUND Olaparib is an oral poly(adenosine diphosphate-ribose) polymerase inhibitor that has promising antitumor activity in patients with metastatic breast cancer and a germline BRCA mutation. METHODS We conducted a randomized, open-label, phase 3 trial in which olaparib monotherapy was compared with standard therapy in patients with a germline BRCA mutation and human epidermal growth factor receptor type 2 (HER2)-negative metastatic breast cancer who had received no more than two previous chemotherapy regimens for metastatic disease. Patients were randomly assigned, in a 2: 1 ratio, to receive olaparib tablets (300 mg twice daily) or standard therapy with single-agent chemotherapy of the physician's choice (capecitabine, eribulin, or vinorelbine in 21-day cycles). The primary end point was progression-free survival, which was assessed by blinded independent central review and was analyzed on an intention-to-treat basis. RESULTS Of the 302 patients who underwent randomization, 205 were assigned to receive olaparib and 97 were assigned to receive standard therapy. Median progression-free survival was significantly longer in the olaparib group than in the standardtherapy group (7.0 months vs. 4.2 months; hazard ratio for disease progression or death, 0.58; 95% confidence interval, 0.43 to 0.80; P<0.001). The response rate was 59.9% in the olaparib group and 28.8% in the standard-therapy group. The rate of grade 3 or higher adverse events was 36.6% in the olaparib group and 50.5% in the standard-therapy group, and the rate of treatment discontinuation due to toxic effects was 4.9% and 7.7%, respectively. CONCLUSIONS Among patients with HER2-negative metastatic breast cancer and a germline BRCA mutation, olaparib monotherapy provided a significant benefit over standard therapy; median progression-free survival was 2.8 months longer and the risk of disease progression or death was 42% lower with olaparib monotherapy than with standard therapy. (Funded by AstraZeneca; OlympiAD ClinicalTrials.gov number, NCT02000622.)	[Robson, Mark] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA; [Im, Seock-Ah] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea; [Senkus, Elzbieta] Med Univ Gdansk, Gdansk, Poland; [Xu, Binghe] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China; [Xu, Binghe] Peking Union Med Coll, Beijing, Peoples R China; [Li, Wei] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China; [Domchek, Susan M.] Univ Penn, Basser Ctr, Philadelphia, PA 19104 USA; [Masuda, Norikazu] Natl Hosp Org, Osaka Natl Hosp, Osaka, Japan; [Delaloge, Suzette] Inst Gustave Roussy, Villejuif, France; [Tung, Nadine] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Armstrong, Anne] Univ Manchester, Christie Hosp NHS Fdn Trust, Manchester, Lancs, England; [Armstrong, Anne] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Wu, Wenting; Goessl, Carsten; Runswick, Sarah] Astra Zeneca, Macclesfield, Cheshire, England; [Conte, Pierfranco] Univ Padua, Padua, Italy; [Conte, Pierfranco] Ist Ricovero & Cura Carattere Sci, Ist Oncol Veneto, Padua, Italy	Memorial Sloan Kettering Cancer Center; Seoul National University (SNU); Seoul National University Hospital; Fahrenheit Universities; Medical University Gdansk; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jilin University; University of Pennsylvania; Osaka National Hospital; UNICANCER; Gustave Roussy; Harvard University; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Manchester; AstraZeneca; University of Padua; IRCCS Istituto Oncologico Veneto (IOV)	Robson, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	robsonm@mskcc.org	MASUDA, NORIKAZU/AAM-2417-2021; CONTE, PIERFRANCO/F-7418-2014	MASUDA, NORIKAZU/0000-0002-7302-0278; CONTE, PIERFRANCO/0000-0002-5210-5344; Armstrong, Anne/0000-0002-0774-7006; Senkus, Elzbieta/0000-0001-6855-397X	AstraZeneca	AstraZeneca(AstraZeneca)	Funded by AstraZeneca; OlympiAD ClinicalTrials.gov number, NCT02000622.	Anders Carey K, 2016, Am Soc Clin Oncol Educ Book, V35, P34, DOI 10.14694/EDBK_159135; Antoniou AC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3121; Cardoso F, 2017, ANN ONCOL, V28, P16, DOI 10.1093/annonc/mdw544; Cardoso F, 2017, BREAST, V31, P244, DOI 10.1016/j.breast.2016.10.001; Cocks K, 2012, EUR J CANCER, V48, P1713, DOI 10.1016/j.ejca.2012.02.059; Couch FJ, 2015, J CLIN ONCOL, V33, P304, DOI 10.1200/JCO.2014.57.1414; de Bono J, 2017, CANCER DISCOV, V7, P620, DOI 10.1158/2159-8290.CD-16-1250; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Han HS, 2016, 39 ANN SAN ANT BREAS; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kurian AW, 2009, CANCER EPIDEM BIOMAR, V18, P1084, DOI 10.1158/1055-9965.EPI-08-1090; Ledermann JA, 2016, LANCET ONCOL, V17, P1579, DOI 10.1016/S1470-2045(16)30376-X; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; NCCN (National Comprehensive Cancer Network), 2016, CLIN PRACT GUID ONC; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; Pujade-Lauraine E, 2017, SOC GYN ONC 48 ANN M; Tutt A, 2014, 37 ANN SAN ANT BREAS; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; van den Broek AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120189; Walsh CS, 2015, GYNECOL ONCOL, V137, P343, DOI 10.1016/j.ygyno.2015.02.017	24	1492	1546	2	148	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					523	533		10.1056/NEJMoa1706450	http://dx.doi.org/10.1056/NEJMoa1706450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0EM	28578601	Green Published, Bronze			2022-12-28	WOS:000407212600005
J	Sommers, BD; Gawande, AA; Baicker, K				Sommers, Benjamin D.; Gawande, Atul A.; Baicker, Katherine			Health Insurance Coverage and Health - What the Recent Evidence Tells Us	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AFFORDABLE CARE ACT; EMERGENCY-DEPARTMENT USE; 1ST 2 YEARS; OREGON HEALTH; MEDICAID EXPANSION; CANCER STAGE; YOUNG-ADULTS; MORTALITY; ACCESS; IMPACT		[Sommers, Benjamin D.; Gawande, Atul A.; Baicker, Katherine] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Sommers, Benjamin D.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Gawande, Atul A.] Harvard Med Sch, Dept Surg, Boston, MA USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Sommers, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Sommers, BD (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Allen H, 2010, HEALTH AFFAIR, V29, P1498, DOI 10.1377/hlthaff.2010.0191; American Cancer Society, 2016, CANC TREATM SURV FAC; Antwi YA, 2015, ANN EMERG MED, V65, P664, DOI 10.1016/j.annemergmed.2015.01.010; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Cannon MF., 2013, OREGON STUDY THROWS; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Chua KP, 2014, JAMA-J AM MED ASSOC, V311, P2437, DOI 10.1001/jama.2014.2202; Cole MB, 2017, HEALTH AFFAIR, V36, P40, DOI 10.1377/hlthaff.2016.0804; Collins SR., 2021, PANDEMIC EASES WHAT; Courtemanche C, 2017, EARLY EFFECTS AFFORD; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Epstein AM, 2014, HEALTH AFFAIR, V33, P2041, DOI 10.1377/hlthaff.2014.0747; Finkelstein A, 2008, J PUBLIC ECON, V92, P1644, DOI 10.1016/j.jpubeco.2007.10.005; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Garthwaite C, 2017, NEW ENGL J MED, V376, P907, DOI 10.1056/NEJMp1614545; Gawande A., NEW YORKER; Ghosh A, 2017, EFFECT STATE MEDICAI; Hu L., 2016, EFFECT PATIENT PROTE; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Kaufman HW, 2015, DIABETES CARE, V38, P833, DOI 10.2337/dc14-2334; Keating NL, 2013, CANCER-AM CANCER SOC, V119, P250, DOI 10.1002/cncr.27757; Krieger N., 2013, EPIDEMIOLOGY PEOPLES; Kronick R, 2009, HEALTH SERV RES, V44, P1211, DOI 10.1111/j.1475-6773.2009.00973.x; Loehrer AP, 2016, J CLIN ONCOL, V34, P4110, DOI 10.1200/JCO.2016.68.5701; Mazumder B, 2016, AM ECON J-ECON POLIC, V8, P284, DOI 10.1257/pol.20150045; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; McWilliams JM, 2009, MILBANK Q, V87, P443, DOI 10.1111/j.1468-0009.2009.00564.x; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Miller S, 2017, NEW ENGL J MED, V376, P947, DOI 10.1056/NEJMsa1612890; Miller S, 2012, J PUBLIC ECON, V96, P893, DOI 10.1016/j.jpubeco.2012.07.004; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Robbins AS, 2015, JAMA-J AM MED ASSOC, V314, P2189, DOI 10.1001/jama.2015.10546; Robinson LA, 2007, REV ENV ECON POLICY, V1, P283, DOI 10.1093/reep/rem018; Roy A., 2014, ROMNEYCARE IMPROVED; Schlesinger R, 2017, US NEWS WORLD REPORT; Scott JW, 2016, MED CARE, V54, P818, DOI 10.1097/MLR.0000000000000586; Shartzer A, 2016, HEALTH AFFAIR, V35, P161, DOI 10.1377/hlthaff.2015.0755; Simon K, 2017, J POLICY ANAL MANAG, V36, P390, DOI 10.1002/pam.21972; Sommers BD., 2017, AM J HLTH EC; Sommers BD, 2017, HEALTH AFFAIR, V36, P1119, DOI 10.1377/hlthaff.2017.0293; Sommers BD, 2017, NEW ENGL J MED, V376, P1708, DOI 10.1056/NEJMp1614378; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Sommers BD, 2015, HEALTH AFFAIR, V34, P1010, DOI 10.1377/hlthaff.2015.0215; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; Torres H, 2017, ANN INTERN MED, V166, P472, DOI [10.7326/M16-1256, 10.7326/m16-1256]; Van der Wees PJ, 2013, MILBANK Q, V91, P663, DOI 10.1111/1468-0009.12029; Watson K., 2017, CBS NEWS; Wherry LR, 2016, ANN INTERN MED, V164, P795, DOI 10.7326/M15-2234; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	53	236	236	5	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2017	377	6					586	593		10.1056/NEJMsb1706645	http://dx.doi.org/10.1056/NEJMsb1706645			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD0EM	28636831				2022-12-28	WOS:000407212600014
J	Aaron, HJ; Fiedler, M; Ginsburg, PB; Adler, L; Rivlin, AM				Aaron, Henry J.; Fiedler, Matthew; Ginsburg, Paul B.; Adler, Loren; Rivlin, Alice M.			Turmoil in the Individual Insurance Market - Where It Came From and How to Fix It	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aaron, Henry J.; Fiedler, Matthew; Ginsburg, Paul B.; Adler, Loren; Rivlin, Alice M.] Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							[Anonymous], 2017, INS COMM ANN SIGNL D; [Anonymous], 2017, EST AV ACA MARK PREM; Fiedler M, 2017, NEW DATA SIGN UPS AC; Garthwaite C, 2017, NEW ENGL J MED, V376, P907, DOI 10.1056/NEJMp1614545	4	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					314	315		10.1056/NEJMp1707593	http://dx.doi.org/10.1056/NEJMp1707593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB7BB	28636481				2022-12-28	WOS:000406295000003
J	Kilpinen, H; Goncalves, A; Leha, A; Afzal, V; Alasoo, K; Ashford, S; Bala, S; Bensaddek, D; Casale, FP; Culley, OJ; Danecek, P; Faulconbridge, A; Harrison, PW; Kathuria, A; McCarthy, D; McCarthy, SA; Meleckyte, R; Memari, Y; Moens, N; Soares, F; Mann, A; Streeter, I; Agu, CA; Alderton, A; Nelson, R; Harper, S; Patel, M; White, A; Patel, SR; Clarke, L; Halai, R; Kirton, CM; Kolb-Kokocinski, A; Beales, P; Birney, E; Danovi, D; Lamond, AI; Ouwehand, WH; Vallier, L; Watt, FM; Durbin, R; Stegle, O; Gaffney, DJ				Kilpinen, Helena; Goncalves, Angela; Leha, Andreas; Afzal, Vackar; Alasoo, Kaur; Ashford, Sofie; Bala, Sendu; Bensaddek, Dalila; Casale, Francesco Paolo; Culley, Oliver J.; Danecek, Petr; Faulconbridge, Adam; Harrison, Peter W.; Kathuria, Annie; McCarthy, Davis; McCarthy, Shane A.; Meleckyte, Ruta; Memari, Yasin; Moens, Nathalie; Soares, Filipa; Mann, Alice; Streeter, Ian; Agu, Chukwuma A.; Alderton, Alex; Nelson, Rachel; Harper, Sarah; Patel, Minal; White, Alistair; Patel, Sharad R.; Clarke, Laura; Halai, Reena; Kirton, Christopher M.; Kolb-Kokocinski, Anja; Beales, Philip; Birney, Ewan; Danovi, Davide; Lamond, Angus I.; Ouwehand, Willem H.; Vallier, Ludovic; Watt, Fiona M.; Durbin, Richard; Stegle, Oliver; Gaffney, Daniel J.			Common genetic variation drives molecular heterogeneity in human iPSCs (vol 546, pg 370, 2017)	NATURE			English	Correction													Durbin, Richard/AAE-7178-2019; Beales, Philip L/C-7367-2009; Stegle, Oliver/AAU-9177-2020; Danovi, Davide/P-2874-2019; Watt, Fiona/AHB-0226-2022	Durbin, Richard/0000-0002-9130-1006; Stegle, Oliver/0000-0002-8818-7193; Danovi, Davide/0000-0003-4119-5337; Watt, Fiona/0000-0001-9151-5154; Kilpinen, Helena/0000-0001-6692-6154; Faulconbridge, Adam/0000-0002-4733-3270; McCarthy, Davis/0000-0002-2218-6833; Mann, Alice/0000-0003-2402-8545; Vallier, Ludovic/0000-0002-3848-2602; Harrison, Peter/0000-0002-4007-2899; Clarke, Laura/0000-0002-5989-6898; Gaffney, Daniel/0000-0002-1529-1862; Birney, Ewan/0000-0001-8314-8497	BBSRC [BB/M020991/1] Funding Source: UKRI; MRC [G0801843] Funding Source: UKRI; Medical Research Council [G0801843] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/M020991/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10151, NF-SI-0513-10008] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1296] Funding Source: researchfish; The British Council [216377911] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; The British Council		Kilpinen H, 2017, NATURE, V546, P370, DOI 10.1038/nature22403	1	8	8	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					686	686		10.1038/nature23012	http://dx.doi.org/10.1038/nature23012			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28614302	Bronze			2022-12-28	WOS:000404332000054
J	Malavelle, FF; Haywood, JM; Jones, A; Gettelman, A; Larisse, LC; Bauduin, S; Allan, RP; Karset, IHH; Kristjansson, JE; Oreopoulos, L; Ho, NYC; Lee, D; Bellouin, N; Boucher, O; Grosvenor, DP; Carslaw, KS; Dhomse, S; Mann, GW; Schmidt, A; Coe, H; Hartley, ME; Dalvi, M; Hill, AA; Johnson, BT; Johnson, CE; Knight, JR; O'Connor, FM; Partridge, DG; Stier, P; Myhre, G; Platnick, S; Stephens, GL; Takahashi, H; Thordarson, T				Malavelle, Florent F.; Haywood, Jim M.; Jones, Andy; Gettelman, Andrew; Larisse, Lieven C.; Bauduin, Sophie; Allan, Richard P.; Karset, Inger Helene H.; Kristjansson, Jon Egill; Oreopoulos, Lazaros; Ho, Nayeong C.; Lee, Dongmin; Bellouin, Nicolas; Boucher, Olivier; Grosvenor, Daniel P.; Carslaw, Ken S.; Dhomse, Sandip; Mann, Graham W.; Schmidt, Anja; Coe, Hugh; Hartley, Margaret E.; Dalvi, Mohit; Hill, Adrian A.; Johnson, Ben T.; Johnson, Colin E.; Knight, Jeff R.; O'Connor, Fiona M.; Partridge, Daniel G.; Stier, Philip; Myhre, Gunnar; Platnick, Steven; Stephens, Graeme L.; Takahashi, Hanii; Thordarson, Thorvaldur			Strong constraints on aerosol-cloud interactions from volcanic eruptions	NATURE			English	Article							PINATUBO ERUPTION; MOUNT KILAUEA; CLIMATE MODEL; A-TRAIN; PRECIPITATION; IMPACT; MICROPHYSICS; REGIMES; SYSTEM; ALBEDO	Aerosols have a potentially large effect on climate, particularly through their interactions with clouds, but the magnitude of this effect is highly uncertain. Large volcanic eruptions produce sulfur dioxide, which in turn produces aerosols; these eruptions thus represent a natural experiment through which to quantify aerosol-cloud interactions. Here we show that the massive 2014-2015 fissure eruption in Holuhraun, Iceland, reduced the size of liquid cloud droplets-consistent with expectations-but had no discernible effect on other cloud properties. The reduction in droplet size led to cloud brightening and global-mean radiative forcing of around -0.2 watts per square metre for September to October 2014. Changes in cloud amount or cloud liquid water path, however, were undetectable, indicating that these indirect effects, and cloud systems in general, are well buffered against aerosol changes. This result will reduce uncertainties in future climate projections, because we are now able to reject results from climate models with an excessive liquid-water-path response.	[Malavelle, Florent F.; Haywood, Jim M.; Partridge, Daniel G.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Haywood, Jim M.; Jones, Andy; Dalvi, Mohit; Hill, Adrian A.; Johnson, Ben T.; Johnson, Colin E.; Knight, Jeff R.; O'Connor, Fiona M.] Met Off Hadley Ctr, Exeter, Devon, England; [Gettelman, Andrew] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Larisse, Lieven C.; Bauduin, Sophie] Univ Libre Bruxelles, Chim Quant & Photophys CP160 09, Brussels, Belgium; [Allan, Richard P.; Bellouin, Nicolas] Univ Reading, Dept Meteorol, Reading, Berks, England; [Allan, Richard P.] Univ Reading, Natl Ctr Earth Observat, Reading, Berks, England; [Karset, Inger Helene H.; Kristjansson, Jon Egill] Univ Oslo, Dept Geosci, Oslo, Norway; [Oreopoulos, Lazaros; Ho, Nayeong C.; Lee, Dongmin; Platnick, Steven] NASA, GSFC, Div Earth Sci, Greenbelt, MD USA; [Ho, Nayeong C.] USRA, Columbia, MD USA; [Lee, Dongmin] Morgan State Univ, Baltimore, MD 21239 USA; [Boucher, Olivier] UPMC, CNRS, IPSL, Lab Meteorol Dynam, Jussieu, France; [Grosvenor, Daniel P.; Carslaw, Ken S.; Dhomse, Sandip; Mann, Graham W.; Schmidt, Anja] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Mann, Graham W.] Univ Leeds, Natl Ctr Atmospher Sci, Leeds, W Yorkshire, England; [Coe, Hugh; Hartley, Margaret E.] Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England; [Partridge, Daniel G.] Univ Stockholm, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Partridge, Daniel G.] Univ Stockholm, Bert Bolin Ctr Climate Res, Stockholm, Sweden; [Partridge, Daniel G.; Stier, Philip] Univ Oxford, Dept Phys, Atmospher Ocean & Planetary Phys, Oxford, England; [Myhre, Gunnar] Ctr Int Climate & Environm Res, Oslo, Norway; [Stephens, Graeme L.; Takahashi, Hanii] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Takahashi, Hanii] Univ Calif Los Angeles, Joint Inst Reg Earth Syst Sci & Engn, Los Angeles, CA USA; [Thordarson, Thorvaldur] Univ Iceland, Fac Earth Sci, Reykjavik, Iceland	University of Exeter; Met Office - UK; Hadley Centre; National Center Atmospheric Research (NCAR) - USA; Universite Libre de Bruxelles; University of Reading; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation; University of Reading; University of Oslo; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Morgan State University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Leeds; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Leeds; University of Manchester; Stockholm University; Stockholm University; University of Oxford; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; University of Iceland	Malavelle, FF (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England.	f.malavelle@exeter.ac.uk	Boucher, Olivier/J-5810-2012; Myhre, Gunnar/A-3598-2008; Dhomse, Sandip/AAM-1119-2021; Stier, Philip/B-2258-2008; Hartley, Margaret/HCI-4271-2022; Johnson, Ben/A-6563-2013; Gettelman, Andrew/AAY-2312-2021; Myhre, Gunnar/J-5483-2014; Allan, Richard/B-5782-2008; Oreopoulos, Lazaros/E-5868-2012; Platnick, Steven E/J-9982-2014; Schmidt, Anja/ABD-7113-2021; Thordarson, Thorvaldur/M-2422-2015; Carslaw, Ken S/C-8514-2009; Dhomse, Sandip/C-8198-2011; Haywood, Jim/GQA-6691-2022; Mann, Graham/L-9529-2017; Malavelle, Florent/K-6738-2017	Boucher, Olivier/0000-0003-2328-5769; Myhre, Gunnar/0000-0002-4309-476X; Stier, Philip/0000-0002-1191-0128; Hartley, Margaret/0000-0002-2698-8622; Myhre, Gunnar/0000-0002-4309-476X; Allan, Richard/0000-0003-0264-9447; Oreopoulos, Lazaros/0000-0001-6061-6905; Platnick, Steven E/0000-0003-3964-3567; Schmidt, Anja/0000-0001-8759-2843; Thordarson, Thorvaldur/0000-0003-4011-7185; Carslaw, Ken S/0000-0002-6800-154X; Dhomse, Sandip/0000-0003-3854-5383; Mann, Graham/0000-0003-1746-2837; Haywood, Jim/0000-0002-2143-6634; Grosvenor, Daniel/0000-0002-4919-7751; Coe, Hugh/0000-0002-3264-1713; Cho, Nayeong/0000-0001-6401-2391; O'Connor, Fiona/0000-0003-2893-4828; Malavelle, Florent/0000-0002-2754-9226	Joint UK BEIS/Defra Met Office Hadley Centre Climate Programme [GA01101]; US National Science Foundation; FRS-FNRS; European Research Council (ERC) project ACCLAIM [FP7-280025]; UK Natural Environment Research Council project ACID-PRUF [NE/I020148/1]; University of Leeds; NERC [NE/M021130/1]; NERC SMURPHS [NE/N006054/1]; National Centre for Atmospheric Science, one of the UK Natural Environment Research Council's research centres; School of Earth and Environment at the University of Leeds; EU from the ERC [283576, 633080]; Leeds-Met Office Academic Partnership (ASCI project); Research Council of Norway through the EVA [229771]; NOTUR [nn2345k]; NorStore [ns2345k]; NERC [NE/I020113/1, NE/I020148/1, NE/E017150/1, nceo020006, NE/N006038/1, NE/I015604/1, NE/N006054/1] Funding Source: UKRI; Natural Environment Research Council [NE/I020113/1, NE/I020148/1, NE/N006054/1, NE/N006038/1, NE/I015604/1, NE/E017150/1, nceo020006, NE/M021130/1] Funding Source: researchfish	Joint UK BEIS/Defra Met Office Hadley Centre Climate Programme; US National Science Foundation(National Science Foundation (NSF)); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); European Research Council (ERC) project ACCLAIM(European Research Council (ERC)); UK Natural Environment Research Council project ACID-PRUF; University of Leeds; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC SMURPHS; National Centre for Atmospheric Science, one of the UK Natural Environment Research Council's research centres; School of Earth and Environment at the University of Leeds; EU from the ERC; Leeds-Met Office Academic Partnership (ASCI project); Research Council of Norway through the EVA(Research Council of Norway); NOTUR; NorStore; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J.M.H., A.J., M.D., B.T.J., C.E.J., J.R.K. and F.M.O.C. were supported by the Joint UK BEIS/Defra Met Office Hadley Centre Climate Programme (GA01101). The National Center for Atmospheric Research is sponsored by the US National Science Foundation. S.B. and L.C. are respectively Research Fellow and Research Associate funded by FRS-FNRS. P.S. acknowledges support from the European Research Council (ERC) project ACCLAIM (grant agreement FP7-280025). J.M.H., F.F.M., D.G.P. and P.S. were part-funded by the UK Natural Environment Research Council project ACID-PRUF (NE/I020148/1). A.S. was funded by an Academic Research Fellowship from the University of Leeds and NERC urgency grant NE/M021130/1 ('The source and longevity of sulphur in an Icelandic flood basalt eruption plume'). R.A. was supported by the NERC SMURPHS project NE/N006054/1. G.W.M. was funded by the National Centre for Atmospheric Science, one of the UK Natural Environment Research Council's research centres. D.P.G. is funded by the School of Earth and Environment at the University of Leeds. G.W.M. and S.D. acknowledge additional EU funding from the ERC under the FP7 consortium project MACC-II (grant agreement 283576) and Horizon 2020 project MACC-III (grant agreement 633080). G.W.M., K.S.C. and D.G. were also supported via the Leeds-Met Office Academic Partnership (ASCI project). The work done with CAM5-Oslo is supported by the Research Council of Norway through the EVA project (grant 229771), NOTUR project nn2345k and NorStore project ns2345k. We thank the following researchers who have contributed to the development version of CAM5-Oslo used in this study: K. Alterskjaer, A. Grini, M. Hummel, T. Iversen, A. Kirkevag, D. Olivie, M. Schulz and O. Seland. The AQUA/MODIS MYD08 L3 Global 1 Deg. data set was acquired from the Level- 1 and Atmosphere Archive and Distribution System (LAADS) Distributed Active Archive Center (DAAC), located in the Goddard Space Flight Center in Greenbelt, Maryland (https://ladsweb.nascom.nasa.gov/). This work is dedicated to the memory of co-author Jon Egill Kristjansson who died in a climbing accident in Norway.	Ackerman AS, 2004, NATURE, V432, P1014, DOI 10.1038/nature03174; Ackerman S., 2015 MODIS ATMOSPHER, DOI [10.5067/MODIS/MYD35_L2.006, DOI 10.5067/MODIS/MYD35_L2.006]; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Bellouin N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016074; Boucher O., 2013, CONTRIBUTION WORKING; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; Clarisse L, 2008, ATMOS CHEM PHYS, V8, P7723, DOI 10.5194/acp-8-7723-2008; Dhomse SS, 2014, ATMOS CHEM PHYS, V14, P11221, DOI 10.5194/acp-14-11221-2014; Eguchi K, 2011, SOLA, V7, P77, DOI 10.2151/sola.2011-020; Gasso S, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009106; Gettelman A, 2015, ATMOS CHEM PHYS, V15, P12397, DOI 10.5194/acp-15-12397-2015; Gettelman A, 2015, NAT GEOSCI, V8, P243, DOI 10.1038/ngeo2376; Ghan S, 2016, P NATL ACAD SCI USA, V113, P5804, DOI 10.1073/pnas.1514036113; Golaz JC, 2013, GEOPHYS RES LETT, V40, P2246, DOI 10.1002/grl.50232; Gryspeerdt E, 2016, J GEOPHYS RES-ATMOS, V121, P3566, DOI 10.1002/2015JD023744; Hamilton DS, 2014, P NATL ACAD SCI USA, V111, P18466, DOI 10.1073/pnas.1415440111; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; Haywood JM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014447; Haywood JM, 2014, ATMOS SCI LETT, V15, P92, DOI 10.1002/asl2.471; Kirkevag A, 2013, GEOSCI MODEL DEV, V6, P207, DOI 10.5194/gmd-6-207-2013; Lebo ZJ, 2014, ATMOS CHEM PHYS, V14, P11817, DOI 10.5194/acp-14-11817-2014; Lohmann U, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024625; Lohmann U, 2010, ATMOS CHEM PHYS, V10, P3235, DOI 10.5194/acp-10-3235-2010; Mace GG, 2016, GEOPHYS RES LETT, V43, P2981, DOI 10.1002/2016GL067830; Mauger GS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029952; MCCORMICK MP, 1995, NATURE, V373, P399, DOI 10.1038/373399a0; McCoy DT, 2015, GEOPHYS RES LETT, V42, P10409, DOI 10.1002/2015GL067070; Michibata T, 2016, ATMOS CHEM PHYS, V16, P15413, DOI 10.5194/acp-16-15413-2016; Myhre G. D., 2013, CLIMATE CHANGE 2013, DOI [10.1017/c bo9781107415324.018, DOI 10.1017/CBO9781107415324.018]; Oreopoulos L, 2016, J GEOPHYS RES-ATMOS, V121, P2299, DOI 10.1002/2015JD024502; Penner JE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051870; Penner JE, 2011, P NATL ACAD SCI USA, V108, P13404, DOI 10.1073/pnas.1018526108; Polashenski CM, 2015, GEOPHYS RES LETT, V42, P9319, DOI 10.1002/2015GL065912; Quaas J, 2009, ATMOS CHEM PHYS, V9, P8697, DOI 10.5194/acp-9-8697-2009; Sandu I, 2008, J ATMOS SCI, V65, P2705, DOI 10.1175/2008JAS2451.1; Schmidt A, 2012, ATMOS CHEM PHYS, V12, P7321, DOI 10.5194/acp-12-7321-2012; Schmidt A, 2010, ATMOS CHEM PHYS, V10, P6025, DOI 10.5194/acp-10-6025-2010; Schmidt A, 2015, J GEOPHYS RES-ATMOS, V120, P9739, DOI 10.1002/2015JD023638; Seifert A, 2012, ATMOS CHEM PHYS, V12, P709, DOI 10.5194/acp-12-709-2012; Seifert A, 2015, J ADV MODEL EARTH SY, V7, P1918, DOI 10.1002/2015MS000489; Stevens B, 2009, CLOUDS PERTURBED CLI, V2; Stevens B, 2015, J CLIMATE, V28, P4794, DOI 10.1175/JCLI-D-14-00656.1; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Thordarson T, 2003, GEOL SOC SPEC PUBL, V213, P103, DOI 10.1144/GSL.SP.2003.213.01.07; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; Yuan T, 2011, ATMOS CHEM PHYS, V11, P7119, DOI 10.5194/acp-11-7119-2011; Zhang SP, 2016, ATMOS CHEM PHYS, V16, P2765, DOI 10.5194/acp-16-2765-2016; Zhang ZB, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016216; Zhou C, 2017, ATMOS CHEM PHYS, V17, P21, DOI 10.5194/acp-17-21-2017	49	137	138	10	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					485	491		10.1038/nature22974	http://dx.doi.org/10.1038/nature22974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640263	Green Accepted, Green Submitted			2022-12-28	WOS:000403814100030
J	Friedrich, MJ				Friedrich, M. J.			Blood-Clotting Drug Saves Lives During Childbirth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2362	2362		10.1001/jama.2017.7314	http://dx.doi.org/10.1001/jama.2017.7314			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MT	28632877				2022-12-28	WOS:000426799500002
J	Hwang, JY; Chung, JJ				Hwang, Jae Yeon; Chung, Jean-Ju			Sex at Atomic Resolution	CELL			English	Editorial Material							VITELLINE ENVELOPE RECEPTOR; SPERM LYSIN; PROTEIN; FERTILIZATION; MECHANISM	Interspecies fertilization is rare, partly due to species separation enforced at the molecular level. In this issue, Raj et al. now reveal the crystal structures of mollusk egg coat protein, VERL, complexed with cognate sperm protein lysin. Given that VERL is structurally similar to mammalian ZP2, the mechanism elucidating species-specific gamete recognition likely exists in mammals.	[Hwang, Jae Yeon; Chung, Jean-Ju] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Chung, Jean-Ju] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA	Yale University; Yale University	Chung, JJ (corresponding author), Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.; Chung, JJ (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.	jean-ju.chung@yale.edu		Chung, Jean-Ju/0000-0001-8018-1355; Hwang, Jae Yeon/0000-0002-6493-4182				Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Galindo BE, 2002, GENE, V288, P111, DOI 10.1016/S0378-1119(02)00459-6; LEWIS CA, 1982, DEV BIOL, V92, P227, DOI 10.1016/0012-1606(82)90167-1; Lillie FR, 1914, J EXP ZOOL, V16, P523, DOI 10.1002/jez.1400160404; Raj I, 2017, CELL, V169, P1315, DOI 10.1016/j.cell.2017.05.033; SHAW A, 1993, SCIENCE, V262, P1864, DOI 10.1126/science.8266073; Swanson WJ, 1997, P NATL ACAD SCI USA, V94, P6724, DOI 10.1073/pnas.94.13.6724; VACQUIER VD, 1990, P NATL ACAD SCI USA, V87, P5792, DOI 10.1073/pnas.87.15.5792	9	0	0	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1174	1176		10.1016/j.cell.2017.05.043	http://dx.doi.org/10.1016/j.cell.2017.05.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622504	Bronze			2022-12-28	WOS:000403332400007
J	Donohue, MC; Sperling, RA; Petersen, R; Sun, CK; Weiner, MW; Aisen, PS				Donohue, Michael C.; Sperling, Reisa A.; Petersen, Ronald; Sun, Chung-Kai; Weiner, Michael W.; Aisen, Paul S.		Alzheimer's Dis Neuroimaging	Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; DEMENTIA	IMPORTANCE Among cognitively normal individuals, elevated brain amyloid (defined by cerebrospinal fluid assays or positron emission tomography regional summaries) can be related to risk for later Alzheimer-related cognitive decline. OBJECTIVE To characterize and quantify the risk for Alzheimer-related cognitive decline among cognitively normal individuals with elevated brain amyloid. DESIGN, SETTING, AND PARTICIPANTS Exploratory analyses were conducted with longitudinal cognitive and biomarker data from 445 cognitively normal individuals in the United States and Canada. Participants were observed from August 23, 2005, to June 7, 2016, for a median of 3.1 years (interquartile range, 2.0-4.2 years; maximum follow-up, 10.3 years) as part of the Alzheimer's Disease Neuroimaging Initiative (ADNI). EXPOSURES Individuals were classified at baseline as having normal (n=243) or elevated (n=202) brain amyloid using positron emission tomography amyloid imaging or a cerebrospinal fluid assay of amyloid beta. MAIN OUTCOMES AND MEASURES Outcomes included scores on the Preclinical Alzheimer Cognitive Composite (PACC; a sum of 4 baseline standardized Z scores, which decreases with worse performance), Mini-Mental State Examination (MMSE; 0 [worst] to 30 [best] points), Clinical Dementia Rating Sum of Boxes (CDR-Sum of Boxes; 0 [best] to 18 [worst] points), and Logical Memory Delayed Recall (0 [worst] to 25 [best] story units). RESULTS Among the 445 participants (243 with normal amyloid, 202 with elevated amyloid), mean (SD) age was 74.0 (5.9) years, mean education was 16.4 (2.7) years, and 52% were women. The mean score for PACC at baseline was 0.00 (2.60); for MMSE, 29.0 (1.2); for CDR-Sum of Boxes, 0.04 (0.14); and for Logical Memory Delayed Recall, 13.1 (3.3). Compared with the group with normal amyloid, those with elevated amyloid had worse mean scores at 4 years on the PACC (mean difference, 1.51 points [95% CI, 0.94-2.10]; P<.001), MMSE (mean difference, 0.56 points [95% CI, 0.32-0.80]; P<.001), and CDR-Sum of Boxes (mean difference, 0.23 points [95% CI, 0.08-0.38]; P=.002). For Logical Memory Delayed Recall, between-group score was not statistically significant at 4 years (mean difference, 0.73 story units [95% CI, -0.02 to 1.48]; P=.056). CONCLUSIONS AND RELEVANCE Exploratory analyses of a cognitively normal cohort followed up for a median of 3.1 years suggest that elevation in baseline brain amyloid level, compared with normal brain amyloid level, was associated with higher likelihood of cognitive decline, although the findings are of uncertain clinical significance. Further research is needed to assess the clinical importance of these differences and measure longer-term associations.	[Donohue, Michael C.; Sun, Chung-Kai; Aisen, Paul S.] Univ Southern Calif, Dept Neurol, Alzheimers Therapeut Res Inst, 9860 Mesa Rim Rd, San Diego, CA 92121 USA; [Sperling, Reisa A.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Alzheimer Res & Treatment, Boston, MA USA; [Sperling, Reisa A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; [Sperling, Reisa A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Petersen, Ronald] Mayo Clin, Dept Neurol, Rochester, MN USA; [Weiner, Michael W.] Univ Calif San Francisco, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94143 USA; [Weiner, Michael W.] San Francisco VA Med Ctr, San Francisco, CA USA	University of Southern California; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Mayo Clinic; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Donohue, MC (corresponding author), Univ Southern Calif, Dept Neurol, Alzheimers Therapeut Res Inst, 9860 Mesa Rim Rd, San Diego, CA 92121 USA.	mdonohue@usc.edu			Biomarkers Across Neurodegenerative Disease grant from the Alzheimer's Association [BAND-14-338179]; Michael J. Fox Foundation; Weston Brain Institute; Weston Brain Institute, ADNI; NIH [U01 AG024904]; DOD [W81XWH-12-2-0012]; NIA; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica; Biogen; Bristol-Myers Squibb; CereSpir; Eisai; Elan Pharmaceuticals; Eli Lilly; EuroImmun; F. Hoffmann-La Roche; Genentech; Fujirebio; GE Healthcare; IXICO; Janssen Alzheimer Immunotherapy Research Development; Johnson & Johnson Pharmaceutical Research Development; Lumosity; Lundbeck; Merck; Meso Scale Diagnostics; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals; Pfizer; Piramal Imaging; Servier; Takeda; Transition Therapeutics; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904, R01AG049750, K24AG035007, U19AG010483] Funding Source: NIH RePORTER	Biomarkers Across Neurodegenerative Disease grant from the Alzheimer's Association; Michael J. Fox Foundation; Weston Brain Institute; Weston Brain Institute, ADNI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica; Biogen(Biogen); Bristol-Myers Squibb(Bristol-Myers Squibb); CereSpir; Eisai(Eisai Co Ltd); Elan Pharmaceuticals; Eli Lilly(Eli Lilly); EuroImmun; F. Hoffmann-La Roche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO; Janssen Alzheimer Immunotherapy Research Development; Johnson & Johnson Pharmaceutical Research Development(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck(Merck & Company); Meso Scale Diagnostics; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals(Novartis); Pfizer(Pfizer); Piramal Imaging; Servier(Servier); Takeda(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Biomarkers Across Neurodegenerative Disease (BAND-14-338179) grant from the Alzheimer's Association, Michael J. Fox Foundation, Weston Brain Institute, ADNI, NIH (U01 AG024904), DOD (W81XWH-12-2-0012), NIA, the National Institute of Biomedical Imaging and Bioengineering, AbbVie, Alzheimer's Drug Discovery Foundation, Araclon Biotech, BioClinica, Biogen, Bristol-Myers Squibb, CereSpir, Eisai, Elan Pharmaceuticals, Eli Lilly, EuroImmun, F. Hoffmann-La Roche, Genentech, Fujirebio, GE Healthcare, IXICO, Janssen Alzheimer Immunotherapy Research & Development, Johnson & Johnson Pharmaceutical Research & Development, Lumosity, Lundbeck, Merck, Meso Scale Diagnostics, NeuroRx Research, Neurotrack Technologies, Novartis Pharmaceuticals, Pfizer, Piramal Imaging, Servier, Takeda, Transition Therapeutics, and the Canadian Institutes of Health Research.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DAVIES L, 1988, NEUROLOGY, V38, P1688, DOI 10.1212/WNL.38.11.1688; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Insel PS, 2016, NEUROBIOL AGING, V48, P172, DOI 10.1016/j.neurobiolaging.2016.08.017; Jack CR, 2016, LANCET NEUROL, V15, P56, DOI 10.1016/S1474-4422(15)00323-3; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kozauer N, 2013, NEW ENGL J MED, V368, P1169, DOI 10.1056/NEJMp1302513; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Mormino EC, 2014, NEUROLOGY, V82, P1760, DOI 10.1212/WNL.0000000000000431; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Reitan RM., 1993, HALSTEAD REITAN NEUR, V2nd ed.; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wechsler D., 1984, WMS R WECHSLER MEMOR; Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P865, DOI 10.1016/j.jalz.2015.04.005; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300	28	220	221	4	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2305	2316		10.1001/jama.2017.6669	http://dx.doi.org/10.1001/jama.2017.6669			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609533	Green Accepted, Bronze			2022-12-28	WOS:000403149900017
J	Powers, JM; Buchanan, GR; Adix, L; Zhang, S; Gao, A; McCavit, TL				Powers, Jacquelyn M.; Buchanan, George R.; Adix, Leah; Zhang, Song; Gao, Ang; McCavit, Timothy L.			Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ABSORPTION; MANAGEMENT; INFANTS; PREVALENCE; THERAPY	IMPORTANCE Iron-deficiency anemia (IDA) affects millions of persons worldwide, and is associated with impaired neurodevelopment in infants and children. Ferrous sulfate is the most commonly prescribed oral iron despite iron polysaccharide complex possibly being better tolerated. OBJECTIVE To compare the effect of ferrous sulfate with iron polysaccharide complex on hemoglobin concentration in infants and children with nutritional IDA. DESIGN, SETTING, AND PARTICIPANTS Double-blind, superiority randomized clinical trial of infants and children aged 9 to 48 months with nutritional IDA (assessed by history and laboratory criteria) that was conducted in an outpatient hematology clinic at a US tertiary care hospital from September 2013 through November 2015; 12-week follow-up ended in January 2016. INTERVENTIONS Three mg/kg of elemental iron once daily as either ferrous sulfate drops or iron polysaccharide complex drops for 12 weeks. MAIN OUTCOMES AND MEASURES Primary outcome was change in hemoglobin over 12 weeks. Secondary outcomes included complete resolution of IDA (defined as hemoglobin concentration >11 g/dL, mean corpuscular volume >70 fL, reticulocyte hemoglobin equivalent >25 pg, serum ferritin level >15 ng/mL, and total iron-binding capacity <425 mu g/dL at the 12-week visit), changes in serum ferritin level and total iron-binding capacity, adverse effects. RESULTS Of 80 randomized infants and children (median age, 22 months; 55% male; 61% Hispanic white; 40 per group), 59 completed the trial (28 [70%] in ferrous sulfate group; 31 [78%] in iron polysaccharide complex group). From baseline to 12 weeks, mean hemoglobin increased from 7.9 to 11.9 g/dL (ferrous sulfate group) vs 7.7 to 11.1 g/dL (iron complex group), a greater difference of 1.0 g/dL (95% CI, 0.4 to 1.6 g/dL; P < .001) with ferrous sulfate (based on a linear mixed model). Proportion with a complete resolution of IDA was higher in the ferrous sulfate group (29% vs 6%; P=.04). Median serum ferritin level increased from 3.0 to 15.6 ng/mL (ferrous sulfate) vs 2.0 to 7.5 ng/mL (iron complex) over 12 weeks, a greater difference of 10.2 ng/mL (95% CI, 6.2 to 14.1 ng/mL; P<.001) with ferrous sulfate. Mean total iron-binding capacity decreased from 501 to 389 mu g/dL (ferrous sulfate) vs 506 to 417 mu g/dL (iron complex) (a greater difference of -50 mu g/dL [95% CI, -86 to -14 mu g/dL] with ferrous sulfate; P<.001). There were more reports of diarrhea in the iron complex group than in the ferrous sulfate group (58% vs 35%, respectively; P=.04). CONCLUSIONS AND RELEVANCE Among infants and children aged 9 to 48 months with nutritional iron-deficiency anemia, ferrous sulfate compared with iron polysaccharide complex resulted in a greater increase in hemoglobin concentration at 12 weeks. Once daily, low-dose ferrous sulfate should be considered for children with nutritional iron-deficiency anemia.	[Powers, Jacquelyn M.] Baylor Coll Med, Div Hematol & Oncol, Houston, TX 77030 USA; [Powers, Jacquelyn M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Powers, Jacquelyn M.] Texas Childrens Hosp, Houston, TX 77030 USA; [Buchanan, George R.] Univ Texas Southwestern Med Ctr Dallas, Div Hematol & Oncol, Dallas, TX 75390 USA; [Buchanan, George R.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Buchanan, George R.; Adix, Leah] Childrens Hlth, Dallas, TX USA; [Zhang, Song; Gao, Ang] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [McCavit, Timothy L.] Cook Childrens Med Ctr, Div Hematol & Oncol, Ft Worth, TX USA; [McCavit, Timothy L.] Cook Childrens Med Ctr, Dept Pediat, Ft Worth, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cook Children's Medical Center; Cook Children's Medical Center	Powers, JM (corresponding author), Baylor Coll Med, 6701 Fannin St,Ste 1580, Houston, TX 77030 USA.	jacquelyn.powers@bcm.edu			Gensavis Pharmaceuticals LLC; National Center for Advancing Translational Sciences [KL2TR001103]; National Heart, Lung, and Blood Institute [K23HL132001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL132001] Funding Source: NIH RePORTER	Gensavis Pharmaceuticals LLC; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was an investigator-initiated trial with sponsorship from Gensavis Pharmaceuticals LLC, the manufacturer of the iron polysaccharide complex used in this trial. The company provided funding for both trial drugs, central organizational costs, and salary support for Dr McCavit. This work was additionally supported by grant KL2TR001103 from the National Center for Advancing Translational Sciences and grant K23HL132001 from the National Heart, Lung, and Blood Institute.	Abdullah K, 2017, J PEDIATR-US, V188, P287, DOI 10.1016/j.jpeds.2017.03.028; Brotanek JM, 2008, ARCH PEDIAT ADOL MED, V162, P374, DOI 10.1001/archpedi.162.4.374; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; DIAMOND LK, 1963, PEDIATRICS, V31, P1041; Gupta PM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060330; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; KERR DNS, 1958, LANCET, V2, P489; Looker AC, 2002, JAMA-J AM MED ASSOC, V288, P2114; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Lukowski AF, 2010, NUTR NEUROSCI, V13, P54, DOI 10.1179/147683010X12611460763689; McDonagh MS, 2015, PEDIATRICS, V135, P723, DOI 10.1542/peds.2014-3979; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moore CV, 1939, J CLIN INVEST, V18, P553, DOI 10.1172/JCI101069; Moore CV, 1944, J CLIN INVEST, V23, P755, DOI 10.1172/JCI101548; Moretti D, 2015, BLOOD, V126, P1981, DOI 10.1182/blood-2015-05-642223; Powers JM, 2016, PEDIATR BLOOD CANCER, V63, P743, DOI 10.1002/pbc.25861; Powers JM, 2015, PEDIATR BLOOD CANCER, V62, P842, DOI 10.1002/pbc.25433; Powers JM, 2014, HEMATOL ONCOL CLIN N, V28, P729, DOI 10.1016/j.hoc.2014.04.007; PRITCHAR.JA, 1966, J AMER MED ASSOC, V195, P717, DOI 10.1001/jama.195.9.717; REEVES JD, 1985, PEDIATRICS, V75, P352; Rimon E, 2005, AM J MED, V118, P1142, DOI 10.1016/j.amjmed.2005.01.065; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schrier SL, 2015, BLOOD, V126, P1971, DOI 10.1182/blood-2015-09-666511; SCHULZ J, 1958, AMA J DIS CHILD, V95, P109, DOI 10.1001/archpedi.1958.02060050111001; SMITH NJ, 1958, J PEDIATR-US, V53, P37, DOI 10.1016/S0022-3476(58)80197-3; Stoltzfus R. J., 2004, COMP QUANTIFICATION, V1; WHO, 2001, IRON DEFICIENCY ANAE; Zlotkin S, 2001, PEDIATRICS, V108, P613, DOI 10.1542/peds.108.3.613	29	55	55	2	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2297	2304		10.1001/jama.2017.6846	http://dx.doi.org/10.1001/jama.2017.6846			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609534	Green Published, Bronze			2022-12-28	WOS:000403149900016
J	Li, X; Meng, XR; Timofeeva, M; Tzoulaki, I; Tsilidis, KK; Ioannidis, PA; Campbell, H; Theodoratou, E				Li, Xue; Meng, Xiangrui; Timofeeva, Maria; Tzoulaki, Ioanna; Tsilidis, Konstantinos K.; Ioannidis, P. A.; Campbell, Harry; Theodoratou, Evropi			Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; TRANSPORTER GENE SLC2A9; INDEPENDENT RISK-FACTOR; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; PLASMA URATE; PARKINSONS-DISEASE; OXIDATIVE STRESS	OBJECTIVE To map the diverse health outcomes associated with serum uric acid (SUA) levels. DESIGN Umbrella review. DATA SOURCES Medline, Embase, Cochrane Database of Systematic Reviews, and screening of citations and references. ELIGIBILITY CRITERIA Systematic reviews and meta-analyses of observational studies that examined associations between SUA level and health outcomes, meta-analyses of randomised controlled trials that investigated health outcomes related to SUA lowering treatment, and Mendelian randomisation studies that explored the causal associations of SUA level with health outcomes. RESULTS 57 articles reporting 15 systematic reviews and 144 meta-analyses of observational studies (76 unique outcomes), 8 articles reporting 31 meta-analyses of randomised controlled trials (20 unique outcomes), and 36 articles reporting 107 Mendelian randomisation studies (56 unique outcomes) met the eligibility criteria. Across all three study types, 136 unique health outcomes were reported. 16 unique outcomes in meta-analyses of observational studies had P< 10-6, 8 unique outcomes in meta-analyses of randomised controlled trials had P< 0.001, and 4 unique outcomes in Mendelian randomisation studies had P< 0.01. Large between study heterogeneity was common (80% and 45% in meta-analyses of observational studies and of randomised controlled trials, respectively). 42 (55%) meta-analyses of observational studies and 7 (35%) meta-analyses of randomised controlled trials showed evidence of small study effects or excess significance bias. No associations from meta-analyses of observational studies were classified as convincing; five associations were classified as highly suggestive (increased risk of heart failure, hypertension, impaired fasting glucose or diabetes, chronic kidney disease, coronary heart disease mortality with high SUA levels). Only one outcome from randomised controlled trials (decreased risk of nephrolithiasis recurrence with SUA lowering treatment) had P< 0.001, a 95% prediction interval excluding the null, and no large heterogeneity or bias. Only one outcome from Mendelian randomisation studies (increased risk of gout with high SUA levels) presented convincing evidence. Hypertension and chronic kidney disease showed concordant evidence in meta-analyses of observational studies, and in some (but not all) meta-analyses of randomised controlled trials with respective intermediate or surrogate outcomes, but they were not statistically significant in Mendelian randomisation studies. Conclusion Despite a few hundred systematic reviews, meta-analyses, and Mendelian randomisation studies exploring 136 unique health outcomes, convincing evidence of a clear role of SUA level only exists for gout and nephrolithiasis.	[Li, Xue; Meng, Xiangrui; Campbell, Harry; Theodoratou, Evropi] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH8 9AG, Midlothian, Scotland; [Timofeeva, Maria; Theodoratou, Evropi] Univ Edinburgh, Colon Canc Genet Grp, Med Res Council Human Genet Unit, Med Res Council Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Tzoulaki, Ioanna; Tsilidis, Konstantinos K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Ioannidis, P. A.] Stanford Sch Med, Stanford Prevent Res Ctr, Stanford, CA USA; [Ioannidis, P. A.] Stanford Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Ioannidis, P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	University of Edinburgh; University of Edinburgh; Imperial College London; University of Ioannina; Stanford University; Stanford University; Stanford University	Theodoratou, E (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH8 9AG, Midlothian, Scotland.; Theodoratou, E (corresponding author), Univ Edinburgh, Colon Canc Genet Grp, Med Res Council Human Genet Unit, Med Res Council Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	E.Theodoratou@ed.ac.uk	Campbell, Harry/E-2959-2010; Tzoulaki, Ioanna/ABE-6269-2020; Theodoratou, Evropi/C-3430-2014	Campbell, Harry/0000-0002-6169-6262; Tzoulaki, Ioanna/0000-0002-4275-9328; Ioannidis, John P./0000-0003-3118-6859; Timofeeva, Maria/0000-0002-2503-4253; Theodoratou, Evropi/0000-0001-5887-9132; Tsilidis, Konstantinos/0000-0002-8452-8472	China Scholarship Council; CRUK Career Development Fellowship	China Scholarship Council(China Scholarship Council); CRUK Career Development Fellowship	XL and XM are supported by the China Scholarship Council. ET is supported by a CRUK Career Development Fellowship.	Abraham A, 2014, J NEUROL, V261, P1133, DOI 10.1007/s00415-014-7331-x; Agarwal V, 2013, J CLIN HYPERTENS, V15, P435, DOI 10.1111/j.1751-7176.2012.00701.x; Alonso Alvaro, 2010, Curr Rheumatol Rep, V12, P149, DOI 10.1007/s11926-010-0083-4; Alvarez-Lario B, 2011, QJM-INT J MED, V104, P1015, DOI 10.1093/qjmed/hcr159; Avram Z, 2008, RHEUMATOLOGY, V47, P960, DOI 10.1093/rheumatology/ken070; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550; Bartoli F, 2016, J PSYCHIATR RES, V81, P133, DOI 10.1016/j.jpsychires.2016.07.007; Belbasis L, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0692-5; Bellou V, 2016, PARKINSONISM RELAT D, V23, P1, DOI 10.1016/j.parkreldis.2015.12.008; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Braga F, 2015, CLIN CHEM LAB MED, V53, pS1199; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Burgess S, 2015, INT J EPIDEMIOL, V44, P484, DOI 10.1093/ije/dyu176; Chang YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182303; Chaudhari T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006817.pub3; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Cnossen JS, 2006, ACTA OBSTET GYN SCAN, V85, P519, DOI 10.1080/00016340500342037; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dai XY, 2013, EUR J EPIDEMIOL, V28, P669, DOI 10.1007/s10654-013-9829-4; Dalbeth N, 2015, J BONE MINER RES, V30, P985, DOI 10.1002/jbmr.2434; Davis Jr NS ., 1897, JAMA-J AM MED ASSOC, VXXIX, P261, DOI [10.1001/jama.1897.02440320005001a, DOI 10.1001/JAMA.1897.02440320005001A]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimitroula HV, 2008, NEUROLOGIST, V14, P238, DOI 10.1097/NRL.0b013e31815c666b; Du N, 2016, MOL NEUROBIOL, V53, P2594, DOI 10.1007/s12035-015-9271-6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Facheris MF, 2011, J MOL NEUROSCI, V43, P246, DOI 10.1007/s12031-010-9409-y; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2013, J PEDIATR-US, V162, P896, DOI 10.1016/j.jpeds.2012.12.078; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Fink HA, 2013, ANN INTERN MED, V158, P535, DOI 10.7326/0003-4819-158-7-201304020-00005; Flatow J, 2013, BIOL PSYCHIAT, V74, P400, DOI 10.1016/j.biopsych.2013.03.018; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Gao JJ, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-5; Garrod A B, 1848, Med Chir Trans, V31, P83; George J, 2009, VASC HEALTH RISK MAN, V5, P265, DOI 10.2147/VHRM.S4265; Gonzalez-Aramburu I, 2014, PARKINSONISM RELAT D, V20, P637, DOI 10.1016/j.parkreldis.2014.02.023; Gonzalez-Aramburu I, 2013, MOVEMENT DISORD, V28, P1737, DOI 10.1002/mds.25507; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Greenberg KI, 2015, CLIN J AM SOC NEPHRO, V10, P776, DOI 10.2215/CJN.05870614; Han X, 2015, BMC GENET, V15, DOI 10.1186/s12863-015-0162-7; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Higgins P, 2010, CEREBROVASC DIS, V29, P321; Holme I, 2009, J INTERN MED, V266, P558, DOI 10.1111/j.1365-2796.2009.02133.x; Houlihan LM, 2010, HUM MOL GENET, V19, P2321, DOI 10.1093/hmg/ddq097; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039457; Hughes K, 2014, KIDNEY INT, V85, P344, DOI 10.1038/ki.2013.353; Hwu CM, 2010, MED SCI MONITOR, V16, pRA224; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2016, MILBANK Q, V94, P485, DOI 10.1111/1468-0009.12210; Ioannidis JPA, 2016, STAT MED, V35, P1749, DOI 10.1002/sim.6825; Ioannidis JPA, 2013, J MATH PSYCHOL, V57, P184, DOI 10.1016/j.jmp.2013.03.002; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Jiang M, 2016, CLIN CHEM LAB MED; Kanbay M, 2014, AM J NEPHROL, V39, P348, DOI 10.1159/000360609; Kavanagh BP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000094; Kavvoura FK, 2007, PLOS MED, V4, P456, DOI 10.1371/journal.pmed.0040079; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Khan A, 2013, CEREBROVASC DIS, V35, P821; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Kleber ME, 2015, J AM SOC NEPHROL, V26, P2831, DOI 10.1681/ASN.2014070660; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Korostishevsky M, 2016, EUR J HUM GENET, V24, P277, DOI 10.1038/ejhg.2015.85; Krishnan E, 2012, AM J MED, V125, P499, DOI 10.1016/j.amjmed.2011.11.010; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Li L, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-122; Li M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19520; Li M, 2014, ATHEROSCLEROSIS, V232, P265, DOI 10.1016/j.atherosclerosis.2013.11.051; Li X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003676; Li Yu-lin, 2011, Zhonghua Nei Ke Za Zhi, V50, P555; Liu B, 2012, NEUROL RES, V34, P163, DOI 10.1179/1743132811Y.0000000074; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Lyngdoh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076336; Lyngdoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039321; Mallamaci F, 2015, AM J KIDNEY DIS, V65, P294, DOI 10.1053/j.ajkd.2014.07.021; Mallamaci F, 2014, J HYPERTENS, V32, P1621, DOI 10.1097/HJH.0000000000000224; Mazza A, 2001, EUR J EPIDEMIOL, V17, P1097, DOI 10.1023/A:1021216713504; McKeigue PM, 2010, INT J EPIDEMIOL, V39, P907, DOI 10.1093/ije/dyp397; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Oikonen M, 2012, ATHEROSCLEROSIS, V223, P497, DOI 10.1016/j.atherosclerosis.2012.05.036; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Palmer TM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4262; Parsa A, 2012, KIDNEY INT, V81, P502, DOI 10.1038/ki.2011.414; Pasalic D, 2012, BIOCHEM MEDICA, V22, P63; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Qin TQ, 2016, J CLIN HYPERTENS, V18, P1268, DOI 10.1111/jch.12855; Rasheed H, 2014, CIRC-CARDIOVASC GENE, V7, P830, DOI 10.1161/CIRCGENETICS.114.000556; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Schrag M, 2013, NEUROBIOL DIS, V59, P100, DOI 10.1016/j.nbd.2013.07.005; Sedaghat S, 2014, HYPERTENSION, V64, P1061, DOI 10.1161/HYPERTENSIONAHA.114.03757; Shen CH, 2013, CAN J NEUROL SCI, V40, P73, DOI 10.1017/S0317167100012981; Shen L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003620; Simon KC, 2014, ANN NEUROL, V76, P862, DOI 10.1002/ana.24281; Sluijs I, 2015, DIABETES, V64, P3028, DOI 10.2337/db14-0742; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Song XJ, 2015, INT J CARDIOL, V201, P658, DOI 10.1016/j.ijcard.2015.07.074; Stamp L, 2016, SEMIN ARTHRITIS RHEU; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Sun X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116714; Tabara Y, 2010, AM J NEPHROL, V32, P279, DOI 10.1159/000318943; Tamariz L, 2015, CIRCULATION, V131, P1741, DOI 10.1161/CIRCULATIONAHA.115.016379; Tamariz L, 2014, HEART RHYTHM, V11, P1102, DOI 10.1016/j.hrthm.2014.04.003; Tamariz L, 2009, J AM COLL CARDIOL, V53, pA169; Testa A, 2014, CLIN J AM SOC NEPHRO, V9, P1059, DOI 10.2215/CJN.11041013; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Trkulja V, 2012, CROAT MED J, V53, P162, DOI 10.3325/cmj.2012.53.162; Vaccarino V, 1999, ANN INTERN MED, V131, P62, DOI 10.7326/0003-4819-131-1-199907060-00012; Voruganti VS, 2014, EUR J HUM GENET, V22, P938, DOI 10.1038/ejhg.2013.264; Wang H, 2013, J RENAL NUTR, V23, P389, DOI 10.1053/j.jrn.2012.08.005; Wang LJ, 2016, MULT SCLER RELAT DIS, V9, P17, DOI 10.1016/j.msard.2016.05.008; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0107270; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Wannamethee SG, 1997, HEART, V78, P147, DOI 10.1136/hrt.78.2.147; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; White J, 2016, LANCET DIABETES ENDO, V4, P327, DOI 10.1016/S2213-8587(15)00386-1; Xia X, 2016, METABOLISM, V65, P1326, DOI 10.1016/j.metabol.2016.05.009; Xiong A, 2016, OSTEOPOROSIS INT, V27, P1031, DOI 10.1007/s00198-015-3341-5; Xu X, 2015, INT J CARDIOL, V184, P699, DOI 10.1016/j.ijcard.2015.02.038; Xu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078206; Yan DD, 2016, INT J CARDIOL, V214, P194, DOI 10.1016/j.ijcard.2016.03.206; Yan LR, 2014, CELL BIOCHEM BIOPHYS, V70, P1597, DOI 10.1007/s12013-014-0101-7; Yan SS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764250; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Yang Y, 2015, INT J CARDIOL, V185, P125, DOI 10.1016/j.ijcard.2015.03.121; Yu S, 2016, MOL NEUROBIOL, V53, P1045, DOI 10.1007/s12035-014-9075-0; Zhang CH, 2016, CELL PHYSIOL BIOCHEM, V38, P1589, DOI 10.1159/000443099; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891; Zhang YF, 2014, J HUAZHONG U SCI-MED, V34, P476, DOI 10.1007/s11596-014-1302-4; Zhao G, 2014, CARDIOLOGY, V129, P46; Zhao JP, 2016, INT J CARDIOL, V204, P103, DOI 10.1016/j.ijcard.2015.11.167; Zhou YJ, 2016, CLIN BIOCHEM, V49, P636, DOI 10.1016/j.clinbiochem.2015.12.010; Zhu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100801	147	185	188	4	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2017	357								j2376	10.1136/bmj.j2376	http://dx.doi.org/10.1136/bmj.j2376			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RC	28592419	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000403221400001
J	Watts, G				Watts, Geoff			Bryan Jennett - Obituary	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk						JENNETT B, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2008	371	9613					646	646		10.1016/S0140-6736(08)60293-7	http://dx.doi.org/10.1016/S0140-6736(08)60293-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	28581430				2022-12-28	WOS:000253436700018
J	Jonas, JB; Aung, T; Bourne, RR; Bron, AM; Ritch, R; Panda-Jonas, S				Jonas, Jost B.; Aung, Tin; Bourne, Rupert R.; Bron, Alain M.; Ritch, Robert; Panda-Jonas, Songhomitra			Glaucoma	LANCET			English	Review							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; OPTICAL COHERENCE TOMOGRAPHY; CEREBROSPINAL-FLUID PRESSURE; FIBER LAYER THICKNESS; OCULAR HYPERTENSION TREATMENT; CENTRAL CORNEAL THICKNESS; VISUAL-FIELD PROGRESSION; RETINAL GANGLION-CELLS; INTRAOCULAR-PRESSURE	Glaucoma is a heterogeneous group of diseases characterised by cupping of the optic nerve head and visual-field damage. It is the most frequent cause of irreversible blindness worldwide. Progression usually stops if the intraocular pressure is lowered by 30-50% from baseline. Its worldwide age-standardised prevalence in the population aged 40 years or older is about 3.5%. Chronic forms of glaucoma are painless and symptomatic visual-field defects occur late. Early detection by ophthalmological examination is mandatory. Risk factors for primary open-angle glaucomathe most common form of glaucoma-include older age, elevated intraocular pressure, sub-Saharan African ethnic origin, positive family history, and high myopia. Older age, hyperopia, and east Asian ethnic origin are the main risk factors for primary angle-closure glaucoma. Glaucoma is diagnosed using ophthalmoscopy, tonometry, and perimetry. Treatment to lower intraocular pressure is based on topical drugs, laser therapy, and surgical intervention if other therapeutic modalities fail to prevent progression.	[Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Aung, Tin] Singapore Eye Res Inst, Singapore, Singapore; [Aung, Tin] Singapore Natl Eye Ctr, Singapore, Singapore; [Aung, Tin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Bourne, Rupert R.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Bron, Alain M.] Univ Hosp, Dept Ophthalmol, Dijon, France; [Bron, Alain M.] Bourgogne Franche Comte Univ, Eye & Nutr Res Grp, Dijon, France; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY USA	Ruprecht Karls University Heidelberg; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Anglia Ruskin University; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; New York Eye & Ear Infirmary of Mount Sinai	Jonas, JB (corresponding author), Univ Augenklin, D-68167 Mannheim, Germany.	jost.jonas@medma.uni-heidelberg.de	Androutsos, Georges/AAA-3504-2020; Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X	Alcon; Allergan; Roche; Santen; Tomey; Carl Zeiss Meditec; Ellex; Ocular Therapeutics; Quark; Thea; Horus; Sensimed AG; iSonic Medical; Aeon Astron Europe; Santen Pharmaceutical; Ocular Instruments; Gerson Lehrman Group; Gillis Zago Professional; Donahey Defossez Beausay; Nauts; Tanoury; McKinney Garbarino; Diopsys; GLIA; Guardion Health Sciences; Mobius Therapeutics; Intelon Optics; Xoma; International Eye Wellness Institute	Alcon(Novartis); Allergan(AbbVieAllergan); Roche(Roche Holding); Santen; Tomey; Carl Zeiss Meditec; Ellex; Ocular Therapeutics; Quark; Thea; Horus; Sensimed AG; iSonic Medical; Aeon Astron Europe; Santen Pharmaceutical; Ocular Instruments; Gerson Lehrman Group; Gillis Zago Professional; Donahey Defossez Beausay; Nauts; Tanoury; McKinney Garbarino; Diopsys; GLIA; Guardion Health Sciences; Mobius Therapeutics; Intelon Optics; Xoma; International Eye Wellness Institute	JBJ is a consultant for Mundipharma; holds a patent with Biocompatibles UK (patent number 20120263794); and has applied for a patent with the University of Heidelberg (Europaische Patentanmeldung 15 000 771.4). TA is a consultant for Alcon, Allergan, Belkin Lasers, Carl Zeiss Meditec, Pfizer, Roche, Quark, and Santen; has received lecture fees, travel grants, and research support from Alcon, Allergan, Roche, Santen, and Tomey; has received lecture fees and research support from Carl Zeiss Meditec; and has received research support from Ellex, Ocular Therapeutics, and Quark. RRB is a consultant for and has received lecture fees, travel grants, and research support from Allergan and Tomey; and is a consultant for and has received lecture fees and travel grants from Santen. AMB is a consultant for Allergan, Bausch-Lomb, and Thea; and has received research support from Thea and Horus. RR has received personal fees from Sensimed AG, iSonic Medical, Aeon Astron Europe, Santen Pharmaceutical, Ocular Instruments, Gerson Lehrman Group, Gillis Zago Professional, Donahey Defossez & Beausay, Tanoury, Nauts, McKinney & Garbarino, Diopsys, GLIA, Guardion Health Sciences, Mobius Therapeutics, Intelon Optics, Xoma, and The International Eye Wellness Institute. SP-J holds a patent with Biocompatible UK (patent number 20120263794) and has applied for a patent with the University of Heidelberg (Europaische Patentanmeldung 15 000 771.4).	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; Aung T, 2017, NAT GENET IN PRESS; Aung T, 2015, NAT GENET, V47, P387, DOI 10.1038/ng.3226; Ayyala RS, 2011, OPHTHALMOLOGY; Azuara-Blanco A, 2016, LANCET, V388, P1389, DOI 10.1016/S0140-6736(16)30956-4; Bacharach J, 2015, OPHTHALMOLOGY, V122, P302, DOI 10.1016/j.ophtha.2014.08.022; Bae HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108226; Bailey JNC, 2016, NAT GENET, V48, P189, DOI 10.1038/ng.3482; Belghith A, 2016, INVEST OPHTH VIS SCI, V57, pOCT511, DOI 10.1167/iovs.15-18929; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Congdon NG, 1997, OPHTHALMOLOGY, V104, P1489, DOI 10.1016/S0161-6420(97)30112-2; Crawford MLJ, 2001, INVEST OPHTH VIS SCI, V42, P358; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; Day AC, 2011, INVEST OPHTH VIS SCI, V52, P8407, DOI 10.1167/iovs.11-7927; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Foo LL, 2012, OPHTHALMOLOGY, V119, P278, DOI 10.1016/j.ophtha.2011.07.049; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; GOLDMANN H, 1957, Ophthalmologica, V134, P221; Golzan SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128433; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Gudmundsdottir BS, 2014, J OCUL PHARMACOL TH, V30, P35, DOI 10.1089/jop.2013.0060; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P603, DOI 10.1016/S0002-9394(14)70067-4; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jiang YZ, 2010, OPHTHAL EPIDEMIOL, V17, P321, DOI 10.3109/09286586.2010.508353; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Kang JH, 2015, INVEST OPHTH VIS SCI, V56, P2439, DOI 10.1167/iovs.14-16088; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P4619, DOI 10.1167/iovs.13-12487; Khor CC, 2016, NAT GENET, V48, P556, DOI 10.1038/ng.3540; Kim KE, 2016, OPHTHALMOLOGY; Kim M, 2012, JPN J OPHTHALMOL, V56, P324, DOI 10.1007/s10384-012-0153-4; Ko F, 2015, PROG BRAIN RES, V221, P177, DOI 10.1016/bs.pbr.2015.06.005; Lam DSC, 2002, OPHTHALMOLOGY, V109, P1591, DOI 10.1016/S0161-6420(02)01158-2; Lee KYC, 2010, INVEST OPHTH VIS SCI, V51, P666, DOI 10.1167/iovs.09-3663; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051; Li Z, 2015, HUM MOL GENET, V24, P3880, DOI 10.1093/hmg/ddv128; Li ZW, 2011, INVEST OPHTH VIS SCI, V52, P7205, DOI 10.1167/iovs.10-6868; Lockwood H, 2015, INVEST OPHTH VIS SCI, V56, P1618, DOI 10.1167/iovs.14-15967; Loewen NA, 2015, BRIT J OPHTHALMOL, V99, P1224, DOI 10.1136/bjophthalmol-2014-305907; Moghimi S, 2015, INVEST OPHTH VIS SCI, V56, P7611, DOI 10.1167/iovs.15-17336; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; Moroi SE, 2003, AM J OPHTHALMOL, V136, P1176, DOI 10.1016/S0002-9394(03)00657-3; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Nagaoka N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138825; Nongpiur ME, 2015, INVEST OPHTH VIS SCI, V56, P6879, DOI 10.1167/iovs.15-17930; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Osborne NN, 2014, EXP EYE RES, V128, P8, DOI 10.1016/j.exer.2014.08.012; Pasquale LR, 2016, ACTA OPHTHALMOL, V94, pE505, DOI 10.1111/aos.12918; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Perera SA, 2016, CLIN OPHTHALMOL, V10, P757, DOI 10.2147/OPTH.S102181; Perera SA, 2010, ARCH OPHTHALMOL-CHIC, V128, P900, DOI 10.1001/archophthalmol.2010.125; Qiu M, 2013, INVEST OPHTH VIS SCI, V54, P830, DOI 10.1167/iovs.12-11158; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ritch R, 1994, J Glaucoma, V3, P176; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; Sample PA, 2000, INVEST OPHTH VIS SCI, V41, P1783; Sanchez MIGL, 2016, PHARMACOL THERAPEUT, V165, P132, DOI 10.1016/j.pharmthera.2016.06.004; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; Shaikh Y, 2014, AM J OPHTHALMOL, V158, P1121, DOI 10.1016/j.ajo.2014.08.023; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P9023, DOI 10.1167/iovs.11-8183; Skaat A, 2016, OPHTHALMOLOGY, V123, P1476, DOI 10.1016/j.ophtha.2016.03.025; Somner JEA, 2012, INVEST OPHTH VIS SCI, V53, P5940, DOI 10.1167/iovs.12-10223; Springelkamp H, 2017, HUM MOL GENET, V26, P438, DOI 10.1093/hmg/ddw399; Springelkamp H, 2015, GENET EPIDEMIOL, V39, P207, DOI 10.1002/gepi.21886; Springelkamp H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5883; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Tanihara H, 2016, ACTA OPHTHALMOL, V94, pE26, DOI 10.1111/aos.12829; Tanihara H, 2015, JAMA OPHTHALMOL, V133, P755, DOI 10.1001/jamaophthalmol.2015.0525; Teekhasaenee C, 1999, OPHTHALMOLOGY, V106, P669, DOI 10.1016/S0161-6420(99)90149-5; Tham YC, 2015, OPHTHALMOLOGY, V122, P1149, DOI 10.1016/j.ophtha.2015.01.024; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; Topouzis F, 2008, AM J OPHTHALMOL, V145, P327, DOI 10.1016/j.ajo.2007.09.013; Topouzis F, 2013, AM J OPHTHALMOL, V155, P843, DOI 10.1016/j.ajo.2012.12.007; Trikha S, 2015, OPHTHALMOLOGY, V122, P2416, DOI 10.1016/j.ophtha.2015.08.016; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang JW, 2016, J GLAUCOMA, V25, P459, DOI 10.1097/IJG.0000000000000200; Wang L, 2002, INVEST OPHTH VIS SCI, V43, P1088; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P2452, DOI 10.1167/iovs.15-18986; Wang YX, 2015, OPHTHALMOLOGY, V122, P2022, DOI 10.1016/j.ophtha.2015.06.005; Wang YE, 2016, OPHTHALMOLOGY, V123, P729, DOI 10.1016/j.ophtha.2015.11.029; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wirostko BM, 2016, JAMA OPHTHALMOL, V134, P1255, DOI 10.1001/jamaophthalmol.2016.3411; Xu L, 2008, ACTA OPHTHALMOL, V86, P229, DOI 10.1111/j.1600-0420.2007.01026.x; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yang HL, 2015, INVEST OPHTH VIS SCI, V56, P7661, DOI 10.1167/iovs.15-17624; Yu M, 2016, OPHTHALMOLOGY, V123, P1201, DOI 10.1016/j.ophtha.2016.02.017; Yucel YH, 2000, ARCH OPHTHALMOL-CHIC, V118, P378; Zangwill LM, 2001, ARCH OPHTHALMOL-CHIC, V119, P985, DOI 10.1001/archopht.119.7.985; Zhang XB, 2016, AM J OPHTHALMOL, V163, P29, DOI 10.1016/j.ajo.2015.11.029; Zhang XZ, 2013, JAMA OPHTHALMOL, V131, P1198, DOI 10.1001/jamaophthalmol.2013.4694; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051; Zhao D, 2014, AM J OPHTHALMOL, V158, P615, DOI 10.1016/j.ajo.2014.05.029; Zhao XJ, 2016, J GLAUCOMA, V25, pE413, DOI 10.1097/IJG.0000000000000349; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P3399, DOI 10.1167/iovs.09-4867; Zhou MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102972	133	542	550	18	237	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2017	390	10108					2183	2193		10.1016/S0140-6736(17)31469-1	http://dx.doi.org/10.1016/S0140-6736(17)31469-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN0CL	28577860	Green Accepted			2022-12-28	WOS:000415642200023
J	McConnell, KJ; Chernew, ME				McConnell, K. John; Chernew, Michael E.			Controlling the Cost of Medicaid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McConnell, K. John] Oregon Hlth & Sci Univ, Ctr Hlth Syst Effectiveness, Portland, OR 97201 USA; [McConnell, K. John] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Chernew, Michael E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA	Oregon Health & Science University; Oregon Health & Science University; Harvard University; Harvard Medical School	McConnell, KJ (corresponding author), Oregon Hlth & Sci Univ, Ctr Hlth Syst Effectiveness, Portland, OR 97201 USA.; McConnell, KJ (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA.				NIMH NIH HHS [R01 MH100001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100001] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Coughlin Teresa A., 2013, WHAT DIFFERENCE DOES; Medicaid and CHIP Payment and Access Commission, 2016, C MED CHIP; Mendelson A, 2016, HEALTHCARE-J DEL SCI, V4, P274, DOI 10.1016/j.hjdsi.2016.06.002; Schubel J., 2017, MEDICAID CUTS HOUSE; Smith VK, 2017, HLTH AFFAIRS BL 0517	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					201	203		10.1056/NEJMp1705487	http://dx.doi.org/10.1056/NEJMp1705487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9PI	28614039				2022-12-28	WOS:000405777600001
J	Reddy, ST				Reddy, Sai T.			The patterns of T-cell target recognition	NATURE			English	Editorial Material							REPERTOIRES; ANTIGEN; LEVEL; ALPHA	The binding of T-cell receptors to peptide molecules not normally present in the body can trigger an immune response. Predicting which peptide a T-cell receptor will bind to - a difficult feat - has now been achieved. See Letters p.89 & p.94	[Reddy, Sai T.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Reddy, ST (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	sai.reddy@ethz.ch						Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Attaf M, 2015, CELL MOL IMMUNOL, V12, P391, DOI 10.1038/cmi.2014.134; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Emerson RO, 2017, NAT GENET, V49, P659, DOI 10.1038/ng.3822; Friedensohn S, 2017, TRENDS BIOTECHNOL, V35, P203, DOI 10.1016/j.tibtech.2016.09.010; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Liu XS, 2017, CELL, V168, P600, DOI 10.1016/j.cell.2017.01.014; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Pierce BG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003478; Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Sun YX, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00430	15	9	10	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					36	38		10.1038/nature23091	http://dx.doi.org/10.1038/nature23091			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28636588				2022-12-28	WOS:000404839900024
J	Lipska, KJ; Hirsch, IB; Riddle, MC				Lipska, Kasia J.; Hirsch, Irl B.; Riddle, Matthew C.			Human Insulin for Type 2 Diabetes An Effective, Less-Expensive Option	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lipska, Kasia J.] Yale Sch Med, Dept Internal Med, Sect Endocrinol, New Haven, CT 06520 USA; [Hirsch, Irl B.] Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Riddle, Matthew C.] Oregon Hlth & Sci Univ, Div Endocrinol Diabet & Clin Nutr, Portland, OR 97201 USA	Yale University; University of Washington; University of Washington Seattle; Oregon Health & Science University	Lipska, KJ (corresponding author), Yale Sch Med, Sect Endocrinol, POB 208020, New Haven, CT 06520 USA.	kasia.lipska@yale.edu			National Institute on Aging; American Federation of Aging Research through the Paul Beeson Career Development Award [K23AG048359]; Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]; Rose Hastings Trust; Russell Standley Memorial Trust; NATIONAL INSTITUTE ON AGING [P30AG021342, K23AG048359] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research through the Paul Beeson Career Development Award; Yale Claude D. Pepper Older Americans Independence Center; Rose Hastings Trust; Russell Standley Memorial Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging and the American Federation of Aging Research through the Paul Beeson Career Development Award (K23AG048359) and the Yale Claude D. Pepper Older Americans Independence Center (P30AG021342) (Lipska). The Rose Hastings and Russell Standley Memorial Trusts (Riddle).	Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hirsch Irl B, 2016, Diabetes Spectr, V29, P130, DOI 10.2337/diaspect.29.3.130; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Lipska KJ, 2014, JAMA-J AM MED ASSOC, V311, P2331, DOI 10.1001/jama.2014.6316; Mudaliar SR, 1999, DIABETES CARE, V22, P1501, DOI 10.2337/diacare.22.9.1501; Muller N, 2013, DIABETES CARE, V36, P1865, DOI 10.2337/dc12-1694; Roach P, 1999, DIABETES CARE, V22, P1258, DOI 10.2337/diacare.22.8.1258; Siebenhofer A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003287.pub4	8	53	54	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					23	24		10.1001/jama.2017.6939	http://dx.doi.org/10.1001/jama.2017.6939			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28604935				2022-12-28	WOS:000404717700008
J	Piccolo, R; Gargiulo, G; Franzone, A; Santucci, A; Ariotti, S; Baldo, A; Tumscitz, C; Moschovitis, A; Windecker, S; Valgimigli, M				Piccolo, Raffaele; Gargiulo, Giuseppe; Franzone, Anna; Santucci, Andrea; Ariotti, Sara; Baldo, Andrea; Tumscitz, Carlo; Moschovitis, Aris; Windecker, Stephan; Valgimigli, Marco			Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention	ANNALS OF INTERNAL MEDICINE			English	Article							INDUCED INTIMAL HYPERPLASIA; DRUG-ELUTING STENTS; ARTERY-DISEASE; REVASCULARIZATION; METAANALYSIS; VALIDATION; PREDICTION; POTENCY	Background: The dual-antiplatelet therapy (DAPT) score was developed to identify patients more likely to derive harm (score <2) or benefit (score >= 2) from prolonged DAPT after percutaneous coronary intervention (PCI). Objective: To evaluate the safety and efficacy of DAPT duration according to DAPT score. Design: Retrospective assessment of DAPT score-guided treatment duration in a randomized clinical trial. (ClinicalTrials.gov: NCT00611286) Setting: PCI patients. Patients: 1970 patients undergoing PCI. Intervention: DAPT (aspirin and clopidogrel) for 24 versus 6 months. Measurements: Primary efficacy outcomes were death, myocardial infarction, or cerebrovascular accident. The primary safety outcome was type 3 or 5 bleeding according to the Bleeding Academic Research Consortium definition. Outcomes were assessed between 6 and 24 months. Results: 884 patients (44.9%) had a DAPT score of at least 2, and 1086 (55.1%) had a score less than 2. The reduction in the primary efficacy outcome with 24-versus 6-month DAPT was greater in patients with high scores (risk difference [RD] for score >= 2, -2.05 percentage points [95% CI, -5.04 to 0.95 percentage points]; RD for score <2, 2.91 percentage points [CI, -0.43 to 6.25 percentage points]; P = 0.030). However, the difference by score for the primary efficacy outcome varied by stent type; prolonged DAPT with high scores was effective only in patients receiving paclitaxel-eluting stents (RD, -7.55 percentage points [CI, -12.85 to -2.25 percentage points]). The increase in the primary safety outcome with 24-versus 6-month DAPT was greater in patients with low scores (RD for score >= 2, 0.20 percentage point [CI, -1.20 to 1.60 percentage points]; RD for score <2, 2.58 percentage points [CI, 0.71 to 4.46 percentage points]; P = 0.046). Limitation: Retrospective calculation of the DAPT score. Conclusion: Prolonged DAPT resulted in harm in patients with low DAPT scores undergoing PCI but reduced risk for ischemic events in patients with high scores receiving paclitaxel-eluting stents. Whether prolonged DAPT benefits patients with high scores treated with contemporary drug-eluting stents requires further study.	Bern Univ Hosp, Bern, Switzerland; Univ Naples Federico II, Naples, Italy; Univ Perugia, Perugia, Italy; Azienda Osped Univ Ferrara, Ferrara, Italy	University of Bern; University Hospital of Bern; University of Naples Federico II; University of Perugia; University of Ferrara; Arcispedale Sant'Anna	Valgimigli, M (corresponding author), Univ Bern, Bern Univ Hosp, Dept Cardiol, Freiburgstr 4, CH-3010 Bern, Switzerland.	raffaele.piccolo@insel.ch; marco.valgimigli@insel.ch	Gargiulo, Giuseppe/AAC-2356-2022; Valgimigli, Marco/AAE-9103-2019; Piccolo, Raffaele/AAA-7871-2019; GARGIULO, Giuseppe/AAC-2336-2022; Piccolo, Raffaele/U-4297-2017	Valgimigli, Marco/0000-0002-4353-7110; Piccolo, Raffaele/0000-0002-3124-9912; GARGIULO, Giuseppe/0000-0003-4395-6742; Franzone, Anna/0000-0001-5394-0192				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bittl JA, 2016, CIRCULATION, V134, pE156, DOI 10.1161/CIR.0000000000000405; Cassese S, 2011, INT J CARDIOL, V150, P84, DOI 10.1016/j.ijcard.2011.01.015; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Genereux P, 2015, J AM COLL CARDIOL, V66, P1036, DOI 10.1016/j.jacc.2015.06.1323; Kang SH, 2016, JACC-CARDIOVASC INTE, V9, P1203, DOI 10.1016/j.jcin.2016.03.038; Kereiakes DJ, 2016, J AM COLL CARDIOL, V67, P2492, DOI 10.1016/j.jacc.2016.03.485; Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; Parner ET, 2010, STATA J, V10, P408, DOI 10.1177/1536867X1001000308; Piccolo R, 2016, J AM COLL CARDIOL, V68, P727, DOI 10.1016/j.jacc.2016.05.078; Piccolo R, 2015, LANCET, V386, P702, DOI 10.1016/S0140-6736(15)61220-X; Spencer FA, 2015, ANN INTERN MED, V163, P118, DOI 10.7326/M15-0083; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI [10.1161/CIRCULATIONAHA.111.071589, DOI 10.1161/CIRCULATI0NAHA.111]; Valgimigli M, 2015, EUR HEART J, V36, P1219, DOI 10.1093/eurheartj/ehv053; Valgimigli M, 2015, EUROINTERVENTION, V11, P68, DOI 10.4244/EIJV11I1A11; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460; Valgimigli M, 2010, AM HEART J, V160, P804, DOI 10.1016/j.ahj.2010.07.034; Vranckx P, 2016, J AM COLL CARDIOL, V67, P2135, DOI 10.1016/j.jacc.2016.02.056; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775	23	31	33	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2017	167	1					17	+		10.7326/M16-2389	http://dx.doi.org/10.7326/M16-2389			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ3DW	28605779				2022-12-28	WOS:000404591600006
J	David, WS; Bowley, MP; Mehan, WA; Shin, JH; Gerstner, ER; DeWitt, JC				David, William S.; Bowley, Michael P.; Mehan, William A., Jr.; Shin, John H.; Gerstner, Elizabeth R.; DeWitt, John C.			Case 19-2017: A 53-Year-Old Woman with Leg Numbness and Weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY CNS LYMPHOMA; PRIMARY LEPTOMENINGEAL LYMPHOMA; STEM-CELL TRANSPLANTATION; NERVOUS-SYSTEM LYMPHOMA; NON-HODGKINS-LYMPHOMA; TUBERCULOUS MENINGITIS; RHEUMATOID-ARTHRITIS; INFLAMMATORY DISORDERS; FLOW-CYTOMETRY; RISK		[David, William S.; Bowley, Michael P.; Gerstner, Elizabeth R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Mehan, William A., Jr.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Shin, John H.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [DeWitt, John C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [David, William S.; Bowley, Michael P.; Gerstner, Elizabeth R.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Mehan, William A., Jr.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Shin, John H.] Harvard Med Sch, Dept Neurosurg, Boston, MA USA; [DeWitt, John C.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	David, WS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; David, WS (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA USA.			Shin, John/0000-0001-7490-8108				Abrey LE, 2005, J CLIN ONCOL, V23, P5034, DOI 10.1200/JCO.2005.13.524; Ahluwalia MS, 2012, CANCER-AM CANCER SOC, V118, P1747, DOI 10.1002/cncr.26335; Baehring JM, 2012, CANCER J, V18, P463, DOI 10.1097/PPO.0b013e31826c5ad5; Berrios Idanis, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208188; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Burns TM, 2006, J NEUROL SCI, V244, P77, DOI 10.1016/j.jns.2006.01.014; Chen YB, 2015, CANCER-AM CANCER SOC, V121, P226, DOI 10.1002/cncr.29023; Ferreri AJM, 2016, BLOOD, V127, P1642, DOI 10.1182/blood-2015-10-636340; Garg RK, 2015, SPINAL CORD, V53, P649, DOI 10.1038/sc.2015.58; Glass J, 2016, J CLIN ONCOL, V34, P1620, DOI 10.1200/JCO.2015.64.8634; Grisold W, 2013, HAND CLINIC, V115, P685, DOI 10.1016/B978-0-444-52902-2.00040-0; Groves MD, 2011, NEUROSURG CLIN N AM, V22, P67, DOI 10.1016/j.nec.2010.08.006; Hernandez-Albujar S, 2000, CLIN INFECT DIS, V30, P915, DOI 10.1086/313821; Kisacik B, 2016, J RHEUMATOL, V43, P524, DOI 10.3899/jrheum.150177; Krumholz Allan, 2014, Handb Clin Neurol, V119, P305, DOI 10.1016/B978-0-7020-4086-3.00021-7; LACHANCE DH, 1991, NEUROLOGY, V41, P95, DOI 10.1212/WNL.41.1.95; Lim CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166339; Lu MC, 2015, INT J TUBERC LUNG D, V19, P1500, DOI 10.5588/ijtld.15.0087; Mellemkjaer L, 2008, ARTHRITIS RHEUM, V58, P657, DOI 10.1002/art.23267; Minozzi S, 2016, EXPERT OPIN DRUG SAF, V15, P11, DOI 10.1080/14740338.2016.1240783; Quijano S, 2009, J CLIN ONCOL, V27, P1462, DOI 10.1200/JCO.2008.17.7089; Rubenstein JL, 2013, J CLIN ONCOL, V31, P3061, DOI 10.1200/JCO.2012.46.9957; Schoeman JF, 2013, HAND CLINIC, V112, P1135, DOI 10.1016/B978-0-444-52910-7.00033-7; Scott BJ, 2013, JAMA NEUROL, V70, P311, DOI 10.1001/jamaneurol.2013.606; Shen TC, 2015, INT J TUBERC LUNG D, V19, P1401, DOI 10.5588/ijtld.15.0057; Smedby KE, 2008, J INTERN MED, V264, P514, DOI 10.1111/j.1365-2796.2008.02029.x; Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/djj004; Tavee JO, 2015, CLIN CHEST MED, V36, P643, DOI 10.1016/j.ccm.2015.08.007; Taylor JW, 2013, NEUROLOGY, V81, P1690, DOI 10.1212/01.wnl.0000435302.02895.f3; Thongpooswan S, 2014, CASE REP RHEUMATOL, V2014; Torok ME, 2015, BRIT MED BULL, V113, P117, DOI 10.1093/bmb/ldv003; Ungprasert P, 2016, J EUR ACAD DERMATOL, V30, P1799, DOI 10.1111/jdv.13760; Vigne C, 2013, JOINT BONE SPINE, V80, P104, DOI 10.1016/j.jbspin.2012.05.001; Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P1740, DOI 10.1002/art.20311; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110922; Yu J, 2016, INT J TUBERC LUNG D, V20, P494, DOI 10.5588/ijtld.15.0600	36	4	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2471	2481		10.1056/NEJMcpc1701762	http://dx.doi.org/10.1056/NEJMcpc1701762			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY2BW	28636859				2022-12-28	WOS:000403774400012
J	Kamerkar, S; LeBleu, VS; Sugimoto, H; Yang, SJ; Ruivo, CF; Melo, SA; Lee, JJ; Kalluri, R				Kamerkar, Sushrut; LeBleu, Valerie S.; Sugimoto, Hikaru; Yang, Sujuan; Ruivo, Carolina F.; Melo, Sonia A.; Lee, J. Jack; Kalluri, Raghu			Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer	NATURE			English	Article							DUCTAL ADENOCARCINOMA; EXTRACELLULAR VESICLES; DRUG-DELIVERY; MOUSE MODEL; SIRNA; PROTEIN; CELLS; RAS; CHEMOTHERAPY; MACROPINOCYTOSIS	The mutant form of the GTPase KRAS is a key driver of pancreatic cancer but remains a challenging therapeutic target. Exosomes are extracellular vesicles generated by all cells, and are naturally present in the blood. Here we show that enhanced retention of exosomes, compared to liposomes, in the circulation of mice is likely due to CD47-mediated protection of exosomes from phagocytosis by monocytes and macrophages. Exosomes derived from normal fibroblast-like mesenchymal cells were engineered to carry short interfering RNA or short hairpin RNA specific to oncogenic KrasG12D, a common mutation in pancreatic cancer. Compared to liposomes, the engineered exosomes (known as iExosomes) target oncogenic KRAS with an enhanced efficacy that is dependent on CD47, and is facilitated by macropinocytosis. Treatment with iExosomes suppressed cancer in multiple mouse models of pancreatic cancer and significantly increased overall survival. Our results demonstrate an approach for direct and specific targeting of oncogenic KRAS in tumours using iExosomes.	[Kamerkar, Sushrut; LeBleu, Valerie S.; Sugimoto, Hikaru; Yang, Sujuan; Melo, Sonia A.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77005 USA; [Ruivo, Carolina F.; Melo, Sonia A.] Univ Porto, Inst Invest & Inovacao Saude, Portugal I3S, P-4200 Oporto, Portugal; [Ruivo, Carolina F.; Melo, Sonia A.] Univ Porto, IPATIMUP, Inst Pathol & Mol Immunol, P-4200 Oporto, Portugal; [Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77005 USA	University of Texas System; UTMD Anderson Cancer Center; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Texas System; UTMD Anderson Cancer Center	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77005 USA.	rkalluri@mdanderson.org	Lee, Jack/P-7331-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Kalluri, Raghu/E-2677-2015; MELO, SONIA/H-8972-2013	Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Ruivo, Carolina/0000-0002-1485-2066; Kalluri, Raghu/0000-0002-2190-547X; MELO, SONIA/0000-0002-2291-4263	Cancer Prevention and Research Institute of Texas; MD Anderson Cancer Center; NCI [CA213233]; FEDER [POCI-01/0145-FEDER-016618]; NATIONAL CANCER INSTITUTE [U24CA126577, R01CA213233, P30CA016672] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; MD Anderson Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FEDER(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was primarily supported by the Cancer Prevention and Research Institute of Texas, the Knowledge Gap funding of MD Anderson Cancer Center, and NCI grant CA213233. Other support include: V.S.L. laboratory: UT MDACC Khalifa Bin Zayed Al Nahya Foundation; High Resolution Electron Microscopy Facility: Institutional Core Grant CA16672; MDACC Flow Cytometry core facility; and J.J.L. laboratory: NIH P30CA16672; MDACC Small Animal Imaging Facility: NIH P30-CA016672 and 5U24-CA126577. The mass spectrometry-related analysis (SAM) was supported by the NORTE-01-0145-FEDER-000029 (NORTE 2020; ERDF) and FEDER funds (POCI-01/0145-FEDER-016618) and FCT-PTDC/BIMONC/2754/2014. We thank K. Dunner Jr for the help with the transmission electron microscopy and immunogold techniques, E. Chang for slide scanning, D. Lundy for tissue processing, J. Carstens and C. Kahlert for independent analyses of tissue histopathology, J. Kaye and L. Gibson for mouse husbandry support, C. Kingsley and D. Lundy for MRI support, E. Lawson for IVIS imaging help, and P. Correa-de-Sampaio for microscopy imaging help.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chang DK, 2014, CURR OPIN GENET DEV, V24, P74, DOI 10.1016/j.gde.2013.12.001; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Clayton A, 2003, EUR J IMMUNOL, V33, P522, DOI 10.1002/immu.200310028; Collins MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049707; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Golan T, 2015, ONCOTARGET, V6, P24560, DOI 10.18632/oncotarget.4183; Gomes-da-Silva LC, 2012, ACCOUNTS CHEM RES, V45, P1163, DOI 10.1021/ar300048p; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hidalgo M, 2012, CLIN CANCER RES, V18, P4249, DOI 10.1158/1078-0432.CCR-12-1327; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Kaur S, 2014, MATRIX BIOL, V37, P49, DOI 10.1016/j.matbio.2014.05.007; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; Kibria G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36502; Kordelas L, 2014, LEUKEMIA, V28, P970, DOI 10.1038/leu.2014.41; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Nakase I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10300; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rachagani S, 2011, BRIT J CANCER, V104, P1038, DOI 10.1038/bjc.2011.31; Rejiba S, 2007, CANCER SCI, V98, P1128, DOI 10.1111/j.1349-7006.2007.00506.x; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Simoes Sergio, 2005, Expert Opin Drug Deliv, V2, P237, DOI 10.1517/17425247.2.2.237; Singh H, 2015, J CLIN ONCOL, V33, P3650, DOI 10.1200/JCO.2015.62.1052; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; van der Meel R, 2014, J CONTROL RELEASE, V195, P72, DOI 10.1016/j.jconrel.2014.07.049; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Xue W, 2014, P NATL ACAD SCI USA, V111, pE3553, DOI 10.1073/pnas.1412686111; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan TL, 2014, CANCER DISCOV, V4, P1182, DOI 10.1158/2159-8290.CD-13-0900; Zeitouni D, 2016, CANCERS, V8, DOI 10.3390/cancers8040045; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	51	1190	1247	75	916	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					498	+		10.1038/nature22341	http://dx.doi.org/10.1038/nature22341			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28607485	Green Accepted			2022-12-28	WOS:000403814100032
J	Friedrich, MJ				Friedrich, M. J.			Cholera Vaccine Safe During Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2362	2362		10.1001/jama.2017.7312	http://dx.doi.org/10.1001/jama.2017.7312			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MT	28632876				2022-12-28	WOS:000426799500001
J	Spencer, FA; Guyatt, GH				Spencer, Frederick A.; Guyatt, Gordon H.			In severe aortic stenosis with intermediate surgical risk, TAVR was noninferior to SAVR for death or disabling stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Spencer, Frederick A.; Guyatt, Gordon H.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Spencer, FA (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Johnston DR, 2015, ANN THORAC SURG, V99, P1239, DOI 10.1016/j.athoracsur.2014.10.070; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5130; Vandvik PO, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5085	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC68	JC68		10.7326/ACPJC-2017-166-12-068	http://dx.doi.org/10.7326/ACPJC-2017-166-12-068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630980				2022-12-28	WOS:000403579000009
J	Cohen, BL; Sachar, DB				Cohen, Benjamin L.; Sachar, David B.			Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTI-TNF THERAPY; ACTIVE ULCERATIVE-COLITIS; SEVERE CROHNS-DISEASE; INFLIXIMAB MAINTENANCE THERAPY; PREVENTING POSTOPERATIVE RECURRENCE; NONMELANOMA SKIN CANCERS; EVIDENCE-BASED CONSENSUS; JANUS KINASE INHIBITOR; COMBINATION THERAPY; CLINICAL REMISSION	The treatment of inflammatory bowel disease (IBD)-ulcerative colitis (UC) and Crohn's disease (CD)-has evolved beyond surgery with the introduction of biologic agents, primarily antibodies against mediators of inflammation and cell attraction. Anti-tumor necrosis factor (TNF) agents have been the first line treatment for moderate to severe ulcerative colitis and Crohn's disease for more than 15 years. During that time much has been learnt about how best to use these agents. This review will assess the evidence on how to optimize the use of anti-TNF agents; when and how to start treatment; how to monitor treatment and when to de-escalate it; and the potential adverse effects of these drugs. New and emerging treatments such as anti-attractants, anti-interleukins, and Janus kinase (JAK) inhibitors will also be discussed.	[Cohen, Benjamin L.; Sachar, David B.] Icahn Sch Med Mt Sinai, Susan & Leonard Feinstein Inflammatory Bowel Dis, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Cohen, BL (corresponding author), Icahn Sch Med Mt Sinai, Susan & Leonard Feinstein Inflammatory Bowel Dis, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA.	benjamin.cohen@mssm.edu						Afif W, 2010, AM J GASTROENTEROL, V105, P1133, DOI 10.1038/ajg.2010.9; Alunno A, 2015, EXPERT OPIN BIOL TH, V15, P1727, DOI 10.1517/14712598.2015.1084284; Amiot A, 2016, CLIN GASTROENTEROL H, V14, P1593, DOI 10.1016/j.cgh.2016.02.016; Amiot A, 2015, THER ADV GASTROENTER, V8, P66, DOI 10.1177/1756283X14558193; Ananthakrishnan AN, 2016, INFLAMM BOWEL DIS, V22, P880, DOI 10.1097/MIB.0000000000000754; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Araki T, 2014, SURG TODAY, V44, P291, DOI 10.1007/s00595-013-0538-0; Archer TP, 2016, IMMUNOTHERAPY-UK, V8, P495, DOI 10.2217/imt-2015-0031; Arijs I, 2018, GUT, V67, P43, DOI 10.1136/gutjnl-2016-312293; Ariyaratnam J, 2014, AM J GASTROENTEROL, V109, P163, DOI 10.1038/ajg.2013.451; Axelrad J, 2016, CLIN GASTROENTEROL H, V14, P58, DOI 10.1016/j.cgh.2015.07.037; Baert F, 2016, GUT, V65, P1126, DOI 10.1136/gutjnl-2014-307882; Baert F, 2014, CLIN GASTROENTEROL H, V12, P1474, DOI 10.1016/j.cgh.2014.01.033; Balint A, 2016, J CROHNS COLITIS, V10, P26, DOI 10.1093/ecco-jcc/jjv169; Baumgart DC, 2016, ALIMENT PHARM THER, V43, P1090, DOI 10.1111/apt.13594; Beaugerie L, 2013, GASTROENTEROLOGY, V145, P927, DOI 10.1053/j.gastro.2013.09.035; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Ben-Horin S, 2012, ALIMENT PHARM THER, V35, P714, DOI 10.1111/j.1365-2036.2012.04997.x; Ben-Horin S, 2016, CLIN GASTROENTEROL H, V14, P1685, DOI 10.1016/j.cgh.2016.05.023; Ben-Horin S, 2013, CLIN GASTROENTEROL H, V11, P444, DOI 10.1016/j.cgh.2012.10.020; Benitez JM, 2014, DIGEST DIS, V32, P328, DOI 10.1159/000358132; Benucci M, 2015, BIOL-TARGETS THER, V9, P7, DOI 10.2147/BTT.S69606; Benucci Maurizio, 2013, Open Rheumatol J, V7, P75, DOI 10.2174/1874312901307010075; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Billioud V, 2013, J CROHNS COLITIS, V7, P853, DOI 10.1016/j.crohns.2013.01.014; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; Bond A, 2017, SCAND J GASTROENTERO, V52, P204, DOI 10.1080/00365521.2016.1245777; Bonovas S, 2016, CLIN GASTROENTEROL H, V14, P1385, DOI 10.1016/j.cgh.2016.04.039; Bortlik M, 2016, SCAND J GASTROENTERO, V51, P196, DOI 10.3109/00365521.2015.1079924; Bortlik M, 2013, J CROHNS COLITIS, V7, P736, DOI 10.1016/j.crohns.2012.10.019; Brandse JF, 2015, J CROHNS COLITIS, V9, P973, DOI 10.1093/ecco-jcc/jjv116; Brooks AJ, 2015, J CROHNS COLITIS, DOI [10.1016/j.crohns.2014.09.007., DOI 10.1016/J.CROHNS.2014.09.007]; Bryant RV, 2015, SCAND J GASTROENTERO, V50, P90, DOI 10.3109/00365521.2014.968864; Buisson A, 2012, ALIMENT PHARM THER, V35, P625, DOI 10.1111/j.1365-2036.2012.05002.x; Bye WA, 2017, ALIMENT PHARM THER, V46, P3, DOI 10.1111/apt.14075; Cabre E, 2012, WORLD J GASTROENTERO, V18, P3814, DOI 10.3748/wjg.v18.i29.3814; Carbonnel F, 2016, GASTROENTEROLOGY, V150, P380, DOI 10.1053/j.gastro.2015.10.050; Carla-Moreau A, 2015, DIGEST LIVER DIS, V47, P191, DOI 10.1016/j.dld.2014.11.005; Casanova MJ, 2017, AM J GASTROENTEROL, V112, P120, DOI 10.1038/ajg.2016.569; CELLIER C, 1994, GUT, V35, P231, DOI 10.1136/gut.35.2.231; Cesarini M, 2016, EXPERT REV GASTROENT, DOI [10.1080/174741, DOI 10.1080/174741]; Chiu YL, 2013, INFLAMM BOWEL DIS, V19, P1112, DOI 10.1097/MIB.0b013e3182813242; Choi GJ, 2010, J GASTROEN HEPATOL, V25, pA86; Christensen B, 2015, GASTROENTEROLOGY, V148, pS866; Cleynen I, 2016, ANN INTERN MED, V164, P10, DOI 10.7326/M15-0729; Colman RJ, 2015, J CROHNS COLITIS, V9, P312, DOI 10.1093/ecco-jcc/jjv027; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2017, GUT, V66, P839, DOI 10.1136/gutjnl-2015-311079; Cornillie F, 2014, GUT, V63, P1721, DOI 10.1136/gutjnl-2012-304094; Cote-Daigneault J, 2015, UNITED EUR GASTROENT, V3, P419, DOI 10.1177/2050640615590302; Cottone M, 2011, CLIN GASTROENTEROL H, V9, P30, DOI 10.1016/j.cgh.2010.09.026; Cross RK, 2015, EXPERT REV GASTROENT, V9, P715, DOI 10.1586/17474124.2015.1039989; D'Haens G, 2016, J CROHNS COLITIS, V10, pS17; D'Haens GR, 2011, AM J GASTROENTEROL, V106, P199, DOI 10.1038/ajg.2010.392; Danese S, 2016, J CROHNS COLITIS, V10, P1362, DOI 10.1093/ecco-jcc/jjw090; De Cruz P, 2015, LANCET, V385, P1406, DOI 10.1016/S0140-6736(14)61908-5; de Suray N, 2012, GASTROENTEROLOGY, V142, pS149; Drobne D, 2015, CLIN GASTROENTEROL H, V13, P514, DOI 10.1016/j.cgh.2014.07.027; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Dulai PS, 2016, AM J GASTROENTEROL, V111, P1147, DOI 10.1038/ajg.2016.236; Dulai PS, 2014, GUT, V63, P1843, DOI 10.1136/gutjnl-2014-307126; Duron C, 2015, EUR J GASTROEN HEPAT, V27, P705, DOI 10.1097/MEG.0000000000000354; Ebbers HC, 2016, BIODRUGS, V30, P1, DOI 10.1007/s40259-015-0154-1; Ellinghaus D, 2015, SCAND J GASTROENTERO, V50, P13, DOI 10.3109/00365521.2014.990507; Engel T, 2016, THER ADV CHRONIC DIS, V7, P208, DOI 10.1177/2040622316653306; Essat M, 2016, PHARMACOECONOMICS, V34, P245, DOI 10.1007/s40273-015-0334-3; Farraye FA, 2017, AM J GASTROENTEROL, V112, P241, DOI 10.1038/ajg.2016.537; Feagan BG, 2014, GASTROENTEROLOGY, V146, P681, DOI 10.1053/j.gastro.2013.11.024; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Feagan BG, 2008, CLIN GASTROENTEROL H, V6, P1370, DOI 10.1016/j.cgh.2008.06.007; Fernandes C, 2015, IMMUNOTHERAPY-UK, V7, P175, DOI 10.2217/imt.14.105; Ferrante M, 2015, J CROHNS COLITIS, V9, P617, DOI 10.1093/ecco-jcc/jjv076; Feuerstein JD, 2014, GASTROENTEROL CLIN N, V43, P543, DOI 10.1016/j.gtc.2014.05.002; Filippi J, 2015, J CROHNS COLITIS, V9, P252, DOI 10.1093/ecco-jcc/jjv001; Fiorino G, 2014, AUTOIMMUN REV, V13, P15, DOI 10.1016/j.autrev.2013.06.005; Fischer M, 2014, GASTROENTEROLOGY, V146, pS450; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Fornaro R, 2015, SURG-J R COLL SURG E, V13, P330, DOI 10.1016/j.surge.2015.04.002; Fumery M, 2017, AM J GASTROENTEROL, V112, P337, DOI 10.1038/ajg.2016.541; Garcia-Doval I, 2017, BRIT J DERMATOL, V176, P643, DOI 10.1111/bjd.14776; Ghazi LJ, 2013, INFLAMM BOWEL DIS, V19, P1397, DOI 10.1097/MIB.0b013e318281337d; Gibson DJ, 2015, CLIN GASTROENTEROL H, V13, P330, DOI 10.1016/j.cgh.2014.07.041; Gils A, 2014, THER DRUG MONIT, V36, P669, DOI 10.1097/FTD.0000000000000074; Gionchetti P, 2017, J CROHNS COLITIS, V11, P135, DOI 10.1093/ecco-jcc/jjw169; Gisbert JP, 2015, ALIMENT PHARM THER, V42, P391, DOI 10.1111/apt.13276; Gisbert JP, 2016, AM J GASTROENTEROL, V111, P632, DOI 10.1038/ajg.2016.54; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Guerra I, 2016, INFLAMM BOWEL DIS, V22, P894, DOI 10.1097/MIB.0000000000000757; Hahn L, 2015, AM J HEALTH-SYST PH, V72, P1271, DOI 10.2146/ajhp140449; Han YM, 2016, J GASTROEN HEPATOL, V31, P1436, DOI 10.1111/jgh.13310; Hanauer SB, 2003, BEST PRACT RES CL GA, V17, P131, DOI 10.1053/bega.2003.0361; Hansen T, 2016, EXPERT REV GASTROENT, V10, P989, DOI 10.1080/17474124.2016.1215912; Harbord M, 2017, J CROHNS COLITIS, V11, P769, DOI 10.1093/ecco-jcc/jjx009; Hellstrom AE, 2016, SCAND J GASTROENTERO, V51, P563, DOI 10.3109/00365521.2015.1125524; Herfarth HH, 2016, INFLAMM BOWEL DIS, V22, P224, DOI 10.1097/MIB.0000000000000589; Herfarth HH, 2015, CLIN GASTROENTEROL H, V13, P336, DOI 10.1016/j.cgh.2014.09.045; Hirten R, 2015, AM J GASTROENTEROL, V110, P1737, DOI 10.1038/ajg.2015.355; Hordonneau C, 2014, AM J GASTROENTEROL, V109, P89, DOI 10.1038/ajg.2013.385; Jahnsen Jorgen, 2015, Expert Rev Gastroenterol Hepatol, V9 Suppl 1, P45, DOI 10.1586/17474124.2015.1091308; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Jelsness-Jorgensen LP, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/492034; Jha A, 2015, ADV THER, V32, P742, DOI 10.1007/s12325-015-0233-1; Jones JL, 2015, CLIN GASTROENTEROL H, V13, P2233, DOI 10.1016/j.cgh.2015.06.034; Kamm MA, 2014, J CROHNS COLITIS, V8, pS13, DOI 10.1016/S1873-9946(14)60024-6; Kaplan GG, 2015, WORLD J GASTROENTERO, V21, P1251, DOI 10.3748/wjg.v21.i4.1251; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Karmiris K, 2009, GASTROENTEROLOGY, V137, P1628, DOI 10.1053/j.gastro.2009.07.062; Karoui S, 2013, Tunis Med, V91, P230; Khan N, 2013, GASTROENTEROLOGY, V145, P1007, DOI 10.1053/j.gastro.2013.07.035; Khanna R, 2015, ALIMENT PHARM THER, V41, P77, DOI 10.1111/apt.13001; Khanna R, 2015, LANCET, V386, P1825, DOI 10.1016/S0140-6736(15)00068-9; Kirchgesner J, 2016, ALIMENT PHARM THER, V43, P838, DOI 10.1111/apt.13563; Kopylov U, 2016, THER ADV GASTROENTER, V9, P513, DOI 10.1177/1756283X16638833; Kopylov U, 2012, INFLAMM BOWEL DIS, V18, P2404, DOI 10.1002/ibd.22954; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Kotlyar DS, 2011, CLIN GASTROENTEROL H, V9, P36, DOI 10.1016/j.cgh.2010.09.016; Kotze PG, 2018, CURR DRUG TARGETS, V19, P729, DOI 10.2174/1389450116666151102094922; Kotze PG, 2015, J CROHNS COLITIS, V9, P541, DOI 10.1093/ecco-jcc/jjv055; Kovacs M, 2014, WORLD J GASTROENTERO, V20, P4873, DOI 10.3748/wjg.v20.i17.4873; Kurnik D, 2003, ALIMENT PHARM THER, V18, P57, DOI 10.1046/j.1365-2036.2003.01614.x; Laharie D, 2012, LANCET, V380, P1909, DOI 10.1016/S0140-6736(12)61084-8; Lau C, 2015, ANN SURG, V261, P487, DOI 10.1097/SLA.0000000000000757; LeBlanc K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008655.pub3; Lee YM, 2015, J PEDIATR GASTR NUTR, V60, P737, DOI 10.1097/MPG.0000000000000711; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; LINDBERG E, 1992, GUT, V33, P779, DOI 10.1136/gut.33.6.779; Lobaton T, 2015, ALIMENT PHARM THER, V42, P441, DOI 10.1111/apt.13294; Loftus Edward V Jr, 2016, Gastroenterol Hepatol (N Y), V12, P704; Lopez A, 2015, DIGEST LIVER DIS, V47, P356, DOI 10.1016/j.dld.2015.01.148; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; Ma C, 2017, ALIMENT PHARM THER, V45, P1232, DOI 10.1111/apt.14016; Ma C, 2016, INFLAMM BOWEL DIS, V22, P870, DOI 10.1097/MIB.0000000000000679; Ma C, 2015, J CLIN GASTROENTEROL, V49, P675, DOI 10.1097/MCG.0000000000000265; Mahadevan U, 2014, GASTROENTEROLOGY, V146, pS1; Malkonen T, 2014, INFLAMM BOWEL DIS, V20, P1309, DOI 10.1097/MIB.0000000000000088; Mantzaris GJ, 2016, DIGEST DIS, V34, P132, DOI 10.1159/000443128; Marchetti M, 2013, EUR J HEALTH ECON, V14, P853, DOI 10.1007/s10198-012-0430-7; McConnell RA, 2016, INFLAMM BOWEL DIS, V22, P213, DOI 10.1097/MIB.0000000000000596; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; McLean LP, 2016, EXPERT OPIN INV DRUG, V25, P263, DOI 10.1517/13543784.2016.1148137; Mei WQ, 2015, WORLD J GASTROENTERO, V21, P6044, DOI 10.3748/wjg.v21.i19.6044; Molander P, 2015, J CROHNS COLITIS, V9, P33, DOI 10.1016/j.crohns.2014.06.012; Molnar T, 2013, ALIMENT PHARM THER, V37, P225, DOI 10.1111/apt.12160; Monteleone G, 2015, NEW ENGL J MED, V372, P1104, DOI 10.1056/NEJMoa1407250; Moran GW, 2013, ALIMENT PHARM THER, V38, P1002, DOI 10.1111/apt.12491; Morar PS, 2015, COLORECTAL DIS, V17, pO247, DOI 10.1111/codi.13094; Moss AC, 2008, ALIMENT PHARM THER, V28, P221, DOI 10.1111/j.1365-2036.2008.03734.x; Narula N, 2013, ALIMENT PHARM THER, V37, P1057, DOI 10.1111/apt.12313; Ng SW, 2013, EXPERT REV CLIN IMMU, V9, P161, DOI [10.1586/eci.12.103, 10.1586/ECI.12.103]; Olbjorn C, 2014, SCAND J GASTROENTERO, V49, P1425, DOI 10.3109/00365521.2014.966316; Onali S, 2016, DIGEST LIVER DIS, V48, P489, DOI 10.1016/j.dld.2016.01.009; Ong DEH, 2013, J GASTROEN HEPATOL, V28, P1595, DOI 10.1111/jgh.12263; Oren R, 1996, GASTROENTEROLOGY, V110, P1416, DOI 10.1053/gast.1996.v110.pm8613046; Oussalah A, 2010, AM J GASTROENTEROL, V105, P1142, DOI 10.1038/ajg.2010.158; Panaccione R, 2015, INFLAMM BOWEL DIS, V21, P1329, DOI 10.1097/MIB.0000000000000366; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Papamichael K, 2016, CLIN GASTROENTEROL H, V14, P543, DOI 10.1016/j.cgh.2015.11.014; Papamichael K, 2015, J CROHNS COLITIS, V9, P589, DOI 10.1093/ecco-jcc/jjv062; Papamichael K, 2015, CLIN GASTROENTEROL H, V13, P1103, DOI 10.1016/j.cgh.2014.11.026; Papay P, 2013, J CROHNS COLITIS, V7, P653, DOI 10.1016/j.crohns.2013.02.005; Papp M, 2014, CURR OPIN GASTROEN, V30, P359, DOI 10.1097/MOG.0000000000000076; Pariente B, 2015, GASTROENTEROLOGY, V148, P52, DOI 10.1053/j.gastro.2014.09.015; Parikh A, 2013, INFLAMM BOWEL DIS, V19, P1691, DOI 10.1097/MIB.0b013e318281f538; Park DI, 2016, INTEST RES, V14, P15, DOI 10.5217/ir.2016.14.1.15; Peyrin-Biroulet L, 2015, AM J GASTROENTEROL, V110, P1324, DOI 10.1038/ajg.2015.233; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Poturoglu Sule, 2016, World J Gastrointest Pharmacol Ther, V7, P490; Raaschou P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i262; Rafia R, 2016, PHARMACOECONOMICS, V34, P1241, DOI 10.1007/s40273-016-0436-6; Regueiro M, 2014, CLIN GASTROENTEROL H, V12, P1494, DOI 10.1016/j.cgh.2013.12.035; Regueiro M, 2011, INFLAMM BOWEL DIS, V17, P118, DOI 10.1002/ibd.21355; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; Reinink AR, 2016, INFLAMM BOWEL DIS, V22, P1859, DOI 10.1097/MIB.0000000000000816; Reinisch Walter, 2015, Expert Rev Gastroenterol Hepatol, V9 Suppl 1, P17, DOI 10.1586/17474124.2015.1091306; Reinisch W, 2015, GASTROENTEROLOGY, V148, pS1193, DOI 10.1053/j.gastro.2015.08.023; Rogler G, 2013, DIGEST DIS, V31, P83, DOI 10.1159/000347190; Rosen MJ, 2015, ALIMENT PHARM THER, V41, P1094, DOI 10.1111/apt.13175; Rubin DT, 2012, INFLAMM BOWEL DIS, V18, P2225, DOI 10.1002/ibd.22925; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sachar DB, 2014, INFLAMM BOWEL DIS, V20, P2511, DOI 10.1097/MIB.0000000000000135; Sachar David B, 2013, Curr Gastroenterol Rep, V15, P298, DOI 10.1007/s11894-012-0298-9; Sachar DB, 2002, GUT, V51, P764, DOI 10.1136/gut.51.6.764; Sakuraba A, 2015, DIGESTION, V91, P233, DOI 10.1159/000375302; Sandborn WJ, 2016, J CROHNS COLITIS, V10, pS15; Sandborn WJ, 2007, ANN INTERN MED, V146, P829, DOI 10.7326/0003-4819-146-12-200706190-00159; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, P1250, DOI 10.1053/j.gastro.2009.06.061; Sandborn WJ, 2017, NEW ENGL J MED, V376, P1723, DOI 10.1056/NEJMoa1606910; Sandborn WJ, 2016, CURR MED RES OPIN, V32, P1233, DOI 10.1185/03007995.2016.1168290; Sandborn WJ, 2016, NEW ENGL J MED, V374, P1754, DOI 10.1056/NEJMoa1513248; Sandborn WJ, 2014, J CROHNS COLITIS, V8, P927, DOI 10.1016/j.crohns.2014.02.021; Sandborn WJ, 2014, CLIN GASTROENTEROL H, V12, P1485, DOI 10.1016/j.cgh.2014.01.029; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P96, DOI 10.1053/j.gastro.2013.06.010; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Sandborn WJ, 2010, CLIN GASTROENTEROL H, V8, P688, DOI 10.1016/j.cgh.2010.04.021; Sandborn WJ, 2009, GASTROENTEROLOGY, V136, pA520, DOI 10.1053/j.gastro.2009.06.061; Sands BE, 2005, INFLAMM BOWEL DIS, V11, P133, DOI 10.1097/00054725-200502000-00006; Sands BE, 2001, INFLAMM BOWEL DIS, V7, P83, DOI 10.1097/00054725-200105000-00001; Sands BE, 2007, INFLAMM BOWEL DIS, V13, P2, DOI 10.1002/ibd.20014; Sands BE, 2015, GASTROENTEROLOGY, V149, P1275, DOI 10.1053/j.gastro.2015.07.003; Sands BE, 2014, GASTROENTEROLOGY, V147, P618, DOI 10.1053/j.gastro.2014.05.008; Sartor RB, 2015, CLIN GASTROENTEROL H, V13, P936, DOI 10.1016/j.cgh.2014.12.027; Savarino E, 2013, AM J GASTROENTEROL, V108, P1731, DOI 10.1038/ajg.2013.287; Schreiber S, 2013, J CROHNS COLITIS, V7, P213, DOI 10.1016/j.crohns.2012.05.015; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Schulze K, 2016, BIOLOGICALS, V44, P463, DOI 10.1016/j.biologicals.2016.06.011; Scott FI, 2016, JAMA DERMATOL, V152, P164, DOI 10.1001/jamadermatol.2015.3029; Selvaggi F, 2014, INFLAMM BOWEL DIS, V20, P1296, DOI 10.1097/MIB.0000000000000026; Seow CH, 2010, GUT, V59, P49, DOI 10.1136/gut.2009.183095; Seror R, 2017, RHEUM DIS CLIN N AM, V43, P43, DOI 10.1016/j.rdc.2016.09.006; Setshedi M, 2012, J GASTROEN HEPATOL, V27, P385, DOI 10.1111/j.1440-1746.2011.06865.x; Shah ED, 2017, INFLAMM BOWEL DIS, V23, P570, DOI 10.1097/MIB.0000000000001049; Sieczkowska J, 2016, J CROHNS COLITIS, V10, P127, DOI 10.1093/ecco-jcc/jjv233; Simon EG, 2016, THER ADV GASTROENTER, V9, P26, DOI 10.1177/1756283X15618130; Singh Namita, 2015, Gastroenterol Hepatol (N Y), V11, P48; Singh S, 2016, CLIN GASTROENTEROL H, V14, P1120, DOI 10.1016/j.cgh.2016.03.038; Singh S, 2015, GASTROENTEROLOGY, V148, P64, DOI 10.1053/j.gastro.2014.09.031; Sjoberg M, 2011, GASTROENTEROLOGY, V140, pS590; Smits LJT, 2016, J CROHNS COLITIS, V10, P1287, DOI 10.1093/ecco-jcc/jjw087; Sokol H, 2009, GASTROENTEROLOGY, V136, pA187; Sorrentino D, 2006, EUR J GASTROEN HEPAT, V18, P457, DOI 10.1097/00042737-200604000-00025; Sostegni R, 2003, ALIMENT PHARM THER, V17, P11, DOI 10.1046/j.1365-2036.17.s2.17.x; Steenholdt C, 2011, ALIMENT PHARM THER, V34, P51, DOI 10.1111/j.1365-2036.2011.04682.x; Steenholdt C, 2016, INFLAMM BOWEL DIS, V22, P1999, DOI 10.1097/MIB.0000000000000772; Steenholdt C, 2016, J CLIN GASTROENTEROL, V50, P483, DOI 10.1097/MCG.0000000000000375; Steenholdt C, 2015, J CROHNS COLITIS, V9, P238, DOI 10.1093/ecco-jcc/jjv004; Steenholdt C, 2014, GUT, V63, P919, DOI 10.1136/gutjnl-2013-305279; Steenholdt C, 2012, INFLAMM BOWEL DIS, V18, P2209, DOI 10.1002/ibd.22910; Thia K, 2011, INFLAMM BOWEL DIS, V17, P105, DOI 10.1002/ibd.21400; Thorlund K, 2015, EXPERT REV GASTROENT, V9, P693, DOI 10.1586/17474124.2015.1024657; Thorlund K, 2014, J CROHNS COLITIS, V8, P571, DOI 10.1016/j.crohns.2014.01.010; Torres J, 2015, GASTROENTEROLOGY, V149, P1, DOI 10.1053/j.gastro.2015.08.055; Torres J, 2012, INFLAMM BOWEL DIS, V18, P1356, DOI 10.1002/ibd.22839; Ungar B, 2017, ALIMENT PHARM THER, V45, P276, DOI 10.1111/apt.13862; Ungar B, 2016, ALIMENT PHARM THER, V43, P1293, DOI 10.1111/apt.13631; Ungar B, 2016, CLIN GASTROENTEROL H, V14, P550, DOI 10.1016/j.cgh.2015.10.025; Ungar B, 2014, GUT, V63, P1258, DOI 10.1136/gutjnl-2013-305259; Van Assche G, 2008, GASTROENTEROLOGY, V134, P1861, DOI 10.1053/j.gastro.2008.03.004; van Schaik T, 2014, INFLAMM BOWEL DIS, V20, P2292, DOI 10.1097/MIB.0000000000000208; Vande Casteele N, 2015, GASTROENTEROLOGY, V148, P1320, DOI 10.1053/j.gastro.2015.02.031; Vande Casteele N, 2013, AM J GASTROENTEROL, V108, P962, DOI 10.1038/ajg.2013.12; Varkas G, 2016, ANN RHEUM DIS, V75, P1423, DOI 10.1136/annrheumdis-2015-208194; Vaughn BP, 2014, WORLD J GASTROENTERO, V20, P1147, DOI 10.3748/wjg.v20.i5.1147; Vaysse T, 2015, J CROHNS COLITIS, V9, P303, DOI 10.1093/ecco-jcc/jjv038; Velayos FS, 2013, CLIN GASTROENTEROL H, V11, P654, DOI 10.1016/j.cgh.2012.12.035; Velayos Fernando S, 2007, Curr Gastroenterol Rep, V9, P521, DOI 10.1007/s11894-007-0069-1; Vermeire S, 2016, J CROHNS COLITIS, V10, pS15; Vermeire S, 2007, GUT, V56, P1226, DOI 10.1136/gut.2006.099978; Vermeire S, 2017, LANCET, V389, P266, DOI 10.1016/S0140-6736(16)32537-5; Ward MG, 2015, WORLD J GASTROENTERO, V21, P11331, DOI 10.3748/wjg.v21.i40.11331; Wenger S, 2012, J CROHNS COLITIS, V6, P21, DOI 10.1016/j.crohns.2011.06.006; Yamamoto T, 2013, COLORECTAL DIS, V15, P1471, DOI 10.1111/codi.12326; Yanai H, 2015, CLIN GASTROENTEROL H, V13, P522, DOI 10.1016/j.cgh.2014.07.029; Yang Z, 2012, ALIMENT PHARM THER, V36, P922, DOI 10.1111/apt.12060; Yarur AJ, 2016, INFLAMM BOWEL DIS, V22, P409, DOI 10.1097/MIB.0000000000000689; Yarur AJ, 2015, CLIN GASTROENTEROL H, V13, P1118, DOI 10.1016/j.cgh.2014.12.026	257	90	93	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2017	357								j2505	10.1136/bmj.j2505	http://dx.doi.org/10.1136/bmj.j2505			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YR	28630047	Green Published			2022-12-28	WOS:000404209600001
J	Klompmaker, AA; Kowalewski, M; Huntley, JW; Finnegan, S				Klompmaker, Adiel A.; Kowalewski, Michal; Huntley, John Warren; Finnegan, Seth			Increase in predator-prey size ratios throughout the Phanerozoic history of marine ecosystems	SCIENCE			English	Article							DRILLING PREDATION; LARGE-SCALE; BRACHIOPODS; DIVERSITY; PATTERNS; EVOLUTION; BOREHOLES; SEAFOOD; TIME	The escalation hypothesis posits that predation by increasingly powerful and metabolically active carnivores has been a major driver of metazoan evolution. We test a key tenet of this hypothesis by analyzing predatory drill holes in fossil marine shells, which provide a similar to 500-million-year record of individual predator-prey interactions. We show that drill-hole size is a robust predictor of body size among modern drilling predators and that drill-hole size (and thus inferred predator size and power) rose substantially from the Ordovician to the Quaternary period, whereas the size of drilled prey remained stable. Together, these trends indicate a directional increase in predator-prey size ratios. We hypothesize that increasing predator-prey size ratios reflect increases in prey abundance, prey nutrient content, and predation among predators.	[Klompmaker, Adiel A.; Finnegan, Seth] Univ Calif Berkeley, Dept Integrat Biol, 1005 Valley Life Sci Bldg 3140, Berkeley, CA 94720 USA; [Klompmaker, Adiel A.; Finnegan, Seth] Univ Calif Berkeley, Museum Paleontol, 1005 Valley Life Sci Bldg 3140, Berkeley, CA 94720 USA; [Klompmaker, Adiel A.; Kowalewski, Michal] Univ Florida, Florida Museum Nat Hist, 1659 Museum Rd, Gainesville, FL 32611 USA; [Huntley, John Warren] Univ Missouri, Dept Geol Sci, 101 Geology Bldg, Columbia, MO 65211 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Columbia	Klompmaker, AA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 1005 Valley Life Sci Bldg 3140, Berkeley, CA 94720 USA.; Klompmaker, AA (corresponding author), Univ Calif Berkeley, Museum Paleontol, 1005 Valley Life Sci Bldg 3140, Berkeley, CA 94720 USA.; Klompmaker, AA (corresponding author), Univ Florida, Florida Museum Nat Hist, 1659 Museum Rd, Gainesville, FL 32611 USA.	adielklompmaker@gmail.com	Kowalewski, Michal/B-4263-2008	Kowalewski, Michal/0000-0002-8575-4711; Huntley, John/0000-0001-9955-8853	Packard Foundation; Jon L. and Beverly A. Thompson Endowment Fund; National Science Foundation [EAR-1650745]	Packard Foundation(The David & Lucile Packard Foundation); Jon L. and Beverly A. Thompson Endowment Fund; National Science Foundation(National Science Foundation (NSF))	We acknowledge funding from the Packard Foundation (S.F. and A.A.K.), the Jon L. and Beverly A. Thompson Endowment Fund (A.A.K. and M.K.), and the National Science Foundation EAR-1650745 (J.W.H.). A. Daley, A. Hastings, G. Herbert, and T. Troost provided valuable information. C. Robins offered useful input. We thank two anonymous reviewers and P. Novack-Gottshall for insightful comments that substantially improved this paper. The WoRMS database (marinespecies.org) and the Paleobiology Database (PBDB) (paleobiodb.org) were used to augment taxonomic, lithostratigraphic, lithification, and paleoecologic data. This is PBDB publication 285. All data used to conduct analyses are available from Figshare (database 1, doi:10.6084/m9.figshare.5046949; database 2, doi:10.6084/m9.figshare.5046964).	ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; Allmon WD, 2014, PALEOBIOLOGY, V40, P256, DOI 10.1666/13065; Bambach R. K., 2002, SOC PAP, V8, P319; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Cherns L, 2000, GEOLOGY, V28, P791, DOI 10.1130/0091-7613(2000)28<791:MMAEOL>2.0.CO;2; Daley AC, 2008, CAN J EARTH SCI, V45, P213, DOI 10.1139/E07-061; Gahn FJ, 2006, HIST BIOL, V18, P397, DOI 10.1080/08912960600668524; Hoffmeister AP, 2004, ACTA PALAEONTOL POL, V49, P443; Holland SM, 2015, PALEOBIOLOGY, V41, P369, DOI 10.1017/pab.2015.10; Hunt G, 2015, P NATL ACAD SCI USA, V112, P4885, DOI 10.1073/pnas.1403662111; Huntley JW, 2007, P NATL ACAD SCI USA, V104, P15006, DOI 10.1073/pnas.0704960104; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; KIDWELL SM, 1994, GEOLOGY, V22, P1139, DOI 10.1130/0091-7613(1994)022<1139:PIBATT>2.3.CO;2; Kosnik MA, 2011, PALEOBIOLOGY, V37, P303, DOI 10.1666/10022.1; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; Leighton LR, 2013, GEOLOGY, V41, P275, DOI 10.1130/G33750.1; Leighton LR, 2001, PALAEOGEOGR PALAEOCL, V165, P53, DOI 10.1016/S0031-0182(00)00153-X; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Mondal S, 2017, PALAIOS, V32, P278, DOI 10.2110/palo.2016.050; Mottequin B, 2009, LETHAIA, V42, P274, DOI 10.1111/j.1502-3931.2008.00137.x; ORR VIRGINIA, 1962, VELIGER, V5, P63; Payne JL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3122; PECK LS, 1993, PHILOS T ROY SOC B, V339, P17, DOI 10.1098/rstb.1993.0002; Porter SM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0221; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Simoes MG, 2007, PALAIOS, V22, P143, DOI 10.2110/palo.2006.p06-040r; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Troost TA, 2008, EVOL ECOL, V22, P771, DOI 10.1007/s10682-007-9209-1; Tyler CL, 2013, PALAIOS, V28, P724, DOI 10.2110/palo.2013.p13-037r; Vermeij G.J., 1987, EVOLUTION ESCALATION; Vermeij GJ, 2013, ANNU REV EARTH PL SC, V41, P1, DOI 10.1146/annurev-earth-050212-124123	36	35	35	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1178	1180		10.1126/science.aam7468	http://dx.doi.org/10.1126/science.aam7468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619943				2022-12-28	WOS:000403327400039
J	Raj, I; Al Hosseini, HS; Dioguardi, E; Nishimura, K; Han, L; Villa, A; de Sanctis, D; Jovine, L				Raj, Isha; Al Hosseini, Hamed Sadat; Dioguardi, Elisa; Nishimura, Kaoru; Han, Ling; Villa, Alessandra; de Sanctis, Daniele; Jovine, Luca			Structural Basis of Egg Coat-Sperm Recognition at Fertilization	CELL			English	Article							VITELLINE ENVELOPE RECEPTOR; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; ABALONE LYSIN; PROTEIN; CRYSTALLOGRAPHY; EVOLUTION; SYSTEM; DIFFRACTION; FEATURES	Recognition between sperm and the egg surface marks the beginning of life in all sexually reproducing organisms. This fundamental biological event depends on the species-specific interaction between rapidly evolving counterpart molecules on the gametes. We report biochemical, crystallographic, and mutational studies of domain repeats 1-3 of invertebrate egg coat protein VERL and their interaction with cognate sperm protein lysin. VERL repeats fold like the functionally essential N-terminal repeat of mammalian sperm receptor ZP2, whose structure is also described here. Whereas sequence-divergent repeat 1 does not bind lysin, repeat 3 binds it non-species specifically via a high-affinity, largely hydrophobic interface. Due to its intermediate binding affinity, repeat 2 selectively interacts with lysin from the same species. Exposure of a highly positively charged surface of VERL-bound lysin suggests that complex formation both disrupts the organization of egg coat filaments and triggers their electrostatic repulsion, thereby opening a hole for sperm penetration and fusion.	[Raj, Isha; Al Hosseini, Hamed Sadat; Dioguardi, Elisa; Nishimura, Kaoru; Han, Ling; Villa, Alessandra; Jovine, Luca] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Raj, Isha; Al Hosseini, Hamed Sadat; Dioguardi, Elisa; Nishimura, Kaoru; Han, Ling; Villa, Alessandra; Jovine, Luca] Karolinska Inst, Ctr Innovat Med, SE-14183 Huddinge, Sweden; [de Sanctis, Daniele] European Synchrotron Radiat Facil, F-38000 Grenoble, France	Karolinska Institutet; Karolinska Institutet; European Synchrotron Radiation Facility (ESRF)	Jovine, L (corresponding author), Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden.	luca.jovine@ki.se	Jovine, Luca/E-8170-2010; Villa, Alessandra/A-1554-2010; Jovine, Luca/J-3563-2019	Jovine, Luca/0000-0002-2679-6946; Villa, Alessandra/0000-0002-9573-0326; Jovine, Luca/0000-0002-2679-6946; Raj, Isha/0000-0003-4686-0498	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [260759]; Karolinska Institutet; Center for Biosciences; Center for Innovative Medicine; Swedish Research Council [2012-5093]; Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; Sven and Ebba-Christina Hagberg Foundation; EMBO Young Investigator award	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Karolinska Institutet(Karolinska Institutet); Center for Biosciences; Center for Innovative Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; Sven and Ebba-Christina Hagberg Foundation; EMBO Young Investigator award(European Molecular Biology Organization (EMBO))	We are grateful to R. Aricescu and Y. Zhao (University of Oxford) for mammalian expression vector pHLsec and HEK293T cells; D. Leahy (Johns Hopkins University School of Medicine) for E. coli expression vector pProEX HT-endoglycosidase H; V. Vacquier (University of California San Diego) and W. Swanson (University of Washington) for anti-lysin polyclonal antibodies; A. Stsiapanava (Karolinska Institutet) for data collection at ESRF ID23-1 and comments; ESRF for access to structural biology beamlines. This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 260759; Karolinska Institutet; the Center for Biosciences; the Center for Innovative Medicine; Swedish Research Council grant 2012-5093; the Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; the Sven and Ebba-Christina Hagberg Foundation; and an EMBO Young Investigator award.	Aagaard JE, 2010, MOL BIOL EVOL, V27, P193, DOI 10.1093/molbev/msp221; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Aydin H, 2016, NATURE, V534, P562, DOI 10.1038/nature18595; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; Bokhove M, 2016, J STRUCT BIOL, V194, P1, DOI 10.1016/j.jsb.2016.01.016; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Galindo BE, 2003, P NATL ACAD SCI USA, V100, P4639, DOI 10.1073/pnas.0830022100; Galindo BE, 2002, GENE, V288, P111, DOI 10.1016/S0378-1119(02)00459-6; Gallo A, 2012, MAR DRUGS, V10, P2861, DOI 10.3390/md10122861; Gildea RJ, 2014, ACTA CRYSTALLOGR D, V70, P2652, DOI 10.1107/S1399004714017039; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kresge N, 2001, BIOESSAYS, V23, P95, DOI 10.1002/1521-1878(200101)23:1<95::AID-BIES1012>3.3.CO;2-3; Kresge N, 2000, ACTA CRYSTALLOGR D, V56, P34, DOI 10.1107/S0907444999014626; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee YH, 1995, MAR BIOL, V124, P267, DOI 10.1007/BF00347131; LEWIS CA, 1982, DEV BIOL, V92, P227, DOI 10.1016/0012-1606(82)90167-1; Lillie FR, 1914, J EXP ZOOL, V16, P523, DOI 10.1002/jez.1400160404; Lyon JD, 1999, DEV BIOL, V214, P151, DOI 10.1006/dbio.1999.9411; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MESSIER W, 1994, CURR BIOL, V4, P911, DOI 10.1016/S0960-9822(00)00202-5; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Ohto U, 2016, NATURE, V534, P566, DOI 10.1038/nature18596; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sanchez-Weatherby J, 2009, ACTA CRYSTALLOGR D, V65, P1237, DOI 10.1107/S0907444909037822; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; SHAW A, 1993, SCIENCE, V262, P1864, DOI 10.1126/science.8266073; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Swanson WJ, 2011, MOL BIOL EVOL, V28, P1963, DOI 10.1093/molbev/msr026; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 1997, P NATL ACAD SCI USA, V94, P6724, DOI 10.1073/pnas.94.13.6724; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; VACQUIER VD, 1990, P NATL ACAD SCI USA, V87, P5792, DOI 10.1073/pnas.87.15.5792; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	71	42	44	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1315	+		10.1016/j.cell.2017.05.033	http://dx.doi.org/10.1016/j.cell.2017.05.033			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622512	Green Published, hybrid			2022-12-28	WOS:000403332400019
J	Wang, HZ; Nicolay, BN; Chick, JM; Gao, XL; Geng, Y; Ren, H; Gao, H; Yang, GZ; Williams, JA; Suski, JM; Keibler, MA; Sicinska, E; Gerdemann, U; Haining, WN; Roberts, TM; Polyak, K; Gygi, SP; Dyson, NJ; Sicinski, P				Wang, Haizhen; Nicolay, Brandon N.; Chick, Joel M.; Gao, Xueliang; Geng, Yan; Ren, Hong; Gao, Hui; Yang, Guizhi; Williams, Juliet A.; Suski, Jan M.; Keibler, Mark A.; Sicinska, Ewa; Gerdemann, Ulrike; Haining, W. Nicholas; Roberts, Thomas M.; Polyak, Kornelia; Gygi, Steven P.; Dyson, Nicholas J.; Sicinski, Piotr			The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival	NATURE			English	Article							PYRUVATE-KINASE; PROTEIN-PHOSPHORYLATION; CDK4/6 INHIBITION; FLUX ANALYSIS; M2; SITE; PHOSPHOFRUCTOKINASES; CATABOLISM; CONFIDENCE; GLUTAMINE	D-type cyclins (D1, D2 and D3) and their associated cyclin-dependent kinases (CDK4 and CDK6) are components of the core cell cycle machinery that drives cell proliferation(1,2). Inhibitors of CDK4 and CDK6 are currently being tested in clinical trials for patients with several cancer types, with promising results(2). Here, using human cancer cells and patient-derived xenografts in mice, we show that the cyclin D3-CDK6 kinase phosphorylates and inhibits the catalytic activity of two key enzymes in the glycolytic pathway, 6-phosphofructokinase and pyruvate kinase M2. This re-directs the glycolytic intermediates into the pentose phosphate (PPP) and serine pathways. Inhibition of cyclin D3-CDK6 in tumour cells reduces flow through the PPP and serine pathways, thereby depleting the antioxidants NADPH and glutathione. This, in turn, increases the levels of reactive oxygen species and causes apoptosis of tumour cells. The pro-survival function of cyclin D-associated kinase operates in tumours expressing high levels of cyclin D3-CDK6 complexes. We propose that measuring the levels of cyclin D3-CDK6 in human cancers might help to identify tumour subsets that undergo cell death and tumour regression upon inhibition of CDK4 and CDK6. Cyclin D3-CDK6, through its ability to link cell cycle and cell metabolism, represents a particularly powerful oncoprotein that affects cancer cells at several levels, and this property can be exploited for anti-cancer therapy.	[Wang, Haizhen; Gao, Xueliang; Geng, Yan; Ren, Hong; Suski, Jan M.; Roberts, Thomas M.; Sicinski, Piotr] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Wang, Haizhen; Geng, Yan; Ren, Hong; Suski, Jan M.; Sicinski, Piotr] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Nicolay, Brandon N.; Dyson, Nicholas J.] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02129 USA; [Chick, Joel M.; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Gao, Xueliang; Roberts, Thomas M.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Gao, Hui; Yang, Guizhi; Williams, Juliet A.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Keibler, Mark A.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Sicinska, Ewa] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA; [Gerdemann, Ulrike] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, Boston, MA 02115 USA; [Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Novartis; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Sicinski, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.; Sicinski, P (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	peter_sicinski@dfci.harvard.edu	Suski, Jan/AAP-9727-2021	Gerdemann, Ulrike/0000-0002-3600-0366; Suski, Jan/0000-0001-5657-2655	NIH [T32CA009361, P50 CA090381-14]; Mobilnosc Plus fellowship;  [R01 CA083688];  [R01 CA202634];  [P01 CA080111];  [R01 CA163698];  [F32 CA165856]; NATIONAL CANCER INSTITUTE [R01CA083688, F32CA165856, P01CA080111, P50CA090381, R01CA190509, R01CA163698, R01CA202634, T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mobilnosc Plus fellowship; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by R01 CA083688, R01 CA202634, P01 CA080111 (P.S.), R01 CA163698 (N.J.D.) and F32 CA165856 (B.N.N.). N.J.D. is a James and Shirley Curvey MGH Research Scholar. X.G. was supported by an NIH post-doc training grant (T32CA009361) and NIH grant P50 CA090381-14 (DF/HCC SPORE in Prostate Cancer). J.M.S. was supported by a Mobilnosc Plus fellowship. We thank M. Eck, J. Daly, P. Hydbring, T. Otto, W. Michowski and I. Harris for help.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Bruser A, 2012, J BIOL CHEM, V287, P17546, DOI 10.1074/jbc.M112.347153; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cetica P, 2002, REPRODUCTION, V124, P675, DOI 10.1530/reprod/124.5.675; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Dean JL, 2012, CELL CYCLE, V11, P2756, DOI 10.4161/cc.21195; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; DIVITA G, 1993, J BIOL CHEM, V268, P13178; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; KOTLARZ D, 1982, METHOD ENZYMOL, V90, P60; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Nicolay BN, 2013, GENE DEV, V27, P182, DOI 10.1101/gad.206227.112; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Sawai CM, 2012, CANCER CELL, V22, P452, DOI 10.1016/j.ccr.2012.09.016; Schoneberg T, 2013, BIOL CHEM, V394, P977, DOI 10.1515/hsz-2013-0130; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Vertommen D, 1996, J BIOL CHEM, V271, P17875, DOI 10.1074/jbc.271.30.17875; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632	36	61	61	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					426	+		10.1038/nature22797	http://dx.doi.org/10.1038/nature22797			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28607489	Green Accepted			2022-12-28	WOS:000403250900039
J	Zheng, CH; Zheng, LT; Yoo, JK; Guo, HH; Zhang, YY; Guo, XY; Kang, BX; Hu, RZ; Huang, JY; Zhang, QM; Liu, ZZR; Dong, MH; Hu, XD; Ouyang, WJ; Peng, JR; Zhang, ZM				Zheng, Chunhong; Zheng, Liangtao; Yoo, Jae-Kwang; Guo, Huahu; Zhang, Yuanyuan; Guo, Xinyi; Kang, Boxi; Hu, Ruozhen; Huang, Julie Y.; Zhang, Qiming; Liu, Zhouzerui; Dong, Minghui; Hu, Xueda; Ouyang, Wenjun; Peng, Jirun; Zhang, Zemin			Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing	CELL			English	Article							IMMUNE CHECKPOINT BLOCKADE; RNA-SEQ ANALYSIS; HEPATOCELLULAR-CARCINOMA; MAIT CELLS; LYMPHOCYTES; IMMUNOTHERAPY; EXHAUSTION; THERAPY; IMMUNOPATHOGENESIS; EXPRESSION	Systematic interrogation of tumor-infiltrating lymphocytes is key to the development of immunotherapies and the prediction of their clinical responses in cancers. Here, we perform deep single-cell RNA sequencing on 5,063 single T cells isolated from peripheral blood, tumor, and adjacent normal tissues from six hepatocellular carcinoma patients. The transcriptional profiles of these individual cells, coupled with assembled T cell receptor (TCR) sequences, enable us to identify 11 T cell subsets based on their molecular and functional properties and delineate their developmental trajectory. Specific subsets such as exhausted CD8(+) T cells and Tregs are preferentially enriched and potentially clonally expanded in hepatocellular carcinoma (HCC), and we identified signature genes for each subset. One of the genes, layilin, is upregulated on activated CD8(+) T cells and Tregs and represses the CD8(+) T cell functions in vitro. This compendium of transcriptome data provides valuable insights and a rich resource for understanding the immune landscape in cancers.	[Zheng, Chunhong; Zhang, Yuanyuan; Guo, Xinyi; Kang, Boxi; Zhang, Qiming; Liu, Zhouzerui; Dong, Minghui; Hu, Xueda; Zhang, Zemin] Peking Univ, BIOPIC, Beijing Adv Innovat Ctr Genom, Beijing 100871, Peoples R China; [Zheng, Chunhong; Zhang, Yuanyuan; Guo, Xinyi; Kang, Boxi; Zhang, Qiming; Liu, Zhouzerui; Dong, Minghui; Hu, Xueda; Zhang, Zemin] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Zheng, Liangtao; Zhang, Zemin] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yoo, Jae-Kwang; Hu, Ruozhen; Huang, Julie Y.; Ouyang, Wenjun] Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA; [Guo, Huahu; Peng, Jirun] Capital Med Univ, Beijing Shijitan Hosp, Dept Surg, Beijing 100038, Peoples R China; [Guo, Huahu; Peng, Jirun] Peking Univ, Sch Clin Med 9, Beijing 100038, Peoples R China; [Guo, Huahu; Peng, Jirun] Capital Med Univ, Sch Oncol, Beijing 100038, Peoples R China	Peking University; Peking University; Peking University; Amgen; Capital Medical University; Peking University; Capital Medical University	Zhang, ZM (corresponding author), Peking Univ, BIOPIC, Beijing Adv Innovat Ctr Genom, Beijing 100871, Peoples R China.; Zhang, ZM (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.; Zhang, ZM (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Ouyang, WJ (corresponding author), Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA.; Peng, JR (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Dept Surg, Beijing 100038, Peoples R China.; Peng, JR (corresponding author), Peking Univ, Sch Clin Med 9, Beijing 100038, Peoples R China.; Peng, JR (corresponding author), Capital Med Univ, Sch Oncol, Beijing 100038, Peoples R China.	wouyang@amgen.com; pengjr@medmail.com.cn; zemin@pku.edu.cn	Zhang, Yuanyuan/GYE-1266-2022; Ouyang, Wenjun/ABA-8763-2020	Zhang, Yuanyuan/0000-0001-6972-5606; Ouyang, Wenjun/0000-0002-1811-5864; Liu, Zhouzerui/0000-0001-9282-3327; Kang, Boxi/0000-0002-0276-0519; Zheng, Liangtao/0000-0001-9795-3198	Beijing Advanced Innovation Center for Genomics at Peking University; Key Technologies RD Program [2016YFC0900100]; National Natural Science Foundation of China [81573022, 31530036, 81372604]; Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences	Beijing Advanced Innovation Center for Genomics at Peking University; Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences	We thank Xianwen Ren and Shuang Geng for discussions, the contribution by the BIOPIC high-throughput sequencing facility, and the Computing Platform of the Center for Life Science. We thank National Center for Protein Sciences Beijing (Peking University) and Z. Fu, X. Zhang, S. Wang, and F. Wang for assistance with FACS. This project was supported by grants from Beijing Advanced Innovation Center for Genomics at Peking University, Key Technologies R&D Program (2016YFC0900100) and the National Natural Science Foundation of China (81573022, 31530036, 81372604). C.Z. was supported in part by the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences. W.O., J.-K.Y., R.H., and J.Y.H. are employees of Amgen.	Bhairavabhotla R, 2016, HUM IMMUNOL, V77, P201, DOI 10.1016/j.humimm.2015.12.004; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Campbell K., 2015, LAPLACIAN EIGENMAPS; Cannoodt R, 2016, SCORPIUS IMPROVES TR; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; FERRADINI L, 1993, J CLIN INVEST, V91, P1183, DOI 10.1172/JCI116278; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fousteri G, 2014, CLIN EXP IMMUNOL, V178, P178, DOI 10.1111/cei.12393; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Goode EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053903; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Hindley JP, 2011, CANCER RES, V71, P736, DOI 10.1158/0008-5472.CAN-10-1797; Ji ZC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw430; Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kasper HU, 2009, WORLD J GASTROENTERO, V15, P5053, DOI 10.3748/wjg.15.5053; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Kurioka A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.51; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Pallandre JR, 2007, J IMMUNOL, V179, P7593, DOI 10.4049/jimmunol.179.11.7593; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Prieto J, 2015, NAT REV GASTRO HEPAT, V12, P681, DOI 10.1038/nrgastro.2015.173; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Tanchot C, 2013, CANCER MICROENVIRON, V6, P147, DOI 10.1007/s12307-012-0122-y; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wing K, 2002, IMMUNOLOGY, V106, P190, DOI 10.1046/j.1365-2567.2002.01412.x	50	949	991	48	376	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1342	+		10.1016/j.cell.2017.05.035	http://dx.doi.org/10.1016/j.cell.2017.05.035			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622514	Bronze			2022-12-28	WOS:000403332400021
J	Claesson, A; Backman, A; Ringh, M; Svensson, L; Nordberg, P; Djarv, T; Hollenberg, J				Claesson, Andreas; Backman, Anders; Ringh, Mattias; Svensson, Leif; Nordberg, Per; Djarv, Therese; Hollenberg, Jacob			Time to Delivery of an Automated External Defibrillator Using a Drone for Simulated Out-of-Hospital Cardiac Arrests vs Emergency Medical Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PUBLIC-ACCESS DEFIBRILLATION		[Claesson, Andreas; Backman, Anders; Ringh, Mattias; Svensson, Leif; Nordberg, Per; Djarv, Therese; Hollenberg, Jacob] Karolinska Inst, Ctr Resuscitat Sci, Sjukhusbacken 10, S-11883 Stockholm, Sweden	Karolinska Institutet	Claesson, A (corresponding author), Karolinska Inst, Ctr Resuscitat Sci, Sjukhusbacken 10, S-11883 Stockholm, Sweden.	andreas.claesson@ki.se		Claesson, Andreas/0000-0002-0499-9929	Stockholm city council innovation fund	Stockholm city council innovation fund	This study was funded by the Stockholm city council innovation fund.	Claesson A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0313-5; Kitamura T, 2016, NEW ENGL J MED, V375, P1649, DOI 10.1056/NEJMsa1600011; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Pulver A, 2016, PREHOSP EMERG CARE, V20, P378, DOI 10.3109/10903127.2015.1115932; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Ringh M, 2015, RESUSCITATION, V91, P1, DOI 10.1016/j.resuscitation.2015.02.032	6	109	114	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2332	2334		10.1001/jama.2017.3957	http://dx.doi.org/10.1001/jama.2017.3957			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609525	Bronze, Green Published			2022-12-28	WOS:000403149900022
J	[Anonymous]				[Anonymous]			Minor Comments (Reprinted from JAMA, vol 4823, pg 1948-1949, 1907)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1907, JAMA, V4823, P1948	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2339	2339		10.1001/jama.2017.5055	http://dx.doi.org/10.1001/jama.2017.5055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609524				2022-12-28	WOS:000403149900029
J	Marchesan, S; Ballerini, L; Prato, M				Marchesan, Silvia; Ballerini, Laura; Prato, Maurizio			Nanomaterials for stimulating nerve growth	SCIENCE			English	Editorial Material							SPINAL-CORD-INJURY		[Marchesan, Silvia; Prato, Maurizio] Univ Trieste, Dept Chem & Pharmaceut Sci, Via L Giorgieri 1, I-34127 Trieste, Italy; [Ballerini, Laura] Int Sch Adv Studies SISSA, Via Bonomea 265, I-34136 Trieste, Italy; [Prato, Maurizio] CIC BiomaGUNE, Parque Technol San Sebastian,Paseo Miramon 182, San Sebastian 20009, Guipuzcoa, Spain; [Prato, Maurizio] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain	University of Trieste; International School for Advanced Studies (SISSA); CIC biomaGUNE; Basque Foundation for Science	Marchesan, S (corresponding author), Univ Trieste, Dept Chem & Pharmaceut Sci, Via L Giorgieri 1, I-34127 Trieste, Italy.	smarchesan@units.it; ballerin@sissa.it; prato@units.it	Marchesan, Silvia/F-9366-2011; Prato, Maurizio/G-7067-2012; biomaGUNE, CIC/J-9136-2014	Marchesan, Silvia/0000-0001-6089-3873; Prato, Maurizio/0000-0002-8869-8612; biomaGUNE, CIC/0000-0001-7690-0660; BALLERINI, Laura/0000-0001-8420-0787				Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Donati ARC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30383; Filli L, 2012, ANN NEUROL, V72, P491, DOI 10.1002/ana.23630; Jang H, 2016, ADV MATER, V28, P4184, DOI 10.1002/adma.201504245; Lacour SP, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.63; Lee JH, 2016, NANO LETT, V16, P1509, DOI 10.1021/acs.nanolett.6b00020; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Marchesan S, 2016, NANO TODAY, V11, P398, DOI 10.1016/j.nantod.2015.11.007; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Usmani S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600087; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Zhang AQ, 2016, CHEM REV, V116, P215, DOI 10.1021/acs.chemrev.5b00608; Zhou K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151589	14	54	54	5	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1010	1011		10.1126/science.aan1227	http://dx.doi.org/10.1126/science.aan1227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596325	Green Submitted			2022-12-28	WOS:000402871700029
J	Abbott, A				Abbott, Alison			Italy rebuked for failure to prevent olive-tree tragedy	NATURE			English	News Item																			0	6	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					193	+		10.1038/546193a	http://dx.doi.org/10.1038/546193a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593980	Bronze			2022-12-28	WOS:000402823400005
J	Henderson, G				Henderson, George			Scientific Misconduct Hurts	ANNALS OF INTERNAL MEDICINE			English	Letter									[Henderson, George] Auckland Univ Technol, Auckland, New Zealand	Auckland University of Technology	Henderson, G (corresponding author), Auckland Univ Technol, Auckland, New Zealand.							Laine C, 2017, ANN INTERN MED, V166, P148, DOI 10.7326/M16-2550	1	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					856	856		10.7326/L17-0147	http://dx.doi.org/10.7326/L17-0147			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28586899				2022-12-28	WOS:000402700200019
J	Hawkins, V; Perache, AH				Hawkins, Vickie; Perache, Andre Heller			Humanitarian medicine is more than a technical exercise	LANCET			English	Editorial Material									[Hawkins, Vickie; Perache, Andre Heller] Med Sans Frontieres UK, London EC4A 1AB, England		Hawkins, V (corresponding author), Med Sans Frontieres UK, London EC4A 1AB, England.	vickie.hawkins@london.msf.org						Aly H., 2016, IRIN            0526; [Anonymous], 2017, ECONOMIST; [Anonymous], 2017, AL JAZEERA; [Anonymous], 2016, BBC NEWS; Blanchet K, 2017, LANCET; Bradol J-H, 2004, SHADOW JUST WARS, P9; Checchi F, 2017, LANCET; Clift C., 2014, REF WHO IS IT RIGHT; COLOMBO S, 2017, LANCET; Elamein M, 2017, LANCET; Hofman M., 2017, POLITICS FEAR MED SA; Medecins Sans Frontieres, 2015, EPID NEGL EM; Medecins Sans Frontieres, 2015, YEM STAFF PAT KILL A; Medecins Sans Frontieres, 2014, DOCT BORD REP; Rasmussen Sune Engel, 2015, GUARDIAN; Spiegel PB., 2017, LANCET; United Nations, 2016, SUMM REF MIGR 2016; Walter B., 2014, EBOLA US NATL SECURI; Westcott L, 2016, NEWSWEEK	19	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2226	2228		10.1016/S0140-6736(17)31352-1	http://dx.doi.org/10.1016/S0140-6736(17)31352-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602561				2022-12-28	WOS:000415645700010
J	Glanville, J; Huang, H; Nau, A; Hatton, O; Wagar, LE; Rubelt, F; Ji, XH; Han, A; Krams, SM; Pettus, C; Haas, N; Arlehamn, CSL; Sette, A; Boyd, SD; Scriba, TJ; Martinez, OM; Davis, MM				Glanville, Jacob; Huang, Huang; Nau, Allison; Hatton, Olivia; Wagar, Lisa E.; Rubelt, Florian; Ji, Xuhuai; Han, Arnold; Krams, Sheri M.; Pettus, Christina; Haas, Nikhil; Arlehamn, Cecilia S. Lindestam; Sette, Alessandro; Boyd, Scott D.; Scriba, Thomas J.; Martinez, Olivia M.; Davis, Mark M.			Identifying specificity groups in the T cell receptor repertoire	NATURE			English	Article							CD4(+); DIVERSITY; PROTEIN; NAIVE	T cell receptor (TCR) sequences are very diverse, with many more possible sequence combinations than T cells in any one individual(1-4). Here we define the minimal requirements for TCR antigen specificity, through an analysis of TCR sequences using a panel of peptide and major histocompatibility complex (pMHC)-tetramer-sorted cells and structural data. From this analysis we developed an algorithm that we term GLIPH (grouping of lymphocyte interactions by paratope hotspots) to cluster TCRs with a high probability of sharing specificity owing to both conserved motifs and global similarity of complementarity-determining region 3 (CDR3) sequences. We show that GLIPH can reliably group TCRs of common specificity from different donors, and that conserved CDR3 motifs help to define the TCR clusters that are often contact points with the antigenic peptides. As an independent validation, we analysed 5,711 TCR beta chain sequences from reactive CD4 T cells from 22 individuals with latent Mycobacterium tuberculosis infection. We found 141 TCR specificity groups, including 16 distinct groups containing TCRs from multiple individuals. These TCR groups typically shared HLA alleles, allowing prediction of the likely HLA restriction, and a large number of M. tuberculosis T cell epitopes enabled us to identify pMHC ligands for all five of the groups tested. Mutagenesis and de novo TCR design confirmed that the GLIPH-identified motifs were critical and sufficient for shared-antigen recognition. Thus the GLIPH algorithm can analyse large numbers of TCR sequences and define TCR specificity groups shared by TCRs and individuals, which should greatly accelerate the analysis of T cell responses and expedite the identification of specific ligands.	[Glanville, Jacob] Stanford Univ, Sch Med, Computat & Syst Immunol Program, Stanford, CA 94305 USA; [Glanville, Jacob; Huang, Huang; Nau, Allison; Wagar, Lisa E.; Rubelt, Florian; Ji, Xuhuai; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Huang, Huang; Wagar, Lisa E.; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Hatton, Olivia; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Ji, Xuhuai] Stanford Univ, Sch Med, Human Immune Monitoring Ctr, Stanford, CA 94305 USA; [Han, Arnold; Boyd, Scott D.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pettus, Christina; Haas, Nikhil] Univ San Francisco, PSM Biotechnol, Stanford, CA 94305 USA; [Arlehamn, Cecilia S. Lindestam; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Boyd, Scott D.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Scriba, Thomas J.] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, Cape Town, South Africa; [Scriba, Thomas J.] Univ Cape Town, Div Immunol, Dept Pathol, Cape Town, South Africa; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Hatton, Olivia] Colorado Coll, Dept Mol Biol, Colorado Springs, CO 80905 USA; [Han, Arnold] Columbia Univ, Dept Med & Microbiol & Immunol, New York, NY 10032 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of San Francisco; La Jolla Institute for Immunology; Stanford University; University of Cape Town; University of Cape Town; Howard Hughes Medical Institute; Stanford University; Colorado College; Columbia University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Huang, Huang/AAG-6281-2019; Scriba, Thomas/AAH-9413-2020; Sette, Alessandro/AFO-8916-2022; Scriba, Thomas/GPX-2573-2022	Scriba, Thomas/0000-0002-0641-1359; , Olivia/0000-0002-2798-0251; Krams, Sheri/0000-0002-6049-5119; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002; Huang, Huang/0000-0002-8377-4823; /0000-0001-7593-5511; Davis, Mark/0000-0001-6868-657X; Wagar, Lisa/0000-0001-5980-3586	Stanford Human Immune Monitoring Center; Bill and Melinda Gates Foundation; National Institutes of Health [2U19 AI057229]; Howard Hughes Medical Institute; NIH [S10RR025518-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, T32AI007290, R37AI022511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100739] Funding Source: NIH RePORTER	Stanford Human Immune Monitoring Center; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Stanford Human Immune Monitoring Center for high-throughput sequencing support, and M. Mindrinos and co-workers at Sirona Genomics for the HLA typing. We especially thank The Bill and Melinda Gates Foundation, The National Institutes of Health (2U19 AI057229) and the Howard Hughes Medical Institute for financial support, S.-A. Xue for providing the Jurkat 76 T cell line, C.-Y. Chang and R. Taniguchi for helping with lentiviral transduction, R. Hovde for valuable discussions regarding statistical measures, H. Mahomed, W. Hanekom and members of the Adolescent Cohort Study (ACS) group for enrolment and follow-up of the M. tuberculosis-infected adolescents, and R. Bedi for collecting TCR sequences from the literature. Sorting was (partially) performed in the Shared FACS Facility obtained using NIH S10 Shared instrument grant (S10RR025518-01).	Arlehamn CSL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005760; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Rubelt F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11112; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sallusto F, 2016, ANNU REV IMMUNOL, V34, P317, DOI 10.1146/annurev-immunol-032414-112056; Sharma G, 2014, HUM IMMUNOL, V75, P514, DOI 10.1016/j.humimm.2014.03.003; Shortman K, 1990, Semin Immunol, V2, P3; Song I, 2017, NAT STRUCT MOL BIOL, V24, P395, DOI 10.1038/nsmb.3383; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110	23	442	452	9	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					94	+		10.1038/nature22976	http://dx.doi.org/10.1038/nature22976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28636589	Green Accepted			2022-12-28	WOS:000404839900037
J	Boutron, I; Altman, DG; Moher, D; Schulz, KF; Ravaud, P				Boutron, Isabelle; Altman, Douglas G.; Moher, David; Schulz, Kenneth F.; Ravaud, Philippe		CONSORT NPT Grp	CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-TRIALS; INTERVENTIONS; DESIGN; QUALITY; METHODOLOGY; EXPLANATION; WASTE	Incomplete and inadequate reporting is an avoidable waste that reduces the usefulness of research. The CONSORT (Consolidated Standards of Reporting Trials) Statement is an evidence-based reporting guideline that aims to improve research transparency and reduce waste. In 2008, the CONSORT Group developed an extension to the original statement that addressed methodological issues specific to trials of nonpharmacologic treatments (NPTs), such as surgery, rehabilitation, or psychotherapy. This article describes an update of that extension and presents an extension for reporting abstracts of NPT trials. To develop these materials, the authors reviewed pertinent literature published up to July 2016; surveyed authors of NPT trials; and conducted a consensus meeting with editors, trialists, and methodologists. Changes to the CONSORT Statement extension for NPT trials include wording modifications to improve readers' understanding and the addition of 3 new items. These items address whether and how adherence of participants to interventions is assessed or enhanced, description of attempts to limit bias if blinding is not possible, and specification of the delay between randomization and initiation of the intervention. The CONSORT extension for abstracts of NPT trials includes 2 new items that were not specified in the original CONSORT Statement for abstracts. The first addresses reporting of eligibility criteria for centers where the intervention is performed and for care providers. The second addresses reporting of important changes to the intervention versus what was planned. Both the updated CONSORT extension for NPT trials and the CONSORT extension for NPT trial abstracts should help authors, editors, and peer reviewers improve the transparency of NPT trial reports.	Paris Descartes Univ, INSERM UMR1153, Paris, France; AP HP, Paris, France; Univ Oxford, Oxford, England; Ottawa Hosp, Res Inst, Ottawa, ON, Canada; Univ Ottawa, Ottawa, ON, Canada; FHI 360, Durham, NC USA; Univ N Carolina, Chapel Hill, NC USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); University of Oxford; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; Columbia University	Boutron, I (corresponding author), Hop Hotel Dieu, Ctr Epidemiol Clin, Equipe METHODS CRESS UMR1153, 1 Pl Parvis Notre Dame, F-75004 Paris, France.		Shamseer, Larissa/E-9645-2017; Moher, David/I-3408-2019; ravaud, philippe/C-1694-2009; Glasziou, Paul/A-7832-2008	Shamseer, Larissa/0000-0003-3690-3378; Moher, David/0000-0003-2434-4206; Glasziou, Paul/0000-0001-7564-073X; McCulloch, Peter/0000-0002-3210-8273; Lamb, Sarah/0000-0003-4349-7195; Schnurr, Paula/0000-0002-6195-716X; Bhui, Kamaldeep/0000-0002-9205-2144; Hopewell, Sally/0000-0002-6881-6984; Chescheir, Nancy/0000-0002-0205-5051; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206; Ross, Joseph/0000-0002-9218-3320	Centre d'Epidemiologie Clinique, Assistance Publique des Hopitaux de Paris; Centre of Research in Epidemiology and Statistics Sorbonne Paris Cite - CRESS-UMR1153; Cancer Research UK [16895] Funding Source: researchfish	Centre d'Epidemiologie Clinique, Assistance Publique des Hopitaux de Paris; Centre of Research in Epidemiology and Statistics Sorbonne Paris Cite - CRESS-UMR1153; Cancer Research UK(Cancer Research UK)	Funding was provided by the research funds of the Centre d'Epidemiologie Clinique, Assistance Publique des Hopitaux de Paris, and the METHODS Team of the Centre of Research in Epidemiology and Statistics Sorbonne Paris Cite - CRESS-UMR1153.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Barnes C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0460-y; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Blencowe NS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1127-x; Boutron I, 2004, J CLIN EPIDEMIOL, V57, P543, DOI 10.1016/j.jclinepi.2003.12.010; Boutron I, 2003, JAMA-J AM MED ASSOC, V290, P1062, DOI 10.1001/jama.290.8.1062; Boutron I, 2008, ANN INTERN MED, V148, pW60, DOI 10.7326/0003-4819-148-4-200802190-00008-w1; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Burton AK, 2000, EUR SPINE J, V9, P202, DOI 10.1007/s005869900113; Ceelen WP, 2014, EUR SURG RES, V53, P95, DOI 10.1159/000367606; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan L, 2014, ARCH PHYS MED REHAB, V95, P415, DOI 10.1016/j.apmr.2013.12.010; Cook JA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-2; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Dworkin JD, 2016, J CLIN EPIDEMIOL, V72, P56, DOI 10.1016/j.jclinepi.2015.10.019; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Evrard S, 2016, NAT REV CLIN ONCOL, V13, P55, DOI 10.1038/nrclinonc.2015.176; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Kahan BC, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-58; Lee KJ, 2005, CLIN TRIALS, V2, P163, DOI 10.1191/1740774505cn082oa; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; McCleary N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-146; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Nagendran M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003898; Pibouleau L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4538; Roberts C, 1999, STAT MED, V18, P2605, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2605::AID-SIM237>3.0.CO;2-N; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Roberts C, 2013, STAT MED, V32, P81, DOI 10.1002/sim.5521; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Thornton JG, 2004, LANCET, V364, P513, DOI 10.1016/S0140-6736(04)16809-8; Torgerson DJ, 2008, DESIGNING RANDOMISED TRIALS IN HEALTH, EDUCATION AND THE SOCIAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1057/9780230583993; Wartolowska K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3253; Yu J, 2017, BRIT J SURG, V104, P296, DOI 10.1002/bjs.10331	43	541	556	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2017	167	1					40	+		10.7326/M17-0046	http://dx.doi.org/10.7326/M17-0046			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ3DW	28630973	Green Published, Green Submitted			2022-12-28	WOS:000404591600009
J	Dunkle, LM; Izikson, R; Patriarca, P; Goldenthal, KL; Muse, D; Callahan, J; Cox, MMJ				Dunkle, Lisa M.; Izikson, Ruvim; Patriarca, Peter; Goldenthal, Karen L.; Muse, Derek; Callahan, Janice; Cox, Manon M. J.		PSC12 Study Team	Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED-TRIAL; VIRAL NEURAMINIDASE; HEALTHY-ADULTS; UNITED-STATES; INSECT CELLS; HEMAGGLUTININ; IMMUNOGENICITY; STATISTICS; PROTECTION; SAFETY	BACKGROUND Improved influenza vaccines are needed to control seasonal epidemics. This trial compared the protective efficacy in older adults of a quadrivalent, recombinant influenza vaccine (RIV4) with a standard-dose, egg-grown, quadrivalent, inactivated influenza vaccine (IIV4) during the A/H3N2-predominant 2014-2015 influenza season, when antigenic mismatch between circulating and vaccine influenza strains resulted in the reduced effectiveness of many licensed vaccines. METHODS We conducted a randomized, double-blind, multicenter trial of RIV4 (45 mu g of recombinant hemagglutinin [HA] per strain, 180 mu g of protein per dose) versus standard-dose IIV4 (15 mu g of HA per strain, 60 mu g of protein per dose) to compare the relative vaccine efficacy against reverse-transcriptase polymerase-chain-reaction (RT-PCR)-confirmed, protocol-defined, influenza-like illness caused by any influenza strain starting 14 days or more after vaccination in adults who were 50 years of age or older. The diagnosis of influenza infection was confirmed by means of RT-PCR assay and culture of nasopharyngeal swabs obtained from participants with symptoms of an influenza-like illness. The primary end point was RT-PCR-confirmed, protocol defined, influenza-like illness between 14 days or more after vaccination and the end of the influenza season. RESULTS A total of 9003 participants were enrolled and underwent randomization; 8855 (98.4%) received a trial vaccine and underwent an efficacy follow-up (the modified intention-to-treat population), and 8604 (95.6%) completed the per-protocol follow-up (the modified per-protocol population). Among RIV4 recipients, the RT-PCR-confirmed influenza attack rate was 2.2% (96 cases among 4303 participants) in the modified per-protocol population and 2.2% (96 cases among 4427 participants) in the modified intention-to-treat population. Among IIV4 recipients, the attack rate was 3.2% (138 cases among 4301 participants) in the modified per-protocol population and 3.1% (138 cases among 4428 participants) in the modified intention-to-treat population. A total of 181 cases of influenza A/H3N2, 47 cases of influenza B, and 6 cases of nonsubtypeable influenza A were detected. The probability of influenza-like illness was 30% lower with RIV4 than with IIV4 (95% confidence interval, 10 to 47; P = 0.006) and satisfied prespecified criteria for the primary noninferiority analysis and an exploratory superiority analysis of RIV4 over IIV4. The safety profiles of the vaccines were similar. CONCLUSIONS RIV4 provided better protection than standard-dose IIV4 against confirmed influenzalike illness among older adults. (Funded by Protein Sciences; ClinicalTrials.gov number, NCT02285998.)	[Dunkle, Lisa M.; Izikson, Ruvim; Cox, Manon M. J.] Prot Sci, 1000 Res Pkwy, Meriden, CT 06450 USA; [Patriarca, Peter] Biol Consulting, Rockville, MD USA; [Muse, Derek] Jean Brown Res, Salt Lake City, UT USA; [Callahan, Janice] Callahan Associates, San Diego, CA USA		Dunkle, LM (corresponding author), Prot Sci, 1000 Res Pkwy, Meriden, CT 06450 USA.	ldunkle@proteinsciences.com			Protein Sciences	Protein Sciences	Funded by Protein Sciences; ClinicalTrials.gov number, NCT02285998.	[Anonymous], 2014, PASS 13 STAT SOFTW; [Anonymous], 2015, NAT REG LEV OUTP VIR; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1057; Appiah GD, 2015, MMWR-MORBID MORTAL W, V64, P583; Baxter R, 2011, VACCINE, V29, P2272, DOI 10.1016/j.vaccine.2011.01.039; Cox MMJ, 2007, INFLUENZA OTHER RESP, V1, P35, DOI 10.1111/j.1750-2659.2006.00007.x; Cox MMJ, 2011, J INVERTEBR PATHOL, V107, pS31, DOI 10.1016/j.jip.2011.05.003; Davidoff F, 2001, NEW ENGL J MED, V345, P825, DOI 10.1056/NEJMed20010093; DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; *FDA, 1996, GUID IND E6 GOOD CLI; Flannery B, 2015, END OF SEASON INFLUE; Flannery B, 2014, MMWR-MORBID MORTAL W, V63, P137; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Johansson BE, 1998, VACCINE, V16, P1009, DOI 10.1016/S0264-410X(97)00279-X; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Keitel WA, 2009, VACCINE, V28, P379, DOI 10.1016/j.vaccine.2009.10.037; Milian E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504831; Monto AS, 2015, J INFECT DIS, V212, P1191, DOI 10.1093/infdis/jiv195; Nachbagauer R, 2016, MBIO, V7, DOI 10.1128/mBio.01996-15; POWERS DC, 1995, J INFECT DIS, V171, P1595, DOI 10.1093/infdis/171.6.1595; RAJAKUMAR A, 1990, P NATL ACAD SCI USA, V87, P4154, DOI 10.1073/pnas.87.11.4154; Safdar A, 2006, J INFECT DIS, V194, P1394, DOI 10.1086/508493; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Treanor JJ, 2007, JAMA-J AM MED ASSOC, V297, P1577, DOI 10.1001/jama.297.14.1577; Treanor JJ, 2011, VACCINE, V29, P7733, DOI 10.1016/j.vaccine.2011.07.128; WANG MO, 1989, VIROLOGY, V171, P275, DOI 10.1016/0042-6822(89)90538-2; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	31	136	140	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2427	2436		10.1056/NEJMoa1608862	http://dx.doi.org/10.1056/NEJMoa1608862			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY2BW	28636855	Bronze			2022-12-28	WOS:000403774400006
J	Griffiths, EP				Griffiths, Elizabeth P.			Effective Legislative Advocacy - Lessons from Successful Medical Trainee Campaigns	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Griffiths, Elizabeth P.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Griffiths, EP (corresponding author), Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2409	2411		10.1056/NEJMp1704120	http://dx.doi.org/10.1056/NEJMp1704120			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY2BW	28590793				2022-12-28	WOS:000403774400003
J	Grossman, DC; Bibbins-Domingo, K; Curry, SJ; Barry, MJ; Davidson, K; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Bibbins-Domingo, Kirsten; Curry, Susan J.; Barry, Michael J.; Davidson, KarinaW.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Serv Task Force	Screening for Obesity in Children and Adolescents US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDHOOD OVERWEIGHT; UNITED-STATES; RISK; PREVALENCE; GROWTH	IMPORTANCE Based on year 2000 Centers for Disease Control and Prevention growth charts, approximately 17% of children and adolescents aged 2 to 19 years in the United States have obesity, and almost 32% of children and adolescents are overweight or have obesity. Obesity in children and adolescents is associated with morbidity such as mental health and psychological issues, asthma, obstructive sleep apnea, orthopedic problems, and adverse cardiovascular and metabolic outcomes (eg, high blood pressure, abnormal lipid levels, and insulin resistance). Children and adolescents may also experience teasing and bullying behaviors based on their weight. Obesity in childhood and adolescence may continue into adulthood and lead to adverse cardiovascular outcomes or other obesity-related morbidity, such as type 2 diabetes. SUBPOPULATION CONSIDERATIONS Although the overall rate of child and adolescent obesity has stabilized over the last decade after increasing steadily for 3 decades, obesity rates continue to increase in certain populations, such as African American girls and Hispanic boys. These racial/ethnic differences in obesity prevalence are likely a result of both genetic and nongenetic factors (eg, socioeconomic status, intake of sugar-sweetened beverages and fast food, and having a television in the bedroom). OBJECTIVE To update the 2010 US Preventive Services Task Force (USPSTF) recommendation on screening for obesity in children 6 years and older. EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for obesity in children and adolescents and the benefits and harms of weight management interventions. FINDINGS Comprehensive, intensive behavioral interventions (>= 26 contact hours) in children and adolescents 6 years and older who have obesity can result in improvements in weight status for up to 12 months; there is inadequate evidence regarding the effectiveness of less intensive interventions. The harms of behavioral interventions can be bounded as small to none, and the harms of screening are minimal. Therefore, the USPSTF concluded with moderate certainty that screening for obesity in children and adolescents 6 years and older is of moderate net benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends that clinicians screen for obesity in children and adolescents 6 years and older and offer or refer them to comprehensive, intensive behavioral interventions to promote improvements in weight status. (B recommendation)	[Grossman, David C.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, KarinaW.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA	Kaiser Permanente; University of California System; University of California San Francisco; University of Iowa; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	[Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19430; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P625, DOI 10.1001/jama.2016.9852; *CDCP, 2000 CDC GROWTH CHAR; Centers for Disease Control and Prevention, 2015, OV OB PREV STRAT GUI; Committee on Practice and Ambulatory Medicine and Bright Futures Periodicity Schedule Workgroup, 2016, PEDIATRICS, V137; Community Preventive Services Task Force, 2014, OB BEH INT AIM RED R; Community Preventive Services Task Force, 2013, OB PREV CONTR SCH BA; Dietz WH, 2015, PEDIATRICS, V135, pE559, DOI 10.1542/peds.2014-2972; Epstein LH, 2007, HEALTH PSYCHOL, V26, P381, DOI 10.1037/0278-6133.26.4.381; EPSTEIN LH, 1994, HEALTH PSYCHOL, V13, P373, DOI 10.1037/0278-6133.13.5.373; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Institute of Medicine, 2011, EARL CHILDH OB PREV; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kuczmarski RJ, 2002, VITAL HLTH STAT, V11, P1; Moyer VA, 2013, PEDIATRICS, V132, P907, DOI 10.1542/peds.2013-2864; NAPNAP, 2009, J Pediatr Health Care, V23, pA15; O'Connor EA, 2017, AHRQ PUBLICATION, V15; O'Connor EA, 2017, JAMA-J AM MED ASSOC, V317, P2427, DOI 10.1001/jama.2017.0332; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Parkin P, 2015, CAN MED ASSOC J, V187, P411, DOI 10.1503/cmaj.141285; Rosenbaum M, 2010, BRAIN RES, V1350, P95, DOI 10.1016/j.brainres.2010.05.062; Schuster DP, 2009, SEMIN PEDIATR SURG, V18, P126, DOI 10.1053/j.sempedsurg.2009.04.002; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Stovitz SD, 2010, AM J PREV MED, V38, P74, DOI 10.1016/j.amepre.2009.09.033; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; US Prevent Services Task Force, 2005, PEDIATRICS, V116, P205; Viner RM, 2009, BRIT J CLIN PHARMACO, V68, P844, DOI 10.1111/j.1365-2125.2009.03528.x; Whitlock EP, 2005, PEDIATRICS, V116, pE125, DOI 10.1542/peds.2005-0242; Wiegand S, 2014, HORM RES PAEDIAT, V82, P380, DOI 10.1159/000368963	31	414	419	6	87	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2417	2426		10.1001/jama.2017.6803	http://dx.doi.org/10.1001/jama.2017.6803			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632874	Bronze			2022-12-28	WOS:000403654600015
J	Luginbuehl, LH; Menard, GN; Kurup, S; Van Erp, H; Radhakrishnan, GV; Breakspear, A; Oldroyd, GED; Eastmond, PJ				Luginbuehl, Leonie H.; Menard, Guillaume N.; Kurup, Smita; Van Erp, Harrie; Radhakrishnan, Guru V.; Breakspear, Andrew; Oldroyd, Giles E. D.; Eastmond, Peter J.			Fatty acids in arbuscular mycorrhizal fungi are synthesized by the host plant	SCIENCE			English	Article							BIOSYNTHESIS; TRANSPORTER; METABOLISM; GENES	Plants form beneficial associations with arbuscular mycorrhizal fungi, which facilitate nutrient acquisition from the soil. In return, the fungi receive organic carbon from the plants. The transcription factor RAM1 (REQUIRED FOR ARBUSCULAR MYCORRHIZATION 1) is crucial for this symbiosis, and we demonstrate that it is required and sufficient for the induction of a lipid biosynthetic pathway that is expressed in plant cells accommodating fungal arbuscules. Lipids are transferred from the plant to mycorrhizal fungi, which are fatty acid auxotrophs, and this lipid export requires the glycerol-3-phosphate acyltransferase RAM2, a direct target of RAM1. Our work shows that in addition to sugars, lipids are a major source of organic carbon delivered to the fungus, and this is necessary for the production of fungal lipids.	[Luginbuehl, Leonie H.; Radhakrishnan, Guru V.; Breakspear, Andrew; Oldroyd, Giles E. D.] John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Menard, Guillaume N.; Kurup, Smita; Van Erp, Harrie; Eastmond, Peter J.] Rothamsted Res, Dept Plant Sci, Harpenden AL5 2JQ, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Oldroyd, GED (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.; Eastmond, PJ (corresponding author), Rothamsted Res, Dept Plant Sci, Harpenden AL5 2JQ, Herts, England.	giles.oldroyd@jic.ac.uk; peter.eastmond@rothamsted.ac.uk	Oldroyd, Giles/ABA-7501-2020; menard, guillaume/AAS-2803-2021; Oldroyd, Giles/ABD-8143-2021; Radhakrishnan, Guru/K-3881-2017	menard, guillaume/0000-0002-2187-9013; Oldroyd, Giles/0000-0002-5245-6355; Luginbuehl, Leonie/0000-0002-7353-2556; Breakspear, Andrew/0000-0002-1863-3012; Eastmond, Peter/0000-0003-4526-5136; Radhakrishnan, Guru/0000-0003-0381-8804	NSF [NSF-0703285]; Biotechnology and Biological Sciences Research Council [BB/J004553/1, BB/K003712/1, BB/K002147/1, BBS/E/C/00005207]; BBSRC [BBS/E/C/000I0420, BB/K002147/1, BBS/E/J/000CA336, BBS/E/C/00005207, BB/N021932/1, BBS/E/J/000PR9796, BB/K003712/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA336, BBS/E/C/000I0420, BBS/E/J/000PR9796, BB/N021932/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Mysore and J. Wen of The Samuel Roberts Noble Foundation (TSRNF) for M. truncatula Tnt1 mutants created through research funded, in part, by NSF grant NSF-0703285. The acs-1 and acs-2 mutants are available from P.J.E. under a material agreement with TSRNF. We thank H. Walpole, Rothamsted Bioimaging, for help with microscopy. This work was supported by the Biotechnology and Biological Sciences Research Council (grants BB/J004553/1, BB/K003712/1, BB/K002147/1, and BBS/E/C/00005207). Experiments were performed primarily by L.H.L., G.N.M., P.J.E., S.K., and H.V.E.; G.V.R. provided the phylogenetic analyses; A.B. produced constructs and transgenic material; and L. H. L., P.J.E., and G.E.D.O. wrote the manuscript. The short-read sequencing data have been deposited at the National Center for Biotechnology Information Sequence Read Archive, with accession number SRP099836. The supplementary materials contain additional data.	Bago B, 2002, PLANT PHYSIOL, V128, P108, DOI 10.1104/pp.010466; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Bravo A, 2017, NEW PHYTOL, V214, P1631, DOI 10.1111/nph.14533; Bravo A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.208, 10.1038/NPLANTS.2015.208]; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Devers EA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-82; Gobbato E, 2012, CURR BIOL, V22, P2236, DOI 10.1016/j.cub.2012.09.044; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Lin M, 2008, PLANT PHYSIOL, V147, P1822, DOI 10.1104/pp.108.121269; Park HJ, 2015, PLANT PHYSIOL, V169, P2774, DOI 10.1104/pp.15.01155; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Schussler A, 2006, NATURE, V444, P933, DOI 10.1038/nature05364; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Tang NW, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00233; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; To A, 2012, PLANT CELL, V24, P5007, DOI 10.1105/tpc.112.106120; Trepanier M, 2005, APPL ENVIRON MICROB, V71, P5341, DOI 10.1128/AEM.71.9.5341-5347.2005; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Wewer V, 2014, PLANT J, V79, P398, DOI 10.1111/tpj.12566; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zhang XC, 2015, CURR BIOL, V25, P2189, DOI 10.1016/j.cub.2015.06.075	25	302	321	24	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1175	1178		10.1126/science.aan0081	http://dx.doi.org/10.1126/science.aan0081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28596311	Green Submitted			2022-12-28	WOS:000403327400038
J	Yin, J; Cao, Y; Li, YH; Liao, SK; Zhang, L; Ren, JG; Cai, WQ; Liu, WY; Li, B; Dai, H; Li, GB; Lu, QM; Gong, YH; Xu, Y; Li, SL; Li, FZ; Yin, YY; Jiang, ZQ; Li, M; Jia, JJ; Ren, G; He, D; Zhou, YL; Zhang, XX; Wang, N; Chang, X; Zhu, ZC; Liu, NL; Chen, YA; Lu, CY; Shu, R; Peng, CZ; Wang, JY; Pan, JW				Yin, Juan; Cao, Yuan; Li, Yu-Huai; Liao, Sheng-Kai; Zhang, Liang; Ren, Ji-Gang; Cai, Wen-Qi; Liu, Wei-Yue; Li, Bo; Dai, Hui; Li, Guang-Bing; Lu, Qi-Ming; Gong, Yun-Hong; Xu, Yu; Li, Shuang-Lin; Li, Feng-Zhi; Yin, Ya-Yun; Jiang, Zi-Qing; Li, Ming; Jia, Jian-Jun; Ren, Ge; He, Dong; Zhou, Yi-Lin; Zhang, Xiao-Xiang; Wang, Na; Chang, Xiang; Zhu, Zhen-Cai; Liu, Nai-Le; Chen, Yu-Ao; Lu, Chao-Yang; Shu, Rong; Peng, Cheng-Zhi; Wang, Jian-Yu; Pan, Jian-Wei			Satellite-based entanglement distribution over 1200 kilometers	SCIENCE			English	Article							EXPERIMENTAL REALIZATION; QUANTUM STATE; PURIFICATION; VIOLATION	Long-distance entanglement distribution is essential for both foundational tests of quantum physics and scalable quantum networks. Owing to channel loss, however, the previously achieved distance was limited to similar to 100 kilometers. Here we demonstrate satellite-based distribution of entangled photon pairs to two locations separated by 1203 kilometers on Earth, through two satellite-to-ground downlinks with a summed length varying from 1600 to 2400 kilometers. We observed a survival of two-photon entanglement and a violation of Bell inequality by 2.37 +/- 0.09 under strict Einstein locality conditions. The obtained effective link efficiency is orders of magnitude higher than that of the direct bidirectional transmission of the two photons through telecommunication fibers.	[Yin, Juan; Cao, Yuan; Li, Yu-Huai; Liao, Sheng-Kai; Ren, Ji-Gang; Cai, Wen-Qi; Liu, Wei-Yue; Li, Bo; Dai, Hui; Li, Guang-Bing; Lu, Qi-Ming; Gong, Yun-Hong; Xu, Yu; Li, Shuang-Lin; Li, Feng-Zhi; Yin, Ya-Yun; Liu, Nai-Le; Chen, Yu-Ao; Lu, Chao-Yang; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Yin, Juan; Cao, Yuan; Li, Yu-Huai; Liao, Sheng-Kai; Ren, Ji-Gang; Cai, Wen-Qi; Liu, Wei-Yue; Li, Bo; Dai, Hui; Li, Guang-Bing; Lu, Qi-Ming; Gong, Yun-Hong; Xu, Yu; Li, Shuang-Lin; Li, Feng-Zhi; Yin, Ya-Yun; Liu, Nai-Le; Chen, Yu-Ao; Lu, Chao-Yang; Peng, Cheng-Zhi; Pan, Jian-Wei] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Yin, Juan; Cao, Yuan; Li, Yu-Huai; Liao, Sheng-Kai; Zhang, Liang; Ren, Ji-Gang; Cai, Wen-Qi; Liu, Wei-Yue; Li, Bo; Dai, Hui; Li, Guang-Bing; Lu, Qi-Ming; Gong, Yun-Hong; Xu, Yu; Li, Shuang-Lin; Li, Feng-Zhi; Yin, Ya-Yun; Liu, Nai-Le; Chen, Yu-Ao; Lu, Chao-Yang; Peng, Cheng-Zhi; Wang, Jian-Yu; Pan, Jian-Wei] Univ Sci & Technol China, Ctr Excellence, CAS, Shanghai 201315, Peoples R China; [Yin, Juan; Cao, Yuan; Li, Yu-Huai; Liao, Sheng-Kai; Zhang, Liang; Ren, Ji-Gang; Cai, Wen-Qi; Liu, Wei-Yue; Li, Bo; Dai, Hui; Li, Guang-Bing; Lu, Qi-Ming; Gong, Yun-Hong; Xu, Yu; Li, Shuang-Lin; Li, Feng-Zhi; Yin, Ya-Yun; Liu, Nai-Le; Chen, Yu-Ao; Lu, Chao-Yang; Peng, Cheng-Zhi; Wang, Jian-Yu; Pan, Jian-Wei] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Shanghai 201315, Peoples R China; [Zhang, Liang; Jiang, Zi-Qing; Li, Ming; Jia, Jian-Jun; Shu, Rong; Wang, Jian-Yu] Chinese Acad Sci, Shanghai Inst Tech Phys, Key Lab Space Act Optoelect Technol, Shanghai 200083, Peoples R China; [Ren, Ge; He, Dong] Chinese Acad Sci, Inst Opt & Elect, Key Lab Opt Engn, Chengdu 610209, Peoples R China; [Zhou, Yi-Lin; Zhu, Zhen-Cai] Shanghai Engn Ctr Microsatellites, Shanghai 201203, Peoples R China; [Zhang, Xiao-Xiang] Chinese Acad Sci, Key Lab Space Object & Debris Observat, Purple Mt Observ, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Na] Chinese Acad Sci, Xinjiang Astron Observ, Urumqi 830011, Peoples R China; [Chang, Xiang] Chinese Acad Sci, Yunnan Observ, Kunming 650011, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shanghai Institute of Technical Physics, CAS; Chinese Academy of Sciences; Institute of Optics & Electronics, CAS; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Chinese Academy of Sciences; Xinjiang Astronomy Observatory, NACO, CAS; Chinese Academy of Sciences; Yunnan Astronomical Observatory, NAOC, CAS	Peng, CZ; Pan, JW (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China.; Peng, CZ; Pan, JW (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.; Peng, CZ; Wang, JY; Pan, JW (corresponding author), Univ Sci & Technol China, CAS, Ctr Excellence, Shanghai 201315, Peoples R China.; Peng, CZ; Wang, JY; Pan, JW (corresponding author), Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Shanghai 201315, Peoples R China.; Wang, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Tech Phys, Key Lab Space Act Optoelect Technol, Shanghai 200083, Peoples R China.	pcz@ustc.edu.cn; jywang@mail.sitp.ac.cn; pan@ustc.edu.cn	Pan, Jian-Wei/A-2332-2010; Li, Fengzhi/GXF-0115-2022; yin, juan/AAG-3315-2021; Chen, Yu-Ao/B-2057-2013; liao, shengkai/L-7149-2019; cao, yuan/GRR-9461-2022; Lu, Chao-Yang/D-8481-2011	Pan, Jian-Wei/0000-0002-6100-5142; Chen, Yu-Ao/0000-0002-2309-2281; Lu, Chao-Yang/0000-0002-8227-9177; Dai, Hui/0000-0001-7469-8745; Li, Bo/0000-0001-8417-7927; Xu, Yu/0000-0002-2672-5910	Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences; National Natural Science Foundation of China	Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank many colleagues at the National Space Science Center, National Astronomical Observatories, and China Xi'an Satellite Control Center, especially B.-M. Xu, J. Li, J.-C. Gong, B. Chen, J. Liu, X.-J. Jiang, and T. Xi for their management and coordination. We thank Q. Zhang, L. Li, and S. Chen for helpful discussions. This work was supported by the Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences and by the National Natural Science Foundation of China. C.-Z.P. and J.-W.P. conceived the research. C.-Z.P., J.-Y.W., and J.-W.P. designed the experiments. J.Y., Y.C., G.-B.L., Z.-Q.J., M.L., C.-Z.P., and J.-W.P. developed the spaceborne entangled-photon source. J.Y., Y.C., S.-K.L., L.Z., W.-Q.C., G.-B.L., Z.-Q.J., M.L., J.-J.J., Y.-L.Z., Z.-C.Z., R.S., C.-Z.P., J.-Y.W., and J.-W.P. designed and developed the satellite and payloads. L.Z., J.-J.J., R.S., C.-Z.P., and J.-Y.W. developed the transmitters and the ATP technique. S.-K.L., W.-Q.C., W.-Y.L., and C.-Z.P. developed the software. J.Y., Y.C., L.Z., Y.-H.L., C.-Z.P., and J.-W.P. developed the polarization compensation method. C.-Y.L., C.-Z.P., and J.-W.P. analyzed the data and wrote the manuscript, with input from J.Y., Y.C., and Y.-H.L. All authors contributed to the data collection, discussed the results, and reviewed the manuscript. J.-W.P. supervised the whole project.	ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Aspelmeyer M, 2003, SCIENCE, V301, P621, DOI 10.1126/science.1085593; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Joshi S. K., 2017, ARXIV170308036 MATHF; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Nauerth S, 2013, NAT PHOTONICS, V7, P382, DOI [10.1038/nphoton.2013.46, 10.1038/NPHOTON.2013.46]; Pan JW, 2003, NATURE, V423, P417, DOI 10.1038/nature01623; Pan JW, 2001, NATURE, V410, P1067, DOI 10.1038/35074041; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Peng CZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150501; Rideout D, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/22/224011; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Tsujikawa K, 2005, OPT FIBER TECHNOL, V11, P319, DOI 10.1016/j.yofte.2005.04.003; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; Wang JY, 2013, NAT PHOTONICS, V7, P387, DOI [10.1038/nphoton.2013.89, 10.1038/NPHOTON.2013.89]; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; Yang SJ, 2016, NAT PHOTONICS, V10, P381, DOI [10.1038/nphoton.2016.51, 10.1038/NPHOTON.2016.51]; Yin HL, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.190501; Yin J, 2012, NATURE, V488, P185, DOI 10.1038/nature11332; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	33	537	565	28	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1140	1144		10.1126/science.aan3211	http://dx.doi.org/10.1126/science.aan3211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619937	Green Submitted			2022-12-28	WOS:000403327400029
J	Kelly, AU; McSorley, ST; Patel, P; Talwar, D				Kelly, Alison U.; McSorley, Stephen T.; Patel, Prinesh; Talwar, Dinesh			RATIONAL TESTING Interpreting iron studies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kelly, Alison U.; Talwar, Dinesh] Glasgow Royal Infirm, Dept Biochem, Glasgow, Lanark, Scotland; [McSorley, Stephen T.] Univ Glasgow, Acad Unit Surg, Sch Med, Glasgow Royal Infirm, Glasgow, Lanark, Scotland; [Patel, Prinesh] Alva Med Practice, Alva, Stirling, Scotland	University of Glasgow; University of Glasgow	Kelly, AU (corresponding author), Glasgow Royal Infirm, Dept Biochem, Glasgow, Lanark, Scotland.	alison.kelly7@nhs.net	McSorley, Stephen/AAH-6449-2019	McSorley, Stephen/0000-0002-5459-8445				Adams PC, 2011, J HEPATOL, V55, P453, DOI 10.1016/j.jhep.2011.02.010; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; FAIRBANKS VF, 1991, HOSP PRACT, V26, P17; Frazer DM, 2014, BIOFACTORS, V40, P206, DOI 10.1002/biof.1148; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Koperdanova M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3692; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; McSorley ST, 2016, TRANSL RES, V176, P119, DOI 10.1016/j.trsl.2016.05.004; National Institute for Health and Care Excellence, 2015, NG8 NICE GUID; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Powell LW, 2016, LANCET, V388, P706, DOI 10.1016/S0140-6736(15)01315-X; Stein J, 2013, ANN GASTROENTEROL, V26, P104; Thomas DW, 2013, BRIT J HAEMATOL, V161, P639, DOI 10.1111/bjh.12311; WHO, 013 WHO NHD; WORWOOD M, 1982, CLIN HAEMATOL, V11, P275	15	24	24	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2513	10.1136/bmj.j2513	http://dx.doi.org/10.1136/bmj.j2513			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28620083	Green Accepted, Green Submitted			2022-12-28	WOS:000403753800003
J	Savage, N				Savage, Neil			The Measure of a Man	CELL			English	Editorial Material								Moving beyond simple fitness tracking, wearable devices may soon offer opportunities for monitoring health and bring vast amounts of new data to the study of human diseases.											0	4	4	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1159	1161		10.1016/j.cell.2017.05.037	http://dx.doi.org/10.1016/j.cell.2017.05.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622499	Bronze			2022-12-28	WOS:000403332400002
J	Hockaday, D				Hockaday, Derek			Christopher William Burke OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									[Hockaday, Derek] Radcliffe Infirm, Oxford, England; [Hockaday, Derek] John Radcliffe Hosp, Oxford, England	Radcliffe Infirmary; University of Oxford	Hockaday, D (corresponding author), Radcliffe Infirm, Oxford, England.							BURKE CW, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2017	357								j2822	10.1136/bmj.j2822	http://dx.doi.org/10.1136/bmj.j2822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UJ	28607109				2022-12-28	WOS:000403752200004
J	Alonso, P; Engels, D; Reeder, J				Alonso, Pedro; Engels, Dirk; Reeder, John			Renewed push to strengthen vector control globally	LANCET			English	Editorial Material									[Alonso, Pedro] WHO, Global Malaria Programme, CH-1211 Geneva 27, Switzerland; [Engels, Dirk] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva 27, Switzerland; [Reeder, John] WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland	World Health Organization; World Health Organization; World Health Organization	Alonso, P (corresponding author), WHO, Global Malaria Programme, CH-1211 Geneva 27, Switzerland.	alonsop@who.int	Alonso, Pedro L/AAZ-3645-2020	Alonso, Pedro L/0000-0003-3292-3443; Reeder, John/0000-0003-1395-1289	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2016, GLOB VECT CONTR RESP; [Anonymous], ZIK EP UPD; Chan M, 2016, COMMUNICATION; Cibulskis RE, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0151-8; Golding N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0491-4; Pan America Health Organization, 2017, YELL FEV EP UPD; Patouillard E, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000176; WHO, 2016, WORLD MAL REP 2016; WHO, 2015, INV OV GLOB IMP NEGL; WHO, 2017, INT ENGL TROP DIS GL	10	16	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2270	2271		10.1016/S0140-6736(17)31376-4	http://dx.doi.org/10.1016/S0140-6736(17)31376-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28579150				2022-12-28	WOS:000402872700008
J	de Longpre, J				de Longpre, Jennifer			Large Arachnoid Cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[de Longpre, Jennifer] Metro Hlth Hosp, Wyoming, MI 49519 USA		de Longpre, J (corresponding author), Metro Hlth Hosp, Wyoming, MI 49519 USA.	jenniferdelongpre@gmail.com							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2265	2265		10.1056/NEJMicm1610483	http://dx.doi.org/10.1056/NEJMicm1610483			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW8WG	28591531				2022-12-28	WOS:000402798200010
J	Walton, C				Walton, Caroline			Ernest Walton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		WALTON E, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2017	357								j2740	10.1136/bmj.j2740	http://dx.doi.org/10.1136/bmj.j2740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RC	28592410				2022-12-28	WOS:000403221400005
J	Saper, RB; Lemaster, C; Delitto, A; Sherman, KJ; Herman, PM; Sadikova, E; Stevans, J; Keosaian, JE; Cerrada, CJ; Femia, AL; Roseen, EJ; Gardiner, P; Barnett, KG; Faulkner, C; Weinberg, J				Saper, R. B.; Lemaster, C.; Delitto, A.; Sherman, K. J.; Herman, P. M.; Sadikova, E.; Stevans, J.; Keosaian, J. E.; Cerrada, C. J.; Femia, A. L.; Roseen, E. J.; Gardiner, P.; Barnett, K. Gergen; Faulkner, C.; Weinberg, J.			Yoga, Physical Therapy, or Education for Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Saper, Robert B/Y-4598-2018	Saper, Robert B/0000-0002-0992-6198; Roseen, Eric/0000-0002-3240-6756					0	0	0	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC1	JC1		10.7326/P17-9039	http://dx.doi.org/10.7326/P17-9039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28631006				2022-12-28	WOS:000405573400002
J	Spaulding, CN; Klein, RD; Ruer, S; Kau, AL; Schreiber, HL; Cusumano, ZT; Dodson, KW; Pinkner, JS; Fremont, DH; Janetka, JW; Remaut, H; Gordon, JI; Hultgren, SJ				Spaulding, Caitlin N.; Klein, Roger D.; Ruer, Segolene; Kau, Andrew L.; Schreiber, Henry L.; Cusumano, Zachary T.; Dodson, Karen W.; Pinkner, Jerome S.; Fremont, Daved H.; Janetka, James W.; Remaut, Han; Gordon, Jeffrey I.; Hultgren, Scott J.			Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist	NATURE			English	Article							ESCHERICHIA-COLI; MOUSE MODEL; URINARY; MICROBIOTA; SEQUENCE; BINDING; OPTIMIZATION; COMMUNITIES; INFECTION; BACTERIA	Urinary tract infections (UTIs) caused by uropathogenic Escherichia coli (UPEC) affect 150 million people annually(1,2). Despite effective antibiotic therapy, 30-50% of patients experience recurrent UTIs(1). In addition, the growing prevalence of UPEC that are resistant to last-line antibiotic treatments, and more recently to carbapenems and colistin, make UTI a prime example of the antibiotic-resistance crisis and emphasize the need for new approaches to treat and prevent bacterial infections(3-5). UPEC strains establish reservoirs in the gut from which they are shed in the faeces, and can colonize the periurethral area or vagina and subsequently ascend through the urethra to the urinary tract, where they cause UTIs(6). UPEC isolates encode up to 16 distinct chaperone-usher pathway pili, and each pilus type may enable colonization of a habitat in the host or environment(7). For example, the type 1 pilus adhesin FimH binds mannose on the bladder surface, and mediates colonization of the bladder. However, little is known about the mechanisms underlying UPEC persistence in the gut(5). Here, using a mouse model, we show that F17-like and type 1 pili promote intestinal colonization and show distinct binding to epithelial cells distributed along colonic crypts. Phylogenomic and structural analyses reveal that F17-like pili are closely related to pilus types carried by intestinal pathogens, but are restricted to extra-intestinal pathogenic E. coli. Moreover, we show that targeting FimH with M4284, a high-affinity inhibitory mannoside, reduces intestinal colonization of genetically diverse UPEC isolates, while simultaneously treating UTI, without notably disrupting the structural configuration of the gut microbiota. By selectively depleting intestinal UPEC reservoirs, mannosides could markedly reduce the rate of UTIs and recurrent UTIs.	[Spaulding, Caitlin N.; Klein, Roger D.; Schreiber, Henry L.; Cusumano, Zachary T.; Dodson, Karen W.; Pinkner, Jerome S.; Fremont, Daved H.; Hultgren, Scott J.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; [Spaulding, Caitlin N.; Klein, Roger D.; Kau, Andrew L.; Schreiber, Henry L.; Cusumano, Zachary T.; Dodson, Karen W.; Pinkner, Jerome S.; Janetka, James W.; Hultgren, Scott J.] Washington Univ, CWIDR, St Louis, MO 63110 USA; [Ruer, Segolene; Remaut, Han] VIB, Struct & Mol Microbiol, VIB Ctr Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium; [Ruer, Segolene; Remaut, Han] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Kau, Andrew L.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Schreiber, Henry L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Fremont, Daved H.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Fremont, Daved H.; Janetka, James W.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Gordon, Jeffrey I.] Washington Univ, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hultgren, SJ (corresponding author), Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.; Hultgren, SJ (corresponding author), Washington Univ, CWIDR, St Louis, MO 63110 USA.	hultgren@wustl.edu	Kau, Andrew/AGX-9881-2022; Janetka, James/A-8216-2011	Spaulding, Caitlin/0000-0002-7582-3816; Remaut, Han/0000-0002-9775-4102; Janetka, James/0000-0002-9888-5411; Kau, Andrew/0000-0002-9386-3766; Fremont, Daved/0000-0002-8544-2689; Pinkner, Jerome/0000-0002-7389-7440	NIH [K08AI113184, RO1DK051406, R01AI048689, P50DK064540, RC1DK086378, DK30292, 1F31DK107057]; FWO-Flanders [G030411N]; Hercules Foundation [UABR/09/005]; VIB PRJ9; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI113184, R01AI048689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK107057, RC1DK086378, R37DK030292, P50DK064540, R01DK051406, R01DK030292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FWO-Flanders(FWO); Hercules Foundation; VIB PRJ9; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Earl and A. Manson for assistance in acquiring genomic data, J. Nix and Molecular Biology Consortium (Beamline 4.2.2) for collection/processing crystallographic data, L. Vereecke and A. Goncalves at VIB Bio Imaging Core for support with tissue sectioning/microscopy, Z. Han for synthesizing M4284, K. Tamadonfar for assistance with tissue binding studies, and M. Lukaszczyk for help with protein production. This work was supported by grants from the NIH (K08AI113184 (A. L. K.), RO1DK051406 (S.J.H) R01AI048689 (S.J.H.), P50DK064540 (S.J.H.), RC1DK086378 (S.J.H.), DK30292 (J.I.G.) and 1F31DK107057 (C.N.S.)), FWO-Flanders (G030411N), Hercules Foundation (UABR/09/005) and VIB PRJ9.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cusumano CK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003021; Czaja CA, 2009, J INFECT DIS, V200, P528, DOI 10.1086/600385; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Galtier M, 2016, ENVIRON MICROBIOL, V18, P2237, DOI 10.1111/1462-2920.13284; Han ZF, 2012, J MED CHEM, V55, P3945, DOI 10.1021/jm300165m; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Jarvis C, 2016, CHEMMEDCHEM, V11, P367, DOI 10.1002/cmdc.201600006; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kalas V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601944; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Low AS, 2006, ENVIRON MICROBIOL, V8, P1033, DOI 10.1111/j.1462-2920.2006.00995.x; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mediavilla JR, 2016, MBIO, V7, DOI 10.1128/mBio.01191-16; Merckel MC, 2003, J MOL BIOL, V331, P897, DOI 10.1016/S0022-2836(03)00841-6; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Rosen DA, 2008, INFECT IMMUN, V76, P4290, DOI 10.1128/IAI.00255-08; Schreiber HL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf1283; Spaulding CN, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010030; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wurpel DJ, 2016, J PROTEOMICS, V131, P177, DOI 10.1016/j.jprot.2015.11.001; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Yamamoto S, 1997, J UROLOGY, V157, P1127, DOI 10.1016/S0022-5347(01)65154-1; Yao JW, 2016, ANTIMICROB AGENTS CH, V60, P4264, DOI 10.1128/AAC.00535-16; Zhang LX, 2002, J CLIN MICROBIOL, V40, P3951, DOI 10.1128/JCM.40.11.3951-3955.2002; Zowawi HM, 2015, NAT REV UROL, V12, P570, DOI 10.1038/nrurol.2015.199	46	146	153	12	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					528	+		10.1038/nature22972	http://dx.doi.org/10.1038/nature22972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28614296	Green Accepted			2022-12-28	WOS:000403814100038
J	Witze, A				Witze, Alexandra			The fight to save thousands of lives with sea-floor sensors	NATURE			English	Editorial Material																		Sasagawa G, 2013, IEEE J OCEANIC ENG, V38, P447, DOI 10.1109/JOE.2012.2233312; Schmalzle GM, 2014, GEOCHEM GEOPHY GEOSY, V15, P1515, DOI 10.1002/2013GC005172	2	3	3	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					466	468		10.1038/546466a	http://dx.doi.org/10.1038/546466a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28640284	Bronze			2022-12-28	WOS:000403814100015
J	Grimm, D				Grimm, David			CHIMPS IN WAITING	SCIENCE			English	Editorial Material																			0	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1114	1117		10.1126/science.356.6343.1114	http://dx.doi.org/10.1126/science.356.6343.1114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619896				2022-12-28	WOS:000403327400011
J	Shaffer, SM; Dunagin, MC; Torborg, SR; Torre, EA; Emert, B; Krepler, C; Beqiri, M; Sproesser, K; Brafford, PA; Xiao, M; Ggan, EE; Anastopoulos, IN; Vargas-Garcia, CA; Singh, A; Nathanson, KL; Herlyn, M; Raj, A				Shaffer, Sydney M.; Dunagin, Margaret C.; Torborg, Stefan R.; Torre, Eduardo A.; Emert, Benjamin; Krepler, Clemens; Beqiri, Marilda; Sproesser, Katrin; Brafford, Patricia A.; Xiao, Min; Ggan, Elliott E.; Anastopoulos, Ioannis N.; Vargas-Garcia, Cesar A.; Singh, Abhyudai; Nathanson, Katherine L.; Herlyn, Meenhard; Raj, Arjun			Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance	NATURE			English	Article							MELANOMA REVEALS; VEMURAFENIB; INHIBITION; MECHANISMS; PLASTICITY; MUTATIONS; CHROMATIN; STATE	Therapies that target signalling molecules that are mutated in cancers can often have substantial short-term effects, but the emergence of resistant cancer cells is a major barrier to full cures(1,2). Resistance can result from secondary mutations(3,4), but in other cases there is no clear genetic cause, raising the possibility of non-genetic rare cell variability(5-11). Here we show that human melanoma cells can display profound transcriptional variability at the single-cell level that predicts which cells will ultimately resist drug treatment. This variability involves infrequent, semi-coordinated transcription of a number of resistance markers at high levels in a very small percentage of cells. The addition of drug then induces epigenetic reprogramming in these cells, converting the transient transcriptional state to a stably resistant state. This reprogramming begins with a loss of SOX10-mediated differentiation followed by activation of new signalling pathways, partially mediated by the activity of the transcription factors JUN and/ or AP-1 and TEAD. Our work reveals the multistage nature of the acquisition of drug resistance and provides a framework for understanding resistance dynamics in single cells. We find that other cell types also exhibit sporadic expression of many of these same marker genes, suggesting the existence of a general program in which expression is displayed in rare subpopulations of cells.	[Shaffer, Sydney M.; Dunagin, Margaret C.; Torborg, Stefan R.; Torre, Eduardo A.; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Shaffer, Sydney M.; Torre, Eduardo A.; Emert, Benjamin; Ggan, Elliott E.; Anastopoulos, Ioannis N.; Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Torborg, Stefan R.] Univ Penn, Dept Biochem, Philadelphia, PA 19104 USA; [Emert, Benjamin] Univ Penn, Genom & Computat Biol Grp, Philadelphia, PA 19104 USA; [Krepler, Clemens; Beqiri, Marilda; Sproesser, Katrin; Brafford, Patricia A.; Xiao, Min] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Vargas-Garcia, Cesar A.; Singh, Abhyudai] Univ Delaware, Elect & Comp Engn, Newark, DE 19716 USA; [Singh, Abhyudai] Univ Delaware, Biomed Engn, Newark, DE 19716 USA; [Raj, Arjun] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; The Wistar Institute; University of Delaware; University of Delaware; University of Pennsylvania	Raj, A (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Raj, A (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	arjunraj@seas.upenn.edu	Vargas-Garcia, Cesar/J-8090-2017	Vargas-Garcia, Cesar/0000-0002-4286-8882; Raj, Arjun/0000-0002-2915-6960; Shaffer, Sydney/0000-0003-3539-9886; Torborg, Stefan/0000-0002-6220-803X; Emert, Benjamin/0000-0002-4857-2425	NIH [DP2 OD008514, R33 EB019767, P30 CA016520, F30 AI114475]; NIH/NCI PSOC [U54 CA193417]; NSF CAREER [1350601]; National Science Foundation [DMS-1312926]; SPORE [P50 CA174523]; Melanoma Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation;  [P01 CA114046];  [R01 CA047159]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA174523, P01CA114046, P30CA016520, U54CA193417, R01CA047159, P30CA010815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI114475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB019767] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1350601] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI PSOC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation(National Science Foundation (NSF)); SPORE; Melanoma Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank G. Nair for suggesting Luria-Delbruck experiments, M. MacLean for image software; H. Youk, A. Weeraratna and J. Rood for feedback on the manuscript, and Raj Laboratory members for comments. A. R. acknowledges NIH New Innovator Award DP2 OD008514, NIH/NCI PSOC award number U54 CA193417, NSF CAREER 1350601, NIH R33 EB019767, P30 CA016520. S.M.S. acknowledges NIH F30 AI114475. A.S. acknowledges National Science Foundation Grant DMS-1312926. M. H. acknowledges P01 CA114046, R01 CA047159, SPORE P50 CA174523, Melanoma Research Foundation, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. K.N. acknowledges Melanoma Research Alliance, P50 CA174523, P01 CA114046.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Jiang L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1010-4; Krepler C, 2016, CLIN CANCER RES, V22, P1592, DOI 10.1158/1078-0432.CCR-15-1762; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/065005; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Luria SE, 1943, GENETICS, V28, P491; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nguyen A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11246; O'Connell MP, 2013, CANCER DISCOV, V3, P1378, DOI 10.1158/2159-8290.CD-13-0005; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Pisco AO, 2015, BRIT J CANCER, V112, P1725, DOI 10.1038/bjc.2015.146; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramirez M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10690; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Symmons O, 2016, MOL CELL, V62, P788, DOI 10.1016/j.molcel.2016.05.023; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trunzer K, 2013, J CLIN ONCOL, V31, P1767, DOI 10.1200/JCO.2012.44.7888; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Viswanathan VS, 2017, NATURE; Webster MR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004114	35	518	523	5	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					431	+		10.1038/nature22794	http://dx.doi.org/10.1038/nature22794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28607484	Green Accepted			2022-12-28	WOS:000403250900040
J	Takenaka, H; Grinberg, I; Liu, S; Rappe, AM				Takenaka, Hiroyuki; Grinberg, Ilya; Liu, Shi; Rappe, Andrew M.			Slush-like polar structures in single-crystal relaxors	NATURE			English	Article							GLASSY POLARIZATION BEHAVIOR; LEAD MAGNESIUM NIOBATE; MOLECULAR-DYNAMICS; FERROELECTRICS; WATER; MODEL; OXIDES; ORDER; ICE	Despite more than 50 years of investigation, it is still unclear how the underlying structure of relaxor ferroelectrics gives rise to their defining properties, such as ultrahigh piezoelectric coefficients, high permittivity over a broad temperature range, diffuse phase transitions, strong frequency dependence in dielectric response, and phonon anomalies(1-10). The model of polar nanoregions inside a non-polar matrix has been widely used to describe the structure of relaxor ferroelectrics(11). However, the lack of precise knowledge about the shapes, growth and dipole patterns of polar nanoregions has led to the characterization of relaxors as "hopeless messes"(12), and no predictive model for relaxor behaviour is currently available. Here we use molecular dynamics simulations of the prototypical Pb(Mg-1/3, Nb-2/3)O-3-PbTiO3 relaxor material to examine its structure and the spatial and temporal polarization correlations. Our simulations show that the unusual properties of relaxors stem from the presence of a multi-domain state with extremely small domain sizes (2-10 nanometres), and no non-polar matrix, owing to the local dynamics. We find that polar structures in the multidomain state in relaxors are analogous to those of the slush state of water. The multi-domain structure of relaxors that is revealed by our molecular dynamics simulations is consistent with recent experimental diffuse scattering results and indicates that relaxors have a high density of low-angle domain walls. This insight explains the recently discovered classes of relaxors(13) that cannot be described by the polar nanoregion model, and provides guidance for the design and synthesis of new relaxor materials.	[Takenaka, Hiroyuki; Grinberg, Ilya; Liu, Shi; Rappe, Andrew M.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Grinberg, Ilya] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel	University of Pennsylvania; Bar Ilan University	Takenaka, H; Rappe, AM (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	htakenaka@carnegiescience.edu; rappe@sas.upenn.edu	Rappe, Andrew Marshall/HFZ-8855-2022; LIU, SHI/I-5494-2013	LIU, SHI/0000-0002-8488-4848	ONR [N00014-12-1-1033]; HPCMO	ONR(Office of Naval Research); HPCMO	This work was supported by the ONR under grant N00014-12-1-1033. Computational support was provided by the US DOD through a Challenge Grant from the HPCMO. We thank P.M. Gehring for discussions on his experimental diffuse scattering data and the diffuse scattering method.	Akbas MA, 1997, J AM CERAM SOC, V80, P2933, DOI 10.1111/j.1151-2916.1997.tb03214.x; Blinc R, 1999, PHYS REV LETT, V83, P424, DOI 10.1103/PhysRevLett.83.424; Bokov AA, 2006, J MATER SCI, V41, P31, DOI 10.1007/s10853-005-5915-7; Bokov AA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.052102; Bokov AA, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064103; Bosak A, 2012, ACTA CRYSTALLOGR A, V68, P117, DOI 10.1107/S0108767311040281; Burkovsky RG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.097603; BURNS G, 1983, SOLID STATE COMMUN, V48, P853, DOI 10.1016/0038-1098(83)90132-1; BURNS G, 1983, PHYS REV B, V28, P2527, DOI 10.1103/PhysRevB.28.2527; Chamberlin RV, 2015, ENTROPY-SWITZ, V17, P52, DOI 10.3390/e17010052; Cohen RE, 2006, NATURE, V441, P941, DOI 10.1038/441941a; CROSS LE, 1987, FERROELECTRICS, V76, P241, DOI 10.2109/jcersj.99.829; Dmowski W, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.137602; Elton DC, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869110; Gehring PM, 2000, PHYS REV LETT, V84, P5216, DOI 10.1103/PhysRevLett.84.5216; Grinberg I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.267603; Grinberg I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.197601; Guardia E, 2015, J PHYS CHEM B, V119, P8926, DOI 10.1021/jp507196q; Hiraka H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184105; Hoffmann MM, 1997, J AM CHEM SOC, V119, P3811, DOI 10.1021/ja964331g; Huang C, 2011, PHYS CHEM CHEM PHYS, V13, P19997, DOI 10.1039/c1cp22804h; Jeong IK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.147602; Kirsch B., 1986, Ferroelectrics, V68, P275, DOI 10.1080/00150198608238757; Kumar P, 2009, P NATL ACAD SCI USA, V106, P22130, DOI 10.1073/pnas.0911094106; Kutnjak Z, 2006, NATURE, V441, P956, DOI 10.1038/nature04854; Li F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13807; Liu S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104102; Martin DR, 2015, J PHYS CHEM LETT, V6, P407, DOI 10.1021/jz5025433; Matsuura M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144107; Meissner T, 2004, IEEE T GEOSCI REMOTE, V42, P1836, DOI 10.1109/TGRS.2004.831888; Mischenko AS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2405889; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Phelan D, 2014, P NATL ACAD SCI USA, V111, P1754, DOI 10.1073/pnas.1314780111; Pirc R, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020101; Pirc R, 1999, PHYS REV B, V60, P13470, DOI 10.1103/PhysRevB.60.13470; Rau JG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12234; Rosenfeld HD, 1993, FERROELECTRICS, V150, P183, DOI 10.1080/00150199308008704; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Shin YH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054104; Soper AK, 2000, CHEM PHYS, V258, P121, DOI 10.1016/S0301-0104(00)00179-8; Svitelskiy O, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104107; Takenaka H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.147602; Tinte S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.137601; Toulouse J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.184106; Toulouse J, 2008, FERROELECTRICS, V369, P203, DOI 10.1080/08838150802378160; VAKHRUSHEV SB, 1989, FERROELECTRICS, V90, P173, DOI 10.1080/00150198908211287; VIEHLAND D, 1991, PHYS REV B, V43, P8316, DOI 10.1103/PhysRevB.43.8316; VIEHLAND D, 1991, FERROELECTRICS, V120, P71, DOI 10.1080/00150199108216802; VIEHLAND D, 1992, PHYS REV B, V46, P8003, DOI 10.1103/PhysRevB.46.8003; VIEHLAND D, 1990, J APPL PHYS, V68, P2916, DOI 10.1063/1.346425; Wang D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6100; WESTPHAL V, 1992, PHYS REV LETT, V68, P847, DOI 10.1103/PhysRevLett.68.847; Xu GY, 2008, NAT MATER, V7, P562, DOI 10.1038/nmat2196; Xu RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4120; Yang LY, 2014, MACROMOLECULES, V47, P8119, DOI 10.1021/ma501852x; Zhang C, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4893638	56	144	145	11	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					391	+		10.1038/nature22068	http://dx.doi.org/10.1038/nature22068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617453				2022-12-28	WOS:000403250900032
J	Holmes, JF; Kelley, KM; Wootton-Gorges, SL; Utter, GH; Abramson, LP; Rose, JS; Tancredi, DJ; Kuppermann, N				Holmes, James F.; Kelley, Kenneth M.; Wootton-Gorges, Sandra L.; Utter, Garth H.; Abramson, Lisa P.; Rose, John S.; Tancredi, Daniel J.; Kuppermann, Nathan			Effect of Abdominal Ultrasound on Clinical Care, Outcomes, and Resource Use Among Children With Blunt Torso Trauma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY-DEPARTMENT; FOCUSED ASSESSMENT; ULTRASONOGRAPHY; SONOGRAPHY; PERFORMANCE	IMPORTANCE The utility of the focused assessment with sonography for trauma (FAST) examination in children is unknown. OBJECTIVE To determine if the FAST examination during initial evaluation of injured children improves clinical care. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial (April 2012-May 2015) that involved 975 hemodynamically stable children and adolescents younger than 18 years treated for blunt torso trauma at the University of California, Davis Medical Center, a level I trauma center. INTERVENTIONS Patients were randomly assigned to a standard trauma evaluation with the FAST examination by the treating ED physician or a standard trauma evaluation alone. MAIN OUTCOMES AND MEASURES Coprimary outcomeswere rate of abdominal computed tomographic (CT) scans in the ED, missed intra-abdominal injuries, ED length of stay, and hospital charges. RESULTS Among the 925 patients who were randomized (mean [SD] age, 9.7 [5.3] years; 575 males [62%]), all completed the study. A total of 50 patients (5.4%, 95% CI, 4.0% to 7.1%) were diagnosed with intra-abdominal injuries, including 40 (80%; 95% CI, 66% to 90%) who had intraperitoneal fluid found on an abdominal CT scan, and 9 patients (0.97%; 95% CI, 0.44% to 1.8%) underwent laparotomy. The proportion of patients with abdominal CT scans was 241 of 460 (52.4%) in the FAST group and 254 of 465 (54.6%) in the standard care-only group (difference, -2.2%; 95% CI, -8.7% to 4.2%). One case of missed intra-abdominal injury occurred in a patient in the FAST group and none in the control group (difference, 0.2%; 95% CI, -0.6% to 1.2%). The mean ED length of stay was 6.03 hours in the FAST group and 6.07 hours in the standard care-only group (difference, -0.04 hours; 95% CI, -0.47 to 0.40 hours). Median hospital charges were $46 415 in the FAST group and $47 759 in the standard care-only group (difference, -$1180; 95% CI, -$6651 to $4291). CONCLUSIONS AND RELEVANCE Among hemodynamically stable children treated in an ED following blunt torso trauma, the use of FAST compared with standard care only did not improve clinical care, including use of resources; ED length of stay; missed intra-abdominal injuries; or hospital charges. These findings do not support the routine use of FAST in this setting.	[Holmes, James F.; Kelley, Kenneth M.; Rose, John S.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Wootton-Gorges, Sandra L.] Univ Calif Davis, Sch Med, Dept Radiol, Sacramento, CA 95817 USA; [Utter, Garth H.; Abramson, Lisa P.] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA 95817 USA; [Tancredi, Daniel J.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Holmes, JF (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 2315 Stockton Blvd,PSSB Ste 2100, Sacramento, CA 95817 USA.	jfholmes@ucdavis.edu	Tancredi, Daniel J/O-3381-2013; Rose-John, Stefan/A-7998-2010	Tancredi, Daniel J/0000-0002-3884-7907; Rose-John, Stefan/0000-0002-7519-3279; Utter, Garth/0000-0001-7747-3429	Emergency Medical Services for Children [H34MC19682]	Emergency Medical Services for Children	This work was supported by grant H34MC19682 from the Emergency Medical Services for Children.	Baka AG, 2002, PEDIATR EMERG CARE, V18, P163, DOI 10.1097/00006565-200206000-00003; Fox JC, 2011, ACAD EMERG MED, V18, P476, DOI 10.1111/j.1553-2712.2011.01071.x; Holmes JF, 2007, J PEDIATR SURG, V42, P1588, DOI 10.1016/j.jpedsurg.2007.04.023; Holmes JF, 2004, ANN EMERG MED, V43, P354, DOI 10.1016/j.annemergmed.2003.09.011; Holmes JF, 2001, J PEDIATR SURG, V36, P968, DOI 10.1053/jpsu.2001.24719; Holmes JF, 2013, ANN EMERG MED, V62; MA OJ, 1995, J TRAUMA, V38, P879; Melniker LA, 2006, ANN EMERG MED, V48, P227, DOI 10.1016/j.annemergmed.2006.01.008; Menaker J, 2014, J TRAUMA ACUTE CARE, V77, P427, DOI 10.1097/TA.0000000000000296; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Rose JS, 2001, J TRAUMA, V51, P545, DOI 10.1097/00005373-200109000-00022; ROZYCKI GS, 1993, J TRAUMA, V34, P516, DOI 10.1097/00005373-199304000-00008; Scaife ER, 2013, J PEDIATR SURG, V48, P1377, DOI 10.1016/j.jpedsurg.2013.03.038; Stengel D, 2015, COCHRANE DB SYST REV, V9	14	45	46	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2290	2296		10.1001/jama.2017.6322	http://dx.doi.org/10.1001/jama.2017.6322			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609532	Bronze, Green Published			2022-12-28	WOS:000403149900015
J	Moressa, V; Pastore, S; Naviglio, S; Ventura, A				Moressa, Valentina; Pastore, Serena; Naviglio, Samuele; Ventura, Alessandro			CASE REVIEW A young goalkeeper with buttock pain and fever	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BACTERIAL PYOMYOSITIS; INFECTIONS		[Moressa, Valentina; Naviglio, Samuele; Ventura, Alessandro] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Pastore, Serena; Ventura, Alessandro] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy	University of Trieste; IRCCS Burlo Garofolo	Moressa, V (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	valemorex@gmail.com	Naviglio, Samuele/G-1297-2014	Naviglio, Samuele/0000-0002-1915-9965				Crum NF, 2004, AM J MED, V117, P420, DOI 10.1016/j.amjmed.2004.03.031; Moran GG, 2009, J CHILD ORTHOP, V3, P479, DOI 10.1007/s11832-009-0206-5; Grose C, 2009, FEIGIN CHERRYS TXB P, P749; Have KLV, 2009, J PEDIATR ORTHOPED, V29, P927, DOI 10.1097/BPO.0b013e3181bd1e0c; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; McMullan BJ, 2016, LANCET INFECT DIS, V16, pE139, DOI 10.1016/S1473-3099(16)30024-X; Moriarty P, 2015, PEDIATR INFECT DIS J, V34, P1, DOI 10.1097/INF.0000000000000470; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Section J, 2015, J BONE JOINT SURG AM, V97A, P441, DOI 10.2106/JBJS.N.00477; Sharma A, 2010, CLIN RHEUMATOL, V29, P45, DOI 10.1007/s10067-009-1277-x; Shedek Brian K, 2008, Am J Emerg Med, V26, DOI 10.1016/j.ajem.2007.11.034; Unnikrishnan PN, 2010, INT ORTHOP, V34, P109, DOI 10.1007/s00264-009-0765-6; Yu CW, 2004, MAGN RESON IMAGING, V22, P1233, DOI 10.1016/j.mri.2004.08.005; Zimbelman J, 1999, PEDIATR INFECT DIS J, V18, P1096, DOI 10.1097/00006454-199912000-00014	14	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2017	357								j2400	10.1136/bmj.j2400	http://dx.doi.org/10.1136/bmj.j2400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RE	28596179				2022-12-28	WOS:000403221600002
J	Fizazi, K; Tran, N; Fein, L; Matsubara, N; Rodriguez-Antolin, A; Alekseev, BY; Ozguroglu, M; Ye, DW; Feyerabend, S; Protheroe, A; De Porre, P; Kheoh, T; Park, YC; Todd, MB; Chi, KN				Fizazi, Karim; NamPhuong Tran; Fein, Luis; Matsubara, Nobuaki; Rodriguez-Antolin, Alfredo; Alekseev, Boris Y.; Ozguroglu, Mustafa; Ye, Dingwei; Feyerabend, Susan; Protheroe, Andrew; De Porre, Peter; Kheoh, Thian; Park, Youn C.; Todd, Mary B.; Chi, Kim N.		LATITUDE Investigators	Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANDROGEN-DEPRIVATION THERAPY; PLACEBO-CONTROLLED PHASE-3; LEUPROLIDE ACETATE; SURVIVAL ANALYSIS; CLINICAL-TRIALS; DOUBLE-BLIND; CHEMOTHERAPY; DOCETAXEL; RECOMMENDATIONS; NEOADJUVANT	BACKGROUND Abiraterone acetate, a drug that blocks endogenous androgen synthesis, plus prednisone is indicated for metastatic castration-resistant prostate cancer. We evaluated the clinical benefit of abiraterone acetate plus prednisone with androgen-deprivation therapy in patients with newly diagnosed, metastatic, castration-sensitive prostate cancer. METHODS In this double-blind, placebo-controlled, phase 3 trial, we randomly assigned 1199 patients to receive either androgen-deprivation therapy plus abiraterone acetate (1000 mg daily, given once daily as four 250-mg tablets) plus prednisone (5 mg daily) (the abiraterone group) or androgen-deprivation therapy plus dual placebos (the placebo group). The two primary end points were overall survival and radiographic progression-free survival. RESULTS After a median follow-up of 30.4 months at a planned interim analysis (after 406 patients had died), the median overall survival was significantly longer in the abiraterone group than in the placebo group (not reached vs. 34.7 months) (hazard ratio for death, 0.62; 95% confidence interval [CI], 0.51 to 0.76; P<0.001). The median length of radiographic progression-free survival was 33.0 months in the abiraterone group and 14.8 months in the placebo group (hazard ratio for disease progression or death, 0.47; 95% CI, 0.39 to 0.55; P<0.001). Significantly better outcomes in all secondary end points were observed in the abiraterone group, including the time until pain progression, next subsequent therapy for prostate cancer, initiation of chemotherapy, and prostate-specific antigen progression (P<0.001 for all comparisons), along with next symptomatic skeletal events (P=0.009). These findings led to the unanimous recommendation by the independent data and safety monitoring committee that the trial be unblinded and crossover be allowed for patients in the placebo group to receive abiraterone. Rates of grade 3 hypertension and hypokalemia were higher in the abiraterone group. CONCLUSIONS The addition of abiraterone acetate and prednisone to androgen-deprivation therapy significantly increased overall survival and radiographic progression-free survival in men with newly diagnosed, metastatic, castration-sensitive prostate cancer.	[Fizazi, Karim] Univ Paris Sud, Gustave Roussy, Villejuif, France; [NamPhuong Tran] Janssen Res & Dev, Los Angeles, CA USA; [De Porre, Peter] Janssen Res & Dev, Beerse, Belgium; [Kheoh, Thian] Janssen Res & Dev, San Diego, CA USA; [Park, Youn C.] Janssen Res & Dev, Raritan, NJ USA; [Fein, Luis] Inst Oncol Rosario, Rosario, Santa Fe, Argentina; [Matsubara, Nobuaki] Natl Canc Ctr Hosp East, Chiba, Japan; [Rodriguez-Antolin, Alfredo] 12 Octubre Univ Hosp, Madrid, Spain; [Alekseev, Boris Y.] PA Hertsen Moscow Canc Res Inst, Moscow, Russia; [Ozguroglu, Mustafa] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey; [Ye, Dingwei] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China; [Feyerabend, Susan] Studienpraxis Urol, Nurtingen, Germany; [Protheroe, Andrew] Oxford Univ Hosp Fdn NHS Trust, Oxford, England; [Todd, Mary B.] Janssen Global Serv, Raritan, NJ USA; [Chi, Kim N.] BC Canc Agcy, Vancouver, BC, Canada	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; National Cancer Center - Japan; Hospital Universitario 12 de Octubre; Istanbul University; Istanbul University - Cerrahpasa; Fudan University; Oxford University Hospitals NHS Foundation Trust; British Columbia Cancer Agency	Fizazi, K (corresponding author), Univ Paris Sud, Gustave Roussy, Dept Canc Med, 114 Rue Edouard Vaillant, F-94800 Villejuif, France.	karim.fizazi@gustaveroussy.fr	Alekseev, Boris/O-1008-2017; Pavlik, Ivan/O-5730-2017; Basso, Umberto/F-4229-2014; MUSTAFA, ÖZGÜROĞLU/A-8234-2016; Facchini, Gaetano/P-4491-2015; Volovat, Constantin/N-6580-2013; Vaarala, Markku/B-4116-2013; VILLERS, Arnauld/K-6629-2016	Alekseev, Boris/0000-0002-3398-4128; Pavlik, Ivan/0000-0001-5506-9783; Basso, Umberto/0000-0002-5075-2177; MUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628; Facchini, Gaetano/0000-0002-7430-001X; Fradet, Yves/0000-0002-7581-2500; Volovat, Constantin/0000-0003-1582-0135; Vaarala, Markku/0000-0003-4735-815X; VILLERS, Arnauld/0000-0002-6298-7758	Janssen Research and Development	Janssen Research and Development	Funded by Janssen Research and Development; LATITUDE ClinicalTrials.gov number, NCT01715285.	Amit O, 2011, EUR J CANCER, V47, P1772, DOI 10.1016/j.ejca.2011.02.013; BARRIE SE, 1994, J STEROID BIOCHEM, V50, P267, DOI 10.1016/0960-0760(94)90131-7; Cornford P, 2017, EUR UROL, V71, P630, DOI 10.1016/j.eururo.2016.08.002; Dalesio O, 2000, LANCET, V355, P1491; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Efstathiou E, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.5005; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Fizazi K, 2015, ANN ONCOL, V26, P1660, DOI 10.1093/annonc/mdv245; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Gillessen S, 2015, ANN ONCOL, V26, P1589, DOI 10.1093/annonc/mdv257; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; Gravis G, 2016, EUR UROL, V70, P256, DOI 10.1016/j.eururo.2015.11.005; Gravis G, 2015, EUR UROL, V68, P196, DOI 10.1016/j.eururo.2014.09.022; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; James ND, 2017, NEW ENGL J MED, V377, P338, DOI 10.1056/NEJMoa1702900; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; James ND, 2015, EUR UROL, V67, P1028, DOI 10.1016/j.eururo.2014.09.032; Li ZF, 2015, NATURE, V523, P347, DOI 10.1038/nature14406; Millikan RE, 2008, J CLIN ONCOL, V26, P5936, DOI 10.1200/JCO.2007.15.9830; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Parker C, 2015, ANN ONCOL, V26, pV69, DOI 10.1093/annonc/mdv222; Rathkopf DE, 2014, EUR UROL, V66, P815, DOI 10.1016/j.eururo.2014.02.056; Reese DM, 2000, LANCET, V355, P1474, DOI 10.1016/S0140-6736(00)02155-3; Ryan CJ, 2015, LANCET ONCOL, V16, P152, DOI 10.1016/S1470-2045(14)71205-7; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scosyrev E, 2012, CANCER-AM CANCER SOC, V118, P3062, DOI 10.1002/cncr.26392; Sweeney C., 2016, ANN ONCOL S, V27, pvi243; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Tangen Catherine M, 2003, Clin Prostate Cancer, V2, P41, DOI 10.3816/CGC.2003.n.011; Taplin ME, 2014, J CLIN ONCOL, V32, P3705, DOI 10.1200/JCO.2013.53.4578; Weiner AB, 2016, PROSTATE CANCER P D, V19, P395, DOI 10.1038/pcan.2016.30; Yamaoka M, 2010, CLIN CANCER RES, V16, P4319, DOI 10.1158/1078-0432.CCR-10-0255	34	1155	1174	2	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					352	360		10.1056/NEJMoa1704174	http://dx.doi.org/10.1056/NEJMoa1704174			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28578607	Green Published, Bronze			2022-12-28	WOS:000406295000007
J	Jiao, YP; Peluso, P; Shi, JH; Liang, T; Stitzer, MC; Wang, B; Campbell, MS; Stein, JC; Wei, XH; Chin, CS; Guill, K; Regulski, M; Kumari, S; Olson, A; Gent, J; Schneider, KL; Wolfgruber, TK; May, MR; Springer, NM; Antoniou, E; McCombie, WR; Presting, GG; McMullen, M; Ross-Ibarra, J; Dawe, RK; Hastie, A; Rank, DR; Ware, D				Jiao, Yinping; Peluso, Paul; Shi, Jinghua; Liang, Tiffany; Stitzer, Michelle C.; Wang, Bo; Campbell, Michael S.; Stein, Joshua C.; Wei, Xuehong; Chin, Chen-Shan; Guill, Katherine; Regulski, Michael; Kumari, Sunita; Olson, Andrew; Gent, Jonathan; Schneider, Kevin L.; Wolfgruber, Thomas K.; May, Michael R.; Springer, Nathan M.; Antoniou, Eric; McCombie, W. Richard; Presting, Gernot G.; McMullen, Michael; Ross-Ibarra, Jeffrey; Dawe, R. Kelly; Hastie, Alex; Rank, David R.; Ware, Doreen			Improved maize reference genome with single-molecule technologies	NATURE			English	Article							PLANT GENOMES; TRANSPOSABLE ELEMENTS; LTR RETROTRANSPOSONS; QUALITY-CONTROL; READ ALIGNMENT; MAKER-P; DIFFERENTIATION; ANNOTATIONS; POPULATION; COMPLEXITY	Complete and accurate reference genomes and annotations provide fundamental tools for characterization of genetic and functional variation(1). These resources facilitate the determination of biological processes and support translation of research findings into improved and sustainable agricultural technologies. Many reference genomes for crop plants have been generated over the past decade, but these genomes are often fragmented and missing complex repeat regions(2). Here we report the assembly and annotation of a reference genome of maize, a genetic and agricultural model species, using single-molecule real-time sequencing and high-resolution optical mapping. Relative to the previous reference genome3, our assembly features a 52-fold increase in contig length and notable improvements in the assembly of intergenic spaces and centromeres. Characterization of the repetitive portion of the genome revealed more than 130,000 intact transposable elements, allowing us to identify transposable element lineage expansions that are unique to maize. Gene annotations were updated using 111,000 full-length transcripts obtained by single-molecule real-time sequencing(4). In addition, comparative optical mapping of two other inbred maize lines revealed a prevalence of deletions in regions of low gene density and maize lineage-specific genes.	[Jiao, Yinping; Wang, Bo; Campbell, Michael S.; Stein, Joshua C.; Wei, Xuehong; Regulski, Michael; Kumari, Sunita; Olson, Andrew; Antoniou, Eric; McCombie, W. Richard; Ware, Doreen] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Peluso, Paul; Chin, Chen-Shan; Rank, David R.] Pacific Biosci, Menlo Pk, CA 94025 USA; [Shi, Jinghua; Liang, Tiffany; Hastie, Alex] BioNano Genom, San Diego, CA 92121 USA; [Stitzer, Michelle C.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Stitzer, Michelle C.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Guill, Katherine; McMullen, Michael] USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA; [Gent, Jonathan; Dawe, R. Kelly] Univ Georgia, Athens, GA 30602 USA; [Schneider, Kevin L.; Wolfgruber, Thomas K.; Presting, Gernot G.] Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [May, Michael R.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Ctr Populat Biol, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ware, Doreen] Cornell Univ, NEA Robert W Holley Ctr Agr & Hlth, USDA ARS, Ithaca, NY 14853 USA	Cold Spring Harbor Laboratory; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; University of Hawaii System; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis; Cornell University; United States Department of Agriculture (USDA)	Ware, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.; Ware, D (corresponding author), Cornell Univ, NEA Robert W Holley Ctr Agr & Hlth, USDA ARS, Ithaca, NY 14853 USA.	ware@cshl.edu	Ross-Ibarra, Jeffrey/D-7782-2011	Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Wang, Bo/0000-0002-0912-294X; Liang, Tiffany/0000-0002-1986-5966; , Gernot/0000-0001-9888-9757; Rank, David/0000-0001-9213-6965	NSF [IOS-1127112, 1444624]; NSF Cereal Gene Discovery grant [1032105]; USDA-ARS CRIS [1907-21000-030-00D]; NSF Plant Genome award [1238014, 1444514]; USDA Hatch project [CA-D-PLS-2066-H]; USDA NIFA [HAW05022-H]; NSF PGRP PRFB [1523793]; Direct For Biological Sciences [1523793, 1444514] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1238014, 1127112, 1444624] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF Cereal Gene Discovery grant; USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NSF Plant Genome award(National Science Foundation (NSF)); USDA Hatch project; USDA NIFA(United States Department of Agriculture (USDA)); NSF PGRP PRFB; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Y.J., B.W., J.S., M.S.C., X.W., S.K. and D.W. were supported by NSF Gramene grant IOS-1127112, NSF Cereal Gene Discovery grant 1032105, USDA-ARS CRIS 1907-21000-030-00D and NSF Plant Genome award 1238014. J.R.-I. would like to acknowledge support from USDA Hatch project CA-D-PLS-2066-H and NSF Plant Genome award 1238014. R.K.D. would like to acknowledge support from NSF Plant Genome award 1444514. G.G.P. acknowledges support from NSF grant 1444624 and USDA NIFA project HAW05022-H. M.S.C would also like to acknowledge support from NSF PGRP PRFB 1523793. The authors thank S. Koren for sharing genome assembly-related scripts.	Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Cao HZ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-34; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Fluhr R, 2012, PHYSIOL PLANTARUM, V145, P95, DOI 10.1111/j.1399-3054.2011.01540.x; Fouquet R, 2011, PLANT CELL, V23, P4280, DOI 10.1105/tpc.111.092163; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gent JI, 2015, GENETICS, V200, P1105, DOI 10.1534/genetics.115.177360; Hake S, 2015, ELIFE, V4, DOI 10.7554/eLife.05861; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Hirsch CN, 2016, PLANT CELL, V28, P2700, DOI 10.1105/tpc.16.00353; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Law MY, 2015, PLANT PHYSIOL, V167, P25, DOI 10.1104/pp.114.245027; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Mostovoy Y, 2016, NAT METHODS, V13, P587, DOI [10.1038/NMETH.3865, 10.1038/nmeth.3865]; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Rho MN, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp752; Rodgers-Melnick E, 2016, P NATL ACAD SCI USA, V113, pE3177, DOI 10.1073/pnas.1525244113; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Saxena RK, 2014, BRIEF FUNCT GENOMICS, V13, P296, DOI 10.1093/bfgp/elu016; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schneider KL, 2016, P NATL ACAD SCI USA, V113, pE987, DOI 10.1073/pnas.1522008113; Sharma A, 2008, P NATL ACAD SCI USA, V105, P15470, DOI 10.1073/pnas.0805694105; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Steinbiss S, 2009, NUCLEIC ACIDS RES, V37, P7002, DOI 10.1093/nar/gkp759; Strable J., 2009, COLD SPRING HARB PRO, V2009; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wallace JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004845; Wang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11708; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Wenke T, 2011, PLANT CELL, V23, P3117, DOI 10.1105/tpc.111.088682; Xiong WW, 2014, P NATL ACAD SCI USA, V111, P10263, DOI 10.1073/pnas.1410068111	51	597	623	16	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					524	+		10.1038/nature22971	http://dx.doi.org/10.1038/nature22971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28605751	Green Published, Green Submitted			2022-12-28	WOS:000403814100037
J	Minton, A				Minton, Anna			High rise living after Grenfell	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												a.minton@uel.ac.uk						Baxter R, 2005, 18 ESRCODPM; Greater London Assembly, 2015, KNOCK IT DO IT CHALL; Newman O, 1973, DEFENSIBLE SPACE PEO	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2017	357								j2981	10.1136/bmj.j2981	http://dx.doi.org/10.1136/bmj.j2981			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YX	28637669				2022-12-28	WOS:000404210400010
J	Kuchenbaecker, KB; Hopper, JL; Barnes, DR; Phillips, KA; Mooij, TM; Roos-Blom, MJ; Jervis, S; van Leeuwen, FE; Milne, RL; Andrieu, N; Goldgar, DE; Terry, MB; Rookus, MA; Easton, DF; Antoniou, AC				Kuchenbaecker, Karoline B.; Hopper, John L.; Barnes, Daniel R.; Phillips, Kelly-Anne; Mooij, Thea M.; Roos-Blom, Marie-Jose; Jervis, Sarah; van Leeuwen, Flora E.; Milne, Roger L.; Andrieu, Nadine; Goldgar, David E.; Terry, Mary Beth; Rookus, Matti A.; Easton, Douglas F.; Antoniou, Antonis C.		BRCA1 BRCA2 Cohort Consortium	Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PENETRANCE; SUSCEPTIBILITY; FAMILIES; POSITION; SERIES; WOMEN; MODEL	IMPORTANCE The clinical management of BRCA1 and BRCA2 mutation carriers requires accurate, prospective cancer risk estimates. OBJECTIVES To estimate age-specific risks of breast, ovarian, and contralateral breast cancer for mutation carriers and to evaluate risk modification by family cancer history and mutation location. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 6036 BRCA1 and 3820 BRCA2 female carriers (5046 unaffected and 4810 with breast or ovarian cancer or both at baseline) recruited in 1997-2011 through the International BRCA1/2 Carrier Cohort Study, the Breast Cancer Family Registry and the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, with ascertainment through family clinics (94%) and population-based studies (6%). The majority were from large national studies in the United Kingdom (EMBRACE), the Netherlands (HEBON), and France (GENEPSO). Follow-up ended December 2013; median follow-up was 5 years. EXPOSURES BRCA1/2 mutations, family cancer history, and mutation location. MAIN OUTCOMES AND MEASURES Annual incidences, standardized incidence ratios, and cumulative risks of breast, ovarian, and contralateral breast cancer. RESULTS Among 3886 women (median age, 38 years; interquartile range [IQR], 30-46 years) eligible for the breast cancer analysis, 5066 women (median age, 38 years; IQR, 31-47 years) eligible for the ovarian cancer analysis, and 2213 women (median age, 47 years; IQR, 40-55 years) eligible for the contralateral breast cancer analysis, 426 were diagnosed with breast cancer, 109 with ovarian cancer, and 245 with contralateral breast cancer during follow-up. The cumulative breast cancer risk to age 80 years was 72%(95% CI, 65%-79%) for BRCA1 and 69%(95% CI, 61%-77%) for BRCA2 carriers. Breast cancer incidences increased rapidly in early adulthood until ages 30 to 40 years for BRCA1 and until ages 40 to 50 years for BRCA2 carriers, then remained at a similar, constant incidence (20-30 per 1000 person-years) until age 80 years. The cumulative ovarian cancer risk to age 80 years was 44%(95% CI, 36%-53%) for BRCA1 and 17%(95% CI, 11%-25%) for BRCA2 carriers. For contralateral breast cancer, the cumulative risk 20 years after breast cancer diagnosis was 40% (95% CI, 35%-45%) for BRCA1 and 26%(95% CI, 20%-33%) for BRCA2 carriers (hazard ratio [HR] for comparing BRCA2 vs BRCA1, 0.62; 95% CI, 0.47-0.82; P=.001 for difference). Breast cancer risk increased with increasing number of first-and second-degree relatives diagnosed as having breast cancer for both BRCA1 (HR for >= 2 vs 0 affected relatives, 1.99; 95% CI, 1.41-2.82; P<.001 for trend) and BRCA2 carriers (HR, 1.91; 95% CI, 1.08-3.37; P=.02 for trend). Breast cancer risk was higher if mutations were located outside vs within the regions bounded by positions c. 2282-c. 4071 in BRCA1 (HR, 1.46; 95% CI, 1.11-1.93; P=.007) and c. 2831-c. 6401 in BRCA2 (HR, 1.93; 95% CI, 1.36-2.74; P<.001). CONCLUSIONS AND RELEVANCE These findings provide estimates of cancer risk based on BRCA1 and BRCA2 mutation carrier status using prospective data collection and demonstrate the potential importance of family history and mutation location in risk assessment.	[Kuchenbaecker, Karoline B.; Barnes, Daniel R.; Jervis, Sarah; Easton, Douglas F.; Antoniou, Antonis C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Kuchenbaecker, Karoline B.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Hopper, John L.; Phillips, Kelly-Anne; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Phillips, Kelly-Anne] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia; [Phillips, Kelly-Anne] Univ Melbourne, Dept Med, St Vincents Hosp, Parkville, Vic, Australia; [Phillips, Kelly-Anne] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Mooij, Thea M.; Roos-Blom, Marie-Jose; van Leeuwen, Flora E.; Rookus, Matti A.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Roos-Blom, Marie-Jose] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Amsterdam, Netherlands; [Jervis, Sarah] Univ Warwick, Math Inst, Coventry, W Midlands, England; [Milne, Roger L.] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia; [Andrieu, Nadine] INSERM, U900, Paris, France; [Andrieu, Nadine] Inst Curie, Paris, France; [Andrieu, Nadine] Mines ParisTech, Fontainebleau, France; [Andrieu, Nadine] PSL Res Univ, Paris, France; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Terry, Mary Beth] Columbia Univ, Dept Epidemiol, New York, NY USA	University of Cambridge; Wellcome Trust Sanger Institute; University of Melbourne; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Warwick; Cancer Council Victoria; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; Utah System of Higher Education; University of Utah; Columbia University	Antoniou, AC (corresponding author), Univ Cambridge, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Worts Causeway, Cambridge CB1 8RN, England.	aca20@medschl.cam.ac.uk	ANDRIEU, Nadine/H-4255-2014; Tischkowitz, Marc/O-4452-2018; Kets, M./L-4429-2015; Andrulis, Irene L./E-7267-2013	Tischkowitz, Marc/0000-0002-7880-0628; Machackova, Eva/0000-0002-0246-1471; Olsson, Hakan/0000-0002-8794-9635; Terry, Mary Beth/0000-0002-4106-5033; Adlard, Julian/0000-0002-1693-0435; Gerdes, Anne-Marie/0000-0002-0328-3320; Evans, Gareth/0000-0002-8482-5784; Faivre, Laurence/0000-0001-9770-444X; Eeles, Rosalind/0000-0002-3698-6241; Simard, Jacques/0000-0001-6906-3390; Tan, Yen/0000-0003-1063-5352; Barrowdale, Daniel/0000-0003-1661-3939; Sharma, Priyanka/0000-0001-8592-2239; Engel, Christoph/0000-0002-7247-282X; Foretova, Lenka/0000-0003-0494-2620; Roos-Blom, Marie-Jose/0000-0003-4066-607X; Barnes, Daniel/0000-0002-3781-7570	Cancer Research UK [12677, 11174] Funding Source: Medline; NCI NIH HHS [UM1 CA164920, R01 CA159868] Funding Source: Medline; Cancer Research UK [16563, 17523, 20861, 17528, 23382] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096, NF-SI-0513-10076] Funding Source: researchfish; National Breast Cancer Foundation [PRAC-17-004, IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA164920, R01CA159868] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Brohet RM, 2014, J MED GENET, V51, P98, DOI 10.1136/jmedgenet-2013-101974; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Evans DG, 2014, J MED GENET, V51, P573, DOI 10.1136/jmedgenet-2014-102336; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gabai-Kapara E, 2014, P NATL ACAD SCI USA, V111, P14205, DOI 10.1073/pnas.1415979111; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Goss PE, 2016, NEW ENGL J MED, V375, P209, DOI 10.1056/NEJMoa1604700; Graeser MK, 2009, J CLIN ONCOL, V27, P5887, DOI 10.1200/JCO.2008.19.9430; Hartmann LC, 2016, NEW ENGL J MED, V374, P454, DOI 10.1056/NEJMra1503523; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Metcalfe K, 2011, BRIT J CANCER, V104, P1384, DOI 10.1038/bjc.2011.120; Milne RL, 2008, CLIN CANCER RES, V14, P2861, DOI 10.1158/1078-0432.CCR-07-4436; Milne RL, 2016, ENDOCR-RELAT CANCER, V23, pT69, DOI 10.1530/ERC-16-0277; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Phillips KA, 2013, J CLIN ONCOL, V31, P3091, DOI 10.1200/JCO.2012.47.8313; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Senst N, 2013, CLIN GENET, V84, P43, DOI 10.1111/cge.12037; Thompson D, 2002, CANCER EPIDEM BIOMAR, V11, P329; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181	29	1211	1235	9	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2402	2416		10.1001/jama.2017.7112	http://dx.doi.org/10.1001/jama.2017.7112			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632866	Bronze, Green Submitted			2022-12-28	WOS:000403654600014
J	Ananat, EO; Gassman-Pines, A; Francis, DV; Gibson-Davis, CM				Ananat, Elizabeth O.; Gassman-Pines, Anna; Francis, Dania V.; Gibson-Davis, Christina M.			Linking job loss, inequality, mental health, and education	SCIENCE			English	Editorial Material									[Ananat, Elizabeth O.; Gassman-Pines, Anna; Gibson-Davis, Christina M.] Duke Univ, Durham, NC 27708 USA; [Francis, Dania V.] Univ Massachusetts, Amherst, MA 01003 USA	Duke University; University of Massachusetts System; University of Massachusetts Amherst	Gassman-Pines, A (corresponding author), Duke Univ, Durham, NC 27708 USA.	agassman.pines@duke.edu		Francis, Dania/0000-0002-6251-0992	Russell Sage Foundation	Russell Sage Foundation	E.O.A. and A. G.-P were supported by the Russell Sage Foundation.	Ananat EO, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P299; Ananat EO, 2013, DEMOGRAPHY, V50, P2151, DOI 10.1007/s13524-013-0231-3; Chetty R., W19844 NBER NAT BUR; Danziger Sheldon, 1994, UNEVEN TIDES RISING; DOOLEY D, 1984, AM J COMMUN PSYCHOL, V12, P387, DOI 10.1007/BF00896502; DOOLEY D, 1988, J SOC ISSUES, V44, P107, DOI 10.1111/j.1540-4560.1988.tb02094.x; Dynarski S, 2013, FUTURE CHILD, V23, P67, DOI 10.1353/foc.2013.0002; Gassman-Pines A, 2015, CHILD DEV PERSPECT, V9, P233, DOI 10.1111/cdep.12137; Gassman-Pines A, 2014, AM J PUBLIC HEALTH, V104, P1964, DOI 10.2105/AJPH.2014.302081; Kalil A, 2011, SOC SCI QUART, V92, P57, DOI 10.1111/j.1540-6237.2011.00757.x; Nie J., 2011, RESERVE BANK KANSAS, V2011, P35; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Rodrik D, 1998, J POLIT ECON, V106, P997, DOI 10.1086/250038; Stevens AH, 2011, ECON EDUC REV, V30, P289, DOI 10.1016/j.econedurev.2010.10.002	14	32	32	5	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1127	1128		10.1126/science.aam5347	http://dx.doi.org/10.1126/science.aam5347			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX6BO	28619903				2022-12-28	WOS:000403327400018
J	Da Mesquita, S; Kipnis, J				Da Mesquita, Sandro; Kipnis, Jonathan			DAMed in (Trem) 2 Steps	CELL			English	Editorial Material							ALZHEIMERS-DISEASE; MICROGLIA; BRAIN; CNS	The role of microglia in neurodegenerative diseases has been controversial. In this issue, KerenShaul et al. identify a unique population of disease- associated microglia (DAM) that develop in two steps and may help to restrict damage in Alzheimer and related diseases.	[Da Mesquita, Sandro; Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA	University of Virginia	Kipnis, J (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA.	kipnis@virginia.edu	Kipnis, Jonathan/AGG-9735-2022; Da Mesquita, Sandro/A-7365-2010	Kipnis, Jonathan/0000-0002-3714-517X; Da Mesquita, Sandro/0000-0002-0786-5010				[Anonymous], CELL; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042	10	3	3	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1172	1174		10.1016/j.cell.2017.05.039	http://dx.doi.org/10.1016/j.cell.2017.05.039			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622503	Bronze			2022-12-28	WOS:000403332400006
J	Roundtree, IA; Evans, ME; Pan, T; He, C				Roundtree, Ian A.; Evans, Molly E.; Pan, Tao; He, Chuan			Dynamic RNA Modifications in Gene Expression Regulation	CELL			English	Review							SINGLE-NUCLEOTIDE-RESOLUTION; EMBRYONIC STEM-CELLS; MESSENGER-RNA; RIBOSOMAL-RNA; NUCLEAR-RNA; M(6)A RNA; BASE MODIFICATION; STRUCTURAL BASIS; NONCODING RNA; YTH DOMAIN	Over 100 types of chemical modifications have been identified in cellular RNAs. While the 50 cap modification and the poly(A) tail of eukaryotic mRNA play key roles in regulation, internal modifications are gaining attention for their roles in mRNA metabolism. The most abundant internal mRNA modification is N-6-methyladenosine (m(6)A), and identification of proteins that install, recognize, and remove this and other marks have revealed roles for mRNA modification in nearly every aspect of the mRNA life cycle, as well as in various cellular, developmental, and disease processes. Abundant noncoding RNAs such as tRNAs, rRNAs, and spliceosomal RNAs are also heavily modified and depend on the modifications for their biogenesis and function. Our understanding of the biological contributions of these different chemical modifications is beginning to take shape, but it's clear that in both coding and noncoding RNAs, dynamic modifications represent a new layer of control of genetic information.	[Roundtree, Ian A.; Evans, Molly E.; Pan, Tao; He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA; [Roundtree, Ian A.; Evans, Molly E.; Pan, Tao; He, Chuan] Univ Chicago, Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA; [Roundtree, Ian A.] Univ Chicago, Med Scientist Training Program, 924 East 57th St, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Howard Hughes Med Inst, 929 East 57th St, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Pan, T; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA.; Pan, T; He, C (corresponding author), Univ Chicago, Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, 929 East 57th St, Chicago, IL 60637 USA.	taopan@uchicago.edu; chuanhe@uchicago.edu		Evans, Molly/0000-0002-7239-1667	NIH Medical Scientist National Research Service Award [T32 GM007281]; NIH Chemistry and Biology Training Grant [T32 GM008720]; NSF pre-doctoral fellowship [DGE-1144082]; NIH NHGRI [HG008935]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F30GM117646, T32GM007281, T32GM008720] Funding Source: NIH RePORTER	NIH Medical Scientist National Research Service Award; NIH Chemistry and Biology Training Grant; NSF pre-doctoral fellowship(National Science Foundation (NSF)); NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I.A.R. was supported by the NIH Medical Scientist National Research Service Award T32 GM007281 and is a recipient of the NIH F30 GM117646. M.E.E. was supported by the NIH Chemistry and Biology Training Grant T32 GM008720 and is a recipient of the NSF pre-doctoral fellowship DGE-1144082. We thank NIH NHGRI HG008935 (C.H. and T.P.) for supporting our research. C.H. is an investigator of the Howard Hughes Medical Institute.	ADAMS JM, 1975, NATURE, V255, P28, DOI 10.1038/255028a0; Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Agris PF, 2015, RNA, V21, P552, DOI 10.1261/rna.050575.115; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Anadon C., 2017, LEUKEMIA; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Belanger F, 2010, J BIOL CHEM, V285, P33037, DOI 10.1074/jbc.M110.155283; Blanco S, 2016, NATURE, V534, P335, DOI 10.1038/nature18282; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Buchhaupt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089640; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Cenik C, 2017, RNA, V23, P270, DOI 10.1261/rna.059105.116; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Charette M, 2000, IUBMB LIFE, V49, P341; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116; COHN WE, 1960, J BIOL CHEM, V235, P1488; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Donmez G, 2004, RNA, V10, P1925, DOI 10.1261/rna.7186504; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Esteller M, 2017, CANCER DISCOV, V7, P359, DOI 10.1158/2159-8290.CD-16-1292; Fernandez IS, 2013, NATURE, V500, P107, DOI 10.1038/nature12302; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Fu Y., 2012, DYNAMIC REGULATION R; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792; Hauenschild R, 2015, NUCLEIC ACIDS RES, V43, P9950, DOI 10.1093/nar/gkv895; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169; Hoernes TP, 2016, NUCLEIC ACIDS RES, V44, P852, DOI 10.1093/nar/gkv1182; HOLLEY RW, 1965, J BIOL CHEM, V240, P2122; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Karijolich J, 2010, RNA BIOL, V7, P192, DOI 10.4161/rna.7.2.11207; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Krogh N, 2016, NUCLEIC ACIDS RES, V44, P7884, DOI 10.1093/nar/gkw482; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; LAVI U, 1977, NUCLEIC ACIDS RES, V4, P63, DOI 10.1093/nar/4.1.63; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/nchembio.1836, 10.1038/NCHEMBIO.1836]; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lin Y, 2008, BIOCHEMISTRY-US, V47, P5503, DOI 10.1021/bi7022392; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N., 2017, NUCL ACIDS RES; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Ma LJ, 2017, GENOME RES, V27, P385, DOI 10.1101/gr.212563.116; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Marchand V, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw547; Massenet S, 1999, RNA, V5, P1495, DOI 10.1017/S1355838299991537; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meier UT., 2016, RNA BIOL, P1; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Molinie B, 2016, NAT METHODS, V13, P692, DOI 10.1038/nmeth.3898; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Reddy R., 1988, STRUCTURE FUNCTION M, P1, DOI 10.1007/978-3-642-73020-7_1; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Rubio MAT, 2017, NATURE, V542, P494, DOI 10.1038/nature21396; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; SCHIBLER U, 1977, NUCLEIC ACIDS RES, V4, P4133, DOI 10.1093/nar/4.12.4133; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Sharma S, 2015, TRENDS BIOCHEM SCI, V40, P560, DOI 10.1016/j.tibs.2015.07.008; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Sloan KE, 2017, RNA BIOL, V14, P1138, DOI 10.1080/15476286.2016.1259781; Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Stuart JW, 2003, J MOL BIOL, V334, P901, DOI 10.1016/j.jmb.2003.09.058; Takuma H, 2015, J BIOL CHEM, V290, P5912, DOI 10.1074/jbc.M114.606038; Taoka M, 2016, NUCLEIC ACIDS RES, V44, P8951, DOI 10.1093/nar/gkw564; Turowski TW, 2015, WIRES RNA, V6, P129, DOI 10.1002/wrna.1263; Ueda Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42271; Waas WF, 2007, J BIOL CHEM, V282, P26026, DOI 10.1074/jbc.M703391200; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Wu WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41606; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xu C, 2015, J BIOL CHEM, V290, P24902, DOI 10.1074/jbc.M115.680389; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang X, 2017, CELL RES, V27, P606, DOI 10.1038/cr.2017.55; Yildirim I, 2014, J PHYS CHEM B, V118, P14177, DOI 10.1021/jp506703g; Zhang CZ, 2016, ONCOTARGET, V7, P64527, DOI 10.18632/oncotarget.11743; Zhang MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133788; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhou KI, 2016, J MOL BIOL, V428, P822, DOI 10.1016/j.jmb.2015.08.021; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152	138	1370	1414	70	531	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1187	1200		10.1016/j.cell.2017.05.045	http://dx.doi.org/10.1016/j.cell.2017.05.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622506	Bronze, Green Accepted			2022-12-28	WOS:000403332400009
J	Phadnis, N				Phadnis, Nitin			Poisons, antidotes, and selfish genes	SCIENCE			English	Editorial Material							DIFFERENTIATION GENE; EXPLANATION; STERILITY; PHA-1		[Phadnis, Nitin] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Phadnis, N (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.							Burga A, 2017, SCIENCE, V356, DOI 10.1126/science.aal3345; Burt A., 2009, GENES CONFLICT BIOL; Dawkins R, 1989, SELFISH GENE; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; HURST LD, 1991, GENETICS, V128, P841; SCHNABEL H, 1991, GENETICS, V129, P69; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Seidel HS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001115	9	2	2	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1013	1013		10.1126/science.aan6119	http://dx.doi.org/10.1126/science.aan6119			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596327				2022-12-28	WOS:000402871700031
J	Waldman, RJ; Toole, MJ				Waldman, Ronald J.; Toole, Michael J.			Where is the science in humanitarian health?	LANCET			English	Editorial Material									[Waldman, Ronald J.] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC 20052 USA; [Waldman, Ronald J.] Doctors World USA, New York, NY 10038 USA; [Toole, Michael J.] Burnet Inst, Melbourne, Vic 3004, Australia	George Washington University; Burnet Institute	Waldman, RJ (corresponding author), George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC 20052 USA.; Waldman, RJ (corresponding author), Doctors World USA, New York, NY 10038 USA.	ronwaldman@gwu.edu						Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Barnett M, 2015, FOREIGN AFFAIRS  JUL; Blanchet K, 2017, LANCET; Checchi F, 2017, LANCET; Clarke PN, 2014, ALNAP STUDY 2014; COLOMBO S, 2017, LANCET; O'Mathuna D, 2017, LANCET; SOMMER A, 1972, LANCET, V1, P1029; Spiegel P B, 2001, Prehosp Disaster Med, V16, P281; Spiegel PB., 2017, LANCET; Taylor CE, 1948, J CHRIST MED ASS IND, V23, P113; The Sphere Project, 1998, HUM CHART MIN STAND; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; Toole MJ, 1998, B WORLD HEALTH ORGAN, V66, P237	14	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2224	2226		10.1016/S0140-6736(17)31275-8	http://dx.doi.org/10.1016/S0140-6736(17)31275-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602555				2022-12-28	WOS:000415645700009
J	Chu, DK; Hillis, CM; Leong, DP; Anand, SS; Siegal, DM				Chu, Derek K.; Hillis, Christopher M.; Leong, Darryl P.; Anand, Sonia S.; Siegal, Deborah M.			Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-DOSE ASPIRIN; VERA STUDY-GROUP; POLYCYTHEMIA-VERA; HEMORRHAGIC COMPLICATIONS; DIAGNOSTIC-CRITERIA; MYELOPROLIFERATIVE NEOPLASMS; ANTIPLATELET THERAPY; PRIMARY PROPHYLAXIS; PRIMARY PREVENTION; PROGNOSTIC-FACTORS	Background: Patients with essential thrombocythemia (ET) are at high risk for both thrombosis and hemorrhage. Purpose: To evaluate the risks and benefits of antithrombotic therapy in adults with ET. Data Sources: Multiple databases, including MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials, through 4 March 2017. Study Selection: Randomized and observational studies of antiplatelet or anticoagulant therapy, published in any language and reporting thrombotic or hemorrhagic events. Data Extraction: Two reviewers independently extracted data, assessed risk of bias, and graded certainty of evidence. Data Synthesis: No relevant randomized trials were identified. Twenty-four observational studies (18 comparative and 6 single-group) involving 6153 patients followed for 31 711 patient-years were reviewed; most were deemed to have high risk of bias. Most patients receiving antiplatelet therapy (3613 of 4527 [80%]) received low-dose aspirin (50 to 150 mg/d); 914 (20%) received high-dose aspirin (300 to 600 mg/d), dipyridamole, or other agents. Overall, findings were inconsistent and imprecise. The reported incidence rates of thrombosis, any bleeding, and major bleeding without antiplatelet therapy ranged from 5 to 110 (median, 20), from 3 to 39 (median, 8), and from 2 to 53 (median, 6) cases per 1000 patient-years, respectively. The reported relative risks for thrombosis, any bleeding, and major bleeding with antiplatelet therapy compared with none ranged from 0.26 to 3.48 (median, 0.74), from 0.48 to 11.04 (median, 1.95), and from 0.48 to 5.17 (median, 1.30), respectively. Certainty of evidence was rated low or very low for all outcomes. Limitation: No randomized trials, no extractable data on anticoagulants, lack of uniform bleeding definitions, and systematic reporting of outcomes. Conclusion: Available evidence about the risk-benefit ratio of antiplatelet therapy in adults with ET is highly uncertain.	McMaster Univ, Hamilton, ON, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; [Chu, Derek K.] McMaster Univ, Med Ctr, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada; [Hillis, Christopher M.] McMaster Univ, Juravinski Canc Ctr, Dept Hematol, Room 3-87,699 Concession St, Hamilton, ON L8P 1V4, Canada; [Leong, Darryl P.; Anand, Sonia S.; Siegal, Deborah M.] McMaster Univ, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, Hamilton Gen Hosp, 237 Barton St East, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute	Siegal, DM (corresponding author), McMaster Univ, Populat Hlth Res Inst, Dept Med, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	siegald@mcmaster.ca	T, E/HII-8943-2022	Siegal, Deborah/0000-0003-3806-3245; Chu, Derek/0000-0001-8269-4496	Regional Medical Associates [PROSPERO: CRD42015027051]	Regional Medical Associates	Regional Medical Associates. (PROSPERO: CRD42015027051)	Agarwal MB, 2015, INDIAN J MED PAEDIAT, V36, P3, DOI 10.4103/0971-5851.151770; Alimam S, 2015, BRIT J HAEMATOL, V171, P306, DOI 10.1111/bjh.13605; Alvarez-Larran A, 2014, CURR HEMATOL MALIG R, V9, P319, DOI 10.1007/s11899-014-0226-1; Alvarez-Larran A, 2013, BRIT J HAEMATOL, V161, P865, DOI 10.1111/bjh.12321; Alvarez-Larran A, 2010, BLOOD, V116, P1205, DOI 10.1182/blood-2010-01-263319; [Anonymous], 2015, GRADEEPRO GUID DEV T; Aruch D, 2016, CURR OPIN HEMATOL, V23, P150, DOI 10.1097/MOH.0000000000000216; Barbui T, 2012, BLOOD, V120, P5128, DOI 10.1182/blood-2012-07-444067; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436; Beer PA, 2011, BLOOD, V117, P1472, DOI 10.1182/blood-2010-08-270033; BERLIN NI, 1975, SEMIN HEMATOL, V12, P339; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Borowczyk M, 2015, THROMB RES, V135, P272, DOI 10.1016/j.thromres.2014.11.006; Bradburn MJ, 1998, STATA TECH B, V44, P4; Carobbio A, 2008, BLOOD, V112, P3135, DOI 10.1182/blood-2008-04-153783; Cervantes F, 2011, HEMATOL-AM SOC HEMAT, P215, DOI 10.1182/asheducation-2011.1.215; CHISTOLINI A, 1990, HAEMATOLOGICA, V75, P537; Choi CW, 2015, KOREAN J INTERN MED, V30, P771, DOI 10.3904/kjim.2015.30.6.771; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; COLOMBI M, 1991, CANCER-AM CANCER SOC, V67, P2926, DOI 10.1002/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3; CORTELAZZO S, 1995, NEW ENGL J MED, V332, P1132, DOI 10.1056/NEJM199504273321704; De Stefano V, 2008, HAEMATOLOGICA, V93, P372, DOI 10.3324/haematol.12053; Dombi P, 2017, EUR J HAEMATOL, V98, P106, DOI 10.1111/ejh.12806; FENAUX P, 1990, CANCER, V66, P549, DOI 10.1002/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6; Finazzi G, 2012, LEUKEMIA, V26, P716, DOI 10.1038/leu.2011.258; Gisslinger H, 2013, BLOOD, V121, P1720, DOI 10.1182/blood-2012-07-443770; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gruppo Italiano Studio Policitemia, 1997, BR J HAERNATA, V97, P453, DOI [10.1046/j.1365-2141.1997.362682.x, DOI 10.1046/J.1365-2141.1997.362682.X]; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Harrison C, 2011, LEUKEMIA RES, V35, P286, DOI 10.1016/j.leukres.2010.10.009; Harrison CN, 2010, BRIT J HAEMATOL, V149, P352, DOI 10.1111/j.1365-2141.2010.08122.x; Harrison CN, 2005, NEW ENGL J MED, V353, P33, DOI 10.1056/NEJMoa043800; Jaffe ES, 2001, WHO CLASSIFICATION T; Jensen MK, 2000, EUR J HAEMATOL, V65, P132, DOI 10.1034/j.1600-0609.2000.90236.x; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Latagliata R, 2009, INT J HEMATOL, V90, P486, DOI 10.1007/s12185-009-0401-7; Lim Y, 2015, THROMB RES, V135, P846, DOI 10.1016/j.thromres.2015.02.023; Martinez-Aviles L, 2012, ANN HEMATOL, V91, P1555, DOI 10.1007/s00277-012-1502-6; Michiels JJ, 1997, SEMIN THROMB HEMOST, V23, P339, DOI 10.1055/s-2007-996107; MURPHY S, 1982, CANCER TREAT REP, V66, P1495; Murphy S, 1997, SEMIN HEMATOL, V34, P29; MURPHY S, 1986, SEMIN HEMATOL, V23, P177; Palandri F, 2012, BRIT J HAEMATOL, V156, P676, DOI 10.1111/j.1365-2141.2011.08903.x; Palmer SC, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008834.pub2, 10.1002/14651858.CD008834.pub3]; Passamonti F, 2004, AM J MED, V117, P755, DOI 10.1016/j.amjmed.2004.06.032; Patrono C, 2013, BLOOD, V121, P1701, DOI 10.1182/blood-2012-10-429134; Payzin KB, 2014, CL LYMPH MYELOM LEUK, V14, P525, DOI 10.1016/j.clml.2014.02.013; Radaelli F, 2007, HEMATOL ONCOL, V25, P115, DOI 10.1002/hon.816; Randi ML, 1999, CLIN APPL THROMB-HEM, V5, P131, DOI 10.1177/107602969900500210; Ruggeri M, 1998, BRIT J HAEMATOL, V103, P772; Sagripanti A, 1996, BIOMED PHARMACOTHER, V50, P376, DOI 10.1016/S0753-3322(96)89672-7; Sandercock PAG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000024.pub4; Squizzato A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006503.pub3; Sterne J, 2016, ROBINS 1 TOOL ASSESS; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2007, SEMIN THROMB HEMOST, V33, P313, DOI 10.1055/s-2007-976165; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Tefferi A, 2017, AM J HEMATOL, V92, P95, DOI 10.1002/ajh.24607; Tefferi A, 2016, AM J HEMATOL, V91, P50, DOI 10.1002/ajh.24221; Vale N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006870.pub3; Varghese SJ, 2013, INDIAN J HEMATOL BLO, V29, P139, DOI 10.1007/s12288-012-0172-9; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112; Wong PF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001272.pub2; Yoo HHB, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010222.pub3	67	37	37	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					170	+		10.7326/M17-0284	http://dx.doi.org/10.7326/M17-0284			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28632284				2022-12-28	WOS:000406631400007
J	Charo, RA				Charo, R. Alta			Alternative Science and Human Reproduction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				[Anonymous], 2013, FACTS ARE IMP FET PA; Biggs MA, 2017, JAMA PSYCHIAT, V74, P169, DOI 10.1001/jamapsychiatry.2016.3478; Cohen J., 2017, SCIENCE; Durand M, 2001, CONTRACEPTION, V64, P227, DOI 10.1016/S0010-7824(01)00250-5; [No title captured]	5	5	5	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					309	311		10.1056/NEJMp1707107	http://dx.doi.org/10.1056/NEJMp1707107			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28613992				2022-12-28	WOS:000406295000001
J	Chang, DG; Kertesz, SG				Chang, Douglas G.; Kertesz, Stefan G.			Yoga and Low Back Pain: No Fool's Tool	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chang, Douglas G.] Univ Calif San Diego, San Diego, CA 92103 USA; [Kertesz, Stefan G.] Birmingham Vet Affairs Med Ctr, 700 South 19th St,REAP Mail Stop 151, Birmingham, AL 35233 USA; [Kertesz, Stefan G.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Chang, Douglas G.] Univ Calif San Diego, Dept Orthopaed Surg, 350 Dickinson St,Suite 121, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego	Kertesz, SG (corresponding author), Birmingham Vet Affairs Med Ctr, 700 South 19th St,REAP Mail Stop 151, Birmingham, AL 35233 USA.	skertesz@uabmc.edu						Carey TS, 2003, SPINE, V28, P390, DOI 10.1097/00007632-200302150-00016; Chang Douglas G, 2016, J Orthop Rheumatol, V3, P1; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Saper RB, 2017, ANN INTERN MED, V167, P85, DOI 10.7326/M16-2579; Simons LE, 2014, NEUROSCI BIOBEHAV R, V39, P61, DOI 10.1016/j.neubiorev.2013.12.006; Stratford PW, 2016, PHYSIOTHER CAN, V68, P29, DOI 10.3138/ptc.2014-85; Tucker JA, 2006, ADDICTION, V101, P918, DOI 10.1111/j.1360-0443.2006.01396.x	10	2	2	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					129	+		10.7326/M17-1263	http://dx.doi.org/10.7326/M17-1263			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28631002	Green Accepted			2022-12-28	WOS:000405573400021
J	Paul, A; Chaker, Z; Doetsch, F				Paul, Alex; Chaker, Zayna; Doetsch, Fiona			Hypothalamic regulation of regionally distinct adult neural stem cells and neurogenesis	SCIENCE			English	Article							SUBVENTRICULAR ZONE; TRANSGENIC MICE; NEURONS; NICHE; PROTEIN; IDENTIFICATION; ASTROCYTES; RECEPTORS; BRAIN	Neural stem cells (NSCs) in specialized niches in the adult mammalian brain generate neurons throughout life. NSCs in the adult mouse ventricular-subventricular zone (V-SVZ) exhibit a regional identity and, depending on their location, generate distinct olfactory bulb interneuron subtypes. Here, we show that the hypothalamus, a brain area regulating physiological states, provides long-range regionalized input to the V-SVZ niche and can regulate specific NSC subpopulations. Hypothalamic proopiomelanocortin neurons selectively innervate the anterior ventral V-SVZ and promote the proliferation of Nkx2.1(+) NSCs and the generation of deep granule neurons. Accordingly, hunger and satiety regulate adult neurogenesis by modulating the activity of this hypothalamic-V-SVZ connection. Our findings reveal that neural circuitry, via mosaic innervation of the V-SVZ, can recruit distinct NSC pools, allowing on-demand neurogenesis in response to physiology and environmental signals.	[Paul, Alex] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Paul, Alex; Doetsch, Fiona] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chaker, Zayna; Doetsch, Fiona] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Columbia University; Columbia University; University of Basel	Doetsch, F (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.; Doetsch, F (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	fiona.doetsch@unibas.ch			NIH National Institute of Neurological Disorders and Stroke (NINDS) [NS053884]; NIH NINDS [NS074039]; New York State Stem Cell Science [C024287]; Leona M. and Harry B. Helmsley Charitable Trust; NIH NINDS fellowship [F31NS089252]; Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; University of Basel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074039, R01NS053884, F31NS089252] Funding Source: NIH RePORTER	NIH National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); New York State Stem Cell Science; Leona M. and Harry B. Helmsley Charitable Trust; NIH NINDS fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; University of Basel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Columbia Herbert Irving Comprehensive Cancer Center Flow Cytometry Core for assistance with fluorescence-activated cell sorting; the JP Sulzberger Columbia Genome Center for assistance with small-molecule screening; R. Hen and M. Kheirbek for viruses, Pomc-cre mice, and discussion; P. Scheiffele for VAMP2 antibodies and discussion; members of the Doetsch and Wichterle laboratories for discussion; and V. Silva-Vargas and A. Delgado for comments on the manuscript. This work was supported by NIH National Institute of Neurological Disorders and Stroke (NINDS) grant NS053884 (F.D.), NIH NINDS grant NS074039 (F.D.), New York State Stem Cell Science contract C024287 (F.D.), the Leona M. and Harry B. Helmsley Charitable Trust (F.D.), and NIH NINDS fellowship F31NS089252 (A. P.). Work was also supported by the Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies and the University of Basel. The supplementary materials contain additional data. A. P. and F.D. designed experiments; A. P. and Z.C. performed and analyzed experiments; and A. P., Z.C., and F.D. wrote the manuscript.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Allen RG, 2001, J NEUROSCI, V21, P5864, DOI 10.1523/JNEUROSCI.21-16-05864.2001; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Chaker Z., 2016, REV DEV BIOL, V5, P640, DOI [10.1002/wdev.248, DOI 10.1002/WDEV.248]; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Delgado RN, 2015, DEV BIOL, V407, P265, DOI 10.1016/j.ydbio.2015.09.008; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Garcia-Verdugo J. M., CELL STEM CELL, V3; Gribaudo S, 2009, J COMP NEUROL, V517, P683, DOI 10.1002/cne.22177; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kunwar PS, 2015, ELIFE, V4, DOI 10.7554/eLife.06633; Lennington JB, 2011, J NEUROSCI, V31, P13078, DOI 10.1523/JNEUROSCI.1197-11.2011; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2014, NAT NEUROSCI, V17, P207, DOI 10.1038/nn.3610; Mirzadeh Z., SORIANO NAVARRO; Paez-Gonzalez P, 2014, NAT NEUROSCI, V17, P934, DOI 10.1038/nn.3734; Silva-Vargas V, 2013, CURR OPIN NEUROBIOL, V23, P935, DOI 10.1016/j.conb.2013.09.004; Tong CK, 2014, CELL STEM CELL, V14, P500, DOI 10.1016/j.stem.2014.01.014; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Young SZ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00010; Zeltser LM, 2012, NAT NEUROSCI, V15, P1336, DOI 10.1038/nn.3219; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	26	70	75	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1383	1385		10.1126/science.aal3839	http://dx.doi.org/10.1126/science.aal3839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28619719				2022-12-28	WOS:000404351500037
J	Sevigny, J; Chiao, P; Bussiere, T; Weinreb, PH; Williams, L; Maier, M; Dunstan, R; Salloway, S; Chen, T; Ling, Y; O'Gorman, J; Qian, F; Arastu, M; Li, MW; Chollate, S; Brennan, MS; Quintero-Monzon, O; Scannevin, RH; Arnold, HM; Engber, T; Rhodes, K; Ferrero, J; Hang, YM; Mikulskis, A; Grimm, J; Hock, C; Nitsch, RM; Sandrock, A				Sevigny, Jeff; Chiao, Ping; Bussiere, Thierry; Weinreb, Paul H.; Williams, Leslie; Maier, Marcel; Dunstan, Robert; Salloway, Stephen; Chen, Tianle; Ling, Yan; O'Gorman, John; Qian, Fang; Arastu, Mahin; Li, Mingwei; Chollate, Sowmya; Brennan, Melanie S.; Quintero-Monzon, Omar; Scannevin, Robert H.; Arnold, H. Moore; Engber, Thomas; Rhodes, Kenneth; Ferrero, James; Hang, Yaming; Mikulskis, Alvydas; Grimm, Jan; Hock, Christoph; Nitsch, Roger M.; Sandrock, Alfred			The antibody aducanumab reduces A beta plaques in Alzheimer's disease (vol 537, pg 50, 2016)	NATURE			English	Correction														Scannevin, Robert/0000-0002-5749-2785				Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323	1	37	39	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					564	564		10.1038/nature22809	http://dx.doi.org/10.1038/nature22809			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640269	Bronze			2022-12-28	WOS:000403814100045
J	Burke, R; Auerbach, A				Burke, Robert; Auerbach, Andrew			Inpatient Notes: Research Highlights From Hospital Medicine 2017	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Burke, Robert; Auerbach, Andrew] Denver Vet Affairs Med Ctr, 1055 Clermont St, Denver, CO 80220 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of California System; University of California San Francisco	Burke, R (corresponding author), Denver Vet Affairs Med Ctr, 1055 Clermont St, Denver, CO 80220 USA.	Robert.Burke5@va.gov		Burke, Robert/0000-0002-9521-8699; Auerbach, Andrew/0000-0001-8440-0527					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					H02	H03		10.7326/M17-1243	http://dx.doi.org/10.7326/M17-1243			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630997				2022-12-28	WOS:000403579000001
J	Rooney, MR; Harnack, L; Michos, ED; Ogilvie, RP; Sempos, CT; Lutsey, PL				Rooney, Mary R.; Harnack, Lisa; Michos, Erin D.; Ogilvie, Rachel P.; Sempos, Christopher T.; Lutsey, Pamela L.			Trends in Use of High-Dose Vitamin D Supplements Exceeding 1000 or 4000 International Units Daily, 1999-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Rooney, Mary R.; Harnack, Lisa; Ogilvie, Rachel P.; Lutsey, Pamela L.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Michos, Erin D.] Johns Hopkins Univ, Div Cardiol, Baltimore, MD USA; [Sempos, Christopher T.] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; National Institutes of Health (NIH) - USA	Lutsey, PL (corresponding author), 1300 S Second St,Ste 300, Minneapolis, MN 55454 USA.	lutsey@umn.edu	Rooney, Mary/X-5728-2019	Ogilvie, Rachel/0000-0002-7643-7175; Michos, Erin/0000-0002-5547-5084; Lutsey, Pamela/0000-0002-1572-1340; Harnack, Lisa/0000-0003-1963-5316	National Institutes of Health National Heart, Lung, and Blood Institute [R01 HL103706, T32-HL-007779]; Office of Dietary Supplements [R01 HL103706-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103706, T32HL007779] Funding Source: NIH RePORTER	National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants R01 HL103706 and T32-HL-007779 from the National Institutes of Health National Heart, Lung, and Blood Institute and grant R01 HL103706-S1 from the Office of Dietary Supplements.	Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258; Manson JE, 2015, JAMA-J AM MED ASSOC, V313, P1311, DOI 10.1001/jama.2015.1353; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Schleicher RL, 2016, AM J CLIN NUTR, V104, P454, DOI 10.3945/ajcn.115.127985; Wallace RB, 2011, AM J CLIN NUTR, V94, P270, DOI 10.3945/ajcn.110.003350	6	73	73	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2448	2450		10.1001/jama.2017.4392	http://dx.doi.org/10.1001/jama.2017.4392			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632857	Green Accepted			2022-12-28	WOS:000403654600018
J	Johannsen, NN; Larson, G; Meltzer, DJ; Linden, MV				Johannsen, Niels N.; Larson, Greger; Meltzer, David J.; Linden, Marc Vander			A composite window into human history	SCIENCE			English	Editorial Material							GENOMICS		[Johannsen, Niels N.] Aarhus Univ, Dept Archaeol & Heritage Studies, DK-8270 Aarhus, Hojbjerg, Denmark; [Larson, Greger] Univ Oxford, Res Lab Archaeol & Hist Art, Palaeogen & Bioarchaeol Res Network, Oxford OX1 3QY, England; [Meltzer, David J.] Southern Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Linden, Marc Vander] UCL, Inst Archaeol, Gordon Sq, London WC1H 0PY, England	Aarhus University; University of Oxford; Southern Methodist University; University of London; University College London	Linden, MV (corresponding author), UCL, Inst Archaeol, Gordon Sq, London WC1H 0PY, England.	marc.linden@ucl.ac.uk	Linden, Marc Vander/AFO-2422-2022	Linden, Marc Vander/0000-0002-0120-7754; Johannsen, Niels N./0000-0003-3550-2548; Meltzer, David/0000-0001-8084-9802	Quest Archaeological Research Fund; European Research Council [ERC-2013-StG 337574-UNDEAD, ERC-2012-StG 313716-EUROFARM]	Quest Archaeological Research Fund; European Research Council(European Research Council (ERC)European Commission)	We are grateful to C. Gosden, D.K. Grayson, T. O'Connell, R. Nielsen, D. Russell, and two anonymous reviewers for comments on an earlier version of this manuscript. D.J.M. is supported by the Quest Archaeological Research Fund, G.L. by the European Research Council (ERC-2013-StG 337574-UNDEAD), and M.V.L. by the European Research Council (ERC-2012-StG 313716-EUROFARM).	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Bolnick DA, 2016, ANNU REV ANTHROPOL, V45, P319, DOI 10.1146/annurev-anthro-102215-100036; Furholt M., 2014, P PREHIST SOC, V80, P67, DOI [10.1017/ppr.2013.20, DOI 10.1017/PPR.2013.20]; Goldberg A, 2017, P NATL ACAD SCI USA, V114, P2657, DOI 10.1073/pnas.1616392114; Hymes D., 1968, ESSAYS PROBLEM TRIBE, P23; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; Kintigh KW, 2014, P NATL ACAD SCI USA, V111, P879, DOI 10.1073/pnas.1324000111; Lane, 2013, OXFORD HDB AFRICAN A, P65, DOI DOI 10.1093/OXFORDHB/9780199569885.001.0001; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Le Roy M, 2016, J ARCHAEOL SCI, V73, P45, DOI 10.1016/j.jas.2016.07.003; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Slatkin M, 2016, P NATL ACAD SCI USA, V113, P6380, DOI 10.1073/pnas.1524306113	14	22	22	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1118	1120		10.1126/science.aan0737	http://dx.doi.org/10.1126/science.aan0737			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX6BO	28619897	Green Submitted			2022-12-28	WOS:000403327400012
J	Liz-Marzan, LM; Grzelczak, M				Liz-Marzan, Luis M.; Grzelczak, Marek			Growing anisotropic crystals at the nanoscale	SCIENCE			English	Editorial Material							GOLD NANORODS; GROWTH; EVOLUTION; SILVER		[Liz-Marzan, Luis M.; Grzelczak, Marek] CIC biomaGUNE, Paseo de Miramon 182, Donostia San Sebastian 20014, Spain; [Liz-Marzan, Luis M.; Grzelczak, Marek] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	CIC biomaGUNE; Basque Foundation for Science	Liz-Marzan, LM (corresponding author), CIC biomaGUNE, Paseo de Miramon 182, Donostia San Sebastian 20014, Spain.; Liz-Marzan, LM (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.	llizmarzan@cicbiomagune.es	Liz-Marzán, Luis M/B-8910-2011; biomaGUNE, CIC/J-9136-2014	Liz-Marzán, Luis M/0000-0002-6647-1353; Grzelczak, Marek/0000-0002-3458-8450; biomaGUNE, CIC/0000-0001-7690-0660				Almora-Barrios N, 2014, NANO LETT, V14, P871, DOI 10.1021/nl404661u; Goris B, 2012, NAT MATER, V11, P930, DOI [10.1038/NMAT3462, 10.1038/nmat3462]; Langille MR, 2012, J AM CHEM SOC, V134, P14542, DOI 10.1021/ja305245g; Langille MR, 2012, SCIENCE, V337, P954, DOI 10.1126/science.1225653; Liu MZ, 2005, J PHYS CHEM B, V109, P22192, DOI 10.1021/jp054808n; Sanchez-Iglesias A, 2017, J AM CHEM SOC, V139, P107, DOI 10.1021/jacs.6b12143; Seyed-Razavi A, 2011, CRYST GROWTH DES, V11, P158, DOI 10.1021/cg101088d; Walsh MJ, 2015, ACS NANO, V9, P715, DOI 10.1021/nn506155r; Ye XC, 2016, SCIENCE, V354, P874, DOI 10.1126/science.aah4434; Ye XC, 2012, ACS NANO, V6, P2804, DOI 10.1021/nn300315j; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654	11	56	56	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1120	1121		10.1126/science.aam8774	http://dx.doi.org/10.1126/science.aam8774			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619898				2022-12-28	WOS:000403327400013
J	Popkin, G				Popkin, Gabriel			Spooky action achieved at record distance	SCIENCE			English	News Item																			0	4	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1110	1111		10.1126/science.356.6343.1110	http://dx.doi.org/10.1126/science.356.6343.1110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619893				2022-12-28	WOS:000403327400008
J	Villeneuve, DM; Hockett, P; Vrakking, MJJ; Niikura, H				Villeneuve, D. M.; Hockett, Paul; Vrakking, M. J. J.; Niikura, Hiromichi			Coherent imaging of an attosecond electron wave packet	SCIENCE			English	Article							ANGULAR-DISTRIBUTIONS; PHOTOELECTRON; BIRTH	Electrons detached from atoms or molecules by photoionization carry information about the quantum state from which they originate, as well as the continuum states into which they are released. Generally, the photoelectron momentum distribution is composed of a coherent sum of angular momentum components, each with an amplitude and phase. Here we show, by using photoionization of neon, that a train of attosecond pulses synchronized with an infrared laser field can be used to disentangle these angular momentum components. Two-color, two-photon ionization via a Stark-shifted intermediate state creates an almost pure f-wave with a magnetic quantum number of zero. Interference of the f-wave with a spherically symmetric s-wave provides a holographic reference that enables phase-resolved imaging of the f-wave.	[Villeneuve, D. M.; Hockett, Paul] Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Villeneuve, D. M.] CNR, Joint Attosecond Sci Lab, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Villeneuve, D. M.] Univ Ottawa, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Vrakking, M. J. J.] Max Born Inst, Max Born Str 2A, D-12489 Berlin, Germany; [Vrakking, M. J. J.] Free Univ Berlin, Fachbereich Phys, Arnimallee 14, D-14195 Berlin, Germany; [Niikura, Hiromichi] Waseda Univ, Dept Appl Phys, Shinjyuku Ku, Okubo 3-4-1, Tokyo 1698555, Japan	National Research Council Canada; National Research Council Canada; University of Ottawa; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Free University of Berlin; Waseda University	Villeneuve, DM (corresponding author), Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.; Villeneuve, DM (corresponding author), CNR, Joint Attosecond Sci Lab, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.; Villeneuve, DM (corresponding author), Univ Ottawa, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.; Niikura, H (corresponding author), Waseda Univ, Dept Appl Phys, Shinjyuku Ku, Okubo 3-4-1, Tokyo 1698555, Japan.	david.villeneuve@uottawa.ca; niikura@waseda.jp	Vrakking, Marc JJ/F-6770-2014; Hockett, Paul/HGB-3177-2022; Villeneuve, David M/I-4140-2012	Vrakking, Marc JJ/0000-0002-3249-1663; Villeneuve, David M/0000-0002-2810-3648; Hockett, Paul/0000-0001-9561-8433	Japan Society for the Promotion of Science (JSPS) [25247069]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors gratefully acknowledge discussions with T. Morishita, A. Stolow, M. Ivanov, I. Tamblyn, and A. Korobenko, as well as funding from the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) grant no. 25247069. Data are available upon request from david.villeneuve@uottawa.ca.	Becker U, 1998, J ELECTRON SPECTROSC, V96, P105, DOI 10.1016/S0368-2048(98)00226-6; COOPER J, 1968, J CHEM PHYS, V48, P942, DOI 10.1063/1.1668742; Cooper J., 1969, LECTURES THEORETIC C, VXI-C, P317; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; Dudovich N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.123004; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Gruson V, 2016, SCIENCE, V354, P734, DOI 10.1126/science.aah5188; Haessler S, 2010, NAT PHYS, V6, P200, DOI 10.1038/NPHYS1511; Haessler S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.011404; HANSEN JC, 1980, PHYS REV A, V21, P222, DOI 10.1103/PhysRevA.21.222; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kim KT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.093001; Kraus PM, 2015, SCIENCE, V350, P790, DOI 10.1126/science.aab2160; Laurent G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.083001; Mauritsson J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053001; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Meckel M, 2014, NAT PHYS, V10, P594, DOI 10.1038/NPHYS3010; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Ray D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143002; Reid KL, 2003, ANNU REV PHYS CHEM, V54, P397, DOI 10.1146/annurev.physchem.54.011002.103814; Remetter T, 2006, NAT PHYS, V2, P323, DOI 10.1038/nphys290; Rouzee A, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/12/124017; Saloman EB, 2004, J PHYS CHEM REF DATA, V33, P1113, DOI 10.1063/1.1797771; Stodolna AS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213001; Swoboda M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.103003; Wimmel H., 1992, QUANTUM PHYS OBSERVE; YIN YY, 1992, PHYS REV LETT, V69, P2353, DOI 10.1103/PhysRevLett.69.2353	27	77	78	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1150	1153		10.1126/science.aam8393	http://dx.doi.org/10.1126/science.aam8393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619939	Green Submitted			2022-12-28	WOS:000403327400031
J	Armstrong, DG; Boulton, AJM; Bus, SA				Armstrong, David G.; Boulton, Andrew J. M.; Bus, Sicco A.			Diabetic Foot Ulcers and Their Recurrence	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RISK-FACTORS; PLANTAR PRESSURE; OFFLOADING INTERVENTIONS; THERAPEUTIC FOOTWEAR; SECONDARY PREVENTION; NEUROPATHIC ULCERS; IWGDF GUIDANCE; ULCERATION; CARE; DISEASE		[Armstrong, David G.] Univ Arizona, Coll Med, Dept Surg, SALSA, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Armstrong, David G.; Boulton, Andrew J. M.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Bus, Sicco A.] Univ Amsterdam, Acad Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Bus, Sicco A.] Amsterdam Movement Sci, Amsterdam, Netherlands	University of Arizona; University of Manchester; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Armstrong, DG (corresponding author), Univ Arizona, Coll Med, Dept Surg, SALSA, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	armstrong@usa.net		Bus, Sicco/0000-0002-8357-9163	Spiracur; Kinetic Concepts	Spiracur; Kinetic Concepts	Dr. Armstrong reports receiving grant support from Spiracur and consulting fees from Kinetic Concepts. No other potential conflict of interest relevant to this article was reported.	Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2015, BRUSS INT DIAB FED; APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Armstrong D G, 1998, J Foot Ankle Surg, V37, P460; Armstrong David G, 2007, Int Wound J, V4, P286; Armstrong DG, 2007, AM J MED, V120, P1042, DOI 10.1016/j.amjmed.2007.06.028; Armstrong DG, 2013, J AM PODIAT MED ASSN, V103, P161, DOI 10.7547/1030161; Armstrong DG, 2012, DIABETES-METAB RES, V28, P514, DOI 10.1002/dmrr.2299; Armstrong David G, 2012, Foot Ankle Spec, V5, P235, DOI 10.1177/1938640012449038; Armstrong David G, 2005, Int Wound J, V2, P166, DOI 10.1111/j.1742-4801.2005.00097.x; Armstrong DG, 2005, J AM PODIAT MED ASSN, V95, P353, DOI 10.7547/0950353; Armstrong DG, 2003, DIABETES CARE, V26, P3284, DOI 10.2337/diacare.26.12.3284; Barshes NR, 2013, DIABET FOOT ANKLE, V4, DOI 10.3402/dfa.v4i0.21847; Boulton AJM, 2004, NEW ENGL J MED, V351, P48, DOI 10.1056/NEJMcp032966; Boulton AJM, 2012, DIABETES-METAB RES, V28, P3, DOI 10.1002/dmrr.2230; Boyko EJ, 2006, DIABETES CARE, V29, P1202, DOI 10.2337/dc05-2031; Bus SA, 2016, DIABETES-METAB RES, V32, P25, DOI 10.1002/dmrr.2697; Bus SA, 2016, DIABETES-METAB RES, V32, P16, DOI 10.1002/dmrr.2696; Bus SA, 2016, DIABETES-METAB RES, V32, P99, DOI 10.1002/dmrr.2702; Bus SA, 2016, PLAST RECONSTR SURG, V138, p179S, DOI 10.1097/PRS.0000000000002686; Bus SA, 2016, DIABETES-METAB RES, V32, P195, DOI 10.1002/dmrr.2738; Bus SA, 2013, DIABETES CARE, V36, P4109, DOI 10.2337/dc13-0996; Bus SA, 2012, DIABETES-METAB RES, V28, P54, DOI 10.1002/dmrr.2240; Bus SA, 2011, DIABETES CARE, V34, P1595, DOI 10.2337/dc10-2206; Busch K, 2003, DIABETIC MED, V20, P665, DOI 10.1046/j.1464-5491.2003.01003.x; Calle-Pascual AL, 2001, DIABETES CARE, V24, P405, DOI 10.2337/diacare.24.2.405; CHANTELAU E, 1994, DIABETIC MED, V11, P114, DOI 10.1111/j.1464-5491.1994.tb00240.x; Cisneros LL, 2010, BRAZ J PHYS THER, V14, P31, DOI 10.1590/S1413-35552010000100006; Crawford F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19570; Dargis V, 1999, DIABETES CARE, V22, P1428, DOI 10.2337/diacare.22.9.1428; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Dubsky M, 2013, INT WOUND J, V10, P555, DOI 10.1111/j.1742-481X.2012.01022.x; Faglia E, 2012, J FOOT ANKLE SURG, V51, P593, DOI 10.1053/j.jfas.2012.05.015; Frykberg RG, 2017, DIABETES CARE; Ghanassia E, 2008, DIABETES CARE, V31, P1288, DOI 10.2337/dc07-2145; Hamonet J., 2010, Annals of Physical and Rehabilitation Medicine, V53, P306, DOI 10.1016/j.rehab.2010.04.001; HELM PA, 1991, ARCH PHYS MED REHAB, V72, P967; Hinchliffe RJ, 2016, DIABETES-METAB RES, V32, P136, DOI 10.1002/dmrr.2705; History of foot ulcer among persons with diabetes-United States, 2000, MMWR-MORBID MORTAL W, V52, P1098; Iversen MM, 2009, DIABETES CARE, V32, P2193, DOI 10.2337/dc09-0651; Kerr M, 2014, DIABETIC MED, V31, P1498, DOI 10.1111/dme.12545; Kloos C, 2009, DIABETES CARE, V32, P894, DOI 10.2337/dc08-0490; Lavery LA, 2004, DIABETES CARE, V27, P2642, DOI 10.2337/diacare.27.11.2642; Lavery LA, 2003, DIABETES CARE, V26, P1435, DOI 10.2337/diacare.26.5.1435; Lavery LA, 2007, DIABETES CARE, V30, P14, DOI 10.2337/dc06-1600; Lavery LA, 2012, ADV SKIN WOUND CARE, V25, P519, DOI 10.1097/01.ASW.0000422625.17407.93; Lavery LA, 2010, DIABETES CARE, V33, P2365, DOI 10.2337/dc10-1213; Lavery LA, 2010, DIABETES CARE, V33, P1460, DOI 10.2337/dc10-0310; Lincoln NB, 2008, DIABETOLOGIA, V51, P1954, DOI 10.1007/s00125-008-1110-0; Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis346, 10.1093/cid/cis460]; Margolis DJ, 2011, INCIDENCE DIABETIC F; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Monami M, 2008, J AM PODIAT MED ASSN, V98, P130, DOI 10.7547/0980130; Monteiro-Soares M, 2012, DIABETES-METAB RES, V28, P574, DOI 10.1002/dmrr.2319; Morbach S, 2016, DIABETES-METAB RES, V32, P318, DOI 10.1002/dmrr.2752; Morbach S, 2013, DIABETES CARE, V36, pE62, DOI 10.2337/dc12-2335; Mueller MJ, 2003, J BONE JOINT SURG AM, V85A, P1436, DOI 10.2106/00004623-200308000-00003; Peters EJG, 2007, DIABETES CARE, V30, P2077, DOI 10.2337/dc07-0445; Piaggesi A, 1998, DIABETIC MED, V15, P412, DOI 10.1002/(SICI)1096-9136(199805)15:5<412::AID-DIA584>3.3.CO;2-T; Pilhammar E, 2011, EUR DIABETES NURS, V8, P102; Plank J, 2003, DIABETES CARE, V26, P1691, DOI 10.2337/diacare.26.6.1691; Pound N, 2005, DIABETIC MED, V22, P1306, DOI 10.1111/j.1464-5491.2005.01640.x; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Reiber GE, 2002, JAMA-J AM MED ASSOC, V287, P2552, DOI 10.1001/jama.287.19.2552; Reike H., 1997, DIABETES STOFFWECH H, V6, P107; Rizzo L, 2012, INT J LOW EXTR WOUND, V11, P59, DOI 10.1177/1534734612438729; Scottish Diabetes Survey Monitoring Group, SCOTT DIAB SURV 2014; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Skrepnek GH, 2017, HLTH CARE SERVICE OU; UCCIOLI L, 1995, DIABETES CARE, V18, P1376, DOI 10.2337/diacare.18.10.1376; Ulbrecht JS, 2014, DIABETES CARE, V37, P1982, DOI 10.2337/dc13-2956; van Netten JJ, 2016, DIABETES-METAB RES, V32, P84, DOI 10.1002/dmrr.2701; Vanlerberghe B, 2014, ANN CHIR PLAST ESTH, V59, P161, DOI 10.1016/j.anplas.2013.07.008; Verdin C, 2017, J PALLIAT MED, V20, P6, DOI 10.1089/jpm.2016.0384; Viswanathan V, 2005, DIABETES CARE, V28, P1019, DOI 10.2337/diacare.28.5.1019; Viswanathan V, 2004, DIABETES CARE, V27, P474, DOI 10.2337/diacare.27.2.474; Waaijman R, 2014, DIABETES CARE, V37, P1697, DOI 10.2337/dc13-2470; Walsh JW, 2016, DIABETIC MED, V33, P1493, DOI 10.1111/dme.13054; Ward R, 2017, ANN VASC SURG, V38, P84, DOI 10.1016/j.avsg.2016.08.005; Winkley K, 2007, J DIABETES COMPLICAT, V21, P341, DOI 10.1016/j.jdiacomp.2007.09.004; Zhang PZ, 2017, ANN MED, V49, P106, DOI 10.1080/07853890.2016.1231932	83	1166	1231	83	452	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2367	2375		10.1056/NEJMra1615439	http://dx.doi.org/10.1056/NEJMra1615439			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4UQ	28614678				2022-12-28	WOS:000403230800010
J	Diringer, E				Diringer, Elliot			Let Trump claim a better deal on climate	NATURE			English	Editorial Material									[Diringer, Elliot] US Based Ctr Climate & Energy Solut C2ES, Arlington, VA 22201 USA		Diringer, E (corresponding author), US Based Ctr Climate & Energy Solut C2ES, Arlington, VA 22201 USA.	diringer@c2es.org							0	2	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					329	329		10.1038/546329a	http://dx.doi.org/10.1038/546329a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28617479	Bronze			2022-12-28	WOS:000403250900005
J	Gruber, J; Kennedy, BK				Gruber, Jan; Kennedy, Brian K.			Microbiome and Longevity: Gut Microbes Send Signals to Host Mitochondria	CELL			English	Editorial Material								The microbiome has emerged as a major determinant of the functioning of host organisms, affecting both health and disease. Here, Han et al. use the workhorse of aging research, C. elegans, to identify specific mechanisms by which gut bacteria influence mitochondrial dynamics and aging, a first step toward analogous manipulations to modulate human aging.	[Gruber, Jan; Kennedy, Brian K.] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, MD 7,8 Med Dr, Singapore 117596, Singapore; [Gruber, Jan] Yale NUS Coll, Ageing Res Lab, Sci Div, Singapore 138527, Singapore; [Kennedy, Brian K.] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, MD 9,2 Med Dr, Singapore 117596, Singapore; [Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA 94945 USA	National University of Singapore; Yale NUS College; National University of Singapore; Buck Institute for Research on Aging	Kennedy, BK (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, MD 7,8 Med Dr, Singapore 117596, Singapore.; Kennedy, BK (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, MD 9,2 Med Dr, Singapore 117596, Singapore.; Kennedy, BK (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	bkennedy@buckinstitute.org		Kennedy, Brian/0000-0002-5754-1874				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; [Anonymous], CELL; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025; Yao YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004968	5	26	27	4	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1168	1169		10.1016/j.cell.2017.05.048	http://dx.doi.org/10.1016/j.cell.2017.05.048			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622501	Bronze			2022-12-28	WOS:000403332400004
J	Rubin, R				Rubin, Rita			EULAR: Countries unite to fight rheumatic diseases	LANCET			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2276	2276		10.1016/S0140-6736(17)31582-9	http://dx.doi.org/10.1016/S0140-6736(17)31582-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28612740				2022-12-28	WOS:000402872700012
J	Ng, KF; Owens, S				Ng, Khuen Foong; Owens, Stephen			SPOT DIAGNOSIS A Brazilian child with a nodule in the foot	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ng, Khuen Foong; Owens, Stephen] Royal Victoria Infirm, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Ng, KF (corresponding author), Royal Victoria Infirm, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England.	khuenfoong.ng@doctors.org.uk						Feldmeier H, 2013, EUR J CLIN MICROBIOL, V32, P19, DOI 10.1007/s10096-012-1725-4; Feldmeier H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003133	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2017	357								j2396	10.1136/bmj.j2396	http://dx.doi.org/10.1136/bmj.j2396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4RG	28600285				2022-12-28	WOS:000403221800002
J	Pennisi, E				Pennisi, Elizabeth			SAVING THE 'GOD OF UGLY THINGS'	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1001	1003		10.1126/science.356.6342.1001	http://dx.doi.org/10.1126/science.356.6342.1001			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9XC	28596323				2022-12-28	WOS:000402871700019
J	Arnold, C				Arnold, Carrie			THE MATHEMATICIANS WHO WANT TO SAVE DEMOCRACY	NATURE			English	News Item																			0	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					200	202		10.1038/546200a	http://dx.doi.org/10.1038/546200a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593979	hybrid			2022-12-28	WOS:000402823400010
J	Gostin, LO				Gostin, Lawrence O.			The Fogarty International Center, a National Treasure for Global Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Gostin, Lawrence O.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA; [Gostin, Lawrence O.] WHO, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.; Gostin, LO (corresponding author), WHO, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland.	gostin@law.georgetown.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2155	2156		10.1001/jama.2017.6198	http://dx.doi.org/10.1001/jama.2017.6198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586880	Bronze			2022-12-28	WOS:000402706100003
J	Laine, C				Laine, Christine			Scientific Misconduct Hurts RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter																		Dansinger M, 2017, ANN INTERN MED, V166, P143, DOI 10.7326/M16-2551	1	0	0	2	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					856	856		10.7326/L17-0148	http://dx.doi.org/10.7326/L17-0148			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28586900				2022-12-28	WOS:000402700200020
J	Liapis, K; Vlachou, S; Markou, A; Kakiopoulos, G; Kounadi, T; Anagnostopoulos, NI; Piaditis, GP				Liapis, Konstantinos; Vlachou, Sophia; Markou, Athina; Kakiopoulos, Georgios; Kounadi, Theodora; Anagnostopoulos, Nikolaos I.; Piaditis, George P.			As white as ivory: sclerotic vertebra in POEMS syndrome	LANCET			English	Editorial Material									[Liapis, Konstantinos; Anagnostopoulos, Nikolaos I.] Georgios Gennimatas Hosp, Dept Clin Haematol, Athens 11527, Greece; [Vlachou, Sophia; Markou, Athina; Kounadi, Theodora; Piaditis, George P.] Georgios Gennimatas Hosp, Dept Endocrinol & Diabet Ctr, Athens, Greece; [Kakiopoulos, Georgios] Georgios Gennimatas Hosp, Dept Pathol, Athens, Greece		Liapis, K (corresponding author), Georgios Gennimatas Hosp, Dept Clin Haematol, Athens 11527, Greece.	kosliapis@hotmail.com						Dispenzieri A, 2015, AM J HEMATOL, V90, P952, DOI 10.1002/ajh.24171; ENEVOLDSON TP, 1992, J NEUROL NEUROSUR PS, V55, P71, DOI 10.1136/jnnp.55.1.71; Gandhi GY, 2007, MAYO CLIN PROC, V82, P836, DOI 10.4065/82.7.836; Graham TS, 2005, RADIOLOGY, V235, P614, DOI 10.1148/radiol.2352021743; Watanabe O, 1996, LANCET, V347, P702, DOI 10.1016/S0140-6736(96)91261-1	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2261	2262		10.1016/S0140-6736(17)31374-0	http://dx.doi.org/10.1016/S0140-6736(17)31374-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589896				2022-12-28	WOS:000402540800034
J	Scott, DL; Stevenson, MD				Scott, David L.; Stevenson, Matt D.			Treating active rheumatoid arthritis with Janus kinase inhibitors	LANCET			English	Editorial Material							MODIFYING ANTIRHEUMATIC DRUGS; METHOTREXATE; COMBINATION; THERAPY; TRIAL		[Scott, David L.] Kings Coll London, Dept Clin Rheumatol, Weston Educ Ctr, London SE5 9RJ, England; [Stevenson, Matt D.] Univ Sheffield, Sch Hlth & Related Res, Dept Hlth Technol Assessment Hlth Econ & Decis Sc, Sheffield, S Yorkshire, England	University of London; King's College London; University of Sheffield	Scott, DL (corresponding author), Kings Coll London, Dept Clin Rheumatol, Weston Educ Ctr, London SE5 9RJ, England.	d.scott1@nhs.net		, Matt/0000-0002-3099-9877	National Institute for Health Research and Arthritis Research UK; National Institute for Health and Care Excellence (NICE); NICE multiple technology appraisal	National Institute for Health Research and Arthritis Research UK; National Institute for Health and Care Excellence (NICE); NICE multiple technology appraisal	DLS has received funding from the National Institute for Health Research and Arthritis Research UK for studies of intensive treatment in rheumatoid arthritis. He has advised Eli Lilly and Company, Roche Products Ltd, Napp Pharmaceuticals, Baxalta, and Novartis. MDS has received grants from the National Institute for Health and Care Excellence (NICE) single technology appraisal and NICE multiple technology appraisal.	Fleischmann R, 2017, LANCET; Hazlewood GS, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1777; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Nikiphorou E, 2017, NAT REV RHEUMATOL, V13, P503, DOI 10.1038/nrrheum.2017.81; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; Sauer BC, 2017, ARTHRIT CARE RES, V69, P313, DOI 10.1002/acr.22944; Scott DL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1046; Singh JA, 2016, ANN RHEUM DIS, V68, P1; Singh JA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012183; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Stevenson MD, 2017, J RHEUMATOL, V44, P973, DOI 10.3899/jrheum.160941; Tarp S, 2017, RHEUMATOLOGY, V56, P417, DOI 10.1093/rheumatology/kew442; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345	13	7	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					431	432		10.1016/S0140-6736(17)31659-8	http://dx.doi.org/10.1016/S0140-6736(17)31659-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28629666	Green Accepted			2022-12-28	WOS:000406463400004
J	Lv, BQ; Feng, ZL; Xu, QN; Gao, X; Ma, JZ; Kong, LY; Richard, P; Huang, YB; Strocov, VN; Fang, C; Weng, HM; Shi, YG; Qian, T; Ding, H				Lv, B. Q.; Feng, Z-L.; Xu, Q. -N.; Gao, X.; Ma, J. -Z.; Kong, L. -Y.; Richard, P.; Huang, Y. -B.; Strocov, V. N.; Fang, C.; Weng, H. -M.; Shi, Y. -G.; Qian, T.; Ding, H.			Observation of three-component fermions in the topological semimetal molybdenum phosphide	NATURE			English	Article							MAJORANA FERMIONS; DIRAC SEMIMETAL; DISCOVERY; SURFACE	In quantum field theory, Lorentz invariance leads to three types of fermion-Dirac, Weyl and Majorana. Although the existence of Weyl and Majorana fermions as elementary particles in high-energy physics is debated, all three types of fermion have been proposed to exist as low-energy, long-wavelength quasiparticle excitations in condensed-matter systems(1-12). The existence of Dirac and Weyl fermions in condensed-matter systems has been confirmed experimentally(13-18), and that of Majorana fermions is supported by various experiments(19,20). However, in condensed-matter systems, fermions in crystals are constrained by the symmetries of the 230 crystal space groups rather than by Lorentz invariance, giving rise to the possibility of finding other types of fermionic excitation that have no counterparts in high-energy physics(21-29). Here we use angle-resolved photoemission spectroscopy to demonstrate the existence of a triply degenerate point in the electronic structure of crystalline molybdenum phosphide. Quasiparticle excitations near a triply degenerate point are three-component fermions, beyond the conventional Dirac-Weyl-Majorana classification, which attributes Dirac and Weyl fermions to four-and two-fold degenerate points, respectively. We also observe pairs of Weyl points in the bulk electronic structure of the crystal that coexist with the three-component fermions. This material thus represents a platform for studying the interplay between different types of fermions. Our experimental discovery opens up a way of exploring the new physics of unconventional fermions in condensed-matter systems.	[Lv, B. Q.; Feng, Z-L.; Xu, Q. -N.; Gao, X.; Ma, J. -Z.; Kong, L. -Y.; Richard, P.; Fang, C.; Weng, H. -M.; Shi, Y. -G.; Qian, T.; Ding, H.] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Lv, B. Q.; Feng, Z-L.; Xu, Q. -N.; Gao, X.; Ma, J. -Z.; Kong, L. -Y.; Richard, P.; Fang, C.; Weng, H. -M.; Shi, Y. -G.; Qian, T.; Ding, H.] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Lv, B. Q.; Feng, Z-L.; Xu, Q. -N.; Gao, X.; Ma, J. -Z.; Kong, L. -Y.; Richard, P.; Ding, H.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Richard, P.; Weng, H. -M.; Qian, T.; Ding, H.] Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China; [Huang, Y. -B.] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai 201204, Peoples R China; [Strocov, V. N.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Shi, YG; Qian, T; Ding, H (corresponding author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China.; Shi, YG; Qian, T; Ding, H (corresponding author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.; Ding, H (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Qian, T; Ding, H (corresponding author), Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China.	ygshi@iphy.ac.cn; tqian@iphy.ac.cn; dingh@iphy.ac.cn	Shi, Youguo/B-6316-2018; Feng, Zili/A-2876-2017; Kong, Lingyuan/V-3107-2018; Fang, Chen/C-8263-2011; Xu, Qiunan/ABG-6717-2020; Weng, Hongming/F-2948-2011; huang, yao/GWR-5388-2022; Richard, Pierre/F-7652-2010; Ma, Junzhang/I-4054-2012	Feng, Zili/0000-0001-5148-9000; Kong, Lingyuan/0000-0002-0012-8341; Weng, Hongming/0000-0001-8021-9413; Richard, Pierre/0000-0003-0544-4551; Ma, Junzhang/0000-0002-4648-3576	National Natural Science Foundation of China [11622435, 11474330, 11422428, 11674369, 11474340, 11674371, 11234014]; Ministry of Science and Technology of China [2016YFA0401000, 2016YFA0300600, 2015CB921300, 2013CB921700, 2016YFA0302400, 2016YFA0300300]; Chinese Academy of Sciences [XDB07000000]; CAS Pioneer 'Hundred Talents Program'	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); CAS Pioneer 'Hundred Talents Program'	We thank B.-B. Fu, N. Xu and A. Chikina for assistance with the ARPES experiments. We thank Y. Shao and Y.-L. Wang for examining the topography of the (100) cleavage surface using scanning tunnelling microscopy, although the results are not shown. This work was supported by the National Natural Science Foundation of China (11622435, 11474330, 11422428, 11674369, 11474340, 11674371 and 11234014), the Ministry of Science and Technology of China (2016YFA0401000, 2016YFA0300600, 2015CB921300, 2013CB921700, 2016YFA0302400 and 2016YFA0300300) and the Chinese Academy of Sciences (XDB07000000). Y.-B.H. acknowledges support by the CAS Pioneer 'Hundred Talents Program' (type C).	Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chang G., 2016, PREPRINT; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Heikkila TT, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/9/093019; Huang SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8373; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Liu ZK, 2014, NAT MATER, V13, P677, DOI [10.1038/NMAT3990, 10.1038/nmat3990]; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Lv BQ, 2015, NAT PHYS, V11, P724, DOI [10.1038/NPHYS3426, 10.1038/nphys3426]; Lv BQ, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031013; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Soluyanov AA, 2015, NATURE, V527, P495, DOI 10.1038/nature15768; Strocov VN, 2014, J SYNCHROTRON RADIAT, V21, P32, DOI 10.1107/S1600577513019085; Strocov VN, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.086401; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125427; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Weng HM, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.165201; Weng HM, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.241202; Weng HM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011029; Wieder BJ, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.186402; Winkler GW, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.076403; Xu G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186806; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297; Yang LX, 2015, NAT PHYS, V11, P728, DOI [10.1038/nphys3425, 10.1038/NPHYS3425]; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405; Zhu ZM, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031003	34	254	257	15	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					627	+		10.1038/nature22390	http://dx.doi.org/10.1038/nature22390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28628922	Green Submitted			2022-12-28	WOS:000404332000042
J	Emmett, MJ; Lim, HW; Jager, J; Richter, HJ; Adlanmerini, M; Peed, LC; Briggs, ER; Steger, DJ; Ma, T; Sims, CA; Baur, JA; Pei, LM; Won, KJ; Seale, P; Gerhart-Hines, Z; Lazar, MA				Emmett, Matthew J.; Lim, Hee-Woong; Jager, Jennifer; Richter, Hannah J.; Adlanmerini, Marine; Peed, Lindsey C.; Briggs, Erika R.; Steger, David J.; Ma, Tao; Sims, Carrie A.; Baur, Joseph A.; Pei, Liming; Won, Kyoung-Jae; Seale, Patrick; Gerhart-Hines, Zachary; Lazar, Mitchell A.			Histone deacetylase 3 prepares brown adipose tissue for acute thermogenic challenge	NATURE			English	Article							INTEGRATIVE GENOMICS VIEWER; ENERGY-EXPENDITURE; ADIPOCYTE IDENTITY; BEIGE FAT; IN-VIVO; GENE; MICE; TRANSCRIPTION; METABOLISM; MACROPHAGE	Brown adipose tissue is a thermogenic organ that dissipates chemical energy as heat to protect animals against hypothermia and to counteract metabolic disease(1). However, the transcriptional mechanisms that determine the thermogenic capacity of brown adipose tissue before environmental cold are unknown. Here we show that histone deacetylase 3 (HDAC3) is required to activate brown adipose tissue enhancers to ensure thermogenic aptitude. Mice with brown adipose tissue-specific genetic ablation of HDAC3 become severely hypothermic and succumb to acute cold exposure. Uncoupling protein 1 (UCP1) is nearly absent in brown adipose tissue lacking HDAC3, and there is also marked downregulation of mitochondrial oxidative phosphorylation genes resulting in diminished mitochondrial respiration. Remarkably, although HDAC3 acts canonically as a transcriptional corepressor(2), it functions as a coactivator of oestrogen-related receptor alpha (ERR alpha) in brown adipose tissue. HDAC3 coactivation of ERR alpha is mediated by deacetylation of PGC-1 alpha and is required for the transcription of Ucp1, Ppargc1a (encoding PGC-1 alpha), and oxidative phosphorylation genes. Importantly, HDAC3 promotes the basal transcription of these genes independently of adrenergic stimulation. Thus, HDAC3 uniquely primes Ucp1 and the thermogenic transcriptional program to maintain a critical capacity for thermogenesis in brown adipose tissue that can be rapidly engaged upon exposure to dangerously cold temperature.	[Emmett, Matthew J.; Lim, Hee-Woong; Jager, Jennifer; Richter, Hannah J.; Adlanmerini, Marine; Peed, Lindsey C.; Briggs, Erika R.; Steger, David J.; Sims, Carrie A.; Baur, Joseph A.; Pei, Liming; Won, Kyoung-Jae; Seale, Patrick; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Emmett, Matthew J.; Jager, Jennifer; Richter, Hannah J.; Adlanmerini, Marine; Peed, Lindsey C.; Briggs, Erika R.; Steger, David J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Lim, Hee-Woong; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Ma, Tao; Gerhart-Hines, Zachary] Univ Copenhagen, Novo Nordisk Fdn, Sect Metab Receptol, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Ma, Tao; Gerhart-Hines, Zachary] Univ Copenhagen, Inst Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Sims, Carrie A.] Univ Penn, Perelman Sch Med, Dept Surg, Trauma Ctr Penn, Philadelphia, PA 19104 USA; [Baur, Joseph A.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Pei, Liming] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigenom Med, Philadelphia, PA 19104 USA; [Pei, Liming] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Seale, Patrick] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lim, HW/GRY-3517-2022; Lazar, Mitchell A/AAF-3738-2019; Lim, Hee Woong/AAX-6835-2021	Lim, Hee Woong/0000-0001-8599-1808; Gerhart-Hines, Zachary/0000-0003-2981-4991; ADLANMERINI, Marine/0000-0001-5230-2797; Pei, Liming/0000-0002-1924-0333; Richter, Hannah/0000-0001-8954-9136; Won, Kyoung Jae/0000-0002-2924-9630; Jager, Jennifer/0000-0003-3740-9742; Emmett, Matthew/0000-0002-8855-423X	NIH [R01 DK45586, F30 DK104513, R01 DK106027]; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK045586, R01DK043806, R01DK106027, P30DK019525, R01DK111495, F30DK104513] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Next-Generation Sequencing Core and the Mouse Phenotyping, Physiology and Metabolism Core of the Penn Diabetes Research Center (National Institutes of Health (NIH) P30 DK19525). This work was supported by NIH R01 DK45586 (M.A.L.), NIH F30 DK104513 (M.J.E.), NIH R01 DK106027 (K.-J.W.), and the JPB Foundation.	Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dixen K, 2013, OBESITY, V21, P516, DOI 10.1002/oby.20067; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harms MJ, 2015, GENE DEV, V29, P298, DOI 10.1101/gad.252734.114; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoeksema MA, 2014, EMBO MOL MED, V6, P1124, DOI 10.15252/emmm.201404170; HOUSTEK J, 1975, EUR J BIOCHEM, V54, P11, DOI 10.1111/j.1432-1033.1975.tb04107.x; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loft A, 2017, TRENDS ENDOCRIN MET, V28, P104, DOI 10.1016/j.tem.2016.11.005; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Porter C, 2016, CELL METAB, V24, P246, DOI 10.1016/j.cmet.2016.07.004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Sun Z, 2011, J BIOL CHEM, V286, P33301, DOI 10.1074/jbc.M111.277707; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang H, 2015, SHOCK, V44, P173, DOI 10.1097/SHK.0000000000000390	58	90	94	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					544	+		10.1038/nature22819	http://dx.doi.org/10.1038/nature22819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28614293	Green Accepted			2022-12-28	WOS:000403814100041
J	Abbasi, J				Abbasi, Jennifer			Junk Food Ads Reach Children Despite Food Industry Self-regulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2359	2361		10.1001/jama.2017.4653	http://dx.doi.org/10.1001/jama.2017.4653			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632864				2022-12-28	WOS:000403654600001
J	Cole, KP; Groh, JM; Johnson, MD; Burcham, CL; Campbell, BM; Diseroad, WD; Heller, MR; Howell, JR; Kallman, NJ; Koenig, TM; May, SA; Miller, RD; Mitchell, D; Myers, DP; Myers, SS; Phillips, JL; Polster, CS; White, TD; Cashman, J; Hurley, D; Moylan, R; Sheehan, P; Spencer, RD; Desmond, K; Desmond, P; Gowran, O				Cole, Kevin P.; Groh, Jennifer McClary; Johnson, Martin D.; Burcham, Christopher L.; Campbell, Bradley M.; Diseroad, William D.; Heller, Michael R.; Howell, John R.; Kallman, Neil J.; Koenig, Thomas M.; May, Scott A.; Miller, Richard D.; Mitchell, David; Myers, David P.; Myers, Steven S.; Phillips, Joseph L.; Polster, Christopher S.; White, Timothy D.; Cashman, Jim; Hurley, Declan; Moylan, Robert; Sheehan, Paul; Spencer, Richard D.; Desmond, Kenneth; Desmond, Paul; Gowran, Olivia			Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions	SCIENCE			English	Article							PHARMACEUTICALS; PURIFICATION	Advances in drug potency and tailored therapeutics are promoting pharmaceutical manufacturing to transition from a traditional batch paradigm to more flexible continuous processing. Here we report the development of a multistep continuous-flow CGMP (current good manufacturing practices) process that produced 24 kilograms of prexasertib monolactate monohydrate suitable for use in human clinical trials. Eight continuous unit operations were conducted to produce the target at roughly 3 kilograms per day using small continuous reactors, extractors, evaporators, crystallizers, and filters in laboratory fume hoods. Success was enabled by advances in chemistry, engineering, analytical science, process modeling, and equipment design. Substantial technical and business drivers were identified, which merited the continuous process. The continuous process afforded improved performance and safety relative to batch processes and also improved containment of a highly potent compound.	[Cole, Kevin P.; Groh, Jennifer McClary; Johnson, Martin D.; Burcham, Christopher L.; Campbell, Bradley M.; Heller, Michael R.; Howell, John R.; Kallman, Neil J.; May, Scott A.; Miller, Richard D.; Mitchell, David; Myers, David P.; Myers, Steven S.; Phillips, Joseph L.; Polster, Christopher S.; White, Timothy D.] Eli Lilly & Co, Lilly Res Labs, Small Mol Design & Dev, Indianapolis, IN 46285 USA; [Diseroad, William D.] Eli Lilly & Co, Tech Serv Mfg Sci, Indianapolis, IN 46285 USA; [Koenig, Thomas M.] Eli Lilly & Co, Tech Serv Mfg Sci, Greenfield, IN 46140 USA; [Cashman, Jim] Eli Lilly & Co, Qual Assurance, Kinsale, Cork, Ireland; [Hurley, Declan; Moylan, Robert; Sheehan, Paul] Eli Lilly & Co, Tech Serv Mfg Sci, Kinsale, Cork, Ireland; [Spencer, Richard D.] Eli Lilly & Co, Proc Engn, Kinsale, Cork, Ireland; [Desmond, Kenneth; Desmond, Paul; Gowran, Olivia] Eli Lilly & Co, Qual Control, Kinsale, Cork, Ireland	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Cole, KP (corresponding author), Eli Lilly & Co, Lilly Res Labs, Small Mol Design & Dev, Indianapolis, IN 46285 USA.	k_cole@lilly.com	Burcham, Chris/AAX-6635-2020	Burcham, Chris/0000-0002-1251-4725; Polster, Christopher/0000-0003-3376-8561				Adamo A, 2016, SCIENCE, V352, P61, DOI 10.1126/science.aaf1337; [Anonymous], 2006, GUID IND QUAL SYST A; [Anonymous], 2016, IRISH TIMES; [Anonymous], 2015, NIACIN NIACINAMIDE C; Bogdan AR, 2009, ANGEW CHEM INT EDIT, V48, P8547, DOI 10.1002/anie.200903055; Cole KP, 2016, ORG PROCESS RES DEV, V20, P820, DOI 10.1021/acs.oprd.6b00030; Faanes A, 2003, IND ENG CHEM RES, V42, P2198, DOI 10.1021/ie020525v; Farouz F. S., 2011, U.S. Patent, Patent No. [20110144126 A1, 20110144126]; Farouz F. S., 2010, WO Patent, Patent No. [2010077758 A1, 2010077758]; Frederick MO, 2015, ORG PROCESS RES DEV, V19, P1411, DOI 10.1021/acs.oprd.5b00240; Gautam A, 2016, DRUG DISCOV TODAY, V21, P379, DOI 10.1016/j.drudis.2015.10.002; Gutmann B, 2015, ANGEW CHEM INT EDIT, V54, P6688, DOI 10.1002/anie.201409318; Hong D, 2016, J CLIN ONCOL, V34, P1764, DOI 10.1200/JCO.2015.64.5788; Johnson MD, 2012, ORG PROCESS RES DEV, V16, P1017, DOI 10.1021/op200362h; King C, 2015, MOL CANCER THER, V14, P2004, DOI 10.1158/1535-7163.MCT-14-1037; Lau SH, 2015, ORG LETT, V17, P3218, DOI 10.1021/acs.orglett.5b01307; Lee J. M., 2016, ANN ONCOL          S, V27, P8550; Lee SL, 2015, J PHARM INNOV, V10, P191, DOI 10.1007/s12247-015-9215-8; Mascia S, 2013, ANGEW CHEM INT EDIT, V52, P12359, DOI 10.1002/anie.201305429; May SA, 2016, ORG PROCESS RES DEV, V20, P1870, DOI 10.1021/acs.oprd.6b00148; May SA, 2012, ORG PROCESS RES DEV, V16, P982, DOI 10.1021/op200351g; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; PALAMIDESSI G, 1974, J HETEROCYCLIC CHEM, V11, P607, DOI 10.1002/jhet.5570110428; Palmer E., 2016, FIERCEPHARMA    0414; Palmer E., 2015, FIERCEPHARMA    0629; Quon JL, 2012, CRYST GROWTH DES, V12, P3036, DOI 10.1021/cg300253a; Richon VM, 2013, HEMATOL-AM SOC HEMAT, P19, DOI 10.1182/asheducation-2013.1.19; Roberge DM, 2008, ORG PROCESS RES DEV, V12, P905, DOI 10.1021/op8001273; Snead DR, 2015, ANGEW CHEM INT EDIT, V54, P983, DOI 10.1002/anie.201409093; Srai JS, 2015, J PHARM SCI-US, V104, P840, DOI 10.1002/jps.24343; Tsubogo T, 2015, NATURE, V520, P329, DOI 10.1038/nature14343; U.S. Food and Drug Administration (FDA), 2013, IFPAC ANN M BALT MD; White TD, 2012, ORG PROCESS RES DEV, V16, P939, DOI 10.1021/op200344a; Wollowitz S, 2010, DRUG DEVELOP RES, V71, P420, DOI 10.1002/ddr.20385; Yu LX, 2014, AAPS J, V16, P771, DOI 10.1208/s12248-014-9598-3	35	174	175	9	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1144	1150		10.1126/science.aan0745	http://dx.doi.org/10.1126/science.aan0745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619938				2022-12-28	WOS:000403327400030
J	Di Malta, C; Siciliano, D; Calcagni, A; Monfregola, J; Punzi, S; Pastore, N; Eastes, AN; Davis, O; De Cegli, R; Zampelli, A; Di Giovannantonio, LG; Nusco, E; Platt, N; Guida, A; Ogmundsdottir, MH; Lanfrancone, L; Perera, RM; Zoncu, R; Pelicci, PG; Settembre, C; Ballabio, A				Di Malta, Chiara; Siciliano, Diletta; Calcagni, Alessia; Monfregola, Jlenia; Punzi, Simona; Pastore, Nunzia; Eastes, Andrea N.; Davis, Oliver; De Cegli, Rossella; Zampelli, Angela; Di Giovannantonio, Luca G.; Nusco, Edoardo; Platt, Nick; Guida, Alessandro; Ogmundsdottir, Margret Helga; Lanfrancone, Luisa; Perera, Rushika M.; Zoncu, Roberto; Pelicci, Pier Giuseppe; Settembre, Carmine; Ballabio, Andrea			Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth	SCIENCE			English	Article							LYSOSOMAL BIOGENESIS; AUTOPHAGY; MUTATIONS; CLEARANCE; TFE3	The mechanistic target of rapamycin complex 1 (mTORC1) is recruited to the lysosome by Rag guanosine triphosphatases (GTPases) and regulates anabolic pathways in response to nutrients. We found that MiT/TFE transcription factors-master regulators of lysosomal and melanosomal biogenesis and autophagy-control mTORC1 lysosomal recruitment and activity by directly regulating the expression of RagD. In mice, this mechanism mediated adaptation to food availability after starvation and physical exercise and played an important role in cancer growth. Up-regulation of MiT/TFE genes in cells and tissues from patients and murine models of renal cell carcinoma, pancreatic ductal adenocarcinoma, and melanoma triggered RagD-mediated mTORC1 induction, resulting in cell hyperproliferation and cancer growth. Thus, this transcriptional regulatory mechanism enables cellular adaptation to nutrient availability and supports the energy-demanding metabolism of cancer cells.	[Di Malta, Chiara; Siciliano, Diletta; Calcagni, Alessia; Monfregola, Jlenia; De Cegli, Rossella; Zampelli, Angela; Di Giovannantonio, Luca G.; Nusco, Edoardo; Settembre, Carmine; Ballabio, Andrea] Telethon Inst Genet & Med TIGEM, Via Campi Flegrei 34, I-80078 Naples, Italy; [Punzi, Simona; Guida, Alessandro; Lanfrancone, Luisa; Pelicci, Pier Giuseppe] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Pastore, Nunzia; Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pastore, Nunzia; Ballabio, Andrea] Baylor Coll Med, Neurol Res Inst, Houston, TX 77030 USA; [Eastes, Andrea N.; Perera, Rushika M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Eastes, Andrea N.; Perera, Rushika M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Davis, Oliver; Zoncu, Roberto] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Davis, Oliver; Zoncu, Roberto] Univ Calif Berkeley, Paul F Glenn Ctr Aging Res, Berkeley, CA 94720 USA; [Platt, Nick] Univ Oxford, Dept Pharmacol, Oxford, England; [Ogmundsdottir, Margret Helga] Univ Iceland, Dept Biochem & Mol Biol, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland; [Pelicci, Pier Giuseppe] Univ Milan, Dept Oncol, I-20139 Milan, Italy; [Settembre, Carmine] Dulbecco Telethon Inst, Via Campi Flegrei 34, I-80078 Naples, Italy; [Settembre, Carmine; Ballabio, Andrea] Univ Naples Federico II, Dept Med & Translat Sci, Med Genet Unit, Via Pansini 5, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); IRCCS European Institute of Oncology (IEO); Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Oxford; University of Iceland; University of Milan; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Naples Federico II	Ballabio, A (corresponding author), Telethon Inst Genet & Med TIGEM, Via Campi Flegrei 34, I-80078 Naples, Italy.; Ballabio, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Ballabio, A (corresponding author), Baylor Coll Med, Neurol Res Inst, Houston, TX 77030 USA.; Ballabio, A (corresponding author), Univ Naples Federico II, Dept Med & Translat Sci, Med Genet Unit, Via Pansini 5, I-80131 Naples, Italy.	ballabio@tigem.it	Pelicci, Pier Giuseppe/AAL-6572-2020; Lanfrancone, Luisa/AAC-8671-2019; Punzi, Simona/K-5574-2018; Monfregola, Jlenia/AAW-9055-2021; Guida, Alessandro/H-6930-2019; Pastore, Nunzia/Q-6665-2017; Settembre, Carmine/AIA-9170-2022; Calcagni, Alessia/AAB-7918-2021; De Cegli, Rossella/ABA-4372-2020; Di Malta, Chiara/AAX-6395-2020	Lanfrancone, Luisa/0000-0002-4523-3815; Guida, Alessandro/0000-0002-8733-4470; Pastore, Nunzia/0000-0002-8701-5592; Calcagni, Alessia/0000-0002-1946-5815; di giovannantonio, luca giovanni/0000-0003-4348-6082; Punzi, Simona/0000-0002-8734-6404; De Cegli, Rossella/0000-0002-8526-8692	Italian Telethon Foundation [TGM11CB6]; MIUR FIRB [RBAP11Z3YA]; European Research Council [250154, 694282, 341131]; U.S. National Institutes of Health [R01-NS078072]; Associazione Italiana per la Ricerca sul Cancro [IG 2015 Id 17639, IG 2015 Id 17717]; NATIONAL CANCER INSTITUTE [DP2CA195761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078072] Funding Source: NIH RePORTER	Italian Telethon Foundation(Fondazione Telethon); MIUR FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); European Research Council(European Research Council (ERC)European Commission); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. A. De Matteis, G. Diez-Roux, and G. Napolitano for helpful suggestions. We thank A. Salzano and E. De Gennaro for technical assistance. This work was supported by grants from the Italian Telethon Foundation (TGM11CB6); MIUR FIRB RBAP11Z3YA (A.B.); European Research Council Advanced Investigator grant no. 250154 (CLEAR) and no. 694282 (LYSOSOMICS) (A.B.) and no. 341131 (InMec) (P.G.P.); U.S. National Institutes of Health (R01-NS078072) (A.B.); and the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.) to A.B (IG 2015 Id 17639) and C.S. (IG 2015 Id 17717). All data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials.	Ban H, 2004, INT J MOL MED, V13, P537; Calcagni A, 2016, ELIFE, V5, DOI 10.7554/eLife.17047; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Kauffman EC, 2014, NAT REV UROL, V11, P465, DOI 10.1038/nrurol.2014.162; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Malouf GG, 2014, CLIN CANCER RES, V20, P4129, DOI 10.1158/1078-0432.CCR-13-3036; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Watson K, 2014, SEMIN CELL DEV BIOL, V36, P130, DOI 10.1016/j.semcdb.2014.08.013; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	25	115	117	4	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1188	1192		10.1126/science.aag2553	http://dx.doi.org/10.1126/science.aag2553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619945	Green Accepted			2022-12-28	WOS:000403327400042
J	Jiang, YN; Wang, WX; Xie, QJ; Liu, N; Liu, LX; Wang, DP; Zhang, XW; Yang, C; Chen, XY; Tang, DZ; Wang, ET				Jiang, Yina; Wang, Wanxiao; Xie, Qiujin; Liu, Na; Liu, Lixia; Wang, Dapeng; Zhang, Xiaowei; Yang, Chen; Chen, Xiaoya; Tang, Dingzhong; Wang, Ertao			Plants transfer lipids to sustain colonization by mutualistic mycorrhizal and parasitic fungi	SCIENCE			English	Article							FATTY-ACID SYNTHESIS; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; TRANSCRIPTION FACTOR; SN-2 PREFERENCE; ARABIDOPSIS; METABOLISM; BIOSYNTHESIS; TRANSPORT; RESPONSES	Arbuscular mycorrhizal (AM) fungi facilitate plant uptake of mineral nutrients and draw organic nutrients fromthe plant. Organic nutrients are thought to be supplied primarily in the form of sugars. Here we show that the AM fungus Rhizophagus irregularis is a fatty acid auxotroph and that fatty acids synthesized in the host plants are transferred to the fungus to sustain mycorrhizal colonization. The transfer is dependent onRAM2 (REQUIRED FOR ARBUSCULAR MYCORRHIZATION 2) and the ATP binding cassette transporter-mediated plant lipid export pathway. We further show that plant fatty acids can be transferred to the pathogenic fungus Golovinomyces cichoracerum and are required for colonization by pathogens. We suggest that the mutualistic mycorrhizal and pathogenic fungi similarly recruit the fatty acid biosynthesis program to facilitate host invasion.	[Jiang, Yina; Wang, Wanxiao; Xie, Qiujin; Liu, Lixia; Wang, Dapeng; Zhang, Xiaowei; Yang, Chen; Chen, Xiaoya; Wang, Ertao] Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Ctr Excellence Mol Plant Sci,Inst Plant Physiol &, Shanghai 200032, Peoples R China; [Liu, Na; Tang, Dingzhong] Fujian Agr & Forestry Univ, Key Lab, Minist Educ Genet Breeding & Multiple Utilizat Cr, Fuzhou 350002, Peoples R China; [Liu, Na; Tang, Dingzhong] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Wang, ET (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Ctr Excellence Mol Plant Sci,Inst Plant Physiol &, Shanghai 200032, Peoples R China.	etwang@sibs.ac.cn	Wang, Ertao/GYU-4506-2022; cxzhou, cxzhou/AEO-7639-2022; Wang, Dapeng/HGD-4818-2022; Tang, Dingzhong/AAZ-2500-2020; WANG, TAO ER/GYV-0174-2022	Wang, Ertao/0000-0002-5178-3530; Tang, Dingzhong/0000-0001-8850-8754; Chen, Xiaoya/0000-0002-2909-8414; jiang, yina/0000-0002-9662-0161; zhang, xiao wei/0000-0001-8235-8687	973 National Key Basic Research Program in China [2015CB158300]; Ministry of Agriculture of China for Transgenic Research [2016ZX08009003005-003]; National Science Foundation of China [31522007]; China Postdoctoral Science Foundation [2014M560358]; Strategic Priority Research Program "Molecular Mechanism of Plant Growth and Development" of the Chinese Academy of Sciences [XDPB0404]	973 National Key Basic Research Program in China(National Basic Research Program of China); Ministry of Agriculture of China for Transgenic Research; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Strategic Priority Research Program "Molecular Mechanism of Plant Growth and Development" of the Chinese Academy of Sciences	We thank J. Murray, C. Stonoha, and D. Wang for helpful suggestions on the manuscript; M. Harrison for providing str mutant seeds; W. Hu for gas chromatography-mass spectrometry and gas chromatography-quadrupole time-of-flight mass spectrometry analysis; Y. Shan for liquid chromatography-high-resolution mass spectrometry analysis; and the company Hanyu Bio for reanalysis of R. irregularis. The research was supported by the 973 National Key Basic Research Program in China (grant 2015CB158300), the Ministry of Agriculture of China for Transgenic Research (grant 2016ZX08009003005-003), the National Science Foundation of China (grant 31522007), the China Postdoctoral Science Foundation (2014M560358), and the Strategic Priority Research Program "Molecular Mechanism of Plant Growth and Development" of the Chinese Academy of Sciences (grant XDPB0404). Y. J. and E.W. directed the research. Y. J., W. W., and Q.X. performed most of the experiments. Other authors contributed to the analytical, molecular cloning, and transformation work. Y. J. and E.W. wrote the manuscript. The authors declare that they have no competing interests. The supplementary materials contain additional data.	Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Bago B, 2002, PLANT PHYSIOL, V128, P108, DOI 10.1104/pp.010466; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bravo A, 2017, NEW PHYTOL, V214, P1631, DOI 10.1111/nph.14533; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Gobbato E, 2012, CURR BIOL, V22, P2236, DOI 10.1016/j.cub.2012.09.044; Gutjahr C, 2012, PLANT J, V69, P906, DOI 10.1111/j.1365-313X.2011.04842.x; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Lin K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004078; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Niklas J, 2010, CURR OPIN BIOTECH, V21, P63, DOI 10.1016/j.copbio.2010.01.011; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Trepanier M, 2005, APPL ENVIRON MICROB, V71, P5341, DOI 10.1128/AEM.71.9.5341-5347.2005; Vannini C, 2016, NEW PHYTOL, V211, P265, DOI 10.1111/nph.13895; Vijayakumar V, 2016, PLANT CELL ENVIRON, V39, P393, DOI 10.1111/pce.12624; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Wewer V, 2014, PLANT J, V79, P398, DOI 10.1111/tpj.12566; Yang WL, 2012, PLANT PHYSIOL, V160, P638, DOI 10.1104/pp.112.201996; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955	30	342	388	71	568	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1172	1175		10.1126/science.aam9970	http://dx.doi.org/10.1126/science.aam9970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28596307				2022-12-28	WOS:000403327400037
J	Graham, JE; Marians, KJ; Kowalczykowski, SC				Graham, James E.; Marians, Kenneth J.; Kowalczykowski, Stephen C.			Independent and Stochastic Action of DNA Polymerases in the Replisome	CELL			English	Article							LAGGING-STRAND SYNTHESIS; SINGLE-MOLECULE OBSERVATION; COORDINATED LEADING-STRAND; REPLICATION FORK; HELICASE; PROTEIN; PRIMASE; DYNAMICS; VISUALIZATION; PURIFICATION	It has been assumed that DNA synthesis by the leading- and lagging-strand polymerases in the replisome must be coordinated to avoid the formation of significant gaps in the nascent strands. Using real-time single-molecule analysis, we establish that leading- and lagging-strand DNA polymerases function independently within a single replisome. Although average rates of DNA synthesis on leading and lagging strands are similar, individual trajectories of both DNA polymerases display stochastically switchable rates of synthesis interspersed with distinct pauses. DNA unwinding by the replicative helicase may continue during such pauses, but a self-governing mechanism, where helicase speed is reduced by similar to 80%, permits recoupling of polymerase to helicase. These features imply a more dynamic, kinetically discontinuous replication process, wherein contacts within the replisome are continually broken and reformed. We conclude that the stochastic behavior of replisome components ensures complete DNA duplication without requiring coordination of leading- and lagging-strand synthesis.	[Graham, James E.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Graham, James E.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA; [Graham, James E.] Oxford Nanopore Technol, Edmund Cartwright House,4 Robert Robinson Ave, Oxford OX4 4GA, England	University of California System; University of California Davis; University of California System; University of California Davis; Memorial Sloan Kettering Cancer Center; Oxford Nanopore Technologies	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.; Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.; Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu; sckowalczykowski@ucdavis.edu		Graham, James/0000-0002-8639-7592	NIH [GM34557, GM064745]; Cancer Center Core Support Grants [NCI P30CA008748, NCI P30CA093373]; NATIONAL CANCER INSTITUTE [P30CA093373, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064745, R37GM034557, R01GM034557] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Support Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Soon Bahng (MSKCC) for purified proteins, Jody Plank for the template preparation protocols used in this work, James Berger (Johns Hopkins) for expression plasmids for mutant DnaG, and Michael Kohl (Oxford) for the basis of the edge-detection code used in this study. We thank all members of the S.C.K. group, especially Neville Gilhooly and Pham Minh Tuan, as well as David Sherratt (Oxford) and Joseph Yeeles (LMB, Cambridge), for their insightful comments on the work. These studies were supported by NIH grants GM34557 to K.J.M., GM064745 to S.C.K., and Cancer Center Core Support Grants NCI P30CA008748 to MSKCC and NCI P30CA093373 to UCD.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Amitani I, 2010, METHOD ENZYMOL, V472, P261, DOI 10.1016/S0076-6879(10)72007-3; Bell JC, 2015, ELIFE, V4, DOI 10.7554/eLife.08646; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Dallmann HG, 2000, J BIOL CHEM, V275, P15512, DOI 10.1074/jbc.M909257199; Dohrmann PR, 2016, NUCLEIC ACIDS RES, V44, P1285, DOI 10.1093/nar/gkv1510; Duderstadt KE, 2016, MOL CELL, V64, P1035, DOI 10.1016/j.molcel.2016.10.028; Forget AL, 2013, NAT PROTOC, V8, P525, DOI 10.1038/nprot.2013.016; Geertsema HJ, 2014, P NATL ACAD SCI USA, V111, P4073, DOI 10.1073/pnas.1402010111; Georgescu RE, 2014, NUCLEIC ACIDS RES, V42, P6497, DOI 10.1093/nar/gku257; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Liu B, 2013, NATURE, V500, P482, DOI 10.1038/nature12333; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; MOK M, 1987, J BIOL CHEM, V262, P16644; Oakley AJ, 2005, J BIOL CHEM, V280, P11495, DOI 10.1074/jbc.M412645200; OKAZAKI R, 1967, JPN J MED SCI BIOL, V20, P255; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Pomerantz AK, 2008, J PHYS CHEM B, V112, P13184, DOI 10.1021/jp806696u; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Rymer R.U., 2012, MOL CELL BIOL; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Strycharska MS, 2013, MOL CELL, V52, P844, DOI 10.1016/j.molcel.2013.11.016; Tanner NA, 2011, EMBO J, V30, P1830, DOI 10.1038/emboj.2011.84; Tanner Nathan A., 2009, V521, P397, DOI [10.1007/978-1-60327-817-5-22, 10.1007/978-1-60327-815-7_22]; Tanner NA, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp006; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Pham TM, 2013, MOL MICROBIOL, V90, P584, DOI 10.1111/mmi.12386; WU CA, 1992, J BIOL CHEM, V267, P4030; WU CA, 1992, J BIOL CHEM, V267, P4074; Xu LW, 2000, J BIOL CHEM, V275, P8196, DOI 10.1074/jbc.275.11.8196; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; Yuan Q, 2014, NUCLEIC ACIDS RES, V42, P1747, DOI 10.1093/nar/gkt1098	42	92	95	7	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1201	+		10.1016/j.cell.2017.05.041	http://dx.doi.org/10.1016/j.cell.2017.05.041			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622507	Green Accepted, Bronze			2022-12-28	WOS:000403332400010
J	Han, B; Sivaramakrishnan, P; Lin, CCJ; Neve, IAA; He, JQ; Tay, LWR; Sowa, JN; Sizovs, A; Du, GW; Wang, J; Herman, C; Wang, MC				Han, Bing; Sivaramakrishnan, Priya; Lin, Chih-Chun J.; Neve, Isaiah A. A.; He, Jingquan; Tay, Li Wei Rachel; Sowa, Jessica N.; Sizovs, Antons; Du, Guangwei; Wang, Jin; Herman, Christophe; Wang, Meng C.			Microbial Genetic Composition Tunes Host Longevity	CELL			English	Article							ESCHERICHIA-COLI K-12; EXTENDS LIFE-SPAN; EXOPOLYSACCHARIDE COLANIC ACID; LACKING COENZYME-Q; CAENORHABDITIS-ELEGANS; C. ELEGANS; BACTERIAL PROLIFERATION; ELECTRON-TRANSPORT; REGULATORY GENES; OXIDATIVE STRESS	Homeostasis of the gut microbiota critically influences host health and aging. Developing genetically engineered probiotics holds great promise as a new therapeutic paradigm to promote healthy aging. Here, through screening 3,983 Escherichia coli mutants, we discovered that 29 bacterial genes, when deleted, increase longevity in the host Caenorhabditis elegans. A dozen of these bacterial mutants also protect the host from age-related progression of tumor growth and amyloid-beta accumulation. Mechanistically, we discovered that five bacterial mutants promote longevity through increased secretion of the polysaccharide colanic acid (CA), which regulates mitochondrial dynamics and unfolded protein response (UPRmt) in the host. Purified CA polymers are sufficient to promote longevity via ATFS-1, the host UPRmt-responsive transcription factor. Furthermore, the mitochondrial changes and longevity effects induced by CA are conserved across different species. Together, our results identified molecular targets for developing pro-longevity microbes and a bacterial metabolite acting on host mitochondria to promote longevity.	[Han, Bing; Lin, Chih-Chun J.; Neve, Isaiah A. A.; Sowa, Jessica N.; Wang, Meng C.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Han, Bing; Sivaramakrishnan, Priya; Lin, Chih-Chun J.; Neve, Isaiah A. A.; Sowa, Jessica N.; Herman, Christophe; Wang, Meng C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [He, Jingquan; Tay, Li Wei Rachel; Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Sizovs, Antons; Wang, Jin] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Herman, Christophe; Wang, Meng C.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Wang, MC (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.; Wang, MC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Wang, MC (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.	wmeng@bcm.edu	Wang, Jin/M-4036-2014; Wang, Jin/AAC-7292-2019; Wang, Meng/F-2951-2019	Wang, Jin/0000-0003-3625-7919; Wang, Jin/0000-0003-3625-7919; Wang, Meng/0000-0002-5898-6007; Lin, Chih-chun J./0000-0001-7891-6412; Sizovs, Antons/0000-0001-6495-6317; Han, Bing/0000-0002-9717-4925; Du, Guangwei/0000-0003-4193-6975	NIH Office of Research Infrastructure Programs [P40 OD010440]; NIH [R01AG045183, R01AT009050, DP1DK113644, R01HL119478, R01GM088653, R01GM115622, R01CA207701]; HHMI Faculty Scholar Award (HHMI) [55108585]; NATIONAL CANCER INSTITUTE [R01CA207701] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT009050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK113644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088653, K12GM068524, R01GM115622, T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045183] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Faculty Scholar Award (HHMI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Doebbler and A. Dervisefendic for laboratory support; C. Kenyon, C. Haynes, and H. Dierick for providing animal strains; J.J. Wang and D.A. Garsin for bacteria; M.A. Frohman for NIH/3T3 cells expressing dsRed2-mito; M.K. Estes for providing a luminometer; H. Dierick, J. Halliday, A. Kuspa, J. Petrosino, S. Rosenberg, and H. Zoghbi for critical reading the manuscript; and the members of the Wang laboratory for insightful discussions. Some worm strains were provided by CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by the NIH (R01AG045183, R01AT009050, and DP1DK113644 to M.C.W.; R01HL119478 to G.D.; R01GM088653 to C.H.; and R01GM115622 and R01CA207701 to J.W.) and an HHMI Faculty Scholar Award (HHMI#55108585 to M.C.W.).	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Breckenridge DG, 2008, MOL CELL, V31, P586, DOI 10.1016/j.molcel.2008.07.015; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen JR, 2004, INT J FOOD MICROBIOL, V93, P281, DOI 10.1016/j.ijfoodmicro.2003.12.004; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clark LC, 2014, CELL MICROBIOL, V16, P27, DOI 10.1111/cmi.12234; DISCHE Z, 1948, J BIOL CHEM, V175, P595; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garigan D, 2002, GENETICS, V161, P1101; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; GRANT WD, 1969, J BACTERIOL, V100, P1187, DOI 10.1128/JB.100.3.1187-1193.1969; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Leiser SF, 2010, BIOL CHEM, V391, P1131, DOI 10.1515/BC.2010.123; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Ramachandran P. V., 2015, CURR PROTOC MOL BIOL, V109, P1; Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639; Riera CE, 2015, NAT CELL BIOL, V17, P196, DOI 10.1038/ncb3107; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; SLEDJESKI D, 1995, P NATL ACAD SCI USA, V92, P2003, DOI 10.1073/pnas.92.6.2003; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; SULSTON JE, 1974, GENETICS, V77, P95; SUTHERLAND IW, 1969, BIOCHEM J, V115, P935, DOI 10.1042/bj1150935; TORRESCABASSA AS, 1987, J BACTERIOL, V169, P981, DOI 10.1128/jb.169.3.981-989.1987; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Virk B, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-67; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004752; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; WILLIAMS BD, 1992, GENETICS, V131, P609; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yao Y., 2015, PLOS GENET, V1; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	63	175	188	9	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1249	+		10.1016/j.cell.2017.05.036	http://dx.doi.org/10.1016/j.cell.2017.05.036			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622510	Bronze, Green Accepted			2022-12-28	WOS:000403332400014
J	Manolio, TA				Manolio, Teri A.			In Retrospect A decade of shared genomic associations	NATURE			English	Editorial Material							WIDE ASSOCIATION; LOCI; AMERICANS; INSIGHTS; DISEASES; TRAITS		[Manolio, Teri A.] NHGRI, Div Genom Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Manolio, TA (corresponding author), NHGRI, Div Genom Med, Bethesda, MD 20892 USA.	manolio@nih.gov						Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cade BE, 2016, AM J RESP CRIT CARE, V194, P886, DOI 10.1164/rccm.201512-2431OC; Chan SL, 2015, PHARMACOGENOMICS, V16, P1161, DOI [10.2217/PGS.15.54, 10.2217/pgs.15.54]; Evans DS, 2016, HUM MOL GENET, V25, P4350, DOI 10.1093/hmg/ddw284; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mossman K, 2008, SCI AM, V298, P42; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Price AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1684; Summerskill W, 2008, LANCET, V371, P370, DOI 10.1016/S0140-6736(08)60183-X; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768	15	17	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					360	361		10.1038/546360a	http://dx.doi.org/10.1038/546360a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28617469				2022-12-28	WOS:000403250900024
J	McDonald, HH; Moore, M				McDonald, Heidi H.; Moore, Milton			Strongyloides stercoralis Hyperinfection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McDonald, Heidi H.; Moore, Milton] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	McDonald, HH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.	heldh@uthscsa.edu							0	13	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2376	2376		10.1056/NEJMicm1612018	http://dx.doi.org/10.1056/NEJMicm1612018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28614685				2022-12-28	WOS:000403230800011
J	Wilker, JJ				Wilker, Jonathan J.			MATERIALS SCIENCE How to suck like an octopus	NATURE			English	Editorial Material									[Wilker, Jonathan J.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Wilker, Jonathan J.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wilker, JJ (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.; Wilker, JJ (corresponding author), Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.	wilker@purdue.edu						Baik S, 2017, NATURE, V546, P396, DOI 10.1038/nature22382; Heepe L, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4860991; Hennebert E, 2014, P NATL ACAD SCI USA, V111, P6317, DOI 10.1073/pnas.1400089111; North MA, 2017, ACS APPL MATER INTER, V9, P7866, DOI 10.1021/acsami.7b00270; Stark AY, 2012, J EXP BIOL, V215, P3080, DOI 10.1242/jeb.070912; Tramacere F, 2013, BIOLOGICAL AND BIOMIMETIC ADHESIVES: CHALLENGES AND OPPORTUNITIES, P89	6	6	6	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					358	359		10.1038/546358a	http://dx.doi.org/10.1038/546358a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5BK	28617458				2022-12-28	WOS:000403250900023
J	Enthoven, WTM; Roelofs, PD; Koes, BW				Enthoven, Wendy T. M.; Roelofs, Pepijn D.; Koes, Bart W.			NSAIDs for Chronic Low Back Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT	CLINICAL QUESTION Are nonsteroidal anti-inflammatory drugs(NSAIDs) associated with greater pain relief than placebo, other drugs, and nondrug treatments for patients with chronic low back pain? BOTTOM LINE Compared with placebo, NSAIDs are associated with a small but significant improvement in pain and disability in patients with chronic low back pain, although this difference became nonsignificant when studies with high risk for bias were excluded. The associated benefits were smaller than the minimal clinically important difference.	[Enthoven, Wendy T. M.; Koes, Bart W.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Roelofs, Pepijn D.] Rotterdam Univ Appl Sci, Res Ctr Innovat Care, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Enthoven, WTM (corresponding author), Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	w.enthoven@erasmusmc.nl	Koes, Bart w/K-4614-2016; Roelofs, Pepijn D.D.M./P-9479-2018	Koes, Bart w/0000-0002-0450-9969; Roelofs, Pepijn D.D.M./0000-0003-2037-1370	ReumaFonds [COI-1] Funding Source: researchfish	ReumaFonds		Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Bedaiwi MK, 2016, ARTHRIT CARE RES, V68, P845, DOI 10.1002/acr.22753; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Enthoven WTM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012087; Gore M, 2012, PAIN PRACT, V12, P550, DOI 10.1111/j.1533-2500.2012.00532.x; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Piccoliori G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-148	7	28	33	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2327	2328		10.1001/jama.2017.4571	http://dx.doi.org/10.1001/jama.2017.4571			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609520				2022-12-28	WOS:000403149900020
J	[Anonymous]				[Anonymous]			The Duty of the Medical Profession in This War	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2241	2241		10.1001/jama.2017.4823	http://dx.doi.org/10.1001/jama.2017.4823			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586881				2022-12-28	WOS:000402706100029
J	Uyeki, TM; Katz, JM; Jernigan, DB				Uyeki, Timothy M.; Katz, Jacqueline M.; Jernigan, Daniel B.			Novel influenza A viruses and pandemic threats	LANCET			English	Editorial Material							A(H7N9) VIRUS; H7N9 VIRUS; OCTOBER 2016; INFECTION; CHINA; MAINLAND		[Uyeki, Timothy M.; Katz, Jacqueline M.; Jernigan, Daniel B.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30329 USA.	tuyeki@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Centers for Disease Control and Prevention (CDC), 2017, SUMM INFL RISK ASS T; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Fraaij PLA, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.48.30416; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Iuliano AD, 2017, MMWR-MORBID MORTAL W, V66, P254, DOI 10.15585/mmwr.mm6609e2; Jernigan DB, 2013, TXB INFLUENZA, P1; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Rovida F, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.5.30456; Skowronski DM, 2016, EMERG INFECT DIS, V22, P71, DOI 10.3201/eid2201.151330; WHO, SUMM ASS 21 APR 16 M; WHO, SUMM ASS 14 FEBR 16; William T, 2015, EMERG INFECT DIS, V21, P142, DOI 10.3201/eid2101.141092; World Health Organization, 2017, DIS OUTBREAK NE 0208; World Health Organization, 2017, ANT GEN CHAR ZOON IN; Xiang NJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2049-2; Zhou L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw182; Zhu W, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.19.30533	20	38	40	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2172	2174		10.1016/S0140-6736(17)31274-6	http://dx.doi.org/10.1016/S0140-6736(17)31274-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589883	Green Accepted			2022-12-28	WOS:000402540800009
J	Williamson, A				Williamson, Arthur			Robert C Gray OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2017	357								j2702	10.1136/bmj.j2702	http://dx.doi.org/10.1136/bmj.j2702			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW6NF	28576930				2022-12-28	WOS:000402626600009
J	Elamein, M; Bower, H; Valderrama, C; Zedan, D; Rihawi, H; Almilaji, K; Abdelhafeez, M; Tabbal, N; Almhawish, N; Maes, S; AbouZeid, A				Elamein, Mohamed; Bower, Hilary; Valderrama, Camilo; Zedan, Daher; Rihawi, Hazem; Almilaji, Khaled; Abdelhafeez, Mohammed; Tabbal, Nabil; Almhawish, Naser; Maes, Sophie; AbouZeid, Alaa			Attacks against health care in Syria, 2015-16: results from a real-time reporting tool	LANCET			English	Article							FACILITIES; WORKERS	Background Collecting credible data on violence against health services, health workers, and patients in war zones is a massive challenge, but crucial to understanding the extent to which international humanitarian law is being breached. We describe a new system used mainly in areas of Syria with a substantial presence of armed opposition groups since November, 2015, to detect and verify attacks on health-care services and describe their effect. Methods All Turkey health cluster organisations with a physical presence in Syria, either through deployed and locally employed staff, were asked to participate in the Monitoring Violence against Health Care (MVH) alert network. The Turkey hub of the health cluster, a UN-activated humanitarian health coordination body, received alerts from health cluster partners via WhatsApp and an anonymised online data-entry tool. Field staff were asked to seek further information by interviewing victims and other witnesses when possible. The MVH data team triangulated alerts to identify individual events and distributed a preliminary flash update of key information (location, type of service, modality of attack, deaths, and casualties) to partners, WHO, United Nations Office for the Coordination of Humanitarian Affairs, and donors. The team also received and entered alerts from several large non-health cluster organisations (known as external partners, who do their own information-gathering and verification processes before sharing their information). Each incident was then assessed in a stringent process of information-matching. Attacks were deemed to be verified if they were reported by a minimum of one health cluster partner and one external partner, and the majority of the key datapoints matched. Alerts that did not meet this standard were deemed to be unverified. Results were tabulated to describe attack occurrence and impact, disaggregated where possible by age, sex, and location. Findings Between early November, 2015, and Dec 31 2016, 938 people were directly harmed in 402 incidents of violence against health care: 677 (72%) were wounded and 261 (28%) were killed. Most of the dead were adult males (68%), but the highest case fatality (39%) was seen in children aged younger than 5 years. 24% of attack victims were health workers. Around 44% of hospitals and 5% of all primary care clinics in mainly areas with a substantial presence of armed opposition groups experienced attacks. Aerial bombardment was the main form of attack. A third of health-care services were hit more than once. Services providing trauma care were attacked more than other services. Interpretation The data system used in this study addressed double-counting, reduced the effect of potentially biased self-reports, and produced credible data from anonymous information. The MVH tool could be feasibly deployed in many conflict areas. Reliable data are essential to show how far warring parties have strayed from international law protecting health care in conflict and to effectively harness legal mechanisms to discourage future perpetrators. Copyright (C) 2017. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved.	[Elamein, Mohamed; Valderrama, Camilo; Maes, Sophie; AbouZeid, Alaa] WHO Gaziantep Field Off, Gaziantep, Turkey; [Bower, Hilary] London Sch Hyg & Trop Med, London, England; [Zedan, Daher] Union Med Care & Relief Org, Gaziantep, Turkey; [Rihawi, Hazem] Syrian Amer Med Soc, Gaziantep, Turkey; [Almilaji, Khaled] Canadian Int Med Relief Org, Gaziantep, Turkey; [Abdelhafeez, Mohammed] Informat Management & Mine Act Programs, Gaziantep, Turkey; [Tabbal, Nabil] Save Children, Gaziantep, Turkey; [Almhawish, Naser] Assistance Coordinat Unit, Early Warning & Response Network, Gaziantep, Turkey; [AbouZeid, Alaa] Cairo Univ, Fac Med, Publ Hlth Dept, Giza, Egypt	WHO Turkey; University of London; London School of Hygiene & Tropical Medicine; Save the Children; Egyptian Knowledge Bank (EKB); Cairo University	AbouZeid, A (corresponding author), Cairo Univ, Fac Med, Publ Hlth Dept, Giza, Egypt.	abouzeida@who.int	Bower, Hilary/AFY-1063-2022	Bower, Hilary/0000-0002-1541-6637; AbouZeid, Alaa/0000-0002-7283-3154; Almhawish, Naser/0000-0003-3010-2588				Foghammar L, 2016, SOC SCI MED, V162, P219, DOI 10.1016/j.socscimed.2016.03.039; Fouad FM, 2017, LANCET; Haar Rohini J, 2014, Confl Health, V8, P23, DOI 10.1186/1752-1505-8-23; Human Rights Watch, 2015, SAF HLTH CONFL 2015; Humanitarian Response, 2016, TURK CROSS BORD HLTH; Humanitarian Response, TURK CROSS BORD HLTH; International Comittee of the Red Cross, 1949, PROT ADD GEN CONV 12; International Committee of the Red Cross, 1949, CONV 4 REL PROT CIV; International Committee of the Red Cross, 2012, HLTH CAR DANG VIOL I; Medecins Sans Frontieres, MED CAR FIR; Patel P, 2017, B WORLD HEALTH ORGAN, V95, P79, DOI 10.2471/BLT.15.168328; Physicians for Human Rights, AN CRIS MAP ATT HLTH; Physicians for Human Rights (New York), 2016, AN CRIS MAP ATT HLTH; Rubenstein LS, 2010, LANCET, V375, P329, DOI 10.1016/S0140-6736(09)61926-7; WHO, ATT HEALTHC DASHB	15	30	30	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2278	2286		10.1016/S0140-6736(17)31328-4	http://dx.doi.org/10.1016/S0140-6736(17)31328-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN0DH	28602556				2022-12-28	WOS:000415645700026
J	Olival, KJ; Hosseini, PR; Zambrana-Torrelio, C; Ross, N; Bogich, TL; Daszak, P				Olival, Kevin J.; Hosseini, Parviez R.; Zambrana-Torrelio, Carlos; Ross, Noam; Bogich, Tiffany L.; Daszak, Peter			Host and viral traits predict zoonotic spillover from mammals	NATURE			English	Article							EMERGING INFECTIOUS-DISEASES; WILD PRIMATES; VIRUSES; TRANSMISSION; BATS; SPECIFICITY; EMERGENCE; DATABASE; HUMANS; PHYLOGENY	The majority of human emerging infectious diseases are zoonotic, with viruses that originate in wild mammals of particular concern (for example, HIV, Ebola and SARS)(1-3). Understanding patterns of viral diversity in wildlife and determinants of successful cross-species transmission, or spillover, are therefore key goals for pandemic surveillance programs(4). However, few analytical tools exist to identify which host species are likely to harbour the next human virus, or which viruses can cross species boundaries(5-7). Here we conduct a comprehensive analysis of mammalian host-virus relationships and show that both the total number of viruses that infect a given species and the proportion likely to be zoonotic are predictable. After controlling for research effort, the proportion of zoonotic viruses per species is predicted by phylogenetic relatedness to humans, host taxonomy and human population within a species range-which may reflect human-wildlife contact. We demonstrate that bats harbour a significantly higher proportion of zoonotic viruses than all other mammalian orders. We also identify the taxa and geographic regions with the largest estimated number of 'missing viruses' and 'missing zoonoses' and therefore of highest value for future surveillance. We then show that phylogenetic host breadth and other viral traits are significant predictors of zoonotic potential, providing a novel framework to assess if a newly discovered mammalian virus could infect people.	[Olival, Kevin J.; Hosseini, Parviez R.; Zambrana-Torrelio, Carlos; Ross, Noam; Bogich, Tiffany L.; Daszak, Peter] EcoHlth Alliance, 460 West 34th St, New York, NY 10001 USA	EcoHealth Alliance	Olival, KJ; Daszak, P (corresponding author), EcoHlth Alliance, 460 West 34th St, New York, NY 10001 USA.	olival@ecohealthalliance.org; daszak@ecohealthalliance.org	daszak, peter/U-4588-2017; Zambrana-Torrelio, Carlos/AAH-3911-2020	daszak, peter/0000-0002-2046-5695; Zambrana-Torrelio, Carlos/0000-0002-5614-7496; Olival, Kevin/0000-0003-3211-1875; Ross, Noam/0000-0002-2136-0000; Bogich, Tiffany/0000-0002-8143-5289	United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT program; NIH NIAID [R01AI079231, R01AI110964]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110964, R01AI079231] Funding Source: NIH RePORTER	United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT program(United States Agency for International Development (USAID)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT program; and NIH NIAID awards R01AI079231 and R01AI110964. The authors thank C. N. Basaraba, J. Baxter, L. Brierley, E. A. Hagan, J. Levinson, E. H. Loh, L. Mendiola, N. Wale and A. R. Willoughby for assistance with data collection, and B. M. Bolker, A. R. Ives, K. E. Jones, C. K. Johnson, A. M. Kilpatrick, J. A. K. Mazet and M. E. J. Woolhouse for comments.	[Anonymous], 2015, SP CLASSES METHODS S; [Anonymous], 2015, RASTER GEOGRAPHIC DA; [Anonymous], 2014, R LANG ENV STAT COMP; Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brierley L, 2016, AM NAT, V187, pE53, DOI 10.1086/684391; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chauhan H.K., 2021, NARDOSTACHYS JATAMAN, V2021, pe.T50126627A50131395, DOI [10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.en., DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN]; Cooper N, 2012, ECOL LETT, V15, P1370, DOI 10.1111/j.1461-0248.2012.01858.x; Cooper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042190; Cuthill JH, 2013, EVOLUTION, V67, P980, DOI 10.1111/evo.12064; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Diniz JAF, 2012, ECOGRAPHY, V35, P239, DOI 10.1111/j.1600-0587.2011.06949.x; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Dunn RR, 2010, P ROY SOC B-BIOL SCI, V277, P2587, DOI 10.1098/rspb.2010.0340; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epstein JH, 2009, MT SINAI J MED, V76, P448, DOI 10.1002/msj.20140; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Geoghegan JL, 2016, P NATL ACAD SCI USA, V113, P4170, DOI 10.1073/pnas.1521582113; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Levinson J, 2013, EMERG INFECT DIS, V19, P743, DOI 10.3201/eid1905.121042; Lipsitch M, 2016, ELIFE, V5, DOI 10.7554/eLife.18491; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Gomez JM, 2013, P NATL ACAD SCI USA, V110, P7738, DOI 10.1073/pnas.1220716110; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Morse Stephen S., 1993, P10; Nunn CL, 2005, EVOL ANTHROPOL, V14, P1, DOI 10.1002/evan.20041; Olival K. J., 2012, NEW DIRECTIONS CONSE, P195, DOI [10.1002/9781118818824.ch11, DOI 10.1002/9781118818824.CH11]; Organtini LJ, 2015, J VIROL, V89, P1909, DOI 10.1128/JVI.02611-14; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parker IM, 2015, NATURE, V520, P542, DOI 10.1038/nature14372; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Pawitan Y., 2001, ALL LIKELIHOOD STAT; Poulin R, 2003, PARASITOLOGY, V126, P473, DOI 10.1017/S0031182003002993; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Pulliam JRC, 2009, J INFECT DIS, V199, P565, DOI 10.1086/596510; Scherf B.D, 2000, WORLD WATCH LIST DOM; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Zhou P, 2016, P NATL ACAD SCI USA, V113, P2696, DOI 10.1073/pnas.1518240113	57	485	500	18	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					646	+		10.1038/nature22975	http://dx.doi.org/10.1038/nature22975			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28636590	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000404332000046
J	Dobrin, AF				Dobrin, Alexandru Florin			PARTICLE PHYSICS No sign of asymmetry in the strong force	NATURE			English	Editorial Material							CONSERVATION; PARITY		[Dobrin, Alexandru Florin] European Org Nucl Res CERN, CH-1211 Geneva 23, Switzerland	European Organization for Nuclear Research (CERN)	Dobrin, AF (corresponding author), European Org Nucl Res CERN, CH-1211 Geneva 23, Switzerland.	alexandru.florin.dobrin@cern.ch	Dobrin, Alexandru F/S-7451-2018	Dobrin, Alexandru F/0000-0003-4432-4026				Abelev B, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.012301; Abelev BI, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.054908; Abelev BI, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.251601; Adam J, 2016, PHYS REV C, V93, DOI 10.1103/PhysRevC.93.044903; Adamczyk L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.052302; Adare A, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.064904; Baker CA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.131801; Deng WT, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.044907; Fukushima K, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.074033; GARWIN RL, 1957, PHYS REV, V105, P1415, DOI 10.1103/PhysRev.105.1415; Khachatryan V, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.122301; Schukraft J, 2013, PHYS LETT B, V719, P394, DOI 10.1016/j.physletb.2013.01.045; Voloshin SA, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.057901; WU CS, 1957, PHYS REV, V105, P1413, DOI 10.1103/PhysRev.105.1413	15	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					477	479		10.1038/nature23086	http://dx.doi.org/10.1038/nature23086			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28614304				2022-12-28	WOS:000403814100024
J	Jung, HJ; Pamer, EG				Jung, Hea-Jin; Pamer, Eric G.			Bacterial pathogens: A spoonful of sugar could be the medicine	NATURE			English	Editorial Material									[Jung, Hea-Jin; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Ctr Microbes Inflammat & Canc, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.	pamere@mskcc.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI124275] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI124275] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Krachler AM, 2013, VIRULENCE, V4, P284, DOI 10.4161/viru.24606; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Ringot-Destrez B, 2017, BIOCHEM SOC T, V45, P389, DOI 10.1042/BST20160167; Spaulding CN, 2017, NATURE, V546, P528, DOI 10.1038/nature22972; Ventola C Lee, 2015, P T, V40, P277	8	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					479	+		10.1038/nature23084	http://dx.doi.org/10.1038/nature23084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28614303	Green Accepted			2022-12-28	WOS:000403814100025
J	Vanjani, R				Vanjani, Rahul			On Incarceration and Health - Reframing the Discussion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vanjani, Rahul] San Quentin State Prison, San Quentin, CA 94964 USA		Vanjani, R (corresponding author), San Quentin State Prison, San Quentin, CA 94964 USA.		Vanjani, Rahul/AGW-0775-2022	Vanjani, Rahul/0000-0001-5774-317X				Marmot M, 2004, STATUS SYNDROME; Noonan M, 2015, BJS PUBLICATION; Travis J, 2014, GROWTH OF INCARCERATION IN THE UNITED STATES: EXPLORING CAUSES AND CONSEQUENCES, P320	3	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2411	2413		10.1056/NEJMp1702373	http://dx.doi.org/10.1056/NEJMp1702373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY2BW	28636856				2022-12-28	WOS:000403774400004
J	Venook, AP; Niedzwiecki, D; Lenz, HJ; Innocenti, F; Fruth, B; Meyerhardt, JA; Schrag, D; Greene, C; O'Neil, BH; Atkins, JN; Berry, S; Polite, BN; O'Reilly, EM; Goldberg, RM; Hochster, HS; Schilsky, RL; Bertagnolli, MM; El-Khoueiry, AB; Watson, P; Benson, A; Mulkerin, DL; Mayer, RJ; Blanke, C				Venook, Alan P.; Niedzwiecki, Donna; Lenz, Heinz-Josef; Innocenti, Federico; Fruth, Briant; Meyerhardt, Jeffrey A.; Schrag, Deborah; Greene, Claire; O'Neil, Bert H.; Atkins, James Norman; Berry, Scott; Polite, Blase N.; O'Reilly, Eileen M.; Goldberg, Richard M.; Hochster, Howard S.; Schilsky, Richard L.; Bertagnolli, Monica M.; El-Khoueiry, Anthony B.; Watson, Peter; Benson, Al B., III; Mulkerin, Daniel L.; Mayer, Robert J.; Blanke, Charles			Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLFIRI PLUS CETUXIMAB; PHASE-II; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; IRINOTECAN; PROGRESSION; THERAPY; FIRE-3; TUMORS	IMPORTANCE Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with advanced or metastatic colorectal cancer, but the optimal choice of the initial biologic therapy in previously untreated patients is unknown. OBJECTIVE To determine if the addition of cetuximab vs bevacizumab to the combination of leucovorin, fluorouracil, and oxaliplatin (mFOLFOX6) regimen or the combination of leucovorin, fluorouracil, and irinotecan (FOLFIRI) regimen is superior as first-line therapy in advanced or metastatic KRAS wild-type (wt) colorectal cancer. DESIGN, SETTING, AND PARTICIPANTS Patients (>= 18 years) enrolled at community and academic centers throughout the National Clinical Trials Network in the United States and Canada (November 2005-March 2012) with previously untreated advanced or metastatic colorectal cancer whose tumors were KRAS wt chose to take either the mFOLFOX6 regimen or the FOLFIRI regimen as chemotherapy and were randomized to receive either cetuximab (n = 578) or bevacizumab (n = 559). The last date of follow-up was December 15, 2015. INTERVENTIONS Cetuximab vs bevacizumab combined with either mFOLFOX6 or FOLFIRI chemotherapy regimen chosen by the treating physician and patient. MAIN OUTCOMES AND MEASURES The primary end pointwas overall survival. Secondary objectives included progression-free survival and overall response rate, site-reported confirmed or unconfirmed complete or partial response. RESULTS Among 1137 patients (median age, 59 years; 440 [39%] women), 1074 (94%) of patients met eligibility criteria. As of December 15, 2015, median follow-up for 263 surviving patients was 47.4 months (range, 0-110.7 months), and 82% of patients (938 of 1137) experienced disease progression. The median overall survival was 30.0 months in the cetuximab-chemotherapy group and 29.0 months in the bevacizumab-chemotherapy group with a stratified hazard ratio (HR) of 0.88 (95% CI, 0.77-1.01; P =.08). The median progression-free survival was 10.5 months in the cetuximab-chemotherapy group and 10.6 months in the bevacizumab-chemotherapy group with a stratified HR of 0.95 (95% CI, 0.84-1.08; P =.45). Response rates were not significantly different, 59.6% vs 55.2% for cetuximab and bevacizumab, respectively (difference, 4.4%, 95% CI, 1.0%-9.0%, P =.13). CONCLUSIONS AND RELEVANCE Among patients with KRAS wt untreated advanced or metastatic colorectal cancer, there was no significant difference in overall survival between the addition of cetuximab vs bevacizumab to chemotherapy as initial biologic treatment.	[Venook, Alan P.; Greene, Claire] Univ Calif San Francisco, 1450 Third St,HD 376, San Francisco, CA 94158 USA; [Niedzwiecki, Donna] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Niedzwiecki, Donna] Duke Univ, Med Ctr, Alliance Stat & Data Ctr, Durham, NC USA; [Lenz, Heinz-Josef; El-Khoueiry, Anthony B.] Univ Southern Calif, Los Angeles, CA USA; [Innocenti, Federico] Univ N Carolina, Chapel Hill, NC USA; [Fruth, Briant] Mayo Clin, Ctr Canc, Alliance Stat & Data Ctr, Rochester, MN USA; [Meyerhardt, Jeffrey A.; Schrag, Deborah; Mayer, Robert J.] Dana Farber Partners CancerCare, Boston, MA USA; [O'Neil, Bert H.] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Atkins, James Norman] Natl Surg Adjuvant Breast & Bowel Project NRG Onc, Goldsboro, NC USA; [Atkins, James Norman] Southeastern Med Oncol Ctr, Goldsboro, NC USA; [Berry, Scott] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Polite, Blase N.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [O'Reilly, Eileen M.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Goldberg, Richard M.] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA; [Hochster, Howard S.] Yale Univ, Sch Med, Dept Med Oncol, New Haven, CT USA; [Schilsky, Richard L.] Amer Soc Clin Oncol, Alexandria, VA USA; [Bertagnolli, Monica M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Watson, Peter] Kinston Med Specialists PA, Lenoir Mem Hosp, Kinston, NC USA; [Benson, Al B., III] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Mulkerin, Daniel L.] Univ Wisconsin, Madison, WI 53706 USA; [Blanke, Charles] Oregon Hlth & Sci Univ, Southwest Oncol Grp Chairs Off, Portland, OR 97201 USA; [Blanke, Charles] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	University of California System; University of California San Francisco; Duke University; Duke University; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Harvard University; Dana-Farber Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Memorial Sloan Kettering Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Yale University; American Society of Clinical Oncology; Harvard University; Brigham & Women's Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; Southwest Oncology Group; Oregon Health & Science University	Venook, AP (corresponding author), Univ Calif San Francisco, 1450 Third St,HD 376, San Francisco, CA 94158 USA.	alan.venook@ucsf.edu	Innocenti, Federico/G-3206-2018; Goldberg, Richard/O-1871-2017	Goldberg, Richard/0000-0003-3713-6895; O'Reilly, Eileen M./0000-0002-8076-9199; Niedzwiecki, Donna/0000-0002-3566-0450	National Cancer Institute of the National Institutes of Health [U10CA180821, U10CA180882, U10CA180790, U10CA180791, U10CA180795, U10CA180799, U10CA180830, U10CA180836, U10CA180838, U10CA180850, U10CA180867, U10CA180888]; Eli Lilly and Company; Genentech; Pfizer Inc; Sanofi; NATIONAL CANCER INSTITUTE [U10CA180836, U10CA180820, U10CA180888, U10CA180795, U10CA180838, U10CA180791, K05CA169384, U10CA180867, U10CA180799, R01CA149222, U10CA180821, U10CA180850, U10CA180790, U10CA180830, U10CA180882] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eli Lilly and Company(Eli Lilly); Genentech(Roche HoldingGenentech); Pfizer Inc(Pfizer); Sanofi(Sanofi-Aventis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health by grants U10CA180821 and U10CA180882 (to the Alliance for Clinical Trials in Oncology), U10CA180790 (Mayo Clinic), U10CA180791 (Memorial Sloan-Kettering), U10CA180795 (Indiana University), U10CA180799 (University of Wisconsin), U10CA180830 (USC Norris Cancer Hospital), U10CA180836 (University of Chicago), U10CA180838 (University of North Carolina), U10CA180850 (Ohio State University), U10CA180867 (Dana-Farber Cancer Institute), and U10CA180888 (Southwest Oncology Group). The trial was also supported in part by Eli Lilly and Company, Genentech, Pfizer Inc, and Sanofi.	Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Heinemann V, OUTCOMES FOLFIRI PLU; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Modest DP, 2015, J CLIN ONCOL, V33, P3718, DOI 10.1200/JCO.2015.61.2887; O'Neil BH, 2015, J CLIN ONCOL, V33, P3686, DOI 10.1200/JCO.2015.62.8495; ODWYER PJ, 1990, J CLIN ONCOL, V8, P1497, DOI 10.1200/JCO.1990.8.9.1497; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; PIEDBOIS P, 1992, J CLIN ONCOL, V10, P896; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Shi Q, 2015, J CLIN ONCOL, V33, P22, DOI 10.1200/JCO.2014.56.5887; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Venook AP, IMPACT PRIMARY 1 TUM	24	510	520	3	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2392	2401		10.1001/jama.2017.7105	http://dx.doi.org/10.1001/jama.2017.7105			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632865	Green Accepted, Bronze			2022-12-28	WOS:000403654600013
J	[Anonymous]				[Anonymous]			Breast cancer targeted therapy: successes and challenges	LANCET			English	Editorial Material																			0	33	33	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2350	2350		10.1016/S0140-6736(17)31662-8	http://dx.doi.org/10.1016/S0140-6736(17)31662-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	28635596	Bronze			2022-12-28	WOS:000403334400005
J	Pennisi, E				Pennisi, Elizabeth			Mini-livers reveal fine details of organ development	SCIENCE			English	News Item																			0	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1109	1109		10.1126/science.356.6343.1109	http://dx.doi.org/10.1126/science.356.6343.1109			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619892				2022-12-28	WOS:000403327400007
J	Denic, A; Mathew, J; Lerman, LO; Lieske, JC; Larson, JJ; Alexander, MP; Poggio, E; Glassock, RJ; Rule, AD				Denic, Aleksandar; Mathew, Jerry; Lerman, Lilach O.; Lieske, John C.; Larson, Joseph J.; Alexander, Mariam P.; Poggio, Emilio; Glassock, Richard J.; Rule, Andrew D.			Single-Nephron Glomerular Filtration Rate in Healthy Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIVING KIDNEY DONORS; RENAL-FUNCTION; RISK-FACTORS; HYPERTENSION; OBESITY; HYPERTROPHY; ASSOCIATION; NUMBER; GLOMERULOSCLEROSIS; NEPHROSCLEROSIS	BACKGROUND The glomerular filtration rate (GFR) assesses the function of all nephrons, and the single-nephron GFR assesses the function of individual nephrons. How the single-nephron GFR relates to demographic and clinical characteristics and kidney-biopsy findings in humans is unknown. METHODS We identified 1388 living kidney donors at the Mayo Clinic and the Cleveland Clinic who underwent a computed tomographic (CT) scan of the kidney with the use of contrast material and an iothalamate-based measurement of the GFR during donor evaluation and who underwent a kidney biopsy at donation. The mean single-nephron GFR was calculated as the GFR divided by the number of nephrons (calculated as the cortical volume of both kidneys as assessed on CT times the biopsy-determined glomerular density). Demographic and clinical characteristics and biopsy findings were correlated with the single-nephron GFR. RESULTS A total of 58% of the donors were women, and the mean (+/- SD) age of the donors was 44 +/- 12 years. The mean GFR was 115 +/- 24 ml per minute, the mean number of nephrons was 860,000 +/- 370,000 per kidney, and the mean single-nephron GFR was 80 +/- 40 nl per minute. The single-nephron GFR did not vary significantly according to age (among donors <70 years of age), sex, or height (among donors <= 190 cm tall). A higher single-nephron GFR was independently associated with larger nephrons on biopsy and more glomerulosclerosis and arteriosclerosis than would be expected for age. A higher single-nephron GFR was associated with a height of more than 190 cm, obesity, and a family history of end-stage renal disease. CONCLUSIONS Among healthy adult kidney donors, the single-nephron GFR was fairly constant with regard to age, sex, and height (if <= 190 cm). A higher single-nephron GFR was associated with certain risk factors for chronic kidney disease and certain kidneybiopsy findings. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.)	[Denic, Aleksandar; Mathew, Jerry; Lerman, Lilach O.; Lieske, John C.; Rule, Andrew D.] Mayo Clin, Div Nephrol, Rochester, MN USA; [Denic, Aleksandar; Mathew, Jerry; Lerman, Lilach O.; Lieske, John C.; Rule, Andrew D.] Mayo Clin, Div Hypertens, Rochester, MN USA; [Larson, Joseph J.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Rule, Andrew D.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Lieske, John C.; Alexander, Mariam P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Poggio, Emilio] Cleveland Clin, Dept Nephrol, Cleveland, OH 44106 USA; [Glassock, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rule, AD (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	rule.andrew@mayo.edu	Lieske, John/ABA-4829-2020; Lerman, Lilach/M-4962-2017	Denic, Aleksandar/0000-0001-9157-5405; Liakopoulos, Vassilios/0000-0002-7564-2724; Zarogiannis, Sotirios/0000-0002-3083-3244	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090358, R01DK100081] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.	Bertram JF, 2001, KIDNEY INT, V59, P792, DOI 10.1046/j.1523-1755.2001.059002792.x; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; BRENNER BM, 1968, J CLIN INVEST, V47, P1358, DOI 10.1172/JCI105828; BRENNER BM, 1972, AM J PHYSIOL, V223, P1184, DOI 10.1152/ajplegacy.1972.223.5.1184; BRENNER BM, 1972, YALE J BIOL MED, V45, P200; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; Denic A, 2017, J AM SOC NEPHROL, V28, P313, DOI 10.1681/ASN.2016020154; Denic A, 2016, AM J KIDNEY DIS, V68, P58, DOI 10.1053/j.ajkd.2015.12.029; Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004; Eide MG, 2005, EPIDEMIOLOGY, V16, P175, DOI 10.1097/01.ede.0000152524.89074.bf; Elsherbiny HE, 2014, CLIN J AM SOC NEPHRO, V9, P1892, DOI 10.2215/CJN.02560314; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; Fulladosa X, 2003, J AM SOC NEPHROL, V14, P2662, DOI 10.1097/01.ASN.0000088025.33462.B0; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; HAYSLETT JP, 1968, J CLIN INVEST, V47, P774, DOI 10.1172/JCI105772; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; HORSTER M, 1971, J CLIN INVEST, V50, P779, DOI 10.1172/JCI106549; HORSTER M, 1968, PFLUG ARCH EUR J PHY, V301, P162, DOI 10.1007/BF00362733; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Hoy WE, 2010, J DEV ORIG HLTH DIS, V1, P216, DOI 10.1017/S204017441000022X; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06.007; Lenihan CR, 2015, J CLIN INVEST, V125, P1311, DOI 10.1172/JCI78885; Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401; Melsom T, 2016, CLIN J AM SOC NEPHRO, V11, P2186, DOI 10.2215/CJN.04940516; Poggio ED, 2009, KIDNEY INT, V75, P1079, DOI 10.1038/ki.2009.11; Rule AD, 2013, KIDNEY INT, V83, P1169, DOI 10.1038/ki.2013.7; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Tan JC, 2010, KIDNEY INT, V78, P686, DOI 10.1038/ki.2010.128; Wang XX, 2015, J AM SOC NEPHROL, V26, P1634, DOI 10.1681/ASN.2014040328	31	174	174	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2349	2357		10.1056/NEJMoa1614329	http://dx.doi.org/10.1056/NEJMoa1614329			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4UQ	28614683	Green Accepted, Bronze			2022-12-28	WOS:000403230800008
J	Keren-Shaul, H; Spinrad, A; Weiner, A; Matcovitch-Natan, O; Dvir-Szternfeld, R; Ulland, TK; David, E; Baruch, K; Lara-Astaiso, D; Toth, B; Itzkovitz, S; Colonna, M; Schwartz, M; Amit, I				Keren-Shaul, Hadas; Spinrad, Amit; Weiner, Assaf; Matcovitch-Natan, Orit; Dvir-Szternfeld, Raz; Ulland, Tyler K.; David, Eyal; Baruch, Kuti; Lara-Astaiso, David; Toth, Beata; Itzkovitz, Shalev; Colonna, Marco; Schwartz, Michal; Amit, Ido			A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease	CELL			English	Article							CELL RNA-SEQ; GENE-EXPRESSION SIGNATURE; CENTRAL-NERVOUS-SYSTEM; SINGLE-CELL; MOUSE MODEL; TREM2 VARIANTS; NEURODEGENERATIVE DISEASE; REGULATORY LANDSCAPE; P2Y(12) RECEPTOR; PLAQUE-FORMATION	Alzheimer's disease (AD) is a detrimental neurodegenerative disease with no effective treatments. Due to cellular heterogeneity, defining the roles of immune cell subsets in AD onset and progression has been challenging. Using transcriptional single-cell sorting, we comprehensively map all immune populations in wild-type and AD-transgenic (Tg-AD) mouse brains. We describe a novel microglia type associated with neurodegenerative diseases (DAM) and identify markers, spatial localization, and pathways associated with these cells. Immunohistochemical staining of mice and human brain slices shows DAM with intracellular/phagocytic A beta particles. Single-cell analysis of DAM in Tg-AD and triggering receptor expressed on myeloid cells 2 (Trem2)(-/-) Tg-AD reveals that the DAM program is activated in a two-step process. Activation is initiated in a Trem2-independent manner that involves downregulation of microglia checkpoints, followed by activation of a Trem2-dependent program. This unique microglia-type has the potential to restrict neurodegeneration, which may have important implications for future treatment of AD and other neurodegenerative diseases.	[Keren-Shaul, Hadas; Spinrad, Amit; Weiner, Assaf; Matcovitch-Natan, Orit; David, Eyal; Lara-Astaiso, David; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Spinrad, Amit; Matcovitch-Natan, Orit; Dvir-Szternfeld, Raz; Baruch, Kuti; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-7610001 Rehovot, Israel; [Weiner, Assaf] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CG Utrecht, Netherlands; [Weiner, Assaf] Univ Med Ctr, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands; [Ulland, Tyler K.; Colonna, Marco] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Toth, Beata; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Washington University (WUSTL); Weizmann Institute of Science	Weiner, A; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel.; Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-7610001 Rehovot, Israel.; Weiner, A (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CG Utrecht, Netherlands.; Weiner, A (corresponding author), Univ Med Ctr, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands.	assaf.weiner@weizmann.ac.il; michal.schwartz@weizmann.ac.il; ido.amit@weizmann.ac.il	zhang, chuengji/AAD-4591-2020	Ulland, Tyler/0000-0002-6507-4989; Spinrad, Amit/0000-0003-0158-6464	NIH [RF1AG05148501, 5T32CA009547-30]; Advanced European Research Council [232835]; EU Seventh Framework Program HEALTH [279017]; Israel Science Foundation (ISF)-Legacy-Bio-Med program [1354/15]; Minerva Foundation; ISF-Neurology [991/16]; HHMI International Scholar award; European Research Council Consolidator Grant (ERC-COG) [724471-HemTree2.0]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space; David and Fela Shapell Family Foundation; NeuroMac DFG/Transregional Collaborative Research Center Grant; Abramson Family Center for Young Scientists; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced European Research Council(European Research Council (ERC)); EU Seventh Framework Program HEALTH; Israel Science Foundation (ISF)-Legacy-Bio-Med program; Minerva Foundation; ISF-Neurology; HHMI International Scholar award(Howard Hughes Medical Institute); European Research Council Consolidator Grant (ERC-COG); Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space; David and Fela Shapell Family Foundation; NeuroMac DFG/Transregional Collaborative Research Center Grant; Abramson Family Center for Young Scientists; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Genia Brodsky for help with the artwork. We thank M. Esiri and A. Troen for their help in obtaining human brain sections. This work was funded by NIH grants RF1AG05148501 (M.C.) and 5T32CA009547-30 (T.K.U.). M.S. is supported by the Advanced European Research Council (232835), by the EU Seventh Framework Program HEALTH-2011 (279017), Israel Science Foundation (ISF)-Legacy-Bio-Med program (1354/15), the Minerva Foundation, and ISF-Neurology (991/16). M.S. holds the Maurice and Ilse Katz Professorial Chair in Neuroimmunology. I. A. is supported by the HHMI International Scholar award, the European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0, the Israel Science Foundation (703/15), the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine, the Helen and Martin Kimmel award for innovative investigation, a Minerva Stiftung research grant, the Israeli Ministry of Science, Technology, and Space, the David and Fela Shapell Family Foundation, the NeuroMac DFG/Transregional Collaborative Research Center Grant, and the Abramson Family Center for Young Scientists. I. A. is the incumbent of the Alan and Laraine Fischer Career Development Chair. A patent application has been filed related to this work.	Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Baum L, 1999, AM J MED GENET, V88, P136, DOI 10.1002/(SICI)1096-8628(19990416)88:2<136::AID-AJMG8>3.0.CO;2-D; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deardorff WJ, 2017, EXPERT REV NEUROTHER, V17, P17, DOI 10.1080/14737175.2016.1200972; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Koronyo Y, 2015, BRAIN, V138, P2399, DOI 10.1093/brain/awv150; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lai AY, 2012, FUTUR NEUROL, V7, P165, DOI 10.2217/FNL.12.6; Landel V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-33; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lauro C, 2015, ANN NY ACAD SCI, V1351, P141, DOI 10.1111/nyas.12805; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Ma J, 2015, MOL NEUROBIOL, V51, P820, DOI 10.1007/s12035-014-8811-9; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McCombe PA, 2011, CURR MOL MED, V11, P246; Merino JJ, 2016, CURR ALZHEIMER RES, V13, P403, DOI 10.2174/1567205013666151116125714; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Painter MM, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0040-9; Paz-y-Mino CA, 2015, AM J MED SCI, V350, P296, DOI 10.1097/MAJ.0000000000000555; Pottier C, 2016, NEUROBIOL AGING, V48, DOI 10.1016/j.neurobiolaging.2016.07.028; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Rajamohamedsait HB, 2012, METHODS MOL BIOL, V849, P411, DOI 10.1007/978-1-61779-551-0_28; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Scacchi R, 2004, NEUROSCI LETT, V367, P177, DOI 10.1016/j.neulet.2004.05.111; Schlegelmilch T, 2011, CURR OPIN NEUROBIOL, V21, P5, DOI 10.1016/j.conb.2010.08.004; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Tejera D, 2016, CURR ALZHEIMER RES, V13, P370, DOI 10.2174/1567205013666151116125012; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Winter DR, 2015, NAT REV IMMUNOL, V15, P585, DOI 10.1038/nri3884; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	88	1883	1921	27	467	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1276	+		10.1016/j.cell.2017.05.018	http://dx.doi.org/10.1016/j.cell.2017.05.018			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28602351	Bronze			2022-12-28	WOS:000403332400016
J	Nozawa, RS; Boteva, L; Soares, DC; Naughton, C; Dun, AR; Buckle, A; Ramsahoye, B; Bruton, PC; Saleeb, RS; Arnedo, M; Hill, B; Duncan, RR; Maciver, SK; Gilbert, N				Nozawa, Ryu-Suke; Boteva, Lora; Soares, Dinesh C.; Naughton, Catherine; Dun, Alison R.; Buckle, Adam; Ramsahoye, Bernard; Bruton, Peter C.; Saleeb, Rebecca S.; Arnedo, Maria; Hill, Bill; Duncan, Rory R.; Maciver, Sutherland K.; Gilbert, Nick			SAF-A Regulates Interphase Chromosome Structure through Oligomerization with Chromatin-Associated RNAs	CELL			English	Article							SCAFFOLD ATTACHMENT FACTOR; HNRNP U-PROTEIN; NUCLEAR-MATRIX; HUMAN GENOME; IN-VIVO; BINDING; ARCHITECTURE; REVEALS; ORIGIN; GENE	Higher eukaryotic chromosomes are organized into topologically constrained functional domains; however, the molecular mechanisms required to sustain these complex interphase chromatin structures are unknown. A stable matrix underpinning nuclear organization was hypothesized, but the idea was abandoned as more dynamic models of chromatin behavior became prevalent. Here, we report that scaffold attachment factor A (SAF-A), originally identified as a structural nuclear protein, interacts with chromatin-associated RNAs (caRNAs) via its RGG domain to regulate human interphase chromatin structures in a transcription-dependent manner. Mechanistically, this is dependent on SAF-A's AAA(+) ATPase domain, which mediates cycles of protein oligomerization with caRNAs, in response to ATP binding and hydrolysis. SAF-A oligomerization decompacts large-scale chromatin structure while SAF-A loss or monomerization promotes aberrant chromosome folding and accumulation of genome damage. Our results show that SAF-A and caRNAs form a dynamic, transcriptionally responsive chromatin mesh that organizes large-scale chromosome structures and protects the genome from instability.	[Nozawa, Ryu-Suke; Boteva, Lora; Soares, Dinesh C.; Naughton, Catherine; Buckle, Adam; Bruton, Peter C.; Arnedo, Maria; Hill, Bill; Gilbert, Nick] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Ramsahoye, Bernard] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Maciver, Sutherland K.] Univ Edinburgh, Edinburgh Med Sch, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland; [Dun, Alison R.; Saleeb, Rebecca S.; Duncan, Rory R.] Heriot Watt Univ, Edinburgh Super Resolut Imaging Consortium, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; Heriot Watt University	Gilbert, N (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	nick.gilbert@ed.ac.uk	Arnedo, Maria/ABF-8821-2020; Maciver, Sutherland Kester/H-6284-2019; Soares, Dinesh/A-4425-2012	Arnedo, Maria/0000-0001-9962-2157; Maciver, Sutherland Kester/0000-0001-8234-6061; Soares, Dinesh/0000-0001-7557-0495; Naughton, Catherine/0000-0002-9576-5983; Gilbert, Nick/0000-0003-0505-6081; Duncan, Rory/0000-0003-0693-910X; buckle, adam/0000-0002-9861-6959	UK Medical Research Council senior non-clinical fellowship [MR/J00913X/1]; Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS); Medical Research Council [MR/K01563X/1, MR/J00913X/1, 1232345, 1233358] Funding Source: researchfish; MRC [MR/K01563X/1, MR/J00913X/1] Funding Source: UKRI	UK Medical Research Council senior non-clinical fellowship; Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Shelagh Boyle for help with microscopy and image analysis, David Lleres for advice on FLIM-FRET, Wendy Bickmore, Javier Caceres, and Nick Hastie for helpful discussions and comments on the manuscript. This work was funded by a UK Medical Research Council senior non-clinical fellowship (MR/J00913X/1) to N.G., and R.-S.N. was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS).	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Armit C, 2015, MAMM GENOME, V26, P431, DOI 10.1007/s00335-015-9596-5; Belmont AS, 2014, CURR OPIN CELL BIOL, V26, P69, DOI 10.1016/j.ceb.2013.10.002; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Brackley CA, 2016, NUCLEIC ACIDS RES, V44, P3503, DOI 10.1093/nar/gkw135; Britton S, 2014, NUCLEIC ACIDS RES, V42, P9047, DOI 10.1093/nar/gku601; Caudron-Herger M, 2012, CURR OPIN GENET DEV, V22, P179, DOI 10.1016/j.gde.2011.12.005; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Douglas P, 2015, MOL CELL BIOL, V35, P2699, DOI 10.1128/MCB.01312-14; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; FEY EG, 1986, J CELL SCI, P99; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Ghanbarian AT, 2015, MOL BIOL EVOL, V32, P1748, DOI 10.1093/molbev/msv053; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hall LL, 2016, CURR OPIN GENET DEV, V37, P137, DOI 10.1016/j.gde.2016.04.005; Hall LL, 2014, CELL, V156, P907, DOI 10.1016/j.cell.2014.01.042; Hancock R, 2000, CHROMOSOMA, V109, P219, DOI 10.1007/s004120000077; Helbig R, 2003, CHROMOSOMA, V112, P173, DOI 10.1007/s00412-003-0258-0; HOLMES DS, 1972, SCIENCE, V177, P72, DOI 10.1126/science.177.4043.72; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lleres D, 2017, CELL REP, V18, P1791, DOI 10.1016/j.celrep.2017.01.043; Ma H, 1999, J CELL BIOL, V146, P531, DOI 10.1083/jcb.146.3.531; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mele M, 2016, MOL CELL, V62, P657, DOI 10.1016/j.molcel.2016.05.011; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Nozawa RS, 2014, CELL, V156, P864, DOI 10.1016/j.cell.2014.02.005; Pederson T, 1998, J MOL BIOL, V277, P147, DOI 10.1006/jmbi.1997.1618; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Roshon MJ, 2005, TRANSGENIC RES, V14, P179, DOI 10.1007/s11248-004-8147-8; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Ye JQ, 2015, P NATL ACAD SCI USA, V112, pE3020, DOI 10.1073/pnas.1508461112	58	90	92	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1214	+		10.1016/j.cell.2017.05.029	http://dx.doi.org/10.1016/j.cell.2017.05.029			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622508	Green Published, hybrid			2022-12-28	WOS:000403332400011
J	Stafford, N				Stafford, Ned			Stefania Jablonska OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de						Beutner EH, 2002, J AM ACAD DERMATOL, V47, P841, DOI 10.1067/mjd.2002.123486; JABLONSKA S, 1955, Bull Soc Fr Dermatol Syphiligr, P316; JABLONSKA S, PUBLICATION LIST; RODNAN GP, 1974, BRIT MED J, V1, P246, DOI 10.1136/bmj.1.5901.246-a; 1963, BMJ, V2, P196; 1983, BMJ-BRIT MED J, P357, DOI DOI 10.1136/BMJ.2.5351; 1976, BMJ, V357	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2017	357								j2891	10.1136/bmj.j2891	http://dx.doi.org/10.1136/bmj.j2891			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UX	28619843				2022-12-28	WOS:000403753800013
J	Sheather, J; Perache, AH				Sheather, Julian; Perache, Andre Heller			Medicine is still a victim of war: we desperately need new ideas	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheather, Julian] BMA, London, England; [Perache, Andre Heller] Med Sans Frontieres UK, London, England		Sheather, J (corresponding author), BMA, London, England.	jsheather@bma.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2017	357								j2805	10.1136/bmj.j2805	http://dx.doi.org/10.1136/bmj.j2805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UT	28615168				2022-12-28	WOS:000403753400002
J	Tzahor, E; Poss, KD				Tzahor, Eldad; Poss, Kenneth D.			Cardiac regeneration strategies: Staying young at heart	SCIENCE			English	Review							CARDIOMYOCYTE PROLIFERATION; DEFINED FACTORS; STEM-CELLS; FIBROBLASTS; ZEBRAFISH; MICE; DEDIFFERENTIATION; PREADOLESCENCE; GENERATION; RENEWAL	The human heart is continually operating as a muscular pump, contracting, on average, 80 times per minute to propel 8000 liters of blood through body tissues each day. Whereas damaged skeletal muscle has a profound capacity to regenerate, heart muscle, at least in mammals, has poor regenerative potential. This deficiency is attributable to the lack of resident cardiac stem cells, combined with roadblocks that limit adult cardiomyocytes from entering the cell cycle and completing division. Insights for regeneration have recently emerged from studies of animals with an elevated innate capacity for regeneration, the innovation of stem cell and reprogramming technologies, and a clearer understanding of the cardiomyocyte genetic program and key extrinsic signals. Methods to augment heart regeneration now have potential to counteract the high morbidity and mortality of cardiovascular disease.	[Tzahor, Eldad] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Poss, Kenneth D.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Poss, Kenneth D.] Duke Univ, Regenerat Next, Durham, NC 27710 USA	Weizmann Institute of Science; Duke University; Duke University	Tzahor, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.; Poss, KD (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.; Poss, KD (corresponding author), Duke Univ, Regenerat Next, Durham, NC 27710 USA.	eldad.tzahor@weizmann.ac.il; kenneth.poss@duke.edu	TZAHOR, ELDAD/AAD-9886-2021	Tzahor, Eldad/0000-0002-5212-9426; Poss, Kenneth/0000-0002-6743-5709	Fondation Leducq Transatlantic Network of Excellence; European Research Council; Israel Science Foundation; Britain Israel Research and Academic Exchange Partnership; European Research Area Network on Cardiovascular Diseases; American Heart Association [16MERIT27940012]; National, Heart, Lung, and Blood Institute [R01 HL081674, R01 HL131319, R01 HL136182]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131319, R01HL081674, R01HL136182] Funding Source: NIH RePORTER	Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Britain Israel Research and Academic Exchange Partnership; European Research Area Network on Cardiovascular Diseases; American Heart Association(American Heart Association); National, Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Bassat and A. Dickson for figures and M. Foglia, R. Karra, R. Harvey, P. Riley, and N. Bursac for comments on the manuscript. We apologize to our colleagues in the field for omitted citations of original reports due to restrictions on space and number of references. E.T. and K.D.P. are supported by a Fondation Leducq Transatlantic Network of Excellence. E.T. acknowledges support from the European Research Council, the Israel Science Foundation, the Britain Israel Research and Academic Exchange Partnership, and the European Research Area Network on Cardiovascular Diseases. K.D.P. acknowledges support from the American Heart Association (grant 16MERIT27940012) and the National, Heart, Lung, and Blood Institute (grants R01 HL081674, R01 HL131319, and R01 HL136182).	Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Bassat E, 2017, NATURE, V547, P179, DOI 10.1038/nature22978; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Cao N, 2016, SCIENCE, V352, P1216, DOI 10.1126/science.aaf1502; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Goldman JA, 2017, DEV CELL, V40, P392, DOI 10.1016/j.devcel.2017.01.013; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Keith MCL, 2015, CIRC RES, V116, P1216, DOI 10.1161/CIRCRESAHA.116.305557; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kimura W, 2015, NATURE, V523, P226, DOI 10.1038/nature14582; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lalit PA, 2016, CELL STEM CELL, V18, P354, DOI 10.1016/j.stem.2015.12.001; Lenihan Daniel J, 2016, JACC Basic Transl Sci, V1, P576, DOI 10.1016/j.jacbts.2016.09.005; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Lin ZQ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006681; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morikawa Y, 2017, NATURE, V547, P227, DOI 10.1038/nature22979; Morikawa Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005781; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Ogle BM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad2304; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Reuter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115871; Santini MP, 2016, DEVELOPMENT, V143, P1242, DOI 10.1242/dev.111591; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815; Soonpaa MH, 2015, CELL, V163, P781, DOI 10.1016/j.cell.2015.10.037; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Wang JH, 2015, NATURE, V522, P226, DOI 10.1038/nature14325; Yahalom-Ronen Y, 2015, ELIFE, V4, DOI [10.7554/eLife.07455.001, 10.7554/eLife.07455]; Zebrowski DC, 2015, ELIFE, V4, DOI 10.7554/eLife.05563	51	190	199	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1035	1039		10.1126/science.aam5894	http://dx.doi.org/10.1126/science.aam5894			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596337	Green Accepted			2022-12-28	WOS:000402871700043
J	Ciezarek, G; Sevilla, MF; Hamilton, B; Kowalewski, R; Kuhr, T; Luth, V; Sato, Y				Ciezarek, Gregory; Sevilla, Manuel Franco; Hamilton, Brian; Kowalewski, Robert; Kuhr, Thomas; Lueth, Vera; Sato, Yutaro			A challenge to lepton universality in B-meson decays	NATURE			English	Review							PROTON-PROTON COLLISIONS; CP-VIOLATION; SEARCH; LEPTOQUARKS; MASS; DETECTOR; ENERGY; RATIO; BOSON; W'	One of the key assumptions of the standard model of particle physics is that the interactions of the charged leptons, namely electrons, muons and taus, differ only because of their different masses. Whereas precision tests comparing processes involving electrons and muons have not revealed any definite violation of this assumption, recent studies of B-meson decays involving the higher-mass tau lepton have resulted in observations that challenge lepton universality at the level of four standard deviations. A confirmation of these results would point to new particles or interactions, and could have profound implications for our understanding of particle physics.	[Ciezarek, Gregory] Nikhef Natl Inst Subat Phys, Amsterdam, Netherlands; [Sevilla, Manuel Franco] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Hamilton, Brian] Univ Maryland, College Pk, MD 20742 USA; [Kowalewski, Robert] Univ Victoria, Victoria, BC V8P 5C2, Canada; [Kuhr, Thomas] Ludwig Maximilians Univ Munchen, D-80539 Munich, Germany; [Lueth, Vera] SLAC Natl Accelerator Lab, Stanford, CA 94309 USA; [Sato, Yutaro] Nagoya Univ, Kobayashi Maskawa Inst, Nagoya, Aichi 4648602, Japan	FOM National Institute for Subatomic Physics; University of California System; University of California Santa Barbara; University System of Maryland; University of Maryland College Park; University of Victoria; University of Munich; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Nagoya University	Luth, V (corresponding author), SLAC Natl Accelerator Lab, Stanford, CA 94309 USA.	luth@slac.stanford.edu	Sato, Yutaro/G-9595-2019	Sato, Yutaro/0000-0002-4430-5290; Franco Sevilla, Manuel/0000-0002-5250-2948; Kowalewski, Robert/0000-0002-7314-0990	Organisation for Scientific Research (NWO) of the Netherlands; US National Science Foundation; Department of Energy; Natural Sciences and Engineering Research Council (NSERC) of Canada; Excellence Cluster of the DFG of Germany: Origin and Structure of the Universe; Japan Society for the Promotion of Science (JSPS)	Organisation for Scientific Research (NWO) of the Netherlands; US National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Excellence Cluster of the DFG of Germany: Origin and Structure of the Universe(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	recognize the contributions and dedication of our colleagues in the large international collaborations supporting the operation of the BaBar (M.F.S., R.K., V.L.), Belle (T.K., Y.S.) and LHCb (G.C., B.H.) detectors, the data processing and the data analyses on which the results presented in this Review are based. None of this would have been achieved without the efforts of the teams at SLAC, KEK and CERN who achieved excellent beam conditions and delivered high luminosities of the e<SUP>+</SUP>e<SUP>-</SUP> and pp storage rings over many years. We acknowledge support from the Organisation for Scientific Research (NWO) of the Netherlands, the US National Science Foundation and Department of Energy, the Natural Sciences and Engineering Research Council (NSERC) of Canada, the Excellence Cluster of the DFG of Germany: Origin and Structure of the Universe, and the Japan Society for the Promotion of Science (JSPS).	Aad G, 2015, PHYS LETT B, V743, P235, DOI 10.1016/j.physletb.2015.02.051; Aad G, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2013)033; Aaij R, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2016)104; Aaij R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.111803; Aaij R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.151601; Aaltonen T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.081807; Aaron FD, 2011, PHYS LETT B, V704, P388, DOI 10.1016/j.physletb.2011.09.017; Abashian A, 2002, NUCL INSTRUM METH A, V479, P117, DOI 10.1016/S0168-9002(01)02013-7; Ablikim M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.012001; Alonso R, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.094021; Alves AA, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08005; Amhis Y., 2014, PREPRINT; Aoki S, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2890-7; Aubert B, 2013, NUCL INSTRUM METH A, V729, P615, DOI 10.1016/j.nima.2013.05.107; Aubert B, 2002, NUCL INSTRUM METH A, V479, P1, DOI 10.1016/S0168-9002(01)02012-5; Aubert B, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.051101; Aubert B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.021801; Bailey JA, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.034506; BARGER V, 1990, PHYS REV D, V41, P3421, DOI 10.1103/PhysRevD.41.3421; Bauer M, 2016, PHYS REV LETT, V116, DOI [10.1140/epjc/s10052-021-09843-w, 10.1103/PhysRevLett.116.141802]; Becirevic D, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.115021; Bozek A, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.072005; Buchmuller W, 1999, PHYS LETT B, V448, P320; Charles J, 2005, EUR PHYS J C, V41, P1, DOI 10.1140/epjc/s2005-02169-1; Chatrchyan S, 2013, PHYS LETT B, V718, P1229, DOI 10.1016/j.physletb.2012.12.008; Chatrchyan S, 2012, PHYS LETT B, V711, P15, DOI 10.1016/j.physletb.2012.03.029; Chekanov S, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.052004; CMS Collaboration, 2012, Physics Letters B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; Crivellin A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.054014; Datta A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.034027; Dettori F, 2013, NUCL INSTRUM METH A, V732, P40, DOI 10.1016/j.nima.2013.05.125; Dorsner I, 2016, PHYS REP, V641, P1, DOI 10.1016/j.physrep.2016.06.001; Dumont B, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.034001; Fajfer S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.161801; Fajfer S, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.094025; Feindt M, 2011, NUCL INSTRUM METH A, V654, P432, DOI 10.1016/j.nima.2011.06.008; Freytsis M, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.054018; GUNION JF, 1993, NUCL PHYS B, V402, P567; Hara K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.131801; Heavy Flavor Averaging Group, 2016, AV GROUP AV RD RD WI; Heavy Flavor Averaging Group, 2016, COMP B B LEPT BRANCH; Hiller G, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.054014; Hirose S, 2016, PREPRINT; Huschle M, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.072014; Khachatryan V, 2014, PHYS LETT B, V739, P229, DOI 10.1016/j.physletb.2014.10.063; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; KORNER JG, 1990, Z PHYS C PART FIELDS, V46, P93, DOI 10.1007/BF02440838; Kronenbitter B, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.051102; Lees JP, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.072012; Lees JP, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.031102; Mann RB, 2010, INTRO PARTICLE PHYS; Matyja A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.191807; Na H, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.054510; Neddermeyer SH, 1937, PHYS REV, V51, P0884, DOI 10.1103/PhysRev.51.884; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; PERL ML, 1975, PHYS REV LETT, V35, P1489, DOI 10.1103/PhysRevLett.35.1489; Pohl R, 2013, ANNU REV NUCL PART S, V63, P175, DOI 10.1146/annurev-nucl-102212-170627; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Prieels R, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.112003; Sakaki Y, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.114028; Sakaki Y, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.094012; Sato Y, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.072007; Stahl A, 2000, SPRINGER TR MOD PHYS, V160, P1; TANAKA M, 1995, Z PHYS C PART FIELDS, V67, P321, DOI 10.1007/BF01571294; Thomson J. J., 1967, NOBEL LECTURES PHYSI; Wehle S, 2016, PREPRINT; Wei JT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.171801; Weinberg S., 2013, QUANTUM THEORY FIELD, V2	70	32	32	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					227	233		10.1038/nature22346	http://dx.doi.org/10.1038/nature22346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593973	Green Submitted			2022-12-28	WOS:000402823400026
J	Leichsenring, F; Leweke, F				Leichsenring, Falk; Leweke, Frank			Social Anxiety Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; NATIONAL COMORBIDITY SURVEY; PSYCHODYNAMIC THERAPY; POSTTRAUMATIC-STRESS; PHOBIA; METAANALYSIS; PHENELZINE; PLACEBO; RISK	A 26-year-old student reports feeling very anxious when giving a presentation, taking an examination, or meeting an authority figure. In these situations, he has palpitations, tremors, blushing, and sweating, and he is fearful that he will embarrass himself. He reports having few social contacts and avoids going to parties and making phone calls, but he feels lonely. His anxieties started during his teenage years and have increased considerably since he started attending a university. How should this case be managed?	[Leichsenring, Falk; Leweke, Frank] Justus Liebig Univ Giessen, Dept Psychosomat & Psychotherapy, Giessen, Germany	Justus Liebig University Giessen	Leichsenring, F (corresponding author), Univ Giessen, Dept Psychosomat & Psychotherapy, Ludwigstr 76, D-35392 Giessen, Germany.	falk.leichsenring@psycho.med.uni-giessen.de						Acarturk C, 2009, PSYCHOL MED, V39, P241, DOI 10.1017/S0033291708003590; Aktar E, 2014, J CHILD PSYCHOL PSYC, V55, P77, DOI 10.1111/jcpp.12121; American Psychiatric Asociation, 2013, DIAGN STATS MAN MENT; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Andrews G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0533-1; Baldwin DS, 2014, J PSYCHOPHARMACOL, V28, P403, DOI 10.1177/0269881114525674; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; Beidel D.C., 2007, SHY CHILDREN PHOBIC, DOI [10.1037/11533-000, DOI 10.1037/11533-000]; Blanco C, 2013, INT J NEUROPSYCHOPH, V16, P235, DOI 10.1017/S1461145712000119; Blanco C, 2010, ARCH GEN PSYCHIAT, V67, P286, DOI 10.1001/archgenpsychiatry.2010.11; Bogels SM, 2014, DEPRESS ANXIETY, V31, P363, DOI 10.1002/da.22246; Bogels SM, 2010, DEPRESS ANXIETY, V27, P168, DOI 10.1002/da.20670; Canton J, 2012, NEUROPSYCH DIS TREAT, V8, P203, DOI 10.2147/NDT.S23317; Clark DM, 2006, J CONSULT CLIN PSYCH, V74, P568, DOI 10.1037/0022-006X.74.3.568; Cuijpers P, 2016, WORLD PSYCHIATRY, V15, P245, DOI 10.1002/wps.20346; Curtiss J, 2017, EXPERT OPIN PHARMACO, V18, P243, DOI 10.1080/14656566.2017.1285907; Davidson JRT, 2004, ARCH GEN PSYCHIAT, V61, P1005, DOI 10.1001/archpsyc.61.10.1005; DAVIDSON JRT, 1993, PSYCHOL MED, V23, P709, DOI 10.1017/S0033291700025484; Fox AS, 2014, AM J PSYCHIAT, V171, P1162, DOI 10.1176/appi.ajp.2014.14040449; Gross R, 2005, GEN HOSP PSYCHIAT, V27, P161, DOI 10.1016/j.genhosppsych.2005.01.006; Haug TT, 2003, BRIT J PSYCHIAT, V182, P312, DOI 10.1192/bjp.182.4.312; Heimberg RG, 1998, ARCH GEN PSYCHIAT, V55, P1133, DOI 10.1001/archpsyc.55.12.1133; Ipser Jonathan C, 2008, Expert Rev Neurother, V8, P235, DOI 10.1586/14737175.8.2.235; Katzman MA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-S1-S1; Keller MB, 2003, ACTA PSYCHIAT SCAND, V108, P85, DOI 10.1034/j.1600-0447.108.s417.6.x; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kimmel RJ, 2015, GUIDE TREATMENTS WOR, P463; Knijnik Daniela Zippin, 2004, Rev. Bras. Psiquiatr., V26, P77, DOI 10.1590/S1516-44462004000200003; Knijnk DZ, 2008, EUR PSYCHIAT, V23, P567, DOI 10.1016/j.eurpsy.2008.05.004; Koszycki D, 2007, BEHAV RES THER, V45, P2518, DOI 10.1016/j.brat.2007.04.011; Lecrubier Y, 2000, EUR PSYCHIAT, V15, P5, DOI 10.1016/S0924-9338(00)00216-9; Leichsenring F, 2014, AM J PSYCHIAT, V171, P1074, DOI 10.1176/appi.ajp.2014.13111514; Leichsenring F, 2013, AM J PSYCHIAT, V170, P759, DOI [10.1176/appi.ajp.2013.13060744r, 10.1176/appi.ajp.2013.12081125]; Liebowitz MR, 1999, DEPRESS ANXIETY, V10, P89, DOI 10.1002/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.3.CO;2-X; Lipsitz JD, 2008, DEPRESS ANXIETY, V25, P542, DOI 10.1002/da.20364; Magee WJ, 1996, ARCH GEN PSYCHIAT, V53, P159; Majdandzic M, 2014, J ABNORM CHILD PSYCH, V42, P301, DOI 10.1007/s10802-013-9774-4; National Institute for Health and Care Excellence, 2013, SOC ANX REC ASS TREA; Nikolic M, 2016, J CHILD PSYCHOL PSYC, V57, P1047, DOI 10.1111/jcpp.12563; Nordahl HM, 2016, PSYCHOTHER PSYCHOSOM, V85, P346, DOI 10.1159/000447013; Pollack MH, 2014, AM J PSYCHIAT, V171, P44, DOI 10.1176/appi.ajp.2013.12101353; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; Scaini S, 2014, J ANXIETY DISORD, V28, P650, DOI 10.1016/j.janxdis.2014.07.002; Schneier FR, 2006, NEW ENGL J MED, V355, P1029, DOI 10.1056/NEJMcp060145; Stangier U, 2011, ARCH GEN PSYCHIAT, V68, P692, DOI 10.1001/archgenpsychiatry.2011.67; Stein DJ, 2002, J CLIN PSYCHIAT, V63, P152, DOI 10.4088/JCP.v63n0211; Stein MB, 1996, AM J PSYCHIAT, V153, P278; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Stein MB, 2015, JAMA PSYCHIAT, V72, P845, DOI 10.1001/jamapsychiatry.2015.0486; Steinert C, 2013, J ANXIETY DISORD, V27, P692, DOI 10.1016/j.janxdis.2013.08.002	51	60	64	4	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2255	2264		10.1056/NEJMcp1614701	http://dx.doi.org/10.1056/NEJMcp1614701			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW8WG	28591542				2022-12-28	WOS:000402798200009
J	Kanes, S; Colquhoun, H; Gunduz-Bruce, H; Raines, S; Arnold, R; Schacterle, A; Doherty, J; Epperson, CN; Deligiannidis, KM; Riesenberg, R; Hoffmann, E; Rubinow, D; Jonas, J; Paul, S; Meltzer-Brody, S				Kanes, Stephen; Colquhoun, Helen; Gunduz-Bruce, Handan; Raines, Shane; Arnold, Ryan; Schacterle, Amy; Doherty, James; Epperson, C. Neill; Deligiannidis, Kristina M.; Riesenberg, Robert; Hoffmann, Ethan; Rubinow, David; Jonas, Jeffrey; Paul, Steven; Meltzer-Brody, Samantha			Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial	LANCET			English	Article							POSTNATAL DEPRESSION; SERUM ALLOPREGNANOLONE; NEUROACTIVE STEROIDS; PERINATAL WOMEN; PREGNANCY; SUICIDE; SCALE; RISK; ANTIDEPRESSANTS; SERTRALINE	Background Post-partum depression is a serious mood disorder in women that might be triggered by peripartum fluctuations in reproductive hormones. This phase 2 study investigated brexanolone (USAN; formerly SAGE-547 injection), an intravenous formulation of allopregnanolone, a positive allosteric modulator of gamma-aminobutyric acid (GABA(A)) receptors, for the treatment of post-partum depression. Methods For this double-blind, randomised, placebo-controlled trial, we enrolled self-referred or physician-referred female inpatients (<= 6 months post partum) with severe post-partum depression (Hamilton Rating Scale for Depression [HAM-D] total score >= 26) in four hospitals in the USA. Eligible women were randomly assigned (1: 1), via a computer-generated randomisation program, to receive either a single, continuous intravenous dose of brexanolone or placebo for 60 h. Patients and investigators were masked to treatment assignments. The primary efficacy endpoint was the change from baseline in the 17-item HAM-D total score at 60 h, assessed in all randomised patients who started infusion of study drug or placebo and who had a completed baseline HAM-D assessment and at least one post-baseline HAM-D assessment. Patients were followed up until day 30. This trial is registered with ClinicalTrials.gov, number NCT02614547. Findings This trial was done between Dec 15, 2015 (first enrolment), and May 19, 2016 (final visit of the last enrolled patient). 21 women were randomly assigned to the brexanolone (n=10) and placebo (n=11) groups. At 60 h, mean reduction in HAM-D total score from baseline was 21.0 points (SE 2.9) in the brexanolone group compared with 8.8 points (SE 2.8) in the placebo group (difference -12.2, 95% CI -20.77 to -3.67; p=0.0075; effect size 1.2). No deaths, serious adverse events, or discontinuations because of adverse events were reported in either group. Four of ten patients in the brexanolone group had adverse events compared with eight of 11 in the placebo group. The most frequently reported adverse events in the brexanolone group were dizziness (two patients in the brexanolone group vs three patients in the placebo group) and somnolence (two vs none). Moderate treatment-emergent adverse events were reported in two patients in the brexanolone group (sinus tachycardia, n=1; somnolence, n=1) and in two patients in the placebo group (infusion site pain, n=1; tension headache, n=1); one patient in the placebo group had a severe treatment-emergent adverse event (insomnia). Interpretation In women with severe post-partum depression, infusion of brexanolone resulted in a significant and clinically meaningful reduction in HAM-D total score, compared with placebo. Our results support the rationale for targeting synaptic and extrasynaptic GABA(A) receptors in the development of therapies for patients with post-partum depression. A pivotal clinical programme for the investigation of brexanolone in patients with post-partum depression is in progress.	[Kanes, Stephen; Colquhoun, Helen; Gunduz-Bruce, Handan; Arnold, Ryan; Schacterle, Amy; Doherty, James; Hoffmann, Ethan; Jonas, Jeffrey; Paul, Steven] Sage Therapeut Inc, Cambridge, MA USA; [Raines, Shane] 2b Analyt, Wallingford, PA USA; [Epperson, C. Neill] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA USA; [Deligiannidis, Kristina M.] Univ Massachusetts, Med Sch, Worcester, MA USA; [Deligiannidis, Kristina M.] Zucker Hillside Hosp, Womens Behav Hlth, New York, NY USA; [Riesenberg, Robert] Atlanta Ctr Med Res, Atlanta, GA USA; [Rubinow, David; Meltzer-Brody, Samantha] UNC, Sch Med, Dept Psychiat, Chapel Hill, NC 27514 USA	University of Pennsylvania; Pennsylvania Medicine; University of Massachusetts System; University of Massachusetts Worcester; Northwell Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Meltzer-Brody, S (corresponding author), UNC, Sch Med, Dept Psychiat, Chapel Hill, NC 27514 USA.	samantha_meltzer-brody@med.unc.edu	Meltzer-Brody, Samantha/J-6926-2019; Deligiannidis, Kristina M./C-3654-2014; Kanes, Steve/AAX-6132-2021; Kanes, Stephen/AAX-5531-2021; Epperson, Cynthia Neill/ABE-9424-2021; Paul, Steve/ABE-5400-2020	Meltzer-Brody, Samantha/0000-0002-8509-408X; Deligiannidis, Kristina M./0000-0001-7439-2236; 	Sage Therapeutics, Inc.	Sage Therapeutics, Inc.	Sage Therapeutics, Inc.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Barkin JL, 2014, JOGNN-J OBST GYN NEO, V43, P792, DOI 10.1111/1552-6909.12505; Bech P, 2000, BRIT J PSYCHIAT, V176, P421, DOI 10.1192/bjp.176.5.421; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Concas A, 1998, P NATL ACAD SCI USA, V95, P13284, DOI 10.1073/pnas.95.22.13284; Cox EQ, 2016, J CLIN PSYCHIAT, V77, P1189, DOI 10.4088/JCP.15r10174; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; De Crescenzo F, 2014, J AFFECT DISORDERS, V152, P39, DOI 10.1016/j.jad.2013.09.019; Deligiannidis KM, 2016, PSYCHONEUROENDOCRINO, V70, P98, DOI 10.1016/j.psyneuen.2016.05.010; Deligiannidis KM, 2013, J PSYCHIATR RES, V47, P816, DOI 10.1016/j.jpsychires.2013.02.010; Epperson CN, 2006, PSYCHOPHARMACOLOGY, V186, P425, DOI 10.1007/s00213-006-0313-7; Epperson CN, 2003, PEDIATRICS, V112, pE425, DOI 10.1542/peds.112.5.e425; Epperson CN, 1997, NEW ENGL J MED, V336, P1189, DOI 10.1056/NEJM199704173361615; Fellmeth G, 2017, BJOG-INT J OBSTET GY, V124, P742, DOI 10.1111/1471-0528.14184; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; First M.B., 1996, STRUCTURED CLIN INTE, DOI DOI 10.1037/T07827-000; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Guy W., 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hantsoo L, 2014, PSYCHOPHARMACOLOGY, V231, P939, DOI 10.1007/s00213-013-3316-1; Harris B, 1996, BRIT J PSYCHIAT, V168, P739, DOI 10.1192/bjp.168.6.739; Hendrick V, 2000, DEPRESS ANXIETY, V11, P66, DOI 10.1002/(SICI)1520-6394(2000)11:2<66::AID-DA3>3.0.CO;2-D; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Johannsen BMW, 2016, AM J PSYCHIAT, V173, P635, DOI 10.1176/appi.ajp.2015.14121510; Kanes SJ, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2576; Khalifeh H, 2016, LANCET PSYCHIAT, V3, P233, DOI 10.1016/S2215-0366(16)00003-1; Kim JJ, 2015, OBSTET GYNECOL, V125, P885, DOI 10.1097/AOG.0000000000000718; Klak J, 2003, PHYSIOL RES, V52, P211; Luisi S, 2000, J CLIN ENDOCR METAB, V85, P2429, DOI 10.1210/jc.85.7.2429; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Meltzer-Brody S, 2017, PSYCHOL MED, V47, P1427, DOI 10.1017/S0033291716003020; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murrough JW, 2013, AM J PSYCHIAT, V170, P1134, DOI 10.1176/appi.ajp.2013.13030392; Nappi RE, 2001, OBSTET GYNECOL, V97, P77, DOI 10.1016/S0029-7844(00)01112-1; Noorlander Y, 2008, ARCH WOMEN MENT HLTH, V11, P49, DOI 10.1007/s00737-008-0217-0; Paoletti AM, 2006, PSYCHONEUROENDOCRINO, V31, P485, DOI 10.1016/j.psyneuen.2005.11.006; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Putnam K, 2015, LANCET PSYCHIAT, V2, P59, DOI 10.1016/S2215-0366(14)00055-8; Schiller CE, 2015, CNS SPECTRUMS, V20, P48, DOI 10.1017/S1092852914000480; Serati M, 2016, J AFFECT DISORDERS, V193, P391, DOI 10.1016/j.jad.2016.01.027; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; van Calker D, 2009, J AFFECT DISORDERS, V114, P243, DOI 10.1016/j.jad.2008.07.023; World Health Organization, 2018, INT CLASSIFICATION D; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028; Zorumski CF, 2013, NEUROSCI BIOBEHAV R, V37, P109, DOI 10.1016/j.neubiorev.2012.10.005	54	192	203	4	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2017	390	10093					480	489		10.1016/S0140-6736(17)31264-3	http://dx.doi.org/10.1016/S0140-6736(17)31264-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB9MO	28619476				2022-12-28	WOS:000406463400029
J	Fawcett, A; Pradeilles, J; Wang, Y; Mutsuga, T; Myers, EL; Aggarwal, VK				Fawcett, Alexander; Pradeilles, Johan; Wang, Yahui; Mutsuga, Tatsuya; Myers, Eddie L.; Aggarwal, Varinder K.			Photoinduced decarboxylative borylation of carboxylic acids	SCIENCE			English	Article							REDOX-ACTIVE ESTERS; CATALYZED DECARBONYLATIVE BORYLATION; LEWIS-BASES; RADICALS; BORON; BOND; REACTIVITY; ALKYL	The conversion of widely available carboxylic acids into versatile boronic esters would be highly enabling for synthesis. We found that this transformation can be effected by illuminating the N-hydroxyphthalimide ester derivative of the carboxylic acid under visible light at room temperature in the presence of the diboron reagent bis(catecholato)diboron. A simple workup allows isolation of the pinacol boronic ester. Experimental evidence suggests that boryl radical intermediates are involved in the process. The methodology is illustrated by the transformation of primary, secondary, and tertiary alkyl carboxylic acids as well as a diverse range of natural-product carboxylic acids, thereby demonstrating its broad utility and functional group tolerance.	[Fawcett, Alexander; Pradeilles, Johan; Wang, Yahui; Mutsuga, Tatsuya; Myers, Eddie L.; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Aggarwal, VK (corresponding author), Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England.	v.aggarwal@bristol.ac.uk	Pradeilles, Johan/F-9251-2018; Aggarwal, Varinder/AAG-8504-2019; Wang, Yahui/H-7940-2016; Fawcett, Alexander/AAA-4220-2020; Pradeilles, Johan A./M-6010-2019	Pradeilles, Johan/0000-0003-0895-3239; Wang, Yahui/0000-0003-4109-8318; Fawcett, Alexander/0000-0003-1880-3269; Pradeilles, Johan A./0000-0003-0895-3239; Myers, Eddie/0000-0001-7742-4934; Aggarwal, Varinder/0000-0003-0344-6430	Marie Sklodowska-Curie Fellowship [EMTECS/652890]; European Research Council [670668]; UK Engineering and Physical Sciences Research Council [EP/I038071/1]; Engineering and Physical Sciences Research Council [EP/K03927X/1, EP/I038071/1] Funding Source: researchfish; EPSRC [EP/I038071/1, EP/K03927X/1] Funding Source: UKRI	Marie Sklodowska-Curie Fellowship; European Research Council(European Research Council (ERC)European Commission); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by Marie Sklodowska-Curie Fellowship EMTECS/652890 (Y.W.), European Research Council award 670668, and UK Engineering and Physical Sciences Research Council award EP/I038071/1. A provisional UK patent application on this work has been filed (application number GB 1705897.5).	Ajami D, 2011, J AM CHEM SOC, V133, P9689, DOI 10.1021/ja203123k; Ballatore C, 2013, CHEMMEDCHEM, V8, P385, DOI 10.1002/cmdc.201200585; Bedford RB, 2014, ORGANOMETALLICS, V33, P5940, DOI 10.1021/om500847j; Bose SK, 2016, ACS CATAL, V6, P8332, DOI 10.1021/acscatal.6b02918; Cadot C, 2000, CHEM COMMUN, P1017, DOI 10.1039/b001903h; Candish L, 2017, J AM CHEM SOC, V139, P7440, DOI 10.1021/jacs.7b03127; Dewhurst RD, 2015, CHEM COMMUN, V51, P9594, DOI 10.1039/c5cc02316e; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; Guo L, 2016, CHEM-EUR J, V22, P16786, DOI 10.1002/chem.201604504; Hall D, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, pXV; Hioe J, 2010, CHEM-EUR J, V16, P6861, DOI 10.1002/chem.200903395; Hu DW, 2017, ORG LETT, V19, P2770, DOI 10.1021/acs.orglett.7b01181; Hu JF, 2016, ANGEW CHEM INT EDIT, V55, P8718, DOI 10.1002/anie.201603068; Huihui KMM, 2016, J AM CHEM SOC, V138, P5016, DOI 10.1021/jacs.6b01533; Kachkovskyi G, 2013, ADV SYNTH CATAL, V355, P2240, DOI 10.1002/adsc.201300221; Lawlor FJ, 1998, INORG CHEM, V37, P5282, DOI 10.1021/ic980425a; Li C, 2017, SCIENCE, V356, DOI 10.1126/science.aam7355; Lima F, 2016, ANGEW CHEM INT EDIT, V55, P14085, DOI 10.1002/anie.201605548; Lu DM, 2014, CHEM-EUR J, V20, P1630, DOI 10.1002/chem.201303705; Martin CD, 2013, CHEM SCI, V4, P3020, DOI 10.1039/c3sc51174j; Miyaura N., 2004, NEW STRATEGIES METAL; NGUYEN P, 1995, INORG CHEM, V34, P4290, DOI 10.1021/ic00121a002; Ochiai H, 2017, ANGEW CHEM INT EDIT, V56, P2482, DOI 10.1002/anie.201611974; OELGEMOLLER M, 2002, J PHOTOCH PHOTOBIO C, V3, P109, DOI DOI 10.1016/S1389-5567(02)00022-9; OKADA K, 1991, J AM CHEM SOC, V113, P9401, DOI 10.1021/ja00024a074; Patra T, 2017, CHEM-EUR J, V23, P7382, DOI 10.1002/chem.201604496; Pratsch G, 2015, J ORG CHEM, V80, P6025, DOI 10.1021/acs.joc.5b00795; Qin T, 2016, SCIENCE, V352, P801, DOI 10.1126/science.aaf6123; Renaud P, 2007, PURE APPL CHEM, V79, P223, DOI 10.1351/pac200779020223; Sandford C, 2017, CHEM COMMUN, V53, P5481, DOI 10.1039/c7cc01254c; Toriyama F, 2016, J AM CHEM SOC, V138, P11132, DOI 10.1021/jacs.6b07172; Trippier PC, 2010, MEDCHEMCOMM, V1, P183, DOI 10.1039/c0md00119h; Ueng SH, 2009, J AM CHEM SOC, V131, P11256, DOI 10.1021/ja904103x; Villa G, 2011, J AM CHEM SOC, V133, P5913, DOI 10.1021/ja110224d; Walton JC, 2010, J AM CHEM SOC, V132, P2350, DOI 10.1021/ja909502q; Wang GQ, 2016, ANGEW CHEM INT EDIT, V55, P5985, DOI 10.1002/anie.201511917; Wang J, 2016, ANGEW CHEM INT EDIT, V55, P9676, DOI 10.1002/anie.201605463; Zhang L, 2017, J AM CHEM SOC, V139, P607, DOI 10.1021/jacs.6b11813	38	362	365	14	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348								10.1126/science.aan3679	http://dx.doi.org/10.1126/science.aan3679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28619717	Green Submitted			2022-12-28	WOS:000405901600036
J	Saper, RB; Lemaster, C; Delitto, A; Sherman, KJ; Herman, PM; Sadikova, E; Stevans, J; Keosaian, JE; Cerrada, CJ; Femia, AL; Roseen, EJ; Gardiner, P; Barnett, KG; Faulkner, C; Weinberg, J				Saper, Robert B.; Lemaster, Chelsey; Delitto, Anthony; Sherman, Karen J.; Herman, Patricia M.; Sadikova, Ekaterina; Stevans, Joel; Keosaian, Julia E.; Cerrada, Christian J.; Femia, Alexandra L.; Roseen, Eric J.; Gardiner, Paula; Barnett, Katherine Gergen; Faulkner, Carol; Weinberg, Janice			Yoga, Physical Therapy, or Education for Chronic Low Back Pain A Randomized Noninferiority Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICALLY IMPORTANT DIFFERENCE; FEAR-AVOIDANCE BELIEFS; SELF-CARE BOOK; SUBGROUPING PATIENTS; COMPARING YOGA; EXERCISE; PREVALENCE; DISABILITY; INTERVENTION; METAANALYSIS	Background: Yoga is effective for mild to moderate chronic low back pain (cLBP), but its comparative effectiveness with physical therapy (PT) is unknown. Moreover, little is known about yoga's effectiveness in underserved patients with more severe functional disability and pain. Objective: To determine whether yoga is noninferior to PT for cLBP. Design: 12-week, single-blind, 3-group randomized noninferiority trial and subsequent 40-week maintenance phase. (Clinical Trials.gov: NCT01343927) Setting: Academic safety-net hospital and 7 affiliated community health centers. Participants: 320 predominantly low-income, racially diverse adults with nonspecific cLBP. Intervention: Participants received 12 weekly yoga classes, 15 PT visits, or an educational book and newsletters. The maintenance phase compared yoga drop-in classes versus home practice and PT booster sessions versus home practice. Measurements: Primary outcomes were back-related function, measured by the Roland Morris Disability Questionnaire (RMDQ), and pain, measured by an 11-point scale, at 12 weeks. Prespecified noninferiority margins were 1.5 (RMDQ) and 1.0 (pain). Secondary outcomes included pain medication use, global improvement, satisfaction with intervention, and healthrelated quality of life. Results: One-sided 95% lower confidence limits were 0.83 (RMDQ) and 0.97 (pain), demonstrating noninferiority of yoga to PT. However, yoga was not superior to education for either outcome. Yoga and PT were similar for most secondary outcomes. Yoga and PT participants were 21 and 22 percentage points less likely, respectively, than education participants to use pain medication at 12 weeks. Improvements in yoga and PT groups were maintained at 1 year with no differences between maintenance strategies. Frequency of adverse events, mostly mild self-limited joint and back pain, did not differ between the yoga and PT groups. Limitations: Participants were not blinded to treatment assignment. The PT group had disproportionate loss to follow-up. Conclusion: A manualized yoga program for nonspecific cLBP was noninferior to PT for function and pain.	Boston Univ, Sch Med, Boston, MA USA; [Saper, Robert B.; Lemaster, Chelsey; Femia, Alexandra L.; Roseen, Eric J.; Gardiner, Paula; Barnett, Katherine Gergen; Faulkner, Carol] Boston Med Ctr, Dept Family Med, 1 Boston Med Ct Pl,Dowling 5 South, Boston, MA 02118 USA; [Keosaian, Julia E.] Boston Med Ctr, Sect Gen Internal Med, Crosstown Ctr, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA; [Sadikova, Ekaterina] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Weinberg, Janice] Boston Univ, Sch Publ Hlth, Dept Biostat, Crosstown Ctr, 801 Massachusetts Ave,3nd Floor, Boston, MA 02118 USA; [Delitto, Anthony; Stevans, Joel] Univ Pittsburgh, Sch Hlth & Rehabil Sci, 4029 Forbes Tower, Pittsburgh, PA 15260 USA; Grp Hlth Res Inst, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA; [Herman, Patricia M.] RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA; [Sherman, Karen J.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Cerrada, Christian J.] Soto St Bldg,SSB 1,2001 North Soto, Los Angeles, CA 90032 USA	Boston University; Boston Medical Center; Boston Medical Center; Harvard University; Harvard Medical School; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; RAND Corporation; Group Health Cooperative	Saper, RB (corresponding author), Boston Med Ctr, Dept Family Med, 1 Boston Med Ct Pl,Dowling 5 South, Boston, MA 02118 USA.	robert.saper@bmc.org	Stevans, Joel/M-2058-2018; Saper, Robert B/Y-4598-2018	Stevans, Joel/0000-0001-8642-9446; Saper, Robert B/0000-0002-0992-6198; Weinberg, Janice/0000-0002-3503-0061	National Center for Complementary and Integrative Health of the National Institutes of Health; National Center for Complementary & Integrative Health [R01AT005956] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Center for Complementary and Integrative Health of the National Institutes of Health.	American Physical Therapy Association, FAIR PHYS THER COP; Balding DJ, 2004, APPL LONGITUDINAL AN; Beinart NA, 2013, SPINE J, V13, P1940, DOI 10.1016/j.spinee.2013.08.027; Bombardier C, 2001, J RHEUMATOL, V28, P431; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Chibnall JT, 2005, PAIN, V114, P462, DOI 10.1016/j.pain.2005.01.011; Chou R, 2016, AHRQ PUBLICATION; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Freburger Janet K, 2005, Spine J, V5, P530, DOI 10.1016/j.spinee.2005.03.008; Freburger JK, 2003, ARCH PHYS MED REHAB, V84, P1839, DOI 10.1016/S0003-9993(03)00375-7; Fritz JM, 2006, SPINE, V31, P77, DOI 10.1097/01.brs.0000193898.14803.8a; Fritz JM, 2002, PHYS THER, V82, P973, DOI 10.1093/ptj/82.10.973; Fritz JM, 2007, J ORTHOP SPORT PHYS, V37, P290, DOI 10.2519/jospt.2007.2498; Hausmann LRM, 2013, PAIN, V154, P46, DOI 10.1016/j.pain.2012.07.034; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Heapy AA, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0924-z; Hudak PL, 2000, SPINE, V25, P3167, DOI 10.1097/00007632-200012150-00012; Institute of Medicine Committee on Advancing Pain Research Care and Education, 2011, REL PAIN AM BLUEPR T; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P45, DOI 10.1016/j.jclinepi.2005.03.018; Keosaian JE, 2016, COMPLEMENT THER MED, V24, P34, DOI 10.1016/j.ctim.2015.11.007; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Meng XG, 2015, AM J PHYS MED REHAB, V94, P358, DOI 10.1097/PHM.0000000000000188; MOORE JEL, 1999, BACK PAIN HELPBOOK; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Patrick N, 2016, MED CLIN N AM, V100, P173, DOI 10.1016/j.mcna.2015.08.015; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Roland M, 1996, THE BACK BOOK; Saper Robert, 2016, Glob Adv Health Med, V5, P5, DOI 10.7453/gahmj.2015.133; Saper RB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-67; Saper RB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/658030; Saper RB, 2009, ALTERN THER HEALTH M, V15, P18; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Sherman KJ, 2011, ARCH INTERN MED, V171, P2019, DOI 10.1001/archinternmed.2011.524; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Tilbrook HE, 2011, ANN INTERN MED, V155, P569, DOI 10.7326/0003-4819-155-9-201111010-00003; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Werneke MW, 2009, ARCH PHYS MED REHAB, V90, P768, DOI 10.1016/j.apmr.2008.11.008; Wieland LS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010671.pub2; Wiens BL, 2002, CONTROL CLIN TRIALS, V23, P2, DOI 10.1016/S0197-2456(01)00196-9	44	84	87	14	61	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					85	94		10.7326/M16-2579	http://dx.doi.org/10.7326/M16-2579			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28631003	Green Accepted			2022-12-28	WOS:000405573400014
J	Gurwitz, JH; Bonner, A; Berwick, DM				Gurwitz, Jerry H.; Bonner, Alice; Berwick, Donald M.			Reducing Excessive Use of Antipsychotic Agents in Nursing Homes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUG-USE		[Gurwitz, Jerry H.] Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA; [Gurwitz, Jerry H.] Univ Massachusetts, Sch Med, Div Geriatr Med, Worcester, MA USA; [Bonner, Alice] Massachusetts Execut Off Elder Affairs, Boston, MA USA; [Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Institute for Healthcare Improvement	Gurwitz, JH (corresponding author), Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA.	jgurwitz@meyersprimary.org			NATIONAL INSTITUTE ON AGING [R24AG045050] Funding Source: NIH RePORTER; NIA NIH HHS [R24 AG045050] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Centers for Medicare and Medicaid Services, NAT PARTN IMPR DEM C; Centers for Medicare and Medicaid Services, 2022, NAT PARTN IMPR DEM C; Harris-Kojetin L., 2016, VITAL HLTH STAT, V3, DOI DOI 10.1111/J.1532-5415.2010.02875.X; Levinson DR, OVERPRESCRIBED HUMAN; Levinson DR, MEDICARE ATYPICAL AN; RAY WA, 1980, AM J PUBLIC HEALTH, V70, P485, DOI 10.2105/AJPH.70.5.485; SHORR RI, 1994, JAMA-J AM MED ASSOC, V271, P358	7	28	28	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					118	119		10.1001/jama.2017.7032	http://dx.doi.org/10.1001/jama.2017.7032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28617907				2022-12-28	WOS:000405190800008
J	Huang, CS; Pedersen, BP; Stokes, DL				Huang, Ching-Shin; Pedersen, Bjorn Panyella; Stokes, David L.			Crystal structure of the potassium-importing KdpFABC membrane complex	NATURE			English	Article							P-TYPE ATPASE; AMINO-ACID SUBSTITUTIONS; TRANSLOCATING KDP-ATPASE; ESCHERICHIA-COLI; CALCIUM-PUMP; TRANSPORT ATPASE; PROTEIN-SEQUENCE; ASPARTIC-ACID; K+-TRANSPORT; SUBUNIT	Cellular potassium import systems play a fundamental role in osmoregulation, pH homeostasis and membrane potential in all domains of life. In bacteria, the kdp operon encodes a four-subunit potassium pump that maintains intracellular homeostasis, cell shape and turgor under conditions in which potassium is limiting(1). This membrane complex, called KdpFABC, has one channel-like subunit (KdpA) belonging to the superfamily of potassium transporters and another pump-like subunit (KdpB) belonging to the superfamily of P-type ATPases. Although there is considerable structural and functional information about members of both superfamilies, the mechanism by which uphill potassium transport through KdpA is coupled with ATP hydrolysis by KdpB remains poorly understood. Here we report the 2.9 angstrom X-ray structure of the complete Escherichia coli KdpFABC complex with a potassium ion within the selectivity filter of KdpA and a water molecule at a canonical cation site in the transmembrane domain of KdpB. The structure also reveals two structural elements that appear to mediate the coupling between these two subunits. Specifically, a protein-embedded tunnel runs between these potassium and water sites and a helix controlling the cytoplasmic gate of KdpA is linked to the phosphorylation domain of KdpB. On the basis of these observations, we propose a mechanism that repurposes protein channel architecture for active transport across biomembranes.	[Huang, Ching-Shin] NYU, Sch Med, Mol Biophys Grad Program, Skirball Inst, 540 First Ave, New York, NY 10016 USA; [Pedersen, Bjorn Panyella] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark; [Pedersen, Bjorn Panyella] Aarhus Univ, Aarhus Inst Adv Studies, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark; [Stokes, David L.] NYU, Sch Med, Skirball Inst, Dept Cell Biol, 540 First Ave, New York, NY 10016 USA	New York University; Aarhus University; Aarhus University; New York University	Pedersen, BP (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.; Pedersen, BP (corresponding author), Aarhus Univ, Aarhus Inst Adv Studies, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark.; Stokes, DL (corresponding author), NYU, Sch Med, Skirball Inst, Dept Cell Biol, 540 First Ave, New York, NY 10016 USA.	bpp@mbg.au.dk; stokes@nyu.edu	Huang, Ching-Shin/AAD-9521-2021; Pedersen, Bjørn/AAT-2409-2021	Huang, Ching-Shin/0000-0002-6435-9309; Pedersen, Bjørn/0000-0001-7860-7230	NIH [R01 GM108043, T32 GM088118]; European Research Council [637372]; Danish Council for Independent Research [DFF-4002-00052]; AIAS fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108043, T32GM088118] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); AIAS fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge beamline 23IDB/IDD at the Advanced Photon Source-Argonne National Laboratory, where all the X-ray data were collected, as well as the National Synchrotron Light Source and the Stanford Synchrotron Radiation Light Source. We also thank W. Epstein and D. Sauer for discussions, W. Epstein for the plasmid and bacterial strain for expression, and J. Deng and T. Neubert for mass spectrometry. This work was supported by funding from NIH R01 GM108043 and NIH T32 GM088118 to D.L.S., the European Research Council (grant agreement No. 637372), the Danish Council for Independent Research (grant agreement no. DFF-4002-00052) and an AIAS fellowship to B.P.P.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Becker D, 2007, BIOCHEMISTRY-US, V46, P13920, DOI 10.1021/bi701394h; Bertrand J, 2004, J BACTERIOL, V186, P5519, DOI 10.1128/JB.186.16.5519-5522.2004; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bramkamp M, 2005, BIOCHEMISTRY-US, V44, P8260, DOI 10.1021/bi050135n; Bramkamp M, 2007, MOL MEMBR BIOL, V24, P375, DOI 10.1080/09687680701418931; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; Cao Y, 2013, NATURE, V496, P317, DOI 10.1038/nature12056; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diskowski M, 2015, BIOL CHEM, V396, P1003, DOI 10.1515/hsz-2015-0123; Dorus S, 2001, J BIOL CHEM, V276, P9590, DOI 10.1074/jbc.M009365200; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EPSTEIN W, 1978, J BIOL CHEM, V253, P6666; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Eser E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115445; Fendler K, 1999, BIOCHEMISTRY-US, V38, P1850, DOI 10.1021/bi982238u; Gassel M, 1998, BBA-BIOMEMBRANES, V1415, P77, DOI 10.1016/S0005-2736(98)00179-5; Gassel M, 1999, J BIOL CHEM, V274, P37901, DOI 10.1074/jbc.274.53.37901; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Greie JC, 2011, EUR J CELL BIOL, V90, P705, DOI 10.1016/j.ejcb.2011.04.011; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; Heitkamp T, 2008, BIOCHEMISTRY-US, V47, P3564, DOI 10.1021/bi702038e; Heitkamp T, 2009, J STRUCT BIOL, V166, P295, DOI 10.1016/j.jsb.2009.02.016; Hu GB, 2008, J STRUCT BIOL, V161, P411, DOI 10.1016/j.jsb.2007.09.006; Irzik K, 2011, FEBS J, V278, P3041, DOI 10.1111/j.1742-4658.2011.08224.x; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Liu SA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3746; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 2003, ANN NY ACAD SCI, V986, P82, DOI 10.1111/j.1749-6632.2003.tb07142.x; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; PUPPE W, 1992, MOL MICROBIOL, V6, P3511, DOI 10.1111/j.1365-2958.1992.tb01786.x; Rasaiah JC, 2008, ANNU REV PHYS CHEM, V59, P713, DOI 10.1146/annurev.physchem.59.032607.093815; Schrader M, 2000, BIOPHYS J, V79, P802, DOI 10.1016/S0006-3495(00)76337-5; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SIEBERS A, 1988, EUR J BIOCHEM, V178, P131, DOI 10.1111/j.1432-1033.1988.tb14438.x; SIEBERS A, 1989, J BIOL CHEM, V264, P5831; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sitsel O, 2015, BIOCHEMISTRY-US, V54, P5673, DOI 10.1021/acs.biochem.5b00512; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; van der Laan M, 2002, J BACTERIOL, V184, P5491, DOI 10.1128/JB.184.19.5491-5494.2002; Vieira-Pires RS, 2013, NATURE, V496, P323, DOI 10.1038/nature12055; WALDERHAUG MO, 1992, J BACTERIOL, V174, P2152, DOI 10.1128/JB.174.7.2152-2159.1992; WARREN GB, 1974, BIOCHEMISTRY-US, V13, P5501, DOI 10.1021/bi00724a008; Wheeler MJ, 2012, ACTA CRYSTALLOGR F, V68, P111, DOI [10.1107/S1744309111054029111, 10.1107/S1744309111054029]; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	62	35	36	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					681	+		10.1038/nature22970	http://dx.doi.org/10.1038/nature22970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28636601	Green Accepted			2022-12-28	WOS:000404332000053
J	Livneh, Y; Ramesh, RN; Burgess, CR; Levandowski, KM; Madara, JC; Fenselau, H; Goldey, GJ; Diaz, VE; Jikomes, N; Resch, JM; Lowell, BB; Andermann, ML				Livneh, Yoav; Ramesh, Rohan N.; Burgess, Christian R.; Levandowski, Kirsten M.; Madara, Joseph C.; Fenselau, Henning; Goldey, Glenn J.; Diaz, Veronica E.; Jikomes, Nick; Resch, Jon M.; Lowell, Bradford B.; Andermann, Mark L.			Homeostatic circuits selectively gate food cue responses in insular cortex	NATURE			English	Article							BASOLATERAL AMYGDALA; GUSTATORY CORTEX; NEURONS; NUCLEUS; RATS; REPRESENTATIONS; THALAMUS; BEHAVIOR; SEEKING; REWARD	Physiological needs bias perception and attention to relevant sensory cues. This process is 'hijacked' by drug addiction, causing cue-induced cravings and relapse. Similarly, its dysregulation contributes to failed diets, obesity, and eating disorders. Neuroimaging studies in humans have implicated insular cortex in these phenomena. However, it remains unclear how 'cognitive' cortical representations of motivationally relevant cues are biased by subcortical circuits that drive specific motivational states. Here we develop a microprism-based cellular imaging approach to monitor visual cue responses in the insular cortex of behaving mice across hunger states. Insular cortex neurons demonstrate food-cuebiased responses that are abolished during satiety. Unexpectedly, while multiple satiety-related visceral signals converge in insular cortex, chemogenetic activation of hypothalamic 'hunger neurons' (expressing agouti-related peptide (AgRP)) bypasses these signals to restore hunger-like response patterns in insular cortex. Circuit mapping and pathwayspecific manipulations uncover a pathway from AgRP neurons to insular cortex via the paraventricular thalamus and basolateral amygdala. These results reveal a neural basis for state-specific biased processing of motivationally relevant cues.	[Livneh, Yoav; Ramesh, Rohan N.; Burgess, Christian R.; Levandowski, Kirsten M.; Madara, Joseph C.; Fenselau, Henning; Goldey, Glenn J.; Diaz, Veronica E.; Jikomes, Nick; Resch, Jon M.; Lowell, Bradford B.; Andermann, Mark L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Ramesh, Rohan N.; Jikomes, Nick; Lowell, Bradford B.; Andermann, Mark L.] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Lowell, BB; Andermann, ML (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.; Lowell, BB; Andermann, ML (corresponding author), Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA.	blowell@bidmc.harvard.edu; manderma@bidmc.harvard.edu	Livneh, Yoav/AAA-4007-2021	Livneh, Yoav/0000-0002-0434-4201; Burgess, Christian/0000-0001-6133-8089; Levandowski, Kirsten/0000-0002-4811-9217; Resch, Jon/0000-0002-5409-7771	Center for Neuroanatomy with Neurotropic Viruses [P40RR018604]; European Molecular Biology Organization postdoctoral fellowship; Edmond and Lily Safra Center for Brain Sciences postdoctoral award; Davis Family Foundation postdoctoral fellowship; National Science Foundation Graduate Research Fellowship Program; Sackler Scholars Program; National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NRSA [F31 DK105678, F32 DK103387]; NIH New Innovator Award [DP2 DK105570, R01 DK109930]; Klarman Family Foundation; McKnight Scholar Award; Pew Scholar Award; Smith Family Foundation; NIH [R01 DK075632, R01 DK096010, R01 DK089044, R01 DK111401, P30 DK046200, P30 DK057521]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096010, DP2DK105570, R01DK109930, F31DK105678, P30DK057521, R01DK089044, R01DK111401, P30DK020572, F32DK103387, P30DK046200, R01DK075632] Funding Source: NIH RePORTER	Center for Neuroanatomy with Neurotropic Viruses; European Molecular Biology Organization postdoctoral fellowship; Edmond and Lily Safra Center for Brain Sciences postdoctoral award; Davis Family Foundation postdoctoral fellowship; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Sackler Scholars Program; National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NRSA; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Family Foundation; McKnight Scholar Award; Pew Scholar Award; Smith Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Subramanian, N. Patel, M. Gyetvan, G. Niyazov, D. Anderson, and M. Dello Russo (mouse training), and A. Sugden (electronics). We thank the Lowell laboratory, Andermann laboratory, D. Nachmani, T. Anthony, and J. Assad for discussions. We thank the GENIE Project, Howard Hughes Medical Institute, for GCaMP6. The HSV129 Delta TK-TT was provided by the Center for Neuroanatomy with Neurotropic Viruses (grant P40RR018604). Authors were supported by a European Molecular Biology Organization postdoctoral fellowship; Edmond and Lily Safra Center for Brain Sciences postdoctoral award (Y.L.); Davis Family Foundation postdoctoral fellowship (C.R.B.); National Science Foundation Graduate Research Fellowship Program and the Sackler Scholars Program (N. J.); National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NRSA F31 DK105678 (R.N.R.); F32 DK103387 (J.M.R.); an NIH New Innovator Award DP2 DK105570 and R01 DK109930, the Klarman Family Foundation, a McKnight Scholar Award, a Pew Scholar Award and a Smith Family Foundation Award (M.L.A.); NIH R01s DK075632, DK096010, DK089044, DK111401, and P30s DK046200 and DK057521 (B.B.L.).	Accolla R, 2008, P NATL ACAD SCI USA, V105, P4010, DOI 10.1073/pnas.0708927105; Andermann ML, 2013, NEURON, V80, P900, DOI 10.1016/j.neuron.2013.07.052; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Burgess CR, 2016, NEURON, V91, P1154, DOI 10.1016/j.neuron.2016.07.032; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; de Araujo IE, 2006, NEURON, V51, P483, DOI 10.1016/j.neuron.2006.07.009; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Frank S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00499; Gardner MPH, 2014, J NEUROSCI, V34, P13000, DOI 10.1523/JNEUROSCI.1820-14.2014; Garfield AS, 2016, NAT NEUROSCI, V19, P1628, DOI 10.1038/nn.4392; Hanamori T, 1998, J NEUROPHYSIOL, V79, P2535, DOI 10.1152/jn.1998.79.5.2535; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huerta CI, 2014, OBESITY, V22, P1439, DOI 10.1002/oby.20659; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kusumoto-Yoshida I, 2015, P NATL ACAD SCI USA, V112, P1190, DOI 10.1073/pnas.1416573112; Labouebe G, 2016, NAT NEUROSCI, V19, P999, DOI 10.1038/nn.4331; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Naqvi NH, 2014, ANN NY ACAD SCI, V1316, P53, DOI 10.1111/nyas.12415; Oliveira-Maia AJ, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00005; Parkes SL, 2013, J NEUROSCI, V33, P8753, DOI 10.1523/JNEUROSCI.5071-12.2013; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Piette CE, 2012, J NEUROSCI, V32, P9981, DOI 10.1523/JNEUROSCI.0669-12.2012; Reimer J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13289; Saddoris MP, 2009, J NEUROSCI, V29, P15386, DOI 10.1523/JNEUROSCI.3233-09.2009; Samuelsen CL, 2012, NEURON, V74, P410, DOI 10.1016/j.neuron.2012.02.031; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; Stratford TR, 2013, BRAIN RES, V1490, P128, DOI 10.1016/j.brainres.2012.10.043; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954	49	145	149	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					611	+		10.1038/nature22375	http://dx.doi.org/10.1038/nature22375			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28614299	Green Accepted			2022-12-28	WOS:000404332000039
J	Green, J				Green, Jane			A year on, Brexit brings lessons in uncertainty	NATURE			English	Editorial Material									[Green, Jane] Univ Manchester, British Elect Study, Manchester, Lancs, England; [Green, Jane] Univ Manchester, Manchester, Lancs, England	University of Manchester; University of Manchester	Green, J (corresponding author), Univ Manchester, British Elect Study, Manchester, Lancs, England.; Green, J (corresponding author), Univ Manchester, Manchester, Lancs, England.	jane.green@manchester.ac.uk							0	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					453	453		10.1038/546453a	http://dx.doi.org/10.1038/546453a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28640283				2022-12-28	WOS:000403814100008
J	Mosialou, I; Shikhel, S; Liu, JM; Maurizi, A; Luo, N; He, ZY; Huang, YR; Zong, HH; Friedman, RA; Barasch, J; Lanzano, P; Deng, LY; Leibel, RL; Rubin, M; Nickolas, T; Chung, W; Zeltser, LM; Williams, KW; Pessin, JE; Kousteni, S				Mosialou, Ioanna; Shikhel, Steven; Liu, Jian-Min; Maurizi, Antonio; Luo, Na; He, Zhenyan; Huang, Yiru; Zong, Haihong; Friedman, Richard A.; Barasch, Jonathan; Lanzano, Patricia; Deng, Liyong; Leibel, Rudolph L.; Rubin, Mishaela; Nickolas, Thomas; Chung, Wendy; Zeltser, Lori M.; Williams, Kevin W.; Pessin, Jeffrey E.; Kousteni, Stavroula			MC4R-dependent suppression of appetite by bone-derived lipocalin 2 (vol 543, pg 385, 2017)	NATURE			English	Correction													Williams, Kevin W/AAA-4243-2020; Maurizi, Antonio/AAI-7728-2020; Williams, Kevin W/ABD-5818-2021	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658	NIDDK NIH HHS [R01 DK100699] Funding Source: Medline; NIMH NIH HHS [R01 MH113353] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Mosialou I, 2017, NATURE, V543, P385, DOI 10.1038/nature21697	1	3	3	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					440	440		10.1038/nature22808	http://dx.doi.org/10.1038/nature22808			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28617454	Bronze			2022-12-28	WOS:000403250900042
J	Voelker, R				Voelker, Rebecca			Decline in Death Rates Among Blacks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2272	2272		10.1001/jama.2017.6562	http://dx.doi.org/10.1001/jama.2017.6562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28609541				2022-12-28	WOS:000403149900005
J	Almeida, M; Pintacuda, G; Masui, O; Koseki, Y; Gdula, M; Cerase, A; Brown, D; Mould, A; Innocent, C; Nakayama, M; Schermelleh, L; Nesterova, TB; Koseki, H; Brockdorff, N				Almeida, Mafalda; Pintacuda, Greta; Masui, Osamu; Koseki, Yoko; Gdula, Michal; Cerase, Andrea; Brown, David; Mould, Arne; Innocent, Cassandravictoria; Nakayama, Manabu; Schermelleh, Lothar; Nesterova, Tatyana B.; Koseki, Haruhiko; Brockdorff, Neil			PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation	SCIENCE			English	Article							HISTONE H3 METHYLATION; XIST RNA; H2A UBIQUITYLATION; PRC2 RECRUITMENT; PROTEINS; COMPLEXES; RYBP; JARID2	Recruitment of the Polycomb repressive complexes PRC1 and PRC2 by Xist RNA is an important paradigm for chromatin regulation by long noncoding RNAs. Here, we show that the noncanonical Polycomb group RING finger 3/5 (PCGF3/5)-PRC1 complex initiates recruitment of both PRC1 and PRC2 in response to Xist RNA expression. PCGF3/5-PRC1-mediated ubiquitylation of histone H2A signals recruitment of other noncanonical PRC1 complexes and of PRC2, the latter leading to deposition of histone H3 lysine 27 methylation chromosome-wide. Pcgf3/5 gene knockout results in female-specific embryo lethality and abrogates Xist-mediated gene repression, highlighting a key role for Polycomb in Xist-dependent chromosome silencing. Our findings overturn existing models for Polycomb recruitment by Xist RNA and establish precedence for H2AK119u1 in initiating Polycomb domain formation in a physiological context.	[Almeida, Mafalda; Pintacuda, Greta; Gdula, Michal; Cerase, Andrea; Nesterova, Tatyana B.; Brockdorff, Neil] Univ Oxford, Dept Biochem, Dev Epigenet, Oxford OX1 3QU, England; [Masui, Osamu; Koseki, Yoko; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Lab Dev Genet, Tsurumi Ku, 1-7-22 Suehiro, Yokohama, Kanagawa 2300045, Japan; [Brown, David] Univ Oxford, Dept Biochem, Chromatin Biol & Transcript, Oxford OX1 3QU, England; [Mould, Arne] Univ Oxford, Sir William Dunn Sch Pathol, Mammalian Dev, South Parks Rd, Oxford OX1 3RE, England; [Innocent, Cassandravictoria; Schermelleh, Lothar] Univ Oxford, Dept Biochem, Micron Adv BioImaging Unit, Oxford OX1 3QU, England; [Nakayama, Manabu] Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Cerase, Andrea] European Mol Biol Lab Monterotondo, Adriano Buzzati Traverso Campus,Via Ramarini 32, I-00015 Monterotondo, Italy	University of Oxford; RIKEN; University of Oxford; University of Oxford; University of Oxford; Kazusa DNA Research Institute; European Molecular Biology Laboratory (EMBL)	Brockdorff, N (corresponding author), Univ Oxford, Dept Biochem, Dev Epigenet, Oxford OX1 3QU, England.	neil.brockdorff@bioch.ox.ac.uk	Gdula, Michal/AAX-2755-2020; Schermelleh, Lothar/H-4588-2019; Masui, Osamu/AAH-4111-2019; Cerase, Andrea/P-4741-2016	Gdula, Michal/0000-0002-8667-7359; Schermelleh, Lothar/0000-0002-1612-9699; Cerase, Andrea/0000-0002-1985-2049; Nesterova, Tatyana/0000-0001-7740-4386; Pintacuda, Greta/0000-0001-5126-2279; Almeida, Mafalda/0000-0002-3894-4248; Mould, Arne/0000-0002-2004-4348; Innocent, Cassandravictoria/0000-0002-2179-7093; Brockdorff, Neil/0000-0003-4838-2653	Wellcome Trust [103768, 091911, 102811, 092926]; European Research Council [340081]; Ph.D. fellowship from Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/51706/2011]; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency-Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16H02622, 16K14773] Funding Source: KAKEN	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Ph.D. fellowship from Fundacao para a Ciencia e Tecnologia, Portugal; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency-Agency for Medical Research and Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Brockdorff and Koseki laboratories for comments, A. Otte and F. Barr for antibodies, R. Klose for plasmids and antibodies, A. Bassett for facilitating CRISPR/Cas9 mutagenesis, D. Moralli and C. Green for transgene mapping, and E. Hookway for sequencing. Work in the N.B. laboratory was funded by grants from the Wellcome Trust (103768 and 091911) and European Research Council (340081). M.A. was funded by a Ph.D. fellowship from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/51706/2011). H.K. was funded by Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency-Agency for Medical Research and Development. A.M. was funded by Wellcome Trust (102811). Accession no. ArrayExpress E-MTAB-5642. D.B. was funded by a Wellcome Trust Ph.D. studentship (092926).	Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Cerase A, 2014, P NATL ACAD SCI USA, V111, P2235, DOI 10.1073/pnas.1312951111; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Cooper S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13661; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Tang YA, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-10; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	19	151	156	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1081	+		10.1126/science.aal2512	http://dx.doi.org/10.1126/science.aal2512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596365	Green Accepted, Green Published			2022-12-28	WOS:000402871700055
J	Faries, MB; Thompson, JF; Cochran, AJ; Andtbacka, RH; Mozzillo, N; Zager, JS; Jahkola, T; Bowles, TL; Testori, A; Beitsch, PD; Hoekstra, HJ; Moncrieff, M; Ingvar, C; Wouters, MWJM; Sabel, MS; Levine, EA; Agnese, D; Henderson, M; Dummer, R; Rossi, CR; Neves, RI; Trocha, SD; Wright, F; Byrd, DR; Matter, M; Hsueh, E; MacKenzie-Ross, A; Johnson, DB; Terheyden, P; Berger, AC; Huston, TL; Wayne, JD; Smithers, BM; Neuman, HB; Schneebaum, S; Gershenwald, JE; Ariyan, CE; Desai, DC; Jacobs, L; McMasters, KM; Gesierich, A; Hersey, P; Bines, SD; Kane, JM; Barth, RJ; McKinnon, G; Farma, JM; Schultz, E; Vidal-Sicart, S; Hoefer, RA; Lewis, JM; Scheri, R; Kelley, MC; Nieweg, OE; Noyes, RD; Hoon, DSB; Wang, HJ; Elashoff, DA; Elashoff, RM				Faries, M. B.; Thompson, J. F.; Cochran, A. J.; Andtbacka, R. H.; Mozzillo, N.; Zager, J. S.; Jahkola, T.; Bowles, T. L.; Testori, A.; Beitsch, P. D.; Hoekstra, H. J.; Moncrieff, M.; Ingvar, C.; Wouters, M. W. J. M.; Sabel, M. S.; Levine, E. A.; Agnese, D.; Henderson, M.; Dummer, R.; Rossi, C. R.; Neves, R. I.; Trocha, S. D.; Wright, F.; Byrd, D. R.; Matter, M.; Hsueh, E.; MacKenzie-Ross, A.; Johnson, D. B.; Terheyden, P.; Berger, A. C.; Huston, T. L.; Wayne, J. D.; Smithers, B. M.; Neuman, H. B.; Schneebaum, S.; Gershenwald, J. E.; Ariyan, C. E.; Desai, D. C.; Jacobs, L.; McMasters, K. M.; Gesierich, A.; Hersey, P.; Bines, S. D.; Kane, J. M.; Barth, R. J.; McKinnon, G.; Farma, J. M.; Schultz, E.; Vidal-Sicart, S.; Hoefer, R. A.; Lewis, J. M.; Scheri, R.; Kelley, M. C.; Nieweg, O. E.; Noyes, R. D.; Hoon, D. S. B.; Wang, H. -J.; Elashoff, D. A.; Elashoff, R. M.			Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPH-NODES; BIOPSY; MULTICENTER; TRIAL; LYMPHADENECTOMY; MORBIDITY; IMPACT	BACKGROUND Sentinel-lymph-node biopsy is associated with increased melanoma-specific survival (i.e., survival until death from melanoma) among patients with node-positive intermediate-thickness melanomas (1.2 to 3.5 mm). The value of completion lymph-node dissection for patients with sentinel-node metastases is not clear. METHODS In an international trial, we randomly assigned patients with sentinel-node metastases detected by means of standard pathological assessment or a multimarker molecular assay to immediate completion lymph-node dissection (dissection group) or nodal observation with ultrasonography (observation group). The primary end point was melanoma-specific survival. Secondary end points included disease-free survival and the cumulative rate of nonsentinel-node metastasis. RESULTS Immediate completion lymph-node dissection was not associated with increased melanoma-specific survival among 1934 patients with data that could be evaluated in an intention-to-treat analysis or among 1755 patients in the per-protocol analysis. In the per-protocol analysis, the mean (+/-SE) 3-year rate of melanoma-specific survival was similar in the dissection group and the observation group (86+/-1.3% and 86+/-1.2%, respectively; P = 0.42 by the log-rank test) at a median follow-up of 43 months. The rate of disease-free survival was slightly higher in the dissection group than in the observation group (68+/-1.7% and 63+/-1.7%, respectively; P = 0.05 by the log-rank test) at 3 years, based on an increased rate of disease control in the regional nodes at 3 years (92+/-1.0% vs. 77+/-1.5%; P<0.001 by the log-rank test); these results must be interpreted with caution. Nonsentinel-node metastases, identified in 11.5% of the patients in the dissection group, were a strong, independent prognostic factor for recurrence (hazard ratio, 1.78; P = 0.005). Lymphedema was observed in 24.1% of the patients in the dissection group and in 6.3% of those in the observation group. CONCLUSIONS Immediate completion lymph-node dissection increased the rate of regional disease control and provided prognostic information but did not increase melanoma-specific survival among patients with melanoma and sentinel-node metastases.	[Faries, M. B.; Hoon, D. S. B.] St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA 90404 USA; [Cochran, A. J.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA; [Wang, H. -J.; Elashoff, D. A.; Elashoff, R. M.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA; [Elashoff, D. A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Thompson, J. F.; Nieweg, O. E.] Melanoma Inst Australia, Sydney, NSW, Australia; [Thompson, J. F.; Nieweg, O. E.] Univ Sydney, Sydney, NSW, Australia; [Henderson, M.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Smithers, B. M.] Princess Alexandra Hosp, Brisbane, Qld, Australia; [Hersey, P.] Newcastle Melanoma Unit, Waratah, NSW, Australia; [Andtbacka, R. H.; Noyes, R. D.] Huntsman Canc Inst, Salt Lake City, UT USA; [Bowles, T. L.] Intermt Med Ctr, Intermt Healthcare Canc Serv, Murray, UT USA; [Mozzillo, N.] Ist Nazl Tumori Napoli, Naples, Italy; [Testori, A.] Ist Europeo Oncol, Milan, Italy; [Rossi, C. R.] Univ Padua, Ist Oncol Veneto, Padua, Italy; [Zager, J. S.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Jahkola, T.] Helsinki Univ Hosp, Helsinki, Finland; [Beitsch, P. D.] Dallas Surg Grp, Dallas, TX USA; [Hoekstra, H. J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Wouters, M. W. J. M.] Netherlands Canc Inst, Amsterdam, Netherlands; [Moncrieff, M.] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [MacKenzie-Ross, A.] Guys & St Thomas NHS Fdn Trust, London, England; [Ingvar, C.] Univ Lund Hosp, Swedish Melanoma Study Grp, Lund, Sweden; [Sabel, M. S.] Univ Michigan, Ann Arbor, MI USA; [Levine, E. A.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Scheri, R.] Duke Univ, Durham, NC USA; [Agnese, D.] Ohio State Univ, Columbus, OH 43210 USA; [Dummer, R.] Univ Zurich, Zurich, Switzerland; [Matter, M.] CHU Vaudois, Lausanne, Switzerland; [Neves, R. I.] Penn State Hershey Canc Inst, Hershey, PA USA; [Berger, A. C.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Farma, J. M.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Desai, D. C.] St Lukes Univ, Hlth Network, Bethlehem, PA USA; [Trocha, S. D.] Greenville Hlth Syst Canc Ctr, Greenville, SC USA; [Wright, F.] Sunnybrook Res Inst, Toronto, ON, Canada; [McKinnon, G.] Tom Baker Canc Clin, Calgary, AB, Canada; [Byrd, D. R.] Univ Washington, Seattle, WA 98195 USA; [Hsueh, E.] St Louis Univ, St Louis, MO 63103 USA; [Johnson, D. B.; Kelley, M. C.] Vanderbilt Univ, Nashville, TN USA; [Lewis, J. M.] Univ Tennessee, Knoxville, TN USA; [Terheyden, P.] Univ Hosp Schleswig Holstein, Campus Lubeck, Lubeck, Germany; [Gesierich, A.] Univ Hosp Wurzburg, Wurzburg, Germany; [Schultz, E.] City Hosp Nurnberg, Nurnberg, Germany; [Huston, T. L.] SUNY Stony Brook, Hosp Med Ctr, Stony Brook, NY 11794 USA; [Ariyan, C. E.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Kane, J. M.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Wayne, J. D.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bines, S. D.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Neuman, H. B.] Univ Wisconsin, Madison, WI 53706 USA; [Schneebaum, S.] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Gershenwald, J. E.] MD Anderson Med Ctr, Houston, TX USA; [Jacobs, L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [McMasters, K. M.] Univ Louisville, Louisville, KY 40292 USA; [Barth, R. J.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Vidal-Sicart, S.] Hosp Clin Barcelona, Barcelona, Spain; [Hoefer, R. A.] Sentara CarePlex Hosp, Hampton, VA USA	John Wayne Cancer Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Melanoma Institute Australia; University of Sydney; Peter Maccallum Cancer Center; Huntsman Cancer Institute; Intermountain Healthcare; Intermountain Medical Center; IRCCS European Institute of Oncology (IEO); IRCCS Istituto Oncologico Veneto (IOV); University of Padua; H Lee Moffitt Cancer Center & Research Institute; University of Helsinki; Helsinki University Central Hospital; University of Groningen; Netherlands Cancer Institute; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Guy's & St Thomas' NHS Foundation Trust; Lund University; Skane University Hospital; University of Michigan System; University of Michigan; Wake Forest University; Duke University; University System of Ohio; Ohio State University; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Jefferson University; Fox Chase Cancer Center; Greenville Health System; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tom Baker Cancer Clinic; University of Calgary; University of Washington; University of Washington Seattle; Saint Louis University; Vanderbilt University; University of Tennessee System; University of Tennessee Knoxville; University of Kiel; Schleswig Holstein University Hospital; University of Wurzburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Northwestern University; Feinberg School of Medicine; Rush University; University of Wisconsin System; University of Wisconsin Madison; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; University of Louisville; Dartmouth College; University of Barcelona; Hospital Clinic de Barcelona; Sentara Healthcare	Faries, MB (corresponding author), 11818 Wilshire Blvd,Suite 200, Los Angeles, CA 90025 USA.	mfaries@theangelesclinic.org	Ingvar, Christian/AAE-9841-2019; Smithers, Bernard Mark/F-2060-2010; hoekstra, harald/AAR-3263-2021; Neves, Rogerio Izar/AAV-5842-2020; Gershenwald, Jeff/AAX-4367-2020; Nieweg, Omgo E./AAN-6887-2020; Vidal-Sicart, Sergi/ABC-5818-2020; Maurice Joseph, César Matter/J-6717-2017; Rossi, Carlo Riccardo/A-7685-2010; Wouters, Michel/B-5882-2019	Smithers, Bernard Mark/0000-0002-8333-8685; Neves, Rogerio Izar/0000-0003-4866-5215; Gershenwald, Jeff/0000-0003-4519-5369; Vidal-Sicart, Sergi/0000-0002-6303-3606; Maurice Joseph, César Matter/0000-0003-1816-3003; Thompson, John/0000-0002-2816-2496; Moncrieff, Marc/0000-0003-4492-235X; TESTORI, ALESSANDRO/0000-0003-3685-0210; Agnese, Doreen/0000-0002-9910-9422; Rossi, Carlo Riccardo/0000-0001-7875-5655; Ariyan, Charlotte/0000-0003-0818-3895; Wouters, Michel/0000-0001-6173-0662	National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA189163, P01CA029605] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and others; MSLT-II ClinicalTrials.gov number, NCT00297895.	Altstein LL, 2011, STAT MED, V30, P709, DOI 10.1002/sim.4131; Australian Cancer Network Melanoma Guidelines Revision Working Party, 2008, CLIN PRACT GUID MAN; Bamboat ZM, 2014, ANN SURG ONCOL, V21, P3117, DOI 10.1245/s10434-014-3758-7; Chakera AH, 2009, EUR J NUCL MED MOL I, V36, P1713, DOI 10.1007/s00259-009-1228-4; Cochran AJ, 2004, MODERN PATHOL, V17, P747, DOI 10.1038/modpathol.3800117; Coit DG, 2016, J NATL COMPR CANC NE, V14, P945, DOI 10.6004/jnccn.2016.0101; Faries MB, 2010, ANN SURG ONCOL, V17, P3324, DOI 10.1245/s10434-010-1203-0; Garbe C, 2012, EUR J CANCER, V48, P2375, DOI 10.1016/j.ejca.2012.06.013; Lee DY, 2016, J AM COLL SURGEONS, V223, P9, DOI 10.1016/j.jamcollsurg.2016.01.045; Leiter U, 2016, LANCET ONCOL, V17, P757, DOI 10.1016/S1470-2045(16)00141-8; Leung AM, 2013, JAMA SURG, V148, P879, DOI 10.1001/jamasurg.2013.3044; McMasters KM, 2016, J CLIN ONCOL, V34, P1079, DOI 10.1200/JCO.2015.63.3776; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Reintgen M, 2013, ANN SURG ONCOL, V20, P668, DOI 10.1245/s10434-012-2652-4; Snow HM, 1892, LANCET, V140, P869, DOI [10.1016/S0140-6736(01)88089-2, DOI 10.1016/S0140-6736(01)88089-2]; Starz H, 2011, J CLIN ONCOL, V29, P4843, DOI 10.1200/JCO.2011.38.6284; Takeuchi H, 2004, J CLIN ONCOL, V22, P2671, DOI 10.1200/JCO.2004.12.009; Wong SL, 2006, ANN SURG ONCOL, V13, P809, DOI 10.1245/ASO.2006.03.058; Wong SL, 2012, J CLIN ONCOL, V30, P2912, DOI 10.1200/JCO.2011.40.3519	21	738	750	2	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2211	2222		10.1056/NEJMoa1613210	http://dx.doi.org/10.1056/NEJMoa1613210			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW8WG	28591523	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000402798200005
J	Hemens, BJ; Iorio, A				Hemens, Brian J.; Iorio, Alfonso			Computer-Aided Systematic Review Screening Comes of Age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH-CARE		[Hemens, Brian J.; Iorio, Alfonso] McMaster Univ, 1280 Main St W,HSC 2C, Hamilton, ON L3N 8Z5, Canada; [Iorio, Alfonso] McMaster Univ, Hlth Informat Res Unit, 1280 Main St W,CRL 140, Hamilton, ON M4Y 2X6, Canada	McMaster University; McMaster University	Iorio, A (corresponding author), McMaster Univ, Hlth Informat Res Unit, 1280 Main St W,CRL 140, Hamilton, ON L8S 4K1, Canada.	iorioa@mcmaster.ca	Iorio, Alfonso/B-9478-2013	Iorio, Alfonso/0000-0002-3331-8766				Eden J, 2011, FIND WHAT WORKS HLTH, DOI [10.17226/13059, DOI 10.17226/13059]; Garner P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3507; Hemens BJ, 2012, J CLIN EPIDEMIOL, V65, P62, DOI 10.1016/j.jclinepi.2011.02.010; Paynter R, 2016, 16EHC023EF AG HEALTH; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Sampson M, 2011, RES SYNTH METHODS, V2, P119, DOI 10.1002/jrsm.42; Shekelle PG, 2017, ANN INTERN MED, V167, P213, DOI 10.7326/L17-0124; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Wilczynski Nancy L, 2011, AMIA Annu Symp Proc, V2011, P1506; Wilczynski NL, 2001, STUD HEALTH TECHNOL, V84, P390	10	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					210	+		10.7326/M17-1295	http://dx.doi.org/10.7326/M17-1295			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28605802				2022-12-28	WOS:000406631400015
J	Bachelez, H				Bachelez, Herve			Interleukin 23 inhibitors for psoriasis: not just another number	LANCET			English	Editorial Material							ANTI-INTERLEUKIN-23 MONOCLONAL-ANTIBODY; PHASE-III; MODERATE; ADALIMUMAB; GUSELKUMAB; EFFICACY; SAFETY; TRIAL		[Bachelez, Herve] Univ Paris Diderot, Hop St Louis, AP HP,Inst Imagine, Sorbonne Paris Cite,Serv Dermatol,INSERM UMR 1163, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bachelez, H (corresponding author), Univ Paris Diderot, Hop St Louis, AP HP,Inst Imagine, Sorbonne Paris Cite,Serv Dermatol,INSERM UMR 1163, Paris, France.	herve.bachelez@sls.aphp.fr		bachelez, herve/0000-0003-3567-9095	AbbVie; Amgen; Boehringer Ingelheim; Baxalta; Celgene; Janssen; Leo Pharma; Eli Lilly; Novartis; Pfizer; Sun Pharmaceuticals; UCB	AbbVie(AbbVie); Amgen(Amgen); Boehringer Ingelheim(Boehringer Ingelheim); Baxalta; Celgene(Bristol-Myers SquibbCelgene Corporation); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Leo Pharma(LEO Pharma); Eli Lilly(Eli Lilly); Novartis(Novartis); Pfizer(Pfizer); Sun Pharmaceuticals; UCB(UCB Pharma SA)	I have received personal fees from AbbVie, Amgen, Boehringer Ingelheim, Baxalta, Celgene, Janssen, Leo Pharma, Eli Lilly, Novartis, Pfizer, Sun Pharmaceuticals, and UCB for work on psoriasis; non-financial support (travel grants and attendance at scientific congresses) from AbbVie, Celgene, and Janssen; and grants from Pfizer for work in psoriasis. I am also a principal investigator for AbbVie, Amgen, Boehringer ingelheim, Celgene, Novartis, and Pfizer for studies in psoriasis.	Bachelez H, 2015, LANCET, V386, P510, DOI 10.1016/S0140-6736(15)60857-1; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Harden JL, 2015, J ALLERGY CLIN IMMUN, V135, P553, DOI 10.1016/j.jaci.2014.05.046; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Papp KA, 2017, NEW ENGL J MED, V376, P1551, DOI 10.1056/NEJMoa1607017; Reich K., 2017, LANCET; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042; Reich K, 2017, J AM ACAD DERMATOL, V76, P441, DOI 10.1016/j.jaad.2016.10.027; Saunte DM, 2017, BRIT J DERMATOL, V177, P47, DOI 10.1111/bjd.15015	11	6	7	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					208	210		10.1016/S0140-6736(17)31474-5	http://dx.doi.org/10.1016/S0140-6736(17)31474-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5IZ	28596042				2022-12-28	WOS:000405477900006
J	Holmes, D				Holmes, David			EARDRUM REGENERATION: MEMBRANE REPAIR	NATURE			English	Editorial Material																			0	5	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					S5	S5		10.1038/546S5a	http://dx.doi.org/10.1038/546S5a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28636586	Bronze			2022-12-28	WOS:000403814100001
J	Kowal, E; Llamas, B; Tishkoff, S				Kowal, Emma; Llamas, Bastien; Tishkoff, Sarah			Data-sharing for indigenous peoples	NATURE			English	Letter									[Kowal, Emma] Deakin Univ, Melbourne, Vic, Australia; [Llamas, Bastien] Univ Adelaide, Adelaide, SA, Australia; [Tishkoff, Sarah] Univ Penn, Pittsburgh, PA USA	Deakin University; University of Adelaide; University of Pennsylvania	Kowal, E (corresponding author), Deakin Univ, Melbourne, Vic, Australia.	emma.kowal@deakin.edu.au	Llamas, Bastien/AAK-1693-2021; Llamas, Bastien/Y-2781-2018	Llamas, Bastien/0000-0002-5550-9176; Llamas, Bastien/0000-0002-5550-9176; Kowal, Emma/0000-0003-3866-3224				Kaye J, 2015, EUR J HUM GENET, V23, P141, DOI 10.1038/ejhg.2014.71; Knoppers Bartha Maria, 2014, Hugo J, V8, P3, DOI 10.1186/s11568-014-0003-1	2	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					474	474		10.1038/546474a	http://dx.doi.org/10.1038/546474a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640268	Green Submitted, Bronze			2022-12-28	WOS:000403814100018
J	Dunn, A				Dunn, Andrew			In VTE, extending anticoagulation with rivaroxaban vs aspirin reduced recurrence without increasing bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dunn, Andrew] Mt Sinai Hlth Syst New York, New York, NY 10029 USA		Dunn, A (corresponding author), Mt Sinai Hlth Syst New York, New York, NY 10029 USA.							Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC65	JC65		10.7326/ACPJC-2017-166-12-065	http://dx.doi.org/10.7326/ACPJC-2017-166-12-065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630977				2022-12-28	WOS:000403579000006
J	Friedrich, MJ				Friedrich, M. J.			Podoconiosis Is the Diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2362	2362		10.1001/jama.2017.6505	http://dx.doi.org/10.1001/jama.2017.6505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632875				2022-12-28	WOS:000403654600002
J	Kazmi, A				Kazmi, Ahmed			A GP's experience of the Grenfell Tower fire	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ahmedkazmi@doctors.org.uk							0	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2017	357								j2975	10.1136/bmj.j2975	http://dx.doi.org/10.1136/bmj.j2975			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YT	28634190				2022-12-28	WOS:000404210000011
J	Winzeler, EA				Winzeler, Elizabeth A.			Glycophorin alleles link to malaria protection	SCIENCE			English	Editorial Material									[Winzeler, Elizabeth A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92030 USA	University of California System; University of California San Diego	Winzeler, EA (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92030 USA.	ewinzeler@ucsd.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113				Band G, 2015, NATURE, V526, P253, DOI 10.1038/nature15390; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; Leffler EM, 2017, SCIENCE, V356, DOI 10.1126/science.aam6393; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; SCHOFIELD AE, 1992, NATURE, V355, P836, DOI 10.1038/355836a0; Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943	6	2	2	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1122	1123		10.1126/science.aan4184	http://dx.doi.org/10.1126/science.aan4184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619899				2022-12-28	WOS:000403327400014
J	Burgess, A; Vuong, J; Rogers, S; Malumbres, M; O'Donoghue, SI				Burgess, Andrew; Vuong, Jenny; Rogers, Samuel; Malumbres, Marcos; O'Donoghue, Sean I.			SnapShot: Phosphoregulation of Mitosis	CELL			English	Editorial Material							MITOTIC EXIT		[Burgess, Andrew; Rogers, Samuel; O'Donoghue, Sean I.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Burgess, Andrew] UNSW, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Vuong, Jenny; O'Donoghue, Sean I.] CSIRO, Data61, Sydney, NSW 2015, Australia; [Malumbres, Marcos] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain	Garvan Institute of Medical Research; University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Burgess, A (corresponding author), Garvan Inst Med Res, Sydney, NSW 2010, Australia.; Burgess, A (corresponding author), UNSW, St Vincents Clin Sch, Sydney, NSW 2010, Australia.		Burgess, Andrew/H-3339-2019; Burgess, Andrew/C-7952-2009; Malumbres, Marcos/E-8834-2011; O'Donoghue, Sean/A-9522-2012	Burgess, Andrew/0000-0003-4536-9226; Burgess, Andrew/0000-0003-4536-9226; Malumbres, Marcos/0000-0002-0829-6315; Rogers, Samuel/0000-0002-5345-5741; O'Donoghue, Sean/0000-0001-9520-6623	CINSW FRL [10/FRL/3-02]; Patricia Helen Guest Fellowship; MINECO [SAF2015-69920-R, ERDF-EU, BFU2014-52125-REDT]; CSIRO's OCE Science Leader programme	CINSW FRL; Patricia Helen Guest Fellowship; MINECO(Spanish Government); CSIRO's OCE Science Leader programme	A.B. is supported by CINSW FRL (ID# 10/FRL/3-02) and The Patricia Helen Guest Fellowship. S.R. is an Australian Government RTP Scholarship. M.M. is supported by MINECO (SAF2015-69920-R, ERDF-EU, and BFU2014-52125-REDT grants). J.V. and S.I. O'D. are supported by CSIRO's OCE Science Leader programme. The authors thank Benedetta Frida Baldi and Christopher Hammang for creative input.	Alvarez-Fernandez M, 2013, P NATL ACAD SCI USA, V110, P17374, DOI 10.1073/pnas.1310745110; Cundell MJ, 2016, J CELL BIOL, V214, P539, DOI 10.1083/jcb.201606033; Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Kuilman T, 2015, EMBO J, V34, P81, DOI 10.15252/embj.201488958; Ma DKG, 2013, AIP CONF PROC, V1559, P185, DOI 10.1063/1.4825010; McCloy RA, 2015, MOL CELL PROTEOMICS, V14, P2194, DOI 10.1074/mcp.M114.046938; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036	7	12	12	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7							1358.e1	10.1016/j.cell.2017.06.003	http://dx.doi.org/10.1016/j.cell.2017.06.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622516	Bronze			2022-12-28	WOS:000403332400023
J	Thomas, JJ; Brigham, KS; Sally, ST; Hazen, EP; Eddy, KT				Thomas, Jennifer J.; Brigham, Kathryn S.; Sally, Sarah T.; Hazen, Eric P.; Eddy, Kamryn T.			Case 18-2017: An 11-Year-Old Girl with Difficulty Eating after a Choking Incident	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOOD-INTAKE DISORDER; CHILDREN; PREVALENCE; PHOBIA		[Thomas, Jennifer J.; Hazen, Eric P.; Eddy, Kamryn T.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Brigham, Kathryn S.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Sally, Sarah T.] Massachusetts Gen Hosp, Dept Speech Language & Swallowing Disorders & Rea, Boston, MA 02114 USA; [Thomas, Jennifer J.; Hazen, Eric P.; Eddy, Kamryn T.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Brigham, Kathryn S.] Harvard Med Sch, Dept Pediat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Thomas, JJ (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.; Thomas, JJ (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.		Thomas, Jennifer J./AAM-4096-2020	Thomas, Jennifer J/0000-0003-2601-581X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103402, R01MH108595] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Arvedson JC, 2002, PEDIAT SWALLOWING FE, P527; Becker AE, 2009, INT J EAT DISORDER, V42, P620, DOI 10.1002/eat.20727; Becker AE, 2009, INT J EAT DISORDER, V42, P611, DOI 10.1002/eat.20723; Durvasula VSPB, 2014, OTOLARYNG CLIN N AM, V47, P691, DOI 10.1016/j.otc.2014.06.004; Eddy KT, 2015, INT J EAT DISORDER, V48, P464, DOI 10.1002/eat.22350; Eddy KT, 2010, J AM ACAD CHILD PSY, V49, P277, DOI 10.1016/j.jaac.2009.10.012; Golden NH, 2015, J ADOLESCENT HEALTH, V56, P370, DOI 10.1016/j.jadohealth.2014.11.020; Goldstein MA, 2011, PEDIATR REV, V32, P508, DOI 10.1542/pir.32-12-508; Katzman DK, 2014, PAED CHILD HEALT-CAN, V19, P445, DOI 10.1093/pch/19.8.445; Lock J, 2013, TREATMENT MANUAL ANO, V2nd; Lock J, 2007, INT J EAT DISORDER, V40, pS117; Logemann JA, 1998, EVALUATION TREATMENT, V2nd, P135; Marshall J, 2015, J PEDIATR GASTR NUTR, V60, P680, DOI 10.1097/MPG.0000000000000669; MCNALLY RJ, 1986, J BEHAV THER EXP PSY, V17, P185, DOI 10.1016/0005-7916(86)90025-X; Nicely TA, 2014, J EAT DISORD, V2, DOI 10.1186/s40337-014-0021-3; Nock MK, 2002, J BEHAV THER EXP PSY, V33, P217, DOI 10.1016/S0005-7916(02)00046-0; Norris ML, 2014, INT J EAT DISORDER, V47, P495, DOI 10.1002/eat.22217; Ornstein Rollyn M, 2014, Adolesc Med State Art Rev, V25, P360; Remington A, 2012, AM J CLIN NUTR, V95, P72, DOI 10.3945/ajcn.111.024596; Rosen DS, 2010, PEDIATRICS, V126, P1240, DOI 10.1542/peds.2010-2821; Tanidir C, 2015, J CHILD ADOL PSYCHOP, V25, P659, DOI 10.1089/cap.2015.0145; Thomas JJ, COGNITIVE B IN PRESS	23	22	26	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2377	2386		10.1056/NEJMcpc1616394	http://dx.doi.org/10.1056/NEJMcpc1616394			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28614676	Green Accepted			2022-12-28	WOS:000403230800013
J	Lane, R				Lane, Richard			Gerd Burmester: enduring leader in rheumatoid arthritis	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2279	2279		10.1016/S0140-6736(17)31498-8	http://dx.doi.org/10.1016/S0140-6736(17)31498-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28612741				2022-12-28	WOS:000402872700015
J	Sahu, KC; Anderson, J; Casertano, S; Bond, HE; Bergeron, P; Nelan, EP; Pueyo, L; Brown, TM; Bellini, A; Levay, ZG; Sokol, J; Dominik, M; Calamida, A; Kains, N; Livio, M				Sahu, Kailash C.; Anderson, Jay; Casertano, Stefano; Bond, Howard E.; Bergeron, Pierre; Nelan, Edmund P.; Pueyo, Laurent; Brown, Thomas M.; Bellini, Andrea; Levay, Zoltan G.; Sokol, Joshua; Dominik, Martin; Calamida, Annalisa; Kains, Noe; Livio, Mario			Relativistic deflection of background starlight measures the mass of a nearby white dwarf star	SCIENCE			English	Article							HUBBLE-SPACE-TELESCOPE; RADIUS RELATION; MICROLENSING EVENTS; PROPER MOTIONS; GALACTIC HALO; ASTROMETRY; CATALOG; SYSTEM; CONSTRAINTS; ISOCHRONES	Gravitational deflection of starlight around the Sun during the 1919 total solar eclipse provided measurements that confirmed Einstein's general theory of relativity. We have used the Hubble Space Telescope to measure the analogous process of astrometric microlensing caused by a nearby star, the white dwarf Stein 2051 B. As Stein 2051 B passed closely in front of a background star, the background star's position was deflected. Measurement of this deflection at multiple epochs allowed us to determine the mass of Stein 2051 B-the sixth-nearest white dwarf to the Sun-as 0.675 +/- 0.051 solar masses. This mass determination provides confirmation of the physics of degenerate matter and lends support to white dwarf evolutionary theory.	[Sahu, Kailash C.; Anderson, Jay; Casertano, Stefano; Nelan, Edmund P.; Pueyo, Laurent; Brown, Thomas M.; Bellini, Andrea; Levay, Zoltan G.; Sokol, Joshua; Calamida, Annalisa; Kains, Noe] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Bond, Howard E.] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA; [Bergeron, Pierre] Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Dominik, Martin] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Livio, Mario] Univ Nevada, Dept Phys & Astron, 4505 South Maryland Pkwy, Las Vegas, NV 89154 USA	Space Telescope Science Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universite de Montreal; University of St Andrews; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Sahu, KC (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	ksahu@stsci.edu	Dominik, Martin/AAA-9501-2020; Bellini, Andrea/O-4139-2019	Dominik, Martin/0000-0002-3202-0343; Bellini, Andrea/0000-0003-3858-637X; Sahu, Kailash/0000-0001-6008-1955; Brown, Thomas/0000-0002-1793-9968	Association of Universities for Research in Astronomy under NASA [NAS 5-26555]; NASA through a grant from STScI; Space Telescope Science Institute, NASA Administration [NNX08AR22G]; National Science Foundation [AST-1238877]; Qatar National Research Fund (QNRF) [NPRP 09-476-1-078]	Association of Universities for Research in Astronomy under NASA; NASA through a grant from STScI; Space Telescope Science Institute, NASA Administration; National Science Foundation(National Science Foundation (NSF)); Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF))	Based in part on observations made with the NASA-European Space Agency Hubble Space Telescope, obtained at Space Telescope Science Institute (STScI), which is operated by the Association of Universities for Research in Astronomy under NASA contract NAS 5-26555. HST data used in this paper are available from the Mikulski Archive for Space Telescopes at STScI (https://archive.stsci.edu/hst/search.php), under proposal ID 13457 and 14448. Support for this program was provided by NASA through a grant from STScI. We thank J. Mack and M. Sosey for help with image processing, P.-E. Tremblay for useful discussions, A. Rest for assistance with the Pan-STARRS data, D. Taylor for support with the observations, and G. Bacon for help with the preparation of an animated movie. The Pan-STARRS1 Surveys (PS1) have been made possible through contributions of the Institute for Astronomy, the University of Hawaii, the Pan-STARRS Project Office, the Max Planck Society and its participating institutes, Johns Hopkins University, Durham University, the University of Edinburgh, Queen's University Belfast, the Harvard-Smithsonian Center for Astrophysics, the Las Cumbres Observatory Global Telescope Network Incorporated, the National Central University of Taiwan, the Space Telescope Science Institute, NASA Administration under grant no. NNX08AR22G, the National Science Foundation under grant no. AST-1238877, the University of Maryland, and Eotvos Lorand University. M. D. thanks Qatar National Research Fund (QNRF) for support by grant NPRP 09-476-1-078.	ALCOCK C, 1993, NATURE, V365, P621, DOI 10.1038/365621a0; Anderson J, 2003, PUBL ASTRON SOC PAC, V115, P113, DOI 10.1086/345491; [Anonymous], 1919, NY TIMES, P6; AUBOURG E, 1993, NATURE, V365, P623, DOI 10.1038/365623a0; Bakos GA, 2002, ASTROPHYS J SUPPL S, V141, P187, DOI 10.1086/340115; Barstow MA, 2005, MON NOT R ASTRON SOC, V362, P1134, DOI 10.1111/j.1365-2966.2005.09359.x; Beaulieu JP, 2006, NATURE, V439, P437, DOI 10.1038/nature04441; Bellini A, 2011, PUBL ASTRON SOC PAC, V123, P622, DOI 10.1086/659878; Bergeron P, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/28; Bevington P. R., 2003, DATA REDUCTION ERROR; Bond HE, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6af8; Bond HE, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/2/106; Brown AGA, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629512; Chambers K. C., 2016, ARXIV161205560; Chandrasekhar S, 1935, MON NOT R ASTRON SOC, V96, P0021; Cummings JD, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/90; Davidson C., 1920, PHILOS T R SOC A, V220, P291, DOI DOI 10.1098/RSTA.1920.0009; Dominik M, 2000, ASTROPHYS J, V534, P213, DOI 10.1086/308716; Dressel L., 2014, WID FIELD CAM 3 INST; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; Einstein A, 1916, ANN PHYS-BERLIN, V49, P769; Gaudi BS, 2012, ANNU REV ASTRON ASTR, V50, P411, DOI 10.1146/annurev-astro-081811-125518; Giammichele N, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/29; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; HAMADA T, 1961, ASTROPHYS J, V134, P683, DOI 10.1086/147195; HARRINGTON RS, 1993, ASTRON J, V105, P1571, DOI 10.1086/116537; HEINTZ WD, 1990, ASTRON J, V99, P420, DOI 10.1086/115340; Holberg JB, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/68; Kalirai JS, 2008, ASTROPHYS J, V676, P594, DOI 10.1086/527028; Kruse E, 2014, SCIENCE, V344, P275, DOI 10.1126/science.1251999; Lasker BM, 2008, ASTRON J, V136, P735, DOI 10.1088/0004-6256/136/2/735; Lepine S, 2005, ASTRON J, V129, P1483, DOI 10.1086/427854; Luyten W. J., 1979, LHS CATALOG; Newton ER, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/20; Novati SC, 2002, ASTRON ASTROPHYS, V381, P848, DOI 10.1051/0004-6361:20011590; PACZYNSKI B, 1986, ASTROPHYS J, V304, P1, DOI 10.1086/164140; Paczynski B, 1996, ANNU REV ASTRON ASTR, V34, P419, DOI 10.1146/annurev.astro.34.1.419; Proft S, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117663; Provencal JL, 1998, ASTROPHYS J, V494, P759, DOI 10.1086/305238; Sahu KC, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/89; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Strand K., 1989, P IAU C, V114, P413; STRAND KA, 1977, ASTRON J, V82, P745, DOI 10.1086/112119; Tremblay PE, 2017, MON NOT R ASTRON SOC, V465, P2849, DOI 10.1093/mnras/stw2854; Treu T, 2010, ANNU REV ASTRON ASTR, V48, P87, DOI 10.1146/annurev-astro-081309-130924; UDALSKI A, 1993, ACTA ASTRONOM, V43, P289; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Will CM, 2014, LIVING REV RELATIV, V17, DOI 10.12942/lrr-2014-4; Zacharias N, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/44	50	61	61	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1046	1050		10.1126/science.aal2879	http://dx.doi.org/10.1126/science.aal2879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28592430	Green Submitted, Green Accepted			2022-12-28	WOS:000402871700047
J	Lannin, DR; Wang, SY				Lannin, Donald R.; Wang, Shiyi			Are Small Breast Cancers Good because They Are Small or Small because They Are Good?	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOJOURN TIME; OVERDIAGNOSIS		[Lannin, Donald R.] Yale Univ, Sch Med, Dept Surg, POB 208062, New Haven, CT 06520 USA; [Wang, Shiyi] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Lannin, Donald R.; Wang, Shiyi] Yale Comprehens Canc Ctr, New Haven, CT USA	Yale University; Yale University; Yale University	Lannin, DR (corresponding author), Yale Univ, Sch Med, Dept Surg, POB 208062, New Haven, CT 06520 USA.			Wang, Shi-Yi/0000-0002-3294-5784				Amin MB, 2017, AJCC CANC STAGING MA; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Drukker CA, 2014, BREAST CANCER RES TR, V144, P103, DOI 10.1007/s10549-013-2830-5; DUFFY SW, 1995, STAT MED, V14, P1531, DOI 10.1002/sim.4780141404; Etzioni R, 2014, JNCI-J NATL CANCER I, V106, P106; Hayse B, 2016, SURGERY, V160, P454, DOI 10.1016/j.surg.2016.03.031; Reis JS, 2005, PATHOL RES PRACT, V201, P713, DOI 10.1016/j.prp.2005.05.013; Schymik B, 2012, BREAST CANCER RES TR, V135, P693, DOI 10.1007/s10549-012-2195-1; Shen Y, 2001, J CLIN ONCOL, V19, P3490, DOI 10.1200/JCO.2001.19.15.3490; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Surveillance Epidemiology andEndResults(SEER) Program, RES DAT 1973 2013; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249	13	56	57	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2286	2291		10.1056/NEJMsr1613680	http://dx.doi.org/10.1056/NEJMsr1613680			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW8WG	28591529	Bronze			2022-12-28	WOS:000402798200016
J	Topiwala, A; Allan, CL; Valkanova, V; Zsoldos, E; Filippini, N; Sexton, C; Mahmood, A; Fooks, P; Singh-Manoux, A; Mackay, CE; Kivimaki, M; Ebmeier, KP				Topiwala, Anya; Allan, Charlotte L.; Valkanova, Vyara; Zsoldos, Eniko; Filippini, Nicola; Sexton, Claire; Mahmood, Abda; Fooks, Peggy; Singh-Manoux, Archana; Mackay, Clare E.; Kivimaki, Mika; Ebmeier, Klaus P.			Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIPPOCAMPAL VOLUME; ALZHEIMERS-DISEASE; CAGE QUESTIONNAIRE; CORPUS-CALLOSUM; COMMON VARIANTS; VERBAL FLUENCY; MRI; DEMENTIA; ATROPHY; MATTER	OBJECTIVES To investigate whether moderate alcohol consumption has a favourable or adverse association or no association with brain structure and function. DESIGN Observational cohort study with weekly alcohol intake and cognitive performance measured repeatedly over 30 years (1985-2015). Multimodal magnetic resonance imaging (MRI) was performed at study endpoint (2012-15). SETTING Community dwelling adults enrolled in the Whitehall II cohort based in the UK (the Whitehall II imaging substudy). PARTICIPANTS 550 men and women with mean age 43.0 (SD 5.4) at study baseline, none were "alcohol dependent" according to the CAGE screening questionnaire, and all safe to undergo MRI of the brain at follow-up. Twenty three were excluded because of incomplete or poor quality imaging data or gross structural abnormality (such as a brain cyst) or incomplete alcohol use, sociodemographic, health, or cognitive data. MAIN OUTCOME MEASURES Structural brain measures included hippocampal atrophy, grey matter density, and white matter microstructure. Functional measures included cognitive decline over the study and cross sectional cognitive performance at the time of scanning. RESULTS Higher alcohol consumption over the 30 year follow-up was associated with increased odds of hippocampal atrophy in a dose dependent fashion. While those consuming over 30 units a week were at the highest risk compared with abstainers (odds ratio 5.8, 95% confidence interval 1.8 to 18.6; P <= 0.001), even those drinking moderately (14-21 units/week) had three times the odds of right sided hippocampal atrophy (3.4, 1.4 to 8.1; P=0.007). There was no protective effect of light drinking (1-<7 units/week) over abstinence. Higher alcohol use was also associated with differences in corpus callosum microstructure and faster decline in lexical fluency. No association was found with cross sectional cognitive performance or longitudinal changes in semantic fluency or word recall. CONCLUSIONS Alcohol consumption, even at moderate levels, is associated with adverse brain outcomes including hippocampal atrophy. These results support the recent reduction in alcohol guidance in the UK and question the current limits recommended in the US.	[Topiwala, Anya; Allan, Charlotte L.; Valkanova, Vyara; Zsoldos, Eniko; Filippini, Nicola; Mahmood, Abda; Mackay, Clare E.; Ebmeier, Klaus P.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Sexton, Claire] Univ Oxford, FMRIB Ctr, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Fooks, Peggy] Univ Oxford, Warneford Hosp, Oxford OX3 9DU, England; [Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Oxford; University of Oxford; University of Oxford; University of London; University College London	Topiwala, A (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	anya.topiwala@psych.ox.ac.uk	Sexton, Claire/W-3990-2019; Singh-Manoux, Archana/F-6804-2013; Filippini, Nicola/H-6869-2013; Ebmeier, Klaus Peter/B-4789-2008; Filippini, Nicola/Q-5250-2019	Sexton, Claire/0000-0002-3846-2986; Singh-Manoux, Archana/0000-0002-1244-5037; Filippini, Nicola/0000-0003-1513-5269; Ebmeier, Klaus Peter/0000-0002-5190-7038; Filippini, Nicola/0000-0003-1513-5269; Mackay, Clare/0000-0001-6111-8318; Mahmood, Abda/0000-0002-3267-4590; Topiwala, Anya/0000-0002-8408-0372; Kivimaki, Mika/0000-0002-4699-5627; Zsoldos, Eniko/0000-0002-0478-6165; Allan, Charlotte/0000-0001-6827-5420	UK Medical Research Council [G1001354]; Gordon Edward Small's Charitable Trust [SC008962]; HDH Wills 1965 charitable trust [1117747]; Medical Research Council [K013351]; NordForsk; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [G1001354, MR/L023784/1, MR/M024962/1, MC_EX_MR/N50192X/1, MR/L023784/2, MR/K013351/1] Funding Source: researchfish; Parkinson&quot;s UK [J-1403] Funding Source: researchfish; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/L023784/1, MR/K013351/1, MC_EX_MR/N50192X/1, MR/L023784/2, MR/M024962/1, G1001354] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gordon Edward Small's Charitable Trust; HDH Wills 1965 charitable trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by UK Medical Research Council (G1001354; KPE), the Gordon Edward Small's Charitable Trust (SC008962; KPE), and the HDH Wills 1965 charitable trust (charity No: 1117747; KPE). MK was supported by the Medical Research Council (K013351) and NordForsk.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2015, 2015 2020 DIETARY GU; Anstey KJ, 2006, PSYCHOSOM MED, V68, P778, DOI 10.1097/01.psy.0000237779.56500.af; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; ARENDT T, 1988, NATURE, V332, P448, DOI 10.1038/332448a0; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; BENGOECHEA O, 1991, NEUROSCI LETT, V123, P112, DOI 10.1016/0304-3940(91)90170-X; BERESFORD TP, 1990, LANCET, V336, P482, DOI 10.1016/0140-6736(90)92022-A; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bookstein FL, 2002, NEUROIMAGE, V15, P233, DOI 10.1006/nimg.2001.0977; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Brown ES, 2014, NEUROPSYCHOPHARMACOL, V39, P770, DOI 10.1038/npp.2013.271; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; CADETELEITE A, 1989, ALCOHOL, V6, P303, DOI 10.1016/0741-8329(89)90087-6; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; CUENOD CA, 1993, ARCH NEUROL-CHICAGO, V50, P941, DOI 10.1001/archneur.1993.00540090046009; de Bruin EA, 2005, NEUROIMAGE, V26, P536, DOI 10.1016/j.neuroimage.2005.01.036; den Heijer T, 2004, AM J CLIN NUTR, V80, P992, DOI 10.1093/ajcn/80.4.992; Ding JZ, 2004, STROKE, V35, P16, DOI 10.1161/01.STR.0000105929.88691.8E; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Fein G, 2006, NEUROIMAGE, V32, P1465, DOI 10.1016/j.neuroimage.2006.06.013; Filippini N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-159; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Fukuda K, 2009, J NEUROL SCI, V278, P30, DOI 10.1016/j.jns.2008.11.007; Gu Y, 2014, CLIN NUTR, V33, P662, DOI 10.1016/j.clnu.2013.08.004; HARPER C, 1988, J NEUROL NEUROSUR PS, V51, P909, DOI 10.1136/jnnp.51.7.909; Harper Lorna, 2016, Brain, V139, P1211, DOI 10.1093/brain/aww005; Health Do, 2016, KEEP HLTH RISK DRINK; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; HM Government, 2012, GOV ALC STRAT; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Koob GF, 2003, EUR NEUROPSYCHOPHARM, V13, P442, DOI 10.1016/j.euroneuro.2003.08.005; Kubota M, 2001, J NEUROL NEUROSUR PS, V71, P104, DOI 10.1136/jnnp.71.1.104; LANGLAIS PJ, 1995, BEHAV BRAIN RES, V68, P75, DOI 10.1016/0166-4328(94)00162-9; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; McGuire LC, 2007, ANN EPIDEMIOL, V17, P93, DOI 10.1016/j.annepidem.2006.06.005; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MCMULLEN PA, 1984, J COMP NEUROL, V225, P111, DOI 10.1002/cne.902250112; Molenberghs G, 2007, AM STAT, V61, P22, DOI 10.1198/000313007X171322; Mooney C.Z., 1997, MONTE CARLO SIMULATI, DOI [DOI 10.4135/9781412985116, 10.4135/9781412985116]; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Paul CA, 2008, ARCH NEUROL-CHICAGO, V65, P1363, DOI 10.1001/archneur.65.10.1363; Pfefferbaum A, 1996, ALCOHOL CLIN EXP RES, V20, P752, DOI 10.1111/j.1530-0277.1996.tb01682.x; POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215; Preti A, 2014, PSYCHIAT RES-NEUROIM, V224, P96, DOI 10.1016/j.pscychresns.2014.06.005; R_Core_Team, 2015, R LANG ENV STAT COMP; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; Sabia S, 2014, NEUROLOGY, V82, P332, DOI 10.1212/WNL.0000000000000063; Sachdev PS, 2008, PSYCHIAT RES-NEUROIM, V163, P61, DOI 10.1016/j.pscychresns.2007.08.009; Sasaki H, 2009, NEUROIMAGE, V46, P505, DOI 10.1016/j.neuroimage.2009.02.007; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; SOININEN HS, 1994, NEUROLOGY, V44, P1660, DOI 10.1212/WNL.44.9.1660; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; Thomas AG, 2016, NEUROIMAGE, V131, P162, DOI 10.1016/j.neuroimage.2015.10.090; Tohgi H, 1997, NEUROSCI LETT, V236, P21, DOI 10.1016/S0304-3940(97)00743-X; Touvier M, 2014, INT J CANCER, V134, P445, DOI 10.1002/ijc.28365; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wrase J, 2008, AM J PSYCHIAT, V165, P1179, DOI 10.1176/appi.ajp.2008.07121877	78	199	202	5	75	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2017	357								j2353	10.1136/bmj.j2353	http://dx.doi.org/10.1136/bmj.j2353			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4QY	28588063	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000403221000001
J	Forster, D; Moorhead, AM; Jacobs, SE; Davis, PG; Walker, SP; McEgan, KM; Opie, GF; Donath, SM; Gold, L; McNamara, C; Aylward, A; East, C; Ford, R; Amir, LH				Forster, Della A.; Moorhead, Anita M.; Jacobs, Susan E.; Davis, Peter G.; Walker, Susan P.; McEgan, Kerri M.; Opie, Gillian F.; Donath, Susan M.; Gold, Lisa; McNamara, Catharine; Aylward, Amanda; East, Christine; Ford, Rachael; Amir, Lisa H.			Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial	LANCET			English	Article							MATERNAL OBESITY; LACTATION; EPIDEMIOLOGY; OUTCOMES; GLUCOSE; INFANTS; MOTHERS	Background Infants of women with diabetes in pregnancy are at increased risk of hypoglycaemia, admission to a neonatal intensive care unit (NICU), and not being exclusively breastfed. Many clinicians encourage women with diabetes in pregnancy to express and store breastmilk in late pregnancy, yet no evidence exists for this practice. We aimed to determine the safety and efficacy of antenatal expressing in women with diabetes in pregnancy. Methods We did a multicentre, two-group, unblinded, randomised controlled trial in six hospitals in Victoria, Australia. We recruited women with pre-existing or gestational diabetes in a singleton pregnancy from 34 to 37 weeks' gestation and randomly assigned them (1:1) to either expressing breastmilk twice per day from 36 weeks' gestation (antenatal expressing) or standard care (usual midwifery and obstetric care, supplemented by support from a diabetes educator). Randomisation was done with a computerised random number generator in blocks of size two and four, and was stratified by site, parity, and diabetes type. Investigators were masked to block size but masking of caregivers was not possible. The primary outcome was the proportion of infants admitted to the NICU. We did the analyses by intention to treat; the data were obtained and analysed masked to group allocation. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12611000217909. Findings Between June 6, 2011, and Oct 29, 2015, we recruited and randomly assigned 635 women: 319 to antenatal expressing and 316 to standard care. Three were not included in the primary analysis (one withdrawal from the standard care group, and one post-randomisation exclusion and one withdrawal from the antenatal expressing group). The proportion of infants admitted to the NICU did not differ between groups (46 [15%] of 317 assigned to antenatal expressing vs 44 [14%] of 315 assigned to standard care; adjusted relative risk 1.06, 95% CI 0.66 to 1.46). In the antenatal expressing group, the most common serious adverse event for infants was admission to the NICU for respiratory support (for three [<1%] of 317. In the standard care group, the most common serious adverse event for infants was moderate to severe encephalopathy with or without seizures (for three [<1%] of 315). Interpretation There is no harm in advising women with diabetes in pregnancy at low risk of complications to express breastmilk from 36 weeks' gestation. Funding Australian National Health and Medical Research Council.	[Forster, Della A.; Moorhead, Anita M.; Amir, Lisa H.] La Trobe Univ, Sch Nursing & Midwifery, Judith Lumley Ctr, 215 Franklin St, Melbourne, Vic 3000, Australia; [Forster, Della A.; Moorhead, Anita M.; Jacobs, Susan E.; Davis, Peter G.; Walker, Susan P.; Aylward, Amanda; Ford, Rachael; Amir, Lisa H.] Royal Womens Hosp, Parkville, Vic, Australia; [Jacobs, Susan E.; Davis, Peter G.; Walker, Susan P.; Opie, Gillian F.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Donath, Susan M.] Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic, Australia; [Jacobs, Susan E.] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Walker, Susan P.; McEgan, Kerri M.; Opie, Gillian F.; McNamara, Catharine] Mercy Hosp Women, Heidelberg, Vic, Australia; [Gold, Lisa] Deakin Univ, Sch Hlth & Social Dev, Geelong, Vic, Australia; [East, Christine] Monash Univ & Monash Hlth, Sch Nursing & Midwifery, Clayton, Vic, Australia	La Trobe University; University of Melbourne; Murdoch Children's Research Institute; Murdoch Children's Research Institute; Deakin University	Forster, D (corresponding author), La Trobe Univ, Sch Nursing & Midwifery, Judith Lumley Ctr, 215 Franklin St, Melbourne, Vic 3000, Australia.	d.forster@latrobe.edu.au	Amir, Lisa/AAA-9786-2019; East, Christine/H-4938-2013	Amir, Lisa/0000-0002-2510-1399; East, Christine/0000-0002-1196-8426; Donath, Susan/0000-0003-2489-3977; Gold, Lisa/0000-0002-2733-900X	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aune D, 2014, NUTR METAB CARDIOVAS, V24, P107, DOI 10.1016/j.numecd.2013.10.028; Australian Institute of Health and Welfare, 2009, AIHW DIAB SER, V14; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Chapman T, 2013, WOMEN BIRTH, V26, P41, DOI 10.1016/j.wombi.2012.01.001; Cox Sue, 2010, Breastfeed Rev, V18, P5; De Bortoli J, 2016, DIABETIC MED, V33, P17, DOI 10.1111/dme.12846; Della Forster A, 2011, MIDWIFERY, V27, pE301, DOI 10.1016/j.midw.2010.03.003; East CE, 2014, COCHRANE DB SYST REV, V7; Fenger-Gron J, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0051-8; Forster DA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006571; Forster DA, 2011, MIDWIFERY, V27, P209, DOI 10.1016/j.midw.2009.05.009; Hawkins JS, 2007, OBSTET GYN CLIN N AM, V34, P323, DOI 10.1016/j.ogc.2007.04.003; Ho HT, 2004, ARCH DIS CHILD-FETAL, V89, pF356, DOI 10.1136/adc.2003.033548; Martens PJ, 2016, OBSTET GYNECOL, V128, P1095, DOI 10.1097/AOG.0000000000001689; Mitanchez D, 2015, BEST PRACT RES CL OB, V29, P256, DOI 10.1016/j.bpobgyn.2014.08.004; Mitanchez D, 2014, J PEDIATR-US, V164, P445, DOI 10.1016/j.jpeds.2013.10.076; MURTAUGH M A, 1989, FASEB Journal, V3, pA769; Nommsen-Rivers LA, 2016, ADV NUTR, V7, P407, DOI 10.3945/an.115.011007; Nucci AM, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12354; Oza-Frank R, 2016, J HUM LACT, V32, P658, DOI 10.1177/0890334416663196; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Renfrew MJ, 2010, CHILD CARE HLTH DEV, V36, P165, DOI 10.1111/j.1365-2214.2009.01018.x; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Soltani H, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-18; Tozier PK, 2013, JOGNN-J OBST GYN NEO, V42, P619, DOI 10.1111/1552-6909.12260; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wszolek K., 2015, BR J MIDWIFERY, V23, P268	30	42	43	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2204	2213		10.1016/S0140-6736(17)31373-9	http://dx.doi.org/10.1016/S0140-6736(17)31373-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW5JC	28589894				2022-12-28	WOS:000402540800028
J	Neal, B; Perkovic, V; Mahaffey, KW; de Zeeuw, D; Fulcher, G; Erondu, N; Shaw, W; Law, G; Desai, M; Matthews, DR				Neal, Bruce; Perkovic, Vlado; Mahaffey, Kenneth W.; de Zeeuw, Dick; Fulcher, Greg; Erondu, Ngozi; Shaw, Wayne; Law, Gordon; Desai, Mehul; Matthews, David R.		CANVAS Program Collaborative Grp	Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE GLUCOSE CONTROL; ATRIAL-NATRIURETIC-PEPTIDE; BASE-LINE CHARACTERISTICS; STAGE KIDNEY-DISEASE; OUTCOMES; EMPAGLIFLOZIN; PROGRESSION; INHIBITORS; RATIONALE; DESIGN	BACKGROUND Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that reduces glycemia as well as blood pressure, body weight, and albuminuria in people with diabetes. We report the effects of treatment with canagliflozin on cardiovascular, renal, and safety outcomes. METHODS The CANVAS Program integrated data from two trials involving a total of 10,142 participants with type 2 diabetes and high cardiovascular risk. Participants in each trial were randomly assigned to receive canagliflozin or placebo and were followed for a mean of 188.2 weeks. The primary outcome was a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. RESULTS The mean age of the participants was 63.3 years, 35.8% were women, the mean duration of diabetes was 13.5 years, and 65.6% had a history of cardiovascular disease. The rate of the primary outcome was lower with canagliflozin than with placebo (occurring in 26.9 vs. 31.5 participants per 1000 patient-years; hazard ratio, 0.86; 95% confidence interval [CI], 0.75 to 0.97; P< 0.001 for noninferiority; P = 0.02 for superiority). Although on the basis of the prespecified hypothesis testing sequence the renal outcomes are not viewed as statistically significant, the results showed a possible benefit of canagliflozin with respect to the progression of albuminuria (hazard ratio, 0.73; 95% CI, 0.67 to 0.79) and the composite outcome of a sustained 40% reduction in the estimated glomerular filtration rate, the need for renal-replacement therapy, or death from renal causes (hazard ratio, 0.60; 95% CI, 0.47 to 0.77). Adverse reactions were consistent with the previously reported risks associated with canagliflozin except for an increased risk of amputation (6.3 vs. 3.4 participants per 1000 patient-years; hazard ratio, 1.97; 95% CI, 1.41 to 2.75); amputations were primarily at the level of the toe or metatarsal. CONCLUSIONS In two trials involving patients with type 2 diabetes and an elevated risk of cardiovascular disease, patients treated with canagliflozin had a lower risk of cardiovascular events than those who received placebo but a greater risk of amputation, primarily at the level of the toe or metatarsal.	[Neal, Bruce; Perkovic, Vlado] UNSW Sydney, Fac Med, George Inst Global Hlth, Sydney, NSW, Australia; [Neal, Bruce] Charles Perkins Ctr, Sydney, NSW, Australia; [Perkovic, Vlado; Fulcher, Greg] Royal North Shore Hosp, Sydney, NSW, Australia; [Neal, Bruce] Univ Sydney, Sydney, NSW, Australia; [Neal, Bruce] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Neal, Bruce] Imperial Coll London, London, England; [Matthews, David R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Matthews, David R.] Univ Oxford, Harris Manchester Coll, Oxford, England; [Mahaffey, Kenneth W.] Stanford Univ, Dept Med, Sch Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA; [de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Erondu, Ngozi; Shaw, Wayne; Law, Gordon; Desai, Mehul] Janssen Res & Dev, Raritan, NJ USA	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; University of New South Wales Sydney; Imperial College London; University of Oxford; University of Oxford; Stanford University; University of Groningen; Johnson & Johnson; Janssen Pharmaceuticals	Neal, B (corresponding author), UNSW Sydney, George Inst Global Hlth, Level 5,1 King St, Newtown, NSW 2042, Australia.	bneal@georgeinstitute.org.au	Malynovsky, Yaroslav/T-1898-2017; de Zeeuw, Dick/E-9080-2014; Salas-Salvado, Jordi/C-7229-2017; Boldueva, Svetlana/AAH-3862-2019; Vigil, Luis/C-6875-2016; Panina, Svitlana/W-2900-2019; sharma, kamal/AAG-7271-2019; Khokhlov, Alexander L./E-2765-2017; Perkovic, Vlado/AAY-1933-2021; Buse, John Bernard/J-9742-2019; Mirolyubova, Olga/C-8376-2018; Oliveras, Anna/I-2269-2019; Rafalskiy, Vladimir V/G-3172-2013; Nolan, Christopher J/B-2026-2008; Genovese, Stefano/F-9706-2017; Pijl, Hanno/W-8719-2018	Malynovsky, Yaroslav/0000-0002-9118-1104; de Zeeuw, Dick/0000-0003-3434-7777; Salas-Salvado, Jordi/0000-0003-2700-7459; Boldueva, Svetlana/0000-0002-1898-084X; Vigil, Luis/0000-0001-7484-2911; Panina, Svitlana/0000-0003-1080-7185; sharma, kamal/0000-0001-5866-2566; Khokhlov, Alexander L./0000-0002-0032-0341; Buse, John Bernard/0000-0002-9723-3876; Mirolyubova, Olga/0000-0003-4562-8398; Oliveras, Anna/0000-0002-5503-545X; Rafalskiy, Vladimir V/0000-0002-2503-9580; Nolan, Christopher J/0000-0002-6964-3819; Genovese, Stefano/0000-0002-6085-437X; Tinahones, Francisco J/0000-0001-6871-4403; Madej, Andrzej/0000-0002-7626-0840; TOFE, SANTIAGO/0000-0003-3034-4667; Pijl, Hanno/0000-0002-3076-1551; Hocking, Samantha/0000-0002-2514-9392; Alpizar, Melchor/0000-0003-2033-481X; Neal, Bruce/0000-0002-0490-7465; FERNANDEZ-BALSELLS, MERCE/0000-0001-8221-4237	Janssen Research and Development; Janssen Global Services	Janssen Research and Development; Janssen Global Services	Funded by Janssen Research and Development; CANVAS and CANVAS-R ClinicalTrials.gov numbers, NCT01032629 and NCT01989754, respectively.; We thank all investigators, trial teams, and patients for participating in these trials and the following people for their contributions to the statistical monitoring and analyses and the protocol development, safety monitoring, and operational implementation over the duration of the two trials: Lyndal Hones, Lucy Perry, Sharon Dunkley, Tao Sun, Hsiaowei Deng, George Capuano, Qiang Li, Severine Bompoint, Laurent Billot, Mary Lee, Joan Lind, Roger Simpson, Mary Kavalam, Terry Barrett, Ed Connell, Michele Wells, Jacqueline Yee, Dainius Balis, Frank Vercruysse, Elisa Fabbrini, Richard Oh, Nicole Meyers, Gary Meininger, and Norm Rosenthal. Medical writing support was provided by Kimberly Dittmar, Ph.D., of MedErgy, and was funded by Janssen Global Services.	BALLERMANN BJ, 1987, AM J KIDNEY DIS, V10, P7; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; COX DR, 1972, J R STAT SOC B, V34, P187; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Neal B, 2017, DIABETES OBES METAB; Neal B, 2017, DIABETES OBES METAB, V19, P387, DOI 10.1111/dom.12829; Neal B, 2013, AM HEART J, V166, P217, DOI 10.1016/j.ahj.2013.05.007; ORTOLA FV, 1987, J CLIN INVEST, V80, P670, DOI 10.1172/JCI113120; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Rabelink TJ, 2015, NAT REV NEPHROL, V11, P667, DOI 10.1038/nrneph.2015.162; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Vallianou NG, 2016, DIABETES METAB SYNDR; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Watts NB, 2016, J CLIN ENDOCR METAB, V101, P156, DOI 10.1210/jc.2015-3167; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wong MG, 2016, DIABETES CARE, V39, P694, DOI 10.2337/dc15-2322; Wu JHY, 2016, LANCET DIABETES ENDO, V4, P411, DOI 10.1016/S2213-8587(16)00052-8; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zoungas S, 2017, LANCET DIABETES ENDO, V5, P431, DOI 10.1016/S2213-8587(17)30104-3	24	4153	4318	16	301	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2017	377	7					644	657		10.1056/NEJMoa1611925	http://dx.doi.org/10.1056/NEJMoa1611925			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD7FG	28605608	Green Published, Bronze			2022-12-28	WOS:000407691400007
J	Dash, P; Fiore-Gartland, AJ; Hertz, T; Wang, GC; Sharma, S; Souquette, A; Crawford, JC; Clemens, EB; Nguyen, THO; Kedzierska, K; La Gruta, NL; Bradley, P; Thomas, PG				Dash, Pradyot; Fiore-Gartland, Andrew J.; Hertz, Tomer; Wang, George C.; Sharma, Shalini; Souquette, Aisha; Crawford, Jeremy Chase; Clemens, E. Bridie; Nguyen, Thi H. O.; Kedzierska, Katherine; La Gruta, Nicole L.; Bradley, Philip; Thomas, Paul G.			Quantifiable predictive features define epitope-specific T cell receptor repertoires	NATURE			English	Article							ALPHA-BETA; TCR-ALPHA; STRUCTURAL BASIS; DIVERSITY; CHAINS	T cells are defined by a heterodimeric surface receptor, the T cell receptor (TCR), that mediates recognition of pathogen-associated epitopes through interactions with peptide and major histocompatibility complexes (pMHCs). TCRs are generated by genomic rearrangement of the germline TCR locus, a process termed V(D)J recombination, that has the potential to generate marked diversity of TCRs (estimated to range from 10(15) (ref. 1) to as high as 10(61) (ref. 2) possible receptors). Despite this potential diversity, TCRs from T cells that recognize the same pMHC epitope often share conserved sequence features, suggesting that it may be possible to predictively model epitope specificity. Here we report the in-depth characterization of ten epitope-specific TCR repertoires of CD8(+) T cells from mice and humans, representing over 4,600 in-frame single-cell-derived TCR alpha beta sequence pairs from 110 subjects. We developed analytical tools to characterize these epitope-specific repertoires: a distance measure on the space of TCRs that permits clustering and visualization, a robust repertoire diversity metric that accommodates the low number of paired public receptors observed when compared to single-chain analyses, and a distance-based classifier that can assign previously unobserved TCRs to characterized repertoires with robust sensitivity and specificity. Our analyses demonstrate that each epitope-specific repertoire contains a clustered group of receptors that share core sequence similarities, together with a dispersed set of diverse 'outlier' sequences. By identifying shared motifs in core sequences, we were able to highlight key conserved residues driving essential elements of TCR recognition. These analyses provide insights into the generalizable, underlying features of epitope-specific repertoires and adaptive immune recognition.	[Dash, Pradyot; Souquette, Aisha; Crawford, Jeremy Chase; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Fiore-Gartland, Andrew J.; Hertz, Tomer] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Hertz, Tomer] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Wang, George C.] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Biol Hlth Aging Program, Baltimore, MD 21224 USA; [Sharma, Shalini] Lala Lajpat Rai Univ Vet & Anim Sci, Dept Vet Physiol & Biochem, Hisar 125004, Haryana, India; [Clemens, E. Bridie; Nguyen, Thi H. O.; Kedzierska, Katherine; La Gruta, Nicole L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [La Gruta, Nicole L.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [La Gruta, Nicole L.] Monash Univ, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic 3800, Australia; [Bradley, Philip] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Bradley, Philip] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA	St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; Ben Gurion University; Johns Hopkins University; Lala Lajpat Rai University of Veterinary & Animal Sciences; University of Melbourne; Monash University; Monash University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Bradley, P (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.; Bradley, P (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.	pbradley@fredhutch.org; paul.thomas@stjude.org	Crawford, Jeremy Chase/G-5711-2013; Nguyen, Thi Hoang Oanh/AAM-6827-2021; Hertz, Tomer/S-5744-2016; Souquette, Aisha/AAA-6169-2019; Souquette, Aisha/CAF-4630-2022; Thomas, Paul G./H-1063-2018	Crawford, Jeremy Chase/0000-0003-4096-6048; Nguyen, Thi Hoang Oanh/0000-0002-9294-7693; Hertz, Tomer/0000-0002-0561-1578; Souquette, Aisha/0000-0001-6197-5870; Souquette, Aisha/0000-0001-6197-5870; Thomas, Paul G./0000-0001-7955-0256; Kedzierska, Katherine/0000-0001-6141-335X; La Gruta, Nicole/0000-0001-5358-9363	St Jude Children's Research Hospital Animal Resource Center; NIH [AI107625]; ALSAC; FHCRC; NHMRC [1071916]; Sylvia and Charles Viertel Senior Medical Research Fellowship; National Institute on Aging (NIA) [K23 AG033113, P30 AG021334]; John A. Hartford Foundation's Center of Excellence in Geriatric Medicine Scholars Award; Johns Hopkins Biology of Healthy Aging Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107625, UM1AI068635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG033113, P30AG021334] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	St Jude Children's Research Hospital Animal Resource Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); FHCRC; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Research Fellowship; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John A. Hartford Foundation's Center of Excellence in Geriatric Medicine Scholars Award; Johns Hopkins Biology of Healthy Aging Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the St Jude Children's Research Hospital Animal Resource Center's staff for their support and excellent animal care. We thank G. Lennon for the help with single-cell sorting. We thank the Hartwell Center at St Jude for sequencing support. We also thank M. Morris, L. McLaren, T. H. Oguin III, W. Awad, A. Zamora, D. Boyd, X. Guo, S. Valkenburg, E. Grant, N. Bird and N. Mifsud for their help in conducting experiments and preparation of the manuscript. The work was supported by NIH grant AI107625 and ALSAC (to P.G.T.), FHCRC internal development funding to P.B., and an NHMRC Program Grant (1071916) to K.K. and N. L. L. N. L. L. is the recipient of a Sylvia and Charles Viertel Senior Medical Research Fellowship. E.B.C. is an NHMRC Peter Doherty Fellow and K.K. is an NHMRC SRF Level B Fellow. G.C.W. was the recipient of National Institute on Aging (NIA) K23 AG033113, NIA P30 AG021334, John A. Hartford Foundation's Center of Excellence in Geriatric Medicine Scholars Award, and Johns Hopkins Biology of Healthy Aging Program.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Cinelli M, 2017, BIOINFORMATICS, V33, P951, DOI 10.1093/bioinformatics/btw771; Cukalac T, 2015, IMMUNOL CELL BIOL, V93, P804, DOI 10.1038/icb.2015.44; Dash P, 2015, METHODS MOL BIOL, V1343, P181, DOI 10.1007/978-1-4939-2963-4_15; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; Genolet R, 2012, EMBO J, V31, P1666, DOI 10.1038/emboj.2012.48; Gerritsen B, 2016, BIOINFORMATICS, V32, P3098, DOI 10.1093/bioinformatics/btw339; Giraud M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-409; Guo XZJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.54; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Howie B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5624; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; La Gruta NL, 2008, P NATL ACAD SCI USA, V105, P2034, DOI 10.1073/pnas.0711682102; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li B, 2016, NAT GENET, V48, P725, DOI 10.1038/ng.3581; Li HJ, 2012, J IMMUNOL, V189, P2404, DOI 10.4049/jimmunol.1102087; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Mora T., 2016, BIORXIV; Ndifon W, 2012, P NATL ACAD SCI USA, V109, P15865, DOI 10.1073/pnas.1203916109; Nguyen X. V., 2009, P 26 ANN INT C MACHI, P1073, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]; Parkhurst M, 2017, CLIN CANCER RES, V23, P2491, DOI 10.1158/1078-0432.CCR-16-2680; Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001; Putintseva EV, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00463; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P321, DOI 10.1007/0-387-25465-X_15; Rudd BD, 2011, J IMMUNOL, V186, P2056, DOI 10.4049/jimmunol.1003013; Ruggiero E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9081; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Thomas N, 2014, BIOINFORMATICS, V30, P3181, DOI 10.1093/bioinformatics/btu523; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Venturi V, 2007, J IMMUNOL METHODS, V321, P182, DOI 10.1016/j.jim.2007.01.019; Venturi V, 2006, P NATL ACAD SCI USA, V103, P18691, DOI 10.1073/pnas.0608907103; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647	39	336	344	8	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					89	+		10.1038/nature22383	http://dx.doi.org/10.1038/nature22383			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28636592	Green Accepted			2022-12-28	WOS:000404839900036
J	Rustomji, CS; Yang, Y; Kim, TK; Mac, J; Kim, YJ; Caldwell, E; Chung, H; Meng, S				Rustomji, Cyrus S.; Yang, Yangyuchen; Kim, Tae Kyoung; Mac, Jimmy; Kim, Young Jin; Caldwell, Elizabeth; Chung, Hyeseung; Meng, Shirley			Liquefied gas electrolytes for electrochemical energy storage devices	SCIENCE			English	Article							LOW-TEMPERATURE PERFORMANCE; DOUBLE-LAYER CAPACITORS; 1,1,1,2-TETRAFLUOROETHANE HFC 134A; LI-ION CELLS; DIELECTRIC-CONSTANT; LITHIUM METAL; SUPERCRITICAL TRIFLUOROMETHANE; ELECTRICAL-CONDUCTIVITY; AMMONIA SOLUTIONS; ORGANIC ESTERS	Electrochemical capacitors and lithium-ion batteries have seen little change in their electrolyte chemistry since their commercialization, which has limited improvements in device performance. Combining superior physical and chemical properties and a high dielectric-fluidity factor, the use of electrolytes based on solvent systems that exclusively use components that are typically gaseous under standard conditions show a wide potential window of stability and excellent performance over an extended temperature range. Electrochemical capacitors using difluoromethane show outstanding performance from -78 degrees to + 65 degrees C, with an increased operation voltage. The use of fluoromethane shows a high coulombic efficiency of similar to 97% for cycling lithium metal anodes, together with good cyclability of a 4-volt lithium cobalt oxide cathode and operation as low as -60 degrees C, with excellent capacity retention.	[Rustomji, Cyrus S.; Mac, Jimmy; Chung, Hyeseung; Meng, Shirley] Univ Calif San Diego, Dept Nano Engn, La Jolla, CA 92121 USA; [Yang, Yangyuchen; Kim, Tae Kyoung; Kim, Young Jin; Caldwell, Elizabeth] Univ Calif San Diego, Mat Sci & Engn Program, Dept Mech & Aerosp Engn, La Jolla, CA 92121 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Meng, S (corresponding author), Univ Calif San Diego, Dept Nano Engn, La Jolla, CA 92121 USA.	shmeng@ucsd.edu	Kim, Tae Kyoung/O-4252-2015	Kim, Tae Kyoung/0000-0001-5193-1428; Meng, Ying Shirley/0000-0001-8936-8845; Rustomji, Cyrus/0000-0001-6260-1264	Advanced Research Projects Agency-Energy (ARPA-E) of the U.S. Department of Energy [DE-AR0000646]; Energy Efficiency and Renewable Energy, Office of Vehicle Technologies of the U.S. Department of Energy under the Battery500 consortium; National Science Foundation Major Research Instrumentation Program [CHE-1338173]; National Science Foundation [ECCS-1542148]	Advanced Research Projects Agency-Energy (ARPA-E) of the U.S. Department of Energy(United States Department of Energy (DOE)); Energy Efficiency and Renewable Energy, Office of Vehicle Technologies of the U.S. Department of Energy under the Battery500 consortium(United States Department of Energy (DOE)); National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Advanced Research Projects Agency-Energy (ARPA-E) of the U.S. Department of Energy under award DE-AR0000646. The authors gratefully acknowledge R. Chen for use of facilities for much of the scope of this work, S. Jin for the helpful discussions, J.Z. Lee for valuable inputs and manuscript review, and the kind donation from Maxwell Technologies of their capacitor materials. For the advanced characterization efforts, Y.Y., H.C., and Y.S.M. acknowledge the partial funding support from the Assistant Secretary for Energy Efficiency and Renewable Energy, Office of Vehicle Technologies of the U.S. Department of Energy under the Battery500 consortium. Y.Y. thanks I.C. Tran and T. Salk for their help and thoughtful discussions regarding XPS experiments performed at the University of California Irvine Materials Research Institute (IMRI) using instrumentation funded in part by the National Science Foundation Major Research Instrumentation Program (grant CHE-1338173). The SEM analysis in this work was performed at the San Diego Nanotechnology Infrastructure (SDNI) of the University of California San Diego, a member of the National Nanotechnology Coordinated Infrastructure, which is supported by the National Science Foundation (grant ECCS-1542148). C.S.R. especially thanks the PowerStor team for their support and thoughtful discussions on electrochemical capacitor technology. All experimental and computational data described in the paper are presented, curated, and archived in Cloud Storage system and CommVault Enterprise Backup service. Raw data and metadata are available upon request. Patent applications relating to this work have been filed to date as follows: U.S. patent application 15/036,763, European application 14861242.7, and provisional application 62/342,838.	Abbott AP, 1998, J ELECTROANAL CHEM, V457, P1, DOI 10.1016/S0022-0728(98)00337-4; Abbott AP, 1999, J CHEM ENG DATA, V44, P112, DOI 10.1021/je980130b; Abbott AP, 2000, J PHYS CHEM B, V104, P775, DOI 10.1021/jp9932867; Abbott AP, 2000, J PHYS CHEM B, V104, P9351, DOI 10.1021/jp0003353; [Anonymous], 1967, SELECTED VALUES ELEC; Anouti M, 2012, J CHEM THERMODYN, V50, P71, DOI 10.1016/j.jct.2012.01.027; Aurbach D, 2002, SOLID STATE IONICS, V148, P405, DOI 10.1016/S0167-2738(02)00080-2; AURBACH D, 1994, J ELECTROCHEM SOC, V141, P603, DOI 10.1149/1.2054777; Barao MT, 1997, INT J THERMOPHYS, V18, P419, DOI 10.1007/BF02575172; Barao MT, 1998, FLUID PHASE EQUILIBR, V150, P753, DOI 10.1016/S0378-3812(98)00356-2; BERNARD L, 1984, J PHYS CHEM-US, V88, P3833, DOI 10.1021/j150661a029; Brandon EJ, 2007, J POWER SOURCES, V170, P225, DOI 10.1016/j.jpowsour.2007.04.001; Chmiola J, 2006, SCIENCE, V313, P1760, DOI [10.1126/science.1132195, 10.1126/science/1132195]; Clifford A., 1999, FUNDAMENTALS SUPERCR; Daheron L, 2008, CHEM MATER, V20, P583, DOI 10.1021/cm702546s; DESILVESTRO J, 1989, J ELECTROANAL CHEM, V267, P207, DOI 10.1016/0022-0728(89)80249-9; DESJARDINS CD, 1985, J ELECTROCHEM SOC, V132, P529, DOI 10.1149/1.2113881; Di Nicola G, 2005, J CHEM ENG DATA, V50, P312, DOI 10.1021/je049939g; Edstrom K, 2004, ELECTROCHIM ACTA, V50, P397, DOI 10.1016/j.electacta.2004.03.049; FONG R, 1990, J ELECTROCHEM SOC, V137, P2009, DOI 10.1149/1.2086855; GOFER Y, 1992, J POWER SOURCES, V39, P163, DOI 10.1016/0378-7753(92)80135-X; Goldfarb DL, 2000, ELECTROCHEM COMMUN, V2, P663, DOI 10.1016/S1388-2481(00)00099-0; Goldfarb DL, 2004, J PHYS CHEM B, V108, P3358, DOI 10.1021/jp0345102; Grosse AV, 1940, J PHYS CHEM-US, V44, P275, DOI 10.1021/j150399a002; Han XH, 2011, J CHEM ENG DATA, V56, P3038, DOI 10.1021/je2000827; HIRAI T, 1994, J ELECTROCHEM SOC, V141, P611, DOI 10.1149/1.2054778; Janes A, 2006, J ELECTROANAL CHEM, V588, P285, DOI 10.1016/j.jelechem.2006.01.003; Kanamura K, 1996, J ELECTROCHEM SOC, V143, P2187, DOI 10.1149/1.1836979; KOCH VR, 1982, J ELECTROCHEM SOC, V129, P1, DOI 10.1149/1.2123756; Kotz R, 2010, J POWER SOURCES, V195, P923, DOI 10.1016/j.jpowsour.2009.08.045; Kraus CA, 1904, PHYS REV, V18, P89, DOI 10.1103/PhysRevSeriesI.18.89; Lemmon E. W., 2005, NIST CHEM WEBBOOK NI, V69; LINDEN D, 1980, J POWER SOURCES, V5, P35, DOI 10.1016/0378-7753(80)80094-2; Lu YY, 2014, NAT MATER, V13, P961, DOI [10.1038/nmat4041, 10.1038/NMAT4041]; Meng XY, 2015, INT J THERMOPHYS, V36, P2497, DOI 10.1007/s10765-013-1546-4; OLSEN SA, 1994, ANAL CHEM, V66, P503, DOI 10.1021/ac00076a014; Olsen SA, 1996, ANAL CHEM, V68, P2054, DOI 10.1021/ac9511152; OSAKA T, 1995, J ELECTROCHEM SOC, V142, P1057, DOI 10.1149/1.2044131; Park MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03815; Qian JF, 2016, ADV FUNCT MATER, V26, P7094, DOI 10.1002/adfm.201602353; Ratnakumar BV, 2001, J POWER SOURCES, V97-8, P137, DOI 10.1016/S0378-7753(01)00682-6; REUTER K, 1989, PHYSICA A, V156, P294, DOI 10.1016/0378-4371(89)90124-6; Rustomji CS, 2016, J APPL ELECTROCHEM, V46, P59, DOI 10.1007/s10800-015-0859-3; Smart MC, 2013, ECS TRANSACTIONS, V50, P355, DOI 10.1149/05026.0355ecst; Smart MC, 2010, J ELECTROCHEM SOC, V157, pA1361, DOI 10.1149/1.3501236; Smart MC, 2002, J ELECTROCHEM SOC, V149, pA361, DOI 10.1149/1.1453407; STALEY RH, 1975, J AM CHEM SOC, V97, P5920, DOI 10.1021/ja00853a050; UE M, 1994, J ELECTROCHEM SOC, V141, P2989, DOI 10.1149/1.2059270; URIBE FA, 1989, J ELECTROCHEM SOC, V136, P3559, DOI 10.1149/1.2096509; West WC, 2010, J ELECTROCHEM SOC, V157, pA571, DOI 10.1149/1.3353235; Wu JT, 2012, INT J THERMOPHYS, V33, P220, DOI 10.1007/s10765-011-1151-3; Yaws C., 1995, HDB VAPOR PRESSURE, V4; Zhang SS, 2004, ELECTROCHIM ACTA, V49, P1057, DOI 10.1016/j.electacta.2003.10.016; Zhang SS, 2003, J SOLID STATE ELECTR, V7, P147, DOI 10.1007/s10008-002-0300-9; Zurek E, 2009, ANGEW CHEM INT EDIT, V48, P8198, DOI 10.1002/anie.200900373	55	178	182	31	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345							eaal4263	10.1126/science.aal4263	http://dx.doi.org/10.1126/science.aal4263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28619715	Green Submitted			2022-12-28	WOS:000404351500029
J	Collins, FS; Fleming, R				Collins, Francis S.; Fleming, Renee			Sound Health An NIH-Kennedy Center Initiative to Explore Music and the Mind	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; HYPOTHESIS; SPEECH		[Collins, Francis S.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Fleming, Renee] John F Kennedy Ctr Performing Arts, Washington, DC USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Off Director, One Ctr Dr, Bethesda, MD 20892 USA.	collinsf@mail.nih.gov						[Anonymous], 2011, ARTS HUM DEV LEARN L; Bailey JA, 2014, J COGNITIVE NEUROSCI, V26, P755, DOI 10.1162/jocn_a_00527; Hallam S, 2010, INT J MUSIC EDUC, V28, P269, DOI 10.1177/0255761410370658; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Norman-Haignere S, 2015, NEURON, V88, P1281, DOI 10.1016/j.neuron.2015.11.035; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Schlaug G, 2015, PROG BRAIN RES, V217, P37, DOI 10.1016/bs.pbr.2014.11.020	9	13	13	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2470	2471		10.1001/jama.2017.7423	http://dx.doi.org/10.1001/jama.2017.7423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	EY6PV	28586832	Green Published			2022-12-28	WOS:000404106600001
J	Carbone, DP; Reck, M; Paz-Ares, L; Creelan, B; Horn, L; Steins, M; Felip, E; van den Heuvel, MM; Ciuleanu, TE; Badin, F; Ready, N; Hiltermann, TJN; Nair, S; Juergens, R; Peters, S; Minenza, E; Wrangle, JM; Rodriguez-Abreu, D; Borghaei, H; Blumenschein, GR; Villaruz, LC; Havel, L; Krejci, J; Jaime, JC; Chang, H; Geese, WJ; Bhagavatheeswaran, P; Chen, AC; Socinski, MA				Carbone, D. P.; Reck, M.; Paz-Ares, L.; Creelan, B.; Horn, L.; Steins, M.; Felip, E.; van den Heuvel, M. M.; Ciuleanu, T. -E.; Badin, F.; Ready, N.; Hiltermann, T. J. N.; Nair, S.; Juergens, R.; Peters, S.; Minenza, E.; Wrangle, J. M.; Rodriguez-Abreu, D.; Borghaei, H.; Blumenschein, G. R.; Villaruz, L. C.; Havel, L.; Krejci, J.; Corral Jaime, J.; Chang, H.; Geese, W. J.; Bhagavatheeswaran, P.; Chen, A. C.; Socinski, M. A.		CheckMate 026 Investigators	First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PACLITAXEL PLUS CARBOPLATIN; PHASE-III; OPEN-LABEL; MAINTENANCE BEVACIZUMAB; THERAPY; CISPLATIN; CHEMOTHERAPY; GEMCITABINE; DOCETAXEL; TRIAL	BACKGROUND Nivolumab has been associated with longer overall survival than docetaxel among patients with previously treated non-small-cell lung cancer (NSCLC). In an open-label phase 3 trial, we compared first-line nivolumab with chemotherapy in patients with programmed death ligand 1 (PD-L1)-positive NSCLC. METHODS We randomly assigned, in a 1:1 ratio, patients with untreated stage IV or recurrent NSCLC and a PD-L1 tumor-expression level of 1% or more to receive nivolumab (administered intravenously at a dose of 3 mg per kilogram of body weight once every 2 weeks) or platinum-based chemotherapy (administered once every 3 weeks for up to six cycles). Patients receiving chemotherapy could cross over to receive nivolumab at the time of disease progression. The primary end point was progression-free survival, as assessed by means of blinded independent central review, among patients with a PD-L1 expression level of 5% or more. RESULTS Among the 423 patients with a PD-L1 expression level of 5% or more, the median progression-free survival was 4.2 months with nivolumab versus 5.9 months with chemotherapy (hazard ratio for disease progression or death, 1.15; 95% confidence interval [CI], 0.91 to 1.45; P = 0.25), and the median overall survival was 14.4 months versus 13.2 months (hazard ratio for death, 1.02; 95% CI, 0.80 to 1.30). A total of 128 of 212 patients (60%) in the chemotherapy group received nivolumab as subsequent therapy. Treatment-related adverse events of any grade occurred in 71% of the patients who received nivolumab and in 92% of those who received chemotherapy. Treatment-related adverse events of grade 3 or 4 occurred in 18% of the patients who received nivolumab and in 51% of those who received chemotherapy. CONCLUSIONS Nivolumab was not associated with significantly longer progression-free survival than chemotherapy among patients with previously untreated stage IV or recurrent NSCLC with a PD-L1 expression level of 5% or more. Overall survival was similar between groups. Nivolumab had a favorable safety profile, as compared with chemotherapy, with no new or unexpected safety signals. (Funded by Bristol-Myers Squibb and others; CheckMate 026 ClinicalTrials.gov number, NCT02041533.)	[Carbone, D. P.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Reck, M.] LungenClin Grosshansdorf, German Ctr Lung Res, Airway Res Ctr North, Grosshansdorf, Germany; [Steins, M.] Heidelberg Univ Hosp, Thoraxklin, Heidelberg, Germany; [Paz-Ares, L.; Corral Jaime, J.] Hosp Univ Doce Octubre, Ctr Nacl Invest Oncol, Madrid, Spain; [Paz-Ares, L.; Corral Jaime, J.] Univ Complutense Madrid, Madrid, Spain; [Felip, E.] Vall Dhebron Univ Hosp, Barcelona, Spain; [Rodriguez-Abreu, D.] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain; [Creelan, B.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Horn, L.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [van den Heuvel, M. M.] Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands; [Hiltermann, T. J. N.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Ciuleanu, T. -E.] Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca, Romania; [Ciuleanu, T. -E.] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania; [Badin, F.] Baptist Hlth Lexington, Lexington, KY USA; [Ready, N.] Duke Univ, Durham, NC USA; [Nair, S.] Lehigh Valley Hlth Network, Allentown, PA USA; [Borghaei, H.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Villaruz, L. C.; Socinski, M. A.] Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USA; [Juergens, R.] Juravinski Canc Ctr, Hamilton, ON, Canada; [Peters, S.] Lausanne Univ Hosp, Oncol Dept, Lausanne, Switzerland; [Minenza, E.] Santa Maria Hosp, Terni, Italy; [Wrangle, J. M.] Hollings Canc Ctr, Charleston, SC USA; [Blumenschein, G. R.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Havel, L.; Krejci, J.] Nemocnice Na Bulovce, Klin Pneumol & Hrudni Chirurg, Prague, Czech Republic; [Chang, H.; Geese, W. J.; Bhagavatheeswaran, P.; Chen, A. C.] Bristol Myers Squibb, Princeton, NJ USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Grosshansdorf Hospital; Ruprecht Karls University Heidelberg; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitari Vall d'Hebron; H Lee Moffitt Cancer Center & Research Institute; Vanderbilt University; University of Groningen; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy; Central Baptist Hospital; Duke University; Lehigh Valley Health Network; Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McMaster University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Texas System; UTMD Anderson Cancer Center; Bulovka University Hospital; Bristol-Myers Squibb	Carbone, DP (corresponding author), 488 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	david.carbone@osumc.edu	Paz-Ares, Luis/AAH-2750-2019; Curioni-Fontecedro, Alessandra/R-4950-2018; Ciuleanu, Tudor-Eliade/ABH-8452-2020; , HiltermannTJN/ABA-9144-2021; FELIP, ENRIQUETA/AAG-6316-2019; van den Heuvel, Michel M/D-9491-2017; Reck, Martin/ABF-5721-2020	van den Heuvel, Michel M/0000-0002-6372-2153; Reck, Martin/0000-0002-5348-4462; Ostoros, Gyula/0000-0001-5339-7257; Juergens, Rosalyn/0000-0001-8627-4704; Balmana, Judith/0000-0002-0762-6415; Blasco Cordellat, Ana/0000-0001-5889-0382; Arrieta, Oscar/0000-0002-1164-3779; Decoster, Lore/0000-0001-7563-0179; Creelan, Ben/0000-0002-2728-8070; O'Byrne, Kenneth/0000-0002-6754-5633; Fujita, Shiro/0000-0002-2629-0152; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; Trigo, Jose/0000-0002-4489-2683; Curioni-Fontecedro, Alessandra/0000-0002-5778-5270; Ciuleanu, Tudor Eliade/0000-0003-0958-5597; Boyer, Michael/0000-0002-0452-2987; FELIP, ENRIQUETA/0000-0002-7620-0098	Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [UG1CA233259, P30CA016672, P30CA016058, K12CA157688] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Bristol-Myers Squibb and others; CheckMate 026 ClinicalTrials.gov number, NCT02041533.	BARLESI F, 2016, ANN ONCOL SUPPL 6, V27; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ettinger DS, 2016, J NATL COMPR CANC NE, V14, P255, DOI 10.6004/jnccn.2016.0031; Gettinger S, 2014, AM SOC CLIN ONC ANN; Gettinger S, 2016, J CLIN ONCOL, V34, P2980, DOI 10.1200/JCO.2016.66.9929; Hellmann M., 2016, 14 INT C TARG ANT TH; Kowanetz M, 2017, J THORAC ONCOL, V12, pS321, DOI 10.1016/j.jtho.2016.11.343; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Patel JD, 2013, J CLIN ONCOL, V31, P4349, DOI 10.1200/JCO.2012.47.9626; Paz-Ares L, 2015, LANCET ONCOL, V16, P328, DOI 10.1016/S1470-2045(15)70046-X; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Remon J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0819-3; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Socinski MA, 2012, J CLIN ONCOL, V30, P2055, DOI 10.1200/JCO.2011.39.5848; Thatcher N, 2015, LANCET ONCOL, V16, P763, DOI 10.1016/S1470-2045(15)00021-2; Wakelee HA, 2006, J THORAC ONCOL, V1, P441, DOI 10.1097/01243894-200606000-00011; Zinner RG, 2015, J THORAC ONCOL, V10, P134, DOI 10.1097/JTO.0000000000000366	20	1608	1705	8	160	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2017	376	25					2415	2426		10.1056/NEJMoa1613493	http://dx.doi.org/10.1056/NEJMoa1613493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY2BW	28636851	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000403774400005
J	Demb, JB; Clark, DA				Demb, Jonathan B.; Clark, Damon A.			VISION These retinas are made for walkin'	NATURE			English	Editorial Material							DIRECTION-SELECTIVITY; GANGLION-CELLS; CIRCUIT; ASYMMETRY; MOTION		[Demb, Jonathan B.] Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06511 USA; [Demb, Jonathan B.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06511 USA; [Clark, Damon A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Clark, Damon A.] Yale Univ, Dept Phys, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Demb, JB (corresponding author), Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06511 USA.; Demb, JB (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06511 USA.	jonathan.demb@yale.edu; damon.clark@yale.edu			NATIONAL EYE INSTITUTE [R01EY014454, R01EY026555] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY026555, R01 EY014454] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Ding HY, 2016, NATURE, V535, P105, DOI 10.1038/nature18609; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Rousso DL, 2016, CELL REP, V15, P1930, DOI 10.1016/j.celrep.2016.04.069; Sabbah S, 2017, NATURE, V546, P492, DOI 10.1038/nature22818; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Yonehara K, 2016, NEURON, V89, P177, DOI 10.1016/j.neuron.2015.11.032	10	1	1	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					476	477		10.1038/nature22505	http://dx.doi.org/10.1038/nature22505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY2QK	28607483				2022-12-28	WOS:000403814100023
J	Gunasekera, D				Gunasekera, Don			Fight fake reagents with digital tools	NATURE			English	Letter									[Gunasekera, Don] Deakin Univ, Melbourne, Vic, Australia	Deakin University	Gunasekera, D (corresponding author), Deakin Univ, Melbourne, Vic, Australia.	don.gunasekera@deakin.edu.au						Chapron G, 2017, NATURE, V545, P403, DOI 10.1038/545403a; Mackey TK, 2017, EXPERT OPIN DRUG SAF, V16, P587, DOI 10.1080/14740338.2017.1313227; 2017, NATURE, V545, P148	3	2	2	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					474	474		10.1038/546474c	http://dx.doi.org/10.1038/546474c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640264	Green Submitted, Bronze			2022-12-28	WOS:000403814100020
J	Liuzzi, G; Castilletti, C; Vairo, F; Nicastri, E; Ippolito, G				Liuzzi, Giuseppina; Castilletti, Concetta; Vairo, Francesco; Nicastri, Emanuele; Ippolito, Giuseppe			Travel-Associated Zika Virus Disease	ANNALS OF INTERNAL MEDICINE			English	Letter									[Liuzzi, Giuseppina; Castilletti, Concetta; Nicastri, Emanuele; Ippolito, Giuseppe] Natl Inst Infect Dis INMI L Spallanzani, Rome, Italy; [Vairo, Francesco] Natl Inst Infect Dis INMI L Spallanzani, Rome, Italy; [Vairo, Francesco] Reg Serv Infect Dis Surveillance Control & Respon, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Liuzzi, G (corresponding author), Natl Inst Infect Dis INMI L Spallanzani, Rome, Italy.		nicastri, emanuele/K-7780-2016; Ippolito, Giuseppe/J-7207-2017; Castilletti, Concetta/AAA-8408-2019; Castilletti, Concetta/B-6545-2016	nicastri, emanuele/0000-0002-5606-8712; Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Ippolito, Giuseppe/0000-0002-1076-2979				Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842; Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					913	913		10.7326/L17-0196	http://dx.doi.org/10.7326/L17-0196			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630989				2022-12-28	WOS:000403579000024
J	Merrill, DG				Merrill, Douglas G.			Speak Up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Merrill, Douglas G.] Renown Hlth, Reno, NV 89502 USA		Merrill, DG (corresponding author), Renown Hlth, Reno, NV 89502 USA.	merrill2@renown.org						[Anonymous], 2004, SETTING MORAL COMPAS; Ballou Kathryn A, 2010, Policy Polit Nurs Pract, V11, P71, DOI 10.1177/1527154410372973; Brown Robert McAfee, 1984, UNEXPECTED NEWS READ, P19; Cudd AE., 2006, ANAL OPPRESSION, P85; Leape LL, 2012, ACAD MED, V87, P853, DOI 10.1097/ACM.0b013e3182583536; National Public Radio, 2016, TRANSCR MICH OB SPEE; Nelson HL, 2001, DAMAGED IDENTITIES N, P106; Pompeii LA, 2015, AM J IND MED, V58, P1194, DOI 10.1002/ajim.22489	8	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2373	2374		10.1001/jama.2017.2022	http://dx.doi.org/10.1001/jama.2017.2022			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28632871				2022-12-28	WOS:000403654600008
J	O'Connor, EA; Evans, CV; Burda, BU; Walsh, ES; Eder, M; Lozano, P				O'Connor, Elizabeth A.; Evans, Corinne V.; Burda, Brittany U.; Walsh, Emily S.; Eder, Michelle; Lozano, Paula			Screening for Obesity and Intervention for Weight Management in Children and Adolescents Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; BODY-MASS INDEX; PEDIATRIC PRIMARY-CARE; CARDIOVASCULAR-DISEASE RISK; LIFE-STYLE INTERVENTION; CHILDHOOD OBESITY; OVERWEIGHT CHILDREN; INSULIN-RESISTANCE; METABOLIC PARAMETERS; GLUCOSE-TOLERANCE	IMPORTANCE Obesity is common in children and adolescents in the United States, is associated with negative health effects, and increases the likelihood of obesity in adulthood. OBJECTIVE Tosystematically reviewthebenefitsandharmsof screeningandtreatment forobesity and overweight in children and adolescents to inform the US Preventive Services Task Force. DATA SOURCES MEDLINE, PubMed, PsycINFO, Cochrane Collaboration Registry of Controlled Trials, and the Education Resources Information Center through January 22, 2016; references of relevant publications; governmentwebsites. Surveillance continued through December 5, 2016. STUDY SELECTION English-language trials of benefits or harms of screening or treatment (behavior-based, orlistat, metformin) for overweight or obesity in children aged 2 through 18 years, conducted in or recruited from health care settings. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles, then extracted data from fair-and good-quality trials. Random-effects meta-analysis was used to estimate the benefits of lifestyle-based programs and metformin. MAIN OUTCOMES AND MEASURES Weight or excessweight (eg, body mass index [BMI]; BMI z score, measuring the number of standard deviations from the median BMI for age and sex), cardiometabolic outcomes, quality of life, other health outcomes, harms. RESULTS Therewas no direct evidence on the benefits or harms of screening children and adolescents for excessweight. Among 42 trials of lifestyle-based interventions to reduce excess weight (N = 6956), those with an estimated 26 hours or more of contact consistently demonstrated mean reductions in excessweight compared with usual care or other control groups after 6 to 12 months, with no evidence of causing harm. Generally, intervention groups showed absolute reductions in BMI z score of0.20or more and maintained their baselineweight within a mean of approximately 5 lb, while control groups showed small increases or no change in BMI z score, typically gaining a mean of 5 to 17 lb. Only 3 of 26 interventions with fewer contact hours showed a benefit inweight reduction. Use ofmetformin (8 studies, n = 616) and orlistat (3 studies, n = 779) were associated with greater BMI reductions compared with placebo: -0.86 (95% CI, -1.44 to -0.29; 6 studies; I2 = 0%) formetformin and -0.50 to -0.94 for orlistat. Groups receiving lifestyle-based interventions offering 52 or more hours of contact showed greater improvements in blood pressure than control groups: -6.4 mmHg (95% CI, -8.6 to -4.2; 6 studies; I-2 = 51%) for systolic blood pressure and -4.0 mmHg (95% CI, -5.6 to -2.5; 6 studies; I-2 = 17%) for diastolic blood pressure. Therewere mixed findings for insulin or glucose measures and no benefit for lipids. Medications showed small or no benefit for cardiometabolic outcomes, including fasting glucose level. Nonserious harmswerecommonwith medication use, although discontinuation due to adverse effectswas usually less than 5%. CONCLUSIONS AND RELEVANCE Lifestyle-based weight loss interventions with 26 or more hours of intervention contact are likely to help reduce excess weight in children and adolescents. The clinical significance of the small benefit of medication use is unclear.	[O'Connor, Elizabeth A.; Evans, Corinne V.; Burda, Brittany U.; Walsh, Emily S.; Eder, Michelle] Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA; [Lozano, Paula] Kaiser Permanente Res Affiliates Evidence Based P, Grp Hlth Res Inst, Seattle, WA USA	Kaiser Permanente; Kaiser Permanente	O'Connor, EA (corresponding author), Kaiser Permanente Northwest, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	elizabeth.oconnor@kpchr.org	Lozano, Paula Maria/GPP-4090-2022		Agency for Healthcare Research and Quality (AHRQ) [HHSA-290-2012-00015-I-EPC4]; US Department of Health and Human Services	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Health and Human Services	This research was funded under contract number HHSA-290-2012-00015-I-EPC4, Task Order 4, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Abrams P, 2013, J PEDIATR-US, V163, P785, DOI 10.1016/j.jpeds.2013.04.003; Atabek ME, 2008, J PEDIATR ENDOCR MET, V21, P339; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bocca G, 2013, HORM RES PAEDIAT, V80, P201, DOI 10.1159/000354662; Boudreau ADA, 2013, AM J PREV MED, V44, pS247, DOI 10.1016/j.amepre.2012.11.026; Boutelle KN, 2014, J PEDIATR PSYCHOL, V39, P405, DOI 10.1093/jpepsy/jst142; Broccoli S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1979; Bryant M, 2011, CLIN TRIALS, V8, P755, DOI 10.1177/1740774511424766; Burgert TS, 2008, PEDIATR DIABETES, V9, P567, DOI 10.1111/j.1399-5448.2008.00434.x; Chanoine JP, 2005, JAMA-J AM MED ASSOC, V293, P2873, DOI 10.1001/jama.293.23.2873; Clarson CL, 2009, ENDOCRINE, V36, P141, DOI 10.1007/s12020-009-9196-9; Clarson CL, 2014, INT SCH RES NOTICES, V2014; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Croker H, 2012, INT J OBESITY, V36, P16, DOI 10.1038/ijo.2011.182; Davis JN, 2012, PEDIATR OBES, V7, P16, DOI 10.1111/j.2047-6310.2011.00002.x; Debar LL, 2012, PEDIATRICS, V129, pE611, DOI 10.1542/peds.2011-0863; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egan KB, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-121; Ford AL, 2010, ARCH DIS CHILD, V95, P256, DOI 10.1136/adc.2009.165340; Lison JF, 2012, ACAD PEDIATR, V12, P319, DOI 10.1016/j.acap.2012.03.003; Freemark M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e55; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Gerards SMPL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122240; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho M, 2012, PEDIATRICS, V130, pE1647, DOI 10.1542/peds.2012-1176; Hofsteenge GH, 2014, CLIN NUTR, V33, P385, DOI 10.1016/j.clnu.2013.06.002; Janicke DM, 2014, J PEDIATR PSYCHOL, V39, P809, DOI 10.1093/jpepsy/jsu023; Kalarchian MA, 2009, PEDIATRICS, V124, P1060, DOI 10.1542/peds.2008-3727; Kalavainen MP, 2007, INT J OBESITY, V31, P1500, DOI 10.1038/sj.ijo.0803628; Kay JP, 2001, METABOLISM, V50, P1457, DOI 10.1053/meta.2001.28078; Kendall D, 2013, J CLIN ENDOCR METAB, V98, P322, DOI 10.1210/jc.2012-2710; Kirk S, 2005, OBES RES, V13, P876, DOI 10.1038/oby.2005.101; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kolsgaard MLP, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-47; Kong AS, 2013, J OBES, V2013, DOI 10.1155/2013/575016; Kuczmarski RJ, 2000, HEALTH, V11, P1; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Evia-Viscarra ML, 2012, J PEDIATR ENDOCR MET, V25, P41, DOI 10.1515/jpem-2011-0469; Looney SM, 2014, CLIN PEDIATR, V53, P1367, DOI 10.1177/0009922814541803; Love-Osborne K, 2008, J PEDIATR, V152, P817, DOI 10.1016/j.jpeds.2008.01.018; Love-Osborne K, 2014, CHILD OBES, V10, P424, DOI 10.1089/chi.2013.0165; Maahs David, 2006, Endocr Pract, V12, P18; Markert J, 2014, INT J ENV RES PUB HE, V11, P10327, DOI 10.3390/ijerph111010327; Mauras N, 2012, J PEDIATR ENDOCR MET, V25, P33, DOI 10.1515/jpem-2011-0450; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; Mazor-Aronovitch K, 2014, ISR MED ASSOC J, V16, P157; McCallum Z, 2007, INT J OBESITY, V31, P630, DOI 10.1038/sj.ijo.0803509; McDonagh MS, 2014, JAMA PEDIATR, V168, P178, DOI 10.1001/jamapediatrics.2013.4200; MELLIN LM, 1987, J AM DIET ASSOC, V87, P333; Nemet D, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-2172; Norman G, 2016, PEDIATR OBES, V11, P18, DOI 10.1111/ijpo.12013; Nowicka P, 2008, INT J PEDIATR OBES, V3, P141, DOI 10.1080/17477160802102475; O'Connor TM, 2013, CHILD CARE HLTH DEV, V39, P141, DOI 10.1111/j.1365-2214.2011.01344.x; Organisation for Economic Co-operation and Development (OECD), 2015, LIST OECD MAMB COUNT; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Pecin I, 2013, COLLEGIUM ANTROPOL, V37, P761; Peirson Leslea, 2015, CMAJ Open, V3, pE35, DOI 10.9778/cmajo.20140047; Raynor HA, 2012, PEDIATR OBES, V7, P28, DOI 10.1111/j.2047-6310.2011.00005.x; Reinehr T, 2004, ARCH DIS CHILD, V89, P419, DOI 10.1136/adc.2003.028803; Reinehr T, 2010, CLIN NUTR, V29, P331, DOI 10.1016/j.clnu.2009.12.010; Reinehr T, 2006, AM J CLIN NUTR, V84, P490, DOI 10.1093/ajcn/84.3.490; Reinehr T, 2009, ATHEROSCLEROSIS, V207, P174, DOI 10.1016/j.atherosclerosis.2009.03.041; Resnicow K, 2015, PEDIATRICS, V135, P649, DOI 10.1542/peds.2014-1880; Rezvanian H, 2010, WORLD J PEDIATR, V6, P317, DOI 10.1007/s12519-010-0232-x; Sacher PM, 2010, OBESITY, V18, pS62, DOI 10.1038/oby.2009.433; Saelens BE, 2002, OBES RES, V10, P22, DOI 10.1038/oby.2002.4; Savoye M, 2007, JAMA-J AM MED ASSOC, V297, P2697, DOI 10.1001/jama.297.24.2697; Sherwood NE, 2015, CHILD OBES, V11, P674, DOI 10.1089/chi.2015.0009; Silveira LS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-115; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Srinivasan S, 2006, J CLIN ENDOCR METAB, V91, P2074, DOI 10.1210/jc.2006-0241; Stark LJ, 2014, J PEDIATR PSYCHOL, V39, P1001, DOI 10.1093/jpepsy/jsu059; Stark LJ, 2011, OBESITY, V19, P134, DOI 10.1038/oby.2010.87; Stettler N, 2015, PEDIATR OBES, V10, P267, DOI 10.1111/ijpo.260; Tanofsky-Kraff M, 2010, INT J EAT DISORDER, V43, P701, DOI 10.1002/eat.20773; Taveras EM, 2015, JAMA PEDIATR, V169, P535, DOI 10.1001/jamapediatrics.2015.0182; Taveras EM, 2011, ARCH PEDIAT ADOL MED, V165, P714, DOI 10.1001/archpediatrics.2011.44; Taylor RW, 2015, PEDIATRICS, V136, P281, DOI 10.1542/peds.2015-0595; Turner EH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5992; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; van Grieken A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065376; Vos RC, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.5; Wake M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3092; Wake M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3308; Weigel C, 2008, J NUTR EDUC BEHAV, V40, P369, DOI [10.1016/j.jneb.2007.07.009, 10.1016/J.JNEB.2007.07.009]; Whitlock EP, 2005, PEDIATRICS, V116, pE125, DOI 10.1542/peds.2005-0242; Whitlock EP, 2010, AHRQ PUBLICATION, V10-05144-EF-1; Wiegand S, 2010, EUR J ENDOCRINOL, V163, P585, DOI 10.1530/EJE-10-0570; Wilson DM, 2010, ARCH PEDIAT ADOL MED, V164, P116, DOI 10.1001/archpediatrics.2009.264; Yanovski JA, 2011, DIABETES, V60, P477, DOI 10.2337/db10-1185	92	251	256	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2427	2444		10.1001/jama.2017.0332	http://dx.doi.org/10.1001/jama.2017.0332			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY0NJ	28632873				2022-12-28	WOS:000403654600016
J	Daniels, JP				Daniels, Joe Parkin			Preparedness for natural disasters in Colombia	LANCET			English	Editorial Material																			0	0	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2363	2364		10.1016/S0140-6736(17)31664-1	http://dx.doi.org/10.1016/S0140-6736(17)31664-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	28635602				2022-12-28	WOS:000403334400014
J	Park, HB; Kamcev, J; Robeson, LM; Elimelech, M; Freeman, BD				Park, Ho Bum; Kamcev, Jovan; Robeson, Lloyd M.; Elimelech, Menachem; Freeman, Benny D.			Maximizing the right stuff: The trade-off between membrane permeability and selectivity	SCIENCE			English	Review							HOLLOW-FIBER MEMBRANES; BLOCK-COPOLYMER MEMBRANES; GRAPHENE OXIDE MEMBRANES; MIXED-MATRIX MEMBRANES; CARBON-DIOXIDE CAPTURE; THIN-FILM COMPOSITE; ORGANIC-SOLVENT NANOFILTRATION; SUSTAINABLE POWER-GENERATION; PROTON-EXCHANGE MEMBRANES; GAS SEPARATION MEMBRANES	Increasing demands for energy-efficient separations in applications ranging from water purification to petroleum refining, chemicals production, and carbon capture have stimulated a vigorous search for novel, high-performance separation membranes. Synthetic membranes suffer a ubiquitous, pernicious trade-off: highly permeable membranes lack selectivity and vice versa. However, materials with both high permeability and high selectivity are beginning to emerge. For example, design features frombiological membranes have been applied to break the permeability-selectivity trade-off. We review the basis for the permeability-selectivity trade-off, state-of-the-art approaches to membrane materials design to overcome the trade-off, and factors other than permeability and selectivity that govern membrane performance and, in turn, influence membrane design.	[Park, Ho Bum] Hanyang Univ, Dept Energy Engn, Seoul 04763, South Korea; [Kamcev, Jovan; Freeman, Benny D.] Univ Texas Austin, Ctr Res Water Resources, Texas Mat Inst, Dept Chem Engn, 10100 Burnet Rd,Bldg 133 CEER, Austin, TX 78758 USA; [Kamcev, Jovan; Freeman, Benny D.] Univ Texas Austin, Ctr Energy & Environm Res, 10100 Burnet Rd,Bldg 133 CEER, Austin, TX 78758 USA; [Robeson, Lloyd M.] Lehigh Univ, Dept Mat Sci & Engn, 1801 Mill Creek Rd, Macungie, PA 18062 USA; [Elimelech, Menachem] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA	Hanyang University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Lehigh University; Yale University	Freeman, BD (corresponding author), Univ Texas Austin, Ctr Res Water Resources, Texas Mat Inst, Dept Chem Engn, 10100 Burnet Rd,Bldg 133 CEER, Austin, TX 78758 USA.; Freeman, BD (corresponding author), Univ Texas Austin, Ctr Energy & Environm Res, 10100 Burnet Rd,Bldg 133 CEER, Austin, TX 78758 USA.	freeman@che.utexas.edu	Kamcev, Jovan/S-3505-2018; Park, Ho Bum/C-2941-2016; Freeman, Benny/G-5405-2016	Kamcev, Jovan/0000-0003-0379-5171; Park, Ho Bum/0000-0002-8003-9698; Freeman, Benny/0000-0003-2779-7788	Korea CCS R&D Center (KCRC) grant - Ministry of Science, ICT, and Future Planning from the Korean government [2016910057]; Australian-American Fulbright Commission; Commonwealth Scientific and Industrial Research Organization (CSIRO); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-02ER15362]; International Institute for Carbon Neutral Energy Research (WPI-I2CNER) - World Premier International Research Center Initiative (WPI), MEXT, Japan; National Science Foundation (NSF) Graduate Research Fellowship [DGE-1110007]; National Science Foundation through the Engineering Research Center for Nanotechnology-Enabled Water Treatment [ERC-1449500];  [CBET 1437630]; Div Of Chem, Bioeng, Env, & Transp Sys [1437630] Funding Source: National Science Foundation	Korea CCS R&D Center (KCRC) grant - Ministry of Science, ICT, and Future Planning from the Korean government; Australian-American Fulbright Commission; Commonwealth Scientific and Industrial Research Organization (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); International Institute for Carbon Neutral Energy Research (WPI-I2CNER) - World Premier International Research Center Initiative (WPI), MEXT, Japan; National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation through the Engineering Research Center for Nanotechnology-Enabled Water Treatment; ; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We are grateful to many members of the membrane community worldwide who contributed articles, advice, and perspectives during the preparation of this review. H.B.P and B.D.F. acknowledge financial support by the Korea CCS R&D Center (KCRC) grant funded by Ministry of Science, ICT, and Future Planning from the Korean government (grant 2016910057). The work of J.K. and B.D.F. was supported by the Australian-American Fulbright Commission for the award to B.D.F. of the U.S. Fulbright Distinguished Chair in Science, Technology, and Innovation sponsored by the Commonwealth Scientific and Industrial Research Organization (CSIRO); the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (grant DE-FG02-02ER15362); and the International Institute for Carbon Neutral Energy Research (WPI-I2CNER), sponsored by the World Premier International Research Center Initiative (WPI), MEXT, Japan. The work of J.K. was also sponsored by the National Science Foundation (NSF) Graduate Research Fellowship under grant DGE-1110007. The work of M.E. was supported by the National Science Foundation through the Engineering Research Center for Nanotechnology-Enabled Water Treatment (ERC-1449500) and by grant CBET 1437630. We also thank E. Zumalt and P. Wiseman for preparing the graphic for the print summary.	Abetz V, 2015, MACROMOL RAPID COMM, V36, P10, DOI 10.1002/marc.201400556; Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Arora P, 2004, CHEM REV, V104, P4419, DOI 10.1021/cr020738u; Bachman JE, 2016, NAT MATER, V15, P845, DOI [10.1038/NMAT4621, 10.1038/nmat4621]; Bai JW, 2010, NAT NANOTECHNOL, V5, P190, DOI [10.1038/nnano.2010.8, 10.1038/NNANO.2010.8]; Baker R. W., 2012, MEMBRANE TECHNOLOGY; Blaney LM, 2007, WATER RES, V41, P1603, DOI 10.1016/j.watres.2007.01.008; Brown AJ, 2014, SCIENCE, V345, P72, DOI 10.1126/science.1251181; Budd PM, 2005, J MATER CHEM, V15, P1977, DOI 10.1039/b417402j; Burns RL, 2003, J MEMBRANE SCI, V211, P299, DOI 10.1016/S0376-7388(02)00430-1; Cohen-Tanugi D, 2014, ENERG ENVIRON SCI, V7, P1134, DOI 10.1039/c3ee43221a; Curcio E, 2005, SEP PURIF REV, V34, P35, DOI 10.1081/SPM-200054951; Dong GX, 2013, J MATER CHEM A, V1, P4610, DOI 10.1039/c3ta00927k; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Freeman BD, 1999, MACROMOLECULES, V32, P375, DOI 10.1021/ma9814548; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Geise GM, 2014, PROG POLYM SCI, V39, P1, DOI 10.1016/j.progpolymsci.2013.07.001; Geise GM, 2013, ACS APPL MATER INTER, V5, P10294, DOI 10.1021/am403207w; Geise GM, 2011, J MEMBRANE SCI, V369, P130, DOI 10.1016/j.memsci.2010.11.054; Geise GM, 2010, J POLYM SCI POL PHYS, V48, P1685, DOI 10.1002/polb.22037; Gravelle S, 2013, P NATL ACAD SCI USA, V110, P16367, DOI 10.1073/pnas.1306447110; GREENFIELD ML, 1993, MACROMOLECULES, V26, P5461, DOI 10.1021/ma00072a026; Grzelakowski M, 2015, J MEMBRANE SCI, V479, P223, DOI 10.1016/j.memsci.2015.01.023; Gusev AA, 2007, ADV MATER, V19, P2672, DOI 10.1002/adma.200602018; Ha H, 2016, J MEMBRANE SCI, V518, P131, DOI 10.1016/j.memsci.2016.06.028; Ha H, 2016, POLYMER, V93, P53, DOI 10.1016/j.polymer.2016.04.016; HENIS JMS, 1983, SCIENCE, V220, P11, DOI 10.1126/science.220.4592.11; HENIS JMS, 1981, J MEMBRANE SCI, V8, P233, DOI 10.1016/S0376-7388(00)82312-1; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Huang Y, 2014, J MEMBRANE SCI, V463, P33, DOI 10.1016/j.memsci.2014.03.016; Husain S, 2007, J MEMBRANE SCI, V288, P195, DOI 10.1016/j.memsci.2006.11.016; Joscelyne SM, 2000, J MEMBRANE SCI, V169, P107, DOI 10.1016/S0376-7388(99)00334-8; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kamcev J, 2017, ACS APPL MATER INTER, V9, P4044, DOI 10.1021/acsami.6b14902; Kamcev J, 2016, PHYS CHEM CHEM PHYS, V18, P6021, DOI 10.1039/c5cp06747b; Kattula M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15016; Kim HW, 2013, SCIENCE, V342, P91, DOI 10.1126/science.1236098; Kingsbury RS, 2015, J MEMBRANE SCI, V495, P502, DOI 10.1016/j.memsci.2015.06.050; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104; Kwon HT, 2015, J AM CHEM SOC, V137, P12304, DOI 10.1021/jacs.5b06730; Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686; Li XS, 2015, J MEMBRANE SCI, V494, P68, DOI 10.1016/j.memsci.2015.07.040; Liu L, 2014, J MEMBRANE SCI, V465, P49, DOI 10.1016/j.memsci.2014.03.060; Logan BE, 2012, NATURE, V488, P313, DOI 10.1038/nature11477; Lu XL, 2015, ENVIRON SCI TECHNOL, V49, P1436, DOI 10.1021/es5044062; Lutz H., 2015, ULTRAFILTRATION BIOP; Marchetti P, 2014, CHEM REV, V114, P10735, DOI 10.1021/cr500006j; McGrath J.E., 2011, US Patent, Patent No. [8,028,842, 8028842, 8,028,842 B2]; Mehta A, 2005, J MEMBRANE SCI, V249, P245, DOI 10.1016/j.memsci.2004.09.040; MEIER IK, 1994, J MEMBRANE SCI, V94, P195, DOI 10.1016/0376-7388(93)E0174-I; Merkel T.C., 2006, MAT SCI MEMBRANES GA, P251; Merkel TC, 2012, J MEMBRANE SCI, V389, P441, DOI 10.1016/j.memsci.2011.11.012; Merkel TC, 2010, J MEMBRANE SCI, V359, P126, DOI 10.1016/j.memsci.2009.10.041; Miller DJ, 2014, J MEMBRANE SCI, V454, P505, DOI 10.1016/j.memsci.2013.12.027; Moore TT, 2005, J MOL STRUCT, V739, P87, DOI 10.1016/j.molstruc.2004.05.043; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; NISHIDE H, 1994, J PHYS CHEM-US, V98, P5084, DOI 10.1021/j100070a023; Ohs B, 2016, J MEMBRANE SCI, V498, P291, DOI 10.1016/j.memsci.2015.10.007; Park CH, 2016, NATURE, V532, P480, DOI 10.1038/nature17634; Park HB, 2008, ANGEW CHEM INT EDIT, V47, P6019, DOI 10.1002/anie.200800454; Park HB, 2007, SCIENCE, V318, P254, DOI 10.1126/science.1146744; Park S, 2015, J MEMBRANE SCI, V486, P29, DOI 10.1016/j.memsci.2015.03.030; Paul DR, 2004, J MEMBRANE SCI, V241, P371, DOI 10.1016/j.memsci.2004.05.026; Peighambardoust SJ, 2010, INT J HYDROGEN ENERG, V35, P9349, DOI 10.1016/j.ijhydene.2010.05.017; Peinemann K. V., 2010, MEMBRANE TECHNOLOGY, V3; Peinemann KV, 2007, NAT MATER, V6, P992, DOI 10.1038/nmat2038; Peng Y, 2014, SCIENCE, V346, P1356, DOI 10.1126/science.1254227; Pimentel BR, 2014, CHEMSUSCHEM, V7, P3202, DOI 10.1002/cssc.201402647; PINNAU I, 1988, J MEMBRANE SCI, V37, P81, DOI 10.1016/S0376-7388(00)85070-X; PINTAURO PN, 1984, IND ENG CHEM FUND, V23, P234, DOI 10.1021/i100014a017; Post JW, 2008, ENVIRON SCI TECHNOL, V42, P5785, DOI 10.1021/es8004317; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Qiu XY, 2013, ACS NANO, V7, P768, DOI 10.1021/nn305073e; Ribeiro CP, 2012, J MEMBRANE SCI, V390, P182, DOI 10.1016/j.memsci.2011.11.042; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Robeson LM, 2007, J MEMBRANE SCI, V302, P70, DOI 10.1016/j.memsci.2007.06.029; Robeson LM, 2017, J MEMBRANE SCI, V525, P18, DOI 10.1016/j.memsci.2016.11.085; Robeson LM, 2015, J MEMBRANE SCI, V476, P421, DOI 10.1016/j.memsci.2014.11.058; Robeson LM, 2010, IND ENG CHEM RES, V49, P11859, DOI 10.1021/ie100153q; ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J; Rodenas T, 2015, NAT MATER, V14, P48, DOI [10.1038/NMAT4113, 10.1038/nmat4113]; Rungta M, 2013, AICHE J, V59, P3475, DOI 10.1002/aic.14105; Sanders DE, 2013, POLYMER, V54, P4729, DOI 10.1016/j.polymer.2013.05.075; Sata T., 2004, ION EXCHANGE MEMBRAN; Seoane B, 2015, CHEM SOC REV, V44, P2421, DOI 10.1039/c4cs00437j; Shaffer DL, 2015, DESALINATION, V356, P271, DOI [10.1016/j.desa12014.10.031, 10.1016/j.desal.2014.10.031]; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Shen J, 2015, ANGEW CHEM INT EDIT, V54, P578, DOI 10.1002/anie.201409563; Sholl DS, 2015, J PHYS CHEM LETT, V6, P3437, DOI 10.1021/acs.jpclett.5b01135; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desal.2005.12.052; Song W, 2003, J CHEM PHYS, V119, P9145, DOI 10.1063/1.1610435; Stamatialis DF, 2008, J MEMBRANE SCI, V308, P1, DOI 10.1016/j.memsci.2007.09.059; Straub AP, 2016, ENERG ENVIRON SCI, V9, P31, DOI 10.1039/c5ee02985f; Surwade SP, 2015, NAT NANOTECHNOL, V10, P459, DOI [10.1038/nnano.2015.37, 10.1038/NNANO.2015.37]; Tarabara VV., 2013, ENCY MEMBRANE SCI TE; van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045; Wang HL, 2012, SMALL, V8, P1185, DOI 10.1002/smll.201102120; Wang Y, 2011, APPL ENERG, V88, P981, DOI 10.1016/j.apenergy.2010.09.030; Wei J, 2011, J MEMBRANE SCI, V381, P110, DOI 10.1016/j.memsci.2011.07.034; Werber JR, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.18; Werber JR, 2016, ENVIRON SCI TECH LET, V3, P112, DOI 10.1021/acs.estlett.6b00050; White LS, 2006, J MEMBRANE SCI, V286, P26, DOI 10.1016/j.memsci.2006.09.006; Wickramasinghe SR, 2009, J MEMBRANE SCI, V340, P1, DOI 10.1016/j.memsci.2009.04.056; WIJMANS JG, 1995, J MEMBRANE SCI, V107, P1, DOI 10.1016/0376-7388(95)00102-I; Yang SY, 2006, ADV MATER, V18, P709, DOI 10.1002/adma.200501500; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P4360, DOI 10.1021/es104325z; Yu HZ, 2015, ANGEW CHEM INT EDIT, V54, P13937, DOI 10.1002/anie.201505663; Zhang H, 2016, J MEMBRANE SCI, V520, P790, DOI 10.1016/j.memsci.2016.08.035; Zhang RN, 2016, CHEM SOC REV, V45, P5888, DOI 10.1039/c5cs00579e; Zhao Y, 2012, J MEMBRANE SCI, V423, P422, DOI 10.1016/j.memsci.2012.08.039; Zimmerman CM, 1997, J MEMBRANE SCI, V137, P145, DOI 10.1016/S0376-7388(97)00194-4	118	1432	1471	259	2040	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343							eaab0530	10.1126/science.aab0530	http://dx.doi.org/10.1126/science.aab0530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619885				2022-12-28	WOS:000403327400024
J	Vozzi, C				Vozzi, Caterina			Tracking the dynamics of electron expulsion	SCIENCE			English	Editorial Material									[Vozzi, Caterina] CNR, Inst Photon & Nanotechnol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR)	Vozzi, C (corresponding author), CNR, Inst Photon & Nanotechnol, Milan, Italy.	caterina.vozzi@cnr.it						Calegari F, 2014, SCIENCE, V346, P336, DOI 10.1126/science.1254061; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kraus PM, 2015, SCIENCE, V350, P790, DOI 10.1126/science.aab2160; Ossiander M, 2017, NAT PHYS, V13, P280, DOI [10.1038/NPHYS3941, 10.1038/nphys3941]; Shafir D, 2012, NATURE, V485, P343, DOI 10.1038/nature11025; Swoboda M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.103003; Villeneuve DM, 2017, SCIENCE, V356, P1150, DOI 10.1126/science.aam8393; Xie XH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021005	8	2	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1126	1126		10.1126/science.aan5213	http://dx.doi.org/10.1126/science.aan5213			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619902				2022-12-28	WOS:000403327400017
J	Aronson, L				Aronson, Louise			A Tale of Two Doctors - Structural Inequalities and the Culture of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; MIDLEVEL PROVIDERS; SPECIALTY CHOICES; HEALTH; PHYSICIAN; STUDENTS; SCRIBES; IMPACT; TIME		[Aronson, Louise] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Aronson, L (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA.							Alkureishi MA, 2016, J GEN INTERN MED, V31, P548, DOI 10.1007/s11606-015-3582-1; Beckman H, 2015, ACAD MED, V90, P710, DOI 10.1097/ACM.0000000000000711; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Brown DFM, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-21; Brownlee S., 2014, HLTH AFFAIRS BL 0425; Darves B., 2014, COMPENSATION PHYS SP; Dezee KJ, 2013, FAM MED, V45, P240; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Ferguson TB, 2012, CIRC-CARDIOVASC QUAL, V5, pE93, DOI 10.1161/CIRCOUTCOMES.112.968768; Friedberg M.W., 2013, FACTORS AFFECTING PH; Fuchs V.R., 2014, ATLANTIC; Jeffe DB, 2010, ACAD MED, V85, P947, DOI 10.1097/ACM.0b013e3181dbe77d; Liu HS, 2017, MED CARE, V55, P12, DOI 10.1097/MLR.0000000000000590; Lown BA, 2011, HEALTH AFFAIR, V30, P1772, DOI 10.1377/hlthaff.2011.0539; Masri A, 2017, NEW ENGL J MED, V376, pE39, DOI 10.1056/NEJMp1701251; McDonald CJ, 2014, JAMA INTERN MED, V174, P1860, DOI 10.1001/jamainternmed.2014.4506; National Library of Medicine, 2016, HLTH DISP; Newton DA, 2005, ACAD MED, V80, P809, DOI 10.1097/00001888-200509000-00005; Obama BH, 2017, NEW ENGL J MED, V376, P297, DOI 10.1056/NEJMp1616577; Office of Disease Prevention and Health Promotion, 2014, DISP; Phillips JP, 2014, ANN FAM MED, V12, P542, DOI 10.1370/afm.1697; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Soudi A, 2015, JAMA-J AM MED ASSOC, V314, P518, DOI 10.1001/jama.2015.6947; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stone T., 2016, HARVARD BUSINESS REV; Yan C, 2016, J GEN INTERN MED, V31, P990, DOI 10.1007/s11606-016-3719-x; Yao NL, 2016, HEALTH AFFAIR, V35, P1404, DOI 10.1377/hlthaff.2015.1437	28	2	2	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2390	2393		10.1056/NEJMms1702140	http://dx.doi.org/10.1056/NEJMms1702140			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28614681				2022-12-28	WOS:000403230800015
J	Matheson, S				Matheson, Stephen			Sorting Out Complex Thoughts and Messy Emotions	CELL			English	Editorial Material														Matheson, Stephen/0000-0003-0561-8152				Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Bendesky A, 2017, NATURE, V544, P434, DOI 10.1038/nature22074; Robinson MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0016; Sniekers S, 2017, NAT GENET; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029	5	2	2	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2017	169	7					1157	1157		10.1016/j.cell.2017.06.004	http://dx.doi.org/10.1016/j.cell.2017.06.004			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EX6DJ	28622498	Bronze			2022-12-28	WOS:000403332400001
J	Ross, AG				Ross, Allen G.			Vaccination alone will not halt the next global pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ross, Allen G.] Griffith Univ, Trop Med & Infect Dis, Nathan, Qld, Australia	Griffith University	Ross, AG (corresponding author), Griffith Univ, Trop Med & Infect Dis, Nathan, Qld, Australia.	a.ross@griffith.edu.au		Ross, Allen/0000-0002-2329-0907	National Health and Medical Research Council, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	I thank the National Health and Medical Research Council, Australia, for providing financial support for my research.	[Anonymous], 2015, NEW UN REPORT FINDS; Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9; Butler D, 2017, NATURE, V541, P444, DOI 10.1038/nature.2017.21329; Bui CM, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0182-z; Choi J, 2017, EXPERT OPIN THER PAT, V27, P721, DOI 10.1080/13543776.2017.1281248; Clayton BA, 2017, CURR OPIN VIROL, V22, P97, DOI 10.1016/j.coviro.2016.12.003; Geisbert TW, 2017, LANCET, V389, P479, DOI 10.1016/S0140-6736(16)32618-6; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Marc MA, 2015, EXPERT OPIN DRUG DEL, V12, P1851, DOI 10.1517/17425247.2015.1077559; Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047; Perry HB, 2016, B WORLD HEALTH ORGAN, V94, P551, DOI 10.2471/BLT.15.164020; Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2017	357								j2864	10.1136/bmj.j2864	http://dx.doi.org/10.1136/bmj.j2864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UL	28611055	Green Published			2022-12-28	WOS:000403752500008
J	Voelker, R				Voelker, Rebecca			Therapy for Rare Nerve Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2017	317	21					2157	2157		10.1001/jama.2017.6334	http://dx.doi.org/10.1001/jama.2017.6334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7PG	28586876				2022-12-28	WOS:000402706100005
J	Colombo, S; Pavignani, E				Colombo, Sandro; Pavignani, Enrico			Recurrent failings of medical humanitarianism: intractable, ignored, or just exaggerated?	LANCET			English	Article							HEALTH-CARE; PSYCHOSOCIAL SUPPORT; EMERGENCIES; ASSISTANCE; CONFLICT; FAMINE; EBOLA; WAR; AID; REFLECTIONS	Humanitarian health workers operate in dangerous and uncertain contexts, in which mistakes and failures are common, often have severe consequences, and are regularly repeated, despite being documented by many reviews. This Series paper aims to discuss the failures of medical humanitarianism. We describe why some of these recurrent failings, which are often not identified until much later, seem intractable: they are so entrenched in humanitarian action that they cannot be addressed by simple technical fixes. We argue that relief health-care interventions should be contextualised. Perhaps medical humanitarianism deserves a better reputation than the one at times tarnished by unfair criticism, resulting from inapplicable guiding principles and unrealistic expectations. The present situation is not conducive to radical reforms of humanitarian medicine; complex crises multiply and no political, diplomatic, or military solutions are in sight. Relief agencies have to compete for financial resources that do not increase at the same pace as health needs. Avoiding the repetition of failures requires recognising previous mistakes and addressing them through different policies by donors, stronger documentation and analysis of humanitarian programmes and interventions, increased professionalisation, improved, opportunistic relationships with the media, and better ways of working together with local health stakeholders and through indigenous institutions.	[Pavignani, Enrico] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia	University of Queensland		sandrocolombo@live.com						Abramowitz S, 2015, PA STUD HUM RIGHTS, P1, DOI 10.9783/9780812291698; Ager A, 2014, SCIENCE, V345, P1290, DOI 10.1126/science.1254164; Akseer N, 2016, LANCET GLOB HEALTH, V4, pE395, DOI 10.1016/S2214-109X(16)30002-X; Allen T, 2006, TRIAL JUSTICE INT CR; Allen T, 2015, MED HUMANITARIANISM; Anderson Mary B., 1999, DO NO HARM AID CAN S; [Anonymous], 2016, LANCET, V388, P2, DOI 10.1016/S0140-6736(16)30936-9; Assistance GH, 2016, HUMANITARIAN ASSISTA; Autesserre S, 2012, AFR AFFAIRS, V111, P202, DOI 10.1093/afraf/adr080; Bailey S, 2011, HUMANITARIAN ACTION; Benn H, 2004, COMMUNICATION; Bennett C, 2016, REMAKING HUMANITARIA; Benthall J., 2010, DISASTERS RELIEF MED; Bertone Maria Paola, 2014, Confl Health, V8, P11, DOI 10.1186/1752-1505-8-11; Bolton P, 2007, PREHOSP DISASTER MED, V22, P390, DOI 10.1017/S1049023X00005100; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; BRACKEN PJ, 1995, SOC SCI MED, V40, P1073, DOI 10.1016/0277-9536(94)00181-R; Brauman R., 2009, MED HUMANITAIRE; Capobianco E, 2010, THE WORLD BANK; Carruth L, 2014, SOC SCI MED, V120, P405, DOI 10.1016/j.socscimed.2014.03.007; Chair's Summary, 2016, STAND HUM COMM ACT; Checchi F, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i469; Collinson S., 2013, PARADOXES PRESENCE R; Cooley A, 2002, INT SECURITY, V27, P5, DOI 10.1162/016228802320231217; Darcy J., 2013, USE EVIDENCE HUMANIT; de Ville de Goyet C, 2011, HLTH RESPONSE EARTHQ; De Waal A, 2010, LONDON REV BOOKS, P38; de Waal A, 2015, MED HUMANITARIANISM; de Waal A, 2010, DISASTERS, V34, pS130, DOI 10.1111/j.1467-7717.2010.01149.x; de Waal Alex, 1997, FAMINE CRIMES POLITI; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; del Valle H, 2013, DISASTERS, V37, pS188, DOI 10.1111/disa.12021; Dewachi O, 2014, LANCET, V383, P449, DOI 10.1016/S0140-6736(13)62299-0; Diaz J, 2003, IRAQ SOCIAL SECTOR W; Dijkzeul D, 2010, DISASTERS, V34, P1139, DOI 10.1111/j.1467-7717.2010.01187.x; Donini A, 2012, GOLDEN FLEECE MANIPU; Donini A, 2013, INT REV RED CROSS, V95, P383, DOI 10.1017/S1816383114000265; Donini A, 2010, DISASTERS, V34, pS220, DOI 10.1111/j.1467-7717.2010.01155.x; DuBois M, 2015, HUMANITARIAN POLICY; Duffield M, 2012, SECUR DIALOGUE, V43, P475, DOI 10.1177/0967010612457975; Farmer P., 2011, HAITI EARTHQUAKE; Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471; Fouad FM, 2017, LANCET; Fox S, 2014, HEALTH POLICY PLANN, V29, P96, DOI 10.1093/heapol/czs138; Frank S, 2013, REPORTING DISASTERS; Good BJ, 2014, SOC SCI MED, V120, P311, DOI 10.1016/j.socscimed.2014.09.027; Gordon S, 2013, J INTERV STATEBUILD, V7, P29, DOI 10.1080/17502977.2012.655615; Grunewald F., 2010, INTERAGENCY REAL TIM; Helander B, 1990, NOMADIC PEOPLES, P122; Howe Kimberly, 2016, NO END SIGHT CASE ST; Hummelbrunner R, GUIDE PLANNING STRAT; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; Interagency Guidelines, GUID MED DON; James E, 2016, DISASTERS, V40, P185, DOI 10.1111/disa.12140; Keen D., 2008, COMPLEX POLITICAL EM; Kennedy J, 2017, HEALTH POLICY PLANN, V32, P690, DOI 10.1093/heapol/czw148; Kligerman M, 2015, AM J TROP MED HYG, V92, P448, DOI 10.4269/ajtmh.14-0379; Lautze S, 2012, GLOB FOOD SECUR-AGR, V1, P43, DOI 10.1016/j.gfs.2012.07.006; Le More Anne, 2008, INT ASSISTANCE PALES; Lewis D, 2009, EUR J DEV RES, V21, P32, DOI 10.1057/ejdr.2008.7; Lind C, 2011, TAKING RESPONSIBILITY, LAW AND THE CHANGING FAMILY, P1; Lucchi E, 2012, DISASTERS, V36, pS87, DOI 10.1111/j.1467-7717.2012.01283.x; Lucchi E, 2010, DISASTERS, V34, P973, DOI 10.1111/j.1467-7717.2010.01178.x; Lynch Colum, 2010, FOREIGN POLICY; Management Sciences for Health, 2011, PHARM DONATIONS; Manning R, 242012 UNU WIDER; Marriage Z, 2006, DEV CHANGE, V37, P479, DOI 10.1111/j.0012-155X.2006.00487.x; Medecins Sans Frontieres, 2005, ACC SOINS MORT VIOL; Medley M, 2014, AFRICAN ARGUMENTS; Michael M, 2006, HUMANITARIAN OASIS P; Mohamed AH, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-200; Mosse D., 2011, ADVENTURES AIDLAND A; Osterholm MT, 2015, JAMA INTERN MED, V175, P7, DOI 10.1001/jamainternmed.2014.6235; Palmer JJ, 2014, SOC SCI MED, V120, P396, DOI 10.1016/j.socscimed.2014.03.012; Parkinson SE, 2015, SOC SCI MED, V146, P324, DOI 10.1016/j.socscimed.2015.10.008; Philips M, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0039-4; Ramalingam B, 2013, AID EDGE CHAOS RETHI; Riddell R. C., 2007, DOES FOREIGN AID REA; Rieff D, 2002, HUMANITARIANISM CRIS; Roberts L, 2007, PREHOSPITAL DISASTER, V22, P384, DOI 10.1017/S1049023X00005094; Roberts L, 2014, SCIENCE, V343, P1302, DOI 10.1126/science.343.6177.1302; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Salama P, 1999, ONGOING OMISSION ADO; Slim H, 1997, DISASTERS, V21, P244, DOI 10.1111/1467-7717.00059; Slim H., 2014, SYRIA CRISIS COMMON; Smirl L., 2015, SPACES AID CARS COMP; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; Spiegel PB, LANCET; Ssengooba F, 2012, SOC SCI MED, V75, P377, DOI 10.1016/j.socscimed.2012.02.050; Svoboda E., 2015, INT LOCAL DIASPORA A; Svoboda Eva., 2015, ISLAMIC HUMANITARIAN; Tiller S, 2013, MABAN RESPONSE; Tol WA, 2012, EVID-BASED MENT HEAL, V15, P25, DOI 10.1136/ebmental-2012-100644; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; UN High Commissioner for Refugees, 2015, CASH BAS INT HLTH PR; Van Damme W, 2002, HEALTH POLICY PLANN, V17, P49, DOI 10.1093/heapol/17.1.49; van Ommeren M, 2005, B WORLD HEALTH ORGAN, V83, P71; von Schreeb J, 2004, JOINT ASS HLTH STAT; Walker P., 2012, CLIMATE CHANGE DRIVE; Wessells MG, 2009, AM PSYCHOL, V64, P842, DOI 10.1037/0003-066X.64.8.842; Whittall J, 2014, MED SANS FRONTIERS; Wilkinson A, 2015, AFR AFFAIRS, V114, P136, DOI 10.1093/afraf/adu080; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0	104	19	19	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2314	2324		10.1016/S0140-6736(17)31277-1	http://dx.doi.org/10.1016/S0140-6736(17)31277-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28602557				2022-12-28	WOS:000415645700029
J	Perkins, MD; Dye, C; Balasegaram, M; Brechot, C; Mombouli, JV; Rottingen, JA; Tanner, M; Boehme, CC				Perkins, Mark D.; Dye, Christopher; Balasegaram, Manica; Brechot, Christian; Mombouli, Jean-Vivien; Rottingen, John-Arne; Tanner, Marcel; Boehme, Catharina C.			Diagnostic preparedness for infectious disease outbreaks	LANCET			English	Editorial Material							EBOLA-VIRUS DISEASE; EPIDEMIC	Diagnostics are crucial in mitigating the effect of disease outbreaks. Because diagnostic development and validation are time consuming, they should be carried out in anticipation of epidemics rather than in response to them. The diagnostic response to the 2014-15 Ebola epidemic, although ultimately effective, was slow and expensive. If a focused mechanism had existed with the technical and financial resources to drive its development ahead of the outbreak, point-of-care Ebola tests supporting a less costly and more mobile response could have been available early on in the diagnosis process. A new partnering model could drive rapid development of tests and surveillance strategies for novel pathogens that emerge in future outbreaks. We look at lessons learned from the Ebola outbreak and propose specific solutions to improve the speed of new assay development and ensure their effective deployment.	[Perkins, Mark D.; Boehme, Catharina C.] Fdn Innovat New Diagnost FIND, CH-1202 Geneva, Switzerland; [Dye, Christopher] World Hlth Org, Off Director Gen, Geneva, Switzerland; [Balasegaram, Manica] Medecins Sans Frontieres Access Campaign, Geneva, Switzerland; [Brechot, Christian] Pasteur Inst, Paris, France; [Mombouli, Jean-Vivien] Natl Inst Publ Hlth, Brazzaville, Rep Congo; [Rottingen, John-Arne] Univ Oslo, Dept Hlth & Soc, Coalit Epidem Preparedness Innovat CEPI, Oslo, Norway; [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Oslo, Norway; [Rottingen, John-Arne] Harvard TH Chan Sch Publ Hlth, Dept Global Heallth & Populat, Boston, MA USA; [Tanner, Marcel] Swiss TPH, Basel, Switzerland	Foundation For Innovative New Diagnostics; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oslo; Norwegian Institute of Public Health (NIPH); Harvard University; Harvard T.H. Chan School of Public Health; University of Basel; Swiss Tropical & Public Health Institute	Boehme, CC (corresponding author), Fdn Innovat New Diagnost FIND, CH-1202 Geneva, Switzerland.	catharina.boehme@finddx.org	BRECHOT, Christian/S-2011-2018; Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793	GlaxoSmithKline; PATH's Malaria Vaccine Initiative; Optimus Foundation; Novartis Institute of Tropical Diseases; Bill & Melinda Gates Foundation; MVI	GlaxoSmithKline(GlaxoSmithKline); PATH's Malaria Vaccine Initiative; Optimus Foundation; Novartis Institute of Tropical Diseases; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MVI	CB is President of Institut Pasteur, a non-profit research organisation that receives funding from multiple funders including industries, and is involved in infectious diseases surveillance and research on diagnostics and contributes to the identification of mechanisms, molecules, and methods that are useful for diagnosis discovery and development. J-AR is interim CEO, Coalitiation for Epidemic Preparedness Innovations (CEPI). MT declares grants and travel grants from GlaxoSmithKline and PATH's Malaria Vaccine Initiative, individual board fees from Optimus Foundation, institutional board fees from Novartis Institute of Tropical Diseases, pending grants from the Bill & Melinda Gates Foundation and MVI. and travel grants from MVI and Sanaria outside the area of the work discussed in this Viewpoint. All other authors declare no competing interests.	Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109; Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8; Fitchett JRA, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020703; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Global Biodefense, 2014, MRIGLOBAL DEPL MOB L; Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Nyenswah T, 2015, MMWR-MORBID MORTAL W, V64, P500; Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577; Whitty CJM, 2014, NATURE, V515, P192, DOI 10.1038/515192a; WHO, 2015, EB SIT REP; WHO, 2015, HLTH SYST STRENGTH E; WHO, ESS MED PROD; WHO, 2014, WHOHSEGCRLYO20144; WHO, 2015, EB SIT REP ARCH; WHO, 2015, PREP MAP PRIOR COUNT; WHO, WHO R D BLUEPR PUBL; WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992; WHO Ebola Response Team, 2016, NEW ENGL J MED, V371, P1481; WHO (World Health Organization), 2015, WHO PUBL LIST TOP EM; World Health Organization, 2010, TECHN GUID INT DIS S	25	36	36	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2017	390	10108					2111	2114		10.1016/S0140-6736(17)31224-2	http://dx.doi.org/10.1016/S0140-6736(17)31224-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0CL	28577861				2022-12-28	WOS:000415642200025
J	Clarke, R; Youngstein, T				Clarke, Rachel; Youngstein, Taryn			Cyberattack on Britain's National Health Service - A Wake-up Call for Modern Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Clarke, Rachel] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Youngstein, Taryn] Imperial Coll Healthcare NHS Trust, London, England	Oxford University Hospitals NHS Foundation Trust; Imperial College London	Clarke, R (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Oxford, England.							Bienkov A, 2017, BUSINESS INSIDE 0515; Jones S., 2017, FINANCIAL TIMES 0512; Perakslis ED, 2014, NEW ENGL J MED, V371, P395, DOI 10.1056/NEJMp1404358; Rawlinson K, 2017, THE GUARDIAN    0512	4	23	24	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					409	411		10.1056/NEJMp1706754	http://dx.doi.org/10.1056/NEJMp1706754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3NW	28591519				2022-12-28	WOS:000406747100001
J	Bononi, A; Giorgi, C; Patergnani, S; Larson, D; Verbruggen, K; Tanji, M; Pellegrini, L; Signorato, V; Olivetto, F; Pastorino, S; Nasu, M; Napolitano, A; Gaudino, G; Morris, P; Sakamoto, G; Ferris, LK; Danese, A; Raimondi, A; Tacchetti, C; Kuchay, S; Pass, HI; Affar, E; Yang, HN; Pinton, P; Carbone, M				Bononi, Angela; Giorgi, Carlotta; Patergnani, Simone; Larson, David; Verbruggen, Kaitlyn; Tanji, Mika; Pellegrini, Laura; Signorato, Valentina; Olivetto, Federica; Pastorino, Sandra; Nasu, Masaki; Napolitano, Andrea; Gaudino, Giovanni; Morris, Paul; Sakamoto, Greg; Ferris, Laura K.; Danese, Alberto; Raimondi, Andrea; Tacchetti, Carlo; Kuchay, Shafi; Pass, Harvey I.; Affar, El Bachir; Yang, Haining; Pinton, Paolo; Carbone, Michele			BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation	NATURE			English	Article							HUMAN MESOTHELIAL CELLS; STRAND BREAK REPAIR; TUMOR-SUPPRESSOR; MALIGNANT MESOTHELIOMA; ENDOPLASMIC-RETICULUM; GERMLINE MUTATIONS; ASBESTOS; CANCER; PREDISPOSES; APOPTOSIS	BRCA1-associated protein 1 (BAP1) is a potent tumour suppressor gene that modulates environmental carcinogenesis(1-3). All carriers of inherited heterozygous germline BAP1-inactivating mutations (BAP1(+/-)) developed one and often several BAP1(-/-) malignancies in their lifetime(4), mostly malignant mesothelioma, uveal melanoma(2,5), and so on(6-10). Moreover, BAP1-acquired biallelic mutations are frequent in human cancers(8,11-14). BAP1 tumour suppressor activity has been attributed to its nuclear localization, where it helps to maintain genome integrity(15-17). The possible activity of BAP1 in the cytoplasm is unknown. Cells with reduced levels of BAP1 exhibit chromosomal abnormalities and decreased DNA repair by homologous recombination(18), indicating that BAP1 dosage is critical. Cells with extensive DNA damage should die and not grow into malignancies. Here we discover that BAP1 localizes at the endoplasmic reticulum. Here, it binds, deubiquitylates, and stabilizes type 3 inositol-1,4,5-trisphosphate receptor (IP3R3), modulating calcium (Ca2+) release from the endoplasmic reticulum into the cytosol and mitochondria, promoting apoptosis. Reduced levels of BAP1 in BAP1(+/-) carriers cause reduction both of IP3R3 levels and of Ca2+ flux, preventing BAP1(+/-) cells that accumulate DNA damage from executing apoptosis. A higher fraction of cells exposed to either ionizing or ultraviolet radiation, or to asbestos, survive genotoxic stress, resulting in a higher rate of cellular transformation. We propose that the high incidence of cancers in BAP1(+/-) carriers results from the combined reduced nuclear and cytoplasmic activities of BAP1. Our data provide a mechanistic rationale for the powerful ability of BAP1 to regulate gene-environment interaction in human carcinogenesis.	[Bononi, Angela; Larson, David; Verbruggen, Kaitlyn; Tanji, Mika; Pellegrini, Laura; Signorato, Valentina; Olivetto, Federica; Pastorino, Sandra; Nasu, Masaki; Napolitano, Andrea; Gaudino, Giovanni; Morris, Paul; Sakamoto, Greg; Yang, Haining; Carbone, Michele] Univ Hawaii, Canc Ctr, Honolulu, HI 96813 USA; [Giorgi, Carlotta; Patergnani, Simone; Signorato, Valentina; Olivetto, Federica; Danese, Alberto; Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy; [Ferris, Laura K.] Univ Pittsburgh, Med Ctr, Dept Dermatol, Pittsburgh, PA 15213 USA; [Raimondi, Andrea; Tacchetti, Carlo] San Raffaele Sci Inst Milano, Expt Imaging Ctr, I-20132 Milan, Italy; [Tacchetti, Carlo] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Kuchay, Shafi; Pass, Harvey I.] NYU, Canc Ctr, New York, NY 10016 USA; [Affar, El Bachir] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Dept Med, Montreal, PQ H1T 2M4, Canada	Cancer Research Center of Hawaii; University of Hawaii System; University of Ferrara; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Genoa; New York University; Universite de Montreal	Yang, HN; Carbone, M (corresponding author), Univ Hawaii, Canc Ctr, Honolulu, HI 96813 USA.; Pinton, P (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy.	HYang@cc.hawaii.edu; paolo.pinton@unife.it; MCarbone@cc.hawaii.edu	Danese, Alberto/AAK-2943-2021; Napolitano, Andrea/I-3146-2019; Pinton, Paolo/J-8025-2012; Giorgi, Carlotta/K-4649-2016; Patergnani, Simone/AAC-3969-2021; Danese, Alberto/AAC-2666-2019; Raimondi, Andrea/AAN-2475-2020; Pellegrini, Laura/K-7940-2016; Patergnani, Simone/AAK-2929-2021	Danese, Alberto/0000-0002-0833-9987; Napolitano, Andrea/0000-0002-7509-1555; Pinton, Paolo/0000-0001-7108-6508; Pellegrini, Laura/0000-0002-8833-2987; Patergnani, Simone/0000-0001-7951-9267; TACCHETTI, CARLO/0000-0003-4602-000X; Raimondi, Andrea/0000-0002-4563-386X; Pass, Harvey/0000-0003-3222-3471	National Cancer Institute (NCI) [R01 CA198138, R01 CA160715]; DOD [CA120355]; University of Hawai'i Foundation; Honeywell International; Riviera United 4-a Cure; Italian Association for Cancer Research (AIRC) [IG-18624, MFAG13521]; Italian Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA198138, P30CA071789, R01CA160715] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); University of Hawai'i Foundation; Honeywell International; Riviera United 4-a Cure; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the members of the L and W families who donated their cells to our research. We acknowledge K. Dixon for advice on ultraviolet radiation studies, M. Pagano for advice on ubiquitylation assays, H. Yu for advice on DNA repair studies, I. Pagano for review of all statistical analyses, and G. Khan for technical support. This work was supported by grants National Cancer Institute (NCI) R01 CA198138 to M.C.; by NCI R01 CA160715, DOD CA120355 to H.Y.; by the University of Hawai'i Foundation, which received unrestricted donations to support mesothelioma research from Honeywell International, to M.C.; by The Riviera United 4-a Cure to M.C. and H.Y.; and by the Italian Association for Cancer Research (AIRC) (IG-18624, MFAG13521) and the Italian Ministry of Health to P.P. and C.G. P.P. thanks C. degli Scrovegni for support.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Baumann F, 2015, CARCINOGENESIS, V36, P76, DOI 10.1093/carcin/bgu227; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Bhattacharya S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18462; Bocchetta M, 2000, P NATL ACAD SCI USA, V97, P10214, DOI 10.1073/pnas.170207097; Bonora M, 2013, NAT PROTOC, V8, P2105, DOI 10.1038/nprot.2013.127; Carbone M, 2016, J THORAC ONCOL, V11, P1246, DOI 10.1016/j.jtho.2016.04.028; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; de la Fouchardiere A, 2015, CLIN GENET, V88, P273, DOI 10.1111/cge.12472; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Farley MN, 2013, MOL CANCER RES, V11, P1061, DOI 10.1158/1541-7786.MCR-13-0111; Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Ismail IH, 2014, CANCER RES, V74, P4282, DOI 10.1158/0008-5472.CAN-13-3109; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Lee HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6128; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Mikoshiba K, 2007, BIOCHEM SOC SYMP, V74, P9, DOI 10.1042/BSS2007c02; Napolitano A, 2016, ONCOGENE, V35, P1996, DOI 10.1038/onc.2015.243; Nasu M, 2015, J THORAC ONCOL, V10, P565, DOI 10.1097/JTO.0000000000000471; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Qi F, 2013, AM J PATHOL, V183, P1654, DOI 10.1016/j.ajpath.2013.07.029; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Vangipuram M, 2013, JOVE-J VIS EXP, DOI 10.3791/3779; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Yang HN, 2010, P NATL ACAD SCI USA, V107, P12611, DOI 10.1073/pnas.1006542107; Yoshikawa Y, 2016, P NATL ACAD SCI USA, V113, P13432, DOI 10.1073/pnas.1612074113; Yu H, 2014, P NATL ACAD SCI USA, V111, P285, DOI 10.1073/pnas.1309085110; Zarrizi R, 2014, CANCER RES, V74, P6499, DOI 10.1158/0008-5472.CAN-14-0221	41	230	233	6	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					549	+		10.1038/nature22798	http://dx.doi.org/10.1038/nature22798			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28614305	Green Accepted			2022-12-28	WOS:000403814100042
J	Tai, ME; Lukin, A; Rispoli, M; Schittko, R; Menke, T; Borgnia, D; Preiss, PM; Grusdt, F; Kaufman, AM; Greiner, M				Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Schittko, Robert; Menke, Tim; Borgnia, Dan; Preiss, Philipp M.; Grusdt, Fabian; Kaufman, Adam M.; Greiner, Markus			Microscopy of the interacting Harper-Hofstadter model in the two-body limit	NATURE			English	Article							MAGNETIC-FIELDS; OPTICAL LATTICE; EDGE STATES; NEUTRAL ATOMS; QUANTUM; FERMIONS; REGIME; GAS	The interplay between magnetic fields and interacting particles can lead to exotic phases of matter that exhibit topological order and high degrees of spatial entanglement(1). Although these phases were discovered in a solid-state setting(2,3), recent innovations in systems of ultracold neutral atoms-uncharged atoms that do not naturally experience a Lorentz force-allow the synthesis of artificial magnetic, or gauge, fields(4-10). This experimental platform holds promise for exploring exotic physics in fractional quantum Hall systems, owing to the microscopic control and precision that is achievable in cold-atom systems(11,12). However, so far these experiments have mostly explored the regime of weak interactions, which precludes access to correlated many-body states(4,13-17). Here, through microscopic atomic control and detection, we demonstrate the controlled incorporation of strong interactions into a two-body system with a chiral band structure. We observe and explain the way in which interparticle interactions induce chirality in the propagation dynamics of particles in a ladder-like, real-space lattice governed by the interacting Harper-Hofstadter model, which describes lattice-confined, coherently mobile particles in the presence of a magnetic field(18). We use a bottom-up strategy to prepare interacting chiral quantum states, thus circumventing the challenges of a top-down approach that begins with a many-body system, the size of which can hinder the preparation of controlled states. Our experimental platform combines all of the necessary components for investigating highly entangled topological states, and our observations provide a benchmark for future experiments in the fractional quantum Hall regime.	[Tai, M. Eric; Lukin, Alexander; Rispoli, Matthew; Schittko, Robert; Menke, Tim; Borgnia, Dan; Preiss, Philipp M.; Grusdt, Fabian; Kaufman, Adam M.; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Preiss, Philipp M.] Heidelberg Univ, Phys Inst, D-69120 Heidelberg, Germany	Harvard University; Ruprecht Karls University Heidelberg	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu		Grusdt, Fabian/0000-0003-3531-8089	National Science Foundation; Gordon and Betty Moore Foundation's EPiQS Initiative; Air Force Office of Scientific Research MURI programme; Army Research Office MURI programme; NSF Graduate Research Fellowship Program	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation's EPiQS Initiative; Air Force Office of Scientific Research MURI programme; Army Research Office MURI programme; NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	We acknowledge conversations with M. Aidelsburger, I. Cirac, E. Demler, M. Endres, M. Foss-Feig, N. Gemelke, D. Greif, W. Ketterle, R. Ma, H. C. Po, J. Simon and A. Vishwanath. We are supported by grants from the National Science Foundation, the Gordon and Betty Moore Foundation's EPiQS Initiative, an Air Force Office of Scientific Research MURI programme, an Army Research Office MURI programme and the NSF Graduate Research Fellowship Program (M.R.).	Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; An FA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602685; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Celi A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043001; Dhar A, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.041602; Gemelke N., 2010, PREPRINT; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023613; HARPER PG, 1955, P PHYS SOC LOND A, V68, P874, DOI 10.1088/0370-1298/68/10/304; He Y., 2017, PREPRINT; Hugel D, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023619; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kolkowitz S, 2017, NATURE, V542, P66, DOI 10.1038/nature20811; Kolovsky AR, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/20003; Leder M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13112; Lignier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220403; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Preiss PM, 2015, SCIENCE, V347, P1229, DOI 10.1126/science.1260364; Roushan P, 2017, NAT PHYS, V13, P146, DOI [10.1038/NPHYS3930, 10.1038/nphys3930]; Schweikhard V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040404; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515; Zupancic P, 2016, OPT EXPRESS, V24, P13881, DOI 10.1364/OE.24.013881	29	161	161	10	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2017	546	7659					519	523		10.1038/nature22811	http://dx.doi.org/10.1038/nature22811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY2QK	28640260	Green Submitted			2022-12-28	WOS:000403814100036
J	Williamson, OD				Williamson, Owen D.			An online exercise program plus automated coping skills training improved pain and function in chronic knee pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TELEREHABILITATION		[Williamson, Owen D.] Monash Univ, Melbourne, Vic, Australia	Monash University	Williamson, OD (corresponding author), Monash Univ, Melbourne, Vic, Australia.							Cottrell MA, 2017, CLIN REHABIL, V31, P625, DOI 10.1177/0269215516645148; Cranen K, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5951; Richardson BR, 2017, J TELEMED TELECARE, V23, P88, DOI 10.1177/1357633X15627237	3	2	2	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					JC67	JC67		10.7326/ACPJC-2017-166-12-067	http://dx.doi.org/10.7326/ACPJC-2017-166-12-067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28630979				2022-12-28	WOS:000403579000008
J	Kaiser, J				Kaiser, Jocelyn			NIH abandons grant cap, offers new help to younger scientists	SCIENCE			English	News Item																			0	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1108	1108		10.1126/science.356.6343.1108	http://dx.doi.org/10.1126/science.356.6343.1108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619891				2022-12-28	WOS:000403327400006
J	[Anonymous]				[Anonymous]			China selects a lunar target	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1104	1106		10.1126/science.356.6343.1104	http://dx.doi.org/10.1126/science.356.6343.1104			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28619889				2022-12-28	WOS:000403327400004
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: How can we plan for old age if we won't discuss it honestly?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Age UK, 2012, HEALTHC QUAL ACT LAT; Age UK, 2013, OLD PEOPL FEEL BURD; Age UK, 2013, END LIF CAR EV REV; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Mackenzie John M., 2009, MUSEUMS EMPIRE NATUR; Meyrowitz Joshua, 1986, NO SENSE PLACE IMPAC; NHS Confederation, 2016, GROW OLD TOG SHAR NE; University of Birmingham Birmingham Policy Commission, 2014, HLTH AG 21 CENT BEST	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2017	357								j2759	10.1136/bmj.j2759	http://dx.doi.org/10.1136/bmj.j2759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY1UL	28611185	Green Published, Bronze			2022-12-28	WOS:000403752500001
J	Bouchery, T; Harris, NL				Bouchery, Tiffany; Harris, Nicola L. v			Specific repair by discerning macrophages	SCIENCE			English	Editorial Material							MECHANISMS; CELLS		[Bouchery, Tiffany; Harris, Nicola L. v] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Harris, NL (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland.	nicola.harris@epfl.ch	harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210; bouchery, tiffany/0000-0003-3743-7356				Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	8	17	18	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1014	1014		10.1126/science.aan6782	http://dx.doi.org/10.1126/science.aan6782			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28596328				2022-12-28	WOS:000402871700032
J	Butler, D				Butler, Declan			TECHNOLOGY AI summit aims to help world's poorest	NATURE			English	News Item																			0	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					196	197		10.1038/546196a	http://dx.doi.org/10.1038/546196a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28593977	Bronze			2022-12-28	WOS:000402823400007
J	Polaner, DM; Zuk, J; McCann, ME; Davidson, A				Polaner, David M.; Zuk, Jeannie; McCann, Mary Ellen; Davidson, Andrew			Warnings, uncertainty, and clinical practice	LANCET			English	Editorial Material							GENERAL-ANESTHESIA; EXPOSURE; OUTCOMES; AGE; CHILDHOOD; INFANCY		[Polaner, David M.; Zuk, Jeannie] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA; [Polaner, David M.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Zuk, Jeannie] Univ Colorado, Sch Med, Dept Surg, Aurora, CO 80045 USA; Childrens Hosp Colorado, Aurora, CO 80045 USA; [McCann, Mary Ellen] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Davidson, Andrew] Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Anaesthesia & Pain Management, Anaesthesia & Pain Management Res Grp, Melbourne, Vic, Australia; [Davidson, Andrew] Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Davidson, Andrew] Univ Melbourne, Melbourne, Vic, Australia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Harvard University; Boston Children's Hospital; Harvard Medical School; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Polaner, DM (corresponding author), Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA.; Polaner, DM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	david.polaner@ucdenver.edu	Polaner, David M/AAX-2514-2021	Polaner, David M/0000-0001-8716-6289				Andropoulos DB, 2017, NEW ENGL J MED, V376, P905, DOI 10.1056/NEJMp1700196; Bester Johan, 2016, AMA J Ethics, V18, P869, DOI 10.1001/journalofethics.2016.18.9.peer2-1609; Bong CL, 2013, ANESTH ANALG, V117, P1419, DOI 10.1213/ANE.0b013e318299a7c2; Coleman K, 2017, ANESTHESIOLOGY, V126, P74, DOI 10.1097/ALN.0000000000001383; Corn BW, 2012, LANCET ONCOL, V13, P123, DOI 10.1016/S1470-2045(11)70372-2; Davidson A, 2017, PEDIATR ANESTH, V27, P336, DOI 10.1111/pan.13122; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; DiMaggio C, 2012, J NEUROSURG ANESTH, V24, P376, DOI 10.1097/ANA.0b013e31826a038d; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Ing CH, 2014, J NEUROSURG ANESTH, V26, P377, DOI 10.1097/ANA.0000000000000121; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; U. S. Food and Drug Administration, 2017, FDA DRUG SAF COMM FD; United States Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Wells RE, 2012, AM J BIOETHICS, V12, P22, DOI 10.1080/15265161.2011.652798	16	6	6	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2174	2176		10.1016/S0140-6736(17)31506-4	http://dx.doi.org/10.1016/S0140-6736(17)31506-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589884				2022-12-28	WOS:000402540800010
J	Reinl, J				Reinl, James			Trump administration and the opioid epidemic in the USA	LANCET			English	Editorial Material																			0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2181	2181		10.1016/S0140-6736(17)31543-X	http://dx.doi.org/10.1016/S0140-6736(17)31543-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28589887				2022-12-28	WOS:000402540800015
J	Purnell, BA; Hines, PJ				Purnell, Beverly A.; Hines, Pamela J.			REPAIR AND REGENERATION	SCIENCE			English	Editorial Material																			0	8	9	4	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1020	1021		10.1126/science.356.6342.1020	http://dx.doi.org/10.1126/science.356.6342.1020			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28104876				2022-12-28	WOS:000402871700039
